Citrus Sinensis ID: 017994
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 362 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.801 | 0.743 | 0.647 | 1e-111 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.718 | 0.283 | 0.408 | 2e-56 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.712 | 0.200 | 0.411 | 2e-53 | |
| Q54I36 | 1338 | Dual specificity protein | no | no | 0.723 | 0.195 | 0.378 | 7e-50 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.817 | 0.461 | 0.363 | 2e-49 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.732 | 0.163 | 0.370 | 3e-49 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.720 | 0.157 | 0.360 | 3e-48 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.701 | 0.368 | 0.389 | 1e-47 | |
| P18161 | 1155 | Dual specificity protein | no | no | 0.812 | 0.254 | 0.373 | 1e-46 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.701 | 0.190 | 0.363 | 1e-46 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 400 bits (1028), Expect = e-111, Method: Compositional matrix adjust.
Identities = 191/295 (64%), Positives = 231/295 (78%), Gaps = 5/295 (1%)
Query: 30 SWSKYLVSSGAEI----KGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKL 85
SWS L S E KGE EEW+AD+SQLFIG KFASG HSRIYRGIYKQR VA+K+
Sbjct: 56 SWSMILESENVETWEASKGE-REEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKM 114
Query: 86 VSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRK 145
V P + LE+QF SEVALL RL HP+I+ F+AACKKPPV+CIITEY++ G+LR
Sbjct: 115 VRIPTHKEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRM 174
Query: 146 YLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205
YL+++EPYS+ + VL+LALDI+RGM+YLHSQG++HRDLKS NLLL ++M VKVADFG S
Sbjct: 175 YLNKKEPYSLSIETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTS 234
Query: 206 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA 265
CLE+QC AKG GTYRWMAPEMIKEK +T+KVDVYSFGIVLWEL TAL PF MTP QA
Sbjct: 235 CLETQCREAKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQA 294
Query: 266 AFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 320
AFAV +KN RPP+P +C A ++LI RCWS +P +RP F IV++LE Y E +++
Sbjct: 295 AFAVAEKNERPPLPASCQPALAHLIKRCWSENPSKRPDFSNIVAVLEKYDECVKE 349
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 219 bits (559), Expect = 2e-56, Method: Compositional matrix adjust.
Identities = 111/272 (40%), Positives = 168/272 (61%), Gaps = 12/272 (4%)
Query: 47 EEEWSADM----SQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQ 102
++++ +D+ S+L I K G +Y+G+++ VAIK + E+ + + + ++
Sbjct: 648 QQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINED---VNNQVLEE 704
Query: 103 FTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVL- 161
F E+ +L RL HP+I+ +AAC PP C ITEYL GGSL LH ++ + +N+ L
Sbjct: 705 FRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKK---IKMNMQLY 761
Query: 162 -KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT 220
KLA+ IA+GM YLH G++HRD+KS NLLL E M VK+ DFG+S L+S+ G+
Sbjct: 762 KKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGS 821
Query: 221 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP 280
WM+PE++ + +T+KVDVY+FGI+LWEL T P+ + Q A AV K+ RPP+P
Sbjct: 822 PIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPN 881
Query: 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
P S+LI CW P +RP F +I+++L
Sbjct: 882 AWPYQLSHLIQACWHQDPLKRPSFTEILNLLN 913
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 210 bits (534), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 110/267 (41%), Positives = 164/267 (61%), Gaps = 9/267 (3%)
Query: 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
EW +S++ IG + G + +++RG ++ +VA+K++ + L S L K EV
Sbjct: 843 EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRK----EVD 898
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
LL +L HP+I+ F+ AC +P CI+TEYL+ GSL L E + L L+L D A
Sbjct: 899 LLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANIL-LDESIEMDWGLRLQLGFDCA 957
Query: 169 RGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP 226
RGM YLHS+ I+HRDLK++NLL+ + VKVADFG++ ++S AK GT W+AP
Sbjct: 958 RGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHT-FAKTMCGTTGWVAP 1016
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286
E++ E+ +T+K DVYS+ IVLWELLT L P+ Q ++ + R P+P CP +
Sbjct: 1017 EVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSI-DRGERLPMPAWCPPKY 1075
Query: 287 SYLISRCWSSSPDRRPHFDQIVSILEG 313
+ L++RCW + P RP F +I+ I+EG
Sbjct: 1076 AALMNRCWETDPTHRPSFPEILPIMEG 1102
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54I36|PYK3_DICDI Dual specificity protein kinase pyk3 OS=Dictyostelium discoideum GN=pyk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (502), Expect = 7e-50, Method: Composition-based stats.
Identities = 103/272 (37%), Positives = 165/272 (60%), Gaps = 10/272 (3%)
Query: 62 KFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF 121
K +G + ++ GI+ VAIK++ ++ S+++ +++F EV+ L + +HP+++TF
Sbjct: 1062 KVGAGSFANVFLGIWNGYKVAIKIL----KNESISN--DEKFIKEVSSLIKSHHPNVVTF 1115
Query: 122 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILH 181
+ AC PP CI TEYL GGSL LH Q+ PL ++ K+ D++ GM++LHS +LH
Sbjct: 1116 MGACIDPP--CIFTEYLQGGSLYDVLHIQKIKLNPL-MMYKMIHDLSLGMEHLHSIQMLH 1172
Query: 182 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVY 241
RDL S+N+LL E +K+ADFG++ S + G T RW +PE+ K + +KVDVY
Sbjct: 1173 RDLTSKNILLDEFKNIKIADFGLATTLSDDMTLSGITNP-RWRSPELTKGLVYNEKVDVY 1231
Query: 242 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 301
SFG+V++E+ T PF+ + +A +N RP +PP CP + LI++CW+S P +R
Sbjct: 1232 SFGLVVYEIYTGKIPFEGLDGTASAAKAAFENYRPAIPPDCPVSLRKLITKCWASDPSQR 1291
Query: 302 PHFDQIVSILEGYSESLEQDPEFFSSFIPSPD 333
P F +I++ LE + F + I +PD
Sbjct: 1292 PSFTEILTELETMKSKFIKQLSFLNDLIQNPD 1323
|
Involved in the development. Negatively regulates tyrosine phosphorylation and activation state of dstC/STATc, probably by activating a dstC/STATc phosphatase. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (498), Expect = 2e-49, Method: Compositional matrix adjust.
Identities = 112/308 (36%), Positives = 174/308 (56%), Gaps = 12/308 (3%)
Query: 19 MLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ 78
L +R R+ + K + +IK +G++ D+ Q+ IG + G + +Y G ++
Sbjct: 340 FLLIRNRYRSSGYYKPDKNDYTQIK-DGKD---IDIHQIKIGVRIGKGNYGEVYLGTWRG 395
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYL 138
VA+K + + ++ K+F E+ L+ L HP++I F+ +C PP CI TEY+
Sbjct: 396 SQVAVKKLPAHNINENIL----KEFHREINLMKNLRHPNVIQFLGSCLIPPDICICTEYM 451
Query: 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMC 196
GSL LH Q + +L++K+ +D A+G+ YLH+ ILHRDLKS NLL+ E+
Sbjct: 452 PRGSLYSILHDQA-LQLQWSLLIKMMIDAAKGVIYLHNSTPVILHRDLKSHNLLVDENWK 510
Query: 197 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP 256
VKVADFG+S +E Q G+ GT W +PE+++ +R+T+K DVYSFGI+LWE T P
Sbjct: 511 VKVADFGLSTIEQQ-GATMTACGTPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDP 569
Query: 257 FDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316
+ + P Q FAV ++ RPPVP P + L+ C + +P RP +Q + LE
Sbjct: 570 YFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLLIDCLNENPSHRPTMEQCLERLESIDS 629
Query: 317 SLEQDPEF 324
S D ++
Sbjct: 630 SGYSDLQY 637
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 196 bits (497), Expect = 3e-49, Method: Compositional matrix adjust.
Identities = 103/278 (37%), Positives = 156/278 (56%), Gaps = 13/278 (4%)
Query: 43 KGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQ 102
+ +W D S+L IG +G + +Y+ I+K +VA+KL+S ++ +E+
Sbjct: 772 RNTTNNDWEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLISSKH----VSKDMERS 827
Query: 103 FTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLK 162
F EV ++ L HP+++ F+AA K P CI+ E+++ GSL L + +P L +K
Sbjct: 828 FFEEVKIMTSLRHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGNELIPEIPYALKIK 887
Query: 163 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK---GFTG 219
+A ++GM +LHS GI+HRDLKS NLLL VKV+DFG++ ++S+ K G
Sbjct: 888 MAYQASKGMHFLHSSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIG 947
Query: 220 TYRWMAPEMIKEKRHTKKV--DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 277
T W+APE++ + + DVYSFGI+LWELLT P+ MTP A +V + RPP
Sbjct: 948 TIHWIAPEILNDSTEVDYILADVYSFGIILWELLTREQPYKGMTPAAIAVSVIRDGMRPP 1007
Query: 278 VPPTCPKAFSY----LISRCWSSSPDRRPHFDQIVSIL 311
+ A S LI +CW S RP F +I++ L
Sbjct: 1008 ISDEAVTAHSIEYIDLIKQCWHSDTIIRPTFLEIMTRL 1045
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 192 bits (488), Expect = 3e-48, Method: Compositional matrix adjust.
Identities = 98/272 (36%), Positives = 156/272 (57%), Gaps = 11/272 (4%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEV 107
++W D +L +G + +G +++G ++ +VA+K++S D ++ +E+ F EV
Sbjct: 777 DDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMIS---PDKTITKDIERNFKDEV 833
Query: 108 ALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDI 167
++ L HP+++ F+AA KPP CI+ E++A GSL L + +P L +K+A
Sbjct: 834 RVMTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLLKNELIPDIPFALKVKIAYQA 893
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA--KGFTGTYRWMA 225
++GM +LHS GI HRDLKS NLLL VKV+DFG++ +S S + F GT +W A
Sbjct: 894 SKGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKFAGTIQWTA 953
Query: 226 PEMIKEKRHTKKV--DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT-- 281
PE++ E R + DVYSFGI++WEL+T P+ M+P A +V + N RP +
Sbjct: 954 PEILSEDREVDYILSDVYSFGIIMWELITRDQPYFGMSPAAIAVSVIRDNYRPVISDQLR 1013
Query: 282 --CPKAFSYLISRCWSSSPDRRPHFDQIVSIL 311
+ L++ CW P RP F +I++ L
Sbjct: 1014 SEVAPEYIELLTSCWHFDPTIRPTFLEIMTRL 1045
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (484), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 102/262 (38%), Positives = 151/262 (57%), Gaps = 8/262 (3%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR 112
D Q+ IG + G +Y G ++ VA+K + + ++ K+F E+ L+
Sbjct: 387 DTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENIL----KEFHREINLMKN 442
Query: 113 LNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQ 172
L HP++I F+ +C P CI TEY+ GSL LH E + +LV ++ +D A+G+
Sbjct: 443 LRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHN-EKIKISWSLVKRMMIDAAKGII 501
Query: 173 YLHSQG--ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK 230
YLH ILHRDLKS NLL+ E+ VKVADFG+S +E Q G+ GT W +PE+++
Sbjct: 502 YLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQ-GATMTACGTPCWTSPEVLR 560
Query: 231 EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290
+R+T+K DVYSFGI+LWE T P+ + P Q FAV ++ RPP P P + L+
Sbjct: 561 SQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLL 620
Query: 291 SRCWSSSPDRRPHFDQIVSILE 312
C + +P +RP +Q + ILE
Sbjct: 621 KDCLNENPSQRPTMEQCLEILE 642
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 187 bits (475), Expect = 1e-46, Method: Composition-based stats.
Identities = 119/319 (37%), Positives = 174/319 (54%), Gaps = 25/319 (7%)
Query: 11 SINAKPERMLSLREYRRAVSWSKYLVSSGAEIKG-EGEEEWSADMSQLFIGCKFASGRHS 69
S+ P SL + +RA+ K + E+K GE E+ D++ + K G S
Sbjct: 806 SLIMSPINKESLNDIQRAIESEKIKKTKFEELKSILGEREYIIDINDIQFIQKVGEGAFS 865
Query: 70 RIYRGIYKQRDVAIK---LVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126
++ G +K VAIK ++ E+ +++F EV L + NH +I+ F+ AC
Sbjct: 866 EVWEGWWKGIHVAIKKLKIIGDEEQ-------FKERFIREVQNLKKGNHQNIVMFIGACY 918
Query: 127 KPPVFCIITEYLAGGSLRKYLHQ------QEPYSVPLNLVLKLALDIARGMQYLHSQGIL 180
KP CIITEY+AGGSL LH + YS PL VLK+A D+A G+ +LHS I+
Sbjct: 919 KPA--CIITEYMAGGSLYNILHNPNSSTPKVKYSFPL--VLKMATDMALGLLHLHSITIV 974
Query: 181 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RWMAPEMIKEKRH-TK 236
HRDL S+N+LL E +K++DFG+S +S+ GS G RW PE+ K H ++
Sbjct: 975 HRDLTSQNILLDELGNIKISDFGLSREKSREGSMTMTNGGICNPRWRPPELTKNLGHYSE 1034
Query: 237 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296
KVDVY F +V+WE+LT PF ++ QA+ V RPP+P C L+++CW +
Sbjct: 1035 KVDVYCFSLVVWEILTGEIPFSDLDGSQASAQVAYAGLRPPIPEYCDPELKLLLTQCWEA 1094
Query: 297 SPDRRPHFDQIVSILEGYS 315
P+ RP F IV+ L+ S
Sbjct: 1095 DPNDRPPFTYIVNKLKEIS 1113
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 187 bits (474), Expect = 1e-46, Method: Composition-based stats.
Identities = 96/264 (36%), Positives = 153/264 (57%), Gaps = 10/264 (3%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR 112
+ S + I + G S++ +G +K +DVA+K ++ +D + M++ +F +EV LL
Sbjct: 1069 NYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLNS-NKDKAREEMIQ-EFKAEVELLGS 1126
Query: 113 LNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLH-----QQEPYSVPLNLVLKLALDI 167
L HP+++T P CI+ E+L G+L + +H QQ+ + L+L +A DI
Sbjct: 1127 LQHPNLVTCYGYSLNP--MCIVMEFLPSGNLFELIHSKPSEQQQSIKLDSTLILAIAFDI 1184
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE 227
ARGMQ+LH++ I+HRDLKS NLL+ + +K+AD GI+ E+ GT W APE
Sbjct: 1185 ARGMQHLHTRNIIHRDLKSSNLLMDKHFNIKIADLGIA-RETSFTQTMTTIGTVAWTAPE 1243
Query: 228 MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287
+++ + + +K DVYS+ IVL+ELLT P+ + P A V K RP +P C +
Sbjct: 1244 ILRHESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGLRPELPDNCDPNWK 1303
Query: 288 YLISRCWSSSPDRRPHFDQIVSIL 311
L+ CWS P++RP F++I + L
Sbjct: 1304 KLVVWCWSEDPNKRPSFEEITNYL 1327
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 362 | ||||||
| 147839113 | 741 | hypothetical protein VITISV_012751 [Viti | 0.950 | 0.464 | 0.850 | 1e-174 | |
| 449469533 | 361 | PREDICTED: serine/threonine-protein kina | 0.983 | 0.986 | 0.815 | 1e-173 | |
| 255540687 | 354 | protein with unknown function [Ricinus c | 0.977 | 1.0 | 0.858 | 1e-173 | |
| 356565010 | 352 | PREDICTED: serine/threonine-protein kina | 0.947 | 0.974 | 0.827 | 1e-169 | |
| 357461999 | 387 | Fibroblast growth factor receptor [Medic | 0.983 | 0.919 | 0.808 | 1e-168 | |
| 356513323 | 352 | PREDICTED: serine/threonine-protein kina | 0.947 | 0.974 | 0.827 | 1e-167 | |
| 356508663 | 357 | PREDICTED: serine/threonine-protein kina | 0.958 | 0.971 | 0.814 | 1e-165 | |
| 356516676 | 357 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.977 | 0.991 | 0.801 | 1e-164 | |
| 357477361 | 391 | Fibroblast growth factor receptor [Medic | 0.972 | 0.900 | 0.775 | 1e-162 | |
| 359491247 | 379 | PREDICTED: serine/threonine-protein kina | 0.883 | 0.844 | 0.863 | 1e-162 |
| >gi|147839113|emb|CAN68094.1| hypothetical protein VITISV_012751 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1591), Expect = e-174, Method: Compositional matrix adjust.
Identities = 295/347 (85%), Positives = 313/347 (90%), Gaps = 3/347 (0%)
Query: 2 KNFHWFKQISINA---KPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLF 58
+NF WFK+IS N K E LSL EYRRAVSWSKYLVSSGAEIK EGE +WSADMSQLF
Sbjct: 385 RNFQWFKKISNNGIIGKSEGRLSLGEYRRAVSWSKYLVSSGAEIKEEGEGDWSADMSQLF 444
Query: 59 IGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118
IGCKFASGRHSRIYRGIYKQRDVAIKL+SQPEED SLA++LEKQFTSEVALLFRL HP+I
Sbjct: 445 IGCKFASGRHSRIYRGIYKQRDVAIKLISQPEEDESLANLLEKQFTSEVALLFRLRHPNI 504
Query: 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 178
ITFVAACKKPPVFCIITEYLAGGSLRK+LHQQEP SVP +LVLK +LDIA GMQYLHSQG
Sbjct: 505 ITFVAACKKPPVFCIITEYLAGGSLRKFLHQQEPXSVPYDLVLKFSLDIACGMQYLHSQG 564
Query: 179 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 238
ILHRDLKSENLLLGEDMCVKVADFGISCLE+QCGSAKGFTGTYRWMAPEMIKEK HTKKV
Sbjct: 565 ILHRDLKSENLLLGEDMCVKVADFGISCLETQCGSAKGFTGTYRWMAPEMIKEKHHTKKV 624
Query: 239 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 298
DVYSFGIVLWELLTAL PFDNMTPEQ AFAV QKNARPP+ P CP AF +LISRCWSSS
Sbjct: 625 DVYSFGIVLWELLTALIPFDNMTPEQXAFAVSQKNARPPLDPACPMAFRHLISRCWSSSA 684
Query: 299 DRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTCIA 345
D+RPHFD+IVSILE YSES +QDP+FFSS+ PS DH LRCLP CIA
Sbjct: 685 DKRPHFDEIVSILESYSESFKQDPDFFSSYKPSDDHAFLRCLPKCIA 731
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449469533|ref|XP_004152474.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] gi|449487764|ref|XP_004157789.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1581), Expect = e-173, Method: Compositional matrix adjust.
Identities = 291/357 (81%), Positives = 316/357 (88%), Gaps = 1/357 (0%)
Query: 1 MKNFHWFKQISINAKPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIG 60
M+N +WFK ISIN KP R LSL EY+RAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIG
Sbjct: 1 MRNLNWFKPISINGKPGRRLSLGEYQRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIG 60
Query: 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
KFA+GRHSRIYRG+YKQRDVAIKL+SQPEED +LA+ LE QF SEVALLFRL HP+IIT
Sbjct: 61 FKFATGRHSRIYRGVYKQRDVAIKLISQPEEDENLANFLENQFISEVALLFRLRHPNIIT 120
Query: 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 180
F+AACKKPPVFCIITEY+ GGSLRKYLHQQEP+SVPLNLVLKLALDI+RGMQYLHSQGIL
Sbjct: 121 FIAACKKPPVFCIITEYMTGGSLRKYLHQQEPHSVPLNLVLKLALDISRGMQYLHSQGIL 180
Query: 181 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 240
HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK HTKKVDV
Sbjct: 181 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKHHTKKVDV 240
Query: 241 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 300
YSFGIVLWELLTALTPFDN+TPEQAAFAVCQKNARPP+P CP+AF +LI RCWS PD+
Sbjct: 241 YSFGIVLWELLTALTPFDNLTPEQAAFAVCQKNARPPLPSACPQAFRHLIKRCWSKKPDK 300
Query: 301 RPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTIL-RCLPTCIARHCCAHSKAKE 356
RPHFD+IVSILE Y ES +DPEFF ++PS I +CLP CI + A K +
Sbjct: 301 RPHFDEIVSILETYVESYNEDPEFFCHYVPSSSRYIAWKCLPKCITKQSSASLKPRN 357
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255540687|ref|XP_002511408.1| protein with unknown function [Ricinus communis] gi|223550523|gb|EEF52010.1| protein with unknown function [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1579), Expect = e-173, Method: Compositional matrix adjust.
Identities = 304/354 (85%), Positives = 327/354 (92%)
Query: 1 MKNFHWFKQISINAKPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIG 60
MKN +WFKQIS N + R LSL EY+RAVSWSKYLVSSGAEIKGEGE EWSADMSQLFIG
Sbjct: 1 MKNLYWFKQISNNGRSGRRLSLGEYKRAVSWSKYLVSSGAEIKGEGEIEWSADMSQLFIG 60
Query: 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
KFASGRHSRIYRGIYKQRDVAIK+VSQPEED LA+MLEKQFTSEVALLFRL+HP+IIT
Sbjct: 61 NKFASGRHSRIYRGIYKQRDVAIKIVSQPEEDEDLAAMLEKQFTSEVALLFRLSHPNIIT 120
Query: 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 180
FVAACKK PV+CIITEYLAGGSLRKYLHQQEP+SVPLNLVLKLA+DIARGMQYLHSQGIL
Sbjct: 121 FVAACKKTPVYCIITEYLAGGSLRKYLHQQEPHSVPLNLVLKLAIDIARGMQYLHSQGIL 180
Query: 181 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 240
HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK HTKKVDV
Sbjct: 181 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKHHTKKVDV 240
Query: 241 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 300
YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP+PP CP AFS+LI+RCWSS+PD+
Sbjct: 241 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPLPPACPPAFSHLINRCWSSNPDK 300
Query: 301 RPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTCIARHCCAHSKA 354
RPHFD+IV+ILE Y+ESLEQDPEFFS++ P H+ILRC P C A +C + KA
Sbjct: 301 RPHFDEIVAILEIYTESLEQDPEFFSNYKPHSGHSILRCFPICRAGNCYSSVKA 354
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565010|ref|XP_003550738.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 598 bits (1543), Expect = e-169, Method: Compositional matrix adjust.
Identities = 284/343 (82%), Positives = 311/343 (90%)
Query: 1 MKNFHWFKQISINAKPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIG 60
MKN +WFK+IS N + R LSL EY+RAVSWSKYL+SSGA IKGEGEEEWSAD+SQLFIG
Sbjct: 1 MKNLYWFKEISNNVRSGRRLSLGEYKRAVSWSKYLISSGAAIKGEGEEEWSADLSQLFIG 60
Query: 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
KFASGRHSRIYRGIYK DVAIKLVSQPEED LA +LEKQFTSEVALLFRL HP+IIT
Sbjct: 61 SKFASGRHSRIYRGIYKHMDVAIKLVSQPEEDEELAVLLEKQFTSEVALLFRLRHPNIIT 120
Query: 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 180
FVAACKKPPVFCIITEYL+GGSLRKYL Q+ P+SVPL +VLKLALDIARGMQYLHSQGIL
Sbjct: 121 FVAACKKPPVFCIITEYLSGGSLRKYLVQEGPHSVPLRVVLKLALDIARGMQYLHSQGIL 180
Query: 181 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 240
HRDLKSENLLLGED+CVKVADFGISCLESQ GSAKGFTGTYRWMAPEMIKEKRHTKKVDV
Sbjct: 181 HRDLKSENLLLGEDLCVKVADFGISCLESQTGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 240
Query: 241 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 300
YSF IVLWELLT LTPFDNMTPEQAA+AV KN RPP+P CPKAFS+LI+RCWSS+PD+
Sbjct: 241 YSFAIVLWELLTGLTPFDNMTPEQAAYAVTHKNERPPLPCDCPKAFSHLINRCWSSNPDK 300
Query: 301 RPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTC 343
RPHFD+IV+ILE Y+E+LEQDPEFFS++ P P++ ILRCL C
Sbjct: 301 RPHFDEIVAILESYTEALEQDPEFFSTYKPCPNNIILRCLSKC 343
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357461999|ref|XP_003601281.1| Fibroblast growth factor receptor [Medicago truncatula] gi|355490329|gb|AES71532.1| Fibroblast growth factor receptor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 597 bits (1539), Expect = e-168, Method: Compositional matrix adjust.
Identities = 288/356 (80%), Positives = 314/356 (88%)
Query: 1 MKNFHWFKQISINAKPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIG 60
MKN +W+KQIS + K R LSL EY+RAVSWSKYLVS GA IKGEGEEEWSADMSQL IG
Sbjct: 32 MKNLNWYKQISNSGKSGRRLSLGEYKRAVSWSKYLVSPGAAIKGEGEEEWSADMSQLLIG 91
Query: 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
KFASGRHSRIYRG+YKQ+DVAIKLVSQPEED LAS LEKQFTSEVALL RL HP+I+T
Sbjct: 92 SKFASGRHSRIYRGVYKQKDVAIKLVSQPEEDEDLASFLEKQFTSEVALLLRLRHPNILT 151
Query: 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 180
F+AACKKPPVFCIITEYLAGGSLRKYLHQQEP+SVP LVLKLALDIARGM+YLHSQGIL
Sbjct: 152 FIAACKKPPVFCIITEYLAGGSLRKYLHQQEPHSVPHELVLKLALDIARGMKYLHSQGIL 211
Query: 181 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 240
HRDLKSENLLL EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI+EK HTKKVDV
Sbjct: 212 HRDLKSENLLLDEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIREKHHTKKVDV 271
Query: 241 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 300
YSFGIVLWELLTAL PFDNMTPEQAAFAV KNARPP+P CP AFS LI+RCWSS+P++
Sbjct: 272 YSFGIVLWELLTALIPFDNMTPEQAAFAVSYKNARPPLPSECPWAFSNLINRCWSSNPNK 331
Query: 301 RPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTCIARHCCAHSKAKE 356
RPHF +IVSILE ++ESLE DP+FF+++ P P +TIL CLP C AR KAK+
Sbjct: 332 RPHFVEIVSILECFTESLELDPDFFTTYKPRPINTILGCLPKCKARQKSDTCKAKQ 387
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356513323|ref|XP_003525363.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1533), Expect = e-167, Method: Compositional matrix adjust.
Identities = 284/343 (82%), Positives = 308/343 (89%)
Query: 1 MKNFHWFKQISINAKPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIG 60
MKN +WFK+IS N + R LSL EY+RAVSWSKYLVSSGA IKGEGEEEWSAD+SQLFIG
Sbjct: 1 MKNLYWFKEISNNVRSGRRLSLGEYKRAVSWSKYLVSSGAAIKGEGEEEWSADLSQLFIG 60
Query: 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
KFASGRHSRIYRGIYK DVAIKLVSQPEED LA +LEKQFTSEVALLFRL HP+IIT
Sbjct: 61 SKFASGRHSRIYRGIYKHMDVAIKLVSQPEEDEDLAVLLEKQFTSEVALLFRLRHPNIIT 120
Query: 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 180
FVAACKKPPVFCIITEYLAGGSLRKYL QQ P+SV +VLKLALDIARGMQYLHSQGIL
Sbjct: 121 FVAACKKPPVFCIITEYLAGGSLRKYLVQQGPHSVTHKVVLKLALDIARGMQYLHSQGIL 180
Query: 181 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 240
HRDLKSENLLLGED+CVKVADFGISCLESQ GSAKGFTGTYRWMAPEMIKEKRHTKKVDV
Sbjct: 181 HRDLKSENLLLGEDLCVKVADFGISCLESQTGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 240
Query: 241 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 300
YSF IVLWELLT LTPFDNMTPEQAA+AV KN RPP+P CPKAFS+LI+RCWSS+PD+
Sbjct: 241 YSFAIVLWELLTGLTPFDNMTPEQAAYAVTHKNERPPLPCDCPKAFSHLINRCWSSNPDK 300
Query: 301 RPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTC 343
RPHF++IV+ILE Y E+LEQDPEFFS++ P P++ ILRCL C
Sbjct: 301 RPHFNEIVTILESYIEALEQDPEFFSTYKPRPNNIILRCLSKC 343
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508663|ref|XP_003523074.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1511), Expect = e-165, Method: Compositional matrix adjust.
Identities = 285/350 (81%), Positives = 308/350 (88%), Gaps = 3/350 (0%)
Query: 1 MKNFHWFKQISINA-KPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFI 59
MKN W KQIS + K R LSL EY RAVSWSKYLVS GAEIKGEGEEEWSADMSQL I
Sbjct: 1 MKNLKWHKQISNSGNKLGRRLSLGEYNRAVSWSKYLVSPGAEIKGEGEEEWSADMSQLLI 60
Query: 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
G KFASGRHSRIYRG+YKQ+DVAIKL+SQPEED LA+ LEKQF SEV+LL RL HP+II
Sbjct: 61 GSKFASGRHSRIYRGVYKQKDVAIKLISQPEEDEDLAAFLEKQFASEVSLLLRLGHPNII 120
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 179
TF+AACKKPPVFCIITEYLAGGSL K+LH Q+P +PL LVLKLALDIARGM+YLHSQGI
Sbjct: 121 TFIAACKKPPVFCIITEYLAGGSLGKFLHHQQPNILPLKLVLKLALDIARGMKYLHSQGI 180
Query: 180 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVD 239
LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK HTKKVD
Sbjct: 181 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKHHTKKVD 240
Query: 240 VYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 299
VYSFGIVLWELLT TPFDNMTPEQAA+AV KNARPP+P CP AFS LI+RCWSS+PD
Sbjct: 241 VYSFGIVLWELLTGKTPFDNMTPEQAAYAVSHKNARPPLPSKCPWAFSDLINRCWSSNPD 300
Query: 300 RRPHFDQIVSILEGYSESLEQDPEFFSSFIPSP--DHTILRCLPTCIARH 347
+RPHFD+IVSILE Y+ESL+QDPEFFS++ PSP +TIL CLP C ARH
Sbjct: 301 KRPHFDEIVSILEYYTESLQQDPEFFSTYKPSPTSSNTILGCLPKCNARH 350
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516676|ref|XP_003527019.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1506), Expect = e-164, Method: Compositional matrix adjust.
Identities = 286/357 (80%), Positives = 309/357 (86%), Gaps = 3/357 (0%)
Query: 1 MKNFHWFKQISINA-KPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFI 59
MKN W KQIS + K R LSL EY RAVSWSKYLVS GAEIKGEGEEEWSADMSQL I
Sbjct: 1 MKNLKWHKQISNSGNKLGRRLSLGEYNRAVSWSKYLVSPGAEIKGEGEEEWSADMSQLLI 60
Query: 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
G KFASGRHSRIYRG+YKQ+DVAIKL+SQPEED LA+ LEKQFTSEV+LL RL HP+II
Sbjct: 61 GSKFASGRHSRIYRGVYKQKDVAIKLISQPEEDEDLAAFLEKQFTSEVSLLLRLGHPNII 120
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 179
TF+AACKKPPVFCIITEYLAGGSL K+LH Q+P +PL LVLKLALDIARGM+YLHSQGI
Sbjct: 121 TFIAACKKPPVFCIITEYLAGGSLGKFLHHQQPNILPLKLVLKLALDIARGMKYLHSQGI 180
Query: 180 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVD 239
LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG TGTYRWMAPEMIKEK HTKKVD
Sbjct: 181 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGXTGTYRWMAPEMIKEKHHTKKVD 240
Query: 240 VYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 299
VYSFGIVLWELLT TPFDNMTPEQAA+AV KNARPP+P CP AFS LI+RCWSS+PD
Sbjct: 241 VYSFGIVLWELLTGKTPFDNMTPEQAAYAVSHKNARPPLPSECPWAFSDLINRCWSSNPD 300
Query: 300 RRPHFDQIVSILEGYSESLEQDPEFFSSFIPSP--DHTILRCLPTCIARHCCAHSKA 354
+RPHFD+IVSILE Y+ESL+QDPEFFS++ PSP +TIL C P C ARH KA
Sbjct: 301 KRPHFDEIVSILEYYTESLQQDPEFFSTYKPSPSSSNTILGCFPKCNARHKFGACKA 357
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357477361|ref|XP_003608966.1| Fibroblast growth factor receptor [Medicago truncatula] gi|355510021|gb|AES91163.1| Fibroblast growth factor receptor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1491), Expect = e-162, Method: Compositional matrix adjust.
Identities = 273/352 (77%), Positives = 306/352 (86%)
Query: 2 KNFHWFKQISINAKPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIGC 61
KN HW K+IS N + R LSL EY+RAVSWSKYL SSGA IKG +++W+ADMSQLFIG
Sbjct: 3 KNLHWLKEISNNVRSGRRLSLGEYKRAVSWSKYLTSSGAAIKGNEQDDWNADMSQLFIGA 62
Query: 62 KFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF 121
KF SGRHSRIYRGIYK DVAIKLVSQPEED LA++LEK FTSEVALLFRL HP+II+F
Sbjct: 63 KFDSGRHSRIYRGIYKNMDVAIKLVSQPEEDEELAALLEKHFTSEVALLFRLRHPNIISF 122
Query: 122 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILH 181
V ACKKPPVFCIITEY+AGGSLRKYL QQ P+SVPL LVL+LALDIARGMQYLHSQGILH
Sbjct: 123 VGACKKPPVFCIITEYMAGGSLRKYLLQQGPHSVPLKLVLELALDIARGMQYLHSQGILH 182
Query: 182 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVY 241
RDLKSENLLL E+MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI+EKRHTKKVDVY
Sbjct: 183 RDLKSENLLLDEEMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIREKRHTKKVDVY 242
Query: 242 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 301
SF IVLWEL+T LTPFDNMTPEQAA+AV KNARPP+PP CP A S LI RCWSS+P++R
Sbjct: 243 SFAIVLWELITGLTPFDNMTPEQAAYAVTHKNARPPLPPDCPLAISNLIKRCWSSNPNKR 302
Query: 302 PHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTCIARHCCAHSK 353
PHF +IV ILE Y++SLEQDPEFFS++ PS + +++CLPTC A + +SK
Sbjct: 303 PHFTEIVKILEKYTDSLEQDPEFFSTYKPSSSNMLVKCLPTCNAGNEFTYSK 354
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491247|ref|XP_002279698.2| PREDICTED: serine/threonine-protein kinase HT1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 575 bits (1483), Expect = e-162, Method: Compositional matrix adjust.
Identities = 279/323 (86%), Positives = 296/323 (91%), Gaps = 3/323 (0%)
Query: 2 KNFHWFKQISINA---KPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLF 58
+NF WFK+IS N K E LSL EYRRAVSWSKYLVSSGAEIK EGE +WSADMSQLF
Sbjct: 47 ENFQWFKKISNNGIIGKSEGRLSLGEYRRAVSWSKYLVSSGAEIKEEGEGDWSADMSQLF 106
Query: 59 IGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118
IGCKFASGRHSRIYRGIYKQRDVAIKL+SQPEED SLA++LEKQFTSEVALLFRL HP+I
Sbjct: 107 IGCKFASGRHSRIYRGIYKQRDVAIKLISQPEEDESLANLLEKQFTSEVALLFRLRHPNI 166
Query: 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 178
ITFVAACKKPPVFCIITEYLAGGSLRK+LHQQEPYSVP +LVLK +LDIA GMQYLHSQG
Sbjct: 167 ITFVAACKKPPVFCIITEYLAGGSLRKFLHQQEPYSVPYDLVLKFSLDIACGMQYLHSQG 226
Query: 179 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 238
ILHRDLKSENLLLGEDMCVKVADFGISCLE+QCGSAKGFTGTYRWMAPEMIKEK HTKKV
Sbjct: 227 ILHRDLKSENLLLGEDMCVKVADFGISCLETQCGSAKGFTGTYRWMAPEMIKEKHHTKKV 286
Query: 239 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 298
DVYSFGIVLWELLTAL PFDNMTPEQAAFAV QKNARPP+ P CP AF +LISRCWSSS
Sbjct: 287 DVYSFGIVLWELLTALIPFDNMTPEQAAFAVSQKNARPPLDPACPMAFRHLISRCWSSSA 346
Query: 299 DRRPHFDQIVSILEGYSESLEQD 321
D+RPHFD+IVSILE YSES +Q+
Sbjct: 347 DKRPHFDEIVSILESYSESFKQE 369
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 362 | ||||||
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.817 | 0.563 | 0.515 | 1.9e-83 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.732 | 0.644 | 0.494 | 9.6e-73 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.732 | 0.643 | 0.501 | 8.6e-72 | |
| TAIR|locus:2102802 | 475 | AT3G46930 [Arabidopsis thalian | 0.814 | 0.621 | 0.450 | 6.5e-67 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.759 | 0.478 | 0.433 | 4.3e-61 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.792 | 0.525 | 0.417 | 5e-60 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.748 | 0.475 | 0.420 | 4e-58 | |
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.732 | 0.765 | 0.444 | 9.6e-57 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.729 | 0.747 | 0.434 | 3.3e-56 | |
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.748 | 0.813 | 0.440 | 1.1e-55 |
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 836 (299.3 bits), Expect = 1.9e-83, P = 1.9e-83
Identities = 154/299 (51%), Positives = 211/299 (70%)
Query: 26 RRAVSWSKYLVSSGAEIKG-EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIK 84
++ WSK ++G + E EE+ DMS+LF G KFA G +SR+Y G Y+ + VA+K
Sbjct: 175 KKDTGWSKLFDNTGRRVSAVEASEEFRVDMSKLFFGLKFAHGLYSRLYHGKYEDKAVAVK 234
Query: 85 LVSQPEEDAS--LASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGS 142
L++ P++D + L + LEKQFT EV LL RL HP++I FV A K PPV+C++T+YL GS
Sbjct: 235 LITVPDDDDNGCLGARLEKQFTKEVTLLSRLTHPNVIKFVGAYKDPPVYCVLTQYLPEGS 294
Query: 143 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202
LR +LH+ E S+PL +++ A+DIARGM+Y+HS+ I+HRDLK EN+L+ E+ +K+ADF
Sbjct: 295 LRSFLHKPENRSLPLKKLIEFAIDIARGMEYIHSRRIIHRDLKPENVLIDEEFHLKIADF 354
Query: 203 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP 262
GI+C E C GTYRWMAPEMIK K H +K DVYSFG+VLWE++ P+++M P
Sbjct: 355 GIACEEEYCDMLADDPGTYRWMAPEMIKRKPHGRKADVYSFGLVLWEMVAGAIPYEDMNP 414
Query: 263 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 321
QAAFAV KN RP +P CP A LI +CWS +PD+RP F QIV +LE ++ SLE++
Sbjct: 415 IQAAFAVVHKNIRPAIPGDCPVAMKALIEQCWSVAPDKRPEFWQIVKVLEQFAISLERE 473
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 735 (263.8 bits), Expect = 9.6e-73, P = 9.6e-73
Identities = 131/265 (49%), Positives = 186/265 (70%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEV 107
+EW+ D+ +L +G FA G ++Y+G Y DVAIK++ +PE A +E+QF EV
Sbjct: 121 DEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFMEQQFQQEV 180
Query: 108 ALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDI 167
++L L HP+I+ F+ AC+KP V+CI+TEY GGS+R++L +++ +VPL L +K ALD+
Sbjct: 181 SMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 240
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE 227
ARGM Y+H + +HRDLKS+NLL+ D +K+ADFG++ +E Q TGTYRWMAPE
Sbjct: 241 ARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPE 300
Query: 228 MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287
MI+ + + +KVDVYSFGIVLWEL+T L PF NMT QAAFAV + RP VP C S
Sbjct: 301 MIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPNDCLPVLS 360
Query: 288 YLISRCWSSSPDRRPHFDQIVSILE 312
+++RCW ++P+ RP F ++V +LE
Sbjct: 361 DIMTRCWDANPEVRPCFVEVVKLLE 385
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 726 (260.6 bits), Expect = 8.6e-72, P = 8.6e-72
Identities = 133/265 (50%), Positives = 184/265 (69%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEV 107
EEW+ D+ +L +G FA G ++YRG Y DVAIKL+ + + + A LE+QF EV
Sbjct: 122 EEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQFQQEV 181
Query: 108 ALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDI 167
++L L HP+I+ F+ AC KP V+CI+TEY GGS+R++L +++ +VPL L + ALD+
Sbjct: 182 SMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDV 241
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE 227
ARGM Y+H + +HRDLKS+NLL+ D +K+ADFG++ +E Q TGTYRWMAPE
Sbjct: 242 ARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRWMAPE 301
Query: 228 MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287
MI+ + +T+KVDVYSFGIVLWEL+T L PF NMT QAAFAV + RP VP C
Sbjct: 302 MIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPADCLPVLG 361
Query: 288 YLISRCWSSSPDRRPHFDQIVSILE 312
+++RCW + P+ RP F +IV++LE
Sbjct: 362 EIMTRCWDADPEVRPCFAEIVNLLE 386
|
|
| TAIR|locus:2102802 AT3G46930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 680 (244.4 bits), Expect = 6.5e-67, P = 6.5e-67
Identities = 137/304 (45%), Positives = 195/304 (64%)
Query: 32 SKYLVSSGAEIKGEGE-EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPE 90
SK + G+++ G EE D+S+L G +FA G++S+IY G Y+ + VA+K+++ PE
Sbjct: 135 SKSVDYRGSKVSSAGVLEECLIDVSKLSYGDRFAHGKYSQIYHGEYEGKAVALKIITAPE 194
Query: 91 E--DASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLH 148
+ D L + LEK+F E LL RL+HP+++ FV CIITEY+ GSLR YLH
Sbjct: 195 DSDDIFLGARLEKEFIVEATLLSRLSHPNVVKFVGVNTGN---CIITEYVPRGSLRSYLH 251
Query: 149 QQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208
+ E S+PL ++ LDIA+GM+Y+HS+ I+H+DLK EN+L+ D +K+ADFGI+C E
Sbjct: 252 KLEQKSLPLEQLIDFGLDIAKGMEYIHSREIVHQDLKPENVLIDNDFHLKIADFGIACEE 311
Query: 209 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAF 267
C GTYRWMAPE++K H +K DVYSFG++LWE++ P++ M EQ A+
Sbjct: 312 EYCDVLGDNIGTYRWMAPEVLKRIPHGRKCDVYSFGLLLWEMVAGALPYEEMKFAEQIAY 371
Query: 268 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSS 327
AV K RP +P CP A LI RCWSS D+RP F QIV +LE + +SL + + +
Sbjct: 372 AVIYKKIRPVIPTDCPAAMKELIERCWSSQTDKRPEFWQIVKVLEHFKKSLTSEGKL--N 429
Query: 328 FIPS 331
+PS
Sbjct: 430 LLPS 433
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 625 (225.1 bits), Expect = 4.3e-61, P = 4.3e-61
Identities = 123/284 (43%), Positives = 184/284 (64%)
Query: 42 IKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEK 101
I +G + W ++ L G K ASG + +Y+G Y ++VAIK++ +PE L S LEK
Sbjct: 275 IPNDGTDVWEINLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVL-KPER---LDSDLEK 330
Query: 102 QFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLV 160
+F EV ++ ++ H +++ F+ AC KPP CI+TE++ GGS+ YLH+Q+ + +P +
Sbjct: 331 EFAQEVFIMRKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPT--L 388
Query: 161 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT 220
K+A+DI +GM YLH I+HRDLK+ NLL+ E+ VKVADFG++ +++Q G TGT
Sbjct: 389 FKVAIDICKGMSYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAETGT 448
Query: 221 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP 280
YRWMAPE+I+ K + K DV+S+GIVLWELLT P++ MTP QAA V QK RP +P
Sbjct: 449 YRWMAPEVIEHKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPK 508
Query: 281 -TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 323
T PK + L+ R W +RP F +I+ L+ ++ + ++ E
Sbjct: 509 NTHPK-LAELLERLWEHDSTQRPDFSEIIEQLQEIAKEVGEEGE 551
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 615 (221.5 bits), Expect = 5.0e-60, P = 5.0e-60
Identities = 124/297 (41%), Positives = 193/297 (64%)
Query: 17 ERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIY 76
++ +S E+ ++ S L+ + EI +G +EW D++QL I K ASG + ++RG Y
Sbjct: 249 QKSISFFEHDKS---SNELIPACIEIPTDGTDEWEIDVTQLKIEKKVASGSYGDLHRGTY 305
Query: 77 KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITE 136
++VAIK + +P+ + ML ++F+ EV ++ ++ H +++ F+ AC + P CI+TE
Sbjct: 306 CSQEVAIKFL-KPDRVNN--EML-REFSQEVFIMRKVRHKNVVQFLGACTRSPTLCIVTE 361
Query: 137 YLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 196
++A GS+ +LH+Q+ + L +LK+ALD+A+GM YLH I+HRDLK+ NLL+ E
Sbjct: 362 FMARGSIYDFLHKQK-CAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANLLMDEHGL 420
Query: 197 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP 256
VKVADFG++ ++ + G TGTYRWMAPE+I+ K + K DV+S+ IVLWELLT P
Sbjct: 421 VKVADFGVARVQIESGVMTAETGTYRWMAPEVIEHKPYNHKADVFSYAIVLWELLTGDIP 480
Query: 257 FDNMTPEQAAFAVCQKNARPPVPP-TCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
+ +TP QAA V QK RP +P T PK L+ RCW P++RP F++I+ +L+
Sbjct: 481 YAFLTPLQAAVGVVQKGLRPKIPKKTHPKVKG-LLERCWHQDPEQRPLFEEIIEMLQ 536
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 597 (215.2 bits), Expect = 4.0e-58, P = 4.0e-58
Identities = 117/278 (42%), Positives = 179/278 (64%)
Query: 35 LVSSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDAS 94
L+ + EI +G +EW DM QL I K A G + ++RG Y ++VAIK++ +PE
Sbjct: 270 LLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKIL-KPERVN- 327
Query: 95 LASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYS 154
A ML ++F+ EV ++ ++ H +++ F+ AC + P CI+TE++ GS+ +LH+ +
Sbjct: 328 -AEML-REFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKGV- 384
Query: 155 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 214
+ +LK+ALD+++GM YLH I+HRDLK+ NLL+ E VKVADFG++ ++++ G
Sbjct: 385 FKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVADFGVARVQTESGVM 444
Query: 215 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 274
TGTYRWMAPE+I+ K + + DV+S+ IVLWELLT P+ +TP QAA V QK
Sbjct: 445 TAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQKGL 504
Query: 275 RPPVPP-TCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 311
RP +P T PK + L+ +CW P RP+F +I+ +L
Sbjct: 505 RPKIPKETHPK-LTELLEKCWQQDPALRPNFAEIIEML 541
|
|
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 584 (210.6 bits), Expect = 9.6e-57, P = 9.6e-57
Identities = 123/277 (44%), Positives = 167/277 (60%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSE 106
E +W D LF+G K G H+++Y G YK + VAIK+V + E +A + +F E
Sbjct: 10 EPKWQIDPQLLFVGPKIGEGAHAKVYEGKYKNQTVAIKIVHRGETPEEIAKR-DSRFLRE 68
Query: 107 VALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALD 166
V +L R+ H +++ F+ ACK+P V I+TE L GG+LRKYL P + + + ALD
Sbjct: 69 VEMLSRVQHKNLVKFIGACKEP-VMVIVTELLQGGTLRKYLLNLRPACLETRVAIGFALD 127
Query: 167 IARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISCLESQCGSAKGFTGTYRWMA 225
IARGM+ LHS GI+HRDLK ENLLL D VK+ADFG++ ES TGTYRWMA
Sbjct: 128 IARGMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 187
Query: 226 PEM-------IKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 277
PE+ + EK+H KVD YSF IVLWELL PF+ M+ QAA+A KN RP
Sbjct: 188 PELYSTVTLRLGEKKHYNHKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 247
Query: 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314
+ P+ +++ CW+ P+ RP+F I+ +L Y
Sbjct: 248 AE-SLPEELGDIVTSCWNEDPNARPNFTHIIELLLNY 283
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 579 (208.9 bits), Expect = 3.3e-56, P = 3.3e-56
Identities = 120/276 (43%), Positives = 168/276 (60%)
Query: 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFT 104
E + +W D LF+G K G H++IY G YK + VAIK+V + E +A E +F
Sbjct: 14 ELDPKWVVDPQHLFVGPKIGEGAHAKIYEGKYKNKTVAIKIVKRGESPEEIAKR-ESRFA 72
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
EV++L R+ H +++ F+ ACK+P + I+TE L GG+LRKYL P S+ + + + A
Sbjct: 73 REVSMLSRVQHKNLVKFIGACKEP-IMVIVTELLLGGTLRKYLVSLRPGSLDIRVAVGYA 131
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGISCLESQCGSAKGFTGTYRW 223
LDIAR M+ LHS G++HRDLK E+L+L D VK+ADFG++ ES TGTYRW
Sbjct: 132 LDIARAMECLHSHGVIHRDLKPESLILTADYKTVKLADFGLAREESLTEMMTAETGTYRW 191
Query: 224 MAPEMIK-------EKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 275
MAPE+ EK+H KVD YSF IVLWEL+ PF+ M+ QAA+A KN R
Sbjct: 192 MAPELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQAAYAAAFKNVR 251
Query: 276 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 311
P PK + +++ CW P+ RP+F +I+ +L
Sbjct: 252 PSADDL-PKDLAMIVTSCWKEDPNDRPNFTEIIQML 286
|
|
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 574 (207.1 bits), Expect = 1.1e-55, P = 1.1e-55
Identities = 127/288 (44%), Positives = 172/288 (59%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLV---SQPEEDASLASMLEKQF 103
EE D LFIG K G H ++Y+G Y ++ VAIK+V S+P++ +SL E +F
Sbjct: 8 EESLLVDPKLLFIGSKIGEGAHGKVYQGRYGRQIVAIKVVNRGSKPDQQSSL----ESRF 63
Query: 104 TSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL 163
EV ++ R+ H +++ F+ ACK P + I+TE L G SLRKYL P + L L L
Sbjct: 64 VREVNMMSRVQHHNLVKFIGACKDP-LMVIVTELLPGMSLRKYLTSIRPQLLHLPLALSF 122
Query: 164 ALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISCLESQCGSAKGFTGTYR 222
ALDIAR + LH+ GI+HRDLK +NLLL E+ VK+ADFG++ ES TGTYR
Sbjct: 123 ALDIARALHCLHANGIIHRDLKPDNLLLTENHKSVKLADFGLAREESVTEMMTAETGTYR 182
Query: 223 WMAPEMIK-------EKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 274
WMAPE+ EK+H KVDVYSFGIVLWELLT PF+ M+ QAA+A K
Sbjct: 183 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQE 242
Query: 275 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 322
RP +P + ++++ CW P+ RP F QI+ +L + +L P
Sbjct: 243 RPVMPEGISPSLAFIVQSCWVEDPNMRPSFSQIIRLLNEFLLTLTPPP 290
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_XII000286 | hypothetical protein (323 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 362 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-80 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-78 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-73 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-70 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-67 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-64 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-60 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-50 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-48 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-48 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-48 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-47 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-46 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-46 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-46 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-45 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-45 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-45 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-44 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-44 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-43 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-41 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-41 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-41 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-40 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-40 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-39 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-39 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-39 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-39 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-38 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-38 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-38 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-38 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-38 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-38 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-38 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-38 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-37 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-37 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-37 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-37 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-37 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-37 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-37 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-36 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-36 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-36 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-36 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-36 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-36 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-36 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-35 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-35 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-35 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-35 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-35 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-35 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-34 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-34 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-34 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-34 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-34 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-34 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-34 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-33 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-33 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-33 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-33 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-33 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-32 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-32 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-32 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-32 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-32 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-32 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-32 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-32 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-31 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-31 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-31 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-31 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-30 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-30 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-30 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-30 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-29 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-29 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-29 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-29 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-28 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-28 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-28 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-27 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-27 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-27 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-27 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-26 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-26 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-26 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-26 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-26 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-26 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-25 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-25 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-24 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-24 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-24 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-24 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-23 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-23 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-23 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-22 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-22 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-22 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-22 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-22 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-21 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-21 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-21 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-21 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-21 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-21 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-20 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-20 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-20 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-20 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-20 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-20 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-20 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-19 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-19 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-19 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-19 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-19 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-19 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-18 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-18 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-18 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-18 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-17 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-17 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-17 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-16 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-16 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-15 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-15 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-14 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-14 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-11 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-07 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 7e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 9e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.001 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 245 bits (629), Expect = 2e-80
Identities = 92/264 (34%), Positives = 143/264 (54%), Gaps = 15/264 (5%)
Query: 57 LFIGCKFASGRHSRIYRGIYKQR------DVAIKLVSQPEEDASLASMLEKQFTSEVALL 110
L +G K G +Y+G K + +VA+K + + + + L E ++
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR-----EARIM 55
Query: 111 FRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARG 170
+L+HP+I+ + C + I+ EY+ GG L YL + P + L+ +L AL IARG
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 171 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG--SAKGFTGTYRWMAPEM 228
M+YL S+ +HRDL + N L+GE++ VK++DFG+S KG RWMAPE
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175
Query: 229 IKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287
+KE + T K DV+SFG++LWE+ T P+ M+ + + +K R P PP CP
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL-KKGYRLPKPPNCPPELY 234
Query: 288 YLISRCWSSSPDRRPHFDQIVSIL 311
L+ +CW+ P+ RP F ++V IL
Sbjct: 235 KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 240 bits (616), Expect = 2e-78
Identities = 90/264 (34%), Positives = 144/264 (54%), Gaps = 16/264 (6%)
Query: 57 LFIGCKFASGRHSRIYRGIYKQR------DVAIKLVSQPEEDASLASMLEKQFTSEVALL 110
L +G K G +Y+G K + +VA+K + + + ++F E ++
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ-----QIEEFLREARIM 55
Query: 111 FRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARG 170
+L+HP+++ + C + I+ EY+ GG L YL + P + L+ +L AL IARG
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP-KLSLSDLLSFALQIARG 114
Query: 171 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG--SAKGFTGTYRWMAPEM 228
M+YL S+ +HRDL + N L+GE++ VK++DFG+S +G RWMAPE
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPES 174
Query: 229 IKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287
+KE + T K DV+SFG++LWE+ T P+ M+ E+ + + R P PP CP
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL-KNGYRLPQPPNCPPELY 233
Query: 288 YLISRCWSSSPDRRPHFDQIVSIL 311
L+ +CW+ P+ RP F ++V IL
Sbjct: 234 DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 226 bits (579), Expect = 7e-73
Identities = 87/270 (32%), Positives = 141/270 (52%), Gaps = 31/270 (11%)
Query: 59 IGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR 112
+G K G +Y+G K + VA+K + +E AS E F E +++ +
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL---KEGASEEEREE--FLEEASIMKK 57
Query: 113 LNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQ 172
L+HP+I+ + C + I+TEY+ GG L +L + + L +L++AL IA+GM+
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE-KLTLKDLLQMALQIAKGME 116
Query: 173 YLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY----------R 222
YL S+ +HRDL + N L+ E++ VK++DFG+S Y +
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLS-------RDIYEDDYYRKRGGGKLPIK 169
Query: 223 WMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 281
WMAPE +K+ + T K DV+SFG++LWE+ T P+ M+ E+ + + R P P
Sbjct: 170 WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPEN 228
Query: 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSIL 311
CP L+ +CW+ P+ RP F ++V L
Sbjct: 229 CPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 2e-70
Identities = 90/264 (34%), Positives = 138/264 (52%), Gaps = 22/264 (8%)
Query: 65 SGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
G +Y+G K +VA+K + EDAS K F E ++ +L HP+++
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTLK---EDASEEER--KDFLKEARVMKKLGHPNVV 59
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPY-------SVPLNLVLKLALDIARGMQ 172
+ C + ++ EY+ GG L YL + P ++ L +L A+ IA+GM+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 173 YLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RWMAPEMI 229
YL S+ +HRDL + N L+GED+ VK++DFG+S + TG RWMAPE +
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 230 KEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288
K+ T K DV+SFG++LWE+ T TP+ ++ E+ + +K R P P CP
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-RKGYRLPKPEYCPDELYE 238
Query: 289 LISRCWSSSPDRRPHFDQIVSILE 312
L+ CW P+ RP F ++V LE
Sbjct: 239 LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 213 bits (545), Expect = 1e-67
Identities = 74/253 (29%), Positives = 116/253 (45%), Gaps = 11/253 (4%)
Query: 59 IGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
I K G ++Y K + VAIK++ + + ++ E+ +L +L HP
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD-----RERILREIKILKKLKHP 57
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+I+ + ++ EY GG L L ++ + I ++YLHS
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRL--SEDEARFYLRQILSALEYLHS 115
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTK 236
+GI+HRDLK EN+LL ED VK+ADFG++ F GT +MAPE++ K + K
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 237 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP--TCPKAFSYLISRCW 294
VD++S G++L+ELLT PF F K P PP LI +
Sbjct: 176 AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235
Query: 295 SSSPDRRPHFDQI 307
P++R ++
Sbjct: 236 VKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 7e-64
Identities = 88/255 (34%), Positives = 137/255 (53%), Gaps = 19/255 (7%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
SG +Y+ +K + VA+K++ + E S ++ E+ +L RL+HP+I+ +
Sbjct: 9 SGSFGTVYKAKHKGTGKIVAVKILKKRSEK----SKKDQTARREIRILRRLSHPNIVRLI 64
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
A + ++ EY GG L YL + P S + K+AL I RG++YLHS GI+HR
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLS--EDEAKKIALQILRGLEYLHSNGIIHR 122
Query: 183 DLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVD 239
DLK EN+LL E+ VK+ADFG++ +S S F GT +MAPE++ + KVD
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFVGTPWYMAPEVLLGGNGYGPKVD 181
Query: 240 VYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS------YLISRC 293
V+S G++L+ELLT PF + ++ PP+ PK S LI +C
Sbjct: 182 VWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKC 240
Query: 294 WSSSPDRRPHFDQIV 308
+ P +RP ++I+
Sbjct: 241 LNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 2e-60
Identities = 74/252 (29%), Positives = 120/252 (47%), Gaps = 44/252 (17%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
G +Y K+ + VAIK++ + + L ++ E+ +L +LNHP+I+
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKIIKKEDSS-----SLLEELLREIEILKKLNHPNIVKLY 57
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
+ ++ EY GGSL+ L + E + + +L++ L I G++YLHS GI+HR
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 183 DLKSENLLLGED-MCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVD 239
DLK EN+LL D VK+ADFG+S L S K GT +MAPE++ K + ++K D
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 240 VYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 299
++S G++L+EL LI + P+
Sbjct: 177 IWSLGVILYEL---------------------------------PELKDLIRKMLQKDPE 203
Query: 300 RRPHFDQIVSIL 311
+RP +I+ L
Sbjct: 204 KRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 7e-50
Identities = 69/209 (33%), Positives = 110/209 (52%), Gaps = 4/209 (1%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPL--NLVLK 162
+EV +L +LNHP+II + + ++ CI+ EY GG L + + +Q+ P +L
Sbjct: 48 NEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD 107
Query: 163 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY 221
+ + ++YLHS+ ILHRD+K +N+ L + VK+ DFGIS L S AK GT
Sbjct: 108 WFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTP 167
Query: 222 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 281
+++PE+ + K + K D++S G VL+EL T PF+ + A + + PP+P
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIPSQ 226
Query: 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSI 310
L+S P+ RP QI+
Sbjct: 227 YSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-48
Identities = 82/265 (30%), Positives = 140/265 (52%), Gaps = 13/265 (4%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVAL 109
W+ + +L +G G + G Y+ + VA+K + ++D++ A + F +E ++
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCL---KDDSTAA----QAFLAEASV 53
Query: 110 LFRLNHPHIITFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
+ L HP+++ + + P++ I+TEY+A GSL YL + + L L ALD+
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLY-IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC 112
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 228
GM+YL + +HRDL + N+L+ ED+ KV+DFG++ SQ + +W APE
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL--PVKWTAPEA 170
Query: 229 IKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287
++EK+ + K DV+SFGI+LWE+ + P+ + + V +K R P CP
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV-EKGYRMEAPEGCPPEVY 229
Query: 288 YLISRCWSSSPDRRPHFDQIVSILE 312
++ CW P +RP F Q+ L
Sbjct: 230 KVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 3e-48
Identities = 71/256 (27%), Positives = 119/256 (46%), Gaps = 16/256 (6%)
Query: 60 GCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH 117
G G +Y + K +A+K V + LE+ E+ +L L HP+
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALER----EIRILSSLQHPN 60
Query: 118 IITFVAACKKPP--VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH 175
I+ + + + I EY++GGSL L + +P ++ K I G+ YLH
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK--LPEPVIRKYTRQILEGLAYLH 118
Query: 176 SQGILHRDLKSENLLLGEDMCVKVADFGIS----CLESQCGSAKGFTGTYRWMAPEMIKE 231
S GI+HRD+K N+L+ D VK+ADFG + +E+ G+ GT WMAPE+I+
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT-GSVRGTPYWMAPEVIRG 177
Query: 232 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNARPPVPPTCPKAFSYLI 290
+ + + D++S G + E+ T P+ + AA + + P +P + +
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237
Query: 291 SRCWSSSPDRRPHFDQ 306
+C P +RP D+
Sbjct: 238 RKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-48
Identities = 83/259 (32%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQ-FTSEV 107
W + + K SG ++ G++K + VAIK++ +L++Q F EV
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS-------DDLLKQQDFQKEV 53
Query: 108 ALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDI 167
L RL H H+I+ A C IITE + GSL +L E +P+ ++ +A +
Sbjct: 54 QALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQV 113
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAP 226
A GM YL Q +HRDL + N+L+GED+ KVADFG++ ++ + Y+W AP
Sbjct: 114 AEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAP 173
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285
E + K DV+SFGI+L+E+ T P+ M + R P P CP+
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGYRMPCPAKCPQE 232
Query: 286 FSYLISRCWSSSPDRRPHF 304
++ CW++ P+ RP F
Sbjct: 233 IYKIMLECWAAEPEDRPSF 251
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 9e-48
Identities = 85/269 (31%), Positives = 138/269 (51%), Gaps = 12/269 (4%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIY-KQRDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
W L + K +G+ ++ G + VA+K + +M + F E
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP-------GTMSPEAFLQEAQ 53
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
++ +L H ++ A C + I+TEY++ GSL +L E + L ++ +A IA
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAP 226
GM YL S+ +HRDL + N+L+GE++ K+ADFG++ L + + + +G +W AP
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAP 173
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285
E R T K DV+SFGI+L E++T P+ MT + V ++ R P PP CP+
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV-ERGYRMPRPPNCPEE 232
Query: 286 FSYLISRCWSSSPDRRPHFDQIVSILEGY 314
L+ +CW P+ RP F+ + S LE Y
Sbjct: 233 LYDLMLQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 1e-47
Identities = 80/263 (30%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
D S+L + SG+ ++ G ++ + DVAIK++ + +M E F E ++
Sbjct: 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIRE-------GAMSEDDFIEEAKVMM 54
Query: 112 RLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGM 171
+L+HP+++ C K I+TEY+A G L YL ++ + +L + D+ M
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAM 113
Query: 172 QYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMI 229
+YL S G +HRDL + N L+GED VKV+DFG++ L+ Q S++G +W PE+
Sbjct: 114 EYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVF 173
Query: 230 KEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288
R + K DV+SFG+++WE+ + P++ + + +V R P P
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-SAGYRLYRPKLAPTEVYT 232
Query: 289 LISRCWSSSPDRRPHFDQIVSIL 311
++ CW P+ RP F +++S L
Sbjct: 233 IMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-46
Identities = 93/281 (33%), Positives = 133/281 (47%), Gaps = 36/281 (12%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYKQR-----DVAIKLVSQPEEDASLASMLEKQ---FT 104
D S + I G + RG K DVAIK + A +KQ F
Sbjct: 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLK--------AGSSDKQRLDFL 53
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
+E +++ + +HP+II K IITEY+ GSL K+L + + LV +
Sbjct: 54 TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLV-GML 112
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY-- 221
IA GM+YL +HRDL + N+L+ ++ KV+DFG+S LE TY
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED-------SEATYTT 165
Query: 222 -------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 273
RW APE I ++ T DV+SFGIV+WE+++ P+ +M+ + AV +
Sbjct: 166 KGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDG 224
Query: 274 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314
R P P CP A L+ CW + RP F QIVS L+
Sbjct: 225 YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-46
Identities = 86/270 (31%), Positives = 140/270 (51%), Gaps = 14/270 (5%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIY-KQRDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
W D + + + K +G+ ++ G++ VA+K + +M K F +E
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKP-------GTMDPKDFLAEAQ 53
Query: 109 LLFRLNHPHIITFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDI 167
++ +L HP +I A C + P++ I+TE + GSL +YL ++ L ++ +A +
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIY-IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMA 225
A GM YL +Q +HRDL + N+L+GE+ KVADFG++ + E + +G +W A
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA 172
Query: 226 PEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284
PE R + K DV+SFGI+L E++T P+ MT + V + R P PP CPK
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-DQGYRMPCPPGCPK 231
Query: 285 AFSYLISRCWSSSPDRRPHFDQIVSILEGY 314
++ CW PD RP F+ + LE +
Sbjct: 232 ELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-46
Identities = 77/247 (31%), Positives = 125/247 (50%), Gaps = 10/247 (4%)
Query: 59 IGCKFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+G G +Y+G+ + VAIK +S E ++ K E+ LL L HP
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISL--EKIKEEAL--KSIMQEIDLLKNLKHP 59
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+I+ ++ + + II EY GSLR+ + + P+ P +LV + +G+ YLH
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPF--PESLVAVYVYQVLQGLAYLHE 117
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHT 235
QG++HRD+K+ N+L +D VK+ADFG++ L GT WMAPE+I+ +
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 236 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 295
D++S G + ELLT P+ ++ P A F + Q + PP+P + +C+
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPELKDFLMQCFQ 236
Query: 296 SSPDRRP 302
P+ RP
Sbjct: 237 KDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-45
Identities = 86/258 (33%), Positives = 139/258 (53%), Gaps = 15/258 (5%)
Query: 62 KFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
K +G+ ++ G Y VAIK + Q SM + F +E L+ +L HP ++
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQ-------GSMSPEAFLAEANLMKQLQHPRLVR 65
Query: 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 180
A + P++ IITEY+ GSL +L E + +N ++ +A IA GM ++ + +
Sbjct: 66 LYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 181 HRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 238
HRDL++ N+L+ E +C K+ADFG++ L +++ + +G +W APE I T K
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 239 DVYSFGIVLWELLT-ALTPFDNMT-PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296
DV+SFGI+L E++T P+ MT PE ++ R P P CP+ L+ CW
Sbjct: 185 DVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGYRMPRPDNCPEELYELMRLCWKE 242
Query: 297 SPDRRPHFDQIVSILEGY 314
P+ RP F+ + S+LE +
Sbjct: 243 KPEERPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-45
Identities = 73/254 (28%), Positives = 120/254 (47%), Gaps = 30/254 (11%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--PVFCIITEYL 138
VA+K ++ E+ + F E+ +L L+H +I+ + C+KP +I EYL
Sbjct: 36 VAVKSLNHSGEEQHRSD-----FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYL 90
Query: 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 198
GSLR YL + + L +L + I +GM YL SQ +HRDL + N+L+ + VK
Sbjct: 91 PSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVK 149
Query: 199 VADFGISCLESQCGSAKGFTGTY------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT 252
++DFG++ + + + W APE ++ + + DV+SFG+ L+EL T
Sbjct: 150 ISDFGLAKVLPE--DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
Query: 253 ALTPF--------DNMTPEQAAFAVCQ------KNARPPVPPTCPKAFSYLISRCWSSSP 298
P + Q V + + R P PP+CP L+ CW + P
Sbjct: 208 YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEP 267
Query: 299 DRRPHFDQIVSILE 312
RP F ++ I++
Sbjct: 268 QDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 4e-45
Identities = 83/258 (32%), Positives = 145/258 (56%), Gaps = 16/258 (6%)
Query: 62 KFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
K G +Y+G+ K +VA+K +L L+++F E +L + +HP+I+
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRS-----TLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 121 FVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 179
+ C +K P++ I+ E + GGSL +L +++ + + +L+++LD A GM+YL S+
Sbjct: 57 LIGVCVQKQPIY-IVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNC 114
Query: 180 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT----YRWMAPEMIKEKRHT 235
+HRDL + N L+GE+ +K++DFG+S E + G G +W APE + R+T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS-REEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 236 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 294
+ DV+S+GI+LWE + TP+ M+ +Q + + R P P CP+ L+ +CW
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEIYRLMLQCW 232
Query: 295 SSSPDRRPHFDQIVSILE 312
+ P+ RP F +I + L+
Sbjct: 233 AYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 5e-44
Identities = 88/285 (30%), Positives = 138/285 (48%), Gaps = 31/285 (10%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQ 102
W ++ + + G +Y G+ K VAIK V+ E+AS+ +E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIE-- 55
Query: 103 FTSEVALLFRLNHPHIITF--VAACKKPPVFCIITEYLAGGSLRKYLHQQEP-------Y 153
F +E +++ N H++ V + +P + ++ E +A G L+ YL + P
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGL 113
Query: 154 SVP-LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG----ISCLE 208
P L +++A +IA GM YL ++ +HRDL + N ++ ED+ VK+ DFG I +
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD 173
Query: 209 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAF 267
KG RWMAPE +K+ T K DV+SFG+VLWE+ T A P+ ++ E+
Sbjct: 174 YYRKGGKGLL-PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK 232
Query: 268 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
V P CP L+ CW +P RP F +IVS L+
Sbjct: 233 FVIDGGHLDL-PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 7e-44
Identities = 75/255 (29%), Positives = 128/255 (50%), Gaps = 16/255 (6%)
Query: 66 GRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
G+ +Y+G+Y + VA+K + S + + ++F E ++ + +HPHI+
Sbjct: 17 GQFGDVYQGVYMSPENEKIAVAVKTC---KNCTSPS--VREKFLQEAYIMRQFDHPHIVK 71
Query: 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 180
+ + PV+ I+ E G LR YL Q YS+ L ++ + ++ + YL S+ +
Sbjct: 72 LIGVITENPVW-IVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLESKRFV 129
Query: 181 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY--RWMAPEMIKEKRHTKKV 238
HRD+ + N+L+ CVK+ DFG+S K G +WMAPE I +R T
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSAS 189
Query: 239 DVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 297
DV+ FG+ +WE+L + PF + + R P+PP CP L+++CW+
Sbjct: 190 DVWMFGVCMWEILMLGVKPFQGVKNND-VIGRIENGERLPMPPNCPPTLYSLMTKCWAYD 248
Query: 298 PDRRPHFDQIVSILE 312
P +RP F ++ + L
Sbjct: 249 PSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-43
Identities = 82/268 (30%), Positives = 140/268 (52%), Gaps = 13/268 (4%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEV 107
W + + + + K G++ +Y G++K+ VA+K + +ED M ++F E
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDT----MEVEEFLKEA 53
Query: 108 ALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDI 167
A++ + HP+++ + C + P F IITE++ G+L YL + V ++L +A I
Sbjct: 54 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI 113
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMA 225
+ M+YL + +HRDL + N L+GE+ VKVADFG+S L + G +W A
Sbjct: 114 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 173
Query: 226 PEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284
PE + + + K DV++FG++LWE+ T ++P+ + Q + + +K R P CP
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKGYRMERPEGCPP 232
Query: 285 AFSYLISRCWSSSPDRRPHFDQIVSILE 312
L+ CW +P RP F +I E
Sbjct: 233 KVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 3e-41
Identities = 81/255 (31%), Positives = 123/255 (48%), Gaps = 41/255 (16%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VA+K++ D + F EV +L RL+ P+I + C P C+I EY+
Sbjct: 49 VAVKVLRPDASDNARED-----FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 141 GSLRKYL--HQQEPYSVPLNL-------VLKLALDIARGMQYLHSQGILHRDLKSENLLL 191
G L ++L H E + N +L +A IA GM+YL S +HRDL + N L+
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163
Query: 192 GEDMCVKVADFGISCLESQCGSAKGFTGTY-----------RWMAPEMIKEKRHTKKVDV 240
G++ +K+ADFG+ S ++ Y RWMA E + + T K DV
Sbjct: 164 GKNYTIKIADFGM--------SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215
Query: 241 YSFGIVLWELLT--ALTPFDNMTPEQA---AFAVCQKNARP---PVPPTCPKAFSYLISR 292
++FG+ LWE+LT P++++T +Q A + + R P PP CPK L+
Sbjct: 216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLE 275
Query: 293 CWSSSPDRRPHFDQI 307
CW + RP F +I
Sbjct: 276 CWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 4e-41
Identities = 75/267 (28%), Positives = 140/267 (52%), Gaps = 19/267 (7%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVAL 109
W ++ +L +G G + +G Y + VA+K + + + F E A+
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK--------CDVTAQAFLEETAV 52
Query: 110 LFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR 169
+ +L+H +++ + ++ I+ E ++ G+L +L + V + +L+ +LD+A
Sbjct: 53 MTKLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAE 111
Query: 170 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT---YRWMAP 226
GM+YL S+ ++HRDL + N+L+ ED KV+DFG++ + S G + +W AP
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGS-----MGVDNSKLPVKWTAP 166
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285
E +K K+ + K DV+S+G++LWE+ + P+ M+ ++ V +K R P CP
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-EKGYRMEPPEGCPAD 225
Query: 286 FSYLISRCWSSSPDRRPHFDQIVSILE 312
L++ CW + P +RP F ++ LE
Sbjct: 226 VYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 8e-41
Identities = 77/260 (29%), Positives = 125/260 (48%), Gaps = 33/260 (12%)
Query: 74 GIY-----KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128
G+Y K+ +VA+K + Q A +K+F E +++ +L+HP I+ + CK
Sbjct: 14 GVYLMKSGKEVEVAVKTLKQEHIAA-----GKKEFLREASVMAQLDHPCIVRLIGVCKGE 68
Query: 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 188
P ++ E G L KYL ++ +P++ + +LA +A GM YL S+ +HRDL + N
Sbjct: 69 P-LMLVMELAPLGPLLKYL-KKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARN 125
Query: 189 LLLGEDMCVKVADFGISCLESQCGSAKGFTGTY-----------RWMAPEMIKEKRHTKK 237
+LL K++DFG+S A G Y +W APE I + + K
Sbjct: 126 VLLVNRHQAKISDFGMS-------RALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK 178
Query: 238 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296
DV+S+G+ LWE + P+ M + A+ + R P P CP+ ++ CW
Sbjct: 179 SDVWSYGVTLWEAFSYGAKPYGEMKGAE-VIAMLESGERLPRPEECPQEIYSIMLSCWKY 237
Query: 297 SPDRRPHFDQIVSILEGYSE 316
P+ RP F ++ S E
Sbjct: 238 RPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 4e-40
Identities = 81/256 (31%), Positives = 127/256 (49%), Gaps = 30/256 (11%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VA+K++ +E+AS ++ F E AL+ +HP+I+ + C C++ EY+A
Sbjct: 38 VAVKML---KEEASAD--MQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAY 92
Query: 141 GSLRKYLHQQEPYSV------------------PLNLV--LKLALDIARGMQYLHSQGIL 180
G L ++L + P + PL+ L +A +A GM YL + +
Sbjct: 93 GDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV 152
Query: 181 HRDLKSENLLLGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 237
HRDL + N L+GE+M VK+ADFG+S +++ RWM PE I R+T +
Sbjct: 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE 212
Query: 238 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296
DV+++G+VLWE+ + + P+ M E+ + V N P CP L+ CWS
Sbjct: 213 SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSK 271
Query: 297 SPDRRPHFDQIVSILE 312
P RP F I IL+
Sbjct: 272 LPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 9e-40
Identities = 77/258 (29%), Positives = 134/258 (51%), Gaps = 17/258 (6%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIY-KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
S+L + + SG+ ++ G + ++R VAIK + + +M E+ F E ++
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE-------GAMSEEDFIEEAQVMM 54
Query: 112 RLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGM 171
+L+HP ++ C + C++ E++ G L YL Q +L + LD+ GM
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGM 113
Query: 172 QYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMI 229
YL S ++HRDL + N L+GE+ VKV+DFG++ L+ Q S+ G +W +PE+
Sbjct: 114 AYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVF 173
Query: 230 KEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA--RPPVPPTCPKAF 286
+++ K DV+SFG+++WE+ + TP++N + + V NA R P ++
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETINAGFRLYKPRLASQSV 230
Query: 287 SYLISRCWSSSPDRRPHF 304
L+ CW P+ RP F
Sbjct: 231 YELMQHCWKERPEDRPSF 248
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-39
Identities = 81/247 (32%), Positives = 136/247 (55%), Gaps = 13/247 (5%)
Query: 66 GRHSRIYRGIYKQRD-VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124
G +++G K + VA+K +ED L L+ +F SE +L + +HP+I+ +
Sbjct: 6 GNFGEVFKGTLKDKTPVAVKTC---KED--LPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 125 C-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRD 183
C ++ P++ I+ E + GG +L +++ + ++K ALD A GM YL S+ +HRD
Sbjct: 61 CTQRQPIY-IVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKNCIHRD 118
Query: 184 LKSENLLLGEDMCVKVADFGISCLESQ-CGSAKGFTGT-YRWMAPEMIKEKRHTKKVDVY 241
L + N L+GE+ +K++DFG+S E S+ G +W APE + R++ + DV+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 242 SFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 300
S+GI+LWE + + P+ MT +QA V +K R P CP ++ RCW P+
Sbjct: 179 SYGILLWETFSLGVCPYPGMTNQQAREQV-EKGYRMSCPQKCPDDVYKVMQRCWDYKPEN 237
Query: 301 RPHFDQI 307
RP F ++
Sbjct: 238 RPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-39
Identities = 83/283 (29%), Positives = 133/283 (46%), Gaps = 40/283 (14%)
Query: 57 LFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
L +G G + G Q D VA+K + + D S +E +F SE A +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM---KLDIHTYSEIE-EFLSEAACMK 56
Query: 112 RLNHPHIITFVAAC------KKPPVFCIITEYLAGGSLRKYLH----QQEPYSVPLNLVL 161
+HP+++ + C +K P +I ++ G L +L P +PL +L
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116
Query: 162 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY 221
K +DIA GM+YL ++ +HRDL + N +L EDM V VADFG+ S K ++G Y
Sbjct: 117 KFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL--------SKKIYSGDY 168
Query: 222 -----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAV 269
+W+A E + ++ +T K DV++FG+ +WE+ T TP+ + + +
Sbjct: 169 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228
Query: 270 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
N R P C L+ CW + P RP F ++ +LE
Sbjct: 229 RHGN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 4e-39
Identities = 82/269 (30%), Positives = 140/269 (52%), Gaps = 13/269 (4%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
W L + K +G+ ++ G + VA+K + +P +M + F E
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KP------GTMSPESFLEEAQ 53
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
++ +L H ++ A + P++ I+TEY++ GSL +L E ++ L ++ +A +A
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVA 112
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAP 226
GM Y+ +HRDL+S N+L+G+ + K+ADFG++ L +++ + +G +W AP
Sbjct: 113 AGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285
E R T K DV+SFGI+L EL+T P+ M + V ++ R P P CP +
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV-ERGYRMPCPQDCPIS 231
Query: 286 FSYLISRCWSSSPDRRPHFDQIVSILEGY 314
L+ +CW P+ RP F+ + S LE Y
Sbjct: 232 LHELMLQCWKKDPEERPTFEYLQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 4e-39
Identities = 74/239 (30%), Positives = 125/239 (52%), Gaps = 14/239 (5%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC-KKPPVFCIITE 136
Q DVAIK++ + SM E +F E ++ +L+H ++ C K+ P++ I+TE
Sbjct: 28 QYDVAIKMIKE-------GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY-IVTE 79
Query: 137 YLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 196
Y++ G L YL + P L L++ D+ GM YL S+ +HRDL + N L+ + C
Sbjct: 80 YMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC 138
Query: 197 VKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-A 253
VKV+DFG+S L+ + S+ G RW PE++ + + K DV++FG+++WE+ +
Sbjct: 139 VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLG 198
Query: 254 LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
P++ + V Q R P + ++ CW + RP F Q++S +E
Sbjct: 199 KMPYERFNNSETVEKVSQ-GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 7e-39
Identities = 72/248 (29%), Positives = 118/248 (47%), Gaps = 16/248 (6%)
Query: 62 KFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEK-QFTSEVALLFRLNHPHI 118
K G +++ + K +R A+K + D S + E+ + E +L +L+ +I
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQI-----DLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 178
I + + I+ EY G L K L Q +P + V + + I G+ +LHS+
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 179 ILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 237
ILHRD+KS NL L VK+ D G++ L A GT +++PE+ ++K + +K
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEK 181
Query: 238 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR---PPVPPTCPKAFSYLISRCW 294
DV++ G+VL+E T PFD A+ K R PPV + + LI +C
Sbjct: 182 SDVWALGVVLYECCTGKHPFD----ANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCL 237
Query: 295 SSSPDRRP 302
+ +RP
Sbjct: 238 TKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 1e-38
Identities = 69/248 (27%), Positives = 126/248 (50%), Gaps = 22/248 (8%)
Query: 71 IYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128
+Y+ + ++VAIK + L ++ +E+ ++ HP+I+ + +
Sbjct: 35 VYKATDRATGKEVAIKKMR-------LRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG 87
Query: 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLN--LVLKLALDIARGMQYLHSQGILHRDLKS 186
++ EY+ GGSL + V +N + + ++ +G++YLHSQ ++HRD+KS
Sbjct: 88 DELWVVMEYMDGGSLTDII---TQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKS 144
Query: 187 ENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGI 245
+N+LL +D VK+ADFG + L + GT WMAPE+IK K + KVD++S GI
Sbjct: 145 DNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGI 204
Query: 246 VLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL----ISRCWSSSPDRR 301
+ E+ P+ P +A F + K P P+ +S +++C P++R
Sbjct: 205 MCIEMAEGEPPYLREPPLRALFLITTK---GIPPLKNPEKWSPEFKDFLNKCLVKDPEKR 261
Query: 302 PHFDQIVS 309
P ++++
Sbjct: 262 PSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-38
Identities = 70/239 (29%), Positives = 121/239 (50%), Gaps = 18/239 (7%)
Query: 71 IYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128
+Y+ +K ++VAIK++ ++ ++ +E+ +L + HP+I+ + + K
Sbjct: 16 VYKARHKRTGKEVAIKVIKLESKEKK------EKIINEIQILKKCKHPNIVKYYGSYLKK 69
Query: 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLN--LVLKLALDIARGMQYLHSQGILHRDLKS 186
I+ E+ +GGSL+ L + L + + ++ +G++YLHS GI+HRD+K+
Sbjct: 70 DELWIVMEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKA 126
Query: 187 ENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIV 246
N+LL D VK+ DFG+S S + GT WMAPE+I K + K D++S GI
Sbjct: 127 ANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGIT 186
Query: 247 LWELLTALTPFDNMTPEQAAFAVCQKNARPPV---PPTCPKAFSYLISRCWSSSPDRRP 302
EL P+ + P +A F + PP P F + +C +P++RP
Sbjct: 187 AIELAEGKPPYSELPPMKALFKIATNG--PPGLRNPEKWSDEFKDFLKKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 79/293 (26%), Positives = 143/293 (48%), Gaps = 34/293 (11%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASML 99
+ EW +L +G G ++ + D VA+K++ + L+ ++
Sbjct: 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLV 63
Query: 100 EKQFTSEVALLFRL-NHPHIITFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEP----- 152
SE+ ++ + H +II + C ++ P++ ++ EY A G+LR +L + P
Sbjct: 64 -----SEMEMMKMIGKHKNIINLLGVCTQEGPLY-VVVEYAAHGNLRDFLRARRPPGEYA 117
Query: 153 -YSVPLNLVLKL--------ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203
P L A +ARGM++L S+ +HRDL + N+L+ ED +K+ADFG
Sbjct: 118 SPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFG 177
Query: 204 ISCLESQCGSAKGFTG---TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 259
++ + T +WMAPE + ++ +T + DV+SFG++LWE+ T +P+
Sbjct: 178 LARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237
Query: 260 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
+ E+ F + ++ R P C + +L+ CW P +RP F Q+V L+
Sbjct: 238 IPVEE-LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 2e-38
Identities = 81/221 (36%), Positives = 121/221 (54%), Gaps = 10/221 (4%)
Query: 100 EKQ---FTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVP 156
EKQ F SE +++ + +HP+II K I+TEY+ GSL +L + +
Sbjct: 46 EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV 105
Query: 157 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAK 215
+ LV L IA GM+YL G +HRDL + N+L+ ++ KV+DFG+S LE +A
Sbjct: 106 IQLVGMLR-GIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 164
Query: 216 GFTG---TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ 271
G RW APE I ++ T DV+S+GIV+WE+++ P+ M+ + A+ +
Sbjct: 165 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-E 223
Query: 272 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
+ R P P CP A L+ CW + RP F+QIVSIL+
Sbjct: 224 EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 2e-38
Identities = 85/272 (31%), Positives = 134/272 (49%), Gaps = 19/272 (6%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQFTSEV 107
D+S + I +G + RG K VAIK + + + F SE
Sbjct: 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLK-----SGYTEKQRRDFLSEA 56
Query: 108 ALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDI 167
+++ + +HP+II K IITE++ G+L +L Q + + LV L I
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-GI 115
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY------ 221
A GM+YL +HRDL + N+L+ ++ KV+DFG+S S +T +
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175
Query: 222 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 280
RW APE I ++ T DV+S+GIV+WE+++ P+ +M+ + A+ +++ R P P
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPM 234
Query: 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
CP A L+ CW + RP F QIVS L+
Sbjct: 235 DCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-38
Identities = 88/261 (33%), Positives = 129/261 (49%), Gaps = 23/261 (8%)
Query: 65 SGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQ---FTSEVALLFRLNHP 116
+G ++RGI K + VAIK + EKQ F SE +++ + +H
Sbjct: 15 AGEFGEVFRGILKMPGRKEVAVAIKTLK--------PGYTEKQRQDFLSEASIMGQFSHH 66
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+II K IITEY+ G+L KYL + LV L IA GM+YL
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-GIAAGMKYLSD 125
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTG---TYRWMAPEMIKEK 232
+HRDL + N+L+ ++ KV+DFG+S LE +G RW APE I +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 233 RHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291
+ T DV+SFGIV+WE+++ P+ +M+ + A+ R P P CP A L+
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLPAPMDCPSAVYQLML 244
Query: 292 RCWSSSPDRRPHFDQIVSILE 312
+CW RRP F IV++L+
Sbjct: 245 QCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 3e-38
Identities = 82/269 (30%), Positives = 137/269 (50%), Gaps = 13/269 (4%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
W L + K G ++ G + VAIK + +M+ + F E
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP-------GTMMPEAFLQEAQ 53
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
++ +L H ++ A + P++ I+TE++ GSL +L + + + L ++ +A IA
Sbjct: 54 IMKKLRHDKLVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIA 112
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAP 226
GM Y+ +HRDL++ N+L+G+++ K+ADFG++ L +++ + +G +W AP
Sbjct: 113 DGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285
E R T K DV+SFGI+L EL+T P+ M + V ++ R P P CP++
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV-ERGYRMPCPQGCPES 231
Query: 286 FSYLISRCWSSSPDRRPHFDQIVSILEGY 314
L+ CW PD RP F+ I S LE Y
Sbjct: 232 LHELMKLCWKKDPDERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 4e-38
Identities = 77/240 (32%), Positives = 114/240 (47%), Gaps = 25/240 (10%)
Query: 81 VAIKLVSQP----EEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITE 136
+A+K V P S + K SE+ L L+H +I+ ++ I E
Sbjct: 29 MAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLE 88
Query: 137 YLAGGS----LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 192
Y+ GGS LR Y +E LV + G+ YLHS+GILHRDLK++NLL+
Sbjct: 89 YVPGGSIGSCLRTYGRFEEQ------LVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD 142
Query: 193 EDMCVKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIVL 247
D K++DFGIS G+ WMAPE+I ++ KVD++S G V+
Sbjct: 143 ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVV 202
Query: 248 WELLTALTPFDNMTPEQAAFAVCQKNARPPVPP-----TCPKAFSYLISRCWSSSPDRRP 302
E+ P+ + A F + K + PP+PP P A +L + C++ +PD RP
Sbjct: 203 LEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFL-NACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 7e-38
Identities = 83/269 (30%), Positives = 137/269 (50%), Gaps = 13/269 (4%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
W L + K G ++ G + VAIK + +M + F E
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-------GTMSPEAFLQEAQ 53
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
++ +L H ++ A + P++ I+TEY++ GSL +L + + L ++ +A IA
Sbjct: 54 VMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 112
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAP 226
GM Y+ +HRDL++ N+L+GE++ KVADFG++ L +++ + +G +W AP
Sbjct: 113 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285
E R T K DV+SFGI+L EL T P+ M + V ++ R P PP CP++
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPES 231
Query: 286 FSYLISRCWSSSPDRRPHFDQIVSILEGY 314
L+ +CW P+ RP F+ + + LE Y
Sbjct: 232 LHDLMCQCWRKEPEERPTFEYLQAFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 79/257 (30%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 62 KFASGRHSRIYRGIYKQR-DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
K +G+ ++ G Y VA+K + +P +M + F E L+ L H ++
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTL-KP------GTMSVQAFLEEANLMKTLQHDKLVR 65
Query: 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 180
A K IITEY+A GSL +L E V L ++ + IA GM Y+ + +
Sbjct: 66 LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125
Query: 181 HRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 238
HRDL++ N+L+ E + K+ADFG++ + +++ + +G +W APE I T K
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 239 DVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 297
DV+SFGI+L+E++T P+ M+ A+ Q+ R P CP ++ CW
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGYRMPRMENCPDELYDIMKTCWKEK 244
Query: 298 PDRRPHFDQIVSILEGY 314
+ RP FD + S+L+ +
Sbjct: 245 AEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 82/275 (29%), Positives = 129/275 (46%), Gaps = 47/275 (17%)
Query: 66 GRHSRIYRG-------IYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118
G ++Y+G VAIK + +E+A ++++F E L+ L HP+I
Sbjct: 16 GAFGKVYKGELTGPNERLSATSVAIKTL---KENAEPK--VQQEFRQEAELMSDLQHPNI 70
Query: 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNL--------------VLKLA 164
+ + C K C++ EYLA G L ++L + P+S L +A
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY--- 221
+ IA GM+YL S +HRDL + N L+GE + VK++DFG+S ++ Y
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD--------IYSADYYRV 182
Query: 222 --------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK 272
RWM PE I + T + D++SFG+VLWE+ + L P+ + ++ + +
Sbjct: 183 QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI-RS 241
Query: 273 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307
P P CP L+ CW+ P RRP F I
Sbjct: 242 RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 79/280 (28%), Positives = 135/280 (48%), Gaps = 43/280 (15%)
Query: 66 GRHSRIYRGIY------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
G RI+ GI K+ +V +K V + + +L E LL+ L+H +I+
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLL-----QESCLLYGLSHQNIL 71
Query: 120 TFVAAC---KKPPVFCIITEYLAGGSLRKYLHQ------QEPYSVPLNLVLKLALDIARG 170
+ C +PP ++ Y+ G+L+ +L Q P ++ ++ +A+ IA G
Sbjct: 72 PILHVCIEDGEPPF--VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 171 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY--------- 221
M YLH +G++H+D+ + N ++ E++ VK+ D + L S F Y
Sbjct: 130 MSYLHKRGVIHKDIAARNCVIDEELQVKITD---NAL-----SRDLFPMDYHCLGDNENR 181
Query: 222 --RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 278
+WMA E + K ++ DV+SFG++LWEL+T TP+ + P + A A + R
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQ 240
Query: 279 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318
P CP +++ CW+ P+ RP F Q+V L + L
Sbjct: 241 PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 75/240 (31%), Positives = 124/240 (51%), Gaps = 6/240 (2%)
Query: 72 YRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFT-SEVALLFRLNHPHIITFVAACKKPP 129
Y +YK +R + + E D S E++ +E+ +L +NHP+II++ A
Sbjct: 13 YGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN 72
Query: 130 VFCIITEYLAGGSLRKYLHQQEPYSVPL--NLVLKLALDIARGMQYLHSQGILHRDLKSE 187
CI+ EY G L K + +++ + + ++ + + RG+Q LH Q ILHRDLKS
Sbjct: 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSA 132
Query: 188 NLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 247
N+LL + VK+ D GIS + + AK GT +MAPE+ K + ++ K D++S G +L
Sbjct: 133 NILLVANDLVKIGDLGISKVLKK-NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLL 191
Query: 248 WELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307
+E+ T PF+ + + + V + PP+PP + I P RP+ D+I
Sbjct: 192 YEMATFAPPFEARSMQDLRYKVQRGKY-PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-37
Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 7/234 (2%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYL 138
R++A+K V + D+ E+ LL L H I+ + + I EY+
Sbjct: 28 RELAVKQV-PFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86
Query: 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 198
GGS++ L + + K I G++YLHS I+HRD+K N+L VK
Sbjct: 87 PGGSVKDQLKAYGALTE--TVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVK 144
Query: 199 VADFGIS----CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTAL 254
+ DFG S + S K TGT WM+PE+I + + +K DV+S G + E+LT
Sbjct: 145 LGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
Query: 255 TPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 308
P+ A F + + P +P + R + + +RP ++++
Sbjct: 205 PPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 3e-37
Identities = 72/225 (32%), Positives = 122/225 (54%), Gaps = 12/225 (5%)
Query: 94 SLASMLEKQFTSEVALLFRLNHPHIITFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEP 152
+L L+ +F E +L + +HP+I+ + C +K P++ I+ E + GG +L + P
Sbjct: 31 TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFLRTEGP 89
Query: 153 YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212
+ + ++++ + A GM+YL S+ +HRDL + N L+ E +K++DFG+S E
Sbjct: 90 R-LKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148
Query: 213 SAKGFTGTYR-----WMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAA 266
A TG + W APE + R++ + DV+SFGI+LWE + P+ N++ +Q
Sbjct: 149 YAS--TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR 206
Query: 267 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 311
A+ ++ R P P CP A L+ RCW P +RP F + L
Sbjct: 207 EAI-EQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 4e-37
Identities = 81/259 (31%), Positives = 128/259 (49%), Gaps = 34/259 (13%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VA+K++ + + L +L SE LL ++NHPH+I AC + +I EY
Sbjct: 33 VAVKMLKENASSSELRDLL-----SEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKY 87
Query: 141 GSLRKYLHQQ---EPYSV-----------------PLNL--VLKLALDIARGMQYLHSQG 178
GSLR +L + P + L + ++ A I+RGMQYL
Sbjct: 88 GSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK 147
Query: 179 ILHRDLKSENLLLGEDMCVKVADFGISC----LESQCGSAKGFTGTYRWMAPEMIKEKRH 234
++HRDL + N+L+ E +K++DFG+S +S +KG +WMA E + + +
Sbjct: 148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPV-KWMAIESLFDHIY 206
Query: 235 TKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 293
T + DV+SFG++LWE++T P+ + PE+ F + + R P C + L+ C
Sbjct: 207 TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-LFNLLKTGYRMERPENCSEEMYNLMLTC 265
Query: 294 WSSSPDRRPHFDQIVSILE 312
W PD+RP F I LE
Sbjct: 266 WKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 14/255 (5%)
Query: 58 FIGCKFASGRHSRIYRGIYKQRD----VAIKLVSQPEEDASLASMLEKQFTSEVALLFRL 113
+G SG +Y G+ D A+K VS ++ + + KQ E+ALL +L
Sbjct: 7 LLG----SGSFGSVYEGL--NLDDGDFFAVKEVSLADDGQTGQEAV-KQLEQEIALLSKL 59
Query: 114 NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQY 173
HP+I+ ++ ++ I E + GGSL K L + + P+ + I G++Y
Sbjct: 60 QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV--IRLYTRQILLGLEY 117
Query: 174 LHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK- 232
LH + +HRD+K N+L+ + VK+ADFG++ + AK F G+ WMAPE+I ++
Sbjct: 118 LHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 233 RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292
+ D++S G + E+ T P+ + A F + + PP+P I +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 293 CWSSSPDRRPHFDQI 307
C P RP ++
Sbjct: 238 CLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLAL 165
E +L R+NHP I+ A + ++ EY GG L +L ++ +S A
Sbjct: 43 ERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER--ARFYAA 100
Query: 166 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWM 224
+I ++YLHS GI++RDLK EN+LL D +K+ DFG++ L S+ F GT ++
Sbjct: 101 EIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160
Query: 225 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284
APE++ K + K VD +S G++L+E+LT PF ++ + +K + P P+
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE----IYEKILK--DPLRFPE 214
Query: 285 AFSY----LISRCWSSSPDRR 301
S LIS P +R
Sbjct: 215 FLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 3e-36
Identities = 80/269 (29%), Positives = 139/269 (51%), Gaps = 13/269 (4%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIY-KQRDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
W L + K +G+ ++ Y K VA+K + SM + F +E
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-------GSMSVEAFLAEAN 53
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
++ L H ++ A K P++ IITE++A GSL +L E PL ++ + IA
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 112
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAP 226
GM ++ + +HRDL++ N+L+ + K+ADFG++ + +++ + +G +W AP
Sbjct: 113 EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285
E I T K DV+SFGI+L E++T P+ M+ + A+ ++ R P P CP+
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEE 231
Query: 286 FSYLISRCWSSSPDRRPHFDQIVSILEGY 314
++ RCW + P+ RP F+ I S+L+ +
Sbjct: 232 LYNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 77/262 (29%), Positives = 128/262 (48%), Gaps = 32/262 (12%)
Query: 55 SQLF-IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
++F I K G + +Y+ I+K+ + VAIK+V E+ + K E+++L
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEI----IK----EISILK 53
Query: 112 RLNHPHIITFVAACKKPPVFCIITEYLAGGSLR-------KYLHQQEPYSVPLNLVLKLA 164
+ + P+I+ + + K I+ EY GS+ K L ++E + +L
Sbjct: 54 QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEE-----IAAILYQT 108
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRW 223
L +G++YLHS +HRD+K+ N+LL E+ K+ADFG+S L GT W
Sbjct: 109 L---KGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFW 165
Query: 224 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---VPP 280
MAPE+I+E + K D++S GI E+ P+ ++ P +A F + N PP P
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--PNKPPPTLSDPE 223
Query: 281 TCPKAFSYLISRCWSSSPDRRP 302
F+ + +C P+ RP
Sbjct: 224 KWSPEFNDFVKKCLVKDPEERP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 6e-36
Identities = 73/261 (27%), Positives = 113/261 (43%), Gaps = 18/261 (6%)
Query: 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR 112
S L G +Y+ +K + A+K + + KQ E+ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD-----EEFRKQLLRELKTLRS 55
Query: 113 LNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQ 172
P+++ A K I+ EY+ GGSL L + +P ++ +A I +G+
Sbjct: 56 CESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLD 113
Query: 173 YLHSQ-GILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIK 230
YLH++ I+HRD+K NLL+ VK+ADFGIS LE+ F GT +M+PE I+
Sbjct: 114 YLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 231 EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF-----AVCQKNARPPVPPTCPKA 285
+ ++ D++S G+ L E PF P Q +F A+C
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLP--PGQPSFFELMQAICDGPPPSLPAEEFSPE 231
Query: 286 FSYLISRCWSSSPDRRPHFDQ 306
F IS C P +RP +
Sbjct: 232 FRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 7e-36
Identities = 76/254 (29%), Positives = 130/254 (51%), Gaps = 35/254 (13%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA------ACKKPPVFCII 134
VA+K++ + D +S +E +F E A + +HP++I + A + P+ +I
Sbjct: 30 VAVKML---KADIFSSSDIE-EFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85
Query: 135 TEYLAGGSLRKYLHQ----QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 190
++ G L +L +EP+++PL +++ +DIA GM+YL S+ +HRDL + N +
Sbjct: 86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCM 145
Query: 191 LGEDMCVKVADFGISCLESQCGSAKGFTGTY-----------RWMAPEMIKEKRHTKKVD 239
L E+M V VADFG+ S K ++G Y +W+A E + + +T D
Sbjct: 146 LNENMTVCVADFGL--------SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSD 197
Query: 240 VYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 298
V++FG+ +WE++T TP+ + + + K R PP C + L+ +CWS P
Sbjct: 198 VWAFGVTMWEIMTRGQTPYAGVENSE-IYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEP 256
Query: 299 DRRPHFDQIVSILE 312
RP F + LE
Sbjct: 257 KCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 8e-36
Identities = 70/243 (28%), Positives = 118/243 (48%), Gaps = 17/243 (6%)
Query: 81 VAIK-LVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLA 139
V +K L +E+ F E+ + +L+H +++ + C++ +I EY
Sbjct: 38 VLVKALQKTKDENLQSE------FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTD 91
Query: 140 GGSLRKYLHQQEP-----YSVPLNLVLKLAL--DIARGMQYLHSQGILHRDLKSENLLLG 192
G L+++L + PL+ K+AL IA GM +L + +HRDL + N L+
Sbjct: 92 LGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS 151
Query: 193 EDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 250
VKV+ +S S+ + RW+APE ++E + K DV+SFG+++WE+
Sbjct: 152 SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
Query: 251 LT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309
T PF ++ E+ + PVP CP L++RCW+ +P RP F ++VS
Sbjct: 212 FTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271
Query: 310 ILE 312
L
Sbjct: 272 ALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-35
Identities = 78/276 (28%), Positives = 126/276 (45%), Gaps = 45/276 (16%)
Query: 66 GRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118
G +Y G+Y+ RD VA+K + E S E F E ++ + NH +I
Sbjct: 17 GAFGEVYEGLYRGRDGDAVELQVAVKTLP---ESCSEQD--ESDFLMEALIMSKFNHQNI 71
Query: 119 ITFVAAC-KKPPVFCIITEYLAGGSLRKYL-----HQQEPYSVPLNLVLKLALDIARGMQ 172
+ + ++ P F I+ E +AGG L+ +L + P S+ + +L A D+A+G +
Sbjct: 72 VRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 173 YLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGT--YR----- 222
YL +HRD+ + N LL G K+ADFG+ A+ YR
Sbjct: 131 YLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM---------ARDIYRASYYRKGGRA 181
Query: 223 -----WMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 276
WM PE + T K DV+SFG++LWE+ + P+ T ++ V R
Sbjct: 182 MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG-GGRL 240
Query: 277 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
P CP +++ CW +P+ RP+F I+ ++
Sbjct: 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 80/260 (30%), Positives = 121/260 (46%), Gaps = 28/260 (10%)
Query: 61 CKFASGRHSRIYRGIY--KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118
G + +Y I VAIK + + S+ + + EV + + NHP++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRK-----EVQAMSQCNHPNV 61
Query: 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSV----PLNLVLKLALDIARGMQYL 174
+ + + ++ YL+GGSL + P + VLK L +G++YL
Sbjct: 62 VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL---KGLEYL 118
Query: 175 HSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLE----SQCGSAKGFTGTYRWMAPEMI 229
HS G +HRD+K+ N+LLGED VK+ADFG+S L K F GT WMAPE++
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 230 KEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT------C 282
++ + K D++SFGI EL T P+ P + Q + PP T
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND--PPSLETGADYKKY 236
Query: 283 PKAFSYLISRCWSSSPDRRP 302
K+F +IS C P +RP
Sbjct: 237 SKSFRKMISLCLQKDPSKRP 256
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-35
Identities = 79/268 (29%), Positives = 139/268 (51%), Gaps = 19/268 (7%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVAL 109
W+ +M +L + G + G Y+ VA+K + + DA+ + F +E ++
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI---KNDAT-----AQAFLAEASV 52
Query: 110 LFRLNHPHIITFVAAC--KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDI 167
+ +L H +++ + +K ++ I+TEY+A GSL YL + + + +LK +LD+
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY--RWMA 225
M+YL + +HRDL + N+L+ ED KV+DFG+ ++ S+ TG +W A
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL----TKEASSTQDTGKLPVKWTA 167
Query: 226 PEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284
PE ++EK+ + K DV+SFGI+LWE+ + P+ + P + +K + P CP
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPP 226
Query: 285 AFSYLISRCWSSSPDRRPHFDQIVSILE 312
++ +CW RP F Q+ LE
Sbjct: 227 VVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-35
Identities = 64/245 (26%), Positives = 110/245 (44%), Gaps = 29/245 (11%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VA+K + L+ +++ F E A++ L+H ++I P+ ++TE
Sbjct: 26 VAVKCLK----SDKLSDIMD-DFLKEAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPL 79
Query: 141 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 200
GSL L + ++ + A+ IA GM+YL S+ +HRDL + N+LL D VK+
Sbjct: 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIG 139
Query: 201 DFGIS---CLESQCGSAKGFTGTYR----------WMAPEMIKEKRHTKKVDVYSFGIVL 247
DFG+ Y W APE ++ + + DV+ FG+ L
Sbjct: 140 DFGLMRALPQNEDH---------YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTL 190
Query: 248 WELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQ 306
WE+ T P+ ++ Q + ++ R P CP+ ++ +CW+ +P RP F
Sbjct: 191 WEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAA 250
Query: 307 IVSIL 311
+ L
Sbjct: 251 LREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-35
Identities = 80/263 (30%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 60 GCKFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASL----ASMLEKQFTSEVALLFRL 113
G SG +Y G+ +A+K V P AS SML+ E+ALL L
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDA-LAREIALLKEL 63
Query: 114 NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQY 173
H +I+ ++ + I EY+ GGS+ L+ + LV I +G+ Y
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNY 121
Query: 174 LHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAK------GFTGTYRWMAP 226
LH++GI+HRD+K N+L+ +K++DFGIS LE+ S K G+ WMAP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286
E++K+ +T+K D++S G ++ E+LT PF + T QA F + + NA P +P
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNISSEA 240
Query: 287 SYLISRCWSSSPDRRPHFDQIVS 309
+ + + ++RP +++
Sbjct: 241 IDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 7e-35
Identities = 84/294 (28%), Positives = 142/294 (48%), Gaps = 34/294 (11%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYR----GIYKQR-----DVAIKLVSQPEEDASLAS 97
+ +W +L +G G ++ R GI K R VA+K++ D LA
Sbjct: 4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD 63
Query: 98 MLEKQFTSEVALLFRLN-HPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVP 156
++ SE+ L+ + H +II + C + +I EY A G+LR++L + P
Sbjct: 64 LI-----SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPD 118
Query: 157 LNL--------------VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202
++ A +ARGM+YL S+ +HRDL + N+L+ ED +K+ADF
Sbjct: 119 YTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADF 178
Query: 203 GISCLESQCGSAKGFTG---TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFD 258
G++ K + +WMAPE + ++ +T + DV+SFGI++WE+ T +P+
Sbjct: 179 GLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238
Query: 259 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
+ P + F + ++ R P C L+ CW + P +RP F Q+V L+
Sbjct: 239 GI-PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 8e-35
Identities = 75/244 (30%), Positives = 119/244 (48%), Gaps = 29/244 (11%)
Query: 71 IYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII----TFVAA 124
+Y+ I K + VAIK++ E + + + + E+ L + P+I +F+
Sbjct: 17 VYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ-----EIQFLSQCRSPYITKYYGSFLKG 71
Query: 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 184
K II EY GGS L +P + + + ++ G++YLH +G +HRD+
Sbjct: 72 SK----LWIIMEYCGGGSCLDLL---KPGKLDETYIAFILREVLLGLEYLHEEGKIHRDI 124
Query: 185 KSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSF 243
K+ N+LL E+ VK+ADFG+S L S F GT WMAPE+IK+ + +K D++S
Sbjct: 125 KAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSL 184
Query: 244 GIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP-----KAFSYLISRCWSSSP 298
GI EL P ++ P + F + + N PP+ K F +S C + P
Sbjct: 185 GITAIELAKGEPPLSDLHPMRVLFLIPKNN-----PPSLEGNKFSKPFKDFVSLCLNKDP 239
Query: 299 DRRP 302
RP
Sbjct: 240 KERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 84/267 (31%), Positives = 121/267 (45%), Gaps = 49/267 (18%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VA+K++ DA+ + F EV +L RL P+II + C C+ITEY+
Sbjct: 49 VAVKIL---RPDANKNA--RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 141 GSLRKYL--HQQEPYSVPLN---------------LVLKLALDIARGMQYLHSQGILHRD 183
G L ++L H + N +L +AL IA GM+YL S +HRD
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163
Query: 184 LKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY-----------RWMAPEMIKEK 232
L + N L+GE++ +K+ADFG+ S + G Y RWMA E I
Sbjct: 164 LATRNCLVGENLTIKIADFGM--------SRNLYAGDYYRIQGRAVLPIRWMAWECILMG 215
Query: 233 RHTKKVDVYSFGIVLWELLTAL--TPFDNMTPEQAA------FAVCQKNARPPVPPTCPK 284
+ T DV++FG+ LWE+L P+ +T EQ F + PP CP+
Sbjct: 216 KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQ 275
Query: 285 AFSYLISRCWSSSPDRRPHFDQIVSIL 311
L+ +CWS RP F I + L
Sbjct: 276 GLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 77/256 (30%), Positives = 115/256 (44%), Gaps = 38/256 (14%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VA+K + + + K F E LL H +I+ F C + ++ EY+
Sbjct: 38 VAVKTLKETASND-----ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEH 92
Query: 141 GSLRKYLHQQEPYSV----------PLNLV--LKLALDIARGMQYLHSQGILHRDLKSEN 188
G L K+L P + L L L++A+ IA GM YL SQ +HRDL + N
Sbjct: 93 GDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRN 152
Query: 189 LLLGEDMCVKVADFGISCLESQCGSAKGFTGTY-----------RWMAPEMIKEKRHTKK 237
L+G D+ VK+ DFG+ S +T Y RWM PE I ++ T +
Sbjct: 153 CLVGYDLVVKIGDFGM--------SRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE 204
Query: 238 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296
DV+SFG+VLWE+ T P+ ++ E+ + Q P TCP ++ CW
Sbjct: 205 SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR-PRTCPSEVYDIMLGCWKR 263
Query: 297 SPDRRPHFDQIVSILE 312
P +R + I L+
Sbjct: 264 DPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 2e-34
Identities = 79/256 (30%), Positives = 119/256 (46%), Gaps = 42/256 (16%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VA+K++ A + F E+ ++ RL +P+II + C C+ITEY+
Sbjct: 47 VAVKMLR-----ADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMEN 101
Query: 141 GSLRKYLHQQEPYS----------VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 190
G L ++L Q+E S V + +L +A+ IA GM+YL S +HRDL + N L
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161
Query: 191 LGEDMCVKVADFGISCLESQCGSAKGFTGTY-----------RWMAPEMIKEKRHTKKVD 239
+G +K+ADFG+ S ++G Y RWMA E I + T D
Sbjct: 162 VGNHYTIKIADFGM--------SRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASD 213
Query: 240 VYSFGIVLWELLTALT--PFDNMTPEQAA------FAVCQKNARPPVPPTCPKAFSYLIS 291
V++FG+ LWE+ T P+ ++ EQ F + P CP L+
Sbjct: 214 VWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMM 273
Query: 292 RCWSSSPDRRPHFDQI 307
RCWS RP F++I
Sbjct: 274 RCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-34
Identities = 73/266 (27%), Positives = 132/266 (49%), Gaps = 18/266 (6%)
Query: 54 MSQLFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEV 107
++L SG +Y+G++ + VAIK++ E+ S + K+ E
Sbjct: 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL---REETSPKA--NKEILDEA 60
Query: 108 ALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDI 167
++ ++HPH++ + C V +IT+ + G L Y+ + L L + I
Sbjct: 61 YVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYL-LNWCVQI 118
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWM 224
A+GM YL + ++HRDL + N+L+ VK+ DFG++ L + + A+G +WM
Sbjct: 119 AKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 225 APEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283
A E I + +T K DV+S+G+ +WEL+T P++ + P + +K R P PP C
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQPPICT 237
Query: 284 KAFSYLISRCWSSSPDRRPHFDQIVS 309
++ +CW + RP F ++++
Sbjct: 238 IDVYMVLVKCWMIDAESRPTFKELIN 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 69/263 (26%), Positives = 131/263 (49%), Gaps = 13/263 (4%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
+ S+L + SG+ ++ G ++ Q VAIK +++ +M E+ F E ++
Sbjct: 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE-------GAMSEEDFIEEAKVMM 54
Query: 112 RLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGM 171
+L+HP ++ C + I+TE++ G L YL Q++ +++L + D+ GM
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK-DMLLSMCQDVCEGM 113
Query: 172 QYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMI 229
+YL +HRDL + N L+ VKV+DFG++ L+ + S+ G +W PE+
Sbjct: 114 EYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVF 173
Query: 230 KEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288
+++ K DV+SFG+++WE+ T PF+ + + + + R P
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRPKLASMTVYE 232
Query: 289 LISRCWSSSPDRRPHFDQIVSIL 311
++ CW P+ RP F +++ +
Sbjct: 233 VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 6e-34
Identities = 77/278 (27%), Positives = 127/278 (45%), Gaps = 31/278 (11%)
Query: 57 LFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
L +G G + G Q D +K+ + + A + F SE + +HP
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 117 HIITFVAACKKP------PVFCIITEYLAGGSLRKYLHQQ----EPYSVPLNLVLKLALD 166
+++ + C + P +I ++ G L +L P +P +++K D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 167 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY----- 221
IA GM+YL S+ +HRDL + N +L E+M V VADFG+ S K + G Y
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGL--------SKKIYNGDYYRQGR 172
Query: 222 ------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 274
+W+A E + ++ +T K DV+SFG+ +WE+ T TP+ + + + ++
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLRQGN 231
Query: 275 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
R PP C L+S CW +P RP F+ + LE
Sbjct: 232 RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 8e-34
Identities = 85/281 (30%), Positives = 134/281 (47%), Gaps = 29/281 (10%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEK- 101
W ++ + + G +Y GI K + VAIK V++ ASM E+
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA------ASMRERI 54
Query: 102 QFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYS------- 154
+F +E +++ N H++ + + +I E + G L+ YL P
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 155 -VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQC 211
L ++++A +IA GM YL++ +HRDL + N ++ ED VK+ DFG++ E+
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174
Query: 212 GSAKGFTGTY--RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 268
KG G RWM+PE +K+ T DV+SFG+VLWE+ T A P+ M+ EQ
Sbjct: 175 -YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF 233
Query: 269 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309
V + P CP L+ CW +P RP F +I+S
Sbjct: 234 VMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-33
Identities = 90/340 (26%), Positives = 158/340 (46%), Gaps = 40/340 (11%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYR----GIYKQR-----DVAIKLVSQPEEDASLAS 97
+ +W ++L +G G ++ GI K + VA+K++ D L+
Sbjct: 4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSD 63
Query: 98 MLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP---- 152
++ SE+ ++ + H +II + AC + ++ EY + G+LR+YL + P
Sbjct: 64 LV-----SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMD 118
Query: 153 YS----------VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202
YS + ++ A +ARGM+YL SQ +HRDL + N+L+ ED +K+ADF
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADF 178
Query: 203 GISCLESQCGSAKGFTG---TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFD 258
G++ K T +WMAPE + ++ +T + DV+SFG++LWE+ T +P+
Sbjct: 179 GLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238
Query: 259 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318
+ P + F + ++ R P C ++ CW + P +RP F Q+V L+
Sbjct: 239 GI-PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297
Query: 319 EQDPEFFSSFIPSPDHTILRCLPTCIARHCCAHSKAKELF 358
D E+ +P ++ P C S +F
Sbjct: 298 STD-EYLDLSVPFEQYS-----PGCPDSPSSCSSGDDSVF 331
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-33
Identities = 76/251 (30%), Positives = 131/251 (52%), Gaps = 25/251 (9%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEYLA 139
VA+K++ + L+ ++ SE+ ++ + H +II + AC + +I EY +
Sbjct: 53 VAVKMLKSDATEKDLSDLI-----SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 107
Query: 140 GGSLRKYLHQQEP----YS-----VPLNL-----VLKLALDIARGMQYLHSQGILHRDLK 185
G+LR+YL + P Y VP ++ A +ARGM+YL S+ +HRDL
Sbjct: 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA 167
Query: 186 SENLLLGEDMCVKVADFGISCLESQCGSAKGFTG---TYRWMAPEMIKEKRHTKKVDVYS 242
+ N+L+ ED +K+ADFG++ K T +WMAPE + ++ +T + DV+S
Sbjct: 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 227
Query: 243 FGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 301
FG++LWE+ T +P+ + P + F + ++ R P C ++ CW + P +R
Sbjct: 228 FGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 286
Query: 302 PHFDQIVSILE 312
P F Q+V L+
Sbjct: 287 PTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 3e-33
Identities = 74/251 (29%), Positives = 130/251 (51%), Gaps = 25/251 (9%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEYLA 139
VA+K++ + L+ ++ SE+ ++ + H +II + AC + +I EY +
Sbjct: 50 VAVKMLKDDATEKDLSDLV-----SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 104
Query: 140 GGSLRKYLHQQEP----YSVPLNLV----------LKLALDIARGMQYLHSQGILHRDLK 185
G+LR+YL + P YS + V + +ARGM+YL SQ +HRDL
Sbjct: 105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA 164
Query: 186 SENLLLGEDMCVKVADFGISCLESQCGSAKGFTG---TYRWMAPEMIKEKRHTKKVDVYS 242
+ N+L+ E+ +K+ADFG++ + K T +WMAPE + ++ +T + DV+S
Sbjct: 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 224
Query: 243 FGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 301
FG+++WE+ T +P+ + P + F + ++ R P C ++ CW + P R
Sbjct: 225 FGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHR 283
Query: 302 PHFDQIVSILE 312
P F Q+V L+
Sbjct: 284 PTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-33
Identities = 71/238 (29%), Positives = 122/238 (51%), Gaps = 12/238 (5%)
Query: 81 VAIKLVSQPEEDASLASMLEKQ-FTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEYL 138
VA+K++ +P +S E++ SE+ ++ L NH +I+ + AC +ITEY
Sbjct: 68 VAVKML-KPTAHSS-----EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYC 121
Query: 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 198
G L +L ++ + L +L + +A+GM +L S+ +HRDL + N+LL VK
Sbjct: 122 CYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK 181
Query: 199 VADFGIS--CLESQCGSAKGFTG-TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-AL 254
+ DFG++ + KG +WMAPE I +T + DV+S+GI+LWE+ +
Sbjct: 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241
Query: 255 TPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
P+ M + + + ++ R P P ++ CW + P +RP F QIV ++
Sbjct: 242 NPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-33
Identities = 75/285 (26%), Positives = 143/285 (50%), Gaps = 19/285 (6%)
Query: 63 FASGRHSRIYRGIYKQRDVAIKL-VSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF 121
SG +Y+GI+ +K+ V+ + + +F E ++ ++HPH++
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 122 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILH 181
+ C P + ++T+ + G L Y+H+ + ++ L+L + IA+GM YL + ++H
Sbjct: 75 LGVCLSPTI-QLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERRLVH 132
Query: 182 RDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 238
RDL + N+L+ VK+ DFG++ L + + +A G +WMA E I ++ T +
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQS 192
Query: 239 DVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 297
DV+S+G+ +WEL+T P+D + P + + +K R P PP C ++ +CW
Sbjct: 193 DVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMID 251
Query: 298 PDRRPHFDQIVSILEGYSESLEQDPEFFSSF-------IPSPDHT 335
D RP F ++ + + +DP+ + +PSP+ +
Sbjct: 252 ADSRPKFKELAAEF----SRMARDPQRYLVIQGDDRMKLPSPNDS 292
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 4e-33
Identities = 72/251 (28%), Positives = 116/251 (46%), Gaps = 20/251 (7%)
Query: 59 IGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP-H 117
I K G +Y + + VA+K++++ E S ++F E+ +L LNHP +
Sbjct: 4 ILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSK---EVERFLREIQILASLNHPPN 59
Query: 118 IITFVAACKKPPVFCIITEYLAGGSLRKYLHQ-QEPYSVPLNLVLKLALDIARGMQYLHS 176
I+ + ++ EY+ GGSL L + + + L + I ++YLHS
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 177 QGILHRDLKSENLLLGED-MCVKVADFGISCLESQCGSA-------KGFTGTYRWMAPEM 228
+GI+HRD+K EN+LL D VK+ DFG++ L GS GT +MAPE+
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 229 IKEKRH---TKKVDVYSFGIVLWELLTALTPF---DNMTPEQAAFAVCQKNARPPVPPTC 282
+ + D++S GI L+ELLT L PF N + + + P +
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 283 PKAFSYLISRC 293
+ LIS+
Sbjct: 240 SPSNPELISKA 250
|
Length = 384 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 7e-33
Identities = 70/248 (28%), Positives = 120/248 (48%), Gaps = 21/248 (8%)
Query: 72 YRGIYKQRDV------AIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125
+ Y+ RDV A+K V+ +S + + E+ L+ RLNHPHII + A
Sbjct: 13 FSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT 72
Query: 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 185
+ F + E++AGGS+ L + + +++ + RG+ YLH I+HRD+K
Sbjct: 73 CEDSHFNLFVEWMAGGSVSHLLSKYGAFKE--AVIINYTEQLLRGLSYLHENQIIHRDVK 130
Query: 186 SENLLL---GEDMCVKVADFGISC-LESQ---CGSAKG-FTGTYRWMAPEMIKEKRHTKK 237
NLL+ G+ +++ADFG + L ++ G +G GT +MAPE+++ +++ +
Sbjct: 131 GANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRS 188
Query: 238 VDVYSFGIVLWELLTALTPFDNMTPE---QAAFAVCQKNARPPVPPTCPKAFSYLISRCW 294
DV+S G V+ E+ TA P++ F + P +P + RC
Sbjct: 189 CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCL 248
Query: 295 SSSPDRRP 302
P+ RP
Sbjct: 249 ELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 81/253 (32%), Positives = 121/253 (47%), Gaps = 38/253 (15%)
Query: 72 YRGIYKQRD------VAIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124
Y +YK RD VAIK++ +P +D + E+++L HP+I+ + +
Sbjct: 16 YGDVYKARDIATGELVAIKVIKLEPGDDF-------EIIQQEISMLKECRHPNIVAYFGS 68
Query: 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSV---PLN-----LVLKLALDIARGMQYLHS 176
+ I+ EY GGSL Q+ Y V PL+ V + L +G+ YLH
Sbjct: 69 YLRRDKLWIVMEYCGGGSL------QDIYQVTRGPLSELQIAYVCRETL---KGLAYLHE 119
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKR-- 233
G +HRD+K N+LL ED VK+ADFG+S L + K F GT WMAPE+ +R
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 234 -HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV---PPTCPKAFSYL 289
+ K D+++ GI EL P ++ P +A F + + N PP F
Sbjct: 180 GYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF 239
Query: 290 ISRCWSSSPDRRP 302
I +C + P +RP
Sbjct: 240 IKKCLTKDPKKRP 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-32
Identities = 79/259 (30%), Positives = 126/259 (48%), Gaps = 41/259 (15%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VA+K++ EDA+ + F E+ ++ RL P+II +A C C+ITEY+
Sbjct: 49 VAVKML---REDANKNA--RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103
Query: 141 GSLRKYLHQQEP---------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 191
G L ++L + EP ++ + ++ +A IA GM+YL S +HRDL + N L+
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163
Query: 192 GEDMCVKVADFGISCLESQCGSAKGFTGTY-----------RWMAPEMIKEKRHTKKVDV 240
G++ +K+ADFG+ S ++G Y RWM+ E I + T DV
Sbjct: 164 GKNYTIKIADFGM--------SRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDV 215
Query: 241 YSFGIVLWELLTAL--TPFDNMTPEQAA------FAVCQKNARPPVPPTCPKAFSYLISR 292
++FG+ LWE+LT P+ ++ EQ F + P P CP + L+
Sbjct: 216 WAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLS 275
Query: 293 CWSSSPDRRPHFDQIVSIL 311
CW + RP F +I + L
Sbjct: 276 CWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 72/259 (27%), Positives = 129/259 (49%), Gaps = 29/259 (11%)
Query: 71 IYRGIY-----KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125
+Y G ++ A+K +++ + + QF E ++ +HP++++ + C
Sbjct: 11 VYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-----QFLKEGIIMKDFSHPNVLSLLGIC 65
Query: 126 KKP---PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
P+ ++ Y+ G LR ++ + +L+ L +A+GM+YL S+ +HR
Sbjct: 66 LPSEGSPL--VVLPYMKHGDLRNFIRSETHNPTVKDLI-GFGLQVAKGMEYLASKKFVHR 122
Query: 183 DLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGT---YRWMAPEMIKEKRHTKK 237
DL + N +L E VKVADFG++ + + S TG +WMA E ++ ++ T K
Sbjct: 123 DLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTK 182
Query: 238 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ---KNARPPVPPTCPKAFSYLISRC 293
DV+SFG++LWEL+T P+ P+ +F + + R P CP ++ C
Sbjct: 183 SDVWSFGVLLWELMTRGAPPY----PDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSC 238
Query: 294 WSSSPDRRPHFDQIVSILE 312
W P+ RP F ++VS +E
Sbjct: 239 WHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 69/225 (30%), Positives = 111/225 (49%), Gaps = 20/225 (8%)
Query: 102 QFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYS------- 154
+F E +L+ L+HP+I+ + + C++ EYL G L ++L + P+S
Sbjct: 53 EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112
Query: 155 ----VPLNL----VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206
V +L L +A+ IA GM+YL S +H+DL + N+L+GE + VK++D G+S
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 207 LESQCGSAKGFTGTY---RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 262
+ + RWM PE I + + D++SFG+VLWE+ + L P+ +
Sbjct: 173 EIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS- 231
Query: 263 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307
Q + +K P CP L++ CW P RRP F I
Sbjct: 232 NQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 4e-32
Identities = 85/279 (30%), Positives = 125/279 (44%), Gaps = 34/279 (12%)
Query: 57 LFIGCKFASGRHSRIYRGIYKQRD--------VAIKLVSQPEEDASLASMLEKQFTSEVA 108
F+G SG +Y G VA+K + + D +K+F E
Sbjct: 1 NFLG----SGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-----KKEFLKEAH 51
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQ---QEPYSVPLNLV--LKL 163
L+ NHP+I+ + C II E + GG L YL + L L L +
Sbjct: 52 LMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDI 111
Query: 164 ALDIARGMQYLHSQGILHRDLKSENLLLGE-----DMCVKVADFGIS--CLESQCGSAKG 216
LD+A+G YL +HRDL + N L+ E D VK+ DFG++ +S +G
Sbjct: 112 CLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171
Query: 217 FTG--TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 273
G RWMAPE + + + T + DV+SFG+++WE+LT P+ + Q
Sbjct: 172 -EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-NQEVLQHVTAG 229
Query: 274 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
R P CP L++ CW+ P RP FD+I IL+
Sbjct: 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 7e-32
Identities = 80/251 (31%), Positives = 117/251 (46%), Gaps = 29/251 (11%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VA+K + P A K F E LL L H HI+ F C ++ EY+
Sbjct: 38 VAVKALKDPTLAA------RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKH 91
Query: 141 GSLRKYLHQQEPYS--------------VPLNLVLKLALDIARGMQYLHSQGILHRDLKS 186
G L K+L P + + L+ +L +A IA GM YL SQ +HRDL +
Sbjct: 92 GDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLAT 151
Query: 187 ENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTG-TYRWMAPEMIKEKRHTKKVDVYSF 243
N L+G ++ VK+ DFG+S + G T RWM PE I ++ T + DV+SF
Sbjct: 152 RNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211
Query: 244 GIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA--RPPVPPTCPKAFSYLISRCWSSSPDR 300
G++LWE+ T P+ ++ + + Q RP V CPK ++ CW P +
Sbjct: 212 GVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV---CPKEVYDIMLGCWQREPQQ 268
Query: 301 RPHFDQIVSIL 311
R + +I IL
Sbjct: 269 RLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 7e-32
Identities = 82/252 (32%), Positives = 122/252 (48%), Gaps = 22/252 (8%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VA+K + ++A K F E LL L H HI+ F C + ++ EY+
Sbjct: 38 VAVKTLKDASDNA------RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKH 91
Query: 141 GSLRKYLHQQEPYSV-------PLNL----VLKLALDIARGMQYLHSQGILHRDLKSENL 189
G L K+L P +V P L +L +A IA GM YL SQ +HRDL + N
Sbjct: 92 GDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 151
Query: 190 LLGEDMCVKVADFGIS--CLESQCGSAKGFTG-TYRWMAPEMIKEKRHTKKVDVYSFGIV 246
L+GE++ VK+ DFG+S + G T RWM PE I ++ T + DV+S G+V
Sbjct: 152 LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV 211
Query: 247 LWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFD 305
LWE+ T P+ ++ + + Q P TCPK L+ CW P R +
Sbjct: 212 LWEIFTYGKQPWYQLSNNEVIECITQGRVLQR-PRTCPKEVYDLMLGCWQREPHMRLNIK 270
Query: 306 QIVSILEGYSES 317
+I S+L+ +++
Sbjct: 271 EIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 8e-32
Identities = 74/243 (30%), Positives = 111/243 (45%), Gaps = 33/243 (13%)
Query: 99 LEKQFTSEVALLFRLNHPHIITFVAACKKP--PVFCIITEYLAGGSLRKYLHQQEPYSVP 156
+ E+ +L L H +I+ + C + +I EY+ GSLR YL + + +
Sbjct: 49 NTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLN 105
Query: 157 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS---------CL 207
L +L A I GM YLHSQ +HRDL + N+LL D VK+ DFG++
Sbjct: 106 LAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 165
Query: 208 ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP-------FDNM 260
+ G + F W A E +KE + + DV+SFG+ L+ELLT F+ M
Sbjct: 166 VREDGDSPVF-----WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM 220
Query: 261 T-PEQAAFAVC------QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 313
P+Q V ++ R P P CP+ L+ CW + RP F ++ IL+
Sbjct: 221 IGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280
Query: 314 YSE 316
Sbjct: 281 MHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 71/256 (27%), Positives = 130/256 (50%), Gaps = 19/256 (7%)
Query: 62 KFASGRHSRIYRGIYKQR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH 117
+ SG + +G+YK R DVAIK++ E + M+ E ++ +L++P+
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMM-----REAEIMHQLDNPY 56
Query: 118 IITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 177
I+ + C+ + ++ E +GG L K+L ++ + ++ V++L ++ GM+YL +
Sbjct: 57 IVRMIGVCEAEALM-LVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEGK 114
Query: 178 GILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTG---TYRWMAPEMIKEKR 233
+HRDL + N+LL K++DFG+S L + K + +W APE I ++
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 234 HTKKVDVYSFGIVLWELLT-ALTPFDNMT-PEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291
+ + DV+S+GI +WE + P+ M PE +F ++ R P CP L+
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF--IEQGKRLDCPAECPPEMYALMK 232
Query: 292 RCWSSSPDRRPHFDQI 307
CW + RP+F ++
Sbjct: 233 DCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 81/283 (28%), Positives = 137/283 (48%), Gaps = 27/283 (9%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQ 102
W ++ + + G +Y G + + VA+K V+ E ASL +E
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN---ESASLRERIE-- 55
Query: 103 FTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYS-------V 155
F +E +++ H++ + K ++ E +A G L+ YL P +
Sbjct: 56 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 115
Query: 156 P-LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCG 212
P L ++++A +IA GM YL+++ +HRDL + N ++ D VK+ DFG++ E+
Sbjct: 116 PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY- 174
Query: 213 SAKGFTGTY--RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAV 269
KG G RWMAPE +K+ T D++SFG+VLWE+ + A P+ ++ EQ
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-VLKF 233
Query: 270 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
P CP+ + L+ CW +P RP F +IV++L+
Sbjct: 234 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 69/261 (26%), Positives = 118/261 (45%), Gaps = 30/261 (11%)
Query: 60 GCKFASGRHSRIYRGIYKQ--RDVAIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNHP 116
G K G ++Y + +A+K + Q + ++ K+ E+ +L L HP
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTI-----KEIADEMKVLELLKHP 59
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+++ + I EY +GG+L + L + +++ L + G+ YLHS
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA-----KGFTGTYRWMAPEMIKE 231
GI+HRD+K N+ L + +K+ DFG + + + GT +MAPE+I
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 232 KR---HTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVCQKNARPPVP------PT 281
+ H + D++S G V+ E+ T P+ + E Q F V + +PP+P P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSLQLSPE 236
Query: 282 CPKAFSYLISRCWSSSPDRRP 302
K F + RC S P +RP
Sbjct: 237 G-KDF---LDRCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 7e-31
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 2/204 (0%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLAL 165
E+ +L L HP+II + I EY GG+L + +Q+ +VL
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 166 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWM 224
I + Y+H GILHRD+K+ N+ L + +K+ DFGIS L S+ A+ GT +M
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYM 168
Query: 225 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284
+PE+ + ++ K D+++ G VL+ELLT FD P + Q N PV
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSS 227
Query: 285 AFSYLISRCWSSSPDRRPHFDQIV 308
L+ P++RP D+++
Sbjct: 228 ELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 7e-31
Identities = 70/255 (27%), Positives = 117/255 (45%), Gaps = 17/255 (6%)
Query: 66 GRHSRIYRGIYKQRD-VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124
G + +Y G+ Q +A+K V + A ++ EV LL L H +I+ ++
Sbjct: 11 GAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70
Query: 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 184
C I E++ GGS+ L++ P P+ K I G+ YLH+ ++HRD+
Sbjct: 71 CLDDNTISIFMEFVPGGSISSILNRFGPLPEPV--FCKYTKQILDGVAYLHNNCVVHRDI 128
Query: 185 KSENLLLGEDMCVKVADFGIS---CLESQCGSA----KGFTGTYRWMAPEMIKEKRHTKK 237
K N++L + +K+ DFG + G+ K GT WMAPE+I E + +K
Sbjct: 129 KGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRK 188
Query: 238 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY----LISRC 293
D++S G ++E+ T P +M A F + R +P P +FS ++ C
Sbjct: 189 SDIWSIGCTVFEMATGKPPLASMDRLAAMFYI--GAHRGLMPRL-PDSFSAAAIDFVTSC 245
Query: 294 WSSSPDRRPHFDQIV 308
+ RP Q++
Sbjct: 246 LTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFC------IITEYLAGGSLRKYLHQQEPYSVPLNL 159
E +L LNHP ++ + F ++ + L GG LR +L Q+ +S
Sbjct: 50 ERRILQELNHPFLVNLWYS------FQDEENMYLVVDLLLGGDLRYHLSQKVKFS---EE 100
Query: 160 VLKL-ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT 218
+K +I ++YLHS+GI+HRD+K +N+LL E V + DF I+ + +
Sbjct: 101 QVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160
Query: 219 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN--MTPEQAAFAVCQKNARP 276
GT +MAPE++ + ++ VD +S G+ +E L P+ T A Q+ A
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK-QETADV 219
Query: 277 PVPPTCPKAFSYLISRCWSSSPDRRPHF 304
P T I++ P +R
Sbjct: 220 LYPATWSTEAIDAINKLLERDPQKRLGD 247
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 70/209 (33%), Positives = 114/209 (54%), Gaps = 6/209 (2%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLAL 165
EV LL ++ HP+I+TF A+ ++ I+ EY GG L K +++Q + +L +
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 166 DIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGIS-CLESQCGSAKGFTGTYRW 223
I+ G++++H + ILHRD+KS+N+ L ++ M K+ DFGI+ L A GT +
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYY 168
Query: 224 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283
++PE+ + + + K D++S G VL+EL T PF+ Q +CQ P+ P
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFS 227
Query: 284 KAFSYLISRCWSSSPDRRPHFDQIVSILE 312
+ LIS+ + SP RP I SIL+
Sbjct: 228 RDLRSLISQLFKVSPRDRP---SITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 68/251 (27%), Positives = 128/251 (50%), Gaps = 8/251 (3%)
Query: 63 FASGRHSRIYRGIYKQRDVAIKL-VSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF 121
SG +Y+G++ +K+ V+ E + + K+ E ++ +++PH+
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 122 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILH 181
+ C V +IT+ + G L Y+ + + ++ +L + IA+GM YL + ++H
Sbjct: 75 LGICLTSTV-QLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERRLVH 132
Query: 182 RDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 238
RDL + N+L+ VK+ DFG++ L + + A+G +WMA E I + +T +
Sbjct: 133 RDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQS 192
Query: 239 DVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 297
DV+S+G+ +WEL+T P+D + P ++ +K R P PP C ++ +CW
Sbjct: 193 DVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 251
Query: 298 PDRRPHFDQIV 308
D RP F +++
Sbjct: 252 ADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 9e-30
Identities = 76/249 (30%), Positives = 114/249 (45%), Gaps = 24/249 (9%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VA+K + + E A F E LL L H HI+ F C + ++ EY+
Sbjct: 38 VAVKALKEASESARQ------DFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRH 91
Query: 141 GSLRKYLHQQEPYS-------------VPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 187
G L ++L P + + L +L +A IA GM YL S +HRDL +
Sbjct: 92 GDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATR 151
Query: 188 NLLLGEDMCVKVADFGIS--CLESQCGSAKGFTG-TYRWMAPEMIKEKRHTKKVDVYSFG 244
N L+G+ + VK+ DFG+S + G T RWM PE I ++ T + D++SFG
Sbjct: 152 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFG 211
Query: 245 IVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH 303
+VLWE+ T P+ ++ +A + Q P TCP ++ CW P +R
Sbjct: 212 VVLWEIFTYGKQPWYQLSNTEAIECITQGRELER-PRTCPPEVYAIMQGCWQREPQQRMV 270
Query: 304 FDQIVSILE 312
I S L+
Sbjct: 271 IKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 71/223 (31%), Positives = 110/223 (49%), Gaps = 17/223 (7%)
Query: 101 KQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQE-------- 151
+ F E+ +L +L +HP+II + AC+ I EY G+L +L +
Sbjct: 47 RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAF 106
Query: 152 ------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205
++ +L+ A D+A GMQYL + +HRDL + N+L+GE++ K+ADFG+S
Sbjct: 107 AKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS 166
Query: 206 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQ 264
E RWMA E + +T K DV+SFG++LWE+++ TP+ MT +
Sbjct: 167 RGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE 226
Query: 265 AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307
+ + R P C L+ +CW P RP F QI
Sbjct: 227 -LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 74/244 (30%), Positives = 119/244 (48%), Gaps = 12/244 (4%)
Query: 62 KFASGRHSRIYRGI--YKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
+ G +Y+GI + VAIK++ E + + + + E+ +L + + P+I
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQ-----EITVLSQCDSPYIT 65
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 179
+ + K II EYL GGS L +P + + + +I +G+ YLHS+
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 180 LHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 238
+HRD+K+ N+LL E VK+ADFG++ L F GT WMAPE+IK+ + K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 239 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 298
D++S GI EL P ++ P + F + KN+ P + K F + C + P
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVLFLI-PKNSPPTLEGQYSKPFKEFVEACLNKDP 241
Query: 299 DRRP 302
RP
Sbjct: 242 RFRP 245
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 77/254 (30%), Positives = 121/254 (47%), Gaps = 13/254 (5%)
Query: 53 DMSQLFIGC-KFASGRHSRIYRGI--YKQRDVAIKLVSQPEEDASLASMLEKQFTSEVAL 109
D +LF K G +++GI Q+ VAIK++ E + + + + E+ +
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ-----EITV 55
Query: 110 LFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR 169
L + + P++ + + K II EYL GGS L EP + + + +I +
Sbjct: 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILK 112
Query: 170 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEM 228
G+ YLHS+ +HRD+K+ N+LL E VK+ADFG++ L F GT WMAPE+
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 229 IKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288
IK+ + K D++S GI EL P + P + F + KN P + K
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-PKNNPPTLEGNYSKPLKE 231
Query: 289 LISRCWSSSPDRRP 302
+ C + P RP
Sbjct: 232 FVEACLNKEPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 4e-29
Identities = 73/264 (27%), Positives = 119/264 (45%), Gaps = 26/264 (9%)
Query: 64 ASGRHSRIYRGIYKQ----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118
G ++ + K+ D AIK + + + F E+ +L +L +HP+I
Sbjct: 4 GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----HRDFAGELEVLCKLGHHPNI 58
Query: 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLA 164
I + AC+ + EY G+L +L + ++ +L A
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWM 224
D+ARGM YL + +HRDL + N+L+GE+ K+ADFG+S + RWM
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 178
Query: 225 APEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283
A E + +T DV+S+G++LWE+++ TP+ MT + + + R P C
Sbjct: 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCD 237
Query: 284 KAFSYLISRCWSSSPDRRPHFDQI 307
L+ +CW P RP F QI
Sbjct: 238 DEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-29
Identities = 69/214 (32%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 97 SMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVP 156
++KQ E+ +L + N P+I+ F A I EY+ GGSL K L + + +P
Sbjct: 40 EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQG-RIP 98
Query: 157 LNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGS 213
++ K+A+ + +G+ YLH + I+HRD+K N+L+ +K+ DFG+S + S
Sbjct: 99 ERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155
Query: 214 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQK 272
AK F GT +MAPE I+ ++ K D++S G+ L EL T P+ P F + Q
Sbjct: 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY 215
Query: 273 --NARPPVPPT--CPKAFSYLISRCWSSSPDRRP 302
N PP P+ F ++ C P RP
Sbjct: 216 IVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-29
Identities = 72/275 (26%), Positives = 124/275 (45%), Gaps = 25/275 (9%)
Query: 63 FASGRHSRIYRGIYKQ-RDV-AIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
+ G + R++ K D+ AIK++ + D + +++ T E +L + P+++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVI--KKADMIRKNQVDQVLT-ERDILSQAQSPYVVK 57
Query: 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 180
+ + ++ EYL GG L L S+ ++ +I ++YLHS GI+
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 181 HRDLKSENLLLGEDMCVKVADFGIS---CLESQCG------SAKGFTGTYRWMAPEMIKE 231
HRDLK +N+L+ + +K+ DFG+S + Q K GT ++APE+I
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 232 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291
+ H+K VD +S G +L+E L + PF TPE+ + P LIS
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLIS 235
Query: 292 RCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFS 326
+ P++R I E ++ P FF
Sbjct: 236 KLLVPDPEKRLGAKSI--------EEIKNHP-FFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 80/251 (31%), Positives = 126/251 (50%), Gaps = 31/251 (12%)
Query: 66 GRHSRIYRGIY--KQRDVAIKLVS--QPEEDASLASMLEKQFTSEVALLFRLNH---PHI 118
G + +YRG + R VA+K+++ P++D S EVALL +L P+I
Sbjct: 12 GAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS-------DIQREVALLSQLRQSQPPNI 64
Query: 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQ---EPY-SVPLNLVLKLALDIARGMQYL 174
+ + K P II EY GGS+R + E Y SV + VL +AL +Y+
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL-VAL------KYI 117
Query: 175 HSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG-FTGTYRWMAPEMIKE-K 232
H G++HRD+K+ N+L+ VK+ DFG++ L +Q S + F GT WMAPE+I E K
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177
Query: 233 RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP--TCPKAFSYLI 290
+ K D++S GI ++E+ T P+ ++ +A + + +PP K +
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLREFV 235
Query: 291 SRCWSSSPDRR 301
+ C P R
Sbjct: 236 AACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 9/214 (4%)
Query: 102 QFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSL----RKYLHQQEPYSVPL 157
Q E LL +L+HP I+ F A+ + FCIITEY G L + H + ++
Sbjct: 48 QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK--TLSE 105
Query: 158 NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKG 216
N V + + + G+ Y+H + ILHRDLK++N+ L ++ +K+ DFG+S L C A
Sbjct: 106 NQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT 164
Query: 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 276
FTGT +M+PE +K + + K D++S G +L+E+ F+ + + P
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT-P 223
Query: 277 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310
+P T + + ++ + P RP +I+
Sbjct: 224 SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 72/238 (30%), Positives = 114/238 (47%), Gaps = 32/238 (13%)
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKP--PVFCIITEYLAGGSLRKYLHQQEPYSVPLN 158
+ F E+ +L L H +I+ + C ++ EYL GSLR YL Q+ +
Sbjct: 50 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHR 108
Query: 159 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-------- 210
+L A I +GM+YL S+ +HRDL + N+L+ + VK+ DFG++ + Q
Sbjct: 109 KLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR 168
Query: 211 -CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT----ALTP----FDNMT 261
G + F W APE + E + + DV+SFG+VL+EL T + +P M
Sbjct: 169 EPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMG 223
Query: 262 PE-QAAFAVC------QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
+ Q V + N R P PP CP ++ CW++ P +RP F ++ +E
Sbjct: 224 NDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 19/263 (7%)
Query: 62 KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH 117
+ SG + +G+YK ++ VA+K++ D +L L + E ++ +L++P+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR----EANVMQQLDNPY 57
Query: 118 IITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 177
I+ + C+ + ++ E G L K+L + + V + +L ++ GM+YL
Sbjct: 58 IVRMIGICEAES-WMLVMELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEET 114
Query: 178 GILHRDLKSENLLLGEDMCVKVADFGIS---CLESQCGSAKGFTGTY--RWMAPEMIKEK 232
+HRDL + N+LL K++DFG+S + AK G + +W APE +
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT-HGKWPVKWYAPECMNYY 173
Query: 233 RHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291
+ + K DV+SFG+++WE + P+ M + + + R P CP L+
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT-QMIESGERMECPQRCPPEMYDLMK 232
Query: 292 RCWSSSPDRRPHFDQIVSILEGY 314
CW+ D RP F + L Y
Sbjct: 233 LCWTYGVDERPGFAVVELRLRNY 255
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 64/205 (31%), Positives = 106/205 (51%), Gaps = 3/205 (1%)
Query: 106 EVALLFRLNHPHIITFVAACK-KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
E LL +L HP+I+ + + + + + I+ + GG L L +Q+ +P N V++
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRW 223
+ IA +QYLH + ILHRDLK++N+ L +KV D GI+ LE+QC A GT +
Sbjct: 109 VQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYY 168
Query: 224 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283
M+PE+ K + K DV++ G ++E+ T F+ + + + PP+P
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDYS 227
Query: 284 KAFSYLISRCWSSSPDRRPHFDQIV 308
LI+ S P++RP I+
Sbjct: 228 PELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 78/254 (30%), Positives = 122/254 (48%), Gaps = 13/254 (5%)
Query: 53 DMSQLFIGC-KFASGRHSRIYRGI--YKQRDVAIKLVSQPEEDASLASMLEKQFTSEVAL 109
D +LF + G +++GI Q+ VAIK++ E + + + + E+ +
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ-----EITV 55
Query: 110 LFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR 169
L + + P++ + + K II EYL GGS L + +LK +I +
Sbjct: 56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILK 112
Query: 170 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEM 228
G+ YLHS+ +HRD+K+ N+LL E VK+ADFG++ L F GT WMAPE+
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 229 IKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288
I++ + K D++S GI EL P +M P + F + KN P + K F
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEFSKPFKE 231
Query: 289 LISRCWSSSPDRRP 302
I C + P RP
Sbjct: 232 FIDACLNKDPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 59/190 (31%), Positives = 100/190 (52%), Gaps = 22/190 (11%)
Query: 75 IYKQRD------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHIITFVAACK 126
+YK RD VA+K + E+ + S T+ E++LL L HP+I+ +
Sbjct: 15 VYKARDKKTGEIVALKKIRLDNEEEGIPS------TALREISLLKELKHPNIVKLLDVIH 68
Query: 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 186
++ EY L+KYL ++ P + NL+ + + RG+ Y HS ILHRDLK
Sbjct: 69 TERKLYLVFEYCDM-DLKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKP 126
Query: 187 ENLLLGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPEMI-KEKRHTKKVDVYS 242
+N+L+ D +K+ADFG++ + + + + T YR APE++ K ++ VD++S
Sbjct: 127 QNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR--APEILLGSKHYSTAVDIWS 184
Query: 243 FGIVLWELLT 252
G + E++T
Sbjct: 185 VGCIFAEMIT 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 73/250 (29%), Positives = 109/250 (43%), Gaps = 38/250 (15%)
Query: 100 EKQFTSEVALLFRLN-HPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLN 158
K E +L RLN HP II + + EY G L +Y+ + S+
Sbjct: 45 VKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY--GSLDEK 102
Query: 159 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL-------ESQC 211
A +I ++YLHS+GI+HRDLK EN+LL +DM +K+ DFG + + ES
Sbjct: 103 CTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
Query: 212 GSAKG--------------FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
G A F GT +++PE++ EK K D+++ G +++++LT PF
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
Query: 258 DNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 315
+ QK PP P LI + P R + EGY
Sbjct: 223 RGSNE----YLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRL------GVNEGY- 271
Query: 316 ESLEQDPEFF 325
+ L+ P FF
Sbjct: 272 DELKAHP-FF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 74/242 (30%), Positives = 115/242 (47%), Gaps = 28/242 (11%)
Query: 92 DASLASMLE-------KQFTSEVALLFRLN-HPHIITFVAACKKPPVFCIITEYLAGGSL 143
DA++ M E + F E+ +L +L HP+II + AC+ + EY G+L
Sbjct: 36 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 95
Query: 144 RKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 189
+L + ++ +L A D+ARGM YL + +HRDL + N+
Sbjct: 96 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 155
Query: 190 LLGEDMCVKVADFGISCLESQCGSAKGFTGTY--RWMAPEMIKEKRHTKKVDVYSFGIVL 247
L+GE+ K+ADFG+S Q K G RWMA E + +T DV+S+G++L
Sbjct: 156 LVGENYVAKIADFGLS--RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213
Query: 248 WELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQ 306
WE+++ TP+ MT + + + R P C L+ +CW P RP F Q
Sbjct: 214 WEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 272
Query: 307 IV 308
I+
Sbjct: 273 IL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 65/211 (30%), Positives = 92/211 (43%), Gaps = 30/211 (14%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGS------LRKYLHQQEPYSVPLNL 159
EV L +L HP+ I + + ++ EY G + +K L + E
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVE-------- 116
Query: 160 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 219
+ + +G+ YLHS +HRD+K+ N+LL E VK+ADFG + L A F G
Sbjct: 117 IAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL---VSPANSFVG 173
Query: 220 TYRWMAPEMI---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 276
T WMAPE+I E ++ KVDV+S GI EL P NM A + + Q +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--- 230
Query: 277 PVPPTCPK-----AFSYLISRCWSSSPDRRP 302
PT F + C P RP
Sbjct: 231 --SPTLSSNDWSDYFRNFVDSCLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-27
Identities = 77/255 (30%), Positives = 121/255 (47%), Gaps = 32/255 (12%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI--ITEYL 138
VA+K + +PE + + L+K E+ +L L H +I+ + C + I I E+L
Sbjct: 36 VAVKSL-KPESGGNHIADLKK----EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 198
GSL++YL + + + L LK A+ I +GM YL S+ +HRDL + N+L+ + VK
Sbjct: 91 PSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVK 149
Query: 199 VADFGISCLESQCGSAKGF-------TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 251
+ DFG L + K + W APE + + + DV+SFG+ L+ELL
Sbjct: 150 IGDFG---LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
Query: 252 T-------ALTPFDNMT-PEQAAFAVC------QKNARPPVPPTCPKAFSYLISRCWSSS 297
T +T F M P V ++ R P PP CP+ L+ +CW
Sbjct: 207 TYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQ 266
Query: 298 PDRRPHFDQIVSILE 312
P +R F ++ E
Sbjct: 267 PSKRTTFQNLIEGFE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 73/243 (30%), Positives = 114/243 (46%), Gaps = 26/243 (10%)
Query: 73 RGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132
R + Q +AIK + PE D+ L + E+AL L H +I+ ++ + + F
Sbjct: 28 RDLSTQVRIAIKEI--PERDSRYVQPLHE----EIALHSYLKHRNIVQYLGSDSENGFFK 81
Query: 133 IITEYLAGGSLRKYLHQQ-EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 191
I E + GGSL L + P ++ I G++YLH I+HRD+K +N+L+
Sbjct: 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV 141
Query: 192 GE-DMCVKVADFGIS--------CLESQCGSAKGFTGTYRWMAPEMIKE--KRHTKKVDV 240
VK++DFG S C E+ FTGT ++MAPE+I + + + D+
Sbjct: 142 NTYSGVVKISDFGTSKRLAGINPCTET-------FTGTLQYMAPEVIDKGPRGYGAPADI 194
Query: 241 YSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 299
+S G + E+ T PF + QAA F V P +P + I RC+ PD
Sbjct: 195 WSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPD 254
Query: 300 RRP 302
+R
Sbjct: 255 KRA 257
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-27
Identities = 60/252 (23%), Positives = 116/252 (46%), Gaps = 14/252 (5%)
Query: 70 RIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT----FVAAC 125
IY+GI+ ++V I+ + + +L +E+ L R++ +I+ +
Sbjct: 35 SIYKGIFNNKEVIIRTFKKFHKGHK---VLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91
Query: 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH-SQGILHRDL 184
P +I EY G LR+ L +++ + L +A+D +G+ L+ +++L
Sbjct: 92 DDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNL 149
Query: 185 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYS 242
S + L+ E+ +K+ G+ + S Y + +M+ + +T K D+YS
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIFSEYTIKDDIYS 207
Query: 243 FGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 302
G+VLWE+ T PF+N+T ++ + KN +P CP ++ C S +RP
Sbjct: 208 LGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRP 267
Query: 303 HFDQIVSILEGY 314
+ +I+ L Y
Sbjct: 268 NIKEILYNLSLY 279
|
Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 71/254 (27%), Positives = 128/254 (50%), Gaps = 23/254 (9%)
Query: 69 SRIYRGIYKQRDV------AIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNHPHIITF 121
S Y +YK R+V AIK++ +P ED ++ E+ ++ H +I+ +
Sbjct: 19 SGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ-------QEIIMMKDCKHSNIVAY 71
Query: 122 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILH 181
+ + I E+ GGSL+ H P S + + ++ + +G+ YLHS+G +H
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSE--SQIAYVSRETLQGLYYLHSKGKMH 129
Query: 182 RDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKR---HTKK 237
RD+K N+LL ++ VK+ADFG+S + + K F GT WMAPE+ +R + +
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQL 189
Query: 238 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK---AFSYLISRCW 294
D+++ GI EL P ++ P +A F + + N +PP K +F + +
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMAL 249
Query: 295 SSSPDRRPHFDQIV 308
+ +P +RP ++++
Sbjct: 250 TKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 18/226 (7%)
Query: 97 SMLEK---QFTSEVALLFRLNHPHIITFVAACKKPP--VFCIITEYLAGGSL----RKYL 147
+M EK Q SEV +L L HP+I+ + I+ EY GG L +K
Sbjct: 37 NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKC- 95
Query: 148 HQQEPYSVPLNLVLKLALDIARGMQYLH-----SQGILHRDLKSENLLLGEDMCVKVADF 202
++E + + ++ + + H +LHRDLK N+ L + VK+ DF
Sbjct: 96 -KKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF 154
Query: 203 GIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT 261
G++ L AK + GT +M+PE + + +K D++S G +++EL PF
Sbjct: 155 GLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214
Query: 262 PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307
Q A + + R +P + +I + PD+RP +++
Sbjct: 215 QLQLASKIKEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-26
Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 23/259 (8%)
Query: 65 SGRHSRIYRGIYK---QRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
+GR + RG K +R+ VAI + A + + F +E L + +H +I+
Sbjct: 15 TGRFGELCRGCLKLPSKRELPVAIHTLR-----AGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 179
+ I+TEY++ G+L +L + E V L + + +A GM+YL G
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL-MGMLPGLASGMKYLSEMGY 128
Query: 180 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYR------WMAPEMIKEKR 233
+H+ L + +L+ D+ K++ F Q ++ T W APE I+
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR----RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184
Query: 234 HTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292
+ DV+SFGIV+WE+++ P+ +M+ + AV + R P P CP L+
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAPRNCPNLLHQLMLD 243
Query: 293 CWSSSPDRRPHFDQIVSIL 311
CW RP F QI SIL
Sbjct: 244 CWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-26
Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 7/201 (3%)
Query: 113 LNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQ 172
L+H +I+ + C + ++T+ GSL ++ Q P +L + IA+GM
Sbjct: 66 LDHAYIVRLLGICPGASL-QLVTQLSPLGSLLDHVRQHRDSLDP-QRLLNWCVQIAKGMY 123
Query: 173 YLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT---GTYRWMAPEMI 229
YL ++HR+L + N+LL D V++ADFG++ L ++ +WMA E I
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 230 KEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288
R+T + DV+S+G+ +WE+++ P+ M P + + +K R P C
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGERLAQPQICTIDVYM 242
Query: 289 LISRCWSSSPDRRPHFDQIVS 309
++ +CW + RP F ++ +
Sbjct: 243 VMVKCWMIDENVRPTFKELAN 263
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 68/211 (32%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 99 LEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLN 158
L+KQ SE+ +L++ + P+II F A I TE++ GGSL Y +P +
Sbjct: 42 LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY------RKIPEH 95
Query: 159 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT 218
++ ++A+ + +G+ YL S ILHRD+K N+L+ VK+ DFG+S + AK +
Sbjct: 96 VLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVST-QLVNSIAKTYV 154
Query: 219 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-----VCQKN 273
GT +MAPE I +++ DV+S GI EL P+ + Q + C +
Sbjct: 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD 214
Query: 274 ARPPVPPT--CPKAFSYLISRCWSSSPDRRP 302
PPV P + F + I++C P RP
Sbjct: 215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 83/270 (30%), Positives = 129/270 (47%), Gaps = 37/270 (13%)
Query: 64 ASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT 120
G + ++Y+ +K + VAIK + ED E++ E +L + NHP+I T
Sbjct: 15 GEGTYGKVYKARHKKTGQLVAIK-IMDIIED------EEEEIKEEYNILRKYSNHPNIAT 67
Query: 121 FVAACKKPPVFC------IITEYLAGGS---LRKYLHQQEPYSVPLNLVLKLALDIARGM 171
F A K ++ E GGS L K L ++ + + + + RG+
Sbjct: 68 FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGL 126
Query: 172 QYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMI- 229
YLH ++HRD+K +N+LL ++ VK+ DFG+S L+S G F GT WMAPE+I
Sbjct: 127 AYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIA 186
Query: 230 -KEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC--- 282
E+ + + DV+S GI EL P +M P +A F K R P PPT
Sbjct: 187 CDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF----KIPRNP-PPTLKSP 241
Query: 283 ---PKAFSYLISRCWSSSPDRRPHFDQIVS 309
K F+ IS C + ++RP ++++
Sbjct: 242 ENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-26
Identities = 72/273 (26%), Positives = 129/273 (47%), Gaps = 22/273 (8%)
Query: 63 FASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
SG +Y+GI+ + VAIK++ + + + K+ E ++ + P
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRE-----NTSPKANKEILDEAYVMAGVGSP 69
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
++ + C V ++T+ + G L Y+ + + + +L + IA+GM YL
Sbjct: 70 YVCRLLGICLTSTV-QLVTQLMPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSYLEE 127
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKR 233
++HRDL + N+L+ VK+ DFG++ L + A G +WMA E I +R
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187
Query: 234 HTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292
T + DV+S+G+ +WEL+T P+D + P + + +K R P PP C ++ +
Sbjct: 188 FTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIMVK 246
Query: 293 CWSSSPDRRPHFDQIVSILEGYSESLEQDPEFF 325
CW + RP F ++V + +DP F
Sbjct: 247 CWMIDSECRPRFRELVDEF----SRMARDPSRF 275
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 69/260 (26%), Positives = 129/260 (49%), Gaps = 18/260 (6%)
Query: 62 KFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
K G+ S +Y+ I R VA+K V E + A + E+ LL +L+HP++I
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKA---RQDCLKEIDLLKQLDHPNVI 65
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLH--QQEPYSVPLNLVLKLALDIARGMQYLHSQ 177
++A+ + I+ E G L + + +++ +P + K + + ++++HS+
Sbjct: 66 KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK 125
Query: 178 GILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTK 236
I+HRD+K N+ + VK+ D G+ S+ +A GT +M+PE I E +
Sbjct: 126 RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 185
Query: 237 KVDVYSFGIVLWELLTALTPF--DNMTPEQAAFAVCQKNARPPVPPTCPKAFS----YLI 290
K D++S G +L+E+ +PF D M +++C+K + PP +S L+
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEKCDYPPLPADHYSEELRDLV 241
Query: 291 SRCWSSSPDRRPHFDQIVSI 310
SRC + P++RP ++ +
Sbjct: 242 SRCINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-26
Identities = 68/224 (30%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 98 MLEKQFTSEVALLFRLNHPHIITFVAAC--KKPPVFCIITEYLAGGSLRKYLHQQEPYSV 155
L+KQ E+ + P+I+ + A + I EY GGSL + +
Sbjct: 41 DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGG 100
Query: 156 PLN--LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQC 211
+ ++ K+A + +G+ YLHS+ I+HRD+K N+LL VK+ DFG+S + S
Sbjct: 101 RIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159
Query: 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF-----DNMTP-EQA 265
A FTGT +MAPE I+ K ++ DV+S G+ L E+ PF + P E
Sbjct: 160 --AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL 217
Query: 266 AFAVCQKNARPPVPPTCP-------KAFSYLISRCWSSSPDRRP 302
++ V N P P + F I +C P RRP
Sbjct: 218 SYIV---NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-26
Identities = 68/240 (28%), Positives = 117/240 (48%), Gaps = 10/240 (4%)
Query: 73 RGIYKQRDVAIKL--VSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130
R Q+ V IK V Q +D LA+ +E +L L+HP+II + +
Sbjct: 20 RRKADQKLVIIKQIPVEQMTKDERLAAQ------NECQVLKLLSHPNIIEYYENFLEDKA 73
Query: 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 190
I+ EY GG+L +Y+ ++ + + +L + I + ++H++ ILHRDLK++N+L
Sbjct: 74 LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNIL 133
Query: 191 LGE-DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 249
L + M VK+ DFGIS + S A GT +++PE+ + K + +K D+++ G VL+E
Sbjct: 134 LDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYE 193
Query: 250 LLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309
L + F+ + P+ LI + P +RP QI++
Sbjct: 194 LASLKRAFEAANLPALVLKI-MSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-26
Identities = 60/208 (28%), Positives = 110/208 (52%), Gaps = 5/208 (2%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLAL 165
EVA+L + HP+I+ + + ++ I+ +Y GG L K ++ Q P + +L +
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108
Query: 166 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWM 224
I ++++H + ILHRD+KS+N+ L +D +K+ DFGI+ L S A+ GT ++
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYL 168
Query: 225 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284
+PE+ + + + K D+++ G VL+E+ T F+ + + + + PPV
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSY 227
Query: 285 AFSYLISRCWSSSPDRRPHFDQIVSILE 312
L+S+ + +P RP + SILE
Sbjct: 228 DLRNLVSQLFKRNPRDRP---SVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 72/249 (28%), Positives = 122/249 (48%), Gaps = 23/249 (9%)
Query: 62 KFASGRHSRIYRGI--YKQRDVAIK---LVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
K G +Y I ++VAIK L QP+++ + +E+ ++ HP
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII---------NEILVMRENKHP 76
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+I+ ++ + ++ EYLAGGSL + + + V + L + +++LHS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHS 133
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRH 234
++HRD+KS+N+LLG D VK+ DFG C + +K T GT WMAPE++ K +
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 235 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAFSYLISR 292
KVD++S GI+ E++ P+ N P +A + + N P P F ++R
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNR 251
Query: 293 CWSSSPDRR 301
C ++R
Sbjct: 252 CLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 61/205 (29%), Positives = 108/205 (52%), Gaps = 2/205 (0%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLAL 165
E LL ++ HP+I+ F + + I+ EY GG L + + Q P + +L+ +
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 166 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGTYRWM 224
+ G+Q++H + +LHRD+KS+N+ L ++ VK+ DFG + L + G+ A + GT ++
Sbjct: 108 QMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYV 167
Query: 225 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284
PE+ + + K D++S G +L+EL T PF + + VCQ + + P+P
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-PLPSHYSY 226
Query: 285 AFSYLISRCWSSSPDRRPHFDQIVS 309
LI + + +P RP I+S
Sbjct: 227 ELRSLIKQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 73/274 (26%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 67 RHSRIYRGIY-------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
R ++Y+G + + VAIK + E L ++F E + RL HP+I+
Sbjct: 17 RFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP-----LREEFKHEAMMRSRLQHPNIV 71
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYS----VPLNLVLKLALD--------- 166
+ K +I Y + L ++L + P+S + +K L+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 167 -IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT----Y 221
IA GM++L S ++H+DL + N+L+ + + VK++D G+ E G
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL-FREVYAADYYKLMGNSLLPI 190
Query: 222 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 280
RWM+PE I + + D++S+G+VLWE+ + L P+ + Q + + P P
Sbjct: 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQDVIEMIRNRQVLPCPD 249
Query: 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314
CP L+ CW+ P RRP F I S L +
Sbjct: 250 DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 72/254 (28%), Positives = 119/254 (46%), Gaps = 22/254 (8%)
Query: 66 GRHSRIYRGIYKQRDV--AIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123
G ++Y+ +K+ + A K++ E+ LE F E+ +L HP+I+
Sbjct: 16 GAFGKVYKAQHKETGLFAAAKIIQIESEEE-----LE-DFMVEIDILSECKHPNIVGLYE 69
Query: 124 ACKKPPVFCIITEYLAGGSLRKYLHQQE-PYSVP-LNLVLKLALDIARGMQYLHSQGILH 181
A I+ E+ GG+L + + E + P + V + L+ + +LHS ++H
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE---ALNFLHSHKVIH 126
Query: 182 RDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMI-----KEKRHT 235
RDLK+ N+LL D VK+ADFG+S +S F GT WMAPE++ K+ +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD 186
Query: 236 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRC 293
K D++S GI L EL P + P + + K+ P + P +F+ + C
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHELNPMRVLLKI-LKSEPPTLDQPSKWSSSFNDFLKSC 245
Query: 294 WSSSPDRRPHFDQI 307
PD RP ++
Sbjct: 246 LVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 4e-24
Identities = 60/190 (31%), Positives = 85/190 (44%), Gaps = 21/190 (11%)
Query: 76 YKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIIT 135
K R A+K V + + + ++ SE +L NHP I+ K ++
Sbjct: 16 SKNRTFALKCVKK---RHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLM 72
Query: 136 EYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDLKSE 187
EY GG L L AR +YLH++GI++RDLK E
Sbjct: 73 EYCLGGELWTILRD----------RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPE 122
Query: 188 NLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 247
NLLL + VK+ DFG + F GT ++APE+I K + VD +S GI+L
Sbjct: 123 NLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILL 182
Query: 248 WELLTALTPF 257
+ELLT PF
Sbjct: 183 YELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 48/167 (28%), Positives = 84/167 (50%), Gaps = 5/167 (2%)
Query: 114 NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQY 173
HP + + + + EY+ GG L H Q A +I G+Q+
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGLQF 111
Query: 174 LHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTYRWMAPEMIKE 231
LH +GI++RDLK +N+LL + +K+ADFG+ C E G F GT ++APE++
Sbjct: 112 LHERGIIYRDLKLDNVLLDSEGHIKIADFGM-CKEGILGGVTTSTFCGTPDYIAPEILSY 170
Query: 232 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 278
+ + VD ++ G++L+E+L +PF+ ++ ++ + R P
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR 217
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 5e-24
Identities = 42/161 (26%), Positives = 83/161 (51%), Gaps = 6/161 (3%)
Query: 97 SMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVP 156
++ EK+ +V + I++ A + C++ + GG L+ +++ P
Sbjct: 40 ALNEKKILEKV------SSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP 93
Query: 157 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG 216
+ A I G+++LH + I++RDLK EN+LL + V+++D G++ KG
Sbjct: 94 EARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG 153
Query: 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
GT +MAPE+++ + + VD ++ G L+E++ +PF
Sbjct: 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 5e-24
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 19/220 (8%)
Query: 97 SMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVP 156
S + KQ E+ ++ P+I++F A C+ E++ GSL + + P +P
Sbjct: 44 SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP--IP 101
Query: 157 LNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK 215
+ ++ K+A+ + G+ YL++ I+HRD+K N+L+ +K+ DFG+S E A
Sbjct: 102 VEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG-ELINSIAD 160
Query: 216 GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV------ 269
F GT +M+PE I+ ++T K DV+S GI + EL PF
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF--SNIDDDGQDDPMGI 218
Query: 270 -----CQKNARPPVPPTC--PKAFSYLISRCWSSSPDRRP 302
PP P+ P+ + C P RP
Sbjct: 219 LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 6e-24
Identities = 53/160 (33%), Positives = 87/160 (54%), Gaps = 8/160 (5%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
+E +L ++HP II ++ EY+ GG L YL +S L A
Sbjct: 50 NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY--A 107
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYR 222
+I ++YLHS+ I++RDLK EN+LL ++ +K+ DFG ++ + +T GT
Sbjct: 108 SEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGF----AKKLRDRTWTLCGTPE 163
Query: 223 WMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP 262
++APE+I+ K H K VD ++ GI+++E+L PF + P
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 8e-24
Identities = 71/249 (28%), Positives = 122/249 (48%), Gaps = 23/249 (9%)
Query: 62 KFASGRHSRIYRG--IYKQRDVAIK---LVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
K G +Y I ++VAIK L QP+++ + +E+ ++ +P
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII---------NEILVMRENKNP 76
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+I+ ++ + ++ EYLAGGSL + + + + + + + + +LHS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHS 133
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRH 234
++HRD+KS+N+LLG D VK+ DFG C + +K T GT WMAPE++ K +
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 235 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISR 292
KVD++S GI+ E++ P+ N P +A + + N P + P F ++R
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQNPERLSAVFRDFLNR 251
Query: 293 CWSSSPDRR 301
C DRR
Sbjct: 252 CLEMDVDRR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 9e-24
Identities = 58/170 (34%), Positives = 94/170 (55%), Gaps = 7/170 (4%)
Query: 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 193
+ EYL GG L H Q A +I G+Q+LH +GI++RDLK +N+LL +
Sbjct: 74 VMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 194 DMCVKVADFGISCLESQCGSAKG--FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 251
D +K+ADFG+ C E+ G K F GT ++APE++K +++ + VD +SFG++L+E+L
Sbjct: 132 DGHIKIADFGM-CKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
Query: 252 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 301
+PF ++ ++ N RP P K +S+ + P +R
Sbjct: 191 IGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-23
Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 20/261 (7%)
Query: 54 MSQLFIGCKFASGRHSRIYRG--IYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
++ I K G+ S +YR + ++ VA+K V E + + + E+ LL
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFE---MMDAKARQDCVKEIDLLK 57
Query: 112 RLNHPHIITFVAACKKPPVFCIITEYLAGGSLR---KYLHQQEPYSVPLNLVLKLALDIA 168
+LNHP++I ++ + + I+ E G L KY +Q+ +P V K + +
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL-IPERTVWKYFVQLC 116
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPE 227
++++HS+ ++HRD+K N+ + VK+ D G+ S+ +A GT +M+PE
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 228 MIKEKRHTKKVDVYSFGIVLWELLTALTPF--DNMTPEQAAFAVCQKNARPPVPPTCPKA 285
I E + K D++S G +L+E+ +PF D M F++CQK + PP +
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKIEQCDYPPLPTEH 232
Query: 286 FSY----LISRCWSSSPDRRP 302
+S L+S C PD+RP
Sbjct: 233 YSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 3e-23
Identities = 66/213 (30%), Positives = 108/213 (50%), Gaps = 12/213 (5%)
Query: 91 EDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQ 150
+D +M+EK+ S HP + + + EYL GG L H Q
Sbjct: 36 DDDVECTMVEKRVLS-----LAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQ 88
Query: 151 EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210
+ L A +I G+Q+LHS+GI++RDLK +N+LL D +K+ADFG+ C E+
Sbjct: 89 SCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGM-CKENM 147
Query: 211 CGSAK--GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 268
G AK F GT ++APE++ +++ VD +SFG++L+E+L +PF E+ +
Sbjct: 148 LGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS 207
Query: 269 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 301
+ N P P + ++ + + P+RR
Sbjct: 208 IRMDN--PCYPRWLTREAKDILVKLFVREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-23
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 11/209 (5%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP--VFCIITE 136
R++A+K V Q + ++ S E+ LL L H I+ + + P I E
Sbjct: 28 RELAVKQV-QFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86
Query: 137 YLAGGSLRKYLHQQEPY-SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM 195
++ GGS++ Q + Y ++ N+ K I G+ YLHS I+HRD+K N+L
Sbjct: 87 HMPGGSIKD---QLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG 143
Query: 196 CVKVADFGISC-LESQCGSAKGF---TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 251
VK+ DFG S L++ C S G TGT WM+PE+I + + +K D++S G + E+L
Sbjct: 144 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML 203
Query: 252 TALTPFDNMTPEQAAFAVCQKNARPPVPP 280
T P+ A F + + P +PP
Sbjct: 204 TEKPPWAEFEAMAAIFKIATQPTNPVLPP 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-23
Identities = 72/256 (28%), Positives = 125/256 (48%), Gaps = 25/256 (9%)
Query: 69 SRIYRGIYKQRDV------AIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNHPHIITF 121
S Y +YK R++ A+K++ +P +D SL E+ ++ H +I+ +
Sbjct: 19 SGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-------IQQEIFMVKECKHCNIVAY 71
Query: 122 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYS-VPLNLVLKLALDIARGMQYLHSQGIL 180
+ I EY GGSL+ H P S + + V + L +G+ YLHS+G +
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---QGLAYLHSKGKM 128
Query: 181 HRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMI---KEKRHTK 236
HRD+K N+LL ++ VK+ADFG++ + + K F GT WMAPE+ K + +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 237 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK---AFSYLISRC 293
D+++ GI EL P ++ P +A F + + N +PP K F +
Sbjct: 189 LCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKIS 248
Query: 294 WSSSPDRRPHFDQIVS 309
+ +P +RP +++++
Sbjct: 249 LTKNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 6e-23
Identities = 68/230 (29%), Positives = 119/230 (51%), Gaps = 21/230 (9%)
Query: 79 RDVAIK---LVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIIT 135
++VAIK L QP+++ + +E+ ++ L +P+I+ F+ + ++
Sbjct: 45 QEVAIKQINLQKQPKKELII---------NEILVMKELKNPNIVNFLDSFLVGDELFVVM 95
Query: 136 EYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM 195
EYLAGGSL + + + V + L + +++LH+ ++HRD+KS+N+LLG D
Sbjct: 96 EYLAGGSLTDVVTETCMDEAQIAAVCRECL---QALEFLHANQVIHRDIKSDNVLLGMDG 152
Query: 196 CVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA 253
VK+ DFG C + +K T GT WMAPE++ K + KVD++S GI+ E++
Sbjct: 153 SVKLTDFGF-CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
Query: 254 LTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDRR 301
P+ N P +A + + N P + P F ++RC ++R
Sbjct: 212 EPPYLNENPLRALYLIA-TNGTPELQNPEKLSPIFRDFLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 9e-23
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL- 163
+E +L + HP ++ + + ++ EY+ GG L +L + + P V +
Sbjct: 50 NEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP---VARFY 106
Query: 164 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW 223
A + ++YLHS I++RDLK ENLLL D +K+ DFG + G GT +
Sbjct: 107 AAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK--GRTYTLCGTPEY 164
Query: 224 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPT 281
+APE+I K + K VD ++ GI+++E+L PF + P + +K + P
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----IQIYEKILEGKVRFPSF 220
Query: 282 CPKAFSYLISRCWSSSPDRR 301
LI +R
Sbjct: 221 FSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 51/160 (31%), Positives = 86/160 (53%), Gaps = 4/160 (2%)
Query: 157 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSA 214
+L +ARGM++L S+ +HRDL + N+LL + VK+ DFG++ + +
Sbjct: 236 TLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295
Query: 215 KGFTG-TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK 272
KG T +WMAPE I + +T DV+S+GI+LWE+ + TP+ M + + +
Sbjct: 296 KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS 355
Query: 273 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
R P + ++ +CW+S P++RP F + I+E
Sbjct: 356 GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 2e-22
Identities = 68/260 (26%), Positives = 124/260 (47%), Gaps = 22/260 (8%)
Query: 64 ASGRHSRIYRG--IYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-PHIIT 120
+G + ++Y+G + + AIK++ ++ E++ E+ +L + +H +I T
Sbjct: 15 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIAT 67
Query: 121 FVAAC--KKPP----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYL 174
+ A K PP ++ E+ GS+ + + ++ + + +I RG+ +L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 175 HSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIK--- 230
H ++HRD+K +N+LL E+ VK+ DFG+S L+ G F GT WMAPE+I
Sbjct: 128 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 231 --EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288
+ + K D++S GI E+ P +M P +A F + + A K F
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQS 247
Query: 289 LISRCWSSSPDRRPHFDQIV 308
I C + +RP +Q++
Sbjct: 248 FIESCLVKNHSQRPTTEQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 2e-22
Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 11/208 (5%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK--PPVFCIITE 136
R++A K V Q + ++ S E+ LL L H I+ + + I E
Sbjct: 28 RELAAKQV-QFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86
Query: 137 YLAGGSLRKYLHQQEPY-SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM 195
Y+ GGS++ Q + Y ++ ++ K I GM YLHS I+HRD+K N+L
Sbjct: 87 YMPGGSVKD---QLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG 143
Query: 196 CVKVADFGISC-LESQCGSAKGF---TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 251
VK+ DFG S L++ C S G TGT WM+PE+I + + +K DV+S G + E+L
Sbjct: 144 NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML 203
Query: 252 TALTPFDNMTPEQAAFAVCQKNARPPVP 279
T P+ A F + + P +P
Sbjct: 204 TEKPPWAEYEAMAAIFKIATQPTNPQLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 3e-22
Identities = 64/248 (25%), Positives = 120/248 (48%), Gaps = 21/248 (8%)
Query: 62 KFASGRHSRIYRG--IYKQRDVAIK---LVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
K G +Y + ++VAI+ L QP+++ + +E+ ++ +P
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---------NEILVMRENKNP 77
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+I+ ++ + ++ EYLAGGSL + + + + + + + +++LHS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS 134
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHT 235
++HRD+KS+N+LLG D VK+ DFG + + GT WMAPE++ K +
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 236 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRC 293
KVD++S GI+ E++ P+ N P +A + + N P + P F ++RC
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRC 253
Query: 294 WSSSPDRR 301
++R
Sbjct: 254 LDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-22
Identities = 64/258 (24%), Positives = 121/258 (46%), Gaps = 14/258 (5%)
Query: 62 KFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF 121
K G+ S +YR V + L D + + E+ LL +LNHP++I +
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 122 VAACKKPPVFCIITEYLAGGSLRKYLH--QQEPYSVPLNLVLKLALDIARGMQYLHSQGI 179
A+ + I+ E G L + + +++ +P V K + + ++++HS+ +
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127
Query: 180 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 238
+HRD+K N+ + VK+ D G+ S+ +A GT +M+PE I E + K
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 187
Query: 239 DVYSFGIVLWELLTALTPF--DNMTPEQAAFAVCQKNARPPVPPTCPKAFS----YLISR 292
D++S G +L+E+ +PF D M +++C+K + PP +S L++
Sbjct: 188 DIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 243
Query: 293 CWSSSPDRRPHFDQIVSI 310
C + P++RP + +
Sbjct: 244 CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 4e-22
Identities = 64/253 (25%), Positives = 117/253 (46%), Gaps = 31/253 (12%)
Query: 71 IYRGIYKQRDVAIKL--VSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128
+RG+ K R V +L + P+E + F EV LNHP+++ + C +
Sbjct: 16 AHRGMSKARVVVKELRASATPDE--------QLLFLQEVQPYRELNHPNVLQCLGQCIES 67
Query: 129 PVFCIITEYLAGGSLRKYLHQQ---EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 185
+ ++ E+ G L+ YL +++ ++A ++A G+ +LH +H DL
Sbjct: 68 IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLA 127
Query: 186 SENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEM-------IKEKRHT 235
N L D+ VK+ D+G++ E + RW+APE+ + K T
Sbjct: 128 LRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQT 187
Query: 236 KKVDVYSFGIVLWELLTALT-PFDNMTPEQA-AFAVCQKNARPPVP----PTCPKAFSYL 289
KK +++S G+ +WEL TA P+ +++ EQ V +++ + P P + + +
Sbjct: 188 KKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE-V 246
Query: 290 ISRCWSSSPDRRP 302
+ CW P+ RP
Sbjct: 247 MQFCW-LDPETRP 258
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-22
Identities = 73/261 (27%), Positives = 124/261 (47%), Gaps = 36/261 (13%)
Query: 72 YRGIYKQRDV------AIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-PHIITFVAA 124
Y +YK R V AIK++ E++ E++ E+ +L + +H +I T+ A
Sbjct: 29 YGQVYKGRHVKTGQLAAIKVMDVTEDE-------EEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 125 C--KKPP----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 178
K PP ++ E+ GS+ + + ++ + + + +I RG+ +LH+
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK 141
Query: 179 ILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIK-----EK 232
++HRD+K +N+LL E+ VK+ DFG+S L+ G F GT WMAPE+I +
Sbjct: 142 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 201
Query: 233 RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC-----PKAFS 287
+ + D++S GI E+ P +M P +A F + R P PP K F
Sbjct: 202 TYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI----PRNP-PPKLKSKKWSKKFI 256
Query: 288 YLISRCWSSSPDRRPHFDQIV 308
I C + RP +Q++
Sbjct: 257 DFIEGCLVKNYLSRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-22
Identities = 56/154 (36%), Positives = 91/154 (59%), Gaps = 5/154 (3%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLAL 165
E +L +NHP I+ A + +I ++L GG L L ++ ++ ++ LA
Sbjct: 48 ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-DVKFYLA- 105
Query: 166 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTYRW 223
++A + +LHS GI++RDLK EN+LL E+ +K+ DFG+S ES K F GT +
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS-KESIDHEKKAYSFCGTVEY 164
Query: 224 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
MAPE++ + HT+ D +SFG++++E+LT PF
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 6e-22
Identities = 57/175 (32%), Positives = 91/175 (52%), Gaps = 8/175 (4%)
Query: 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 192
+I +Y+ GG L +L+Q+E ++ + V +I + +LH GI++RD+K EN+LL
Sbjct: 82 LILDYVNGGELFTHLYQREHFT--ESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD 139
Query: 193 EDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIK--EKRHTKKVDVYSFGIVLW 248
+ V + DFG+S L + A F GT +MAPE+I+ H K VD +S G++ +
Sbjct: 140 SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTF 199
Query: 249 ELLTALTPF--DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 301
ELLT +PF D Q+ + ++PP P T I + P +R
Sbjct: 200 ELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 7e-22
Identities = 66/216 (30%), Positives = 121/216 (56%), Gaps = 29/216 (13%)
Query: 82 AIKLVSQP---EEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC-KKPPVFCIITEY 137
AIK++ + ++D +M+EK+ +AL + P +T + +C + + EY
Sbjct: 29 AIKILKKDVIIQDDDVECTMVEKRV---LALPGK---PPFLTQLHSCFQTMDRLYFVMEY 82
Query: 138 LAGGSLRKYLHQ----QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 193
+ GG L ++ Q +EP++V A +IA G+ +LHS+GI++RDLK +N++L
Sbjct: 83 VNGGDLMYHIQQVGKFKEPHAV------FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA 136
Query: 194 DMCVKVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 251
+ +K+ADFG+ C E+ G + + F GT ++APE+I + + K VD ++FG++L+E+L
Sbjct: 137 EGHIKIADFGM-CKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195
Query: 252 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287
PFD ++ ++ + N + PK+ S
Sbjct: 196 AGQPPFDGEDEDELFQSIMEHN------VSYPKSLS 225
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 8e-22
Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 15/180 (8%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQ---QEPYSVPLNLVLK 162
EV ++ HP+I+ ++ ++ E+L GG+L + E +
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ------IAT 119
Query: 163 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI-SCLESQCGSAKGFTGTY 221
+ L + + + +LH+QG++HRD+KS+++LL D VK++DFG + + + K GT
Sbjct: 120 VCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 179
Query: 222 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 281
WMAPE+I + +VD++S GI++ E++ P+ N P QA K R +PP
Sbjct: 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-----MKRIRDNLPPK 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 9e-22
Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 30/187 (16%)
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV 160
K+ +E +L L+HP + T A+ + C++ +Y GG L + L +Q + +
Sbjct: 46 KRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVA 105
Query: 161 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA------ 214
A ++ ++YLH GI++RDLK EN+LL E + ++DF +S
Sbjct: 106 RFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165
Query: 215 ------------------------KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 250
F GT ++APE+I H VD ++ GI+L+E+
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
Query: 251 LTALTPF 257
L TPF
Sbjct: 226 LYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 66/201 (32%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEY-LAGGSLRKYLHQQEPYSVPLNLVLKLA 164
EV L +L HP+ I + K ++ EY L S +H++ V + + A
Sbjct: 71 EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGA 130
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWM 224
L +G+ YLHS ++HRD+K+ N+LL E VK+ADFG + S A F GT WM
Sbjct: 131 L---QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFVGTPYWM 184
Query: 225 APEMI---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 281
APE+I E ++ KVDV+S GI EL P NM A + + Q ++
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE 244
Query: 282 CPKAFSYLISRCWSSSPDRRP 302
+F + C P RP
Sbjct: 245 WTDSFRGFVDYCLQKIPQERP 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-21
Identities = 66/218 (30%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 96 ASMLEKQFTSEVALLFR--LNH----PHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQ 149
A++++K T+E R L H P ++T A + +I +Y+ GG L +L Q
Sbjct: 39 ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ 98
Query: 150 QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CL 207
+E + V + +I +++LH GI++RD+K EN+LL + V + DFG+S
Sbjct: 99 RERFKE--QEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156
Query: 208 ESQCGSAKGFTGTYRWMAPEMIK--EKRHTKKVDVYSFGIVLWELLTALTPF--DNMTPE 263
E + A F GT +MAP++++ + H K VD +S G++++ELLT +PF D
Sbjct: 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS 216
Query: 264 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 301
QA + + PP P +I R P +R
Sbjct: 217 QAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-21
Identities = 67/208 (32%), Positives = 100/208 (48%), Gaps = 12/208 (5%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEY-LAGGSLRKYLHQQEPYSVPLNLVLKLA 164
EV L R+ HP+ I + + ++ EY L S +H++ V + + A
Sbjct: 75 EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGA 134
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWM 224
L +G+ YLHS ++HRD+K+ N+LL E VK+ADFG + + S A F GT WM
Sbjct: 135 L---QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS---PANSFVGTPYWM 188
Query: 225 APEMI---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 281
APE+I E ++ KVDV+S GI EL P NM A + + Q N P +
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPTLQSN 247
Query: 282 -CPKAFSYLISRCWSSSPDRRPHFDQIV 308
F + C P RP ++++
Sbjct: 248 EWSDYFRNFVDSCLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-21
Identities = 70/253 (27%), Positives = 120/253 (47%), Gaps = 24/253 (9%)
Query: 62 KFASGRHSRIYRGIYKQRDV--AIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
+ G ++Y+ K+ V A K++ E+ LE + E+ +L +HP+I+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE-----LE-DYMVEIDILASCDHPNIV 65
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQE-PYSVP-LNLVLKLALDIARGMQYLHSQ 177
+ A I+ E+ AGG++ + + E P + P + +V K L+ + YLH
Sbjct: 66 KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNYLHEN 122
Query: 178 GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK-GFTGTYRWMAPEMI-----KE 231
I+HRDLK+ N+L D +K+ADFG+S ++ + F GT WMAPE++ K+
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 232 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV---PPTCPKAFSY 288
+ + K DV+S GI L E+ P + P + + + + PP P F
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--SEPPTLAQPSRWSSEFKD 240
Query: 289 LISRCWSSSPDRR 301
+ +C + D R
Sbjct: 241 FLKKCLEKNVDAR 253
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-21
Identities = 45/135 (33%), Positives = 70/135 (51%), Gaps = 9/135 (6%)
Query: 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 191
++ EYL GG + +P + + ++ G++ LH +GI+HRD+K ENLL+
Sbjct: 73 YLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI 130
Query: 192 GEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 249
+ +K+ DFG+S LE+ K F GT ++APE I K D +S G V++E
Sbjct: 131 DQTGHLKLTDFGLSRNGLEN-----KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFE 185
Query: 250 LLTALTPFDNMTPEQ 264
L PF TP+
Sbjct: 186 FLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 7e-21
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 28/201 (13%)
Query: 75 IYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128
+YK RD VAIK + E + + E+ LL LNHP+II + +
Sbjct: 15 VYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIKLLDVFRHK 70
Query: 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 188
++ E++ + +Q +P +L+ + +G+ + HS GILHRDLK EN
Sbjct: 71 GDLYLVFEFMDTDLYKLIKDRQRG--LPESLIKSYLYQLLQGLAFCHSHGILHRDLKPEN 128
Query: 189 LLLGEDMCVKVADFGISCLESQCGSAKGFTGTY------RWM-APE-MIKEKRHTKKVDV 240
LL+ + +K+ADFG+ S Y RW APE ++ +K ++ VD+
Sbjct: 129 LLINTEGVLKLADFGL------ARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDI 182
Query: 241 YSFGIVLWELLT--ALTPFDN 259
+S G + ELL+ L P +
Sbjct: 183 WSVGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 7e-21
Identities = 55/161 (34%), Positives = 88/161 (54%), Gaps = 10/161 (6%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL- 163
E ++L L+HP I+ + + + + E++ GG L + H ++ P N V K
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFP-NDVAKFY 123
Query: 164 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTY 221
++ +YLHS+ I++RDLK ENLLL VKV DFG ++ + FT GT
Sbjct: 124 HAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGF----AKKVPDRTFTLCGTP 179
Query: 222 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP 262
++APE+I+ K H K VD ++ G++L+E + PF + TP
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220
|
Length = 329 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 7e-21
Identities = 59/187 (31%), Positives = 90/187 (48%), Gaps = 17/187 (9%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI-ITE 136
+VAIKL+ DA +F E AL RL HP+I+ + + + PP + E
Sbjct: 3 GHEVAIKLL---RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFE 59
Query: 137 YLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GE 193
Y+ G +LR+ L +P +L L + + H+QGI+HRDLK +N+++ G
Sbjct: 60 YVPGRTLREVLAADGA--LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 194 DMCVKVADFGISCLESQCGSAKGFT--------GTYRWMAPEMIKEKRHTKKVDVYSFGI 245
KV DFGI L A T GT + APE ++ + T D+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 246 VLWELLT 252
+ E LT
Sbjct: 178 IFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 7e-21
Identities = 56/171 (32%), Positives = 97/171 (56%), Gaps = 14/171 (8%)
Query: 151 EPYSVPLNL--VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--- 205
E Y PL L ++ + +ARGM++L S+ +HRDL + N+LL E+ VK+ DFG++
Sbjct: 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 223
Query: 206 ---CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMT 261
+ G A+ +WMAPE I +K +T + DV+SFG++LWE+ + +P+ +
Sbjct: 224 YKDPDYVRKGDARL---PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280
Query: 262 PEQAAFAVCQKNARPPVPP-TCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 311
++ ++ R P P+ +S ++ CW ++P+ RP F ++V IL
Sbjct: 281 IDEEFCRRLKEGTRMRAPEYATPEIYSIMLD-CWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 9e-21
Identities = 51/148 (34%), Positives = 82/148 (55%), Gaps = 6/148 (4%)
Query: 112 RLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGM 171
HP ++ A + C + EY AGG L ++H + +S P + A + G+
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFY--AACVVLGL 114
Query: 172 QYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTYRWMAPEMI 229
QYLH I++RDLK +NLLL + VK+ADFG+ C E + F GT ++APE++
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEGFVKIADFGL-CKEGMGFGDRTSTFCGTPEFLAPEVL 173
Query: 230 KEKRHTKKVDVYSFGIVLWELLTALTPF 257
E +T+ VD + G++++E+L +PF
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 9e-21
Identities = 49/126 (38%), Positives = 79/126 (62%), Gaps = 5/126 (3%)
Query: 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 193
+ E+L GG L H Q+ L A +I G+Q+LHS+GI++RDLK +N++L
Sbjct: 74 VMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR 131
Query: 194 DMCVKVADFGISCLESQCGSAKG--FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 251
D +K+ADFG+ C E+ G + F GT ++APE+++ ++T VD +SFG++L+E+L
Sbjct: 132 DGHIKIADFGM-CKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
Query: 252 TALTPF 257
+PF
Sbjct: 191 IGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 50/155 (32%), Positives = 81/155 (52%), Gaps = 10/155 (6%)
Query: 164 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS------CLESQCGSAKGF 217
+ +ARGM++L S+ +HRDL + N+LL E+ VK+ DFG++ + GSA+
Sbjct: 180 SFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR-- 237
Query: 218 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 276
+WMAPE I +K +T + DV+SFG++LWE+ + +P+ + + + R
Sbjct: 238 -LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 277 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 311
P ++ CW P RP F +V IL
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 50/158 (31%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 160 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 219
+L + +A+GM +L S+ +HRDL + N+LL K+ DFG++ + + S G
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA-RDIRNDSNYVVKG 274
Query: 220 TYR----WMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 274
R WMAPE I +T + DV+S+GI+LWE+ + +P+ M + + + ++
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY 334
Query: 275 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
R P P ++ CW + P +RP F QIV ++E
Sbjct: 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP--VFCIITE 136
R++A+K V + D+ S E+ LL L H I+ + + P I E
Sbjct: 28 RELAVKQVPF-DPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86
Query: 137 YLAGGSLRKYLHQQEPY-SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM 195
Y+ GGS++ Q + Y ++ N+ + I +G+ YLHS I+HRD+K N+L
Sbjct: 87 YMPGGSIKD---QLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG 143
Query: 196 CVKVADFGISC-LESQCGSAKGF---TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 251
VK+ DFG S +++ C S G TGT WM+PE+I + + +K DV+S + E+L
Sbjct: 144 NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML 203
Query: 252 TALTPFDNMTPEQAAFAVCQKNARPPVP 279
T P+ A F + + +P +P
Sbjct: 204 TEKPPWAEYEAMAAIFKIATQPTKPMLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEY-LAGGSLRKYLHQQEPYSVPLNLVLKLA 164
EV L +L HP+ I + + ++ EY L S +H++ V + V A
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA 124
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWM 224
L +G+ YLHS ++HRD+K+ N+LL E VK+ DFG + + + A F GT WM
Sbjct: 125 L---QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANXFVGTPYWM 178
Query: 225 APEMI---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 281
APE+I E ++ KVDV+S GI EL P NM A + + Q +
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 282 CPKAFSYLISRCWSSSPDRRPHFDQIVS 309
+ F + C P RP + ++
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 70/258 (27%), Positives = 117/258 (45%), Gaps = 29/258 (11%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
SG +Y+ I++ R A+K++ ED + +Q E+ +L +NHP+++
Sbjct: 84 SGAGGTVYKVIHRPTGRLYALKVIYGNHEDT-----VRRQICREIEILRDVNHPNVVKCH 138
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
++ E++ GGSL E + + +A I G+ YLH + I+HR
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQF------LADVARQILSGIAYLHRRHIVHR 192
Query: 183 DLKSENLLLGEDMCVKVADFGISCLESQ----CGSAKGFTGTYRWMAPEMIKEKRHTKKV 238
D+K NLL+ VK+ADFG+S + +Q C S+ GT +M+PE I +
Sbjct: 193 DIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLNHGAY 249
Query: 239 -----DVYSFGIVLWELLTALTPFD-NMTPEQAAF--AVCQKNARPPVPPTCPKAFSYLI 290
D++S G+ + E PF + A+ A+C P P T + F + I
Sbjct: 250 DGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-PEAPATASREFRHFI 308
Query: 291 SRCWSSSPDRRPHFDQIV 308
S C P +R Q++
Sbjct: 309 SCCLQREPAKRWSAMQLL 326
|
Length = 353 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 53/177 (29%), Positives = 89/177 (50%), Gaps = 5/177 (2%)
Query: 140 GGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 199
+ R L + P ++LV + +A GM++L S+ +HRDL + N+L+ E VK+
Sbjct: 222 ERTRRDTLINESPALSYMDLV-GFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKI 280
Query: 200 ADFGIS--CLESQCGSAKGFTG-TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALT 255
DFG++ + +KG T +WMAPE I +T DV+SFGI+LWE+ T T
Sbjct: 281 CDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGT 340
Query: 256 PFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
P+ + + + ++ R P ++ +CW + RP F Q+V ++
Sbjct: 341 PYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 58/191 (30%), Positives = 99/191 (51%), Gaps = 7/191 (3%)
Query: 116 PHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH 175
P ++T A + +I +Y++GG + +L+Q++ +S + V + +I +++LH
Sbjct: 65 PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE--DEVRFYSGEIILALEHLH 122
Query: 176 SQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKR 233
GI++RD+K EN+LL + V + DFG+S L + F GT +MAPE+I+ K
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG 182
Query: 234 -HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--PPVPPTCPKAFSYLI 290
H K VD +S GI+++ELLT +PF V ++ + PP P L+
Sbjct: 183 GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLL 242
Query: 291 SRCWSSSPDRR 301
+ P +R
Sbjct: 243 HKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 4e-20
Identities = 55/199 (27%), Positives = 101/199 (50%), Gaps = 7/199 (3%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
+E +L HP + + + + C + EY+ GG L +L ++ +S +
Sbjct: 44 TESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSE--DRTRFYG 101
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE--SQCGSAKGFTGTYR 222
+I + YLHS I++RDLK ENL+L +D +K+ DFG+ C E + + K F GT
Sbjct: 102 AEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGL-CKEGITDAATMKTFCGTPE 160
Query: 223 WMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC 282
++APE++++ + + VD + G+V++E++ PF N E+ + ++ + P T
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK--FPRTL 218
Query: 283 PKAFSYLISRCWSSSPDRR 301
L+S P++R
Sbjct: 219 SADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 6e-20
Identities = 51/150 (34%), Positives = 89/150 (59%), Gaps = 13/150 (8%)
Query: 134 ITEYLAGGSLRKYLHQ----QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 189
+ EY+ GG L + Q +EP++V A +IA G+ +LHS+GI++RDLK +N+
Sbjct: 79 VMEYVNGGDLMYQIQQVGRFKEPHAV------FYAAEIAIGLFFLHSKGIIYRDLKLDNV 132
Query: 190 LLGEDMCVKVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 247
+L + +K+ADFG+ C E+ + K F GT ++APE+I + + K VD ++FG++L
Sbjct: 133 MLDSEGHIKIADFGM-CKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191
Query: 248 WELLTALTPFDNMTPEQAAFAVCQKNARPP 277
+E+L PF+ ++ ++ + N P
Sbjct: 192 YEMLAGQAPFEGEDEDELFQSIMEHNVAYP 221
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 6e-20
Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 8/170 (4%)
Query: 150 QEPYSVPLNL--VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207
S PL+L +L+ + +A+GM +L S+ +HRD+ + N+LL + K+ DFG++
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA-R 260
Query: 208 ESQCGSAKGFTGTYR----WMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 262
+ S G R WMAPE I + +T + DV+S+GI+LWE+ + +P+ +
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320
Query: 263 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
+ + ++ + P P ++ CW+ P RP F QI +++
Sbjct: 321 NSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 8e-20
Identities = 70/266 (26%), Positives = 120/266 (45%), Gaps = 36/266 (13%)
Query: 62 KFASGRHSRIYRGIYKQRDV--AIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
+ G ++Y+ K+ A K++ E+ LE + E+ +L NHP+I+
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-----LE-DYMVEIEILATCNHPYIV 72
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQ-----QEPYSVPLNLVLKLALDIARGMQYL 174
+ A I+ E+ GG++ + + EP + ++ + L+ +QYL
Sbjct: 73 KLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP---QIQVICRQMLE---ALQYL 126
Query: 175 HSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK-GFTGTYRWMAPEMI---- 229
HS I+HRDLK+ N+LL D +K+ADFG+S + + F GT WMAPE++
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 230 -KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT--CPKAF 286
K+ + K D++S GI L E+ P + P + + + PPT P +
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-----PPTLSQPSKW 241
Query: 287 SY----LISRCWSSSPDRRPHFDQIV 308
S + P+ RP Q++
Sbjct: 242 SMEFRDFLKTALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 8e-20
Identities = 50/177 (28%), Positives = 92/177 (51%), Gaps = 9/177 (5%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
+EV ++ +H +++ + ++ E+L GG+L + + + +
Sbjct: 68 NEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVC 124
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRW 223
L + R + YLH+QG++HRD+KS+++LL D +K++DFG + + K GT W
Sbjct: 125 LSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYW 184
Query: 224 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP 280
MAPE+I + +VD++S GI++ E++ P+ N P QA + R +PP
Sbjct: 185 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-----MRRIRDNLPP 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 9e-20
Identities = 54/156 (34%), Positives = 86/156 (55%), Gaps = 7/156 (4%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
+E +L + HP I+ + A + +I EYL+GG L +L ++ + +
Sbjct: 49 AERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE---GIFMEDTACFY 105
Query: 165 L-DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTY 221
L +I+ +++LH QGI++RDLK EN+LL VK+ DFG+ C ES F GT
Sbjct: 106 LSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGL-CKESIHEGTVTHTFCGTI 164
Query: 222 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
+MAPE++ H K VD +S G +++++LT PF
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 71 IYRGIYKQRDVAIKLVSQPEEDASLASMLEKQ-----FTSEVALLFRLNHPHIITFVAAC 125
I R + R VA+K++ L KQ +EV ++ H +++ +
Sbjct: 39 IAREKHSGRQVAVKMMD-----------LRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 185
++ E+L GG+L + Q + V + L + + YLHSQG++HRD+K
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVL---QALCYLHSQGVIHRDIK 144
Query: 186 SENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFG 244
S+++LL D VK++DFG + K GT WMAPE+I + +VD++S G
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLG 204
Query: 245 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 281
I++ E++ P+ + +P QA K R PP
Sbjct: 205 IMVIEMVDGEPPYFSDSPVQA-----MKRLRDSPPPK 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 27/199 (13%)
Query: 66 GRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123
G H +++ ++ VA+K V+ + + + + E+ L HP+++ +
Sbjct: 11 GAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR----EIKALQACQHPYVVKLLD 66
Query: 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRD 183
F ++ EY+ L + L E +P V + +G+ Y+H+ GI+HRD
Sbjct: 67 VFPHGSGFVLVMEYM-PSDLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHANGIMHRD 124
Query: 184 LKSENLLLGEDMCVKVADFGISCLES---------QCGSAKGFTGTYRW-MAPEMIKEKR 233
LK NLL+ D +K+ADFG++ L S Q + RW APE++ R
Sbjct: 125 LKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVAT--------RWYRAPELLYGAR 176
Query: 234 H-TKKVDVYSFGIVLWELL 251
VD+++ G + ELL
Sbjct: 177 KYDPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 5/157 (3%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
+E +L HP + + + C + EY GG L +L ++ +S
Sbjct: 44 TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY--G 101
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE--SQCGSAKGFTGTYR 222
+I + YLHS +++RDLK ENL+L +D +K+ DFG+ C E S + K F GT
Sbjct: 102 AEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGL-CKEGISDGATMKTFCGTPE 160
Query: 223 WMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 259
++APE++++ + + VD + G+V++E++ PF N
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 78/251 (31%), Positives = 113/251 (45%), Gaps = 11/251 (4%)
Query: 100 EKQFT---SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVP 156
E+Q SE+ L +H I+ K +I EY +GG L K + Q+ +P
Sbjct: 106 ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLP 165
Query: 157 LNL--VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS- 213
V L I + +HS+ ++HRDLKS N+ L +K+ DFG S S S
Sbjct: 166 FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225
Query: 214 --AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 271
A F GT ++APE+ + KR++KK D++S G++L+ELLT PF + + V
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY 285
Query: 272 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI-LEGYSESLEQDPEFFSSFIP 330
P P L+ S +P RP Q++ Y +L QD S I
Sbjct: 286 GK-YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHSETIS 344
Query: 331 SPDHT-ILRCL 340
D ILR L
Sbjct: 345 PHDREEILRQL 355
|
Length = 478 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 48/162 (29%), Positives = 87/162 (53%), Gaps = 5/162 (3%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
+E +L HP + A + C + EY GG L +L ++ ++
Sbjct: 44 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE--ERARFYG 101
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE--SQCGSAKGFTGTYR 222
+I ++YLHS+ +++RD+K ENL+L +D +K+ DFG+ C E S + K F GT
Sbjct: 102 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKTFCGTPE 160
Query: 223 WMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 264
++APE++++ + + VD + G+V++E++ PF N E+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 57/203 (28%), Positives = 109/203 (53%), Gaps = 18/203 (8%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC-KKPPVFCIITE 136
++DV I ++D +M+EK+ +L + P +T + +C + + E
Sbjct: 34 KKDVVI------QDDDVECTMVEKR------VLALQDKPPFLTQLHSCFQTVDRLYFVME 81
Query: 137 YLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 196
Y+ GG L ++ Q + P + A +I+ G+ +LH +GI++RDLK +N++L +
Sbjct: 82 YVNGGDLMYHIQQVGKFKEPQAVFY--AAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH 139
Query: 197 VKVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTAL 254
+K+ADFG+ C E + + F GT ++APE+I + + K VD +++G++L+E+L
Sbjct: 140 IKIADFGM-CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
Query: 255 TPFDNMTPEQAAFAVCQKNARPP 277
PFD ++ ++ + N P
Sbjct: 199 PPFDGEDEDELFQSIMEHNVSYP 221
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-19
Identities = 67/270 (24%), Positives = 125/270 (46%), Gaps = 39/270 (14%)
Query: 65 SGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEK------QFTSEVALLFRLNHPHI 118
G + IY+G+ + + + +V +E + + +L F +L+ +L+H H+
Sbjct: 5 QGTFTNIYKGVLRVQS-DLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL 63
Query: 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 178
+ C + ++ EY+ G L +LH+ E +V L+ L +A +A + YL +
Sbjct: 64 VKLYGVCVRDE-NIMVEEYVKFGPLDVFLHR-EKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 179 ILHRDLKSENLLL-------GEDMCVKVADFGIS-CLESQCGSAKGFTGTYR-----WMA 225
++H ++ +N+L+ G +K++D GI + S+ R W+A
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR---------EERVERIPWIA 172
Query: 226 PEMIK--EKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP-EQAAFAVCQKNARPPVPPT 281
PE I+ + T D +SFG L E+ + P ++ E+ F Q R P+ P
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY--QDQHRLPM-PD 229
Query: 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSIL 311
C + + LI++CW+ P +RP F I+ L
Sbjct: 230 CAELAN-LINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 50/146 (34%), Positives = 82/146 (56%), Gaps = 10/146 (6%)
Query: 163 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTG 219
L + + + ++HS+ ++HRD+KS N+LL + VK+ DFG S + + S + F G
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 220 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR---P 276
T ++APE+ + K ++KK D++S G++L+ELLT PFD E+ V K
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE----VMHKTLAGRYD 263
Query: 277 PVPPTCPKAFSYLISRCWSSSPDRRP 302
P+PP+ +++ SS P RRP
Sbjct: 264 PLPPSISPEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-19
Identities = 43/160 (26%), Positives = 85/160 (53%)
Query: 100 EKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNL 159
EK E +L ++N P I+ A + C++ + GG L+ +++ + +
Sbjct: 37 EKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMER 96
Query: 160 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 219
V+ + I G+ +LHS I++RD+K EN+LL + +++D G++ + G
Sbjct: 97 VIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG 156
Query: 220 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 259
T +MAPE++KE+ ++ VD ++ G ++E++ TPF +
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 52/170 (30%), Positives = 94/170 (55%), Gaps = 8/170 (4%)
Query: 149 QQEPYSVPLNL--VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS- 205
Q++ Y L L ++ + +A+GM++L S+ +HRDL + N+LL E+ VK+ DFG++
Sbjct: 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR 227
Query: 206 -CLESQCGSAKGFTG-TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 262
+ KG +WMAPE I ++ +T + DV+SFG++LWE+ + +P+ +
Sbjct: 228 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 287
Query: 263 EQAAFAVCQKNARPPVPP-TCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 311
++ ++ R P T P+ + ++ CW P +RP F ++V L
Sbjct: 288 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 7e-19
Identities = 39/153 (25%), Positives = 84/153 (54%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
+E +L ++N +++ A + C++ + GG L+ +++ + A
Sbjct: 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYA 108
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWM 224
+I G++ LH + I++RDLK EN+LL + ++++D G++ + + +G GT +M
Sbjct: 109 AEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYM 168
Query: 225 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
APE++K +R+T D + G +++E++ +PF
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 9e-19
Identities = 49/159 (30%), Positives = 86/159 (54%), Gaps = 8/159 (5%)
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV 160
Q E+ +L N P+I+ F A I E++ GGSL + L ++ +P N++
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPENIL 101
Query: 161 LKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGF 217
K+++ + RG+ YL + I+HRD+K N+L+ +K+ DFG+S ++S A F
Sbjct: 102 GKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSF 158
Query: 218 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP 256
GT +M+PE ++ +T + D++S G+ L E+ P
Sbjct: 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-18
Identities = 58/231 (25%), Positives = 109/231 (47%), Gaps = 20/231 (8%)
Query: 96 ASMLEK-QFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQ---E 151
AS+ E+ +F E L H +++ + C + + ++ E+ G L+ YL E
Sbjct: 34 ASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAE 93
Query: 152 PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL---E 208
+ + ++A +IA G+ +LH +H DL N LL D+ VK+ D+G+S E
Sbjct: 94 LMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153
Query: 209 SQCGSAKGFTGTYRWMAPEMIKEKR-------HTKKVDVYSFGIVLWELLTALT-PFDNM 260
+ RW+APE++ E TK+ +V+S G+ +WEL + P+ ++
Sbjct: 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213
Query: 261 TPEQA-AFAVCQKNARPPVPP---TCPKAFSYLISRCWSSSPDRRPHFDQI 307
+ EQ + V ++ + P P + ++ CW P++RP +++
Sbjct: 214 SDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 84 KLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSL 143
KLV+ + D E F +EV ++ H +++ + ++ E+L GG+L
Sbjct: 46 KLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 144 RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203
+ + V L + + + LH+QG++HRD+KS+++LL D VK++DFG
Sbjct: 105 TDIVTHTRMNEEQIAAV---CLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFG 161
Query: 204 ISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP 262
+ + K GT WMAPE+I + +VD++S GI++ E++ P+ N P
Sbjct: 162 FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 221
Query: 263 EQAAFAVCQKNARPPVPP 280
+A K R +PP
Sbjct: 222 LKA-----MKMIRDNLPP 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 40/158 (25%), Positives = 82/158 (51%)
Query: 100 EKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNL 159
E +E +L ++N ++ A + C++ + GG L+ +++
Sbjct: 44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER 103
Query: 160 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 219
L A +I G++ LH + ++RDLK EN+LL + ++++D G++ + S +G G
Sbjct: 104 ALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVG 163
Query: 220 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
T +MAPE++ +R+T D + G +++E++ +PF
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-18
Identities = 47/165 (28%), Positives = 90/165 (54%), Gaps = 9/165 (5%)
Query: 96 ASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQ--QEPY 153
+M+EK+ +L +++ I++ A + C++ + GG LR +++ +E
Sbjct: 39 GAMVEKR------ILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP 92
Query: 154 SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCG 212
P I G+++LH + I++RDLK EN+LL D V+++D G++ L+
Sbjct: 93 GFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152
Query: 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
KG+ GT +MAPE+++ + + VD ++ G+ L+E++ A PF
Sbjct: 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 57/166 (34%), Positives = 81/166 (48%), Gaps = 29/166 (17%)
Query: 106 EVALLFRLNHPHIITFVAA-CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
E+ LL L HP+II + K + ++ E++ L K + + ++VL A
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNI-NLVFEFMET-DLEKVIKDK-------SIVLTPA 102
Query: 165 ------LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG-- 216
L RG++YLHS ILHRDLK NLL+ D +K+ADFG++ GS
Sbjct: 103 DIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR---SFGSPNRKM 159
Query: 217 ----FTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPF 257
T YR APE++ RH VD++S G + ELL PF
Sbjct: 160 THQVVTRWYR--APELLFGARHYGVGVDMWSVGCIFAELLLR-VPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-18
Identities = 67/254 (26%), Positives = 117/254 (46%), Gaps = 20/254 (7%)
Query: 75 IYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCII 134
IY VA +V E A+ +S + +F + L HP+I+ + C + + ++
Sbjct: 16 IYTDTGVARVVVK--ELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLV 73
Query: 135 TEYLAGGSLRKYLHQQEPY--SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 192
EY G L+ YL Q++ + + L L+ ++A +IA G+ ++H LH DL N L
Sbjct: 74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT 133
Query: 193 EDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKR-------HTKKVDVYS 242
D+ VKV D+GI E + RW+APE++ E TK +V++
Sbjct: 134 SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWA 193
Query: 243 FGIVLWELL-TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS----YLISRCWSSS 297
G+ LWEL A P+ +++ + V + P +S ++ CW S
Sbjct: 194 LGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LS 252
Query: 298 PDRRPHFDQIVSIL 311
P++R +++ +L
Sbjct: 253 PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 63/197 (31%), Positives = 94/197 (47%), Gaps = 37/197 (18%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC----- 132
R VAIK +S+P + A A K+ E+ LL ++H ++I + VF
Sbjct: 40 GRKVAIKKLSRPFQSAIHA----KRTYRELRLLKHMDHENVIGLL------DVFTPASSL 89
Query: 133 -------IITEYLAGGSLRKYLHQQEPYSVPL--NLVLKLALDIARGMQYLHSQGILHRD 183
++T L G L + Q L + + L I RG++Y+HS GI+HRD
Sbjct: 90 EDFQDVYLVTH-LMGADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSAGIIHRD 143
Query: 184 LKSENLLLGEDMCVKVADFGISCLESQCGSA-KGFTGTYRW-MAPEMIKEKRH-TKKVDV 240
LK N+ + ED +K+ DFG L G+ T RW APE++ H + VD+
Sbjct: 144 LKPSNIAVNEDCELKILDFG---LARHTDDEMTGYVAT-RWYRAPEIMLNWMHYNQTVDI 199
Query: 241 YSFGIVLWELLTALTPF 257
+S G ++ ELLT T F
Sbjct: 200 WSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 42/158 (26%), Positives = 86/158 (54%)
Query: 100 EKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNL 159
E +E +L ++N +++ A + C++ + GG L+ +++
Sbjct: 44 ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGR 103
Query: 160 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 219
+ A +I G++ LH + I++RDLK EN+LL + ++++D G++ + + KG G
Sbjct: 104 AVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG 163
Query: 220 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
T +MAPE++K +R+T D ++ G +L+E++ +PF
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 54/230 (23%), Positives = 109/230 (47%), Gaps = 17/230 (7%)
Query: 90 EEDASLASMLEKQFTSEVALLF-RLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYL- 147
E D S+ ++ SEV ++ +L HP+I+ + + I+ + + G L ++
Sbjct: 47 ERDKSIGDIV-----SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFN 101
Query: 148 -----HQQEPYSVPLNLVLKLALDIARGMQYLHSQG-ILHRDLKSENLLLGEDMCVKVAD 201
Q+ N+ +++ L ++YLH + I+HRDL N++LGED V + D
Sbjct: 102 SLKEKKQRFTEERIWNIFVQMVL----ALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITD 157
Query: 202 FGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT 261
FG++ + GT + PE++K + + +K DV++FG +L+++ T PF +
Sbjct: 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217
Query: 262 PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 311
A + + P + + +I+ C + + RP Q+ +++
Sbjct: 218 MLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 4e-18
Identities = 67/259 (25%), Positives = 123/259 (47%), Gaps = 28/259 (10%)
Query: 66 GRHSRIYRGIYKQRDV--AIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123
G + +Y+ +++ V A+K + +++ ++ E+ +L + P+I+ F
Sbjct: 12 GNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM-----ELDILHKAVSPYIVDFYG 66
Query: 124 ACKKPPVFCIITEYLAGGSLRK-YLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILH 181
A + EY+ GSL K Y +P +++ ++ + +G+++L + I+H
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 182 RDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEK------RH 234
RD+K N+L+ + VK+ DFG+S L + AK G +MAPE IK +
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--AKTNIGCQSYMAPERIKSGGPNQNPTY 184
Query: 235 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAA--FAVCQKNARPPVPPTCPKAFSY---- 288
T + DV+S G+ + E+ P+ PE A FA PPT P +S
Sbjct: 185 TVQSDVWSLGLSILEMALGRYPY---PPETYANIFAQLSAIVDGD-PPTLPSGYSDDAQD 240
Query: 289 LISRCWSSSPDRRPHFDQI 307
+++C + P+RRP + Q+
Sbjct: 241 FVAKCLNKIPNRRPTYAQL 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 4e-18
Identities = 56/186 (30%), Positives = 93/186 (50%), Gaps = 15/186 (8%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VAIK + E+D ++K EV +L +L H +I+ A ++ ++ EY+
Sbjct: 29 VAIKKFKESEDD----EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV-E 83
Query: 141 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 200
+L + L P +P + V + + + Y HS I+HRD+K EN+L+ E +K+
Sbjct: 84 RTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLC 142
Query: 201 DFGISCLESQCGSAKGFTGTY---RWM-APE-MIKEKRHTKKVDVYSFGIVLWELLT--A 253
DFG + + A T Y RW APE ++ + + K VDV++ G ++ ELL
Sbjct: 143 DFGFARA-LRARPASPLT-DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200
Query: 254 LTPFDN 259
L P D+
Sbjct: 201 LFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 53/181 (29%), Positives = 84/181 (46%), Gaps = 17/181 (9%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEY--- 137
VAIK + A L K+ E+ +L H +II + +PP Y
Sbjct: 33 VAIKKIPH----AFDVPTLAKRTLRELKILRHFKHDNIIA-IRDILRPPGADFKDVYVVM 87
Query: 138 -LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 196
L L +H +P + + + RG++Y+HS ++HRDLK NLL+ ED
Sbjct: 88 DLMESDLHHIIHSDQPLT--EEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE 145
Query: 197 VKVADFGIS-CLESQCGSAKGFTGTY---RWM-APE-MIKEKRHTKKVDVYSFGIVLWEL 250
+++ DFG++ L S K F Y RW APE ++ +T +D++S G + E+
Sbjct: 146 LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
Query: 251 L 251
L
Sbjct: 206 L 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 6e-18
Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 5/151 (3%)
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
LL + HP ++ + + + +Y+ GG L + H Q S P A +IA
Sbjct: 49 LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAEIA 106
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS--AKGFTGTYRWMAP 226
+ YLHS I++RDLK EN+LL V + DFG+ C E S F GT ++AP
Sbjct: 107 SALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL-CKEGIEHSKTTSTFCGTPEYLAP 165
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
E+++++ + + VD + G VL+E+L L PF
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 7e-18
Identities = 63/193 (32%), Positives = 91/193 (47%), Gaps = 33/193 (17%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF--VAACKKPPVF---C 132
R VAIK +S +D A K+ E+ LL L H +II + P F
Sbjct: 25 GRKVAIKKISNVFDDLIDA----KRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80
Query: 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALD--------IARGMQYLHSQGILHRDL 184
I+TE + L K + +P L D I RG++YLHS ++HRDL
Sbjct: 81 IVTELM-ETDLHKVIKSPQP----------LTDDHIQYFLYQILRGLKYLHSANVIHRDL 129
Query: 185 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RWM-APE-MIKEKRHTKKVD 239
K N+L+ + +K+ DFG++ KGF Y RW APE ++ R+TK +D
Sbjct: 130 KPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAID 189
Query: 240 VYSFGIVLWELLT 252
++S G + ELLT
Sbjct: 190 IWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-18
Identities = 72/265 (27%), Positives = 123/265 (46%), Gaps = 46/265 (17%)
Query: 66 GRHSRIYRGIYKQRD---VAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITF 121
G + ++Y+ + ++D A+K++ P D ++++ +E +L L NHP+++ F
Sbjct: 33 GTYGKVYK-VTNKKDGSLAAVKILD-PISD------VDEEIEAEYNILQSLPNHPNVVKF 84
Query: 122 VAACKKPPVFC-----IITEYLAGGS--------LRKYLHQQEPYSVPLNLVLKLALDIA 168
K ++ E GGS L E ++ +L AL
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM---ISYILYGAL--- 138
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK----GFTGTYRWM 224
G+Q+LH+ I+HRD+K N+LL + VK+ DFG+S +Q S + GT WM
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS---AQLTSTRLRRNTSVGTPFWM 195
Query: 225 APEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV- 278
APE+I + + + DV+S GI EL P +M P + F + +N P +
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI-PRNPPPTLL 254
Query: 279 -PPTCPKAFSYLISRCWSSSPDRRP 302
P ++F++ IS+C + RP
Sbjct: 255 HPEKWCRSFNHFISQCLIKDFEARP 279
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 48/151 (31%), Positives = 80/151 (52%), Gaps = 5/151 (3%)
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
LL L HP ++ + + + +Y+ GG L +L ++ + P A ++A
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFY--AAEVA 106
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE--SQCGSAKGFTGTYRWMAP 226
+ YLHS I++RDLK EN+LL V + DFG+ C E + F GT ++AP
Sbjct: 107 SAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL-CKEGVEPEETTSTFCGTPEYLAP 165
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
E+++++ + + VD + G VL+E+L L PF
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 51/186 (27%), Positives = 91/186 (48%), Gaps = 19/186 (10%)
Query: 95 LASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYS 154
L + +++ F L F N P +++ + + C++ EY+ GG L
Sbjct: 41 LRNQIQQVFVERDILTFAEN-PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA-- 97
Query: 155 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL------- 207
+P+++ + ++YLH+ GI+HRDLK +NLL+ +K+ DFG+S +
Sbjct: 98 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157
Query: 208 ---------ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 258
+++ K GT ++APE+I + + K VD ++ GI+L+E L PF
Sbjct: 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217
Query: 259 NMTPEQ 264
TPE+
Sbjct: 218 GDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 19/166 (11%)
Query: 155 VPLNLVLKLALDIARGMQYL-HSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQC 211
+P +++ K+ + I + + YL G++HRD+K N+LL VK+ DFGIS ++S+
Sbjct: 111 IPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170
Query: 212 GSAKGFTGTYRWMAPEMIKEKRHTKK----VDVYSFGIVLWELLTALTPFDNMTPEQAAF 267
+ G +MAPE I K DV+S GI L EL T P+ N E F
Sbjct: 171 KTRSA--GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---F 225
Query: 268 AVCQK--NARPPVPPTCPKAFSYL----ISRCWSSSPDRRPHFDQI 307
V K PP P + FS + C + +RP + ++
Sbjct: 226 EVLTKILQEEPPSLPP-NEGFSPDFCSFVDLCLTKDHRKRPKYREL 270
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 53/171 (30%), Positives = 90/171 (52%), Gaps = 6/171 (3%)
Query: 90 EEDASLASMLEKQFTSEVALLFR-LNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLH 148
++ A L EK SE +L + + HP ++ + + + +Y+ GG L +L
Sbjct: 29 QKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ 88
Query: 149 QQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208
++ + P A +IA + YLHS I++RDLK EN+LL + + DFG+ C E
Sbjct: 89 RERCFLEPRARFY--AAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL-CKE 145
Query: 209 S--QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
+ G+ F GT ++APE++ ++ + + VD + G VL+E+L L PF
Sbjct: 146 NIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-17
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 37/209 (17%)
Query: 72 YRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125
Y +YK R+ VA+K + E + S + E++LL LNHP+I+ +
Sbjct: 13 YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELNHPNIVKLLDVI 68
Query: 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 185
++ E+L L+K++ +PL L+ + +G+ + HS +LHRDLK
Sbjct: 69 HTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 127
Query: 186 SENLLLGEDMCVKVADFGISCLESQCGSAKGF------------TGTYRWMAPE-MIKEK 232
+NLL+ + +K+ADFG+ A+ F T YR APE ++ K
Sbjct: 128 PQNLLINTEGAIKLADFGL---------ARAFGVPVRTYTHEVVTLWYR--APEILLGCK 176
Query: 233 RHTKKVDVYSFGIVLWELLT--ALTPFDN 259
++ VD++S G + E++T AL P D+
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 44/146 (30%), Positives = 76/146 (52%), Gaps = 2/146 (1%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLAL 165
E LL +NHP +I + C++ + + L YL + +P++ L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYL-TKRSRPLPIDQALIIEK 164
Query: 166 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMA 225
I G++YLH+Q I+HRD+K+EN+ + + V + D G + + G GT A
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNA 224
Query: 226 PEMIKEKRHTKKVDVYSFGIVLWELL 251
PE++ ++ K D++S GIVL+E+L
Sbjct: 225 PEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 51/151 (33%), Positives = 80/151 (52%), Gaps = 5/151 (3%)
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
LL + HP ++ + + + +++ GG L + H Q S P A +IA
Sbjct: 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIA 106
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE--SQCGSAKGFTGTYRWMAP 226
+ YLHS I++RDLK EN+LL V + DFG+ C E +Q + F GT ++AP
Sbjct: 107 SALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGL-CKEGIAQSDTTTTFCGTPEYLAP 165
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
E+I+++ + VD + G VL+E+L L PF
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 4e-17
Identities = 49/161 (30%), Positives = 86/161 (53%), Gaps = 8/161 (4%)
Query: 99 LEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLN 158
+ Q E+ +L N P+I+ F A I E++ GGSL + L +E +P
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEE 103
Query: 159 LVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAK 215
++ K+++ + RG+ YL + I+HRD+K N+L+ +K+ DFG+S ++S A
Sbjct: 104 ILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---AN 160
Query: 216 GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP 256
F GT +M+PE ++ ++ + D++S G+ L EL P
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 5e-17
Identities = 42/147 (28%), Positives = 80/147 (54%), Gaps = 5/147 (3%)
Query: 114 NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQY 173
NHP ++ + + + EY+ GG L H Q +P + +I+ + Y
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 174 LHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES--QCGSAKGFTGTYRWMAPEMIKE 231
LH +GI++RDLK +N+LL + +K+ D+G+ C E + F GT ++APE+++
Sbjct: 112 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 232 KRHTKKVDVYSFGIVLWELLTALTPFD 258
+ + VD ++ G++++E++ +PFD
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 6e-17
Identities = 53/181 (29%), Positives = 94/181 (51%), Gaps = 22/181 (12%)
Query: 142 SLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVK 198
SL K+ + + ++P +++ K+A+ I + ++YLHS+ ++HRD+K N+L+ + VK
Sbjct: 85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVK 144
Query: 199 VADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTK----KVDVYSFGIVLWELLT 252
+ DFGIS ++S + G +MAPE I + + K K DV+S GI + EL T
Sbjct: 145 LCDFGISGYLVDSVAKTID--AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELAT 202
Query: 253 ALTPFDNM-TPEQAAFAVCQKNARPPVPPTCPKA-----FSYLISRCWSSSPDRRPHFDQ 306
P+D+ TP Q V ++ P P F +++C + RP++ +
Sbjct: 203 GRFPYDSWKTPFQQLKQVVEEP-----SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPE 257
Query: 307 I 307
+
Sbjct: 258 L 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 90 EEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQ 149
++D +M EK+ S NHP + + P + E++ GG L ++ +
Sbjct: 35 QDDDVECTMTEKRILS-----LARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK 89
Query: 150 QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209
+ A +I + +LH +GI++RDLK +N+LL + K+ADFG+ C E
Sbjct: 90 SRRFDEARARFY--AAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM-CKEG 146
Query: 210 QCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 258
+ F GT ++APE+++E + VD ++ G++L+E+L PF+
Sbjct: 147 IFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 8/197 (4%)
Query: 63 FASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
+G R+ YK D + + E+ + SE +L +NHP +
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
+ K ++ E++ GG +L + + + P ++ A I +YL S I++R
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRF--PNDVGCFYAAQIVLIFEYLQSLNIVYR 155
Query: 183 DLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDV 240
DLK ENLLL +D +K+ DFG ++ + +T GT ++APE++ H K D
Sbjct: 156 DLKPENLLLDKDGFIKMTDFGF----AKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADW 211
Query: 241 YSFGIVLWELLTALTPF 257
++ GI ++E+L PF
Sbjct: 212 WTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 8/190 (4%)
Query: 115 HPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYL 174
HP + + + C + EY GG L +L ++ +S + +I + YL
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE--DRARFYGAEIVSALDYL 111
Query: 175 HSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLE--SQCGSAKGFTGTYRWMAPEMIKE 231
HS+ +++RDLK ENL+L +D +K+ DFG+ C E + K F GT ++APE++++
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDGHIKITDFGL-CKEGIKDGATMKTFCGTPEYLAPEVLED 170
Query: 232 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291
+ + VD + G+V++E++ PF N E+ + + R P P+A S L+S
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP-RTLSPEAKS-LLS 228
Query: 292 RCWSSSPDRR 301
P +R
Sbjct: 229 GLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-16
Identities = 59/196 (30%), Positives = 97/196 (49%), Gaps = 23/196 (11%)
Query: 72 YRGIYKQRD------VAIKLVSQP--EEDASLASMLEKQFTSEVALLFRL---NHPHIIT 120
Y +YK RD VA+K V E+ L+++ EVALL RL +HP+I+
Sbjct: 13 YGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTV------REVALLKRLEAFDHPNIVR 66
Query: 121 FVAAC-----KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH 175
+ C + ++ E++ LR YL + P +P + L RG+ +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 176 SQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 235
+ I+HRDLK EN+L+ VK+ADFG++ + S + T + APE++ + +
Sbjct: 126 ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYA 185
Query: 236 KKVDVYSFGIVLWELL 251
VD++S G + E+
Sbjct: 186 TPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 60/190 (31%), Positives = 91/190 (47%), Gaps = 33/190 (17%)
Query: 80 DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITE-YL 138
VAIK +S E ++ E+ +L R H +II + +PP F + Y+
Sbjct: 32 KVAIKKISPFEH-----QTFCQRTLREIKILRRFKHENIIGILDI-IRPPSFESFNDVYI 85
Query: 139 AGGSLRKYLHQQEPYSVPLNLVLK---LALD--------IARGMQYLHSQGILHRDLKSE 187
QE L ++K L+ D I RG++Y+HS +LHRDLK
Sbjct: 86 V----------QELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPS 135
Query: 188 NLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RWM-APE-MIKEKRHTKKVDVYS 242
NLLL + +K+ DFG++ + GF Y RW APE M+ K +TK +D++S
Sbjct: 136 NLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWS 195
Query: 243 FGIVLWELLT 252
G +L E+L+
Sbjct: 196 VGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 4e-16
Identities = 46/175 (26%), Positives = 92/175 (52%), Gaps = 8/175 (4%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VAIK + E+D M++K E+ +L +L H +++ + ++ ++ E++
Sbjct: 29 VAIKKFLESEDD----KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH 84
Query: 141 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 200
L ++ P + + V K I RG+++ HS I+HRD+K EN+L+ + VK+
Sbjct: 85 TVLDDL--EKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLC 142
Query: 201 DFGIS-CLESQCGSAKGFTGTYRWMAPEM-IKEKRHTKKVDVYSFGIVLWELLTA 253
DFG + L + + T + APE+ + + ++ + VD+++ G ++ E+LT
Sbjct: 143 DFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 16/161 (9%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPY-----SVPLNL 159
E+ +L ++H II + A + C++ + KY Y +PL
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMV--------MPKYKCDLFTYVDRSGPLPLEQ 186
Query: 160 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK---G 216
+ + + + YLH +GI+HRD+K+EN+ L E + DFG +C G
Sbjct: 187 AITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
++GT +PE++ + K D++S G+VL+E+
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 12/154 (7%)
Query: 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 192
++ EY+ GG L H Q +P A +I + +LH +GI++RDLK +N+LL
Sbjct: 73 LVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 193 EDMCVKVADFGISCLES--QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 250
D +K+ D+G+ C E + F GT ++APE+++ + + VD ++ G++++E+
Sbjct: 131 ADGHIKLTDYGM-CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 189
Query: 251 LTALTPFD------NMTPEQAAFAVC-QKNARPP 277
+ +PFD +M E F V +K R P
Sbjct: 190 MAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 70/258 (27%), Positives = 122/258 (47%), Gaps = 32/258 (12%)
Query: 66 GRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFV 122
G + ++++ + K+ A+K++ P D ++++ +E +L L +HP+++ F
Sbjct: 29 GTYGKVFKVLNKKNGSKAAVKILD-PIHD------IDEEIEAEYNILKALSDHPNVVKFY 81
Query: 123 AACKKPPV-----FCIITEYLAGGSL----RKYLHQQEPYSVPL-NLVLKLALDIARGMQ 172
K V ++ E GGS+ + +L + E P+ +L AL G+Q
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL---MGLQ 138
Query: 173 YLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIK- 230
+LH +HRD+K N+LL + VK+ DFG+S L S GT WMAPE+I
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 198
Query: 231 ----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPK 284
+ + + DV+S GI EL P ++ P +A F + +N P + P
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI-PRNPPPTLHQPELWSN 257
Query: 285 AFSYLISRCWSSSPDRRP 302
F+ I +C + ++RP
Sbjct: 258 EFNDFIRKCLTKDYEKRP 275
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 6e-16
Identities = 44/160 (27%), Positives = 86/160 (53%), Gaps = 15/160 (9%)
Query: 114 NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQY 173
NHP ++ + + + E+++GG L H Q +P + +I+ + +
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLALNF 111
Query: 174 LHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG-----FTGTYRWMAPEM 228
LH +GI++RDLK +N+LL + +K+ D+G+ C E G G F GT ++APE+
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGM-CKE---GIRPGDTTSTFCGTPNYIAPEI 167
Query: 229 IKEKRHTKKVDVYSFGIVLWELLTALTPFD----NMTPEQ 264
++ + + VD ++ G++++E++ +PFD + P+Q
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 7e-16
Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 27/167 (16%)
Query: 106 EVALLFRLNHPHIITF---VAACKKPPVFCIITEY----LAGGSLRKYLHQQEPYSVPLN 158
E+ LL +L HP+I+ V + K ++ ++ EY L G + E
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIY-MVFEYMDHDLTGLLDSPEVKFTESQ----- 101
Query: 159 LVLK-LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKG 216
+K + G+QYLHS GILHRD+K N+L+ D +K+ADFG++ + ++
Sbjct: 102 --IKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR--NSAD 157
Query: 217 FTG---T--YRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLTALTPF 257
+T T YR PE++ R+ +VD++S G +L EL F
Sbjct: 158 YTNRVITLWYR--PPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-16
Identities = 55/176 (31%), Positives = 88/176 (50%), Gaps = 14/176 (7%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYL 138
++VAIK + +P LA K+ E+ LL L H +II+ P L
Sbjct: 36 QNVAIKKIMKPFSTPVLA----KRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91
Query: 139 AGGSLRKYLHQQEPYSVPL--NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 196
G L + L S PL + I RG++Y+HS G++HRDLK N+L+ E+
Sbjct: 92 LGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD 146
Query: 197 VKVADFGISCLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGIVLWELL 251
+K+ DFG++ Q G+ T + APE M+ +++ +VD++S G + E+L
Sbjct: 147 LKICDFGLA--RIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 58 FIGCKFASGRHSRIYRGIYKQ----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL 113
GC G + R+Y+ K ++ AIK +E + S E+ALL L
Sbjct: 4 IEGC-IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQ---SACREIALLREL 59
Query: 114 NHPHIITFVAACKKPPVFCI-----ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
H ++++ V + + E+ + K+ Q + S+P ++V L I
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQII-KFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 169 RGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADFGISCLESQCGSAKGFTG----- 219
G+ YLHS +LHRDLK N+L+ E VK+ D G++ L
Sbjct: 119 NGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPLKPLADLDPVVV 177
Query: 220 TYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPF 257
T + APE++ RH TK +D+++ G + ELLT F
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 64/278 (23%), Positives = 122/278 (43%), Gaps = 60/278 (21%)
Query: 66 GRHSRIYRGIYKQRD--------------VAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
G ++IY GI +D V +K++ D SLA F +++
Sbjct: 6 GTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLA------FFETASMMR 59
Query: 112 RLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQ-EPYSVPLNLVLKLALDIARG 170
+++H HI+ C + ++ E++ G L ++H++ + + P K+A +A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF--KVAKQLASA 117
Query: 171 MQYLHSQGILHRDLKSENLLLGEDMC-------VKVADFGI--------SCLESQCGSAK 215
+ YL + ++H ++ ++N+LL + +K++D GI C+E
Sbjct: 118 LSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER------ 171
Query: 216 GFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWEL-LTALTPF-DNMTPEQAAF--AVC 270
W+APE +++ ++ + D +SFG LWE+ P D E+ F C
Sbjct: 172 -----IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC 226
Query: 271 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 308
V P+C K + L++ C + P++RP F I+
Sbjct: 227 M-----LVTPSC-KELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 51/181 (28%), Positives = 89/181 (49%), Gaps = 13/181 (7%)
Query: 85 LVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLR 144
+VS+ E +LA E +L ++N P I+ + + P ++ ++ GG L
Sbjct: 31 IVSRSEVTHTLA---------ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELF 81
Query: 145 KYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204
+L ++ + + L A ++ LH +++RDLK EN+LL + + DFG+
Sbjct: 82 HHLQREGRFDLSRARFYTAELLCA--LENLHKFNVIYRDLKPENILLDYQGHIALCDFGL 139
Query: 205 SCLE-SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF-DNMTP 262
L F GT ++APE++ +TK VD ++ G++L+E+LT L PF D
Sbjct: 140 CKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN 199
Query: 263 E 263
E
Sbjct: 200 E 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 64/194 (32%), Positives = 91/194 (46%), Gaps = 22/194 (11%)
Query: 72 YRGIYKQRD------VAIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNHPHIITF--V 122
Y +Y+ RD VA+K V E D S L E+ LL L HP+I+ V
Sbjct: 20 YGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-----EITLLLNLRHPNIVELKEV 74
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
K ++ EY + P+S V L L + RG+QYLH I+HR
Sbjct: 75 VVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQ--VKCLMLQLLRGLQYLHENFIIHR 132
Query: 183 DLKSENLLLGEDMCVKVADFGIS-CLESQCG--SAKGFTGTYRWMAPEMI-KEKRHTKKV 238
DLK NLLL + C+K+ADFG++ + K T YR APE++ +T +
Sbjct: 133 DLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYR--APELLLGCTTYTTAI 190
Query: 239 DVYSFGIVLWELLT 252
D+++ G +L ELL
Sbjct: 191 DMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 49/187 (26%), Positives = 93/187 (49%), Gaps = 9/187 (4%)
Query: 73 RGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132
R IY + ++ K + +E A ++ E+ L P I+ + +
Sbjct: 18 RRIYAMKVLSKKEIVAKKEVAH--TIGERNILVRTLLD---ESPFIVGLKFSFQTDSDLY 72
Query: 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 192
++T+Y++GG L + H Q+ + ++ +++LH I++RDLK EN+LL
Sbjct: 73 LVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130
Query: 193 EDMCVKVADFGISCLE-SQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGIVLWEL 250
+ + DFG+S + + F GT ++APE ++ EK +TK VD +S G++++E+
Sbjct: 131 ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190
Query: 251 LTALTPF 257
+PF
Sbjct: 191 CCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 49/185 (26%), Positives = 92/185 (49%), Gaps = 19/185 (10%)
Query: 82 AIKLVSQP---EEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYL 138
AIK++ + ++D +M EK+ + A HP + + + EY+
Sbjct: 24 AIKVLKKDVILQDDDVDCTMTEKRILALAA-----KHPFLTALHCCFQTKDRLFFVMEYV 78
Query: 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 198
GG L + + + P + A ++ + +LH G+++RDLK +N+LL + K
Sbjct: 79 NGGDLMFQIQRSRKFDEPRSRFY--AAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCK 136
Query: 199 VADFGISCLESQCGSAKG-----FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA 253
+ADFG+ C E G G F GT ++APE+++E + VD ++ G++++E++
Sbjct: 137 LADFGM-CKE---GILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG 192
Query: 254 LTPFD 258
PF+
Sbjct: 193 QPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 62 KFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
K G + +Y+G K + VA+K + E+ + S + E++LL L HP+I+
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIV 62
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQG 178
+ +I E+L+ L+KYL + LV I +G+ + HS+
Sbjct: 63 CLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 179 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGF------------TGTYRWMAP 226
+LHRDLK +NLL+ +K+ADFG+ A+ F T YR AP
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGL---------ARAFGIPVRVYTHEVVTLWYR--AP 170
Query: 227 E-MIKEKRHTKKVDVYSFGIVLWELLT 252
E ++ R++ VD++S G + E+ T
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 38/98 (38%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 167 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-----LESQCGSAKGFTGTY 221
I G++Y+HS +LHRDLK NLL+ D +K+ DFG++ G + T
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT- 172
Query: 222 RWM-APE-MIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
RW APE M+ + +TK +DV+S G +L ELL P
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 99 LEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLN 158
+ Q E+ +L N P+I+ F A I E++ GGSL + L ++ +P
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQ 103
Query: 159 LVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAK 215
++ K+++ + +G+ YL + I+HRD+K N+L+ +K+ DFG+S ++S A
Sbjct: 104 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---AN 160
Query: 216 GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA---LTPFDNMTPEQAAFAVCQK 272
F GT +M+PE ++ ++ + D++S G+ L E+ + P D E +
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEG 220
Query: 273 NARPPVPPTCPKAFSYLISRCWSSSPDRRP 302
+ P+ +S S PD RP
Sbjct: 221 DPAESETSPRPRPPGRPLS---SYGPDSRP 247
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 34/91 (37%), Positives = 50/91 (54%), Gaps = 2/91 (2%)
Query: 174 LHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR 233
LH G +HRDLK EN L+ +K+ DFG+S + A G+ +MAPE+++ K
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGLS--KGIVTYANSVVGSPDYMAPEVLRGKG 174
Query: 234 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 264
+ VD +S G +L+E L PF TP +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 5/150 (3%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
+E +L +NHP II C+I L Y + ++ + +L +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTYR 222
+ R +QYLH I+HRD+K+EN+ + V + DFG +C + K G+ GT
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248
Query: 223 WMAPEMIKEKRHTKKVDVYSFGIVLWELLT 252
APE++ + VD++S GIVL+E+ T
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 70/278 (25%), Positives = 112/278 (40%), Gaps = 48/278 (17%)
Query: 64 ASGRHSRIYRG--IYKQRDVAIKLVSQPEEDASL-ASMLEKQFTSEVALLFRL---NHPH 117
G + +Y+ + R VA+K V P + + S L E+ALL +L HP+
Sbjct: 8 GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-----EIALLKQLESFEHPN 62
Query: 118 IITFVAACKKPPVFCIITEYLA----GGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQY 173
I+ + C P + L L YL + +P + L + RG+ +
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 174 LHSQGILHRDLKSENLLLGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPEMIK 230
LHS I+HRDLK +N+L+ D VK+ADFG++ E S T YR APE++
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV-VTLWYR--APEVLL 179
Query: 231 EKRHTKKVDVYSFGIVLWEL--LTAL------------------TPFDNMTPEQAAF--- 267
+ + VD++S G + EL L P + P +
Sbjct: 180 QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239
Query: 268 AVCQKNARPP---VPPTCPKAFSYLISRCWSSSPDRRP 302
+ R VP C + L+ + + +P +R
Sbjct: 240 SFPSYTPRSFKSFVPEICEEGLD-LLKKMLTFNPHKRI 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYL 138
R VA+K + ED S +L+K+F E + L HP I+ + C Y+
Sbjct: 28 RRVALKKI---REDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI 84
Query: 139 AGGSLRKYLH---QQEPYSVPLNL------VLKLALDIARGMQYLHSQGILHRDLKSENL 189
G +L+ L Q+E S L L + I ++Y+HS+G+LHRDLK +N+
Sbjct: 85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNI 144
Query: 190 LLGEDMCVKVADFGI--------------------SCLESQCGSAKGFTGTYRWMAPEMI 229
LLG V + D+G C S K GT +MAPE +
Sbjct: 145 LLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGK-IVGTPDYMAPERL 203
Query: 230 KEKRHTKKVDVYSFGIVLWELLTALTPFDN 259
++ D+Y+ G++L+++LT P+
Sbjct: 204 LGVPASESTDIYALGVILYQMLTLSFPYRR 233
|
Length = 932 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 46/215 (21%)
Query: 133 IITEYLAGGSLRKYLHQQEPYSVPLNLV------LKLALDIARGMQYLHSQGILHRDLKS 186
++ EY+ GG L L +++ P L LALD +H G +HRD+K
Sbjct: 78 LVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALD------SVHKLGFIHRDIKP 129
Query: 187 ENLLLGEDMCVKVADFGIS-----------------CLESQCGSAKGFT----------- 218
+N+L+ D +K+ADFG+ L +
Sbjct: 130 DNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANS 189
Query: 219 --GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC--QKNA 274
GT ++APE+++ + + D +S G++L+E+L PF + T ++ + +++
Sbjct: 190 TVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESL 249
Query: 275 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309
R P P LI R DR F++I S
Sbjct: 250 RFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKS 284
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 7/91 (7%)
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY----RW 223
+ ++Y+HS ++HRDLK N+LL D VK+ADFG++ L + + T RW
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177
Query: 224 M-APE-MIKEKRHTKKVDVYSFGIVLWELLT 252
APE ++ R+TK VD++S G +L E+L
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 55/170 (32%), Positives = 89/170 (52%), Gaps = 17/170 (10%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFC-----IITEYLAGGSLRKYLHQQEPYSVPLNLV 160
E+ +L H ++++ + + P + ++TE L L K + +P S
Sbjct: 49 ELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE-LMQSDLHKIIVSPQPLSSDH--- 104
Query: 161 LKLAL-DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE----SQCGSAK 215
+K+ L I RG++YLHS GILHRD+K NLL+ + +K+ DFG++ +E S+ + +
Sbjct: 105 VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE 164
Query: 216 GFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQ 264
T YR APE++ RH T VD++S G + ELL F +P Q
Sbjct: 165 VVTQYYR--APEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 43/143 (30%), Positives = 76/143 (53%), Gaps = 4/143 (2%)
Query: 116 PHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH 175
P I+ A P I + + GG L +L Q +S + A +I G++++H
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE--AEMRFYAAEIILGLEHMH 114
Query: 176 SQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI-KEKRH 234
++ +++RDLK N+LL E V+++D G++C S+ GT+ +MAPE++ K +
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAY 173
Query: 235 TKKVDVYSFGIVLWELLTALTPF 257
D +S G +L++LL +PF
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 55/190 (28%), Positives = 92/190 (48%), Gaps = 33/190 (17%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTS--------EVALLFRLN-HPHIITFVAACKKPPVF 131
VAIK ++K+F S EV L +LN HP+I+ ++
Sbjct: 27 VAIK-------------KMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDEL 73
Query: 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 191
+ EY+ G +L + + ++ +++ + I +G+ ++H G HRDLK ENLL+
Sbjct: 74 YFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV 132
Query: 192 GEDMCVKVADFGISCLESQCGSAKGFTGTY---RWM-APEMI-KEKRHTKKVDVYSFGIV 246
VK+ADFG L + S +T Y RW APE++ + ++ VD+++ G +
Sbjct: 133 SGPEVVKIADFG---LAREIRSRPPYT-DYVSTRWYRAPEILLRSTSYSSPVDIWALGCI 188
Query: 247 LWELLTALTP 256
+ EL T L P
Sbjct: 189 MAELYT-LRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 51/190 (26%), Positives = 94/190 (49%), Gaps = 20/190 (10%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQ----FTSEVALLFRLNHPHIITFVAACKKPPVFCI 133
Q+ A+KL+S+ E M+++ F E ++ N P ++ A + +
Sbjct: 68 QKVYAMKLLSKFE-------MIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120
Query: 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 193
+ EY+ GG L + Y VP ++ + +HS G++HRD+K +N+LL +
Sbjct: 121 VMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK 177
Query: 194 DMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEK----RHTKKVDVYSFGIVL 247
+K+ADFG + G + T GT +++PE++K + + ++ D +S G+ L
Sbjct: 178 HGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237
Query: 248 WELLTALTPF 257
+E+L TPF
Sbjct: 238 FEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 51/158 (32%), Positives = 82/158 (51%), Gaps = 20/158 (12%)
Query: 106 EVALLFRLNHPHIIT---FVAACKKPPVFCIITEYLAGGSLRKYL-HQQEPYSVPLNLVL 161
E+ +L +L HP+I+T V ++ ++ EY+ L+ + ++P+ V
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIY-MVMEYVE-HDLKSLMETMKQPFLQS--EVK 109
Query: 162 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGT 220
L L + G+ +LH ILHRDLK+ NLLL +K+ DFG L + GS K +T
Sbjct: 110 CLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFG---LAREYGSPLKPYTQL 166
Query: 221 -----YRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT 252
YR APE ++ K ++ +D++S G + ELLT
Sbjct: 167 VVTLWYR--APELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 58/239 (24%), Positives = 99/239 (41%), Gaps = 61/239 (25%)
Query: 58 FIGC----------KFASGRHSRIYRGIYK--QRDVAIK--LVSQPEEDASLASMLEKQF 103
F GC K G +Y+ R VA+K L+ ++ + ++
Sbjct: 1 FYGCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL----- 55
Query: 104 TSEVALLFRLNHPHIITFV--------AACKKPPVFCIITEY----LAGGSLRKYLHQQE 151
E+ +L +L HP+++ + + +K ++T Y L+G L
Sbjct: 56 -REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG-----LLENP- 108
Query: 152 PYSVPLN-----LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206
SV L + L+ G+ YLH ILHRD+K+ N+L+ +K+ADFG++
Sbjct: 109 --SVKLTESQIKCYMLQLLE---GINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163
Query: 207 LESQC---------GSAKGFTG--TYRWM-APEMI-KEKRHTKKVDVYSFGIVLWELLT 252
G + +T RW PE++ E+R+T VD++ G V E+ T
Sbjct: 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 44/143 (30%), Positives = 77/143 (53%), Gaps = 4/143 (2%)
Query: 116 PHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH 175
P I+ A P C I + + GG L +L Q +S + A +I G++++H
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSE--KEMRFYATEIILGLEHMH 114
Query: 176 SQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI-KEKRH 234
++ +++RDLK N+LL E V+++D G++C S+ GT+ +MAPE++ K +
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGTAY 173
Query: 235 TKKVDVYSFGIVLWELLTALTPF 257
D +S G +L++LL +PF
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV 160
K +EV L HP+I+T +I+ ++A GS L P + L+
Sbjct: 44 KALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALI 103
Query: 161 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT 220
+ RG+ YLH G +HR++K+ ++L+ D V ++ G+S L S + +
Sbjct: 104 GNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVV 161
Query: 221 YR----------WMAPEMIKEKRH--TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 268
Y W++PE++++ + K D+YS GI EL T PF +M Q
Sbjct: 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ---M 218
Query: 269 VCQKNARPPVPPTCPKAFSYLISR 292
+ QK PP P F SR
Sbjct: 219 LLQKLKGPPYSPLDITTFPCEESR 242
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 46/179 (25%), Positives = 81/179 (45%), Gaps = 28/179 (15%)
Query: 101 KQFTSEVALLFRLNHPHII--------------TFVAACKKPPVFCIITEYLAGGSLRKY 146
K E+ ++ RL+H +I+ V + + I+ EY+ L
Sbjct: 47 KHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANV 105
Query: 147 LHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-EDMCVKVADFGIS 205
L Q + + RG++Y+HS +LHRDLK N+ + ED+ +K+ DFG++
Sbjct: 106 LEQGP---LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162
Query: 206 CLESQCGSAKGF------TGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPF 257
+ S KG+ T YR +P ++ + TK +D+++ G + E+LT F
Sbjct: 163 RIVDPHYSHKGYLSEGLVTKWYR--SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 61 CKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118
+ SG + + I K+ VAIK +S+P + A K+ E+ LL + H ++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFA----KRAYRELTLLKHMQHENV 76
Query: 119 ITFVAACKKPPVFCIITE-YLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 177
I + + YL ++ L + + + + V L + G++Y+HS
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA 136
Query: 178 GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TK 236
GI+HRDLK NL + ED +K+ DFG++ G+ T + APE+I H +
Sbjct: 137 GIIHRDLKPGNLAVNEDCELKILDFGLA--RHADAEMTGYVVTRWYRAPEVILNWMHYNQ 194
Query: 237 KVDVYSFGIVLWELLTALTPF 257
VD++S G ++ E+LT T F
Sbjct: 195 TVDIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 8e-14
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 62 KFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
K G ++ +Y+G K D VA+K + E+ + + + EV+LL L H +I+
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-----EVSLLKDLKHANIV 67
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 179
T ++ EYL L++YL S+ ++ V + RG+ Y H + +
Sbjct: 68 TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRKV 125
Query: 180 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE--MIKEKRHTKK 237
LHRDLK +NLL+ E +K+ADFG++ +S W P ++ ++ +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 238 VDVYSFGIVLWELLTALTPFDNMTPEQ 264
+D++ G + +E+ T F T E+
Sbjct: 186 IDMWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 54/183 (29%), Positives = 88/183 (48%), Gaps = 15/183 (8%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF-----CIIT 135
VA+K +S+P + A K+ E+ LL + H ++I + +
Sbjct: 45 VAVKKLSRPFQSIIHA----KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100
Query: 136 EYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM 195
+L G L + Q+ + + V L I RG++Y+HS I+HRDLK NL + ED
Sbjct: 101 THLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC 157
Query: 196 CVKVADFGISCLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLTAL 254
+K+ DFG++ G+ T + APE M+ + + VD++S G ++ ELLT
Sbjct: 158 ELKILDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
Query: 255 TPF 257
T F
Sbjct: 216 TLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 49/152 (32%), Positives = 80/152 (52%), Gaps = 15/152 (9%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFC-IITEYLAGGSLRKYLHQQEPYSVPLNL--VLK 162
E LL RL+HP ++ + + C ++ +Y + L YL + PL L V
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS--DLYTYLGAR---LRPLGLAQVTA 264
Query: 163 LALDIARGMQYLHSQGILHRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAK---GF 217
+A + + Y+H +GI+HRD+K+EN+L+ ED+C + DFG +C S G
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWSTPFHYGI 322
Query: 218 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 249
GT APE++ +T VD++S G+V++E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 52/202 (25%), Positives = 100/202 (49%), Gaps = 28/202 (13%)
Query: 70 RIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQ----FTSEVALLFRLNHPHIITFVAAC 125
++ R ++ A+KL+S+ E M+++ F E ++ N P ++ A
Sbjct: 60 QLVRHKSTRKVYAMKLLSKFE-------MIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112
Query: 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 185
+ ++ EY+ GG L + Y VP ++ + +HS G +HRD+K
Sbjct: 113 QDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 169
Query: 186 SENLLLGEDMCVKVADFGISCLES------QCGSAKGFTGTYRWMAPEMIKEK----RHT 235
+N+LL + +K+ADFG +C++ +C +A GT +++PE++K + +
Sbjct: 170 PDNMLLDKSGHLKLADFG-TCMKMNKEGMVRCDTA---VGTPDYISPEVLKSQGGDGYYG 225
Query: 236 KKVDVYSFGIVLWELLTALTPF 257
++ D +S G+ L+E+L TPF
Sbjct: 226 RECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 49/203 (24%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 62 KFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
K G ++ +Y+G + VA+K + E+ + ++ + E++L+ L H +I+
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-----EISLMKELKHENIV 61
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQ-EPYSVPLNLVLKLALDIARGMQYLHSQG 178
++ EY+ L+KY+ ++ N V + +G+ + H
Sbjct: 62 RLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120
Query: 179 ILHRDLKSENLLLGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPEMIKEKR-H 234
+LHRDLK +NLL+ + +K+ADFG++ + S + T YR AP+++ R +
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYR--APDVLLGSRTY 178
Query: 235 TKKVDVYSFGIVLWELLTALTPF 257
+ +D++S G ++ E++T F
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 22/196 (11%)
Query: 72 YRGIYKQRD-------VAIKLVS-QPEEDASLASMLEKQFTSEVALLFRLN---HPHIIT 120
Y ++K RD VA+K V Q E+ S + EVA+L L HP+++
Sbjct: 14 YGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-----EVAVLRHLETFEHPNVVR 68
Query: 121 FVAACK-----KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH 175
C + ++ E++ L YL + VP + + + RG+ +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 176 SQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 235
S ++HRDLK +N+L+ +K+ADFG++ + S + T + APE++ + +
Sbjct: 128 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA 187
Query: 236 KKVDVYSFGIVLWELL 251
VD++S G + E+
Sbjct: 188 TPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 37/158 (23%), Positives = 83/158 (52%)
Query: 100 EKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNL 159
E +E +L ++N +++ A + C++ + GG L+ +++
Sbjct: 44 EAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQR 103
Query: 160 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 219
+ A ++ G++ L + I++RDLK EN+LL + ++++D G++ + + +G G
Sbjct: 104 AIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVG 163
Query: 220 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
T +MAPE+I +++T D + G +++E++ +PF
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 50/190 (26%), Positives = 93/190 (48%), Gaps = 28/190 (14%)
Query: 82 AIKLVSQPEEDASLASMLEKQ----FTSEVALLFRLNHPHIITFVAACKKPPVFCIITEY 137
A+KL+S+ E M+++ F E ++ N I+ A + ++ EY
Sbjct: 72 AMKLLSKFE-------MIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEY 124
Query: 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 197
+ GG L + Y +P ++ + +HS G +HRD+K +N+LL + +
Sbjct: 125 MPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 181
Query: 198 KVADFGISCLES------QCGSAKGFTGTYRWMAPEMIKEKRHT----KKVDVYSFGIVL 247
K+ADFG +C++ +C +A GT +++PE++K + ++ D +S G+ L
Sbjct: 182 KLADFG-TCMKMDANGMVRCDTA---VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237
Query: 248 WELLTALTPF 257
+E+L TPF
Sbjct: 238 YEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 8e-13
Identities = 37/97 (38%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 163 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA-KGFTGTY 221
L + +G++Y+H+ GI+HRDLK NL + ED +K+ DFG L Q S G+ T
Sbjct: 123 LVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFG---LARQTDSEMTGYVVTR 179
Query: 222 RWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPF 257
+ APE+I +T+ VD++S G ++ E+LT F
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 41/221 (18%)
Query: 60 GCKFASGRHSRIYRGIYKQ----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH 115
GCK G + +Y+ K RD A+K + + + E+ALL L H
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIE--------GTGISMSACREIALLRELKH 57
Query: 116 PHIIT----FVAACKKP----------PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVL 161
P++I+ F++ + ++ II + A + +K P +P +V
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKK------PVQLPRGMVK 111
Query: 162 KLALDIARGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADFGISCLESQ----CGS 213
L I G+ YLH+ +LHRDLK N+L+ E VK+AD G + L +
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171
Query: 214 AKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTA 253
T+ + APE++ RH TK +D+++ G + ELLT+
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 36/91 (39%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 167 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RW 223
+ RG++Y+HS +LHRDLK NLLL + +K+ DFG++ S+ G F Y RW
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG---DFMTEYVVTRW 173
Query: 224 M-APEMI-KEKRHTKKVDVYSFGIVLWELLT 252
APE++ +T +DV+S G + ELL
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 39/202 (19%)
Query: 72 YRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHIITFVA 123
Y +YK RD VA+K + ED + S T+ E++LL LNHP+I+ +
Sbjct: 12 YGVVYKARDKLTGEIVALKKIRLETEDEGVPS------TAIREISLLKELNHPNIVRLLD 65
Query: 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRD 183
++ E+L L+KY+ + L+ + +G+ Y HS +LHRD
Sbjct: 66 VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRD 124
Query: 184 LKSENLLLGEDMCVKVADFGISCLESQCGSAKGF------------TGTYRWMAPEMIKE 231
LK +NLL+ + +K+ADFG+ A+ F T YR APE++
Sbjct: 125 LKPQNLLIDREGALKLADFGL---------ARAFGVPVRTYTHEVVTLWYR--APEILLG 173
Query: 232 KRH-TKKVDVYSFGIVLWELLT 252
R + VD++S G + E++
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 62 KFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPH 117
K G ++ +Y+GI + VA+K++S E+ FT+ E +LL L H +
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-------PFTAIREASLLKGLKHAN 64
Query: 118 IITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 177
I+ + EY+ L +Y+ Q P N+ L + RG+ Y+H Q
Sbjct: 65 IVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQ 122
Query: 178 GILHRDLKSENLL---LGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIK 230
ILHRDLK +NLL LGE +K+ADFG++ + SQ S++ T YR P+ ++
Sbjct: 123 HILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYR--PPDVLLG 177
Query: 231 EKRHTKKVDVYSFGIVLWELLTALTPFDNMT--PEQ 264
++ +D++ G + E+L F ++ EQ
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 72 YRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125
Y ++K ++ VA+K V ++D + S + E+ LL L H +I+
Sbjct: 13 YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVRLYDVL 68
Query: 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 185
++ EY L+KY P +V + +G+ + HS +LHRDLK
Sbjct: 69 HSDKKLTLVFEY-CDQDLKKYFDSCNGDIDP-EIVKSFMFQLLKGLAFCHSHNVLHRDLK 126
Query: 186 SENLLLGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVY 241
+NLL+ ++ +K+ADFG++ + +C SA+ T YR P+ + K ++ +D++
Sbjct: 127 PQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYR--PPDVLFGAKLYSTSIDMW 184
Query: 242 SFGIVLWELLTALTP 256
S G + EL A P
Sbjct: 185 SAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 61/262 (23%), Positives = 117/262 (44%), Gaps = 32/262 (12%)
Query: 66 GRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
G ++I++GI + + +V +K++ D S + E F +++ +L+H
Sbjct: 6 GTFTKIFKGIRREVGDYGELHKTEVLLKVL-----DKSHRNYSE-SFFEAASMMSQLSHK 59
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
H++ C ++ EY+ GSL YL + + + ++ L++A +A + +L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLED 118
Query: 177 QGILHRDLKSENLLL--------GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 228
+G+ H ++ ++N+LL G +K++D GIS + W+ PE
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI---TVLPKEILLERIPWVPPEC 175
Query: 229 IKEKRH-TKKVDVYSFGIVLWELLTALT-PFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286
I+ ++ + D +SFG LWE+ + P + Q + + P P A
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKKLQFYEDRHQLPAPKWTELAN 234
Query: 287 SYLISRCWSSSPDRRPHFDQIV 308
LI++C PD RP F I+
Sbjct: 235 --LINQCMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 59/230 (25%), Positives = 103/230 (44%), Gaps = 29/230 (12%)
Query: 100 EKQFTSEVALLFRLNH-PHIITFVAACKKPPVF----CIITEYLAGGSLR---KYLHQQE 151
+K+ ++ ++ R + P+I+ F A +F C I L SL KY+++
Sbjct: 46 QKRLLMDLDVVMRSSDCPYIVKFYGA-----LFREGDCWICMELMDISLDKFYKYVYEVL 100
Query: 152 PYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISC-LES 209
+P ++ K+A+ + + YL + I+HRD+K N+LL + +K+ DFGIS L
Sbjct: 101 KSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160
Query: 210 QCGSAKGFTGTYRWMAPEMIKEKRHTK---KVDVYSFGIVLWELLTALTPFDNMTP--EQ 264
+ G +MAPE I + DV+S GI L+E+ T P+ +Q
Sbjct: 161 SIAKTRD-AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ 219
Query: 265 AAFAVCQKNARPPV-PPTCPKAFSY----LISRCWSSSPDRRPHFDQIVS 309
V PP+ + + FS I+ C +RP + +++
Sbjct: 220 LTQVV---KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 52/192 (27%), Positives = 95/192 (49%), Gaps = 20/192 (10%)
Query: 72 YRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125
Y ++K R+ VAIK + E+D +++K E+ +L +L HP+++ +
Sbjct: 14 YGVVFKCRNRETGQIVAIKKFVESEDDP----VIKKIALREIRMLKQLKHPNLVNLIEVF 69
Query: 126 KKPPVFCIITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQGILHRD 183
++ ++ EY L++ E P VP +L+ K+ + + + H +HRD
Sbjct: 70 RRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRD 125
Query: 184 LKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWM-APEMI-KEKRHTKKVDV 240
+K EN+L+ + +K+ DFG + L + T RW APE++ + ++ VDV
Sbjct: 126 VKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT-RWYRAPELLVGDTQYGPPVDV 184
Query: 241 YSFGIVLWELLT 252
++ G V ELLT
Sbjct: 185 WAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 72 YRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-PHIITFVAA 124
Y +YK RD VA+K ++ + + E++LL L+ +I+ +
Sbjct: 14 YGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQMLSESIYIVRLLDV 69
Query: 125 ------CKKPPVFCIITEYLAGGSLRKYL---HQQEPYSVPLNLVLKLALDIARGMQYLH 175
KP ++ ++ EYL L+K++ + +P + + +G+ + H
Sbjct: 70 EHVEEKNGKPSLY-LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127
Query: 176 SQGILHRDLKSENLLLGED-MCVKVADFGISCLESQCGSAKGFTG---TYRWMAPEMIKE 231
G++HRDLK +NLL+ + +K+AD G+ S K +T T + APE++
Sbjct: 128 KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLLG 185
Query: 232 KRH-TKKVDVYSFGIVLWELLT--ALTPFD 258
H + VD++S G + E+ L P D
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 62 KFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
K G ++ +++G K + VA+K + E+ + + + EV+LL L H +I+
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-----EVSLLKDLKHANIV 67
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 179
T ++ EYL L++Y+ N+ + L I RG+ Y H + +
Sbjct: 68 TLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYCHRRKV 125
Query: 180 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE--MIKEKRHTKK 237
LHRDLK +NLL+ E +K+ADFG++ +S W P ++ ++ +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185
Query: 238 VDVYSFGIVLWELLTALTPFDNMTPE 263
+D++ G + +E+ + F T E
Sbjct: 186 IDMWGVGCIFFEMASGRPLFPGSTVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 6e-12
Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 41/221 (18%)
Query: 60 GCKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH 115
GCK G + +Y+ K +++ A+K + + + E+ALL L H
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIE--------GTGISMSACREIALLRELKH 57
Query: 116 PHIIT----FVAACKKP----------PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVL 161
P++I F++ + ++ II + A + +K P +P ++V
Sbjct: 58 PNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKK------PMQLPRSMVK 111
Query: 162 KLALDIARGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADFGISCLESQ----CGS 213
L I G+ YLH+ +LHRDLK N+L+ E VK+AD G + L +
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171
Query: 214 AKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTA 253
T+ + APE++ RH TK +D+++ G + ELLT+
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 6e-12
Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 11/203 (5%)
Query: 62 KFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
K G ++ +Y+G K + VA+K++ EE+ + + + E +LL L H +I+
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-----EASLLKGLKHANIV 66
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 179
++ EY+ L +Y+ + P N+ L L + RG+ Y+H + I
Sbjct: 67 LLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIHQRYI 124
Query: 180 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE--MIKEKRHTKK 237
LHRDLK +NLL+ + +K+ADFG++ +S W P ++ ++
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 238 VDVYSFGIVLWELLTALTPFDNM 260
+D++ G + E++ + F M
Sbjct: 185 LDMWGVGCIFVEMIQGVAAFPGM 207
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 7e-12
Identities = 56/193 (29%), Positives = 92/193 (47%), Gaps = 20/193 (10%)
Query: 72 YRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125
Y +YK RD +A+K + +ED + S + E++LL + H +I+
Sbjct: 15 YGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR----EISLLKEMQHGNIVRLQDVV 70
Query: 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 185
++ EYL L+K++ ++ L+ I RG+ Y HS +LHRDLK
Sbjct: 71 HSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLK 129
Query: 186 SENLLLGEDM-CVKVADFGISCLESQCG-SAKGFTG---TYRWMAPEMIKEKRH-TKKVD 239
+NLL+ +K+ADFG L G + FT T + APE++ RH + VD
Sbjct: 130 PQNLLIDRRTNALKLADFG---LARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVD 186
Query: 240 VYSFGIVLWELLT 252
++S G + E++
Sbjct: 187 IWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 7e-12
Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 19/152 (12%)
Query: 61 CKFASGRHSRIYRGIYK--QRDVAIKLVS-QPEEDASLASMLEKQFTS--EVALLFRLNH 115
K G ++ +Y+G K + VA+K + + EE A FT+ E +LL L H
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP--------FTAIREASLLKDLKH 62
Query: 116 PHIITF--VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQY 173
+I+T + KK + EYL L++Y+ N+ L L + RG+ Y
Sbjct: 63 ANIVTLHDIIHTKKTLTL--VFEYLDT-DLKQYMDDCGGGLSMHNVRLFL-FQLLRGLAY 118
Query: 174 LHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205
H + +LHRDLK +NLL+ E +K+ADFG++
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 49/183 (26%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYL 138
R+VAIK +S+P ++ + A K+ E+ L+ +NH +II+ + + T
Sbjct: 43 RNVAIKKLSRPFQNQTHA----KRAYRELVLMKCVNHKNIISLLN---------VFTPQK 89
Query: 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIAR----------GMQYLHSQGILHRDLKSEN 188
+ + E L V+++ LD R G+++LHS GI+HRDLK N
Sbjct: 90 SLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149
Query: 189 LLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 248
+++ D +K+ DFG++ + T + APE+I + + VD++S G ++
Sbjct: 150 IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 249 ELL 251
E++
Sbjct: 210 EMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 62 KFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
K G ++ +++G K + VA+K + E+ + + + EV+LL L H +I+
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-----EVSLLKNLKHANIV 66
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 179
T ++ EYL L++YL N+ + + RG+ Y H + I
Sbjct: 67 TLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHKRKI 124
Query: 180 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE--MIKEKRHTKK 237
LHRDLK +NLL+ E +K+ADFG++ +S W P ++ ++
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTP 184
Query: 238 VDVYSFGIVLWELLTALTPFDNMT 261
+D++ G +L+E+ T F T
Sbjct: 185 IDMWGVGCILYEMATGRPMFPGST 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 45/161 (27%), Positives = 87/161 (54%), Gaps = 20/161 (12%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
SE+A + +L HP+I+ + C+ +I EY+ G +L + L ++ K+A
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIA 786
Query: 165 LDIARGMQYLH---SQGILHRDLKSENLLL-GED---MCVKVADFGISCLESQCGSAKGF 217
+ IA+ +++LH S ++ +L E +++ G+D + + + G+ C +++C + +
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLP--GLLCTDTKCFISSAY 844
Query: 218 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 258
+APE + K T+K D+Y FG++L ELLT +P D
Sbjct: 845 ------VAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 35/100 (35%), Positives = 58/100 (58%), Gaps = 5/100 (5%)
Query: 163 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYR 222
L + RG++Y+HS GI+HRDLK N+ + ED +++ DFG++ G+ T
Sbjct: 123 LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA--RQADDEMTGYVATRW 180
Query: 223 WMAPE-MIKEKRHTKKVDVYSFGIVLWELL--TALTPFDN 259
+ APE M+ + + VD++S G ++ ELL AL P ++
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 52/190 (27%), Positives = 95/190 (50%), Gaps = 35/190 (18%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEY 137
+R+VAIK +S+P ++ + A K+ E+ L+ +NH +II ++ +
Sbjct: 49 ERNVAIKKLSRPFQNQTHA----KRAYRELVLMKCVNHKNIIG------------LLNVF 92
Query: 138 LAGGSLRKYLHQQEPYSV------PLNLVLKLALDIAR----------GMQYLHSQGILH 181
SL ++ Q+ Y V L V+++ LD R G+++LHS GI+H
Sbjct: 93 TPQKSLEEF---QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 149
Query: 182 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVY 241
RDLK N+++ D +K+ DFG++ + T + APE+I + + VD++
Sbjct: 150 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209
Query: 242 SFGIVLWELL 251
S G ++ E++
Sbjct: 210 SVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 22/198 (11%)
Query: 81 VAIK---LVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEY 137
VA+K L S +ED K E+ +L HP+I+ +V + +++
Sbjct: 28 VAVKKINLDSCSKEDL-------KLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80
Query: 138 LAGGSLRKYLHQQEPYSVPLNLVLKLAL-DIARGMQYLHSQGILHRDLKSENLLLGEDMC 196
+A GS L P +P L + L D+ + Y+HS+G +HR +K+ ++LL D
Sbjct: 81 MAYGSCEDLLKTHFPEGLP-ELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK 139
Query: 197 VKVADFGISC--------LESQCGSAKGFTGTYRWMAPEMIKEKRH--TKKVDVYSFGIV 246
V ++ S K W++PE++++ +K D+YS GI
Sbjct: 140 VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGIT 199
Query: 247 LWELLTALTPFDNMTPEQ 264
EL PF +M Q
Sbjct: 200 ACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 51/190 (26%), Positives = 93/190 (48%), Gaps = 35/190 (18%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEY 137
++VAIK +S+P ++ + A K+ E+ L+ +NH +II + +
Sbjct: 41 GQNVAIKKLSRPFQNVTHA----KRAYRELVLMKLVNHKNIIGLLNV------------F 84
Query: 138 LAGGSLRKYLHQQEPYSV------PLNLVLKLALDIAR----------GMQYLHSQGILH 181
SL ++ Q+ Y V L V+++ LD R G+++LHS GI+H
Sbjct: 85 TPQKSLEEF---QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIH 141
Query: 182 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVY 241
RDLK N+++ D +K+ DFG++ + T + APE+I + + VD++
Sbjct: 142 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 201
Query: 242 SFGIVLWELL 251
S G ++ E++
Sbjct: 202 SVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 60/246 (24%), Positives = 103/246 (41%), Gaps = 47/246 (19%)
Query: 51 SADMSQLFIGCKFASGRHSRIYRGIYKQRD------VAIKLVSQPE------EDASLASM 98
S +S+ +I G + Y + K D VAIK V E +D L M
Sbjct: 3 SFSISERYIQKGAHLGEGT--YGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGM 60
Query: 99 LEKQFTS--EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVP 156
FT+ E+ ++ + H +I+ V + ++ + +A L+K + ++ +
Sbjct: 61 CGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTES 119
Query: 157 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG---- 212
V + L I G+ LH +HRDL N+ + K+ADFG++ + G
Sbjct: 120 Q--VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA---RRYGYPPY 174
Query: 213 ----------------SAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLT--A 253
++K T YR APE++ +++ VD++S G + ELLT
Sbjct: 175 SDTLSKDETMQRREEMTSKVVTLWYR--APELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
Query: 254 LTPFDN 259
L P +N
Sbjct: 233 LFPGEN 238
|
Length = 335 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 47/200 (23%), Positives = 94/200 (47%), Gaps = 32/200 (16%)
Query: 73 RGIYKQRDVAIK--LVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130
R ++ VA+K L+ +E + ++ E+ +L L H +++ + C+
Sbjct: 32 RHKKTKQIVALKKVLMENEKEGFPITAL------REIKILQLLKHENVVNLIEICRTKAT 85
Query: 131 --------FCIITEY----LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 178
F ++ E+ LAG L + L+ + K+ + G+ Y+H
Sbjct: 86 PYNRYKGSFYLVFEFCEHDLAG------LLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK 139
Query: 179 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG--FTG---TYRWMAPEMIKEKR 233
ILHRD+K+ N+L+ +D +K+ADFG++ S ++K +T T + PE++ +R
Sbjct: 140 ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER 199
Query: 234 H-TKKVDVYSFGIVLWELLT 252
+D++ G ++ E+ T
Sbjct: 200 DYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 53/194 (27%), Positives = 94/194 (48%), Gaps = 35/194 (18%)
Query: 80 DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLA 139
+VA+K +S+P ++ + A K+ E+ LL +NH +II+ ++ +
Sbjct: 48 NVAVKKLSRPFQNQTHA----KRAYRELVLLKCVNHKNIIS------------LLNVFTP 91
Query: 140 GGSLRKYLHQQEPYSV------PLNLVLKLALDIAR----------GMQYLHSQGILHRD 183
SL ++ Q+ Y V L V+ + LD R G+++LHS GI+HRD
Sbjct: 92 QKSLEEF---QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 148
Query: 184 LKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSF 243
LK N+++ D +K+ DFG++ + T + APE+I + + VD++S
Sbjct: 149 LKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 208
Query: 244 GIVLWELLTALTPF 257
G ++ EL+ F
Sbjct: 209 GCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-11
Identities = 62/246 (25%), Positives = 110/246 (44%), Gaps = 40/246 (16%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
V +K++ D +LA F +L+ +++H H+ C + ++ E++
Sbjct: 47 VVLKVLDPSHRDIALA------FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 141 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL-------GE 193
G L L ++E VP+ + +A +A + YL + ++H ++ ++N+LL G
Sbjct: 101 GPLDVCL-RKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159
Query: 194 DMCVKVADFGISCLESQCGSAKGFTGTYR--------WMAPEMIKEKRH-TKKVDVYSFG 244
+K++D G+S FT R W+APE + + D +SFG
Sbjct: 160 SPFIKLSDPGVS-----------FTALSREERVERIPWIAPECVPGGNSLSTAADKWSFG 208
Query: 245 IVLWEL-LTALTPFDNMTP-EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 302
L E+ P TP E+ F +K R P P+C + + LIS+C + P +RP
Sbjct: 209 TTLLEICFDGEVPLKERTPSEKERFY--EKKHRLP-EPSCKE-LATLISQCLTYEPTQRP 264
Query: 303 HFDQIV 308
F I+
Sbjct: 265 SFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 48/175 (27%), Positives = 86/175 (49%), Gaps = 27/175 (15%)
Query: 96 ASMLEKQFTS--------EVALLFRLN-HPHIITFVAACKKPPVFCI--ITEYLAGGSLR 144
++K F S E+ L RL+ HP+I+ + + + E L +L
Sbjct: 29 IKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE-LMDMNLY 87
Query: 145 KYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204
+ + ++ +P V + + + ++H GI HRD+K EN+L+ +D +K+ADFG
Sbjct: 88 ELIKGRKRP-LPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFG- 144
Query: 205 SCLESQCG--SAKGFTGTY---RWM-APE-MIKEKRHTKKVDVYSFGIVLWELLT 252
SC G S +T Y RW APE ++ + + K+D+++ G V +E+L+
Sbjct: 145 SC----RGIYSKPPYT-EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 8e-11
Identities = 36/147 (24%), Positives = 66/147 (44%), Gaps = 6/147 (4%)
Query: 114 NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQY 173
++P+ I + +I +Y+ G L L ++ S V K+ + +
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAE--VKKIIRQLVEALND 124
Query: 174 LHSQGILHRDLKSENLLLGEDMC-VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK 232
LH I+H D+K EN+L + + D+G+ + G+ + GT + +PE IK
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGH 181
Query: 233 RHTKKVDVYSFGIVLWELLTALTPFDN 259
+ D ++ G++ +ELLT PF
Sbjct: 182 NYDVSFDWWAVGVLTYELLTGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 10/208 (4%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VAIK EE+ + ++ E+ +L L +I+ A ++ ++ EY+
Sbjct: 29 VAIKKFKDSEENEEV----KETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK 84
Query: 141 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 200
L L ++ P VP V + + + + H I+HRD+K ENLL+ + +K+
Sbjct: 85 NMLE--LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLC 142
Query: 201 DFGISCLESQCGSAK--GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 258
DFG + S+ +A + T + +PE++ + K VD++S G +L EL F
Sbjct: 143 DFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFP 202
Query: 259 NMTPEQAAFAVCQKNARPPVPPTCPKAF 286
+ F + + P+P K F
Sbjct: 203 GESEIDQLFTI--QKVLGPLPAEQMKLF 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 41/119 (34%), Positives = 60/119 (50%), Gaps = 8/119 (6%)
Query: 170 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMA 225
G+ Y H + LHRD+K N+LL +K+ADFG++ L ES+ + K T YR
Sbjct: 128 GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR--P 185
Query: 226 PE-MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283
PE ++ E+R+ +DV+S G +L EL T P E A + + P P P
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFTK-KPIFQANQELAQLELISRLCGSPCPAVWP 243
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 40/166 (24%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 102 QFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPL--NL 159
F E +L N P I A + ++ EY GG L L++ Y ++
Sbjct: 47 FFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR---YEDQFDEDM 103
Query: 160 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS--AKGF 217
++ + +H G +HRD+K EN+L+ +K+ADFG + + +K
Sbjct: 104 AQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP 163
Query: 218 TGTYRWMAPEMIK------EKRHTKKVDVYSFGIVLWELLTALTPF 257
GT ++APE++ + + + D +S G++ +E++ +PF
Sbjct: 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 28/77 (36%), Positives = 44/77 (57%), Gaps = 10/77 (12%)
Query: 133 IITEYLAGGSLRKYLHQ----QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 188
++ EYL GG ++ LH E +V K ++A + YLH GI+HRDLK +N
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAV------KYISEVALALDYLHRHGIIHRDLKPDN 134
Query: 189 LLLGEDMCVKVADFGIS 205
+L+ + +K+ DFG+S
Sbjct: 135 MLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 44/167 (26%), Positives = 81/167 (48%), Gaps = 31/167 (18%)
Query: 106 EVALLFRLNHPHIITF--------VAACKKPPVFCIITEYLAGGSLRKYL--HQQEPYSV 155
E+ ++ LNH +II +K ++ E++ ++ KY+ + + +++
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167
Query: 156 PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGISCLESQCGSA 214
PL LV + + R + Y+HS+ I HRDLK +NLL+ + +K+ DF GSA
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF---------GSA 218
Query: 215 KGFTGTYR---------WMAPE-MIKEKRHTKKVDVYSFGIVLWELL 251
K R + APE M+ +T +D++S G ++ E++
Sbjct: 219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RWM- 224
R ++Y+H+ + HRDLK +N+L D +K+ DFG++ + F Y RW
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 225 APEMIKE--KRHTKKVDVYSFGIVLWELLT 252
APE+ ++T +D++S G + E+LT
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 47/214 (21%), Positives = 83/214 (38%), Gaps = 53/214 (24%)
Query: 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 193
+ +Y+ GG + L + E + P L ++ ++ +H G +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRMEVF--PEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL 136
Query: 194 DMCVKVADFGI-------------------------------SCLESQCGS--------- 213
D +K+ DFG+ +CG
Sbjct: 137 DGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRA 196
Query: 214 --------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA 265
A GT ++APE++ K +T+ D +S G++L+E+L PF TP +
Sbjct: 197 TKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTET 256
Query: 266 AFAVCQKNARPPVPPT---CPKAFSYLISRCWSS 296
V +PP P+A + C S+
Sbjct: 257 QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSA 290
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 57/267 (21%), Positives = 98/267 (36%), Gaps = 81/267 (30%)
Query: 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 193
+ +Y+ GG + L + + P +L ++ ++ +H G +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRMGIF--PEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDR 136
Query: 194 DMCVKVADFGI----------------------------------SCLESQCGS------ 213
D +K+ DFG+ +C +CG
Sbjct: 137 DGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC---RCGDRLKPLE 193
Query: 214 -----------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP 262
A GT ++APE++ +T+ D +S G++L+E+L PF TP
Sbjct: 194 RRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTP 253
Query: 263 EQAAFAVCQKNARPPVPPTC---PKAFSYLISRCWSSSPDRR------------PHFDQI 307
+ V +PP P+A +I C P+ R P F I
Sbjct: 254 LETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC--RGPEDRLGKNGADEIKAHPFFKTI 311
Query: 308 VSILEGYSESLEQDPEFFSSFIPSPDH 334
+S L Q + +IP H
Sbjct: 312 -----DFSSDLRQQS---APYIPKITH 330
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 36/133 (27%), Positives = 73/133 (54%), Gaps = 10/133 (7%)
Query: 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 192
++ +Y GG L L + E +P ++ ++ + +H +HRD+K +N+LL
Sbjct: 78 LVMDYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD 136
Query: 193 EDMCVKVADFGISCLE-SQCGSAKG--FTGTYRWMAPEMIKEK-----RHTKKVDVYSFG 244
+ +++ADFG SCL+ +Q G+ + GT +++PE+++ ++ + D +S G
Sbjct: 137 MNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLG 195
Query: 245 IVLWELLTALTPF 257
+ ++E+L TPF
Sbjct: 196 VCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 40/163 (24%), Positives = 80/163 (49%), Gaps = 10/163 (6%)
Query: 103 FTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLK 162
F E +L ++ I T A + ++ +Y GG L L + E +P ++
Sbjct: 48 FREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED-RLPEDMARF 106
Query: 163 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTG 219
++ + +H +HRD+K +N+L+ + +++ADFG SCL E + G
Sbjct: 107 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVG 165
Query: 220 TYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPF 257
T +++PE+++ + ++ + D +S G+ ++E+L TPF
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 5e-08
Identities = 37/174 (21%), Positives = 69/174 (39%), Gaps = 48/174 (27%)
Query: 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 193
+ +Y+ GG + L + + +L ++ ++ +H G +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRLGIF--EEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR 136
Query: 194 DMCVKVADFGISCL------------------------------ESQCG----------- 212
D +K+ DFG+ C +C
Sbjct: 137 DGHIKLTDFGL-CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQ 195
Query: 213 ----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP 262
A GT ++APE++ +T+ D +S G++L+E+L PF TP
Sbjct: 196 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 249
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 50/228 (21%), Positives = 90/228 (39%), Gaps = 42/228 (18%)
Query: 96 ASMLEKQ----FTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQE 151
A MLEK+ +E +L + ++ + + +I E+L GG + L +++
Sbjct: 37 ADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD 96
Query: 152 PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC----- 206
+ +A + +H G +HRD+K +NLLL VK++DFG+
Sbjct: 97 TLTEEETQFYIAETVLA--IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154
Query: 207 ------------------LESQCGSAKGFT-------------GTYRWMAPEMIKEKRHT 235
++ K T GT ++APE+ + +
Sbjct: 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN 214
Query: 236 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283
K D +S G++++E+L PF + TP++ V PP P
Sbjct: 215 KLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 52/228 (22%), Positives = 91/228 (39%), Gaps = 42/228 (18%)
Query: 96 ASMLEKQ----FTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQE 151
A MLEK+ +E +L + ++ + + +I E+L GG + L +++
Sbjct: 37 ADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD 96
Query: 152 PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI------- 204
S +A + +H G +HRD+K +NLLL VK++DFG+
Sbjct: 97 TLSEEATQFYIAETVLA--IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154
Query: 205 --------------SCLESQCGSAK---------------GFTGTYRWMAPEMIKEKRHT 235
S Q ++K GT ++APE+ + +
Sbjct: 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN 214
Query: 236 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283
K D +S G++++E+L PF + TP++ V PP P
Sbjct: 215 KLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 34/124 (27%), Positives = 61/124 (49%), Gaps = 6/124 (4%)
Query: 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 192
++ ++ GG L ++ + ++P V + A ++ + LH +GI+ RDL N+LL
Sbjct: 62 LVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119
Query: 193 EDMCVKVADFG-ISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 251
+ +++ F S +E C + Y APE+ T+ D +S G +L+ELL
Sbjct: 120 DRGHIQLTYFSRWSEVEDSCDG-EAVENMY--CAPEVGGISEETEACDWWSLGAILFELL 176
Query: 252 TALT 255
T T
Sbjct: 177 TGKT 180
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 41/143 (28%), Positives = 72/143 (50%), Gaps = 30/143 (20%)
Query: 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDL 184
++ +Y GG L L + E +L D+AR + +H G +HRD+
Sbjct: 78 LVMDYYVGGDLLTLLSKFED---------RLPEDMARFYLAEMVLAIDSVHQLGYVHRDI 128
Query: 185 KSENLLLGEDMC--VKVADFGISCLE-SQCGSAKGF--TGTYRWMAPEMIK-----EKRH 234
K +N+LL D +++ADFG SCL G+ + GT +++PE+++ + R+
Sbjct: 129 KPDNVLL--DKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRY 185
Query: 235 TKKVDVYSFGIVLWELLTALTPF 257
+ D +S G+ ++E+L TPF
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-07
Identities = 37/148 (25%), Positives = 57/148 (38%), Gaps = 20/148 (13%)
Query: 163 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYR 222
+ L ++ LH Q KS N+LL D +K+ G S + + Y
Sbjct: 22 VCLQCLGALRELHRQA------KSGNILLTWDGLLKL--DG-SV--AFKTPEQSRPDPY- 69
Query: 223 WMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC 282
+MAPE+I+ + +T+K D+YS GI L+E L P++ A + P
Sbjct: 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR 129
Query: 283 PKAFSYL--------ISRCWSSSPDRRP 302
+ C S P RR
Sbjct: 130 SNLEGVSAARSFEDFMRLCASRLPQRRE 157
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 51/226 (22%), Positives = 96/226 (42%), Gaps = 33/226 (14%)
Query: 97 SMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITE--------YLAGGSLRKYLH 148
S Q +E+ L RLNH +I+ + +IT+ ++ +
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD---W 260
Query: 149 QQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208
+ P ++K L ++Y+H + ++HRD+K EN+ L D + + DFG +
Sbjct: 261 KDRPLLKQTRAIMKQLLC---AVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317
Query: 209 SQCGSAK--GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMT--PE 263
+ A G+ GT +PE++ + + D++S G++L ++L+ P + P
Sbjct: 318 EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377
Query: 264 QA------AFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH 303
+ + +VC + P PP K F Y+ S+ D H
Sbjct: 378 KQLLKIIDSLSVCDEEF--PDPPC--KLFDYI----DSAEIDHAGH 415
|
Length = 501 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (117), Expect = 2e-06
Identities = 54/238 (22%), Positives = 98/238 (41%), Gaps = 41/238 (17%)
Query: 100 EKQFTSEVALLFRLNHPHIITFVAAC--KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPL 157
+ Q EV ++ L H +I+ ++ K I+ E+ G L + + Q+ Y +
Sbjct: 56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI--QKCYKMFG 113
Query: 158 NLVLKLALDIAR----GMQYLHS-------QGILHRDLKSENLLLGEDM----------- 195
+ +DI R + Y H+ + +LHRDLK +N+ L +
Sbjct: 114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173
Query: 196 ------CVKVADFGIS---CLESQCGSAKGFTGTYRWMAPEMI--KEKRHTKKVDVYSFG 244
K+ DFG+S +ES S GT + +PE++ + K + K D+++ G
Sbjct: 174 NLNGRPIAKIGDFGLSKNIGIESMAHSC---VGTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 245 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 302
+++EL + TPF + ++ P+ K + LI + S RP
Sbjct: 231 CIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGK-SKELNILIKNLLNLSAKERP 287
|
Length = 1021 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 47/222 (21%), Positives = 94/222 (42%), Gaps = 53/222 (23%)
Query: 96 ASMLEKQFT----SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQE 151
+ MLEK+ +E +L ++P ++ + + +I EYL GG + L +++
Sbjct: 37 SEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD 96
Query: 152 PYS--VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI----- 204
++ + + L I +H G +HRD+K +NLLL +K++DFG+
Sbjct: 97 TFTEEETRFYIAETILAI----DSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152
Query: 205 -------------------SCLESQCGSAKGFTGTYR---------------WMAPEMIK 230
S+ S+K T++ ++APE+
Sbjct: 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL 212
Query: 231 EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 272
+ + K+ D +S G++++E+L PF + P++ +K
Sbjct: 213 QTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQET----YRK 250
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 16/170 (9%)
Query: 107 VALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALD 166
V+ LF NHP+I+ + A ++T ++A GS + + + + +
Sbjct: 52 VSKLF--NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQG 109
Query: 167 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA----------KG 216
+ + + Y+H G +HR +K+ ++L+ D KV G+ S K
Sbjct: 110 VLKALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKY 167
Query: 217 FTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 264
W++PE++++ + + K D+YS GI EL PF +M Q
Sbjct: 168 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 20/47 (42%), Positives = 31/47 (65%)
Query: 157 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203
+N++ + + G++ LH GI+HRD+K ENLL+ D VK+ DFG
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 7e-05
Identities = 35/149 (23%), Positives = 60/149 (40%), Gaps = 22/149 (14%)
Query: 64 ASGRHSRIYRGIYKQRDVAIKL-VSQPEEDASLASMLEKQFT-SEVALLFRL-----NHP 116
A G + IY G + IK V + L + ++ T +E LL R N P
Sbjct: 3 AKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTP 62
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+ P I+ EY+ G L+ + L+ ++ + + LH
Sbjct: 63 VVYDV-----DPDNKTIVMEYIEGKPLKDVIE-----EGNDELLREIGRLVGK----LHK 108
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGIS 205
GI+H DL + N+++ +D + DFG+
Sbjct: 109 AGIVHGDLTTSNIIVRDDKLY-LIDFGLG 136
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 19/46 (41%), Positives = 31/46 (67%)
Query: 219 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 264
GT ++APE++ K H VD ++ G+ L+E LT + PF++ TP+Q
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQ 587
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 9e-05
Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 21/151 (13%)
Query: 63 FASGRHSRIYRGIYKQRDVAIKL-VSQPEEDASLASMLEKQFT-SEVALLFRL-----NH 115
G + IY G + IK + + L + ++ T E ++ R N
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNV 63
Query: 116 PHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH 175
P + P F I+ EY+ G L+ ++ L+L+ +I R + LH
Sbjct: 64 PAVYFV-----DPENFIIVMEYIEGEPLKDLINSNGM------EELELSREIGRLVGKLH 112
Query: 176 SQGILHRDLKSENLLL-GEDMCVKVADFGIS 205
S GI+H DL + N++L G + + DFG++
Sbjct: 113 SAGIIHGDLTTSNMILSGGKIY--LIDFGLA 141
|
Length = 211 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 23/81 (28%), Positives = 41/81 (50%), Gaps = 18/81 (22%)
Query: 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDL 184
+I E+L GG L L + + +S D+ R ++ +H G +HRD+
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSE----------DVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 185 KSENLLLGEDMCVKVADFGIS 205
K +N+L+ +K++DFG+S
Sbjct: 128 KPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.001
Identities = 30/149 (20%), Positives = 55/149 (36%), Gaps = 22/149 (14%)
Query: 64 ASGRHSRIYRGIYKQRDVAIKL-VSQPEEDASLASMLEKQFT-SEVALLFRL-----NHP 116
G + IY + +K + + L L ++ T E +L + P
Sbjct: 5 KQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVP 64
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+ P I+ EY+ G L+ L +L+ ++ + + LH
Sbjct: 65 IVYDV-----DPDNGLIVMEYIEGELLKDALE-----EARPDLLREVGRLVGK----LHK 110
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGIS 205
GI+H DL + N++L + DFG+
Sbjct: 111 AGIVHGDLTTSNIILSGGRIYFI-DFGLG 138
|
Length = 204 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 362 | |||
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.64 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.6 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.56 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.55 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.54 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.53 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.33 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.31 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.26 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.22 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.16 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.07 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.03 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.94 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.86 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.76 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.76 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.69 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.58 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.56 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.51 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.41 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.39 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.39 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.3 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.26 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.25 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.2 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.19 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.17 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.15 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.03 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.96 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.93 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.85 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.72 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.64 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.63 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.36 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.3 | |
| PLN02236 | 344 | choline kinase | 97.29 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.23 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.12 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.08 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.05 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.03 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.01 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.01 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.98 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.88 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.88 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.77 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.6 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.59 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.36 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.21 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.14 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.92 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.54 |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-54 Score=397.93 Aligned_cols=271 Identities=46% Similarity=0.827 Sum_probs=246.8
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEECCee-EEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
....|.++..++.+.+.||.|+||+||+|.+.++. ||||++.....+... .+.|.+|+.+|.+++|||||+++|.
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~----~~~f~~E~~il~~l~HpNIV~f~G~ 107 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES----RKAFRREASLLSRLRHPNIVQFYGA 107 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH----HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 34678888899999999999999999999999988 999999886554432 5789999999999999999999999
Q ss_pred EEeCC-eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCcEEEcCCC-ceEEee
Q 017994 125 CKKPP-VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG-ILHRDLKSENLLLGEDM-CVKVAD 201 (362)
Q Consensus 125 ~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-i~H~dlk~~Nil~~~~~-~~kl~D 201 (362)
+.+.. .+++||||+++|+|.+++.......++...+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|
T Consensus 108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 108 CTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred EcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECC
Confidence 99988 7999999999999999998843347999999999999999999999999 99999999999999998 999999
Q ss_pred eccccccccC-CCCCcccccccccChhhhh--cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 017994 202 FGISCLESQC-GSAKGFTGTYRWMAPEMIK--EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 278 (362)
Q Consensus 202 fg~~~~~~~~-~~~~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (362)
||+++..... .......||+.|||||++. ...++.++||||||+++|||+||..||.+..+.+....+.....++.+
T Consensus 188 FGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~ 267 (362)
T KOG0192|consen 188 FGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI 267 (362)
T ss_pred CccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 9999876654 3344478999999999999 568999999999999999999999999999998999999999999999
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccC
Q 017994 279 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 320 (362)
Q Consensus 279 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~ 320 (362)
+..+++.+..++.+||+.||..||++.+++..|+.+......
T Consensus 268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 999999999999999999999999999999999998876554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-53 Score=372.26 Aligned_cols=249 Identities=29% Similarity=0.457 Sum_probs=223.0
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
+..++++..+.||+|..|+||++.++ ++-+|+|++...... ..++++.+|+++++.++||+||.++|.|..+.
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~-----~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDP-----ALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCH-----HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 44568888999999999999999998 788999999554332 23688999999999999999999999999999
Q ss_pred -eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 130 -VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 130 -~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
.+.|+||||++|+|.+++...+ .+++....+++.+++.||.|||. ++||||||||+|||++..|.+||||||.+..
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence 4999999999999999999875 69999999999999999999996 8999999999999999999999999999986
Q ss_pred cccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCCCCCCCCC-
Q 017994 208 ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM-----TPEQAAFAVCQKNARPPVPPT- 281 (362)
Q Consensus 208 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~- 281 (362)
.... ...+++||..|||||.+.+..|+.++||||||++++|+++|+.||... ...+.+..++. ...+..|..
T Consensus 229 lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-~ppP~lP~~~ 306 (364)
T KOG0581|consen 229 LVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-EPPPRLPEGE 306 (364)
T ss_pred hhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-CCCCCCCccc
Confidence 6554 567889999999999999999999999999999999999999999874 55666666664 455666665
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
++++++.|+..||++||.+||++.|+++
T Consensus 307 fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 307 FSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 9999999999999999999999999996
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-53 Score=389.76 Aligned_cols=248 Identities=27% Similarity=0.432 Sum_probs=227.3
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
.+|..++.||+|||+.+|.+++. ++.||+|++.+...... ..++.+.+||++.++|+|||||+++++|++....|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~---~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP---KQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc---chHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence 66999999999999999999983 89999999987433222 22577889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 211 (362)
||+|+|..++|-.+++... .+++..+..++.||+.||.|||+++|+|||||..|++++++.++||+|||+|+.....
T Consensus 95 ivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999999999655 6999999999999999999999999999999999999999999999999999987754
Q ss_pred CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
....+.+|||.|.|||++.....+..+||||+||+||.|++|++||...+-.+....+. .....+|..++.+.++||.
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--~~~Y~~P~~ls~~A~dLI~ 250 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--LNEYSMPSHLSAEAKDLIR 250 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--hcCcccccccCHHHHHHHH
Confidence 67789999999999999999999999999999999999999999999998888888774 4556778899999999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~ 309 (362)
++|+.||.+|||+++|+.
T Consensus 251 ~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 251 KLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHhcCCcccCCCHHHHhc
Confidence 999999999999999996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=382.72 Aligned_cols=262 Identities=31% Similarity=0.619 Sum_probs=238.4
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEECCe-eEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQR-DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
.+.|+++.+.+.+.+.||+|-||.||.|.+++. +||+|.+...... ...|.+|+++|++|+|+|||+++++|
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-------~~~f~~Ea~iMk~L~H~~lV~l~gV~ 270 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-------PEAFLREAQIMKKLRHEKLVKLYGVC 270 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-------hhHHHHHHHHHHhCcccCeEEEEEEE
Confidence 788999999999999999999999999999965 9999999875433 36788999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
..++.+||||||++.|+|.++|+......+...+.+.++.||++|++||+++++|||||..+||||++++.+||+|||++
T Consensus 271 ~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 271 TKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred ecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccc
Confidence 99999999999999999999999866667999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 017994 206 CLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 282 (362)
Q Consensus 206 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (362)
+....... .....-...|.|||.+..+.++.++||||||++||||+| |+.||.+++..+++..+ +.+.+.+.|..+
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-e~GyRlp~P~~C 429 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-ERGYRLPRPEGC 429 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-hccCcCCCCCCC
Confidence 95443322 233344678999999999999999999999999999999 99999999999988776 467888999999
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
|+.+.+++..||+.+|++|||+..+...|+.+..
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 9999999999999999999999999999988754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=365.95 Aligned_cols=249 Identities=27% Similarity=0.511 Sum_probs=220.4
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
..+|.+.+.||.|+||+||+|.++ +..||||.+........ ..+.+..|+.+|+.++|||||.+++++..++.+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k----~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKK----LVELLLSEIKILKELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHH----HHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence 467999999999999999999997 68999999988653332 246677899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC------CceEEeeeccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED------MCVKVADFGIS 205 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~------~~~kl~Dfg~~ 205 (362)
|+|||||.||+|.+|++.++ .+++..+..++.||+.||++||+++||||||||.|||++.. -.+||+|||+|
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999999999987 69999999999999999999999999999999999999764 46999999999
Q ss_pred cccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCCH
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-PPVPPTCPK 284 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 284 (362)
+.........+.+|++.|||||++....|+.|+|+||+|+++|+|++|+.||+..+..+....+...... +..+..++.
T Consensus 163 R~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 163 RFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN 242 (429)
T ss_pred hhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence 9988877888999999999999999999999999999999999999999999999998887766554433 344556677
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIV 308 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell 308 (362)
.+.+++...+..+|.+|-++.+-.
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhh
Confidence 778888888999888887766544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=371.59 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=217.2
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHH-HHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLA-SMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
.+.|.+.+.||+|+||.|-+|..+ ++.||||++++........ ..-...+.+|+++|++++|||||+++++++.++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 466888999999999999999886 7899999999865443221 1112346799999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CceEEeeeccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---MCVKVADFGISCL 207 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~---~~~kl~Dfg~~~~ 207 (362)
.||||||++||+|.+.+-.++ .+.+.....++.|++.|+.|||+.||+||||||+|||+..+ ..+||+|||+|..
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 999999999999999998876 58888889999999999999999999999999999999766 7899999999998
Q ss_pred cccCCCCCcccccccccChhhhhcCCC---CCcccchhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCC--CCCCCCC
Q 017994 208 ESQCGSAKGFTGTYRWMAPEMIKEKRH---TKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQKNA--RPPVPPT 281 (362)
Q Consensus 208 ~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~Dv~slG~~l~ell~g~~p~~~~~~~~-~~~~~~~~~~--~~~~~~~ 281 (362)
........+.+|||.|.|||++.+... ..++|+||+||++|-+++|.+||.+..... ...++..... .++....
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~ 408 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR 408 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence 887777889999999999999987653 447899999999999999999998765544 4445443322 2244567
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
++++..+||.+||..||++||++.|+++
T Consensus 409 Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 409 ISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 8899999999999999999999999986
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-51 Score=357.67 Aligned_cols=245 Identities=25% Similarity=0.388 Sum_probs=218.4
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
...++|++.+.||+|+||+||.+..+ ++-+|+|++++...-.. .-.+...+|..+|.+++||+||+++..|++.+
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~---~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK---KEVRHTKAERNILSKIKHPFIVKLIYSFQTEE 98 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh---hhHHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence 45788999999999999999999876 67899999987543221 11366788999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.+|+|+||+.||.|...|++.+ .++++.+.-++.+|+.||.|||+.|||||||||+|||+|.+|+++|+|||++....
T Consensus 99 kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999999999999877 68999999999999999999999999999999999999999999999999998544
Q ss_pred cC-CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 210 QC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 210 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
.. ......+||+.|||||++.+..|+.++|.||||+++|+|++|.+||...+.......+.... .+..+..++.+.++
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ard 255 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARD 255 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHH
Confidence 43 45667899999999999999999999999999999999999999999998888877776544 34455669999999
Q ss_pred HHHHhcccCCCCCC
Q 017994 289 LISRCWSSSPDRRP 302 (362)
Q Consensus 289 li~~~l~~~p~~Rp 302 (362)
++.++|..||++|.
T Consensus 256 ll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 256 LLKKLLKRDPRQRL 269 (357)
T ss_pred HHHHHhccCHHHhc
Confidence 99999999999996
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-52 Score=349.97 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=218.1
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE-EEE-eC
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA-ACK-KP 128 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~-~~~-~~ 128 (362)
..++|++.++||.|.||.||++.+. +..||.|.+....-+.. .+++...|+.+|++|+|||||++++ .+. +.
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k----~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAK----ARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHH----HHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 3567999999999999999999885 78899999885444332 3578889999999999999999998 444 44
Q ss_pred CeEEEEEecCCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ccccCCCCCcEEEcCCCceEEeee
Q 017994 129 PVFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHS--QG--ILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~--i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
..++||||+|.+|+|..+++. ...+.+++..+|+++.|++.||..+|+ .. ++||||||.||+++.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 559999999999999999974 233469999999999999999999999 44 899999999999999999999999
Q ss_pred ccccccccCC-CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-C
Q 017994 203 GISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP-P 280 (362)
Q Consensus 203 g~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 280 (362)
|+++...... .....+|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+.+-.+...++.+.. -++.| .
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd-~~~~p~~ 251 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD-YPPLPDE 251 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC-CCCCcHH
Confidence 9998766543 3467899999999999999999999999999999999999999999997777777776553 34455 7
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 281 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
.+|.++..||..|+..||+.||+...++..+.
T Consensus 252 ~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 252 HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 88999999999999999999998555544443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=362.19 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=224.2
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKP 128 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~ 128 (362)
....+|.+++.||.|+|++|++|... ++.+|||++.+...-... -.+.+..|-.+|.+| +||+|++|+..|.++
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~---KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEK---KVKYVTREKEALTQLSGHPGIVKLYFTFQDE 146 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhc---ccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence 45789999999999999999999986 789999999874332221 136777899999999 899999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
..+|+|+||+++|+|.++|++.+ .+++..+..++.+|+.||+|||++|||||||||+|||+|.+|+++|.|||.+...
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999999999987 7999999999999999999999999999999999999999999999999998754
Q ss_pred ccCCC------------C--CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Q 017994 209 SQCGS------------A--KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 274 (362)
Q Consensus 209 ~~~~~------------~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 274 (362)
..... . ..++||..|.+||++..+..+..+|+|+|||++|.|+.|.+||.+.++--+...++ ..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--~l 302 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--AL 302 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH--Hh
Confidence 32211 1 45889999999999999999999999999999999999999999988877777764 45
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 275 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 275 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
...+++..++...+|+.++|-.||.+|++..+|.+.
T Consensus 303 ~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 678899999999999999999999999999988874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-50 Score=368.81 Aligned_cols=267 Identities=38% Similarity=0.690 Sum_probs=233.6
Q ss_pred CCcccccccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 45 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
....+|++..+++.++..||+|+||+||+|.|.| +||||++......... .+.|++|+.++++-+|.||+-+.|+
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~q----lqaFKnEVa~lkkTRH~NIlLFMG~ 456 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQ----LQAFKNEVAVLKKTRHENILLFMGA 456 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHH----HHHHHHHHHHHhhcchhhheeeehh
Confidence 3458999999999999999999999999999998 7999999987766543 4789999999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
+..+.. .||+.+|+|.+|+.+++-... +++..+..+|++|++.|+.|||.++|||+|||..||++.+++.|||+|||+
T Consensus 457 ~~~p~~-AIiTqwCeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 457 CMNPPL-AIITQWCEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred hcCCce-eeeehhccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccc
Confidence 999888 899999999999999987653 688899999999999999999999999999999999999999999999999
Q ss_pred ccccccCC---CCCcccccccccChhhhhc---CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--
Q 017994 205 SCLESQCG---SAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-- 276 (362)
Q Consensus 205 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-- 276 (362)
++...... ......|...|||||+++. .+|++.+||||||+++|||++|..||.....++.++.+-.+-.++
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~ 614 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL 614 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence 97544332 2334568889999999864 468999999999999999999999999777777777765543333
Q ss_pred -CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 017994 277 -PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318 (362)
Q Consensus 277 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l 318 (362)
.....+++++++|+..||..++++||.+.+|+..|+.+...+
T Consensus 615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 334677889999999999999999999999999998877654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-49 Score=351.65 Aligned_cols=252 Identities=27% Similarity=0.501 Sum_probs=219.6
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC--
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP-- 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-- 129 (362)
..++..++.||+|+||.||++.+. ++..|||.+....... .+.+.+|+.+|++++|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~ 89 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT------SESLEREIRILSRLNHPNIVQYYGSSSSREND 89 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh------HHHHHHHHHHHHhCCCCCEEeeCCccccccCe
Confidence 456788899999999999999997 5899999988763322 356788999999999999999999854444
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCceEEeeecccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFGISCLE 208 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~~ 208 (362)
.+++.|||+++|+|.+++...+. .+++..+..+++|+++||.|||++||+|+||||+|||++. ++.+||+|||++...
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 69999999999999999999876 7999999999999999999999999999999999999999 799999999998765
Q ss_pred cc----CCCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCCCC
Q 017994 209 SQ----CGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDN-MTPEQAAFAVCQKNARPPVPPTC 282 (362)
Q Consensus 209 ~~----~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~ 282 (362)
.. ........||+.|||||++..+ ....++|||||||++.||+||..||.. .........+......+.+|..+
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~l 248 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSL 248 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCccc
Confidence 53 2234467899999999999864 334599999999999999999999998 56666666776666677899999
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
|.+.++|+.+|+..+|.+|||+.++++..-
T Consensus 249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 999999999999999999999999998653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=347.12 Aligned_cols=259 Identities=25% Similarity=0.463 Sum_probs=226.0
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
.+..|..+.+.|++.+.||.|..++||+|... ++.||||++..+..+.. .+.+.+|++.++.++||||++++.
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-----ld~l~kE~~~msl~~HPNIv~~~~ 91 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-----LDALRKEVQTMSLIDHPNIVTYHC 91 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-----HHHHHHHHHHhhhcCCCCcceEEE
Confidence 45678889999999999999999999999986 78999999998766554 367788999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
.|..+..+++||.||.+|++.++++..-+.++++..+..|+++++.||.|||++|.||||||+.||||+.+|.|||+|||
T Consensus 92 sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFg 171 (516)
T KOG0582|consen 92 SFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFG 171 (516)
T ss_pred EEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCce
Confidence 99999999999999999999999998877789999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC----C-CcccccccccChhhhhc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q 017994 204 ISCLESQCGS----A-KGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 276 (362)
Q Consensus 204 ~~~~~~~~~~----~-~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 276 (362)
.+-.....+. . ...+|++.|||||++.. ..|+.|+||||||++..||.+|..||..+.+..++....+.....
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~ 251 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT 251 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC
Confidence 7643322221 1 56689999999999654 468999999999999999999999999999998877655433221
Q ss_pred --------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 --------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.....++..++.++..||..||.+|||++++++
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 112345668999999999999999999999997
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-50 Score=365.83 Aligned_cols=264 Identities=37% Similarity=0.676 Sum_probs=243.3
Q ss_pred ccccCCCcccccccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCcee
Q 017994 40 AEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119 (362)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv 119 (362)
.+++.+..+.|++.++.+.-.+-||.|+.|.||+|...++.||||+++. .-..+|+-|++|+||||+
T Consensus 109 ~e~k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e-------------lkETdIKHLRkLkH~NII 175 (904)
T KOG4721|consen 109 TEHKQQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE-------------LKETDIKHLRKLKHPNII 175 (904)
T ss_pred eehhhhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh-------------hhhhhHHHHHhccCccee
Confidence 3556667789999999999899999999999999999999999999854 223589999999999999
Q ss_pred eeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEE
Q 017994 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 199 (362)
Q Consensus 120 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl 199 (362)
.+.|+|.....++||||||..|.|...|+... .+......+|..+|+.|+.|||.+.|||||||.-||||+.+..|||
T Consensus 176 ~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKI 253 (904)
T KOG4721|consen 176 TFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKI 253 (904)
T ss_pred eEeeeecCCceeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEe
Confidence 99999999999999999999999999999876 5888999999999999999999999999999999999999999999
Q ss_pred eeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 017994 200 ADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP 279 (362)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (362)
+|||-+...........+.||..|||||+++..+.+.|+||||||++||||+||..||.+.+..-+++.+-......++|
T Consensus 254 sDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvP 333 (904)
T KOG4721|consen 254 SDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVP 333 (904)
T ss_pred ccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCc
Confidence 99999987777677788999999999999999999999999999999999999999999988888888877777888999
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l 318 (362)
..+|+.+.-|++.||+-.|.+||+|.+|+..|+-+...+
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 999999999999999999999999999999998766544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=357.55 Aligned_cols=251 Identities=27% Similarity=0.478 Sum_probs=221.7
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCC
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPP 129 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~ 129 (362)
..+.|.+++.||+|+||+|+.|.+. ++.||||++......... ....+.+.+|+.++++++ ||||++++.++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS-QKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc-cccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3578999999999999999999885 789999987775222111 112456678999999998 999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CceEEeeecccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISCLE 208 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~-~~~kl~Dfg~~~~~ 208 (362)
.+|+||||+.||+|.+++.+.+ .+.+..+..+++|+++|++|+|++||+||||||+||+++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 9999999999999999999854 68999999999999999999999999999999999999999 99999999999877
Q ss_pred -ccCCCCCcccccccccChhhhhcCC-C-CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC-CH
Q 017994 209 -SQCGSAKGFTGTYRWMAPEMIKEKR-H-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC-PK 284 (362)
Q Consensus 209 -~~~~~~~~~~~~~~~~aPE~~~~~~-~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 284 (362)
.........+|++.|+|||++.+.. | +.++||||+|++||.|++|..||++.+.......+ ......+|..+ +.
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~~~S~ 249 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSYLLSP 249 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCCcCCH
Confidence 4556678899999999999999876 6 58999999999999999999999997777666664 34556677777 99
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIV 308 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell 308 (362)
++..++.+||..||.+|+++.+|+
T Consensus 250 ~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 250 EARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHh
Confidence 999999999999999999999999
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=336.16 Aligned_cols=249 Identities=23% Similarity=0.388 Sum_probs=214.7
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
+.|+...++|+|+||.||++.++ |+-||||++.....+... ++-..+||++|++++|||+|.++.+|.....++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~V----kKIAlREIrmLKqLkH~NLVnLiEVFrrkrklh 77 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVV----KKIALREIRMLKQLKHENLVNLIEVFRRKRKLH 77 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHH----HHHHHHHHHHHHhcccchHHHHHHHHHhcceeE
Confidence 46888889999999999999886 789999999887665443 566789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc-cC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-QC 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~-~~ 211 (362)
+|+|||+. ++.+-+...+. +++.+.+.+++.|++.|+.|+|++++|||||||+|||++.+|.+||||||+|+... +.
T Consensus 78 LVFE~~dh-TvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 78 LVFEYCDH-TVLHELERYPN-GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred EEeeecch-HHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 99999966 67777776653 79999999999999999999999999999999999999999999999999999777 44
Q ss_pred CCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------
Q 017994 212 GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-------------- 276 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 276 (362)
..-..++.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+-|++.+.-+.++.+.......
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 44567889999999999987 689999999999999999999999999988877766554422211
Q ss_pred -----CCC----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 -----PVP----------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 -----~~~----------~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+.+ +.++..+.+|+.+||+.||++|++-+|++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111 334557889999999999999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=330.89 Aligned_cols=241 Identities=24% Similarity=0.364 Sum_probs=219.5
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
...++|+..+.||.|+||+|.+++.+ +..+|+|++.+...- .-...+...+|..+|+.+.||+++++++.+.+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV---klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV---KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS 117 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHH---HHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence 34678999999999999999999987 778999999874322 2223467788999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.+||||||++||.|..++++.+ ++++..+..++.||+.||+|||+++|++||+||+|||+|.+|.+||+|||++....
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999999999999876 68999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
. ...+.||||.|+|||++....+..++|.|+||+++|||+.|.+||...++.....++++. ...+|..++.++++|
T Consensus 196 ~--rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~--~v~fP~~fs~~~kdL 271 (355)
T KOG0616|consen 196 G--RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG--KVKFPSYFSSDAKDL 271 (355)
T ss_pred C--cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC--cccCCcccCHHHHHH
Confidence 5 377899999999999999999999999999999999999999999999998888888764 456788999999999
Q ss_pred HHHhcccCCCCC
Q 017994 290 ISRCWSSSPDRR 301 (362)
Q Consensus 290 i~~~l~~~p~~R 301 (362)
+.++|+.|-.+|
T Consensus 272 l~~LL~vD~t~R 283 (355)
T KOG0616|consen 272 LKKLLQVDLTKR 283 (355)
T ss_pred HHHHHhhhhHhh
Confidence 999999999999
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=356.67 Aligned_cols=247 Identities=26% Similarity=0.475 Sum_probs=222.7
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
...|....+||+|+.|.||.|... ++.||||.+....... ++-+.+|+.+|+..+|+|||++++.|...+.+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~------keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK------KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc------hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 456777789999999999999876 6789999999876654 46788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
+.||||++||+|.+.+.... +++.++..|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||++......
T Consensus 346 WVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred EEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 99999999999999998764 899999999999999999999999999999999999999999999999998866554
Q ss_pred C-CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCCHHHHHH
Q 017994 212 G-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYL 289 (362)
Q Consensus 212 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 289 (362)
. .....+|||.|||||+.....|+++.||||||++++||+-|++||-..++-..++.+...+. ....+..+++.+++|
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 3 56788999999999999999999999999999999999999999998888777776654332 235678899999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~ 309 (362)
+.+||..|+.+|+++.|||+
T Consensus 503 L~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHhhcchhcCCCHHHHhc
Confidence 99999999999999999996
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=351.69 Aligned_cols=262 Identities=26% Similarity=0.531 Sum_probs=217.1
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeee
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITF 121 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~ 121 (362)
|.+...+|++.+.||.|+||.||+|.+. ++.||||++........ ...+.+|+.++..+ +||||+++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~ 76 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASE-----HKALMSELKILIHIGNHLNVVNL 76 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHH-----HHHHHHHHHHHHHhccCcceeeE
Confidence 6777889999999999999999999752 35799999875432221 35688899999999 89999999
Q ss_pred eEEEEeC-CeEEEEEecCCCCCHHHHHhhcCC------------------------------------------------
Q 017994 122 VAACKKP-PVFCIITEYLAGGSLRKYLHQQEP------------------------------------------------ 152 (362)
Q Consensus 122 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------ 152 (362)
++++... ..++++|||+++|+|.+++.....
T Consensus 77 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (338)
T cd05102 77 LGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS 156 (338)
T ss_pred EeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcc
Confidence 9988764 468999999999999999975321
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC---CCCcc
Q 017994 153 ------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGF 217 (362)
Q Consensus 153 ------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~ 217 (362)
..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... .....
T Consensus 157 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 157 TNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred cccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence 237778889999999999999999999999999999999999999999999987543211 11223
Q ss_pred cccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 017994 218 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296 (362)
Q Consensus 218 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 296 (362)
.++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+..............+..+++.+.+|+.+||+.
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 316 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQG 316 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 45678999999998899999999999999999997 99999886654444444444555566778899999999999999
Q ss_pred CCCCCCCHHHHHHHHHhhhh
Q 017994 297 SPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 297 ~p~~Rps~~ell~~L~~~~~ 316 (362)
||.+||++.++++.|+.+..
T Consensus 317 dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 317 DPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=336.64 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=220.3
Q ss_pred cccCeeee--eeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe---
Q 017994 53 DMSQLFIG--CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK--- 127 (362)
Q Consensus 53 ~~~~~~~~--~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--- 127 (362)
+..++... ..||+|++|.||+|.++++.||||++....... ....+.+.+|+.++++++||||+++++++.+
T Consensus 16 ~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 16 ESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGH---KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred CHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEecccccccc---HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 34444444 579999999999999999999999997654322 1224667899999999999999999999876
Q ss_pred -CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 128 -PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 128 -~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
....++||||+++|+|.+++.... .+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~ 170 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLE 170 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchH
Confidence 457899999999999999998764 588899999999999999999984 9999999999999999999999999998
Q ss_pred cccccCCCCCcccccccccChhhhhc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (362)
...... .....++..|+|||++.+ ..++.++||||||+++|||++|..||...+..+....+.........+..++
T Consensus 171 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (283)
T PHA02988 171 KILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCP 248 (283)
T ss_pred hhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCc
Confidence 754331 234567899999999976 6789999999999999999999999999888777777666666677777889
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 284 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 284 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
+.+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 249 ~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 249 LEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999999987653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=354.97 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=227.3
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
+-|.+++-||.|+.|.|-+|++. |+.+|||++.+...-. ......+.+||-+|+.+.|||+++++++++...++|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s---~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS---SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccc---cccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 44889999999999999999985 8999999998752111 112356778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+|.||++||.|.+++-.++ .+++..+..+++||+.|+.|+|..+|+|||+||+|+|+|..+++||+|||+|.......
T Consensus 89 lvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 9999999999999999887 69999999999999999999999999999999999999999999999999999888888
Q ss_pred CCCcccccccccChhhhhcCCC-CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
.-.+.||+|.|.|||++.+..| +.++||||-|++||.|+||.+||++.+....+.++.. ....+|..++.+.++||.
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~--G~f~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR--GVFEMPSNISSEAQDLLR 244 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc--CcccCCCcCCHHHHHHHH
Confidence 8889999999999999999877 7899999999999999999999999999888888864 455677999999999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~~ 310 (362)
+|+..||.+|.+..+|++.
T Consensus 245 ~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHhccCccccccHHHHhhC
Confidence 9999999999999999984
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=343.80 Aligned_cols=252 Identities=21% Similarity=0.343 Sum_probs=216.7
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
...++|++...||+|+||.||+++-+ |..+|+|++++..-.. ....+.+..|-.+|...++|.||+++..|.+.+
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~---~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK---KNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh---hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 34688999999999999999999775 7899999998854322 222466778999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.+||||||++||++-.+|...+ .|++..+..++.+++.|++.||+.|+|||||||+|+|||..|++||+|||++....
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999999999999877 69999999999999999999999999999999999999999999999999985311
Q ss_pred c----------------------C--C-----C-------------------CCcccccccccChhhhhcCCCCCcccch
Q 017994 210 Q----------------------C--G-----S-------------------AKGFTGTYRWMAPEMIKEKRHTKKVDVY 241 (362)
Q Consensus 210 ~----------------------~--~-----~-------------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~ 241 (362)
. . . . ....+|||.|+|||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 0 0 0 0 0124599999999999999999999999
Q ss_pred hhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 017994 242 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKN--ARPPVPPTCPKAFSYLISRCWSSSPDRRPH---FDQIVS 309 (362)
Q Consensus 242 slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~ell~ 309 (362)
||||||||||.|.+||.+.++.++...+..-. ...+....++++..+||.+|+. ||++|.. +.||.+
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 99999999999999999999999888876655 3444456678999999999999 9999985 555544
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=350.51 Aligned_cols=275 Identities=30% Similarity=0.555 Sum_probs=243.7
Q ss_pred ccCCCcccccccccCeeeeeeecccCCeeEEEEEECC-----ee-EEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC
Q 017994 42 IKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-----RD-VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH 115 (362)
Q Consensus 42 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~-vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h 115 (362)
..+.....|++..++..+.++||+|+||.||+|.++. .. ||||....... ...+...+|.+|+++|++++|
T Consensus 144 ~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~---~~~~~~~e~m~EArvMr~l~H 220 (474)
T KOG0194|consen 144 KRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE---LTKEQIKEFMKEARVMRQLNH 220 (474)
T ss_pred cccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc---ccHHHHHHHHHHHHHHHhCCC
Confidence 3445678899999999999999999999999998861 23 89999876321 223346889999999999999
Q ss_pred CceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC
Q 017994 116 PHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM 195 (362)
Q Consensus 116 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~ 195 (362)
||||+++|++.....+++|||+|.||+|.+++++.+. .++..+...++.+.+.||+|||+++++||||-.+|+|++.++
T Consensus 221 ~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~ 299 (474)
T KOG0194|consen 221 PNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG 299 (474)
T ss_pred CCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC
Confidence 9999999999999999999999999999999998774 699999999999999999999999999999999999999999
Q ss_pred ceEEeeeccccccccCCCCC-cccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC
Q 017994 196 CVKVADFGISCLESQCGSAK-GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 273 (362)
Q Consensus 196 ~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~ 273 (362)
.+||+|||+++......... .......|+|||.+..+.++.++||||||+++||+++ |..||.+....++...+....
T Consensus 300 ~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~ 379 (474)
T KOG0194|consen 300 VVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG 379 (474)
T ss_pred eEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC
Confidence 99999999987654322222 2245689999999999999999999999999999999 899999999999999988888
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccC
Q 017994 274 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 320 (362)
Q Consensus 274 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~ 320 (362)
.+.+.+...|.++..++.+||..+|+.||++.++.+.|+.+......
T Consensus 380 ~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 380 YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 88899999999999999999999999999999999999998776554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=344.67 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=219.4
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCC-
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPP- 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~- 129 (362)
..+|.+.++||.|.||.||+|+-. +..||||.++....... +-.=.+|+..|++++ ||||+++..++.+.+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-----e~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-----ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-----HHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 468999999999999999999876 78899999887544322 112257999999998 999999999998888
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.+|+||||| ..+|+++++.+ +..+++..+..|+.||+.||+|+|.+|+.|||+||+|||+..+..+||+|||+|+...
T Consensus 84 ~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 84 ILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 999999999 56999999988 5689999999999999999999999999999999999999988899999999999888
Q ss_pred cCCCCCcccccccccChhhh-hcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-----------
Q 017994 210 QCGSAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP----------- 277 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 277 (362)
....-..++.|.+|+|||++ +.+.|+.+.|+|++||+++|+.+-++.|++.+..+.+++++.-...+.
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 77777788999999999986 567799999999999999999999999999999888888776433332
Q ss_pred -----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 278 -----------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 278 -----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
.-+.++.+..++|.+|++.||++||++.|.+++
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 113367889999999999999999999999984
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=315.09 Aligned_cols=251 Identities=26% Similarity=0.422 Sum_probs=227.7
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|++++.||.|.||.||.|..+ +--||+|++.++... ......++.+|+++-+.|+||||++++++|.+....
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~---~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL---KTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH---HhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 578999999999999999999987 457999999875532 233467889999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
|+++||..+|+|...+.......+++...+.++.|++.||.|+|..+++||||||+|+|++.+|.+||+|||.+.... .
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~ 176 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-S 176 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-C
Confidence 999999999999999997777789999999999999999999999999999999999999999999999999987655 5
Q ss_pred CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
+.....+||..|.+||+..+..++..+|+|++|++.||++.|.+||......+....+. .....+|..++...+++|.
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~--k~~~~~p~~is~~a~dlI~ 254 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR--KVDLKFPSTISGGAADLIS 254 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH--HccccCCcccChhHHHHHH
Confidence 66778999999999999999999999999999999999999999999988777766664 3456677999999999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~~ 310 (362)
+|+..+|.+|.+..|+++.
T Consensus 255 ~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 255 RLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHhccCccccccHHHHhhh
Confidence 9999999999999998864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=333.65 Aligned_cols=251 Identities=18% Similarity=0.272 Sum_probs=210.0
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
.|...+.||+|+||.||++.+. ++.||||++........ .....+.+|+.++..++|+||+++++.+.+++..++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~l 77 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCL 77 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhh---hhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEE
Confidence 3778899999999999999875 78999999875432211 113457789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 213 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (362)
||||+++|+|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999999999888765544689999999999999999999999999999999999999999999999999876544333
Q ss_pred CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCCCHHHHHHHH
Q 017994 214 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC--QKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~ 291 (362)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||...........+. ........+..++..+.+|+.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 445678999999999999999999999999999999999999998755432211111 122334566778999999999
Q ss_pred HhcccCCCCCCC-----HHHHHH
Q 017994 292 RCWSSSPDRRPH-----FDQIVS 309 (362)
Q Consensus 292 ~~l~~~p~~Rps-----~~ell~ 309 (362)
+||+.||.+||+ +.++++
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhc
Confidence 999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=361.00 Aligned_cols=265 Identities=29% Similarity=0.580 Sum_probs=235.5
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCcee
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv 119 (362)
....++..++..+.+.||+|+||+||+|... ...||||.++....... +.+|.+|+.++..++|||||
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~-----~~dF~REaeLla~l~H~nIV 552 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQA-----RQDFRREAELLAELQHPNIV 552 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHH-----HHHHHHHHHHHHhccCCCeE
Confidence 3445677889999999999999999999875 25799999988665532 58899999999999999999
Q ss_pred eeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCC------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 017994 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPY------------SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 187 (362)
Q Consensus 120 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~ 187 (362)
+++|.|..++.+++|+|||..|+|.++|+.+.+. .++..+.+.|+.||+.|+.||-++.++||||-.+
T Consensus 553 rLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATR 632 (774)
T KOG1026|consen 553 RLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATR 632 (774)
T ss_pred EEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhh
Confidence 9999999999999999999999999999764331 2788999999999999999999999999999999
Q ss_pred cEEEcCCCceEEeeeccccccccCCCC---CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHH
Q 017994 188 NLLLGEDMCVKVADFGISCLESQCGSA---KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPE 263 (362)
Q Consensus 188 Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~ 263 (362)
|+||.++..|||+|||+++........ ....-..+||+||.+..+.+|.++||||+|++|||+++ |..||.+.+.+
T Consensus 633 NCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 633 NCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred hceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 999999999999999999865443222 12334679999999999999999999999999999999 99999999999
Q ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 264 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
+++..+...+. .+.|..+|.++.+|+..||+.+|.+||+++||-..|++....
T Consensus 713 EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 713 EVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 99999887666 889999999999999999999999999999999999987554
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=341.09 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=215.5
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
..++|.+.+.||+|+||.||+|.+. ++.||||++...... .....+.+.+|+.++++++||||+++++.+..++.
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL---KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh---hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 4578999999999999999999986 678999998753211 11123567889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
.++||||+.|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999999998765 588999999999999999999999999999999999999999999999999875433
Q ss_pred CCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 211 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 211 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
......|++.|+|||++.+..++.++||||||+++|+|++|..||.+..+......+... ...++..++..+.+||
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li 246 (329)
T PTZ00263 171 --RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RLKFPNWFDGRARDLV 246 (329)
T ss_pred --CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CcCCCCCCCHHHHHHH
Confidence 223457899999999999999999999999999999999999999988877666665433 4556777899999999
Q ss_pred HHhcccCCCCCCC-----HHHHHHH
Q 017994 291 SRCWSSSPDRRPH-----FDQIVSI 310 (362)
Q Consensus 291 ~~~l~~~p~~Rps-----~~ell~~ 310 (362)
.+||+.||.+||+ +.++++.
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999996 5777643
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=352.01 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=217.1
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEe
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKK 127 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~ 127 (362)
.+...+|.+.++||+|+||+|+++..+ ++.+|||++++...-... ..+....|.+++... +||++++++..|..
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d---~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT 440 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRD---EVESLMCEKRIFELANRHPFLVNLFSCFQT 440 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccc---cHHHHHHHHHHHHHhccCCeEeeccccccc
Confidence 345789999999999999999999997 578999999986432211 124556788888777 59999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
.+++|+||||+.||++..+.+. ..+++..+..++..++.||.|||++||||||||.+|||+|.+|++||+|||++..
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999999994444433 2699999999999999999999999999999999999999999999999999986
Q ss_pred cc-cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHH
Q 017994 208 ES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286 (362)
Q Consensus 208 ~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (362)
.. ......+++|||.|+|||++.+..|+.++|.||||++||||+.|..||.+.+.+++...+.. ....+|..++.+.
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~--d~~~yP~~ls~ea 595 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN--DEVRYPRFLSKEA 595 (694)
T ss_pred cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CCCCCCCcccHHH
Confidence 55 55677899999999999999999999999999999999999999999999999999888864 4567888999999
Q ss_pred HHHHHHhcccCCCCCCCH
Q 017994 287 SYLISRCWSSSPDRRPHF 304 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~ 304 (362)
.+|++++|..+|++|...
T Consensus 596 ~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 596 IAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHhccCcccccCC
Confidence 999999999999999865
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=344.98 Aligned_cols=247 Identities=28% Similarity=0.476 Sum_probs=221.0
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
..|...+.||+|+||.||+|.+. ++.||||++..+..... ..++.+|+.++.+++++||.++++.+..+..++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-----Iediqqei~~Ls~~~~~~it~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-----IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchh-----hHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence 45777789999999999999997 78999999998765543 367888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 211 (362)
++||||.||++.+.++... .+.+..+.-++++++.||.|||.++.+|||||+.||++..+|.+||+|||.+......
T Consensus 88 iiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 9999999999999998765 3478888899999999999999999999999999999999999999999998765443
Q ss_pred CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
.....++||+.|||||++.+..|+.++||||||++.+||++|.+|+....+..+++.+. ....+.....+++.+++|+.
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~~S~~~kEFV~ 244 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGDFSPPFKEFVE 244 (467)
T ss_pred hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCccccccCHHHHHHHH
Confidence 33478899999999999998899999999999999999999999999999977766654 34455566688999999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~ 309 (362)
.||.+||+.||++.++++
T Consensus 245 ~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 245 ACLDKNPEFRPSAKELLK 262 (467)
T ss_pred HHhhcCcccCcCHHHHhh
Confidence 999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=336.98 Aligned_cols=251 Identities=22% Similarity=0.335 Sum_probs=214.0
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC--
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP-- 128 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-- 128 (362)
....|+..++||+|.||.||+|++. ++-||+|++.....+... .....+||.+|++|+||||+++.+...+.
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~----~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF----PITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc----hHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 3567888999999999999999986 677999999987644332 35667899999999999999999998776
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
..+|||+|||+. +|.-++.... -.+++.++.-++.||+.||+|+|.+||.|||||.+|||||++|.+||+|||+|++.
T Consensus 191 ~siYlVFeYMdh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred ceEEEEEecccc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 799999999966 8988887643 36999999999999999999999999999999999999999999999999999976
Q ss_pred ccCC--CCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------
Q 017994 209 SQCG--SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-------- 277 (362)
Q Consensus 209 ~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 277 (362)
.... .-...+.|.+|.|||++.+. .|+.++|+||.||||.||++|++.|.+.+..+.+..+......+.
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 5544 23556789999999998875 699999999999999999999999999998887777655333221
Q ss_pred C-------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 V-------------------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 ~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+ -..++....+|+..+|..||.+|.|+.+.+.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 1234567788999999999999999998873
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=345.00 Aligned_cols=264 Identities=25% Similarity=0.507 Sum_probs=222.1
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCc
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPH 117 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~ 117 (362)
....|.+...+|++++.||+|+||.||+|++. ...||||++........ ...+.+|+.+++.+ +|||
T Consensus 29 ~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~il~~l~~h~n 103 (374)
T cd05106 29 YNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE-----REALMSELKILSHLGQHKN 103 (374)
T ss_pred ccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHH-----HHHHHHHHHHHHhhccCCc
Confidence 35678888899999999999999999999863 24799999976543221 35678899999999 8999
Q ss_pred eeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcC----------------------------------------------
Q 017994 118 IITFVAACKKPPVFCIITEYLAGGSLRKYLHQQE---------------------------------------------- 151 (362)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------- 151 (362)
|+++++.+...+..++||||+++|+|.+++....
T Consensus 104 Iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (374)
T cd05106 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVE 183 (374)
T ss_pred eeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccc
Confidence 9999999999999999999999999999986432
Q ss_pred ----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 152 ----------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 152 ----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
...+++..+++++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~ 263 (374)
T cd05106 184 MRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIM 263 (374)
T ss_pred cCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeecc
Confidence 1236788899999999999999999999999999999999999999999999987543
Q ss_pred cCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 210 QCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 210 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
.... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.....................+...+++
T Consensus 264 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (374)
T cd05106 264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPE 343 (374)
T ss_pred CCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHH
Confidence 3211 112234567999999988899999999999999999997 999998876655555555555555666778899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
+.+++.+||+.||.+||++.+++++|+.+
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=344.41 Aligned_cols=262 Identities=27% Similarity=0.512 Sum_probs=219.9
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCce
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~i 118 (362)
...|.+..++|.+++.||+|+||.||+|.+. +..||||++........ .+.+.+|+.++..+ +||||
T Consensus 27 ~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----~~~~~~Ei~il~~l~~HpnI 101 (375)
T cd05104 27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTE-----REALMSELKVLSYLGNHINI 101 (375)
T ss_pred ccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHH-----HHHHHHHHHHHHHhcCCcce
Confidence 4567778889999999999999999999742 45799999875432221 35678899999999 89999
Q ss_pred eeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcC-----------------------------------------------
Q 017994 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQE----------------------------------------------- 151 (362)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------- 151 (362)
+++++++...+..++||||+++|+|.+++....
T Consensus 102 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 181 (375)
T cd05104 102 VNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPT 181 (375)
T ss_pred eeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccc
Confidence 999999999999999999999999999996532
Q ss_pred --------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 152 --------------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 152 --------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 261 (375)
T cd05104 182 KADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA 261 (375)
T ss_pred ccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccc
Confidence 114678889999999999999999999999999999999999999999999998
Q ss_pred cccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 206 CLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 206 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
........ .....++..|+|||++.+..++.++||||||+++|+|++ |..||.....................+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (375)
T cd05104 262 RDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPEC 341 (375)
T ss_pred eeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCC
Confidence 75433221 112234567999999999999999999999999999998 99999887665555555555555555667
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 313 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 313 (362)
.+.++.+|+.+||+.||++||++.+|++.|+.
T Consensus 342 ~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 342 APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 78999999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=335.82 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=214.0
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++....... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 77 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR---LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLY 77 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh---hHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEE
Confidence 36889999999999999999987 7889999987532211 112356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.+|.++|+|||++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-- 153 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-- 153 (291)
T ss_pred EEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC--
Confidence 9999999999999998765 589999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 292 (362)
......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+... ...++..++..+.++|.+
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~ 231 (291)
T cd05612 154 RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KLEFPRHLDLYAKDLIKK 231 (291)
T ss_pred CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcCCCccCCHHHHHHHHH
Confidence 233457899999999999888999999999999999999999999988877666665443 345667788999999999
Q ss_pred hcccCCCCCCC-----HHHHHHH
Q 017994 293 CWSSSPDRRPH-----FDQIVSI 310 (362)
Q Consensus 293 ~l~~~p~~Rps-----~~ell~~ 310 (362)
||+.||.+||+ +.++++.
T Consensus 232 ~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 232 LLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HcCCCHHHccCCccCCHHHHhcC
Confidence 99999999995 7787753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=344.55 Aligned_cols=246 Identities=28% Similarity=0.476 Sum_probs=219.8
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||+|..+ .+.||+|.+.+....... .+.+.+|+++++.++||||+.++++|+...+++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~----l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE----LKNLRQEVRILRSLKHPNIVEMLESFETSAHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH----HHHHHHHHHHHHhcCCcchhhHHHhhcccceEE
Confidence 57889999999999999999877 578999999886543321 356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+|.||+.| +|..++...+ .++++.+..++.+++.||.|||+++|.|||+||.||+++.+|++|++|||+++.+....
T Consensus 78 vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred EEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 99999976 9999999876 69999999999999999999999999999999999999999999999999998776643
Q ss_pred C-CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 213 S-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 213 ~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
. .....|||.|||||+..++.|+..+|+|||||++||+++|++||-.....+....+... ....|...+..+..|+.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d--~v~~p~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD--PVKPPSTASSSFVNFLQ 232 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC--CCCCcccccHHHHHHHH
Confidence 3 34567999999999999999999999999999999999999999988777777776543 34445688899999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~ 309 (362)
.+|.+||..|.+..+++.
T Consensus 233 gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHhhcChhhcccHHHHhc
Confidence 999999999999999986
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=325.77 Aligned_cols=257 Identities=30% Similarity=0.564 Sum_probs=222.2
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
|.++.++|++.++||+|++|.||+|.+. +..||+|.+...... .+.+.+|+.++++++||||+++++.+...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-------VQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh-------HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 6677889999999999999999999876 567999987654322 35788899999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
...+++|||+++++|.+++.......+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceec
Confidence 99999999999999999998765557889999999999999999999999999999999999999999999999998754
Q ss_pred ccCCC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 209 SQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 209 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.. ....+....++.+
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 232 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-GYRMPRMENCPDE 232 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHH
Confidence 43211 123345678999999988889999999999999999998 9999998877766665543 3444555678899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
+.+++.+||+.+|++||++++++++|+.+
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=341.40 Aligned_cols=252 Identities=24% Similarity=0.403 Sum_probs=232.2
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe-
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV- 130 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~- 130 (362)
.++|.+++.+|+|+||.++...++ +..+++|.+......... ++...+|+.+++++.|||||.+.+.|..++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~----r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE----RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh----hHHHHHHHHHHHhccCCCeeeeccchhcCCce
Confidence 467999999999999999998887 678999999887654433 3467889999999999999999999998887
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
++|||+||+||+|.+.+.......++++.++.|+.|++.|+.|||+++|.|||||+.||+++.++.|+|+|||++.....
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999999999988777899999999999999999999999999999999999999999999999999998777
Q ss_pred CC-CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 211 CG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 211 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
.. ...+..||+.|++||++.+.+|..++|+|||||++|||++-+++|...+.......+.... ..+.+..++.+++.+
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSL 237 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHH
Confidence 65 6778899999999999999999999999999999999999999999999998888887654 678889999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~~ 310 (362)
+..|+..+|..||++.+|+..
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999986
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=328.97 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=224.5
Q ss_pred ccccCeeeeeeecccCCeeEEEEEECC--eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
...+.|++.+.||+|.-|+||++...+ ..+|+|++.+....... -..+...|.+||+.++||+++.++..++.+.
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rk---Kl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRK---KLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhh---HHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 456788899999999999999999985 68999999875433211 1356778999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
..+++||||+||+|..++++++...+++..+..++.+++.||+|||..|||+|||||+||||.++|++.|+||+++....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999874210
Q ss_pred c---------------------------------C------------------------CCCCcccccccccChhhhhcC
Q 017994 210 Q---------------------------------C------------------------GSAKGFTGTYRWMAPEMIKEK 232 (362)
Q Consensus 210 ~---------------------------------~------------------------~~~~~~~~~~~~~aPE~~~~~ 232 (362)
. . .....++||-.|.|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 011235688999999999999
Q ss_pred CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHH
Q 017994 233 RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH----FDQIV 308 (362)
Q Consensus 233 ~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~ell 308 (362)
..+.++|+|+||+++|||+.|..||.+.+..+++..++......+..+.++..+++||+++|.+||.+|.. +.||.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 99999999999999999999999999999999999998877776666788899999999999999999987 66665
Q ss_pred H
Q 017994 309 S 309 (362)
Q Consensus 309 ~ 309 (362)
+
T Consensus 391 ~ 391 (459)
T KOG0610|consen 391 R 391 (459)
T ss_pred c
Confidence 4
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=338.07 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=212.8
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.++..++||||+++++++...+..|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK---LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh---hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEE
Confidence 36899999999999999999986 6789999987532111 112356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999999998765 588999999999999999999999999999999999999999999999999875443
Q ss_pred CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC------CCCCHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP------PTCPKAF 286 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l 286 (362)
......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.........+ ..++.++
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~ 233 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA 233 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHH
Confidence 3345678999999999999899999999999999999999999999888776655544322211111 2458899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
.++|.+||..+|.+||++.++++.
T Consensus 234 ~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 234 WDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHHhhChhhhcCCHHHHHhC
Confidence 999999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=325.29 Aligned_cols=256 Identities=27% Similarity=0.500 Sum_probs=217.7
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
++..+|.+.+.||+|+||.||+|.++ +..||+|.+....... ....+.+|+.++.+++||||+++++++.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 76 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK-----QRRGFLAEALTLGQFDHSNIVRLEGVIT 76 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHH-----HHHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence 34577999999999999999999864 4689999988653322 1356889999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
..+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++++|||.+.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 77 RGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred cCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 9999999999999999999998654 268999999999999999999999999999999999999999999999999875
Q ss_pred ccccCCC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 017994 207 LESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283 (362)
Q Consensus 207 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (362)
....... .....++..|+|||.+.+..++.++||||||+++|++++ |..||......+....+. .....+.+..++
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCP 234 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCC
Confidence 4322211 112334678999999999999999999999999999775 999999888776655543 344556778899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 284 KAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 284 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus 235 ~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=337.48 Aligned_cols=242 Identities=23% Similarity=0.347 Sum_probs=207.7
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecC
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYL 138 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 138 (362)
+.||+|+||.||++.+. ++.||||++....... ......+.+|+.++++++||||+++++.+...+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA---KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCC
Confidence 36999999999999885 6789999987532111 111345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-CCCCCcc
Q 017994 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKGF 217 (362)
Q Consensus 139 ~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 217 (362)
++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... .......
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 78 NGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence 9999999998765 589999999999999999999999999999999999999999999999999865322 2233456
Q ss_pred cccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccC
Q 017994 218 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 297 (362)
Q Consensus 218 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 297 (362)
.|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. ....++..+++++.++|.+||+.|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccCC
Confidence 799999999999999999999999999999999999999988777665555443 334567789999999999999999
Q ss_pred CCCCC-----CHHHHHH
Q 017994 298 PDRRP-----HFDQIVS 309 (362)
Q Consensus 298 p~~Rp-----s~~ell~ 309 (362)
|++|| ++.++++
T Consensus 234 P~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 234 PKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHcCCCCCCCHHHHHc
Confidence 99999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=338.27 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=217.1
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEECC---eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQ---RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
.......+|.+.+.||+|+||.||+|.+.+ ..||+|++...... .......+.+|+.+++.++||||+++++++
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII---KQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh---hhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 345567889999999999999999998752 57999998653211 111235678899999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
.+....++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.+|.++|+|||++
T Consensus 101 ~~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a 178 (340)
T PTZ00426 101 KDESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178 (340)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCC
Confidence 99999999999999999999998765 5899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
..... ......||+.|+|||++.+..++.++|+||||+++|+|++|..||...++......+... ...++..+++.
T Consensus 179 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~ 254 (340)
T PTZ00426 179 KVVDT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG--IIYFPKFLDNN 254 (340)
T ss_pred eecCC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHH
Confidence 75433 234567899999999999888999999999999999999999999988776665555432 34567788999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHHH
Q 017994 286 FSYLISRCWSSSPDRRP-----HFDQIVSI 310 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rp-----s~~ell~~ 310 (362)
+.++|.+||+.||.+|+ +++++++.
T Consensus 255 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 99999999999999995 78888764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=335.30 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=216.4
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHH--------HHHHHHHHHHHHHHHHcCCCCceeeee
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASL--------ASMLEKQFTSEVALLFRLNHPHIITFV 122 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~--------~~~~~~~~~~Ei~~l~~l~hp~iv~~~ 122 (362)
...+|++++.||+|.||.|-+|.+. ++.||||++.+....... ..+-.+.+.+||.+|++|+|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3688999999999999999999986 789999999875332211 111135788999999999999999999
Q ss_pred EEEEeC--CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEe
Q 017994 123 AACKKP--PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 200 (362)
Q Consensus 123 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~ 200 (362)
.+..+. +.+|||+|||..|.+...-.... .+++.++++++++++.||+|||.+|||||||||+|+|++.+|++||+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~--els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKP--ELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcc--cccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 998765 68999999999887755433222 28899999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCC------CCcccccccccChhhhhcCC----CCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 017994 201 DFGISCLESQCGS------AKGFTGTYRWMAPEMIKEKR----HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 270 (362)
Q Consensus 201 Dfg~~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~ 270 (362)
|||.+........ ....+|||.|+|||...++. .+.+.||||+|++||.|+.|+.||-+....+...++.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 9999876533211 12467999999999987632 4789999999999999999999999998888888888
Q ss_pred hcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017994 271 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 311 (362)
Q Consensus 271 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 311 (362)
......+..+.+.+.+++||.+||.+||++|.++.+|....
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 77666666667889999999999999999999999987654
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=322.99 Aligned_cols=257 Identities=31% Similarity=0.618 Sum_probs=221.5
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
|.++..+|.+.+.||.|++|.||+|.+. ++.||+|++...... ...+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchH-------HHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence 5667788999999999999999999986 678999998754322 2567889999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
++..+++|||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 99999999999999999999876555689999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCC--CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCH
Q 017994 208 ESQCGSA--KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284 (362)
Q Consensus 208 ~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
....... .....+..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+ ........+..++.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKGYRMERPEGCPP 232 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCCCCCCCCCCH
Confidence 5432211 12234567999999998899999999999999999998 99999887776554444 33445667788899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
.+.+++.+||+.+|++||++.+++++|+.+
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=339.28 Aligned_cols=265 Identities=33% Similarity=0.541 Sum_probs=214.1
Q ss_pred CCcccccccccCeeeeeeecccCCeeEEEEEECC-eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 45 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
....+....+++|.-.+.||+|+||.||+|...+ +.||||.+....... ..+|.+|+.++.+++|||+|+++|
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~------~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG------EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc------hhHHHHHHHHHhcCCCcCcccEEE
Confidence 3445556668889889999999999999999985 899999887755431 145999999999999999999999
Q ss_pred EEEeCC-eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCcEEEcCCCceEE
Q 017994 124 ACKKPP-VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG---ILHRDLKSENLLLGEDMCVKV 199 (362)
Q Consensus 124 ~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~dlk~~Nil~~~~~~~kl 199 (362)
||.+.+ ..+||+||+++|+|.+++.......++|.++.+|+.+++.||+|||... |+|||||++|||+|.+.+.||
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 999998 5999999999999999998765336899999999999999999999953 999999999999999999999
Q ss_pred eeecccccccc-CCCCCcc-cccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCH--HH-HHH---HHHh
Q 017994 200 ADFGISCLESQ-CGSAKGF-TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP--EQ-AAF---AVCQ 271 (362)
Q Consensus 200 ~Dfg~~~~~~~-~~~~~~~-~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~--~~-~~~---~~~~ 271 (362)
+|||++..... ....... .||.+|+|||+...+..+.++||||||++++|++||+.+.+...+ .. ... ....
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999965544 3332233 799999999999999999999999999999999999988875421 11 111 1111
Q ss_pred c-----CCCCCCC-CCCC-----HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 017994 272 K-----NARPPVP-PTCP-----KAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 272 ~-----~~~~~~~-~~~~-----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
. ...+.+. ...+ ..+..+..+|++.+|..||++.|++++|+.+.
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 1 1111212 2233 23667899999999999999999999996544
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=329.22 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=224.7
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
..+|++.+.||.|.||+|-+|... |+.||||.+++........ .-.+.+||++|+.|+||||+.++.+|+..+.+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqD---lvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQD---LVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHH---HHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 367999999999999999999874 8999999998866544322 34567899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
.|||||..+|.|++|+...+ ++++..+..+++||++|+.|+|.++++|||||.+|||+|.++++||+|||++......
T Consensus 129 vivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999999999887 7999999999999999999999999999999999999999999999999999888887
Q ss_pred CCCCcccccccccChhhhhcCCC-CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
....+++|++-|.+||+..+.+| ++.+|.||||++||.|+.|..||++.+-.....++...-. ..+.-|....-||
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY---rEP~~PSdA~gLI 283 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY---REPETPSDASGLI 283 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc---cCCCCCchHHHHH
Confidence 77889999999999999999887 7899999999999999999999999888777777654433 3445567889999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 017994 291 SRCWSSSPDRRPHFDQIVSIL 311 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~~L 311 (362)
+.||..||++|.|+.+|....
T Consensus 284 RwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 284 RWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHHHhcCcccchhHHHHhhhh
Confidence 999999999999999998754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=307.33 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=213.5
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
.+|...++||+|.||.||+|.+. ++.||||++...+..... .....+||..|+.++||||+.++++|...+.+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi----~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~ 77 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI----NRTALREIKLLQELKHPNIIELIDVFPHKSNLS 77 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc----cHHHHHHHHHHHHccCcchhhhhhhccCCCceE
Confidence 46888899999999999999996 789999999987544332 356778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
||+||++ .+|...++... ..++...+..++.+++.||+|||++.|.||||||.|+|++.+|.+||+|||+++......
T Consensus 78 lVfEfm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 78 LVFEFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEEEecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9999995 59999998765 368999999999999999999999999999999999999999999999999999876654
Q ss_pred CCC-cccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------------
Q 017994 213 SAK-GFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------- 277 (362)
Q Consensus 213 ~~~-~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 277 (362)
... ..+.|..|.|||.+.+. .|+...|+||.||++.||+-|.+-|.+.+.-+.+..+......+.
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 433 33789999999998764 699999999999999999999999998887776665544333221
Q ss_pred -------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 278 -------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 278 -------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
.-+..+.+..+|+.+||..||.+|.+++|.+++
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 112345677899999999999999999999865
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=340.74 Aligned_cols=264 Identities=29% Similarity=0.531 Sum_probs=222.7
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEECC-------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCce
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHI 118 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~i 118 (362)
...|+++..+|.+++.||.|+||.||+|.+.+ ..||||++....... ..+.+.+|+.+++++. ||||
T Consensus 29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-----~~~~~~~Ei~~l~~l~~HpnI 103 (400)
T cd05105 29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSS-----EKQALMSELKIMTHLGPHLNI 103 (400)
T ss_pred CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChH-----HHHHHHHHHHHHHhcCCCCCe
Confidence 46788889999999999999999999998742 369999997643322 1357889999999996 9999
Q ss_pred eeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcC-----------------------------------------------
Q 017994 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQE----------------------------------------------- 151 (362)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------- 151 (362)
+++++++......++||||+++|+|.+++....
T Consensus 104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (400)
T cd05105 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQA 183 (400)
T ss_pred eeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccc
Confidence 999999999999999999999999999986531
Q ss_pred -----------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 017994 152 -----------------------------------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 184 (362)
Q Consensus 152 -----------------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dl 184 (362)
...+++..+..++.|++.||.|||+.+++|+||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~di 263 (400)
T cd05105 184 DTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDL 263 (400)
T ss_pred cccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 124778888999999999999999999999999
Q ss_pred CCCcEEEcCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCC
Q 017994 185 KSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 260 (362)
Q Consensus 185 k~~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~ 260 (362)
||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 264 kp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred ChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 9999999999999999999987543221 1223346678999999998889999999999999999997 99999887
Q ss_pred CHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 017994 261 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
..................+..++..+.+++.+||+.+|++||++.+|.++|+.+.
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 344 IVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred chhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 6555554444555556667788999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=327.98 Aligned_cols=254 Identities=31% Similarity=0.550 Sum_probs=209.2
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC------------------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK------------------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH 115 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h 115 (362)
..+|.+.++||+|+||.||++.+. +..||||++....... ....+.+|+.++.+++|
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h 78 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKN-----ARNDFLKEVKILSRLKD 78 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHH-----HHHHHHHHHHHHhhcCC
Confidence 467999999999999999999753 2369999987643322 24678899999999999
Q ss_pred CceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 017994 116 PHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-----------------YSVPLNLVLKLALDIARGMQYLHSQG 178 (362)
Q Consensus 116 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~ 178 (362)
|||+++++++...+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.|
T Consensus 79 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 158 (304)
T cd05096 79 PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158 (304)
T ss_pred CCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999999999865321 23677889999999999999999999
Q ss_pred ccccCCCCCcEEEcCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh--C
Q 017994 179 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT--A 253 (362)
Q Consensus 179 i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~--g 253 (362)
|+||||||+||+++.++.+||+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 9999999999999999999999999987543321 1223345778999999988889999999999999999987 6
Q ss_pred CCCCCCCCHHHHHHHHHhc------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 254 LTPFDNMTPEQAAFAVCQK------NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 254 ~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
..||...+..+........ ......++.++..+.+|+.+||+.+|.+||++.+|.+.|+
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7788887766554433211 1122345678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=321.06 Aligned_cols=257 Identities=33% Similarity=0.603 Sum_probs=221.2
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
|++...+|.+.+.||+|++|.||+|.+. ++.||||.+...... .+.+.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-------PKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc-------HHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 5567788999999999999999999986 568999998764432 25678899999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
+..+++|||+++++|.+++.......+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 99999999999999999998765556899999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCC--CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 209 SQCGSA--KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 209 ~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
...... .....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.........+. .....+.+..++..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKE 232 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHH
Confidence 432211 12223457999999988889999999999999999999 999999888776665553 33445566778999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
+.+++.+||+.+|++||++.++++.|+.+
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 99999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=325.72 Aligned_cols=248 Identities=33% Similarity=0.644 Sum_probs=209.4
Q ss_pred eeeeeecccCCeeEEEEEEC------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 58 FIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.+.+.||.|.||.||+|.+. +..|+||++........ .+.+.+|++.+++++||||++++|++...+..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~-----~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEE-----EEEFLNEIQILRKLRHPNIVKLYGFCIENEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHH-----HHHHHHHHHHHHTHSBTTBE-EEEEEESSSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccccc-----ceeeeecccccccccccccccccccccccccc
Confidence 46788999999999999988 57899999965433221 47788999999999999999999999988889
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++|+||+++|+|.+++.......+++..++.|+.|++.||.|||+++++|++|+++||+++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999874457999999999999999999999999999999999999999999999999998765221
Q ss_pred ---CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHH
Q 017994 212 ---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287 (362)
Q Consensus 212 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 287 (362)
...........|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+ ......+.+..++..+.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIY 235 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHH
Confidence 11233456788999999999999999999999999999999 78999999887777666 45566677888999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVSIL 311 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~~L 311 (362)
+++.+||+.+|.+||++.+|++.|
T Consensus 236 ~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 236 SLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHhcC
Confidence 999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=325.90 Aligned_cols=256 Identities=32% Similarity=0.617 Sum_probs=218.6
Q ss_pred ccccCeeeeeeecccCCeeEEEEEECC-------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
++.++|++.+.||+|+||.||+|.+.+ ..||+|.+....... ....+.+|+.++.+++||||++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~-----~~~~~~~ei~~l~~l~h~~i~~~~~~ 76 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK-----VQQEFRQEAELMSDLQHPNIVCLLGV 76 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHH-----HHHHHHHHHHHHHhcCCcccceEEEE
Confidence 345689999999999999999998753 469999987543321 24668899999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 190 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil 190 (362)
+......+++|||+++++|.+++..... ..+++..++.++.|++.||.|||++|++|+||||+||+
T Consensus 77 ~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil 156 (283)
T cd05048 77 CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCL 156 (283)
T ss_pred EcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEE
Confidence 9999999999999999999999976422 35788899999999999999999999999999999999
Q ss_pred EcCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHH
Q 017994 191 LGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAA 266 (362)
Q Consensus 191 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~ 266 (362)
++.++.++|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+..
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999987543221 1233456788999999988889999999999999999998 99999988877766
Q ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 017994 267 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 313 (362)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 313 (362)
..+. .......+..+|+++.+|+.+||+.||.+||++.+|++.|++
T Consensus 237 ~~i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 EMIR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 5554 344456678899999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=318.72 Aligned_cols=254 Identities=29% Similarity=0.560 Sum_probs=218.8
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE-EeC
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC-KKP 128 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~-~~~ 128 (362)
|.++..+|.+.+.||+|+||.||++...+..||+|.+..... .+.+.+|+.++++++|||++++++++ ..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch--------HHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 667788999999999999999999999999999999865322 35678899999999999999999976 455
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
...++++||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceec
Confidence 67899999999999999998766556889999999999999999999999999999999999999999999999988654
Q ss_pred ccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHH
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 287 (362)
... ......+..|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+..+++.+.
T Consensus 153 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 229 (256)
T cd05082 153 SST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVY 229 (256)
T ss_pred ccc--CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHH
Confidence 332 223344668999999988889999999999999999998 999998877766555443 3344556678899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 288 YLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
+++.+||+.+|++||++.++++.|+.+
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=331.33 Aligned_cols=240 Identities=23% Similarity=0.380 Sum_probs=204.5
Q ss_pred ecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCCC
Q 017994 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140 (362)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 140 (362)
||+|+||.||++.+. ++.||+|++....... ......+.+|+.++.+++||||+++++++...+..++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS---RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence 699999999999986 6789999987532111 11235677899999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-CCCCcccc
Q 017994 141 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GSAKGFTG 219 (362)
Q Consensus 141 ~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 219 (362)
++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... .......|
T Consensus 78 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 78 GELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence 99999998754 5899999999999999999999999999999999999999999999999998753322 22345678
Q ss_pred cccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCC
Q 017994 220 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 299 (362)
Q Consensus 220 ~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 299 (362)
++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.. ....++..+++.+.++|.+||+.||.
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~ 233 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ--EPLRFPDGFDRDAKDLLIGLLSRDPT 233 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc--CCCCCCCcCCHHHHHHHHHHcCCCHH
Confidence 9999999999999999999999999999999999999998877766555543 34556778899999999999999999
Q ss_pred CCCCH---HHHHH
Q 017994 300 RRPHF---DQIVS 309 (362)
Q Consensus 300 ~Rps~---~ell~ 309 (362)
+||++ .++++
T Consensus 234 ~R~~~~~~~e~l~ 246 (312)
T cd05585 234 RRLGYNGAQEIKN 246 (312)
T ss_pred HcCCCCCHHHHHc
Confidence 99864 55543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=337.49 Aligned_cols=250 Identities=22% Similarity=0.368 Sum_probs=214.6
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.++..++||||+++++.+.+++..+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK---RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh---ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEE
Confidence 36899999999999999999997 7899999987532111 112356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999999999998764 68999999999999999999999999999999999999999999999999987544332
Q ss_pred ------------------------------CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCH
Q 017994 213 ------------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP 262 (362)
Q Consensus 213 ------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~ 262 (362)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 22345689999999999999999999999999999999999999998887
Q ss_pred HHHHHHHHh--cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 017994 263 EQAAFAVCQ--KNARPPVPPTCPKAFSYLISRCWSSSPDRRPH-FDQIVSI 310 (362)
Q Consensus 263 ~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~ell~~ 310 (362)
......+.. .....+....+++.+.++|.+||. +|.+||+ +.++++.
T Consensus 236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 766666654 222333334469999999999998 9999999 9999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=321.04 Aligned_cols=257 Identities=32% Similarity=0.601 Sum_probs=222.3
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
+....+|.+.+.||.|+||.||+|.+. +..+|+|++....... ...+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (261)
T cd05148 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK------QQDFQKEVQALKRLRHKHLISLFAVCSVGE 75 (261)
T ss_pred cCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhh------HHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence 344577999999999999999999987 6789999987654321 356788999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
..++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 99999999999999999987665678999999999999999999999999999999999999999999999999987543
Q ss_pred cCCC-CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHH
Q 017994 210 QCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287 (362)
Q Consensus 210 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 287 (362)
.... .....++..|+|||.+....++.++|+||||+++|+|++ |..||......+....+. .....+.+..+++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (261)
T cd05148 156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIY 234 (261)
T ss_pred CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHH
Confidence 3221 223345678999999988889999999999999999998 899998887766666554 3455667788899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 288 YLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
+++.+||+.+|.+||++.+|++.|+.+
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 235 KIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=332.05 Aligned_cols=243 Identities=24% Similarity=0.354 Sum_probs=207.6
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecC
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYL 138 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 138 (362)
+.||+|+||.||++.+. ++.||||++....... ......+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA---KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCC
Confidence 36899999999999886 6899999997532211 112356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-CCCCCcc
Q 017994 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKGF 217 (362)
Q Consensus 139 ~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 217 (362)
++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......
T Consensus 78 ~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 78 NGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence 9999999987654 589999999999999999999999999999999999999999999999999865322 2223445
Q ss_pred cccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccC
Q 017994 218 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 297 (362)
Q Consensus 218 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 297 (362)
.|++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+. .....++..+++++.++|.+||+.|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~d 233 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKFPRTLSADAKSLLSGLLIKD 233 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc--cCCccCCCCCCHHHHHHHHHHcCCC
Confidence 78999999999998899999999999999999999999998877766555443 2344567788999999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 017994 298 PDRRP-----HFDQIVSI 310 (362)
Q Consensus 298 p~~Rp-----s~~ell~~ 310 (362)
|.+|| ++.++++.
T Consensus 234 P~~R~~~~~~~~~~il~h 251 (328)
T cd05593 234 PNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHcCCCCCCCHHHHhcC
Confidence 99997 88888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=335.38 Aligned_cols=250 Identities=20% Similarity=0.300 Sum_probs=208.8
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||+|+||+||++.+. ++.||||++...... .......+.+|+.++..++||||+++++.+.+...+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML---EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH---HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEE
Confidence 36899999999999999999886 678999999753211 1122356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999999998765 58999999999999999999999999999999999999999999999999986432110
Q ss_pred ------------------------------------CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCC
Q 017994 213 ------------------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP 256 (362)
Q Consensus 213 ------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p 256 (362)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 01235789999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCC--CCCHHHHHHHHHhcccCCC---CCCCHHHHHHH
Q 017994 257 FDNMTPEQAAFAVCQKNARPPVPP--TCPKAFSYLISRCWSSSPD---RRPHFDQIVSI 310 (362)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~---~Rps~~ell~~ 310 (362)
|.+.+..+....+........+++ .+++++.++|.+++. +|. .||++.||++.
T Consensus 236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 998888777666654333333333 467899999998765 343 56899999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=318.07 Aligned_cols=256 Identities=32% Similarity=0.586 Sum_probs=217.0
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
|.+..++|.+.++||+|+||.||+|.+. ...||+|++...... .+.+.+|+.++++++||||+++++.+. .
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~-------~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-------PEAFLQEAQVMKKLRHEKLVQLYAVVS-E 72 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC-------HHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence 5566788999999999999999999886 457999998764432 256788999999999999999999875 4
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
...++||||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeec
Confidence 56789999999999999998755446889999999999999999999999999999999999999999999999998754
Q ss_pred ccCCC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 209 SQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 209 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
..... .....++..|+|||+..+..++.++|+||||+++|+|++ |..||......+....+. .....+.+..++..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 231 (262)
T cd05071 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 231 (262)
T ss_pred cccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCccccCHH
Confidence 43221 123345678999999988889999999999999999999 899998887766555443 23344556778999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
+.+++.+||+.+|++||++.+++++|+.+
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=336.48 Aligned_cols=251 Identities=20% Similarity=0.287 Sum_probs=207.9
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
+.|.+.+.||+|+||+||+|.+. ++.||||++....... ......+.+|+.+++.++||||+++++.+.+.+.++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~ 77 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN---RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLY 77 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEE
Confidence 36889999999999999999986 6789999997632211 112356888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 211 (362)
+||||++||+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 78 lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999999998765 5889999999999999999999999999999999999999999999999987532100
Q ss_pred -----------------------------------------------CCCCcccccccccChhhhhcCCCCCcccchhhh
Q 017994 212 -----------------------------------------------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFG 244 (362)
Q Consensus 212 -----------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG 244 (362)
.......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 001235689999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHhc--ccCCCCCCCHHHHHHH
Q 017994 245 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCW--SSSPDRRPHFDQIVSI 310 (362)
Q Consensus 245 ~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l--~~~p~~Rps~~ell~~ 310 (362)
|++|||++|..||...+..+....+......... ...+++++.++|.+|+ ..++..||++.++++.
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999999988776665555432222233 3357899999999955 5556669999999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=317.32 Aligned_cols=250 Identities=26% Similarity=0.550 Sum_probs=214.1
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
+.++|++.+.||+|+||.||++.++ +..+|+|.+...... ...+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL 74 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc-------HHHHHHHHHHHHHCCCCCceeEEEEEccCCCE
Confidence 4577999999999999999999887 458999987654322 35678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+++++|.+++..... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 999999999999999976542 5889999999999999999999999999999999999999999999999988754322
Q ss_pred CC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 212 GS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 212 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+.. ......+...+..+.+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~ 232 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYE 232 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHH
Confidence 11 122345568999999988889999999999999999999 9999998877766666544 3344556667889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 017994 289 LISRCWSSSPDRRPHFDQIVSIL 311 (362)
Q Consensus 289 li~~~l~~~p~~Rps~~ell~~L 311 (362)
++.+||+.+|++||++.++++.|
T Consensus 233 li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 233 VMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHccCCcccCcCHHHHHHhh
Confidence 99999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=313.94 Aligned_cols=271 Identities=23% Similarity=0.302 Sum_probs=221.3
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE--e
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK--K 127 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~--~ 127 (362)
...++|+..++|++|.||.||+|.++ ++-||+|.++.+...... .-...+||.+|.+++|||||.+-.+.. +
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GF----PItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGF----PITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCC----cchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 35688999999999999999999997 678999999987644332 234568999999999999999988764 3
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
-+.+|+|||||+. +|..++...+ ..+...++.-++.|++.|++|||.+.|+|||||++|+|++..|.+||+|||+|+.
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhh
Confidence 4679999999966 9999999877 4688899999999999999999999999999999999999999999999999997
Q ss_pred cccC-CCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------
Q 017994 208 ESQC-GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-------- 277 (362)
Q Consensus 208 ~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 277 (362)
...+ ......+.|..|.|||++.+. .|+.+.|+||+||++.||+++.+-|.+....+.+..+......+.
T Consensus 227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 6654 334567789999999998775 589999999999999999999999999888877776655332221
Q ss_pred ---------------------CCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCCCCccccc
Q 017994 278 ---------------------VPPT-CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSF 328 (362)
Q Consensus 278 ---------------------~~~~-~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~~~~~~~~ 328 (362)
++.. +++.-.+|+..+|..||.+|.|+++.++.==....-++.++.+++++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~ 379 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTW 379 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCC
Confidence 1111 45677889999999999999999998864322222234444444443
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=331.25 Aligned_cols=242 Identities=23% Similarity=0.358 Sum_probs=206.6
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecC
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYL 138 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 138 (362)
+.||+|+||.||++.+. ++.||+|++....... ......+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCC
Confidence 36899999999999885 6889999987532111 112356678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-CCCCCcc
Q 017994 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKGF 217 (362)
Q Consensus 139 ~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 217 (362)
++++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 78 NGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence 9999999987664 589999999999999999999999999999999999999999999999998864322 2223346
Q ss_pred cccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccC
Q 017994 218 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 297 (362)
Q Consensus 218 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 297 (362)
.|++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+... ...++..+++.+.++|.+||+.|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCC
Confidence 7899999999999889999999999999999999999999888776665555432 34466788999999999999999
Q ss_pred CCCCC-----CHHHHHH
Q 017994 298 PDRRP-----HFDQIVS 309 (362)
Q Consensus 298 p~~Rp-----s~~ell~ 309 (362)
|.+|| ++.++++
T Consensus 234 P~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 234 PKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHhCCCCCCCHHHHHc
Confidence 99998 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=336.07 Aligned_cols=249 Identities=21% Similarity=0.309 Sum_probs=210.1
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||+|+||.||++.+. ++.||||++...... .......+.+|+.++..++||||+++++.+.++...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML---EKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEE
Confidence 36899999999999999999986 678999999753211 1112356778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+|.++|+|||++.......
T Consensus 78 lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999999998765 58999999999999999999999999999999999999999999999999886432111
Q ss_pred ---------------------------------------CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhC
Q 017994 213 ---------------------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA 253 (362)
Q Consensus 213 ---------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g 253 (362)
.....+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 01124689999999999988999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 017994 254 LTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLISRCWSSSPDRRPH---FDQIVS 309 (362)
Q Consensus 254 ~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~ell~ 309 (362)
..||...+..+....+.........+ ..+++.+.++|.+|+. +|.+|++ +.++++
T Consensus 236 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999888777666655433333333 3568999999999997 8999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=327.77 Aligned_cols=250 Identities=23% Similarity=0.378 Sum_probs=209.2
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
...+|++.+.||+|+||.||++.+. +..||+|++...... .....+.+|+.++++++||||+++++++..++.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP-----AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 77 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH-----HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 3478999999999999999999997 678999998764322 124678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 999999999999999998765 589999999999999999999986 69999999999999999999999999987543
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh------------------
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ------------------ 271 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~------------------ 271 (362)
.. ......+++.|+|||++.+..++.++||||||+++|+|++|+.||......+....+..
T Consensus 156 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 156 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred cc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 32 23455789999999999988999999999999999999999999976655432211100
Q ss_pred ---------------------------cCCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 272 ---------------------------KNARPP-VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 272 ---------------------------~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
....+. ....+++++.+||.+||+.||++||++.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000111 122467899999999999999999999999974
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=323.71 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=205.7
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|.+.+.||.|+||.||+|.+. ++.||+|++........ ...+.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----PCTAIREVSLLKNLKHANIVTLHDIIHTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc-----chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 567999999999999999999886 67899999876432211 24567899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+.+ +|.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 999999965 99999876542 5788999999999999999999999999999999999999999999999998654322
Q ss_pred -CCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------------
Q 017994 212 -GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------------- 276 (362)
Q Consensus 212 -~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~------------- 276 (362)
.......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+..+....+......+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 22334567899999999865 468999999999999999999999998877665544432211100
Q ss_pred ---------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ---------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.....++.++.+||.+||..||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 011346788999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=335.17 Aligned_cols=256 Identities=22% Similarity=0.307 Sum_probs=214.9
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
.+.....+|.+.+.||+|+||.||++.+. ++.||+|++....... ......+.+|+.+++.++||||+++++++.
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~il~~~~h~~iv~~~~~~~ 113 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK---RSDSAFFWEERDIMAHANSEWIVQLHYAFQ 113 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 34556789999999999999999999986 6789999986532111 111345778999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
++...++||||++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 114 DDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence 999999999999999999999764 47889999999999999999999999999999999999999999999999987
Q ss_pred ccccCC--CCCcccccccccChhhhhcC----CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 017994 207 LESQCG--SAKGFTGTYRWMAPEMIKEK----RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP 280 (362)
Q Consensus 207 ~~~~~~--~~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (362)
...... ......|++.|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+........++.
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (370)
T cd05596 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD 270 (370)
T ss_pred eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC
Confidence 544322 22345789999999998653 378999999999999999999999998887766666654433333343
Q ss_pred --CCCHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 017994 281 --TCPKAFSYLISRCWSSSPDR--RPHFDQIVSI 310 (362)
Q Consensus 281 --~~~~~l~~li~~~l~~~p~~--Rps~~ell~~ 310 (362)
.++.++.++|.+||..+|.+ |+++.++++.
T Consensus 271 ~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 57899999999999999987 9999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=316.04 Aligned_cols=255 Identities=31% Similarity=0.605 Sum_probs=221.9
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
|.++..+|++.+.||.|++|.||+|...++.||||.+..... ..+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC
Confidence 445667899999999999999999999999999999976543 1367888999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
..++||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccc
Confidence 99999999999999999987665568999999999999999999999999999999999999999999999999987653
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
.... ....+..|+|||.+....++.++|+||||+++|++++ |..||...+..+....+. .......+..+++.+.+
T Consensus 154 ~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 230 (256)
T cd05039 154 QGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYK 230 (256)
T ss_pred cccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCccCCCHHHHH
Confidence 3221 3344567999999988889999999999999999998 999998887766554443 33445566778999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 289 LISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 289 li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
++.+||..+|++||++.+++++|+.+
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHhccChhhCcCHHHHHHHHhcC
Confidence 99999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=323.41 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=204.6
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||++.++ ++.||||++........ ..+.+.+|+.+++.++||||+++++++..++..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE----VKETTLRELKMLRTLKQENIVELKEAFRRRGKLY 76 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccccc----chhhHHHHHHHHHhCCCccccchhhhEecCCEEE
Confidence 36899999999999999999996 67899999876533221 1356778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||++++.+..+.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 77 LVFEYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred EEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999999887766554433 368999999999999999999999999999999999999999999999999987653322
Q ss_pred --CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------
Q 017994 213 --SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--------------- 275 (362)
Q Consensus 213 --~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--------------- 275 (362)
......+++.|+|||++.+..++.++|+||||+++|+|++|++||...+..+....+......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 223456899999999999888999999999999999999999999887654443322211000
Q ss_pred ----CC-----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 ----PP-----------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 ----~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+ ....++.++.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 01236788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=330.88 Aligned_cols=262 Identities=27% Similarity=0.535 Sum_probs=217.2
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeee
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITF 121 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~ 121 (362)
|.+..++|++.+.||+|+||.||+|.+. ++.||+|++........ .+.+.+|+.++.++ +||||+++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~-----~~~~~~E~~~~~~l~~h~niv~~ 76 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE-----YKALMTELKILIHIGHHLNVVNL 76 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHH-----HHHHHHHHHHHHhhccCcchhhe
Confidence 7777889999999999999999999753 25799999876433221 24567899999999 89999999
Q ss_pred eEEEEe-CCeEEEEEecCCCCCHHHHHhhcCC------------------------------------------------
Q 017994 122 VAACKK-PPVFCIITEYLAGGSLRKYLHQQEP------------------------------------------------ 152 (362)
Q Consensus 122 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------ 152 (362)
++++.. +..+++++||+++++|.+++.....
T Consensus 77 ~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (337)
T cd05054 77 LGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDV 156 (337)
T ss_pred eeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhc
Confidence 998764 4678899999999999999864321
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC---CCccc
Q 017994 153 -----------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFT 218 (362)
Q Consensus 153 -----------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 218 (362)
..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........ .....
T Consensus 157 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 157 EEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred ccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCC
Confidence 2578899999999999999999999999999999999999999999999999875432211 22334
Q ss_pred ccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccC
Q 017994 219 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 297 (362)
Q Consensus 219 ~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 297 (362)
++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+..............+...++++.+++.+||+.+
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 316 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNN 316 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCC
Confidence 5678999999999999999999999999999998 999998765544444444445555566778899999999999999
Q ss_pred CCCCCCHHHHHHHHHhhhh
Q 017994 298 PDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 298 p~~Rps~~ell~~L~~~~~ 316 (362)
|++||++.+++++|+.+.+
T Consensus 317 p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 317 PEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred hhhCcCHHHHHHHHHHHHh
Confidence 9999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=316.43 Aligned_cols=255 Identities=31% Similarity=0.576 Sum_probs=217.7
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
|++..++|++.+.||+|+||.||+|.+. +..||+|.+...... .+.+.+|+.++++++|||++++++++. .
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-------PESFLEEAQIMKKLRHDKLVQLYAVVS-E 72 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC-------HHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence 5666788999999999999999999876 567999998764433 256788999999999999999999875 4
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
...+++|||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 56789999999999999998765556899999999999999999999999999999999999999999999999998754
Q ss_pred ccCCC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 209 SQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 209 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+. .....+.+...+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 231 (260)
T cd05070 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPIS 231 (260)
T ss_pred cCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHH
Confidence 33221 122334567999999988889999999999999999999 999998877766655543 34455667778899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSILEG 313 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~L~~ 313 (362)
+.+|+.+||..+|++|||+.++.+.|+.
T Consensus 232 ~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 232 LHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=322.94 Aligned_cols=252 Identities=19% Similarity=0.290 Sum_probs=210.9
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|++.+.||+|+||.||++.+. ++.||||++....... ......+.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh---hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEE
Confidence 4788899999999999999985 6889999986533221 1113556789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 213 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (362)
||||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999999998765544689999999999999999999999999999999999999999999999999876544333
Q ss_pred CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCCCHHHHHHHH
Q 017994 214 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ--KNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~ 291 (362)
.....|++.|+|||++.+..++.++||||+|+++|+|++|..||.+.........+.. .......+..++..+.+|+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 3455789999999999988899999999999999999999999987655433222211 12334456678999999999
Q ss_pred HhcccCCCCCC-----CHHHHHHH
Q 017994 292 RCWSSSPDRRP-----HFDQIVSI 310 (362)
Q Consensus 292 ~~l~~~p~~Rp-----s~~ell~~ 310 (362)
+||..||.+|| ++.++++.
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 238 QLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHccCCHHHhcCCCCCCHHHHhcC
Confidence 99999999999 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=323.20 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=204.2
Q ss_pred cCeeeeeeecccCCeeEEEEEEC---CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC---CCCceeeeeEEEE--
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL---NHPHIITFVAACK-- 126 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~-- 126 (362)
.+|++.+.||+|+||.||+|.+. ++.||||++......... ...+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~ 76 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM----PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 76 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc----hHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence 36899999999999999999873 578999998764432211 13344566666655 7999999999885
Q ss_pred ---eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 127 ---KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 127 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
....+++||||+. ++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||
T Consensus 77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 77 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred cCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 3457899999995 699999987665568999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------
Q 017994 204 ISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------- 276 (362)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~------- 276 (362)
++.............+++.|+|||++.+..++.++||||||+++|+|++|.+||.+....+....+......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 9876554444455678999999999988889999999999999999999999999887766555544321110
Q ss_pred ------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...+.+++.+.+++.+||+.||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 011346778899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=328.73 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=205.6
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHH---HcCCCCceeeeeEEEEeCCeE
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALL---FRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l---~~l~hp~iv~~~~~~~~~~~~ 131 (362)
|.+.+.||+|+||.||+|.+. ++.||||++........ ...+.+.+|+.++ +.++||||+++++++...+..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR---DEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEE
Confidence 577899999999999999986 68899999875321111 1124455666554 567899999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ- 210 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~- 210 (362)
|+||||++|++|..++... .+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 78 ~lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999999888653 589999999999999999999999999999999999999999999999998864322
Q ss_pred CCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 211 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 211 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+....+... ....+..+++.+.++|
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li 232 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSREAISIM 232 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHH
Confidence 22234567899999999999989999999999999999999999999988877766665443 3456678899999999
Q ss_pred HHhcccCCCCCC-----CHHHHHH
Q 017994 291 SRCWSSSPDRRP-----HFDQIVS 309 (362)
Q Consensus 291 ~~~l~~~p~~Rp-----s~~ell~ 309 (362)
.+||+.||.+|| ++.++++
T Consensus 233 ~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 233 RRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHhhcCHhHcCCCCCCCHHHHhh
Confidence 999999999999 4666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=319.22 Aligned_cols=257 Identities=30% Similarity=0.554 Sum_probs=218.9
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEECC-------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeee
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~ 122 (362)
|+++.++|.+.+.||+|+||.||+|.+++ ..||+|.+....... ....+.+|+.+++.++||||++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~ 75 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR-----ERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHH-----HHHHHHHHHHHHHhCCCCceeEEE
Confidence 56778899999999999999999998752 579999986543221 135677899999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC
Q 017994 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEP--------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 194 (362)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~ 194 (362)
+++......++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 76 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~ 155 (277)
T cd05032 76 GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED 155 (277)
T ss_pred EEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC
Confidence 999999999999999999999999975332 236788999999999999999999999999999999999999
Q ss_pred CceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 017994 195 MCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVC 270 (362)
Q Consensus 195 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~ 270 (362)
+.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 999999999987543321 1223345778999999988889999999999999999998 999998888776665554
Q ss_pred hcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 271 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 271 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
.......+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 236 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 44455667788999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=336.04 Aligned_cols=250 Identities=19% Similarity=0.267 Sum_probs=207.2
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||.|+||.||++.+. ++.||||++...... .....+.+.+|+.+++.++||||+++++++.+....|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~ 77 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF---KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLY 77 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH---HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeE
Confidence 36889999999999999999885 678999998653211 1112356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||++||+|.+++.... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||+++......
T Consensus 78 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999999998754 58899999999999999999999999999999999999999999999999985321100
Q ss_pred ------------------------------------------------CCCcccccccccChhhhhcCCCCCcccchhhh
Q 017994 213 ------------------------------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFG 244 (362)
Q Consensus 213 ------------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG 244 (362)
......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00124689999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 017994 245 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLISRCWSSSPDRR---PHFDQIVSI 310 (362)
Q Consensus 245 ~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~R---ps~~ell~~ 310 (362)
|++|+|++|..||......+....+........++ ..++..+.+||.+||. +|.+| +++.++++.
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999999999887766655554332233333 3578899999999998 66665 599998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=318.73 Aligned_cols=257 Identities=30% Similarity=0.548 Sum_probs=215.0
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeee
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~ 122 (362)
|....++|++.+.||+|+||.||+|.+. +..||||++....... ....+.+|+.+++.++||||++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~iv~~~ 75 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCeeeEE
Confidence 5667788999999999999999999865 3569999986532211 135678899999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC
Q 017994 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEP--------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 194 (362)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~ 194 (362)
+++......++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 155 (277)
T ss_pred EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC
Confidence 999999999999999999999999975331 235678899999999999999999999999999999999999
Q ss_pred CceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 017994 195 MCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVC 270 (362)
Q Consensus 195 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~ 270 (362)
+.++|+|||++........ .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........+.
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998864332111 112345678999999998889999999999999999999 799998887766555443
Q ss_pred hcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 271 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 271 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
.......+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 236 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 -EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 33445567778999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=315.15 Aligned_cols=257 Identities=33% Similarity=0.626 Sum_probs=221.8
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
|++..++|.+.+.||.|+||.||+|.++ +..||||.+...... .+.+.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-------PEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC-------HHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 5677889999999999999999999886 467999998764433 25678899999999999999999999998
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
...+++|||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceec
Confidence 99999999999999999998766557899999999999999999999999999999999999999999999999988754
Q ss_pred ccCC--CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 209 SQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 209 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
.... .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........+. .....+.+...+..
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEE 232 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 4311 1122334568999999998889999999999999999999 999998887766665553 34445566777899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=328.52 Aligned_cols=243 Identities=24% Similarity=0.381 Sum_probs=207.2
Q ss_pred eeecccCCeeEEEEEE-----CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEE
Q 017994 61 CKFASGRHSRIYRGIY-----KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIIT 135 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 135 (362)
+.||+|+||.||++.. .++.||||++........ ......+.+|+.+++.++||||+++++.+..++..|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN--QKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhh--hhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 5799999999999976 367899999875322111 111355678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-CCCC
Q 017994 136 EYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSA 214 (362)
Q Consensus 136 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~ 214 (362)
||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..... ....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 80 EYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred eCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 9999999999998765 578899999999999999999999999999999999999999999999999864322 2223
Q ss_pred CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhc
Q 017994 215 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 294 (362)
Q Consensus 215 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 294 (362)
....|++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.. .....+..+++.+.++|.+||
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l 235 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK--GKLNLPPYLTPEARDLLKKLL 235 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHc
Confidence 445789999999999988899999999999999999999999998887766666543 344667788999999999999
Q ss_pred ccCCCCCC-----CHHHHHH
Q 017994 295 SSSPDRRP-----HFDQIVS 309 (362)
Q Consensus 295 ~~~p~~Rp-----s~~ell~ 309 (362)
+.+|++|| ++.++++
T Consensus 236 ~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 236 KRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ccCHhHcCCCCCCCHHHHhc
Confidence 99999999 7888776
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=315.50 Aligned_cols=256 Identities=32% Similarity=0.633 Sum_probs=218.7
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
|++...+|++.++||+|+||.||+|... ++.||+|.+...... ...+.+|+.++++++||||+++++++. .
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-------PEAFLAEANLMKQLQHPRLVRLYAVVT-Q 72 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc-------HHHHHHHHHHHHhcCCcCeeeEEEEEc-c
Confidence 5566788999999999999999999986 688999998765443 256788999999999999999999874 4
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
+..+++|||+.+++|.+++.......+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence 57899999999999999998766567899999999999999999999999999999999999999999999999998654
Q ss_pred ccCC--CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 209 SQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 209 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
.... ......++..|+|||++....++.++|+||||+++|++++ |..||.+.+..+....+ ......+.+...+.+
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 231 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-ERGYRMPRPDNCPEE 231 (260)
T ss_pred CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-HcCCCCCCCCCCCHH
Confidence 4221 1123345678999999988889999999999999999999 99999887766555444 334455667778899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
+.+++.+||+.+|++||+++++++.|+.+
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 232 LYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 99999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=314.77 Aligned_cols=256 Identities=31% Similarity=0.586 Sum_probs=216.5
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEECC-eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
|++...+|.+...||.|++|.||++.+.+ ..+|+|.+...... .+.+.+|+.++++++|||++++++++. .
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-------PEAFLQEAQIMKKLRHDKLVPLYAVVS-E 72 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc-------HHHHHHHHHHHHhCCCCCeeeEEEEEc-C
Confidence 45566789999999999999999999874 57999988654322 356788999999999999999999875 4
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
...+++|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence 56789999999999999998765556889999999999999999999999999999999999999999999999998754
Q ss_pred ccCC--CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 209 SQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 209 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
.... ......++..|+|||...+..++.++|+||||+++|+|++ |..||.+....+....+. .....+.+...+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 231 (260)
T cd05069 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPES 231 (260)
T ss_pred cCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHH
Confidence 3322 1123345678999999988889999999999999999999 999999877766555443 34445566778899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
+.+++.+||+.+|++||++.+++++|+.+
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 232 LHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=315.31 Aligned_cols=255 Identities=34% Similarity=0.591 Sum_probs=217.6
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
+.++|.+.+.||+|+||.||+|.+. ...||||++....... ....+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK-----QRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChH-----HHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 3567999999999999999999885 2479999987644322 24567889999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
.+..+++|||+++++|.+++..... .+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++..
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 9999999999999999999987543 689999999999999999999999999999999999999999999999999876
Q ss_pred cccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 017994 208 ESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283 (362)
Q Consensus 208 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (362)
...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .....+.+..++
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCP 234 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 542111 122334578999999998889999999999999999998 999998877766655543 333445567789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 284 KAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 284 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=314.76 Aligned_cols=251 Identities=28% Similarity=0.564 Sum_probs=213.9
Q ss_pred cccCeeeeeeecccCCeeEEEEEECC-eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
+.++|.+.+.||+|+||.||.|.+.+ ..+|||.+...... .+.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI 74 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc-------HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence 45679999999999999999998874 46999988754332 25678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
+++|||+.+++|.+++..... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 999999999999999987543 6899999999999999999999999999999999999999999999999988654332
Q ss_pred CC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 212 GS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 212 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.. ......+...+..+.+
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 232 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRPHLASEKVYA 232 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc-CCCCCCCCCCCHHHHH
Confidence 21 122335577999999988889999999999999999999 9999988777665555543 3444556677899999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 017994 289 LISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 289 li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
++.+||+.+|.+||++.+|++.|+
T Consensus 233 li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 233 IMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHHHhhC
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=336.30 Aligned_cols=250 Identities=20% Similarity=0.296 Sum_probs=208.5
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||+|+||.||++.+. ++.||||++...... .......+.+|+.++..++||||+++++.+.+++.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 77 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL---MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLY 77 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH---hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEE
Confidence 46999999999999999999986 678999998653211 1112356778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 211 (362)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 78 lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999999998765 5889999999999999999999999999999999999999999999999987422100
Q ss_pred -------------------------------------------CCCCcccccccccChhhhhcCCCCCcccchhhhHHHH
Q 017994 212 -------------------------------------------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 248 (362)
Q Consensus 212 -------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ 248 (362)
.......||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0012346899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 017994 249 ELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAFSYLISRCWSSSPDRRP---HFDQIVSI 310 (362)
Q Consensus 249 ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~~ 310 (362)
+|++|..||.+..+.+....+....... +....+++.+.++|.+|+ .+|.+|+ ++.++++.
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999999888766655544322222 223467899999999977 5999999 88888864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=332.83 Aligned_cols=265 Identities=28% Similarity=0.514 Sum_probs=223.4
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCc
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPH 117 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~ 117 (362)
....|++..++|.+++.||+|+||.||+|.+. +..||||++........ .+.+.+|+.++.++. |||
T Consensus 28 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----~~~~~~E~~~l~~l~~H~n 102 (401)
T cd05107 28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE-----KQALMSELKIMSHLGPHLN 102 (401)
T ss_pred CCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhH-----HHHHHHHHHHHHhcCCCCC
Confidence 34569999999999999999999999999864 35799999986533221 246788999999997 999
Q ss_pred eeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC---------------------------------------------
Q 017994 118 IITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------------------------------------- 152 (362)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------- 152 (362)
|+++++.+...+..++||||+.+|+|.++++....
T Consensus 103 iv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (401)
T cd05107 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMS 182 (401)
T ss_pred eEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccC
Confidence 99999999999999999999999999999975321
Q ss_pred ---------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 017994 153 ---------------------------------------------------YSVPLNLVLKLALDIARGMQYLHSQGILH 181 (362)
Q Consensus 153 ---------------------------------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H 181 (362)
..+++..++.++.|++.||.|||+.+++|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 262 (401)
T cd05107 183 KDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVH 262 (401)
T ss_pred CccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCc
Confidence 13667788999999999999999999999
Q ss_pred cCCCCCcEEEcCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCC
Q 017994 182 RDLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPF 257 (362)
Q Consensus 182 ~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~ 257 (362)
|||||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|||++ |..||
T Consensus 263 rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999987532211 1223346788999999998889999999999999999998 89999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 017994 258 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
......+...........+..+..++..+.+|+.+||+.+|..||++.+|++.|+.+.
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 8876666555555555556677788999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=333.91 Aligned_cols=249 Identities=20% Similarity=0.307 Sum_probs=207.6
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
+.|.+.+.||+|+||.||+|.+. ++.||||++...... .......+.+|+.+++.++||||+++++.+.+++.++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~---~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~ 77 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL---LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 77 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh---hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEE
Confidence 35889999999999999999986 678999998753211 1122467888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 211 (362)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++......
T Consensus 78 lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999999998764 5889999999999999999999999999999999999999999999999987422100
Q ss_pred -----------------------------------------------CCCCcccccccccChhhhhcCCCCCcccchhhh
Q 017994 212 -----------------------------------------------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFG 244 (362)
Q Consensus 212 -----------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG 244 (362)
.......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 001234689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 017994 245 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDRRPH---FDQIVS 309 (362)
Q Consensus 245 ~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps---~~ell~ 309 (362)
|++|+|++|..||...++.+....+......... ...+++++.++|.+|+ .+|.+|++ +.++++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999999999988877666665543333333 3467899999999986 49999987 777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=320.85 Aligned_cols=262 Identities=27% Similarity=0.508 Sum_probs=221.4
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCcee
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHII 119 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv 119 (362)
..|.+...+|.+.+.||+|+||.||++.+. +..||||++....... ..+.+.+|+.+++++ +||||+
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv 102 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS-----EREALMSELKIMSHLGNHENIV 102 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChH-----HHHHHHHHHHHHHhccCCCCcc
Confidence 456777789999999999999999999752 3479999987643321 135788999999999 799999
Q ss_pred eeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEE
Q 017994 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 199 (362)
Q Consensus 120 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl 199 (362)
++++++...+..+++|||+.+++|.+++.......+++.++..++.|++.||.|||+++++|+||||+||+++.++.++|
T Consensus 103 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred eEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEE
Confidence 99999999999999999999999999998655445899999999999999999999999999999999999999999999
Q ss_pred eeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCC
Q 017994 200 ADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 275 (362)
Q Consensus 200 ~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 275 (362)
+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..................
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 262 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR 262 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence 99999875433211 122345678999999998889999999999999999998 99999887766555555544445
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 276 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 276 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
...+...++.+.+++.+||+.+|++||++.++++.|+++
T Consensus 263 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 555667789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=340.66 Aligned_cols=249 Identities=27% Similarity=0.371 Sum_probs=212.8
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC---CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
...|.+.+.||+|++|.||+|... ++.||+|.+....... ...+.+|+.+++.++||||+++++++..++.
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~------~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQ------AAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHH------HHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 345999999999999999999875 4678888775543221 2456789999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
.|+||||++||+|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 99999999999999988642 2235889999999999999999999999999999999999999999999999998765
Q ss_pred ccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 209 SQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 209 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
.... .....+||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+... ...+.+..++..
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~s~~ 298 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCPVSSG 298 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCccCCHH
Confidence 4322 234556899999999999999999999999999999999999999988877766665543 334566778999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+.++|.+||+.+|++||++.+++.
T Consensus 299 ~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 299 MKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHHhccChhhCcCHHHHHh
Confidence 999999999999999999999875
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=326.31 Aligned_cols=242 Identities=23% Similarity=0.339 Sum_probs=206.1
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC-CceeeeeEEEEeCCeEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-PHIITFVAACKKPPVFC 132 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-p~iv~~~~~~~~~~~~~ 132 (362)
+|.+.+.||+|+||.||+|.+. ++.||||++....... ....+.+..|+.++..++| ++|+++++++...+.+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ---DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEE
Confidence 4888999999999999999987 5689999987532111 1113566789999999876 56888999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc-cC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-QC 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~-~~ 211 (362)
+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.... ..
T Consensus 78 lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999999998765 58899999999999999999999999999999999999999999999999886432 22
Q ss_pred CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....+.. .....+..++..+.+++.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~ 233 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAVSICK 233 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHH
Confidence 233455789999999999999999999999999999999999999998887776666543 345567788999999999
Q ss_pred HhcccCCCCCCCH
Q 017994 292 RCWSSSPDRRPHF 304 (362)
Q Consensus 292 ~~l~~~p~~Rps~ 304 (362)
+||..||.+|++.
T Consensus 234 ~~l~~~P~~R~~~ 246 (324)
T cd05587 234 GLLTKHPAKRLGC 246 (324)
T ss_pred HHhhcCHHHcCCC
Confidence 9999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=352.91 Aligned_cols=261 Identities=30% Similarity=0.585 Sum_probs=228.4
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC---C----eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK---Q----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~---~----~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
+......+.+.||+|+||.||.|.+. + -.||||.+........ ..+|.+|..+|+.++|||||+++|+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~-----~~~Fl~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQE-----VSDFLKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHH-----HHHHHHHHHHHhcCCCcceeeEEEe
Confidence 45677888999999999999999885 2 2489998887544332 5789999999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEE
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQE-----PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 199 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl 199 (362)
+.+....+|++|||+||+|..+|++.. +..++....+.++.||+.|+.||+++++|||||..+|+|++....+||
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEE
Confidence 999999999999999999999998752 235888999999999999999999999999999999999999999999
Q ss_pred eeeccccccccCC--CCCc-ccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCC
Q 017994 200 ADFGISCLESQCG--SAKG-FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 275 (362)
Q Consensus 200 ~Dfg~~~~~~~~~--~~~~-~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 275 (362)
+|||+|+...... .... ..-...|||||.+..+.++.++||||||+++||++| |..||.+.++.++...+.... +
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R 922 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R 922 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c
Confidence 9999998332211 1111 133568999999999999999999999999999999 999999999999988777665 8
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 017994 276 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318 (362)
Q Consensus 276 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l 318 (362)
.+.|..||..+.++|..||+.+|++||++..|++.+..+....
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 9999999999999999999999999999999999998876543
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=329.48 Aligned_cols=238 Identities=26% Similarity=0.393 Sum_probs=204.7
Q ss_pred eeecccCCeeEEEEEE-----CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEE
Q 017994 61 CKFASGRHSRIYRGIY-----KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIIT 135 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 135 (362)
+.||+|+||.||++.+ .++.||+|++....... .....+..|+.++++++||||+++++++..++..|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV----RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh----hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence 5799999999999875 36789999997643211 11345678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-CCC
Q 017994 136 EYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GSA 214 (362)
Q Consensus 136 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 214 (362)
||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...... ...
T Consensus 78 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 78 DFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 9999999999997654 5899999999999999999999999999999999999999999999999998754433 223
Q ss_pred CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhc
Q 017994 215 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 294 (362)
Q Consensus 215 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 294 (362)
....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.. .....+..+++.+.++|.+||
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~l 233 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK--AKLGMPQFLSPEAQSLLRALF 233 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHh
Confidence 456789999999999988899999999999999999999999998887776666543 334567788999999999999
Q ss_pred ccCCCCCCCHHH
Q 017994 295 SSSPDRRPHFDQ 306 (362)
Q Consensus 295 ~~~p~~Rps~~e 306 (362)
+.||.+||++.+
T Consensus 234 ~~~P~~R~~a~~ 245 (318)
T cd05582 234 KRNPANRLGAGP 245 (318)
T ss_pred hcCHhHcCCCCC
Confidence 999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=328.61 Aligned_cols=243 Identities=24% Similarity=0.355 Sum_probs=206.6
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecC
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYL 138 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 138 (362)
+.||+|+||.||++.+. ++.||+|++....... ......+..|+.++..++||||+++++.+...+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 36899999999999885 6789999997632211 111345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCceEEeeecccccccc-CCCCCc
Q 017994 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKG 216 (362)
Q Consensus 139 ~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 216 (362)
++++|..++.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||++..... ......
T Consensus 78 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 78 NGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence 9999999987654 58999999999999999999997 7999999999999999999999999999864322 222334
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 296 (362)
..|++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.. ....++..+++++.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~L~~ 233 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLSPEAKSLLSGLLKK 233 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhhc
Confidence 5789999999999998999999999999999999999999988777665555433 33456778899999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 017994 297 SPDRRP-----HFDQIVSI 310 (362)
Q Consensus 297 ~p~~Rp-----s~~ell~~ 310 (362)
||.+|+ ++.++++.
T Consensus 234 dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 234 DPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CHHHhCCCCCCCHHHHhcC
Confidence 999996 88888863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=316.29 Aligned_cols=255 Identities=29% Similarity=0.559 Sum_probs=214.6
Q ss_pred cccCeeeeeeecccCCeeEEEEEE------CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIY------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
+.++|++.+.||+|+||.||+|.+ .+..|++|.+....... ....+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~ 77 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQ-----QWGEFQQEASLMAELHHPNIVCLLGVVT 77 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHH-----HHHHHHHHHHHHhhCCCCCeeeEEEEEe
Confidence 457899999999999999999985 24689999987543322 1356788999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQE---------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 191 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~ 191 (362)
.....+++|||+++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili 157 (283)
T cd05090 78 QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI 157 (283)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE
Confidence 9999999999999999999996432 1247888999999999999999999999999999999999
Q ss_pred cCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHH
Q 017994 192 GEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAF 267 (362)
Q Consensus 192 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~ 267 (362)
+.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+........
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999987543221 1233445678999999988889999999999999999998 999998877655544
Q ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 017994 268 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 313 (362)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 313 (362)
.+. .....+.+..++..+.+++.+||+.+|.+||++.+|++.|.+
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 443 344556677889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=324.90 Aligned_cols=242 Identities=23% Similarity=0.335 Sum_probs=206.6
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCeEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~ 132 (362)
+|.+.+.||+|+||.||+|.+. ++.||||++....... ......+..|..++..+ +||+|+++++++...+..+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE
Confidence 4788999999999999999987 5689999987642211 11124556678888777 5899999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-C
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-C 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-~ 211 (362)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..... .
T Consensus 78 lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999999997765 588999999999999999999999999999999999999999999999999864332 2
Q ss_pred CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+... ...++..++.++.+++.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~ 233 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAICK 233 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCcCCHHHHHHHH
Confidence 2334567899999999999999999999999999999999999999998887776666543 34566788999999999
Q ss_pred HhcccCCCCCCCH
Q 017994 292 RCWSSSPDRRPHF 304 (362)
Q Consensus 292 ~~l~~~p~~Rps~ 304 (362)
+||+.+|.+|++.
T Consensus 234 ~~l~~~p~~R~~~ 246 (323)
T cd05616 234 GLMTKHPGKRLGC 246 (323)
T ss_pred HHcccCHHhcCCC
Confidence 9999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=330.14 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=212.2
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
.....+|++.+.||+|+||.||++.+. ++.||+|++....... ......+.+|+.+++.++||||+++++.+..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK---RSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 445678999999999999999999986 6789999986522111 11135577899999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
...++||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999999999764 4789999999999999999999999999999999999999999999999998765
Q ss_pred ccCC--CCCcccccccccChhhhhcCC----CCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC--
Q 017994 209 SQCG--SAKGFTGTYRWMAPEMIKEKR----HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP-- 280 (362)
Q Consensus 209 ~~~~--~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 280 (362)
.... ......||+.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+.........+.
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 272 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence 4322 123567999999999987643 78899999999999999999999998887776666655443344443
Q ss_pred CCCHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 017994 281 TCPKAFSYLISRCWSSSPDR--RPHFDQIVSI 310 (362)
Q Consensus 281 ~~~~~l~~li~~~l~~~p~~--Rps~~ell~~ 310 (362)
.++..+.+++.+||..++.+ |+++.++++.
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 56889999999999865543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=312.89 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=216.7
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||.|++|.||++.+. ++.||+|.+........... ..+.+.+|+.++++++||||+++++++..+...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKK-EVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHH-HHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 46889999999999999999875 68999999876543322111 1356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+++||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 9999999999999998765 58889999999999999999999999999999999999999999999999986543221
Q ss_pred CC----CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 213 SA----KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 213 ~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
.. ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....................+..++..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 11 23457789999999998889999999999999999999999998877666655555555566677888999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 017994 289 LISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 289 li~~~l~~~p~~Rps~~ell~~ 310 (362)
++.+||..+|.+||++.++++.
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhC
Confidence 9999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=317.63 Aligned_cols=254 Identities=30% Similarity=0.554 Sum_probs=215.9
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
...+|.+.+.||+|+||.||+|.+. +..||||++....... ..+.+.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~ 77 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND-----ARKDFEREAELLTNFQHENIVKFYGVC 77 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHH-----HHHHHHHHHHHHHhcCCCCchheeeEE
Confidence 3467889999999999999999864 3579999987654331 146788999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCC------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEP------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 193 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~ 193 (362)
......+++|||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+||+++.
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 999999999999999999999976431 34788899999999999999999999999999999999999
Q ss_pred CCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 017994 194 DMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAV 269 (362)
Q Consensus 194 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~ 269 (362)
++.++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 9999999999986432211 1223345678999999999999999999999999999998 99999887777666555
Q ss_pred HhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 270 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 270 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
. .......+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus 238 ~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 4 33344556678999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=325.45 Aligned_cols=243 Identities=20% Similarity=0.309 Sum_probs=205.4
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCeEEEEEec
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
+.||+|+||.||+|.+. ++.||||++....... ......+..|..++..+ +||||+++++++...+..++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ---DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh---hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 36899999999999986 5789999987532111 11134566788888865 799999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-CCCCCc
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKG 216 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 216 (362)
+++++|..++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..... ......
T Consensus 78 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 78 VNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence 99999999997665 588999999999999999999999999999999999999999999999999864322 222345
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 296 (362)
..|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+... ....+..++.++.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVWLSKEAVSILKAFMTK 233 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhcc
Confidence 56899999999999889999999999999999999999999998887776666543 3445667889999999999999
Q ss_pred CCCCCC-------CHHHHHHH
Q 017994 297 SPDRRP-------HFDQIVSI 310 (362)
Q Consensus 297 ~p~~Rp-------s~~ell~~ 310 (362)
||.+|| ++.++++.
T Consensus 234 dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcC
Confidence 999999 77777753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=326.64 Aligned_cols=247 Identities=21% Similarity=0.331 Sum_probs=198.5
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC-----
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP----- 128 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~----- 128 (362)
+|.+.+.||+|+||.||+|.+. ++.||||++........ ....+.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 76 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS----DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 76 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccch----hHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCC
Confidence 5889999999999999999986 68999999875322211 124678899999999999999999987543
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
...|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 77 ~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 77 KDIYVVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred ceEEEEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 3589999999 569999987665 5899999999999999999999999999999999999999999999999998753
Q ss_pred ccCCC----CCcccccccccChhhhhc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------
Q 017994 209 SQCGS----AKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK---------- 272 (362)
Q Consensus 209 ~~~~~----~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~---------- 272 (362)
..... .....+++.|+|||++.+ ..++.++||||||+++|+|++|.+||.+.+.......+...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 22111 134568999999999876 57899999999999999999999999876543322111100
Q ss_pred ----------------CCCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 273 ----------------NARPP---VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 273 ----------------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..... ..+.+++.+.+++.+||+.||++||++.++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000 11346778999999999999999999999996
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=312.79 Aligned_cols=250 Identities=30% Similarity=0.612 Sum_probs=213.4
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
+..+|.+.+.||+|+||.||++.+. +..+|+|++...... ...+.+|+.+++.++||||+++++++...+..
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI 74 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC-------HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence 3467889999999999999999886 457999998654332 24677899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred EEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 999999999999999986543 6899999999999999999999999999999999999999999999999988654322
Q ss_pred CC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 212 GS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 212 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+. .......+..++..+.+
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 232 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYT 232 (256)
T ss_pred cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHH
Confidence 11 112223457999999998889999999999999999999 899998877766655543 34455667778999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 017994 289 LISRCWSSSPDRRPHFDQIVSIL 311 (362)
Q Consensus 289 li~~~l~~~p~~Rps~~ell~~L 311 (362)
++.+||..+|++||++.++++.|
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=317.37 Aligned_cols=263 Identities=27% Similarity=0.539 Sum_probs=222.0
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEECC-------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCce
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~i 118 (362)
...|.++.++|.+.+.||+|+||.||++.+.+ ..+|+|.+........ ...+.+|+.++.++ +||||
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~~i 78 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD-----LSDLVSEMEMMKMIGKHKNI 78 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHH-----HHHHHHHHHHHHhhcCCCCe
Confidence 45678888999999999999999999998752 5799999876433221 34578899999999 79999
Q ss_pred eeeeEEEEeCCeEEEEEecCCCCCHHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 017994 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQ--------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 184 (362)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dl 184 (362)
+++++++..++..+++|||+++++|.+++... ....+++..++.++.|++.||.|||++||+||||
T Consensus 79 ~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dl 158 (293)
T cd05053 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDL 158 (293)
T ss_pred eeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 99999999999999999999999999999753 2235888999999999999999999999999999
Q ss_pred CCCcEEEcCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCC
Q 017994 185 KSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 260 (362)
Q Consensus 185 k~~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~ 260 (362)
||+||+++.++.++|+|||++........ .....++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 159 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred ceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 99999999999999999999875443221 112234567999999988889999999999999999998 99999887
Q ss_pred CHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 017994 261 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
...+....+. .......+...+..+.+|+.+||..+|++|||+.++++.|+++.
T Consensus 239 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 239 PVEELFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 7766554443 34455667778899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=325.60 Aligned_cols=237 Identities=22% Similarity=0.326 Sum_probs=202.0
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCeEEEEEec
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
+.||+|+||.||+|.++ ++.||||++...... .......+..|+.++..+ +||||+++++++...+.+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL---QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh---hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 36899999999999986 678999998753211 111134566788888776 799999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-CCCCCc
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKG 216 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 216 (362)
+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... ......
T Consensus 78 ~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 78 VNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence 99999999998765 589999999999999999999999999999999999999999999999999864322 223345
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 296 (362)
..|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+.. .....+..++.++.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVVYPTWLSQDAVDILKAFMTK 233 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHccc
Confidence 6789999999999988899999999999999999999999998888776666543 33455677899999999999999
Q ss_pred CCCCCCCH
Q 017994 297 SPDRRPHF 304 (362)
Q Consensus 297 ~p~~Rps~ 304 (362)
||.+||++
T Consensus 234 dP~~R~~~ 241 (320)
T cd05590 234 NPTMRLGS 241 (320)
T ss_pred CHHHCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=311.20 Aligned_cols=256 Identities=30% Similarity=0.586 Sum_probs=217.9
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
|++..++|.+.+.||+|+||.||++.+. +..+|+|.+...... ...+.+|+.++++++|+||+++++.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-------VEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhH-------HHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 6677889999999999999999999876 567999988753221 3567889999999999999999999887
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
...+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence 77899999999999999998765556888999999999999999999999999999999999999999999999988654
Q ss_pred ccCCC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 209 SQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 209 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
..... .....++..|+|||++....++.++|+||||+++|++++ |..||...+.......+. .....+.+...+.+
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 231 (260)
T cd05073 153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEE 231 (260)
T ss_pred cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHH
Confidence 32211 122345577999999988889999999999999999999 999999877665554443 34444556778899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 232 ~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 232 LYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=323.57 Aligned_cols=242 Identities=27% Similarity=0.406 Sum_probs=202.5
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHc-CCCCceeeeeEEEEeCCeEEEEEec
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR-LNHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~-l~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
+.||+|+||.||+|.+. ++.||||++........ ...+.+..|..++.. .+||||+++++++...+..++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED---DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 36999999999999986 56799999876321110 012334456666664 4899999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-CCCCCc
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKG 216 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 216 (362)
++|++|..++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ......
T Consensus 78 ~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 78 LNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence 99999999998765 589999999999999999999999999999999999999999999999999875332 223345
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 296 (362)
..|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+. ...+.++..++.++.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFER 233 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccC
Confidence 678999999999998889999999999999999999999999888776666553 345566778899999999999999
Q ss_pred CCCCCCCHH-HHHH
Q 017994 297 SPDRRPHFD-QIVS 309 (362)
Q Consensus 297 ~p~~Rps~~-ell~ 309 (362)
||.+||++. ++++
T Consensus 234 ~P~~R~~~~~~l~~ 247 (316)
T cd05592 234 DPTKRLGVDGDIRQ 247 (316)
T ss_pred CHHHcCCChHHHHc
Confidence 999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=328.40 Aligned_cols=250 Identities=20% Similarity=0.277 Sum_probs=211.1
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
.+|.+.+.||+|+||.||++.+. ++.||||++...... .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL---AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEE
Confidence 36899999999999999999986 778999999764221 1122466788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred EEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999999998763 268999999999999999999999999999999999999999999999999987544322
Q ss_pred C--CCcccccccccChhhhh------cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCC
Q 017994 213 S--AKGFTGTYRWMAPEMIK------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTC 282 (362)
Q Consensus 213 ~--~~~~~~~~~~~aPE~~~------~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 282 (362)
. .....+++.|+|||++. ...++.++||||||+++|+|++|..||...........+........ ....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence 2 22346899999999986 45678999999999999999999999998877766666554333222 23467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+..+.+|+.+||. +|.+||++.++++
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 8999999999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=311.21 Aligned_cols=249 Identities=27% Similarity=0.443 Sum_probs=215.1
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|++.+.||.|+||.||++.+. +..+|+|.+........ .+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA-----VEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHH-----HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 4788999999999999999986 67899999875433221 3567789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~- 212 (362)
+|||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999999999976555568999999999999999999999999999999999999999999999999987544322
Q ss_pred CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 292 (362)
......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.. ....+.+..++..+.+++.+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ-GSYKPLPSHYSYELRSLIKQ 234 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc-CCCCCCCcccCHHHHHHHHH
Confidence 22345688899999999988899999999999999999999999998777666555443 34445667788999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 017994 293 CWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 293 ~l~~~p~~Rps~~ell~~ 310 (362)
||+.||++||++.+++..
T Consensus 235 ~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 235 MFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhCCcccCCCHHHHhhc
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=319.83 Aligned_cols=264 Identities=28% Similarity=0.548 Sum_probs=220.7
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEECC---------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCc
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ---------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPH 117 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~ 117 (362)
..|.+..++|.+++.||+|+||.||++.+.+ ..+|+|.+........ ...+.+|+.+++.+ +|||
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~e~~~l~~l~~h~~ 85 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD-----LSDLISEMEMMKMIGKHKN 85 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHH-----HHHHHHHHHHHHHhcCCCC
Confidence 4567777899999999999999999998642 4699999876432221 35677899999999 7999
Q ss_pred eeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 017994 118 IITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRD 183 (362)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~d 183 (362)
|+++++++...+..++||||+++++|.+++..... ..+++.++..++.|++.||.|||++|++|+|
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d 165 (307)
T cd05098 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRD 165 (307)
T ss_pred EeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 99999999999999999999999999999976432 2478899999999999999999999999999
Q ss_pred CCCCcEEEcCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCC
Q 017994 184 LKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 259 (362)
Q Consensus 184 lk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~ 259 (362)
|||+||+++.++.++|+|||.+........ .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||..
T Consensus 166 lkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred ccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 999999999999999999999865432211 112234568999999998889999999999999999998 8999987
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 260 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
....+....+ ........+..++.++.+++.+||..+|++||++.++++.|+.+.+.
T Consensus 246 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 246 VPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred CCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 7765544443 34445566778899999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=312.62 Aligned_cols=252 Identities=29% Similarity=0.599 Sum_probs=215.8
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
|-....+|.+.+.||+|+||.||++...++.||+|++..... ...+.+|+.+++.++|||++++++++..+.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~--------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT--------AQAFLEETAVMTKLHHKNLVRLLGVILHNG 72 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcch--------HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC
Confidence 445567899999999999999999998899999999865422 256788999999999999999999987654
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.+++|||+.+++|.+++.......+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....
T Consensus 73 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 73 -LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred -cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecc
Confidence 6899999999999999987665568999999999999999999999999999999999999999999999999886543
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
.. ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+. .......+..++..+.+
T Consensus 152 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 228 (254)
T cd05083 152 MG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYV 228 (254)
T ss_pred cc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCCHHHHH
Confidence 21 122334567999999988889999999999999999998 999999888766555443 33444556778899999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHh
Q 017994 289 LISRCWSSSPDRRPHFDQIVSILEG 313 (362)
Q Consensus 289 li~~~l~~~p~~Rps~~ell~~L~~ 313 (362)
++.+||+.+|++||++.++++.|+.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHcc
Confidence 9999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=318.88 Aligned_cols=268 Identities=28% Similarity=0.558 Sum_probs=223.4
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEEC---------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCC
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHP 116 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp 116 (362)
...|.+...+|.+++.||+|+||.||++.+. ...+|+|.+........ ...+.+|+.+++++ +||
T Consensus 4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~ 78 (314)
T cd05099 4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD-----LADLISEMELMKLIGKHK 78 (314)
T ss_pred cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHH-----HHHHHHHHHHHHhccCCC
Confidence 4567777889999999999999999999752 34689999875433221 35678899999999 699
Q ss_pred ceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 017994 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHR 182 (362)
Q Consensus 117 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 182 (362)
||+++++++......+++|||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|+
T Consensus 79 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 158 (314)
T cd05099 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHR 158 (314)
T ss_pred CeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 999999999999999999999999999999976431 247888999999999999999999999999
Q ss_pred CCCCCcEEEcCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCC
Q 017994 183 DLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFD 258 (362)
Q Consensus 183 dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~ 258 (362)
||||+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.
T Consensus 159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 238 (314)
T cd05099 159 DLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238 (314)
T ss_pred cccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999875433211 112234467999999988889999999999999999999 899998
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccC
Q 017994 259 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 320 (362)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~ 320 (362)
.....+....+. .......+..++.++.+++.+||..+|.+||++.++++.|+.+......
T Consensus 239 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 239 GIPVEELFKLLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred CCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 887766555543 3344456678889999999999999999999999999999988765443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=323.62 Aligned_cols=249 Identities=23% Similarity=0.410 Sum_probs=206.0
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
..++|++.+.||.|+||.||++.+. +..+|+|++....... ....+.+|+++++.++||||+++++++..++.
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA-----IRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 77 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHH-----HHHHHHHHHHHHHHCCCCcccceeEEEEECCE
Confidence 3478999999999999999999997 6789999887643221 24668899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999999999998755 588999999999999999999985 79999999999999999999999999986543
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHH--------------------
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV-------------------- 269 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~-------------------- 269 (362)
.. ......++..|+|||++.+..++.++|+||||+++|+|++|..||............
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 156 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred hh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 32 233456899999999999888999999999999999999999999765443221110
Q ss_pred -----------------------HhcCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 270 -----------------------CQKNARPPVP-PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 270 -----------------------~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
......+..+ ...+.++.+|+.+||+.||++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0001111111 235678999999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=317.85 Aligned_cols=245 Identities=20% Similarity=0.292 Sum_probs=201.0
Q ss_pred ecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCCC
Q 017994 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140 (362)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 140 (362)
||+|+||.||++..+ ++.||+|.+........ .....+..|+.++++++||||+++++.+..+...++||||++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK---SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc---hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence 699999999999886 78999999865322111 1124456699999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCCCccccc
Q 017994 141 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT 220 (362)
Q Consensus 141 ~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 220 (362)
++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.............++
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCC
Confidence 99999987766556899999999999999999999999999999999999999999999999998765443333455789
Q ss_pred ccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 017994 221 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE----QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296 (362)
Q Consensus 221 ~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 296 (362)
..|+|||++.+..++.++|+||||+++|+|++|..||...... +........ ........+++++.+++.+||+.
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-EVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-ccccccccCCHHHHHHHHHHhcc
Confidence 9999999999888999999999999999999999999764332 222222111 11122346789999999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 017994 297 SPDRRPHFDQIVSIL 311 (362)
Q Consensus 297 ~p~~Rps~~ell~~L 311 (362)
||.+||++.|+++.+
T Consensus 237 ~P~~R~~~~~~~~~~ 251 (277)
T cd05607 237 KPEDRLGSREKNDDP 251 (277)
T ss_pred CHhhCCCCccchhhh
Confidence 999999998776443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=319.01 Aligned_cols=259 Identities=29% Similarity=0.513 Sum_probs=213.3
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--Ce--eEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QR--DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKK 127 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~ 127 (362)
..++|.+.+.||+|+||.||+|.+. +. .+++|.+...... .....+.+|+.++.++ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-----DDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH-----HHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 3568999999999999999999875 33 4677776542221 1236778899999999 89999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 193 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~ 193 (362)
++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+||+++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 999999999999999999997543 124788999999999999999999999999999999999999
Q ss_pred CCceEEeeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 017994 194 DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK 272 (362)
Q Consensus 194 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~ 272 (362)
++.++|+|||++..............+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..... ..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~ 238 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQ 238 (303)
T ss_pred CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH-hc
Confidence 99999999999864322222222334667999999988889999999999999999998 99999887766554443 23
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 273 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 273 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
......+...+..+.+|+.+||+.+|++||++.+++..|..+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 334445566789999999999999999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=316.02 Aligned_cols=258 Identities=30% Similarity=0.547 Sum_probs=217.9
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
+..+|.+.+.||+|+||.||++... +..+|+|.+...... ....+.+|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN------ARKDFHREAELLTNLQHEHIVKFYGVC 76 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHH------HHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 3467899999999999999999852 346899988754322 135688999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEP-----------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 194 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~ 194 (362)
...+..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 77 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred ecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 999999999999999999999975431 248999999999999999999999999999999999999999
Q ss_pred CceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 017994 195 MCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVC 270 (362)
Q Consensus 195 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~ 270 (362)
+.++|+|||++....... ......++..|+|||++.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999987543221 1123335678999999998889999999999999999998 999998888777666654
Q ss_pred hcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 271 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 271 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
.. .....+..++.++.+|+.+||+.+|.+||++.++++.|+.+...
T Consensus 237 ~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 237 QG-RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred cC-CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 43 33445567889999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=321.01 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=200.1
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
..+|.+.+.||.|+||.||+|.+. ++.||||++........ ...+.+|+.+++.++||||+++++++..+...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-----PFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc-----chhHHHHHHHHhhCCCCCcCeEEEEEecCCeE
Confidence 367999999999999999999986 67899999876432221 23566899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+. ++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred EEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 99999994 68888887654 35889999999999999999999999999999999999999999999999998643322
Q ss_pred -CCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCC------------
Q 017994 212 -GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQKNARP------------ 276 (362)
Q Consensus 212 -~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~-~~~~~~~~~~~~------------ 276 (362)
.......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+..... ....+......+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 22334567899999999865 457889999999999999999999998754322 222211100000
Q ss_pred ---------CC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ---------PV---------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ---------~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.. ...+++.+.+|+.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 0123467889999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=310.89 Aligned_cols=245 Identities=27% Similarity=0.563 Sum_probs=207.4
Q ss_pred eecccCCeeEEEEEEC----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEec
Q 017994 62 KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 62 ~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
.||+|+||.||+|.+. +..+|+|++........ ..+.+.+|+.+++.++||||+++++++. .+..++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPA----LKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHH----HHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEec
Confidence 5899999999999763 57899999876543322 2467888999999999999999999875 4567899999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC----
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---- 213 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 213 (362)
+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||.||+++.++.++|+|||++........
T Consensus 77 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 77 AELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999999997654 588999999999999999999999999999999999999999999999999875433221
Q ss_pred CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 017994 214 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 292 (362)
.....++..|+|||.+....++.++|+||||+++|||++ |..||...........+. ....++.+..+++++.++|.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKL 233 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHH
Confidence 112233578999999988889999999999999999998 999999877766555543 444566778899999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 017994 293 CWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 293 ~l~~~p~~Rps~~ell~~L~~~ 314 (362)
||+.||++||++.+|.+.|+.+
T Consensus 234 ~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 234 CWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=321.18 Aligned_cols=255 Identities=26% Similarity=0.543 Sum_probs=214.1
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--Ce----eEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
..+|++.+.||+|+||.||+|.+. ++ .||||++....... ..+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-----ANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 467999999999999999999874 33 48999987533221 13567889999999999999999999876
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
. ..++++||+++|+|.+++..... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 5 56799999999999999987542 588899999999999999999999999999999999999999999999999976
Q ss_pred cccCCCC---CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 017994 208 ESQCGSA---KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283 (362)
Q Consensus 208 ~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (362)
....... .....+..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+.. .+.......+.+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICT 237 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCCCCCCC
Confidence 5432221 22234668999999999999999999999999999998 99999887765543 4444555566677888
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 284 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 284 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
..+.+++.+||..+|++||++.+++..+..+..
T Consensus 238 ~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 238 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=317.30 Aligned_cols=256 Identities=26% Similarity=0.504 Sum_probs=216.0
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
++.++|.+.+.||.|+||.||+|.+. +..||||++....... ....+.+|+.++..++||||++++++
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP-----LREEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHH-----HHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 45677899999999999999999874 3679999987643321 24668889999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 190 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil 190 (362)
+......++++||+.+++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+
T Consensus 77 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil 156 (283)
T cd05091 77 VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156 (283)
T ss_pred EcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheE
Confidence 999999999999999999999986321 124788889999999999999999999999999999999
Q ss_pred EcCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHH
Q 017994 191 LGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAA 266 (362)
Q Consensus 191 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~ 266 (362)
++.++.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+....+..
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999998875432211 123345678999999988889999999999999999998 89999888777666
Q ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 017994 267 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 313 (362)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 313 (362)
..+.. ....+.+..++..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus 237 ~~i~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRN-RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHc-CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 55543 33445677899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=317.44 Aligned_cols=259 Identities=31% Similarity=0.526 Sum_probs=215.5
Q ss_pred cCeeeeeeecccCCeeEEEEEECC----eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCC
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYKQ----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPP 129 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 129 (362)
++|++.+.||.|+||.||+|.+++ ..+++|.+....... ..+.+.+|+.++.++ +||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN-----DHRDFAGELEVLCKLGHHPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHH-----HHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence 578999999999999999998863 247888876432221 135678899999999 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM 195 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~ 195 (362)
..++++||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++.++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence 99999999999999999975421 2478899999999999999999999999999999999999999
Q ss_pred ceEEeeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 017994 196 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 274 (362)
Q Consensus 196 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~ 274 (362)
.+||+|||++..............+..|+|||++.+..++.++||||||+++|+|++ |..||......+....+.. ..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-~~ 235 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GY 235 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CC
Confidence 999999998864322212222233557999999988889999999999999999998 9999998887766555433 34
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 275 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 275 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
....+..++..+.+|+.+||+.+|.+||++.++++.|..+....+
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 455667789999999999999999999999999999988876544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=337.58 Aligned_cols=254 Identities=24% Similarity=0.411 Sum_probs=215.1
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
....+|.+.+.||+|+||.||++.+. ++.||||++........ ....+.+|+.++..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~----~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEA----DKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHH----HHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34579999999999999999999875 78999999976543322 1356778999999999999999988775432
Q ss_pred --------eEEEEEecCCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEE
Q 017994 130 --------VFCIITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 199 (362)
Q Consensus 130 --------~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl 199 (362)
.+++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence 4789999999999999997532 235889999999999999999999999999999999999999999999
Q ss_pred eeeccccccccC---CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q 017994 200 ADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 276 (362)
Q Consensus 200 ~Dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 276 (362)
+|||++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.. ....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~~~ 263 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GRYD 263 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCC
Confidence 999998754322 223456789999999999999999999999999999999999999998887766665543 3344
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 277 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 277 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
+.+..+++.+.+++.+||+.||.+||++.++++.
T Consensus 264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 5678899999999999999999999999999864
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=325.18 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=204.9
Q ss_pred CeeeeeeecccCCeeEEEEEE-----CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCC
Q 017994 56 QLFIGCKFASGRHSRIYRGIY-----KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPP 129 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 129 (362)
+|++.+.||+|+||.||++.. .++.||+|++....... .....+.+..|+.++..+ +||||+++++++..++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ--KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh--hhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence 488999999999999999876 36789999987532111 111235677899999999 5999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.+++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999999998755 58999999999999999999999999999999999999999999999999987543
Q ss_pred cC--CCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCC
Q 017994 210 QC--GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMT----PEQAAFAVCQKNARPPVPPTC 282 (362)
Q Consensus 210 ~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~ 282 (362)
.. .......|++.|+|||++.+. .++.++||||||+++|+|++|..||.... .......+ ....+..+..+
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 234 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFI 234 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCC
Confidence 22 222345789999999999765 47899999999999999999999996432 22222222 23445667788
Q ss_pred CHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017994 283 PKAFSYLISRCWSSSPDRRP-----HFDQIVS 309 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 309 (362)
++.+.+++.+||+.||++|| +++++++
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 99999999999999999999 6777775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=324.69 Aligned_cols=243 Identities=22% Similarity=0.387 Sum_probs=200.9
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCeEEEEEec
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
+.||+|+||.||++.+. ++.||||++....... ....+.+..|+.++..+ +||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~---~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND---DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 36899999999999986 6789999997632211 11235677899999988 799999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc-ccCCCCCc
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE-SQCGSAKG 216 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~-~~~~~~~~ 216 (362)
++|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++... ........
T Consensus 78 ~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 78 VSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence 99999999987654 6999999999999999999999999999999999999999999999999998642 22233345
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--------PEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
..|++.|+|||++.+..++.++|+||||+++|+|++|..||.... ......... .......|..++..+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~ 234 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-LEKQIRIPRSLSVKASS 234 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH-HcCCCCCCCCCCHHHHH
Confidence 678999999999999999999999999999999999999996321 111222222 22334567788999999
Q ss_pred HHHHhcccCCCCCCC------HHHHHH
Q 017994 289 LISRCWSSSPDRRPH------FDQIVS 309 (362)
Q Consensus 289 li~~~l~~~p~~Rps------~~ell~ 309 (362)
+|.+||+.||.+|++ +.++++
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 235 VLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 999999999999997 566664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=315.84 Aligned_cols=257 Identities=30% Similarity=0.551 Sum_probs=217.3
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
...+|.+.+.||+|+||.||++.+. +..+++|.+....... .+.+.+|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA------RKDFQREAELLTNLQHEHIVKFYGVC 76 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHH------HHHHHHHHHHHhcCCCCCcceEEEEE
Confidence 3467899999999999999999853 3458889886543321 35678899999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 191 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~ 191 (362)
...+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++|++||||||+||++
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 77 GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156 (291)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence 999999999999999999999976432 247899999999999999999999999999999999999
Q ss_pred cCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHH
Q 017994 192 GEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAF 267 (362)
Q Consensus 192 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~ 267 (362)
+.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+...
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999986543321 1223446788999999998899999999999999999999 999998887766555
Q ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 268 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
.+. .......+..+|..+.+++.+||+.+|++||++.+++++|+.+..
T Consensus 237 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 CIT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHh-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 443 334444566788999999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=315.53 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=208.9
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|+..+.||+|+||.||++.+. ++.||||.+........ .....+.+|+.++++++|++|+.+++.+...+..++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~l 77 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMALNEKQILEKVNSRFVVSLAYAYETKDALCL 77 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccch---HHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEE
Confidence 3677889999999999999986 67899999875432211 113456789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 213 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (362)
||||++|++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999999999766555699999999999999999999999999999999999999999999999999875544333
Q ss_pred CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 214 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE---QAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
.....|+..|+|||++.+..++.++|+||||+++|+|++|..||...... ....... .......+..+++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHH
Confidence 34457899999999999888999999999999999999999999865432 1122211 1222345667889999999
Q ss_pred HHhcccCCCCCCC-----HHHHHH
Q 017994 291 SRCWSSSPDRRPH-----FDQIVS 309 (362)
Q Consensus 291 ~~~l~~~p~~Rps-----~~ell~ 309 (362)
.+||+.||.+||+ +.++++
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHc
Confidence 9999999999999 788887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=312.06 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=211.2
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||.|+||.||+|.+. ++.||||.+........ .....+.+|+.+++.++||||+++++++...+..+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDA---KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCH---HHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEE
Confidence 57999999999999999999885 78999998765322111 12356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 133 IITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
+++||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999999886422 23578899999999999999999999999999999999999999999999998875433
Q ss_pred CC-CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCCCCCCCCCCHHHH
Q 017994 211 CG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP--EQAAFAVCQKNARPPVPPTCPKAFS 287 (362)
Q Consensus 211 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~ 287 (362)
.. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+......+.....++..+.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 22 12244678899999999888899999999999999999999999965432 2333332222222222345778899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 288 YLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
+++.+||+.+|++||++.++++.++.+
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=325.84 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=203.2
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
...++|+..+.||.|+||.||+|.+. ++.||||++....... ....+.+|+.+++.++|+||+++++++...+
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 145 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT-----VRRQICREIEILRDVNHPNVVKCHDMFDHNG 145 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHH-----HHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence 34678889999999999999999986 6899999986543221 2467889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.+++||||+++++|.+.. ..++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 146 ~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred eEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 999999999999986532 35677888999999999999999999999999999999999999999999987544
Q ss_pred cCC-CCCcccccccccChhhhhc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHH--HHHHhcCCCCCCCCC
Q 017994 210 QCG-SAKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA--FAVCQKNARPPVPPT 281 (362)
Q Consensus 210 ~~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 281 (362)
... ......|+..|+|||++.. ...+.++||||||+++|+|++|+.||......+.. ............+..
T Consensus 220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (353)
T PLN00034 220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT 299 (353)
T ss_pred cccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCc
Confidence 322 2234578999999998743 23467899999999999999999999743322211 111122334455677
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
++.++.+||.+||+.||++||++.|+++.
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 88999999999999999999999999974
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=308.35 Aligned_cols=250 Identities=28% Similarity=0.430 Sum_probs=215.0
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|.+.+.||+|++|.||++.+. ++.|++|.+........ ....+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR----EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNI 76 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHH----HHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEE
Confidence 4788899999999999999985 68899999876433221 24678889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~- 212 (362)
||||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999999987644578999999999999999999999999999999999999999999999999887544322
Q ss_pred CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 292 (362)
......+++.|+|||++.+..++.++|+||||+++++|++|..||...+.......+.. ...+..+..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR-GVFPPVSQMYSQQLAQLIDQ 235 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHH
Confidence 22345678899999999988899999999999999999999999988876665555433 34455566788999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 017994 293 CWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 293 ~l~~~p~~Rps~~ell~~ 310 (362)
||+.+|++||++.++++.
T Consensus 236 ~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 236 CLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HccCCcccCcCHHHHhhC
Confidence 999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=323.18 Aligned_cols=242 Identities=21% Similarity=0.338 Sum_probs=205.3
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCeEEEEEec
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
+.||+|+||.||++.+. ++.||||++....... ......+..|+.++..+ +||||+++++++...+.+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ---DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh---hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 36999999999999986 5789999987532111 11134566788888877 799999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-CCCCCc
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKG 216 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 216 (362)
++|++|..++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..... ......
T Consensus 78 ~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 78 VNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence 99999999998765 589999999999999999999999999999999999999999999999998864322 222334
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 296 (362)
..+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.. .....+..++..+.+||.+||+.
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE--DEVRYPRWLSKEAKSILKSFLTK 233 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--CCCCCCCcCCHHHHHHHHHHccC
Confidence 5689999999999999999999999999999999999999998877666555543 33456677899999999999999
Q ss_pred CCCCCCCH-----HHHHH
Q 017994 297 SPDRRPHF-----DQIVS 309 (362)
Q Consensus 297 ~p~~Rps~-----~ell~ 309 (362)
||.+||++ .++++
T Consensus 234 dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CHHHcCCCCCCCHHHHhc
Confidence 99999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=323.58 Aligned_cols=238 Identities=24% Similarity=0.364 Sum_probs=199.9
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHH-HHHcCCCCceeeeeEEEEeCCeEEEEEec
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVA-LLFRLNHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
+.||+|+||+||+|.+. ++.||||++........ .. ...+..|.. +++.++||||+++++.+...+..++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~-~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK--KE-QKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh--hH-HHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence 36999999999999986 78899999875322111 11 233444444 56789999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-CCCCCc
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKG 216 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 216 (362)
+++++|..++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... ......
T Consensus 78 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 78 VNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence 99999999998754 589999999999999999999999999999999999999999999999999865322 223345
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 296 (362)
..|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+... ....++.+++.+.++|.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~ 233 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK--PLRLKPNISVSARHLLEGLLQK 233 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhc
Confidence 67899999999999989999999999999999999999999988777666655433 3445667899999999999999
Q ss_pred CCCCCCCHH
Q 017994 297 SPDRRPHFD 305 (362)
Q Consensus 297 ~p~~Rps~~ 305 (362)
||.+||++.
T Consensus 234 ~p~~R~~~~ 242 (323)
T cd05575 234 DRTKRLGAK 242 (323)
T ss_pred CHHhCCCCC
Confidence 999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=327.74 Aligned_cols=257 Identities=22% Similarity=0.309 Sum_probs=212.4
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
.+.....+|.+.+.||+|+||.||++.++ ++.||+|++....... ......+.+|+.+++.++||||+++++.+.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~---~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK---RSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34556789999999999999999999986 6789999986522111 112355778999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
.+...++||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999999999764 48889999999999999999999999999999999999999999999999987
Q ss_pred ccccCC--CCCcccccccccChhhhhcCC----CCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--
Q 017994 207 LESQCG--SAKGFTGTYRWMAPEMIKEKR----HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV-- 278 (362)
Q Consensus 207 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 278 (362)
...... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||...+.......+........+
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence 544322 223567999999999987543 788999999999999999999999988877666666543333333
Q ss_pred CCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 017994 279 PPTCPKAFSYLISRCWSSSPDR--RPHFDQIVSIL 311 (362)
Q Consensus 279 ~~~~~~~l~~li~~~l~~~p~~--Rps~~ell~~L 311 (362)
...++..+.++|.+||..++.+ |+++.++++..
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 3468899999999999844433 78899988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=313.67 Aligned_cols=250 Identities=18% Similarity=0.281 Sum_probs=209.2
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEE
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCII 134 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 134 (362)
|+..+.||.|+||+||++.+. ++.||+|++....... ......+.+|+.+++.++|+||+.+.+.+..++..+++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK---RKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh---hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence 677789999999999999986 6789999986543221 11134567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCC
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 214 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 214 (362)
|||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 99999999999987655446999999999999999999999999999999999999999999999999988654433333
Q ss_pred CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCCCHHHHHHHHH
Q 017994 215 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ--KNARPPVPPTCPKAFSYLISR 292 (362)
Q Consensus 215 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~ 292 (362)
....|+..|+|||++.+..++.++|+||||+++|+|++|..||...........+.. .......+..++..+.+|+.+
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence 455789999999999888899999999999999999999999988765443332222 122234566788999999999
Q ss_pred hcccCCCCCCC-----HHHHHH
Q 017994 293 CWSSSPDRRPH-----FDQIVS 309 (362)
Q Consensus 293 ~l~~~p~~Rps-----~~ell~ 309 (362)
||+.||.+||+ +.+++.
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HccCCHhHcCCCcccChHHHHc
Confidence 99999999999 667775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=309.29 Aligned_cols=245 Identities=29% Similarity=0.577 Sum_probs=206.7
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecC
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYL 138 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 138 (362)
+.||+|+||.||+|.+. ++.||+|.+....... ....+.+|+.++++++||||+++++++......++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD-----LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHH-----HHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeec
Confidence 36899999999999885 7889999876543221 2467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCC---C
Q 017994 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA---K 215 (362)
Q Consensus 139 ~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~ 215 (362)
++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......... .
T Consensus 76 ~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 76 QGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred cCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999999997654 25889999999999999999999999999999999999999999999999998653321111 1
Q ss_pred cccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhc
Q 017994 216 GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 294 (362)
Q Consensus 216 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 294 (362)
....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+. .......+..++..+.+++.+||
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 233 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCW 233 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHHHHHHc
Confidence 1123457999999988889999999999999999998 999998877665544433 34455667788999999999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 017994 295 SSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 295 ~~~p~~Rps~~ell~~L~ 312 (362)
+.+|++||++.+++++|+
T Consensus 234 ~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 234 EYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCChhhCcCHHHHHHHHh
Confidence 999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=328.86 Aligned_cols=249 Identities=21% Similarity=0.319 Sum_probs=207.4
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||+|+||.||++.+. ++.||||++...... .......+.+|+.++..++||||+++++.+.+.+.++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 77 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML---EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLY 77 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh---hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 36889999999999999999986 678999998753211 1122466788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||++||+|.+++.+.. .+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999999998765 58999999999999999999999999999999999999999999999999876432110
Q ss_pred ------------------------------------CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCC
Q 017994 213 ------------------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP 256 (362)
Q Consensus 213 ------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p 256 (362)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 01234689999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCC--CCCHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 017994 257 FDNMTPEQAAFAVCQKNARPPVPP--TCPKAFSYLISRCWSSSPDRRPH---FDQIVS 309 (362)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps---~~ell~ 309 (362)
|...++......+........++. .+++.+.++|.+++. +|.+|++ +.++++
T Consensus 236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 236 FCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 998888776666554333333333 468899999999874 9999985 555554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=322.18 Aligned_cols=241 Identities=24% Similarity=0.360 Sum_probs=202.0
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHc-CCCCceeeeeEEEEeCCeEEEEEec
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR-LNHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~-l~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
+.||+|+||.||+|.++ ++.||||++....... ......+..|..++.. ++||||+++++++...+..|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI---DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 46999999999999986 6789999987632110 0012445667777765 4899999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-CCCCCc
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKG 216 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 216 (362)
+.+++|..++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..... ......
T Consensus 78 ~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 78 LNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence 99999999998754 588999999999999999999999999999999999999999999999998864322 122345
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 296 (362)
..|++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.. ..+..+..++.++.++|.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--DTPHYPRWITKESKDILEKLFER 233 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHccC
Confidence 6789999999999999999999999999999999999999998877666555432 34556677899999999999999
Q ss_pred CCCCCCCHH-HHH
Q 017994 297 SPDRRPHFD-QIV 308 (362)
Q Consensus 297 ~p~~Rps~~-ell 308 (362)
||.+||++. +++
T Consensus 234 dP~~R~~~~~~~~ 246 (316)
T cd05620 234 DPTRRLGVVGNIR 246 (316)
T ss_pred CHHHcCCChHHHH
Confidence 999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=316.62 Aligned_cols=264 Identities=27% Similarity=0.533 Sum_probs=221.0
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEEC---------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCc
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPH 117 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~ 117 (362)
..|.....+|.+.+.||+|+||.||++.+. +..||+|.+........ ...+.+|+.+++.+ +|||
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~~ 82 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD-----LSDLVSEMEMMKMIGKHKN 82 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHH-----HHHHHHHHHHHHhhccCCC
Confidence 356777889999999999999999999752 24699999875432221 35678899999999 8999
Q ss_pred eeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 017994 118 IITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRD 183 (362)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~d 183 (362)
|+++++.+......+++|||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|+|
T Consensus 83 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~d 162 (304)
T cd05101 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRD 162 (304)
T ss_pred chheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 99999999999999999999999999999976421 2477888999999999999999999999999
Q ss_pred CCCCcEEEcCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCC
Q 017994 184 LKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 259 (362)
Q Consensus 184 lk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~ 259 (362)
|||+||+++.++.++|+|||.+........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 163 lkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred cccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999875543221 222345678999999988889999999999999999998 8899988
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 260 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
.+..+....+. .......+..++..+.+|+.+||+.+|++||++.++++.|+.+...
T Consensus 243 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 243 IPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 87766655543 3444556677899999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=311.71 Aligned_cols=243 Identities=24% Similarity=0.371 Sum_probs=207.5
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC-----
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP----- 128 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~----- 128 (362)
.|.-.+.+|.|+||.||+|+.. ++.||||.+....... .+|+++|+.++|||||++..+|...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----------NRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----------cHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 4777889999999999999986 5799999988765432 3699999999999999999988543
Q ss_pred CeEEEEEecCCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CceEEeeeccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGIS 205 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~-~~~kl~Dfg~~ 205 (362)
-...+||||++. +|...++.. ....++.-.+.-+.+||+.||.|||+.||+||||||.|+|+|.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 256789999965 999999842 22368888899999999999999999999999999999999976 99999999999
Q ss_pred cccccCCCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------- 277 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------- 277 (362)
...........+..|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+.+..+.+..+......+.
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 988888888888999999999998765 699999999999999999999999999888777666554333221
Q ss_pred --------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 --------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+....+++..+|+.++|..+|.+|.++.|++.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 23456789999999999999999999999985
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=310.10 Aligned_cols=252 Identities=26% Similarity=0.452 Sum_probs=212.9
Q ss_pred CeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCII 134 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 134 (362)
+|.+++.||.|+||.||+|... ++.+|||.+................+.+|+.++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999874 778999998765433322223346688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC---
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC--- 211 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~--- 211 (362)
+||+++++|.+++.+.. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999999998754 5789999999999999999999999999999999999999999999999988653211
Q ss_pred ----CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCCCCCCCHHH
Q 017994 212 ----GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK-NARPPVPPTCPKAF 286 (362)
Q Consensus 212 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 286 (362)
.......++..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+... ...+..+..++..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 1122346788999999999888999999999999999999999999887665544433332 33455677889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.++|.+||+.+|++||++.++++
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhc
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=323.40 Aligned_cols=242 Identities=24% Similarity=0.353 Sum_probs=201.0
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHH-HHHHcCCCCceeeeeEEEEeCCeEEEEEec
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEV-ALLFRLNHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei-~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
+.||+|+||.||++.+. ++.||+|++........ .....+..|. .+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK---KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh---hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeC
Confidence 36999999999999986 56799999875322111 1122333444 456789999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc-cCCCCCc
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-QCGSAKG 216 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~-~~~~~~~ 216 (362)
+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.... .......
T Consensus 78 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 78 INGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence 99999999998754 57888999999999999999999999999999999999999999999999986432 2223345
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 296 (362)
..|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+... ....++.+++.+.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~ 233 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHLLEGLLQK 233 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CcCCCCCCCHHHHHHHHHHccc
Confidence 67899999999999999999999999999999999999999988877665555432 3345667899999999999999
Q ss_pred CCCCCCCHHHHHH
Q 017994 297 SPDRRPHFDQIVS 309 (362)
Q Consensus 297 ~p~~Rps~~ell~ 309 (362)
||.+||++.+.+.
T Consensus 234 ~p~~R~~~~~~~~ 246 (325)
T cd05602 234 DRTKRLGAKDDFM 246 (325)
T ss_pred CHHHCCCCCCCHH
Confidence 9999998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=341.56 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=216.6
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEEC-C-eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeE-
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK-Q-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVA- 123 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~- 123 (362)
..+.+..-++++.+.|.+|||+.||+|.+. + ..||+|++...+... .+.+.+||.+|++|. |+|||.+++
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~------L~~v~~EI~~MK~L~gh~nIV~yids 103 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEA------LNAVKREIDIMKLLSGHKNIVSYIDS 103 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHH------HHHHHHHHHHHHHhcCCCceeeEecc
Confidence 344556677888999999999999999997 3 899999988764332 477889999999996 999999999
Q ss_pred EEEe------CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCC
Q 017994 124 ACKK------PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDM 195 (362)
Q Consensus 124 ~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dlk~~Nil~~~~~ 195 (362)
.... ...++|+||||.||.|-++++.+....|++..+++|+.|+++|+.+||... |||||||-+||||+.+|
T Consensus 104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g 183 (738)
T KOG1989|consen 104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG 183 (738)
T ss_pred ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC
Confidence 3321 236789999999999999999777667999999999999999999999997 99999999999999999
Q ss_pred ceEEeeeccccccccCCCCC----------cccccccccChhhh---hcCCCCCcccchhhhHHHHHHHhCCCCCCCCCH
Q 017994 196 CVKVADFGISCLESQCGSAK----------GFTGTYRWMAPEMI---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP 262 (362)
Q Consensus 196 ~~kl~Dfg~~~~~~~~~~~~----------~~~~~~~~~aPE~~---~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~ 262 (362)
.+||||||.++......... ...-|+.|+|||++ .+...+.|+|||+|||+||.|+....||+....
T Consensus 184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~ 263 (738)
T KOG1989|consen 184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK 263 (738)
T ss_pred CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence 99999999987544433211 11258999999987 466789999999999999999999999987533
Q ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 263 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
.+|+..+...+..+.++..|.+||+.||+.||++||++-|++..+-.+..
T Consensus 264 ----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 264 ----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 24444455555557899999999999999999999999999998877654
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=314.38 Aligned_cols=254 Identities=30% Similarity=0.562 Sum_probs=213.8
Q ss_pred CeeeeeeecccCCeeEEEEEECC-------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 56 QLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
+|++.+.||+|+||.||+|.... ..+++|.+........ ...+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-----LRDLLSEFNLLKQVNHPHVIKLYGACSQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHH-----HHHHHHHHHHHhhCCCCCEeeEEEEEecC
Confidence 47788999999999999998742 4689998876543221 25678899999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQE----------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 186 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~ 186 (362)
+..++++||+.+++|.+++.... ...+++..++.++.|++.||.|||++|++||||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp 155 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence 99999999999999999986531 12478889999999999999999999999999999
Q ss_pred CcEEEcCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCH
Q 017994 187 ENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 262 (362)
Q Consensus 187 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~ 262 (362)
+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999875432211 122345678999999988889999999999999999998 9999988877
Q ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 017994 263 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
....... ........+..++.++.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 236 ~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 236 ERLFNLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHHHHHH-hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 6655443 344455567788999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=310.32 Aligned_cols=255 Identities=33% Similarity=0.591 Sum_probs=215.3
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
+..+|.+.+.||+|+||.||+|.+. +..+|+|.+....... ..+.+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-----QRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHH-----HHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 4567999999999999999999874 2369999987543221 13678889999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
++..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 9999999999999999999987543 578999999999999999999999999999999999999999999999999875
Q ss_pred cccCCCC----CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 017994 208 ESQCGSA----KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 282 (362)
Q Consensus 208 ~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (362)
....... ....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+.. ....+.+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE-GYRLPAPMDC 234 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC-CCcCCCCCCC
Confidence 4432211 11223567999999998889999999999999999887 9999988776665554433 3445556678
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
++.+.+++.+||+.+|.+||++.++++.|+++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 89999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=313.61 Aligned_cols=259 Identities=28% Similarity=0.531 Sum_probs=215.8
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeee
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~ 122 (362)
|+.+..+|.+.+.||+|+||.||+|..+ +..||+|.+........ ...+.+|+.+++.++||||++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~ 75 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE-----RIEFLNEASVMKGFTCHHVVRLL 75 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHH-----HHHHHHHHHHHHhCCCCCeeeEE
Confidence 6778899999999999999999999754 34799998865432211 24577899999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC
Q 017994 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEP--------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 194 (362)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~ 194 (362)
+++......++||||+++|+|.+++..... ..++...+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~ 155 (288)
T cd05061 76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 155 (288)
T ss_pred EEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC
Confidence 999999999999999999999999975321 234567889999999999999999999999999999999999
Q ss_pred CceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 017994 195 MCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVC 270 (362)
Q Consensus 195 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~ 270 (362)
+.++|+|||++........ .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+.
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999874332211 122234678999999998889999999999999999999 899998887766555443
Q ss_pred hcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 271 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 271 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
. ......+..+++.+.+++.+||+.+|++||++.++++.|+..
T Consensus 236 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 236 D-GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred c-CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 3 334455667789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=322.65 Aligned_cols=250 Identities=25% Similarity=0.379 Sum_probs=224.3
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCCe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPPV 130 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~ 130 (362)
...|.+++.||.|.||.||+++.+ ++.+|+|++.+....... ....+.+|+.+|+++. ||||+.+.+.+++...
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~---~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE---DREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc---cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 467999999999999999999987 788999999886543321 2367889999999998 9999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC----CCceEEeeecccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE----DMCVKVADFGISC 206 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~----~~~~kl~Dfg~~~ 206 (362)
.++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.|++||||||+|+|+.. ++.++++|||++.
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999999887 3899999999999999999999999999999999999953 3579999999999
Q ss_pred ccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCCH
Q 017994 207 LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPK 284 (362)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 284 (362)
...........+||+.|+|||++....|+..+|+||+|+++|.|++|.+||.+.+.......+....... +....++.
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 8777667788999999999999999999999999999999999999999999999888888777665533 34466789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+.+++.+|+..||..|+++.++++
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhc
Confidence 9999999999999999999999998
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=307.21 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=207.4
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe-----
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK----- 127 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----- 127 (362)
..|...+.||.|+||.|..+.++ ++.||||++......... .++..+|+.+|+.++|+||+.+.+++..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~----akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQID----AKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHH----HHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 44555789999999999999997 789999999854443322 4677899999999999999999998855
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
-..+|+|+|+| +.+|...++.+. .++++.+..++.|++.||.|+|+.+++|||+||.|++++.+..+||+|||+|+.
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence 35899999999 679999999875 599999999999999999999999999999999999999999999999999987
Q ss_pred ccc---CCCCCcccccccccChhhhh-cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------
Q 017994 208 ESQ---CGSAKGFTGTYRWMAPEMIK-EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------- 276 (362)
Q Consensus 208 ~~~---~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~------- 276 (362)
... ......++.|..|.|||++. ...|+.+.||||+||++.||++|++-|.+.+.-..+..+......+
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 653 23335677899999999875 4579999999999999999999999999876544433332211111
Q ss_pred -----------------C-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 277 -----------------P-----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 277 -----------------~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
. .-+..++...+|+.+||..||.+|+|++|.++.
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1 124567788999999999999999999999863
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=324.12 Aligned_cols=248 Identities=23% Similarity=0.309 Sum_probs=201.1
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC--
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP-- 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-- 129 (362)
..+|.+.+.||+|+||.||++.+. +..||||++........ ....+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT----HAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchh----HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 478999999999999999999886 68899999976533221 1356778999999999999999999986543
Q ss_pred ----eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 130 ----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 130 ----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
..|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||++
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57999999955 67776643 4788999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR---------- 275 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~---------- 275 (362)
.............+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+......
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 7654433445567899999999999999999999999999999999999999876644322221111000
Q ss_pred ----------C--------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 276 ----------P--------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 276 ----------~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
+ ......++.+.+||.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0112245678999999999999999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=310.19 Aligned_cols=255 Identities=32% Similarity=0.570 Sum_probs=214.8
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--C---eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--Q---RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
+.++|.+.+.||+|+||.||+|.+. + ..||||++....... ....+..|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK-----QRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHH-----HHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence 3467899999999999999999885 2 359999987643221 23678899999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
+...++||||+++++|.+++..... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccc
Confidence 9999999999999999999986543 588999999999999999999999999999999999999999999999998865
Q ss_pred cccCCCCCcc------cccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 017994 208 ESQCGSAKGF------TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 280 (362)
Q Consensus 208 ~~~~~~~~~~------~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (362)
.......... ..+..|+|||.+.+..++.++||||||+++||+++ |..||...........+. .....+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~ 234 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPM 234 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcc
Confidence 4332211111 12457999999998889999999999999999887 999998887766655553 334455567
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 281 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
.++..+.+++.+||+.+|++||++.+++..|+++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 7899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=312.64 Aligned_cols=254 Identities=29% Similarity=0.546 Sum_probs=213.8
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
+..+|.+.++||+|+||.||++... +..+|+|.+...... ....+.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES------ARQDFQREAELLTVLQHQHIVRFYGVC 76 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHH------HHHHHHHHHHHHhcCCCCCCceEEEEE
Confidence 4567889999999999999999742 457899987654322 136788999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEP-------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 192 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~ 192 (362)
......+++|||+++++|.+++..... ..+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 77 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred ecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 999999999999999999999976542 2478899999999999999999999999999999999999
Q ss_pred CCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHH
Q 017994 193 EDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 268 (362)
Q Consensus 193 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~ 268 (362)
.++.++|+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......+....
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 999999999999864432211 122334678999999998899999999999999999998 9999988777665555
Q ss_pred HHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 017994 269 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 313 (362)
Q Consensus 269 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 313 (362)
+. .......+..+++.+.+|+.+||+.||.+||++.+|++.|++
T Consensus 237 ~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 IT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HH-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 43 333445567789999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=333.06 Aligned_cols=245 Identities=23% Similarity=0.348 Sum_probs=199.7
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC---
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--- 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--- 128 (362)
..+|.+++.||+|+||.||+|.+. ++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 467999999999999999999985 6789999886532 2234699999999999999999876432
Q ss_pred -----CeEEEEEecCCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-ceEEe
Q 017994 129 -----PVFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVA 200 (362)
Q Consensus 129 -----~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~-~~kl~ 200 (362)
..+++||||++ ++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 135 ~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 25779999996 578777753 2234689999999999999999999999999999999999998664 79999
Q ss_pred eeccccccccCCCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----
Q 017994 201 DFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR---- 275 (362)
Q Consensus 201 Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~---- 275 (362)
|||++.............+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+......
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99999866554444566789999999998664 6899999999999999999999999987765554443321110
Q ss_pred -----------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 -----------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 -----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..++...++++.+||.+||..||.+|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 1123456789999999999999999999999985
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=320.66 Aligned_cols=242 Identities=25% Similarity=0.382 Sum_probs=202.2
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHc-CCCCceeeeeEEEEeCCeEEEEEec
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR-LNHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~-l~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
+.||+|+||.||+|.+. ++.||||++....... ......+..|..++.. ++||||+++++++.+.+.+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM---DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 36999999999999986 5789999987632110 0012345567777775 4899999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-CCCCc
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GSAKG 216 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 216 (362)
+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... .....
T Consensus 78 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 78 LNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence 99999999998754 5888999999999999999999999999999999999999999999999998643221 22345
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 296 (362)
..|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.. ..+..+..++..+.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNPCYPRWLTREAKDILVKLFVR 233 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHhcc
Confidence 5789999999999988999999999999999999999999998887766555433 23455667889999999999999
Q ss_pred CCCCCCCHH-HHHH
Q 017994 297 SPDRRPHFD-QIVS 309 (362)
Q Consensus 297 ~p~~Rps~~-ell~ 309 (362)
||.+||++. ++++
T Consensus 234 ~P~~R~~~~~~l~~ 247 (316)
T cd05619 234 EPERRLGVKGDIRQ 247 (316)
T ss_pred CHhhcCCChHHHHc
Confidence 999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=321.43 Aligned_cols=238 Identities=22% Similarity=0.386 Sum_probs=197.0
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCeEEEEEec
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
+.||+|+||.||++.+. ++.||+|++........ .....+..|+.++.++ +||||+++++++......++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcch---hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 36999999999999986 67899999986432111 1135567888888776 899999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-CCCCCc
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKG 216 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 216 (362)
+++++|..++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ......
T Consensus 78 ~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 78 VNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence 99999999887654 689999999999999999999999999999999999999999999999999864322 223345
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--------PEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
..|++.|+|||++.+..++.++|+||||+++|+|++|..||.... ......... ......+|..++..+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i-~~~~~~~p~~~~~~~~~ 234 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEKQIRIPRSLSVKAAS 234 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-hcCCCCCCCCCCHHHHH
Confidence 678999999999999999999999999999999999999995311 111222222 23344577888999999
Q ss_pred HHHHhcccCCCCCCCH
Q 017994 289 LISRCWSSSPDRRPHF 304 (362)
Q Consensus 289 li~~~l~~~p~~Rps~ 304 (362)
+|.+||+.||.+||++
T Consensus 235 ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 235 VLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHhcCCHHHcCCC
Confidence 9999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=322.53 Aligned_cols=262 Identities=26% Similarity=0.516 Sum_probs=214.7
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeee
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITF 121 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~ 121 (362)
|.+..++|.+.+.||+|+||.||+|.+. ++.||||++........ ...+.+|+.++.++ +||||+++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~ 76 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNVVNL 76 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHH-----HHHHHHHHHHHHhccCCccHhhh
Confidence 6777789999999999999999999752 46899999976433221 35677899999999 68999999
Q ss_pred eEEEEeC-CeEEEEEecCCCCCHHHHHhhcCC------------------------------------------------
Q 017994 122 VAACKKP-PVFCIITEYLAGGSLRKYLHQQEP------------------------------------------------ 152 (362)
Q Consensus 122 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------ 152 (362)
++++... ...+++|||+++|+|.+++.....
T Consensus 77 ~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (343)
T cd05103 77 LGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEK 156 (343)
T ss_pred cceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCC
Confidence 9987654 568899999999999999875321
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC---
Q 017994 153 -----------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG--- 212 (362)
Q Consensus 153 -----------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 212 (362)
..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 236 (343)
T cd05103 157 SLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236 (343)
T ss_pred ccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh
Confidence 136778889999999999999999999999999999999999999999999987542211
Q ss_pred CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....................+...++++.+++.
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 316 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 1122334667999999988889999999999999999997 999998765444444444444555566677889999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 292 RCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
+||+.+|.+||++.+|++.|+.+.+
T Consensus 317 ~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 317 DCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=307.94 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=214.2
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCc-eeeeeEEEEeCC-
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH-IITFVAACKKPP- 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~-iv~~~~~~~~~~- 129 (362)
...|...++||+|+||+||+|+.+ |+.||+|++.....+.. ......+|+.+++.++|+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG----~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG----VPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC----CCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 466888889999999999999986 78999999998765422 2355678999999999999 999999998877
Q ss_pred -----eEEEEEecCCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 130 -----VFCIITEYLAGGSLRKYLHQQEP--YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 130 -----~~~lv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
.+++|+||+ ..+|.+++..... ..++...+..+++||+.||+|||+++|+||||||.||+|+.+|.+||+||
T Consensus 86 ~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeecc
Confidence 899999999 5599999988664 36888899999999999999999999999999999999999999999999
Q ss_pred ccccccccC-CCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---
Q 017994 203 GISCLESQC-GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--- 277 (362)
Q Consensus 203 g~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--- 277 (362)
|+|+...-+ ..-...++|..|.|||++.+. .|+...|+||+||+++||++++.-|++....+.+..+......+.
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 999865533 334566789999999998876 689999999999999999999999999988877777665433331
Q ss_pred -------------C-----C-------CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 278 -------------V-----P-------PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 278 -------------~-----~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
+ + +..+++..+++.+||+.+|.+|.|+...+++
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 0 1122467889999999999999999999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=327.65 Aligned_cols=262 Identities=31% Similarity=0.626 Sum_probs=236.7
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
.+.|+.+..++...++||.|-||.||.|.|+ .-.||||.++...-. ..+|..|..+|+.++|||+|+++|+
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-------veEFLkEAAvMKeikHpNLVqLLGV 331 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLGV 331 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-------HHHHHHHHHHHHhhcCccHHHHhhh
Confidence 4789999999999999999999999999998 468999998775443 4789999999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
|..+..+|||.|||..|+|.+|+++.....++.-..+.++.||.+|++||..+++|||||..+|+||.++..+|+.|||+
T Consensus 332 CT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 332 CTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred hccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccch
Confidence 99999999999999999999999987766688888999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 205 SCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 205 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
++++..... +....-...|.|||-+....++.++|||+||++|||+.| |-.||.+.+..++ +..++...+..-|..
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV-Y~LLEkgyRM~~PeG 490 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YGLLEKGYRMDGPEG 490 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH-HHHHhccccccCCCC
Confidence 998765433 334445778999999999999999999999999999999 9999999887665 455677888999999
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
||+...+|++.||+.+|.+||++.|+-+.++.+-.
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 99999999999999999999999999999987643
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=313.58 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=201.6
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC---CCCceeeeeEEEEe---
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL---NHPHIITFVAACKK--- 127 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~~--- 127 (362)
+|++.+.||+|+||.||+|.+. ++.||+|.+......... ...+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL----PLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC----chHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence 4889999999999999999986 678999998764322111 12344566666655 79999999998764
Q ss_pred --CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 128 --PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 128 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
....++++||+. ++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++
T Consensus 77 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 77 DRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred CCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 346899999996 58999998765556899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--------- 276 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------- 276 (362)
.............++..|+|||++.+..++.++||||||+++|+|++|.+||......+....+......+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 76554444445678899999999998889999999999999999999999998876655444433211000
Q ss_pred ----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ----------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...+.++..+.+++.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 112356788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=310.43 Aligned_cols=251 Identities=29% Similarity=0.506 Sum_probs=204.5
Q ss_pred eeeeeeecccCCeeEEEEEEC------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC--
Q 017994 57 LFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP-- 128 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-- 128 (362)
|.+.+.||+|+||+||++.+. +..||+|++....... ....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ-----NTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 388899999999999887642 5679999987653321 135677899999999999999999987653
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
...+++|||+++++|.+++... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 4689999999999999999764 4899999999999999999999999999999999999999999999999998754
Q ss_pred ccCCC----CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH--------------HHHHHHH
Q 017994 209 SQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE--------------QAAFAVC 270 (362)
Q Consensus 209 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~--------------~~~~~~~ 270 (362)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 43221 12234566799999998888999999999999999999999998653321 0111112
Q ss_pred hcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 017994 271 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 271 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
......+.+..++..+.+++.+||+.+|++||++++++++|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 222334456778899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=319.11 Aligned_cols=243 Identities=22% Similarity=0.331 Sum_probs=205.6
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCCeEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPPVFC 132 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~ 132 (362)
+|...+.||+|+||.||++.++ ++.||||++....... ....+.+..|+.++..+. |++|+++++++...+.+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLY 77 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEE
Confidence 4678899999999999999986 6789999987532111 111345667888888875 577888999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 211 (362)
+||||++|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 78 lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999999998765 5899999999999999999999999999999999999999999999999998653322
Q ss_pred CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...........+... ....+..++..+.+++.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~ 233 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSLSKEAVSICK 233 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHH
Confidence 2234456899999999999888999999999999999999999999998887766666543 34566778999999999
Q ss_pred HhcccCCCCCCCHH
Q 017994 292 RCWSSSPDRRPHFD 305 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ 305 (362)
+||+.+|.+|++..
T Consensus 234 ~~l~~~p~~R~~~~ 247 (323)
T cd05615 234 GLMTKHPSKRLGCG 247 (323)
T ss_pred HHcccCHhhCCCCC
Confidence 99999999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=311.62 Aligned_cols=249 Identities=24% Similarity=0.429 Sum_probs=206.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
..+|++.+.||+|+||.||+|.+. ++.||+|++....... ...+.+|+.++++++||||+++++.+......
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~------~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD------FSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch------HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 357999999999999999999985 6789999987643322 24577899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 99999999999999997654 5889999999999999999999999999999999999999999999999998754332
Q ss_pred -CCCCcccccccccChhhhh---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---CCCCCCH
Q 017994 212 -GSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---VPPTCPK 284 (362)
Q Consensus 212 -~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 284 (362)
.......++..|+|||.+. ...++.++|+||||+++|+|++|..||....+......+......++ ....++.
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS 239 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence 2233456888999999874 34478899999999999999999999976655443332222222221 1235678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
.+.+++.+||+.+|++||+++++++.
T Consensus 240 ~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 240 TFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 99999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=320.16 Aligned_cols=238 Identities=24% Similarity=0.325 Sum_probs=199.3
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHH-HHHHcCCCCceeeeeEEEEeCCeEEEEEec
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEV-ALLFRLNHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei-~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
+.||+|+||.||+|.+. ++.||+|++....... ......+..|. .+++.++||||+++++.+.+.+..++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK---KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH---hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcC
Confidence 36999999999999986 6789999987532211 11123444454 467889999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc-cCCCCCc
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-QCGSAKG 216 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~-~~~~~~~ 216 (362)
+++++|...+.... .+++..+..++.||+.||.|||+.||+||||||+||+++.+|.+||+|||++.... .......
T Consensus 78 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 78 VNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence 99999999887654 58899999999999999999999999999999999999999999999999986532 2223345
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 296 (362)
..|++.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.. .....+...+..+.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~ 233 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH--KPLQLPGGKTVAACDLLVGLLHK 233 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHccC
Confidence 6789999999999988899999999999999999999999998877666555543 34456677889999999999999
Q ss_pred CCCCCCCHH
Q 017994 297 SPDRRPHFD 305 (362)
Q Consensus 297 ~p~~Rps~~ 305 (362)
||.+||+..
T Consensus 234 ~p~~R~~~~ 242 (321)
T cd05603 234 DQRRRLGAK 242 (321)
T ss_pred CHhhcCCCC
Confidence 999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=312.54 Aligned_cols=255 Identities=31% Similarity=0.558 Sum_probs=212.3
Q ss_pred cccCeeeeeeecccCCeeEEEEEECC------------------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYKQ------------------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN 114 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~ 114 (362)
..++|++.+.||+|+||.||++.+.+ ..||+|++....... ..+.+.+|+.++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~e~~~l~~l~ 77 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN-----AREDFLKEVKILSRLS 77 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHH-----HHHHHHHHHHHHHhcC
Confidence 35689999999999999999998753 458999987654331 2467889999999999
Q ss_pred CCceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 017994 115 HPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP---------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 185 (362)
Q Consensus 115 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk 185 (362)
||||+++++++..++..++++||+++++|.+++..... ..+++..++.++.|++.||.|||++|++|+|||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 99999999999999999999999999999999976541 258899999999999999999999999999999
Q ss_pred CCcEEEcCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh--CCCCCCCC
Q 017994 186 SENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT--ALTPFDNM 260 (362)
Q Consensus 186 ~~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~--g~~p~~~~ 260 (362)
|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ +..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999999999999999987543221 1223445678999999988889999999999999999998 78899877
Q ss_pred CHHHHHHHHHhc------CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 261 TPEQAAFAVCQK------NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 261 ~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
+..+........ ......+..++.++.+++.+||+.||.+||++.+|++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 766654444322 1112344567889999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=308.26 Aligned_cols=253 Identities=29% Similarity=0.525 Sum_probs=211.3
Q ss_pred eeeeeeecccCCeeEEEEEECC-----eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe-
Q 017994 57 LFIGCKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV- 130 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~- 130 (362)
|.+++.||+|+||.||+|.+.. ..||||++......... ...+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 76 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE----IEEFLSEAACMKDFDHPNVMKLIGVCFEASSL 76 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHH----HHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc
Confidence 5678899999999999998752 56999998764333211 3567889999999999999999998866554
Q ss_pred -----EEEEEecCCCCCHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEee
Q 017994 131 -----FCIITEYLAGGSLRKYLHQQ----EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 201 (362)
Q Consensus 131 -----~~lv~e~~~~~~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~D 201 (362)
.++++||+++++|..++... ....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|
T Consensus 77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECC
Confidence 79999999999999998543 223589999999999999999999999999999999999999999999999
Q ss_pred eccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC
Q 017994 202 FGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 277 (362)
Q Consensus 202 fg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 277 (362)
||++........ ......+..|+|||.+.+..++.++||||||+++|||++ |..||.+....+....+. ......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~ 235 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-HGNRLK 235 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCC
Confidence 999875433221 112234668999999988889999999999999999999 999998887766655543 344556
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 278 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
.+..++..+.+++.+||+.||++||++.++++.|+.+
T Consensus 236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 6788899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=317.20 Aligned_cols=264 Identities=28% Similarity=0.542 Sum_probs=221.5
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEEC---------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCC
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHP 116 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp 116 (362)
...|++...+|.+++.||+|+||.||++.+. ...||+|++........ .+.+.+|+.+++++ +||
T Consensus 4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~ 78 (334)
T cd05100 4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD-----LSDLVSEMEMMKMIGKHK 78 (334)
T ss_pred CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHH-----HHHHHHHHHHHHhhcCCC
Confidence 3678888889999999999999999999753 13689998875433221 35678899999999 799
Q ss_pred ceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 017994 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHR 182 (362)
Q Consensus 117 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 182 (362)
||+++++++...+..++++||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||
T Consensus 79 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~ 158 (334)
T cd05100 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHR 158 (334)
T ss_pred CeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 99999999999999999999999999999997642 1247788899999999999999999999999
Q ss_pred CCCCCcEEEcCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCC
Q 017994 183 DLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFD 258 (362)
Q Consensus 183 dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~ 258 (362)
||||+||+++.++.++|+|||++........ .....++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 159 DLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred ccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999875433211 122234567999999999899999999999999999998 899998
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 259 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
..+..+....+. .......+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 239 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 239 GIPVEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 887766555543 344455667788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=315.49 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=204.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||.+........ ...+.+|+.++++++||||+++++++..++..
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIVHTDKSL 79 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc-----chhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence 467999999999999999999886 67899999876433221 23566799999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+++ +|.+++..... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred EEEEeCCCC-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 999999964 89888876542 5788999999999999999999999999999999999999999999999998654332
Q ss_pred C-CCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------------
Q 017994 212 G-SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-------------- 275 (362)
Q Consensus 212 ~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-------------- 275 (362)
. ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+......
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 2 2234567899999999865 45789999999999999999999999887765544333221100
Q ss_pred ------C--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 ------P--------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 ------~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+ .....+++++.++|.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 011346788999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=307.05 Aligned_cols=251 Identities=29% Similarity=0.524 Sum_probs=213.2
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchH---HHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDAS---LASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~---~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
+|.++..||.|++|.||+|.+. ++.||+|.+........ ......+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999885 67899998876543322 222334678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
.++++||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 999999999999999998764 588899999999999999999999999999999999999999999999998875542
Q ss_pred CC-------CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 017994 211 CG-------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283 (362)
Q Consensus 211 ~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (362)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.. ...+..+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 237 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNIS 237 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCcccC
Confidence 11 11234578899999999988899999999999999999999999988766555444433 44556677889
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 284 KAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 284 ~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+.++|.+||+.||++||++.++++
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 238 SEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhh
Confidence 99999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=309.46 Aligned_cols=254 Identities=27% Similarity=0.529 Sum_probs=212.3
Q ss_pred cccCeeeeeeecccCCeeEEEEEECC-------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
...+|.+.+.||+|++|.||+|.+.+ ..||+|.+....... ....+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ-----DESDFLMEALIMSKFNHQNIVRLIGVS 78 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34679999999999999999998854 578889876543222 135688899999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---ce
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEP-----YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM---CV 197 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~---~~ 197 (362)
.+....++||||++|++|.+++..... ..+++..+..++.||+.||.|||+++++|+||||+||+++.++ .+
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 999999999999999999999976532 2488899999999999999999999999999999999998655 59
Q ss_pred EEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC
Q 017994 198 KVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 273 (362)
Q Consensus 198 kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~ 273 (362)
+|+|||++........ ......+..|+|||++.+..++.++||||||+++|+|++ |..||...+.......+ ...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~-~~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-TGG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HcC
Confidence 9999999875432111 112233567999999998899999999999999999997 99999987776655443 334
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 274 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 274 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
.....+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 455667888999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=305.57 Aligned_cols=245 Identities=27% Similarity=0.594 Sum_probs=205.9
Q ss_pred eecccCCeeEEEEEEC----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEec
Q 017994 62 KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 62 ~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
.||+|+||.||+|.+. +..||+|++....... ..+.+.+|+.++++++||||+++++++. .+..++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKS-----VRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChH-----HHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEe
Confidence 3899999999999874 3469999987653321 2467889999999999999999999875 4578899999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC----
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---- 213 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 213 (362)
+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 76 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 76 ASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99999999997543 3689999999999999999999999999999999999999999999999999874433211
Q ss_pred CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 017994 214 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 292 (362)
.....++..|+|||.+....++.++||||||+++|++++ |..||......+....+ ........+..+++++.+++.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-EQGKRLDCPAECPPEMYALMKD 233 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCCCCCCCCHHHHHHHHH
Confidence 111223568999999988889999999999999999996 99999988776655444 3445566778889999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 017994 293 CWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 293 ~l~~~p~~Rps~~ell~~L~~~ 314 (362)
||..+|++||++.+|.+.|+.+
T Consensus 234 c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 234 CWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=321.50 Aligned_cols=241 Identities=24% Similarity=0.341 Sum_probs=200.8
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHH-HHHcCCCCceeeeeEEEEeCCeEEEEEec
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVA-LLFRLNHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
+.||+|+||.||++.+. ++.||||++....... ......+..|.. +++.++||||+++++.+..++..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN---RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcC
Confidence 36899999999999986 7889999987532111 111234445554 56779999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc-cCCCCCc
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-QCGSAKG 216 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~-~~~~~~~ 216 (362)
+++++|..++.... .+++..+..++.||+.||.|||++||+||||||+||+++.+|.++|+|||++.... .......
T Consensus 78 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 78 VNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence 99999999987654 68999999999999999999999999999999999999999999999999986432 2223345
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 296 (362)
..|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+... ....++..+..+.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ll~~ll~~ 233 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK--PLVLRPGASLTAWSILEELLEK 233 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC--CccCCCCCCHHHHHHHHHHhcc
Confidence 67899999999999999999999999999999999999999988777666555432 3344567889999999999999
Q ss_pred CCCCCCCHHHHH
Q 017994 297 SPDRRPHFDQIV 308 (362)
Q Consensus 297 ~p~~Rps~~ell 308 (362)
+|.+||++.+.+
T Consensus 234 ~p~~R~~~~~~~ 245 (325)
T cd05604 234 DRQRRLGAKEDF 245 (325)
T ss_pred CHHhcCCCCCCH
Confidence 999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=309.07 Aligned_cols=257 Identities=24% Similarity=0.394 Sum_probs=210.8
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||.|++|.||++.+. +..+|||.+....... ......+.+|+.+++.++||||+++++++..++..+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD---AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhh---HHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEE
Confidence 56888999999999999999974 7899999876533211 112367888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 133 IITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
++|||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999999998742 223589999999999999999999999999999999999999999999999998865433
Q ss_pred CC-CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCCCCCCCCCHHHH
Q 017994 211 CG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE--QAAFAVCQKNARPPVPPTCPKAFS 287 (362)
Q Consensus 211 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~ 287 (362)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .....+......+..+...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 22 123456888999999998888999999999999999999999999765432 222222211112222345788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 288 YLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
+++.+||..+|++|||+.+|++.+.++
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=305.83 Aligned_cols=246 Identities=34% Similarity=0.675 Sum_probs=214.6
Q ss_pred eeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEE
Q 017994 61 CKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIIT 135 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 135 (362)
+.||+|+||.||+|.+. +..|+||++....... ..+.+.+|+.++..++|+||+++++++......+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-----ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-----HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEE
Confidence 36899999999999886 6689999998755433 2467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 136 EYLAGGSLRKYLHQQE-------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 136 e~~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccc
Confidence 9999999999998752 236899999999999999999999999999999999999999999999999998765
Q ss_pred ccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCH
Q 017994 209 SQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284 (362)
Q Consensus 209 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
.... ......++..|+|||.+....++.++|+||||+++|+|++ |..||......+....+.. ......+..++.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPD 234 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCCh
Confidence 5432 2334557889999999988889999999999999999999 6999999877766665543 555667788899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
++.+++.+||+.+|.+||++.++++.|+
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 235 ELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 9999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=311.70 Aligned_cols=244 Identities=22% Similarity=0.345 Sum_probs=199.0
Q ss_pred ecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCCC
Q 017994 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140 (362)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 140 (362)
||+|+||+||++.+. ++.||||++........ ...+.+..|+.+++.++||||+++.+.+......++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR---KGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhh---HHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence 699999999999886 67899999875432211 1124567899999999999999999999999999999999999
Q ss_pred CCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-CCCcc
Q 017994 141 GSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SAKGF 217 (362)
Q Consensus 141 ~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 217 (362)
++|..++... ....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... .....
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 9999888542 22368999999999999999999999999999999999999999999999999986543322 23345
Q ss_pred cccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCCCHHHHHHHHHhcc
Q 017994 218 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ--KNARPPVPPTCPKAFSYLISRCWS 295 (362)
Q Consensus 218 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~ 295 (362)
.|++.|+|||++.+..++.++|+||||+++|+|++|..||.............. .......+..++..+.+++.+||+
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 789999999999999999999999999999999999999986543221111111 122334566789999999999999
Q ss_pred cCCCCCC-----CHHHHHH
Q 017994 296 SSPDRRP-----HFDQIVS 309 (362)
Q Consensus 296 ~~p~~Rp-----s~~ell~ 309 (362)
.||.+|| +++++++
T Consensus 238 ~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHhcCCCCCCHHHHhc
Confidence 9999999 5566665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=325.11 Aligned_cols=242 Identities=25% Similarity=0.409 Sum_probs=197.0
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
...+|.+.+.||.|+||.||++.+. ++.||||.... ..+.+|+.++++++||||+++++++.....
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------------GGTATEAHILRAINHPSIIQLKGTFTYNKF 157 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence 4567999999999999999999986 67899997432 345689999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
.++|+|++ +++|..++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 158 ~~lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 158 TCLILPRY-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred eEEEEecC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 99999999 578999887654 588999999999999999999999999999999999999999999999999864322
Q ss_pred C--CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCC-------HHHHHHHHHh----------
Q 017994 211 C--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-------PEQAAFAVCQ---------- 271 (362)
Q Consensus 211 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~-------~~~~~~~~~~---------- 271 (362)
. .......||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+..
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 1 22335679999999999998899999999999999999999988764321 1111111100
Q ss_pred ----------------cCCCCCC-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 272 ----------------KNARPPV-------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 272 ----------------~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.....+. ...++.++.+||.+||+.||.+|||+.|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0124668999999999999999999999995
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=308.63 Aligned_cols=255 Identities=25% Similarity=0.461 Sum_probs=211.0
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--Ce----eEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
..+|++.+.||.|+||.||+|.+. ++ .+++|.+....... ....+..|+..+.+++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~~~~~l~~l~h~~iv~~~~~~~~ 80 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQ-----TFQEITDHMLAMGSLDHAYIVRLLGICPG 80 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchH-----HHHHHHHHHHHHhcCCCCCcceEEEEECC
Confidence 467888999999999999999984 33 47888875432211 13567788889999999999999998754
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
...++++||+++|+|.+++..... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++..
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 557789999999999999986542 589999999999999999999999999999999999999999999999999875
Q ss_pred cccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 017994 208 ESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283 (362)
Q Consensus 208 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (362)
...... .....++..|+|||.+.+..++.++||||||+++||+++ |..||.+........ +.........+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD-LLEKGERLAQPQICT 237 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCCCCCCCC
Confidence 433221 223446678999999998889999999999999999998 999998877655433 334455556666778
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 284 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 284 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
.++..++.+||..+|++||++.++++.|..+..
T Consensus 238 ~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 238 IDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=308.73 Aligned_cols=255 Identities=26% Similarity=0.519 Sum_probs=212.7
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--Ce----eEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
..+|++.+.||+|+||.||+|.+. ++ .||+|++....... ....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-----ANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHH-----HHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 467999999999999999999874 33 48999987543322 13567889999999999999999999875
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
. ..++++||+++|+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 81 ~-~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 81 S-TVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred C-CcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 4 5679999999999999998654 2589999999999999999999999999999999999999999999999999875
Q ss_pred cccCCCC---CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 017994 208 ESQCGSA---KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283 (362)
Q Consensus 208 ~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (362)
....... ....++..|+|||...+..++.++||||||+++|||++ |..||........... .......+.+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL-LEKGERLPQPPICT 237 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCcCCCCccCC
Confidence 5432221 12234678999999988889999999999999999998 9999988776655443 33444556667789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 284 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 284 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
..+.+++.+||+.||++||++.++++.|..+..
T Consensus 238 ~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 238 IDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 999999999999999999999999999876643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=305.01 Aligned_cols=246 Identities=29% Similarity=0.572 Sum_probs=208.1
Q ss_pred eeecccCCeeEEEEEEC--C---eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEE
Q 017994 61 CKFASGRHSRIYRGIYK--Q---RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIIT 135 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 135 (362)
++||+|+||.||+|.+. + ..+|+|.+....... ..+.+.+|+.+++.++||||+++++++. ....++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA-----GKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchH-----HHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEE
Confidence 46999999999999875 2 579999988654431 2467888999999999999999999876 44678999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCC-
Q 017994 136 EYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA- 214 (362)
Q Consensus 136 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 214 (362)
||+++++|.+++.... .+++..++.++.|++.||.|||..+++|+||||+||+++.++.++|+|||++.........
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999999998765 6899999999999999999999999999999999999999999999999998754332211
Q ss_pred ---CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 215 ---KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 215 ---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+ ......+.+..++..+.+++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li 231 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML-ESGERLPRPEECPQEIYSIM 231 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-HcCCcCCCCCCCCHHHHHHH
Confidence 11223467999999998889999999999999999998 99999888776655444 34445567778899999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhhh
Q 017994 291 SRCWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
.+||..+|++||++.++++.|+++.
T Consensus 232 ~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 232 LSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHhcCChhhCcCHHHHHHHHHhcc
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=304.60 Aligned_cols=251 Identities=28% Similarity=0.595 Sum_probs=213.6
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
+.++|++.+.||.|+||.||++.+. +..+|+|++...... ...+.+|++++++++|||++++++++......
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-------EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPI 74 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-------HHHHHHHHHHHHhCCCCCeeeEEEEEccCCce
Confidence 4578999999999999999999886 778999998764432 25678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++++||+++++|.+++..... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 999999999999999976542 5789999999999999999999999999999999999999999999999988654322
Q ss_pred CC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 212 GS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 212 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
.. .....++..|+|||.+.++.++.++|+||||+++|+|++ |..||...........+. .......+...+..+.+
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 232 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPRLASQSVYE 232 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-CCCCCCCCCCCCHHHHH
Confidence 11 122335678999999998889999999999999999998 999998877666555543 23344455667899999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 017994 289 LISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 289 li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
|+.+||+.+|++||++.+++++|.
T Consensus 233 l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 233 LMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHHcccChhhCCCHHHHHHhhC
Confidence 999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=318.20 Aligned_cols=238 Identities=21% Similarity=0.364 Sum_probs=198.6
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCeEEEEEec
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
+.||+|+||.||++.+. ++.||||++....... ....+.+.+|+.++.++ +||||+++++++.....+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD---DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 36999999999999886 6789999997643211 11235677899999888 699999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc-cCCCCCc
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-QCGSAKG 216 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~-~~~~~~~ 216 (362)
+++++|..++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.... .......
T Consensus 78 ~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 78 VNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence 99999999987654 58999999999999999999999999999999999999999999999999986422 2223345
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCC------CHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM------TPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
..|++.|+|||++.+..++.++|+||||+++|+|++|..||... ...+....... ......+..++..+.+++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~li 234 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL-EKPIRIPRFLSVKASHVL 234 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-hCCCCCCCCCCHHHHHHH
Confidence 67899999999999999999999999999999999999999632 22222333222 234456778899999999
Q ss_pred HHhcccCCCCCCCH
Q 017994 291 SRCWSSSPDRRPHF 304 (362)
Q Consensus 291 ~~~l~~~p~~Rps~ 304 (362)
.+||+.||.+|+++
T Consensus 235 ~~~L~~dP~~R~~~ 248 (327)
T cd05617 235 KGFLNKDPKERLGC 248 (327)
T ss_pred HHHhccCHHHcCCC
Confidence 99999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=304.85 Aligned_cols=246 Identities=27% Similarity=0.511 Sum_probs=211.5
Q ss_pred eeecccCCeeEEEEEECC-----eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEE
Q 017994 61 CKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIIT 135 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 135 (362)
+.||+|++|.||+|.+.. ..||||.+...... ...+.+.+|+.++++++||||+++++.+.. ...++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEE
Confidence 368999999999998742 36899999876543 224778899999999999999999999988 8999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC--
Q 017994 136 EYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-- 213 (362)
Q Consensus 136 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 213 (362)
||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999999999876534689999999999999999999999999999999999999999999999999875543211
Q ss_pred --CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 214 --AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 214 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.........+..+|..+.+++
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 234 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVM 234 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHH
Confidence 123446778999999998889999999999999999999 99999888877766665544555556677889999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHH
Q 017994 291 SRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~~L~ 312 (362)
.+||+.+|.+||++.++++.|.
T Consensus 235 ~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 235 LQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHCCCCcccCCCHHHHHHHhc
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=335.66 Aligned_cols=260 Identities=32% Similarity=0.555 Sum_probs=234.6
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
+++.+...+.++||.|-||.|++|..+ ...||||.++....+. .+.+|+.|+.+|-+++||||++|.|+.
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytek-----qrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEK-----QRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHH-----HHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 567888999999999999999999986 3579999998765543 368999999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
.......||.|||++|+|..+|+.+.+ .+..-+...+++.|+.|+.||.+.|+|||||..+||||+.+-..|++|||++
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999999999998875 5888899999999999999999999999999999999999999999999999
Q ss_pred cccccCCC----CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 017994 206 CLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 280 (362)
Q Consensus 206 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (362)
+....... ..+..-..+|.|||.+....++.++||||+|++|||.++ |..||-++++.+++..+. ...+.+.|.
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPm 857 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPM 857 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCC
Confidence 86654331 122223578999999999999999999999999999988 999999999999988874 577888899
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 281 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
.+|..|.+|+..||++|-.+||.+.||+..|+++..+
T Consensus 858 DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 858 DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999998753
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=319.48 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=224.6
Q ss_pred cCeeeeeeecccCCeeEEEEEE--CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIY--KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
.-|.+.+.||+|.|+.|-+|.+ +|..||||++.+...+... ...+.+|++.|+.++|||||+++.+......+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s----t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS----TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh----hhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 3477888999999999999976 5999999999987665433 467789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE-cCCCceEEeeeccccccccC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL-GEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~-~~~~~~kl~Dfg~~~~~~~~ 211 (362)
||+|.-.+|+|.+||-++.. ++.++.+.+++.||+.|+.|+|+..++||||||+||.+ ..-|-+||.|||++..+.+.
T Consensus 94 LiLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999999987664 79999999999999999999999999999999999887 45689999999999988888
Q ss_pred CCCCcccccccccChhhhhcCCC-CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
..-...+|+..|.|||++.+..| .+++||||||++||.|++|++||...+..+.+-.++. -....|..++.++++||
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD--CKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD--CKYTVPSHVSKECRDLI 250 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc--ccccCchhhhHHHHHHH
Confidence 88889999999999999998876 5789999999999999999999999888888777754 45678899999999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 017994 291 SRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~ 309 (362)
..||..||.+|.+.++|..
T Consensus 251 ~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred HHHHhcCchhhccHHHHhc
Confidence 9999999999999999985
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=317.27 Aligned_cols=252 Identities=20% Similarity=0.282 Sum_probs=206.4
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||+|+||.||++.+. ++.||||++..... ......+.+.+|+.++..++||||+++++.+..++..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM---LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH---hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEE
Confidence 36899999999999999999986 67899999864211 11112356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 78 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999999997643 258999999999999999999999999999999999999999999999999986543322
Q ss_pred C--CCcccccccccChhhhhc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCC
Q 017994 213 S--AKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV---PPTC 282 (362)
Q Consensus 213 ~--~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 282 (362)
. .....|++.|+|||++.. ..++.++||||||+++|+|++|..||......+....+......... ...+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 2 223468999999999863 45788999999999999999999999887776665555443322222 2357
Q ss_pred CHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 017994 283 PKAFSYLISRCWSSSPD--RRPHFDQIVSI 310 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~--~Rps~~ell~~ 310 (362)
+..+.+++.+|+..+++ .|+++.++++.
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 89999999998865444 37889888875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=304.29 Aligned_cols=256 Identities=26% Similarity=0.443 Sum_probs=212.5
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
.+|.+.+.||.|++|.||+|.+. ++.||+|.++....... ...+.+.+|+.++++++|+|++++++.+...+..+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA---KARQDCLKEIDLLKQLDHPNVIKYLASFIENNELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 57999999999999999999986 78999998875322111 11367888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 133 IITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
++|||+++++|.+++... ....+++.+++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999999998653 223588999999999999999999999999999999999999999999999998865433
Q ss_pred CC-CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCCCCCCC-CCCHHH
Q 017994 211 CG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP--EQAAFAVCQKNARPPVPP-TCPKAF 286 (362)
Q Consensus 211 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~l 286 (362)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........ ....++.+. ..+..+
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPLPADHYSEEL 237 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cCCCCCCChhhcCHHH
Confidence 22 22345678899999999888899999999999999999999999965432 22222222 223333443 678899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
.++|.+||..+|++||++.+|+++|+.+
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=299.89 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=218.0
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
+.|++-+.||+|.|+.||++... |+.+|+|+++....... .-+.+.+|+++.+.|+||||+++++.+.++...|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~----~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR----DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc----cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 56888899999999999999886 78899998876433222 1366788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc---CCCceEEeeeccccccc
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG---EDMCVKVADFGISCLES 209 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~---~~~~~kl~Dfg~~~~~~ 209 (362)
+|+|++.|++|..-|-.+ .-.++..+--.++||++||.|+|.+||+|||+||+|+++- ....+||+|||++....
T Consensus 87 lvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999997766554 2578888999999999999999999999999999999994 34469999999998877
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCCHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAFS 287 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 287 (362)
......+..|||.|||||++...+|+..+|||+-|+++|-|+.|.+||.+.+.......+....... +..+.++++.+
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 6566678899999999999999999999999999999999999999999988888888877654433 34578899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~ 309 (362)
+|+++||..||.+|.|+.|.++
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHHHhccChhhhccHHHHhC
Confidence 9999999999999999998875
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=303.23 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=215.1
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|+..+.||.|+||.||.+... ++.+++|.+......... .+.+.+|+.++++++|+||+++++++.+....++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE----RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhH----HHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEE
Confidence 4888999999999999888875 678999998765433221 3567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~- 212 (362)
+|||+++++|.+++.......+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999999999987644568999999999999999999999999999999999999999999999999987544332
Q ss_pred CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 292 (362)
......+++.|+|||.+.+...+.++|+||||+++|+|++|..||......+....+.... ..+.+..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSSELISLVHS 235 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCccccCHHHHHHHHH
Confidence 2344568899999999988888999999999999999999999998877766666654433 334456788999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 017994 293 CWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 293 ~l~~~p~~Rps~~ell~~ 310 (362)
||+.+|.+||++.++++.
T Consensus 236 ~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 236 LLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HcccCcccCCCHHHHhhC
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=302.55 Aligned_cols=245 Identities=31% Similarity=0.603 Sum_probs=207.8
Q ss_pred eeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCC
Q 017994 61 CKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLA 139 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 139 (362)
+.||+|+||.||+|... +..+|+|++....... ....+.+|+.+++.++||||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE-----LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHH-----HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence 36899999999999876 6789999987644321 23567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCC--Ccc
Q 017994 140 GGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA--KGF 217 (362)
Q Consensus 140 ~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~ 217 (362)
+++|.+++..... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 76 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 76 GGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9999999976542 5789999999999999999999999999999999999999999999999998653332111 122
Q ss_pred cccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 017994 218 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296 (362)
Q Consensus 218 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 296 (362)
.++..|+|||++.+..++.++|+||||+++|++++ |..||...........+. .......+..++..+.+++.+||+.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 233 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDY 233 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccc
Confidence 34567999999988889999999999999999998 999998887766555543 3445556677899999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 017994 297 SPDRRPHFDQIVSILE 312 (362)
Q Consensus 297 ~p~~Rps~~ell~~L~ 312 (362)
+|++||++.++++.|.
T Consensus 234 ~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 234 KPENRPKFSELQKELA 249 (250)
T ss_pred CcccCCCHHHHHHHhc
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.17 Aligned_cols=260 Identities=27% Similarity=0.515 Sum_probs=216.5
Q ss_pred ccccCeeeeeeecccCCeeEEEEEECC------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYKQ------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
++.++|.+.+.||+|+||.||+|.+.+ ..|++|++....... ....+.+|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~-----~~~~~~~e~~~l~~l~h~ni~~~~~~~ 77 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEI-----QVTLLLQESCLLYGLSHQNILPILHVC 77 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHH-----HHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 345789999999999999999999864 678999876533222 136678899999999999999999987
Q ss_pred Ee-CCeEEEEEecCCCCCHHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceE
Q 017994 126 KK-PPVFCIITEYLAGGSLRKYLHQQEP------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 198 (362)
Q Consensus 126 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~k 198 (362)
.. ....+++++|+++++|.+++..... ..+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEE
Confidence 65 5778999999999999999976432 3588999999999999999999999999999999999999999999
Q ss_pred EeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC
Q 017994 199 VADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 274 (362)
Q Consensus 199 l~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~ 274 (362)
|+|||+++....... .....++..|+|||++.+..++.++||||||+++|++++ |..||....+.+....+. ...
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~ 236 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-DGY 236 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-cCC
Confidence 999999875432211 122345677999999988889999999999999999999 999998877766544433 344
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 275 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 275 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
....+..+++++.+++.+||..+|++||++.++++.|+.+...
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 4455667789999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=307.08 Aligned_cols=253 Identities=30% Similarity=0.534 Sum_probs=207.5
Q ss_pred eeeeeeecccCCeeEEEEEECC----eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC----
Q 017994 57 LFIGCKFASGRHSRIYRGIYKQ----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP---- 128 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~---- 128 (362)
+.+++.||+|+||.||+|.+.. ..||+|.+......... .+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE----MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE 76 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHH----HHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence 3467889999999999999863 25899988764322221 35678899999999999999999987432
Q ss_pred --CeEEEEEecCCCCCHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 129 --PVFCIITEYLAGGSLRKYLHQQ----EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 129 --~~~~lv~e~~~~~~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
...++++||+.+++|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+||
T Consensus 77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCC
Confidence 3578999999999999988432 2235889999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 017994 203 GISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 278 (362)
Q Consensus 203 g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (362)
|++........ .....+++.|++||.+.+..++.++|+||||+++|+|++ |..||......+....+. .......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~ 235 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQ 235 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCC
Confidence 99876433221 122345678999999998899999999999999999999 899998877766555443 3334456
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 279 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 279 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
+..++..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 236 PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 677889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=309.97 Aligned_cols=254 Identities=30% Similarity=0.596 Sum_probs=213.3
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
+..+|++.+.||+|+||.||++.+. +..||+|++....... ....+.+|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~ei~~l~~l~h~~iv~~~~~~ 77 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-----MQADFQREAALMAEFDHPNIVKLLGVC 77 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHH-----HHHHHHHHHHHHHhcCCCchheEEEEE
Confidence 4567999999999999999999873 4689999987643321 236688899999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCC--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEP--------------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 185 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk 185 (362)
..++..++++||+++++|.+++..... ..+++..++.++.|++.||.|||++|++||||+
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 999999999999999999999975321 247788899999999999999999999999999
Q ss_pred CCcEEEcCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCC
Q 017994 186 SENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMT 261 (362)
Q Consensus 186 ~~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~ 261 (362)
|+||+++.++.++|+|||++....... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999886433221 1222334667999999988899999999999999999998 888998887
Q ss_pred HHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 262 PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
..+....+.. ....+.+..++..+.+|+.+||+.+|.+||++.|+++.|+
T Consensus 238 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 238 HEEVIYYVRD-GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 7766555443 3333456678899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=307.77 Aligned_cols=248 Identities=26% Similarity=0.462 Sum_probs=208.3
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeC---
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKP--- 128 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~--- 128 (362)
+.|.+.+.||+|+||.||+|.+. ++.||+|++...... ...+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc-------HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 56888899999999999999885 678999998765432 25677899999998 799999999998653
Q ss_pred ---CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 129 ---PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 129 ---~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
...+++|||+.+++|.+++.......+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.++|+|||++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 46899999999999999998765556899999999999999999999999999999999999999999999999998
Q ss_pred cccccC-CCCCcccccccccChhhhh-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 017994 206 CLESQC-GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP 279 (362)
Q Consensus 206 ~~~~~~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (362)
...... .......++..|+|||++. ...++.++|+||||+++|+|++|..||.....................+
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence 754332 2234456889999999986 3357889999999999999999999998777665555444433344445
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..++..+.+|+.+||..+|.+||++.++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 667899999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=320.80 Aligned_cols=248 Identities=21% Similarity=0.287 Sum_probs=202.4
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC---
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--- 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--- 128 (362)
..+|.+.+.||+|+||.||++.+. ++.||||++......... ...+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHH----HHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 478999999999999999999885 788999998765433221 35667899999999999999999988644
Q ss_pred ---CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 129 ---PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 129 ---~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999955 77777653 4788999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR---------- 275 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~---------- 275 (362)
.............+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+...........
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred ccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 7655544445667899999999999889999999999999999999999999876654433222111000
Q ss_pred ------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 276 ------------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 276 ------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
...+...+..+.+||.+||+.||.+|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00112235678999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=320.90 Aligned_cols=248 Identities=22% Similarity=0.293 Sum_probs=203.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC---
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--- 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--- 128 (362)
.++|.+.+.||+|+||.||++.+. ++.||||++......... ...+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchh----HHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 478999999999999999999986 678999998764332221 35667899999999999999999987543
Q ss_pred ---CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 129 ---PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 129 ---~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
...|+||||++ ++|.+++.. .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 99 EEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred cccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 35799999995 578877753 3788899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--------- 276 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------- 276 (362)
.............+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......+
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 76655444455678999999999999999999999999999999999999998877655444433211100
Q ss_pred -------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 277 -------------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 277 -------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
......+..+.+||.+||+.||.+|||+.++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0011124578999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=305.06 Aligned_cols=255 Identities=32% Similarity=0.553 Sum_probs=214.5
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--C---eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--Q---RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
...+|...+.||+|+||.||+|.+. + ..+|+|.+....... ..+.+.+|+.++++++||||+++.+++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK-----QRQDFLSEASIMGQFSHHNIIRLEGVVTK 77 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHH-----HHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence 3467888999999999999999875 2 369999987643222 13567889999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 999999999999999999997654 2588999999999999999999999999999999999999999999999998865
Q ss_pred cccCCCC----CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 017994 208 ESQCGSA----KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 282 (362)
Q Consensus 208 ~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (362)
....... .....+..|+|||++.+..++.++||||||+++|+|++ |..||......+....+.. ....+.+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~ 235 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDC 235 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCCC
Confidence 4332111 11223457999999988889999999999999999998 9999988777665555543 3445556678
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 89999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=299.81 Aligned_cols=255 Identities=23% Similarity=0.391 Sum_probs=221.8
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcc--hHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeC
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEED--ASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKP 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~ 128 (362)
...|...+.||.|..+.|-++.++ +...|+|++...... ......+.+.-.+|+.+|+++ .||+|+.+.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356777889999999999999886 678999988764321 112344566778899999998 799999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
..+++|+|.|+.|.|.|++.+.. .++++...+|++|+++|++|||.++|+||||||+|||++++.+++|+|||+++..
T Consensus 96 sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999999999876 6999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCcccccccccChhhhhcC------CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCC
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEK------RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPP 280 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~ 280 (362)
..+..-...+|||+|+|||.+... .|+...|+|+.|++||.|+.|.+||-.....-.+..+.+++... +...
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa 253 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA 253 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence 988888889999999999998643 57888999999999999999999998766666666666554443 3345
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 281 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
.++...++||.+||+.||.+|.|++|.+..
T Consensus 254 dis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 254 DISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred hccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 678889999999999999999999999963
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.98 Aligned_cols=256 Identities=27% Similarity=0.590 Sum_probs=214.7
Q ss_pred cccCeeeeeeecccCCeeEEEEEECC-----eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
...+|.+.+.||+|+||.||+|.+.+ ..|+||......... ..+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~-----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 78 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS-----VREKFLQEAYIMRQFDHPHIVKLIGVITE 78 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHH-----HHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence 34678899999999999999998753 368999887654321 24678889999999999999999998875
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
...++||||+++++|.+++..... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeee
Confidence 456799999999999999976542 589999999999999999999999999999999999999999999999998865
Q ss_pred cccCCC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCH
Q 017994 208 ESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284 (362)
Q Consensus 208 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
...... .....++..|+|||.+....++.++|+||||+++|++++ |..||......+....+ ......+.+..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~ 235 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPP 235 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HcCCcCCCCCCCCH
Confidence 433221 112234567999999988889999999999999999997 99999888776655444 33445566788899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
.+.+++.+||..+|++||++.++++.|+.+..
T Consensus 236 ~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 236 TLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.20 Aligned_cols=252 Identities=20% Similarity=0.291 Sum_probs=208.0
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||++.++ ++.+|+|++...... .......+.+|+.++..++|+||+++++.+.+...++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML---KRAETACFREERDVLVNGDNQWITTLHYAFQDENNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH---HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEE
Confidence 36899999999999999999987 578999998642211 1112345778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||+++|+|.+++.+... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEEeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999999999986432 58999999999999999999999999999999999999999999999999986543222
Q ss_pred C--CCcccccccccChhhhh-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---CCC
Q 017994 213 S--AKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP---PTC 282 (362)
Q Consensus 213 ~--~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 282 (362)
. .....||+.|+|||++. ...++.++||||||+++|+|++|..||...+..+....+........++ ..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 1 23456899999999986 3457899999999999999999999999888777766665544333333 457
Q ss_pred CHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 017994 283 PKAFSYLISRCWSSSPDR--RPHFDQIVSI 310 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~--Rps~~ell~~ 310 (362)
++++.+|+.+|+..++++ |+++.++++.
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 899999999999765544 6889998875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=302.38 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=211.6
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe-CCeEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK-PPVFC 132 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~~~~ 132 (362)
.|++.+.||.|++|.||++.+. ++.||+|.+........ ..+.+.+|+.++++++|||++++++.+.. +..++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR----ERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHH----HHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEE
Confidence 4889999999999999999886 57899999875433221 13567889999999999999999998764 45689
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 211 (362)
++|||+++++|.+++.......+++.+++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999999999998755556899999999999999999999999999999999999999999999999998754332
Q ss_pred CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
.......+++.|+|||++.+..++.++|+||||+++++|++|..||...+.......+.. ...+..+...++.+.+++.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 235 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKLPPMPKDYSPELGELIA 235 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHHH
Confidence 223345678899999999998899999999999999999999999988776665555443 3334556778899999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~~ 310 (362)
+||+.+|++||++.++++.
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 236 TMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHhccCcccCCCHHHHhcC
Confidence 9999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=316.74 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=207.1
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||++.+. ++.||+|++...... .......+.+|+.++..++|+||+++++++.+++..|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML---KRAETACFREERNVLVNGDCQWITTLHYAFQDENYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH---hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 36899999999999999999986 578999998652211 1112355778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||++||+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999999998743 268999999999999999999999999999999999999999999999999986544322
Q ss_pred C--CCcccccccccChhhhhc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC---CCC
Q 017994 213 S--AKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP---PTC 282 (362)
Q Consensus 213 ~--~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 282 (362)
. .....|++.|+|||++.+ +.++.++|+||||+++|+|++|..||...+..+....+........++ ..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 2 223568999999999875 457889999999999999999999999887776666655443333333 346
Q ss_pred CHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 017994 283 PKAFSYLISRCWSSSPDR--RPHFDQIVSI 310 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~--Rps~~ell~~ 310 (362)
+..+.+++.+|+..++.+ |+++.++++.
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 889999999999876544 4577777753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=309.55 Aligned_cols=247 Identities=24% Similarity=0.454 Sum_probs=210.3
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
..+|.+.+.||+|++|.||+|.+. ++.||+|.+....... ...+.+|+.+++.++||||+++++.+......
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~------~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch------HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 367999999999999999999875 6789999987654432 25677899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+++++|.+++... .+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 9999999999999999754 4788999999999999999999999999999999999999999999999988754332
Q ss_pred C-CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCCHHHHHH
Q 017994 212 G-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYL 289 (362)
Q Consensus 212 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 289 (362)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....+............ ....+..++..+.++
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence 2 22345688899999999988899999999999999999999999988776554443332221 223456678899999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~ 309 (362)
+.+||..+|++||++.++++
T Consensus 250 i~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHHCcCCcccCcCHHHHhh
Confidence 99999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=310.96 Aligned_cols=254 Identities=31% Similarity=0.538 Sum_probs=208.8
Q ss_pred ccCeeeeeeecccCCeeEEEEEECC----------------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCc
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYKQ----------------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH 117 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~ 117 (362)
..+|++.+.||+|+||.||++.+.+ ..||||++....... ....+.+|++++++++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~ei~~l~~l~h~~ 78 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKT-----ARNDFLKEIKIMSRLKNPN 78 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHH-----HHHHHHHHHHHHHhCCCCC
Confidence 4679999999999999999987642 248999987643221 2356889999999999999
Q ss_pred eeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 017994 118 IITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP----------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 187 (362)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~ 187 (362)
++++++++......++||||+.+++|.+++..... ..+++..++.++.|++.||.|||++|++|+||||+
T Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 79 IIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred cCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 99999999999999999999999999999965321 13678899999999999999999999999999999
Q ss_pred cEEEcCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh--CCCCCCCCCH
Q 017994 188 NLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT--ALTPFDNMTP 262 (362)
Q Consensus 188 Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~--g~~p~~~~~~ 262 (362)
||+++.++.++|+|||++........ .....++..|+|||.+.++.++.++|+||||+++|+|++ |..||.....
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 99999999999999999865432211 122344678999999988889999999999999999998 6788888776
Q ss_pred HHHHHHHHh------cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 263 EQAAFAVCQ------KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 263 ~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
.+....... .......+...|+.+.+|+.+||+.+|++||++.+|++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 655443322 11122345567899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=294.56 Aligned_cols=262 Identities=21% Similarity=0.275 Sum_probs=213.3
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEE--CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIY--KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
....++-++|.+.+.||+|||+-||+++. ++..+|+|++.-...+. .+...+|++..++++|||+++++++.
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~------~e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQED------IEEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHH------HHHHHHHHHHHHhhCCcchHHHHHHH
Confidence 34456778999999999999999999985 47789999988765332 46778999999999999999999887
Q ss_pred EeCC-----eEEEEEecCCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCc
Q 017994 126 KKPP-----VFCIITEYLAGGSLRKYLHQQEP--YSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMC 196 (362)
Q Consensus 126 ~~~~-----~~~lv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dlk~~Nil~~~~~~ 196 (362)
..+. ..|++++|...|+|.+.++.... ..+++.+++.|+.++++||++||+.. ++||||||.||++.+.+.
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~ 167 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL 167 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence 5443 59999999999999999975433 35999999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccccCCCC----------CcccccccccChhhhhcC---CCCCcccchhhhHHHHHHHhCCCCCCCCCHH
Q 017994 197 VKVADFGISCLESQCGSA----------KGFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNMTPE 263 (362)
Q Consensus 197 ~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~ 263 (362)
++|.|||.++...-.-.. .....|..|.|||.+.-+ ..+.++|||||||++|.|+.|..||+..-..
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~ 247 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ 247 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence 999999988754322111 112368899999998644 4689999999999999999999999753221
Q ss_pred H--HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 017994 264 Q--AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 264 ~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
. +..++...+...+....+|+.+.++|..|++.||.+||++.+++..++.+.
T Consensus 248 GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1 222333334444455668999999999999999999999999999998753
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=305.38 Aligned_cols=248 Identities=30% Similarity=0.532 Sum_probs=205.0
Q ss_pred eecccCCeeEEEEEECC----eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCeEEEEEe
Q 017994 62 KFASGRHSRIYRGIYKQ----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITE 136 (362)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 136 (362)
.||+|+||.||+|.+.+ ..+++|.+....... ....+.+|+.++.++ +||||+++++++......+++||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHH-----HHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 58999999999999863 357888877432221 135678899999999 89999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 137 YLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 137 ~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
|+++++|.+++..... ..+++.++..++.|++.||+|||++|++|+||||+||+++.++.++|+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence 9999999999975431 24788999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 203 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
|++..............+..|+|||++....++.++|+||||+++|+|++ |..||...+..+....+. .......+..
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~ 235 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLN 235 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-CCCCCCCCCc
Confidence 98753322111222233567999999988889999999999999999997 999998877665554443 3334455667
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
++.++.+++.+||..+|.+||++.+++..|+.+.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 8899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=321.86 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=202.8
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC----
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP---- 129 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~---- 129 (362)
+|++.+.||+|+||.||++.+. ++.||||++.....+.. ..+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 76 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV----SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPF 76 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchH----HHHHHHHHHHHHHhCCCCCcCCHhheecCCCcccc
Confidence 4778899999999999999975 78999999865432211 1356788999999999999999999998776
Q ss_pred -eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 130 -VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 130 -~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
..|+|+||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++...
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 77 EEIYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred ceEEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 8899999995 68888886654 5899999999999999999999999999999999999999999999999998754
Q ss_pred ccCC--CCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------
Q 017994 209 SQCG--SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA----------- 274 (362)
Q Consensus 209 ~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~----------- 274 (362)
.... ......+++.|+|||++.+. .++.++||||||+++|+|++|..||.+.++.+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 3321 22334678899999998774 478999999999999999999999988776554433322110
Q ss_pred ------------CC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 275 ------------RP-------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 275 ------------~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
.+ ......++++.+||.+||+.||.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 11 1223457889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=340.11 Aligned_cols=260 Identities=22% Similarity=0.352 Sum_probs=210.4
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.++||+|+||.||+|.+. ++.||||++....... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~---e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN---PLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC---HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEE
Confidence 57999999999999999999986 6899999997643222 123467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 133 IITEYLAGGSLRKYLHQQE---------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
++|||++|++|.+++.... ...++...++.++.||+.||.|||+.||+||||||+||+++.+|.++|+|||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999999987421 1235567789999999999999999999999999999999999999999999
Q ss_pred cccccccC-------------------CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHH
Q 017994 204 ISCLESQC-------------------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 264 (362)
Q Consensus 204 ~~~~~~~~-------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~ 264 (362)
++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 98754110 01123468999999999999999999999999999999999999998755443
Q ss_pred HHHHHHhcCC-CCCCCCCCCHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhhh
Q 017994 265 AAFAVCQKNA-RPPVPPTCPKAFSYLISRCWSSSPDRRP-HFDQIVSILEGYSES 317 (362)
Q Consensus 265 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~ell~~L~~~~~~ 317 (362)
.......... .......+|+.+.+++.+||+.||++|| +++++++.|+.+...
T Consensus 239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 3222111110 0111246788999999999999999996 677888888876543
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=308.40 Aligned_cols=254 Identities=30% Similarity=0.563 Sum_probs=208.1
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC------------------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK------------------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH 115 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h 115 (362)
.++|++.+.||+|+||.||++.+. +..||+|++....... ....+.+|+.+++.++|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~E~~~l~~l~~ 78 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKN-----ARNDFLKEIKIMSRLKD 78 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHH-----HHHHHHHHHHHHHhCCC
Confidence 467999999999999999998543 2368999987643221 14678899999999999
Q ss_pred CceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 017994 116 PHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP---------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 186 (362)
Q Consensus 116 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~ 186 (362)
|||+++++++...+..+++|||+++++|.+++..... ..+++..++.++.|++.||.|||+.|++|+||||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 79 PNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred CCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 9999999999999999999999999999999976432 2366788999999999999999999999999999
Q ss_pred CcEEEcCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh--CCCCCCCCC
Q 017994 187 ENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT--ALTPFDNMT 261 (362)
Q Consensus 187 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~--g~~p~~~~~ 261 (362)
+||+++.++.++|+|||++........ .....++..|++||...++.++.++|+||||+++|+|++ |..||...+
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 999999999999999999875433211 112234678999999888889999999999999999998 788998776
Q ss_pred HHHHHHHHHh------cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 262 PEQAAFAVCQ------KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 262 ~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
..+....... .....+.+..+++.+.+|+.+||+.||.+||++.+|++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 6554432211 11122445678899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=302.70 Aligned_cols=251 Identities=29% Similarity=0.508 Sum_probs=214.7
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|+..+.||+|++|.||+|... ++.|++|.+........ .....+.+.+|+.+++.++||||+++++++......++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT-GQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc-chHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEE
Confidence 4677789999999999999985 78999999876442211 11124678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 213 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (362)
++||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 80 FLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence 999999999999998764 588999999999999999999999999999999999999999999999999876544333
Q ss_pred CCcccccccccChhhhhcCC-CCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 017994 214 AKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 292 (362)
.....++..|++||.+.... ++.++|+||||+++|+|++|..||...........+......+..+..+++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 45566889999999987766 89999999999999999999999988776555555544345556677889999999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 017994 293 CWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 293 ~l~~~p~~Rps~~ell~ 309 (362)
||+.+|++||++.+++.
T Consensus 238 ~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 238 CLQRDPSLRPTAAELLE 254 (258)
T ss_pred HhhcCcccCcCHHHHhc
Confidence 99999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=301.34 Aligned_cols=249 Identities=26% Similarity=0.395 Sum_probs=214.5
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|++.+.||+|++|.||++.+. ++.+|||.+........ ....+.+|+.+++.++|||++++++.+..++..++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD----ERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccH----HHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEE
Confidence 4888999999999999999885 67899999876533221 13678889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CceEEeeeccccccccCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISCLESQCG 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~-~~~kl~Dfg~~~~~~~~~ 212 (362)
|+||+++++|.+++.......+++..+..++.+++.+|.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999999987655568999999999999999999999999999999999999855 468999999987665544
Q ss_pred CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 292 (362)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.. ......+..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHHHH
Confidence 44456788999999999888889999999999999999999999988776665555443 33345667789999999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 017994 293 CWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 293 ~l~~~p~~Rps~~ell~ 309 (362)
||+.+|++||++.+++.
T Consensus 236 ~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 236 MLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HccCChhhCCCHHHHhh
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=308.06 Aligned_cols=247 Identities=31% Similarity=0.552 Sum_probs=205.3
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEE
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCII 134 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 134 (362)
|++++.||+|+||.||++... ++.||+|++.......... ....+|+.++++++||||+++++++......+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~----~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEER----EENIREIKILRRLRHPNIVQILDVFQDDNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHH----HHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccccc----chhhhhhhcccccccccccccccccccccccccc
Confidence 788999999999999999997 5679999999876554322 2334599999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc-ccCCC
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE-SQCGS 213 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~-~~~~~ 213 (362)
|||+.+++|.+++.... .+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+... .....
T Consensus 77 ~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred ccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999998544 5899999999999999999999999999999999999999999999999998752 23334
Q ss_pred CCcccccccccChhhhh-cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCCC--CCCCCCCHHHH
Q 017994 214 AKGFTGTYRWMAPEMIK-EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA---VCQKNARP--PVPPTCPKAFS 287 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~---~~~~~~~~--~~~~~~~~~l~ 287 (362)
.....++..|+|||++. +...+.++|+||||+++++|++|..||........... ........ ......+..+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR 234 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence 45667899999999998 78899999999999999999999999998743322222 11111111 11122247899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~ 309 (362)
+++.+||+.||++||++.++++
T Consensus 235 ~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 235 DLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=324.20 Aligned_cols=246 Identities=28% Similarity=0.415 Sum_probs=218.1
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
.|.-.+.||.|+||.||.|.+. .+.||||++.....+.... ..++..|+..|.+++|||++.+-|+|..+...+|
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EK---WqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK---WQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHH---HHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 3555688999999999999986 6789999998765443221 3678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 213 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (362)
||||| -|+..|++.-+. +.+.+..+..|+.+.+.||.|||+++.||||||..|||+++.|.|||+|||.+....+
T Consensus 104 VMEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 104 VMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HHHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 99999 669999997654 3688999999999999999999999999999999999999999999999998866544
Q ss_pred CCcccccccccChhhhh---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 214 AKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
.+.++|||.|||||++. .+.|+-++||||||++..||.-.++|+-.++....++.+.....+.-..+.++..+..|+
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 56789999999999974 577999999999999999999999999999999999988776555555678899999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 017994 291 SRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~ 309 (362)
..||++-|.+|||..++++
T Consensus 259 d~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHhhCcccCCcHHHHhh
Confidence 9999999999999999887
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=305.87 Aligned_cols=246 Identities=29% Similarity=0.503 Sum_probs=211.7
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||.|++|.||+|.+. ++.||+|++........ ...+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-----IEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchH-----HHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEE
Confidence 36888899999999999999986 68899999876532211 356778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 211 (362)
+|+||+++++|.+++... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred EEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999999999865 5899999999999999999999999999999999999999999999999998765543
Q ss_pred CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC-CCHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT-CPKAFSYLI 290 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li 290 (362)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++......+.. ...+..+.. ++..+.+++
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 231 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-NNPPSLEGNKFSKPFKDFV 231 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh-cCCCCCcccccCHHHHHHH
Confidence 233455678899999999988899999999999999999999999988776555544433 233333444 788999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 017994 291 SRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~ 309 (362)
.+||..+|++||++.++++
T Consensus 232 ~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 232 SLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHHhhCChhhCcCHHHHhh
Confidence 9999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=306.00 Aligned_cols=248 Identities=25% Similarity=0.448 Sum_probs=206.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|.+.+.||+|+||.||+|.+. ++.||+|++....... ...+.+|+.+++.++||||+++++.+...+..
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED------FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL 81 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH------HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence 357889999999999999999885 6889999987653321 24567899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++++||+++++|.+++.... .+++.+++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 99999999999999997765 5899999999999999999999999999999999999999999999999998644322
Q ss_pred -CCCCcccccccccChhhhh---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC---CCCCCH
Q 017994 212 -GSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV---PPTCPK 284 (362)
Q Consensus 212 -~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 284 (362)
.......++..|+|||++. ...++.++|+||||+++|+|++|..||....+.............++. ...++.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN 239 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence 2234557889999999974 455788999999999999999999999776554443333222222221 124678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+.+++.+||+.+|++||++.+|++
T Consensus 240 ~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 240 SFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhc
Confidence 8999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=305.03 Aligned_cols=254 Identities=27% Similarity=0.508 Sum_probs=214.8
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
.++|.+.+.||.|+||.||+|..+ ...|++|.+...... ...+.+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 78 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-----NLQSEFRRELDMFRKLSHKNVVRLLGLCR 78 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch-----HHHHHHHHHHHHHHhcCCcceeeeEEEEC
Confidence 467899999999999999999864 356999988654332 12366888999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEE
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEP-------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 199 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl 199 (362)
.....++||||+++++|.+++..... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 99999999999999999999986542 14899999999999999999999999999999999999999999999
Q ss_pred eeeccccccccC--CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q 017994 200 ADFGISCLESQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 276 (362)
Q Consensus 200 ~Dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 276 (362)
+|||++...... .......++..|+|||.+.+...+.++||||||+++|+|++ |..||...................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 999987643221 12233456778999999988888999999999999999999 889998777666666555444445
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 277 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 277 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
..+..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 556778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=302.93 Aligned_cols=248 Identities=27% Similarity=0.463 Sum_probs=211.3
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||.|+||.||++.+. ++.+++|++....... .+.+.+|+.++++++||||+++++.+......+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD------FEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhh------HHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence 57999999999999999999985 5789999998654331 367788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
++|||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999999999997753 258999999999999999999999999999999999999999999999999987544322
Q ss_pred -CCCcccccccccChhhhhcC---CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---CCCCCCCHH
Q 017994 213 -SAKGFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP---PVPPTCPKA 285 (362)
Q Consensus 213 -~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 285 (362)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||....+.............+ ..+..++.+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 23345678899999998776 78899999999999999999999999887766655544332222 123445778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+.+++.+||..+|.+||++.+++.
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=322.51 Aligned_cols=246 Identities=28% Similarity=0.368 Sum_probs=210.0
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-C-----CceeeeeEEEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-H-----PHIITFVAACK 126 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h-----p~iv~~~~~~~ 126 (362)
.+|.+.+.||+|+||+|.+|.+. ++.||||+++....- -.+...|+.+|..++ | -|+|+++++|.
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-------~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-------LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-------HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 47889999999999999999996 689999999875433 255567999999996 3 59999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC--CceEEeeecc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED--MCVKVADFGI 204 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~--~~~kl~Dfg~ 204 (362)
..+++|||+|.+ +.+|+++++.+...+++...+..++.||+.||.+||+.||||+||||+|||+... ..+||+|||.
T Consensus 259 fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 259 FRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred cccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 999999999998 6699999999888889999999999999999999999999999999999999643 4799999999
Q ss_pred ccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------
Q 017994 205 SCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------- 277 (362)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------- 277 (362)
++.....-. .+..+..|+|||++.+.+|+.+.|+||||||++||++|.+.|.+.+..+.+..+.+....++
T Consensus 338 Sc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 338 SCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred ccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 988766333 77889999999999999999999999999999999999999999888776665544222221
Q ss_pred -------------------------------------------CC-----------CCCCHHHHHHHHHhcccCCCCCCC
Q 017994 278 -------------------------------------------VP-----------PTCPKAFSYLISRCWSSSPDRRPH 303 (362)
Q Consensus 278 -------------------------------------------~~-----------~~~~~~l~~li~~~l~~~p~~Rps 303 (362)
.| ......+.+||.+||..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 01 011235789999999999999999
Q ss_pred HHHHHHH
Q 017994 304 FDQIVSI 310 (362)
Q Consensus 304 ~~ell~~ 310 (362)
..+.++.
T Consensus 496 p~qal~H 502 (586)
T KOG0667|consen 496 PAQALNH 502 (586)
T ss_pred HHHHhcC
Confidence 9999863
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=307.46 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=211.9
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|++|.||++.+. ++.||+|++....... ....+.+.+|+.++++++||||+++++++......+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK---LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEE
Confidence 36899999999999999999986 6889999986532211 112466788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999999998764 6899999999999999999999999999999999999999999999999998765443
Q ss_pred CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 292 (362)
.....+++.|+|||.+.+...+.++|+||||+++|+|++|..||...........+. ......+..++..+.++|.+
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~ 231 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRN 231 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHH
Confidence 344568899999999988888999999999999999999999998877655544443 33456677789999999999
Q ss_pred hcccCCCCCC-----CHHHHHH
Q 017994 293 CWSSSPDRRP-----HFDQIVS 309 (362)
Q Consensus 293 ~l~~~p~~Rp-----s~~ell~ 309 (362)
||..+|.+|+ ++.++++
T Consensus 232 ~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 232 LLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HccCCHHHccCcccCCHHHHHc
Confidence 9999999999 6677764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=310.73 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=212.2
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|.+.+.||+|++|.||++.+. ++.||||.+........ ...+.+..|+.+++.++||||+++++.+......++
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR---NKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL 78 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchH---HHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence 6889999999999999999986 68999999987543321 113567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 213 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (362)
+|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999999999876555799999999999999999999999999999999999999999999999998764322111
Q ss_pred ------------------------------CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH
Q 017994 214 ------------------------------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE 263 (362)
Q Consensus 214 ------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~ 263 (362)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 11335788899999999888999999999999999999999999888776
Q ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 017994 264 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH----FDQIVS 309 (362)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~ell~ 309 (362)
.....+.......+....++..+.+++.+||+.+|++||+ +.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 6655554433333333347899999999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=317.90 Aligned_cols=259 Identities=29% Similarity=0.515 Sum_probs=225.3
Q ss_pred cccccCeeeeeeecccCCeeEEEEEECC-eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
++..+.+.++++||+|-||.|.++...+ ..||||.++....... ++.|.+|+++|.+|+||||++++|.|..++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~-----r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNA-----RNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhH-----HHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 4567888999999999999999999886 9999999998655432 588999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.+++++||++.|+|.+++..+....+..+....|+.||++|++||.+.+++||||.+.|+|++.++++||+|||+++...
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999999999988754345666788899999999999999999999999999999999999999999998544
Q ss_pred cCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh--CCCCCCCCCHHHHHHHHHhcCCC------CCC
Q 017994 210 QCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT--ALTPFDNMTPEQAAFAVCQKNAR------PPV 278 (362)
Q Consensus 210 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~--g~~p~~~~~~~~~~~~~~~~~~~------~~~ 278 (362)
.... ....+-..+|||+|.+..+.++.++|+|+||+++||+++ ...||...+.+++.......... +..
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence 3322 223456789999999999999999999999999999877 88999999988877655432222 346
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 279 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 279 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
|.-+|..+.+++.+||..+..+||++++|...|+..
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 788999999999999999999999999999988754
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=304.69 Aligned_cols=253 Identities=28% Similarity=0.515 Sum_probs=204.7
Q ss_pred cCeeeeeeecccCCeeEEEEEEC------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe-
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK- 127 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~- 127 (362)
.+|++.+.||+|+||.||++... +..||||.+....... .+.+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH------LRDFEREIEILKSLQHDNIVKYKGVCYSA 77 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHH------HHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence 46888999999999999999752 5789999987643321 3567889999999999999999998743
Q ss_pred -CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 128 -PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 128 -~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
....++|+||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 356899999999999999997653 258999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCC----CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHH---------------HHH
Q 017994 207 LESQCGSA----KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ---------------AAF 267 (362)
Q Consensus 207 ~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~---------------~~~ 267 (362)
........ ....++..|+|||++.+..++.++|+||||+++|+|++|..++....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 54432211 11223456999999988889999999999999999999877654322110 111
Q ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 268 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
.........+.+..++..+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 22233334455677889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=303.27 Aligned_cols=256 Identities=26% Similarity=0.535 Sum_probs=215.9
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--C----eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--Q----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~----~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
...+|.+.+.||+|+||.||+|.+. + ..+|+|......... ....+.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPK-----ANKEILDEAYVMASVDHPHVVRLLGICL 79 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHH-----HHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 3467999999999999999999874 2 258999887654321 2467788999999999999999999998
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
. ...++|+||+++++|.+++..... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 7 788999999999999999987543 58999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCC---CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 017994 207 LESQCGSA---KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 282 (362)
Q Consensus 207 ~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (362)
........ ....++..|+|||.+....++.++|+||||+++|++++ |..||......+....+. .....+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPIC 236 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCC
Confidence 54432211 11223567999999988889999999999999999998 999999887766555443 34455666778
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
+..+.+++.+||..+|++||++.++++.|+.+..
T Consensus 237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 237 TIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 8999999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=305.45 Aligned_cols=254 Identities=27% Similarity=0.492 Sum_probs=206.3
Q ss_pred cCeeeeeeecccCCeeEEEEEEC------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
..|++.+.||+|+||.||++.+. +..||+|.+....... ....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN-----HIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHH-----HHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 45788899999999999999752 5689999987543222 135688999999999999999999998775
Q ss_pred --CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 129 --PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 129 --~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
...++||||++|++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccc
Confidence 578999999999999999976542 58999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCC----CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCC--------------HHHHHHH
Q 017994 207 LESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--------------PEQAAFA 268 (362)
Q Consensus 207 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~--------------~~~~~~~ 268 (362)
....... .....++..|+|||++.+..++.++|+||||+++|+|+++..|+.... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 5433221 123456678999999988889999999999999999999766542210 0111112
Q ss_pred HHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 269 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 269 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
........+.+..++..+.+|+.+||+.+|++||++.++++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 2223344455677899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=299.98 Aligned_cols=249 Identities=24% Similarity=0.427 Sum_probs=214.2
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|++.+.||+|+||.||.+... ++.||+|.+........ ..+.+.+|+.++++++||||+++++++...+..++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK----EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChH----HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEE
Confidence 4888999999999999999885 67899999875432221 13567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 213 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (362)
|+||+.+++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999999999875544689999999999999999999999999999999999999999999999998865433221
Q ss_pred -CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 017994 214 -AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292 (362)
Q Consensus 214 -~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 292 (362)
.....+++.|+|||++.+...+.++|+||||+++++|++|..||......+....+.. ...+..+..++.++.++|.+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR-GSYPPVSSHYSYDLRNLVSQ 235 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc-CCCCCCcccCCHHHHHHHHH
Confidence 2234578889999999888899999999999999999999999988777666655543 34455677889999999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 017994 293 CWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 293 ~l~~~p~~Rps~~ell~ 309 (362)
||+.+|++||++.++++
T Consensus 236 ~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 236 LFKRNPRDRPSVNSILE 252 (256)
T ss_pred HhhCChhhCcCHHHHhh
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=301.74 Aligned_cols=251 Identities=27% Similarity=0.455 Sum_probs=208.2
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC--Ce
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--PV 130 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~ 130 (362)
.+|.+.+.||+|+||.||+|.+. +..||||.+.......... ...+.+.+|+.++++++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETS-KEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccH-HHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 57899999999999999999985 6789999886533221111 1235778899999999999999999988663 56
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
++++|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 889999999999999998764 478889999999999999999999999999999999999999999999998875432
Q ss_pred C----CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHH
Q 017994 211 C----GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286 (362)
Q Consensus 211 ~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (362)
. .......++..|+|||++.+..++.++|+||||+++|+|++|..||..................+..+...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 1 112334678899999999888899999999999999999999999988766555554443344455666778889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+++.+|+. +|.+||+++++++
T Consensus 239 ~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 239 RDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHHHhc-ChhhCCCHHHHhc
Confidence 999999995 9999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=306.49 Aligned_cols=250 Identities=26% Similarity=0.445 Sum_probs=207.7
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEe--
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKK-- 127 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~-- 127 (362)
..+.|++.+.||.|+||.||+|.+. ++.+|+|++...... ...+..|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-------EEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHH-------HHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3467899999999999999999985 678999998664322 24577899999988 79999999999853
Q ss_pred ----CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 128 ----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 128 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
....+++|||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCc
Confidence 4678999999999999999987665568899999999999999999999999999999999999999999999999
Q ss_pred cccccccC-CCCCcccccccccChhhhh-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Q 017994 204 ISCLESQC-GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 277 (362)
Q Consensus 204 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 277 (362)
++...... .......++..|+|||.+. ...++.++|+||||+++|+|++|..||....+......+........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 98754322 2234456889999999875 34578899999999999999999999987766555544433333333
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
....++..+.+||.+||+.||.+||++.+|++
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 34568899999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=317.86 Aligned_cols=241 Identities=22% Similarity=0.340 Sum_probs=196.1
Q ss_pred ecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC---CCCceeeeeEEEEeCCeEEEEEec
Q 017994 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL---NHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
||+|+||.||+|.+. ++.||||++........ .....+..|..++... +||||+++++.+......++||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK---KEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhh---hHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 699999999999986 68999999865321111 1122344566666654 699999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-CCCCCc
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKG 216 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 216 (362)
+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... ......
T Consensus 78 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 78 MSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred CCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence 99999999998654 589999999999999999999999999999999999999999999999999865322 223345
Q ss_pred ccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 017994 217 FTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 295 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 295 (362)
..|++.|+|||++.+. .++.++||||||+++|+|++|..||......+....+....... ....+++++.+++.+||+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~~L~ 234 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF-PKNVLSDEGRQFVKGLLN 234 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcC
Confidence 6799999999998764 47999999999999999999999999887766655554333222 123578999999999999
Q ss_pred cCCCCCC----CHHHHHH
Q 017994 296 SSPDRRP----HFDQIVS 309 (362)
Q Consensus 296 ~~p~~Rp----s~~ell~ 309 (362)
.||.+|| ++.++++
T Consensus 235 ~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 235 RNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCHHHCCCCCCCHHHHhc
Confidence 9999998 4566654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=306.31 Aligned_cols=247 Identities=25% Similarity=0.462 Sum_probs=211.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
..+|.+.+.||.|++|.||+|.+. ++.|+||.+....... .+.+.+|+.+++.++||||+++++++......
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK------KELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch------HHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 356999999999999999999874 7899999987643332 35678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++|+||+++++|..++... .+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 9999999999999998764 4899999999999999999999999999999999999999999999999987654332
Q ss_pred C-CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCCHHHHHH
Q 017994 212 G-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYL 289 (362)
Q Consensus 212 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 289 (362)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...++......+..... ....+..+++.+.++
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF 248 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence 2 22345678899999999988899999999999999999999999988877665544433221 223456788999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~ 309 (362)
|.+||..+|.+||++.++++
T Consensus 249 i~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHhhcChhhCCCHHHHhh
Confidence 99999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=339.31 Aligned_cols=255 Identities=21% Similarity=0.310 Sum_probs=207.4
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
......+|.+.+.||.|+||.||++.+. +..||+|++........ ....+..|+.+++.++||||+++++++..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~----~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER----EKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHH----HHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 3445678999999999999999999987 57899999876543322 13567889999999999999999998854
Q ss_pred --CCeEEEEEecCCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-------CccccCCCCCcEEEcC---
Q 017994 128 --PPVFCIITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQ-------GILHRDLKSENLLLGE--- 193 (362)
Q Consensus 128 --~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~-------~i~H~dlk~~Nil~~~--- 193 (362)
...+|+||||+++++|.++|.... ...+++..++.|+.||+.||.|||+. +|+|+||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 457999999999999999997532 23589999999999999999999995 4999999999999964
Q ss_pred --------------CCceEEeeeccccccccCCCCCcccccccccChhhhhc--CCCCCcccchhhhHHHHHHHhCCCCC
Q 017994 194 --------------DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPF 257 (362)
Q Consensus 194 --------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~p~ 257 (362)
.+.+||+|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 33589999999876544444455678999999999864 45789999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 258 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.................. ......+.++.+||..||+.+|.+||++.|++.
T Consensus 244 ~~~~~~~qli~~lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcCCcHHHHHHHHhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 876554444333332222 122456889999999999999999999999984
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=308.00 Aligned_cols=257 Identities=23% Similarity=0.356 Sum_probs=208.3
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|.+.+.||.|+||.||+|.+. ++.||+|.+........ ...+.+|+.+++.++||||+++++++..+...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc-----hhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence 467999999999999999999886 67899999875433221 23566899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+. ++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred EEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 99999996 59999887654 25889999999999999999999999999999999999999999999999998654322
Q ss_pred C-CCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------------
Q 017994 212 G-SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-------------- 275 (362)
Q Consensus 212 ~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-------------- 275 (362)
. ......+++.|+|||++.+. .++.++||||||+++|+|++|.+||...+..+....+......
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 2 22334568899999998654 4788999999999999999999999887765443322211100
Q ss_pred ------C--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhhhh
Q 017994 276 ------P--------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSES 317 (362)
Q Consensus 276 ------~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~~~ 317 (362)
+ .....+++.+.+||.+||+.||.+|||+.++++ .+..++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence 0 012356788999999999999999999999997 55555443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=308.39 Aligned_cols=247 Identities=24% Similarity=0.418 Sum_probs=204.3
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|.+.+.||+|+||.||++.+. +..+|+|.+....... ....+.+|++++++++||||+++++.+..++..++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPA-----IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHH-----HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 6899999999999999999986 6778999887543221 24567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 77 v~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred EeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 999999999999998764 58999999999999999999997 59999999999999999999999999988654332
Q ss_pred CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh---------------------
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ--------------------- 271 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~--------------------- 271 (362)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 23455788999999999888899999999999999999999999976543332211100
Q ss_pred --------------cCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 272 --------------KNARPPVP-PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 272 --------------~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
....+..+ ..++.++.+|+.+||..+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011111 2367789999999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=299.89 Aligned_cols=248 Identities=36% Similarity=0.713 Sum_probs=212.7
Q ss_pred eeeeeecccCCeeEEEEEECC------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 58 FIGCKFASGRHSRIYRGIYKQ------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.+.+.||.|+||.||++.+.+ ..||+|++....... ..+.+.+|+.++..++||||+++++++...+..
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-----QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-----HHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence 567889999999999999874 779999997654332 146788899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
+++|||+++++|.+++.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999999998765434899999999999999999999999999999999999999999999999998755443
Q ss_pred CCCC--cccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 212 GSAK--GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 212 ~~~~--~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
.... ...+++.|+|||.+.+..++.++|+||||+++++|++ |..||...+.......+.. ......+..++..+.+
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-GYRLPKPENCPPEIYK 235 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcCCHHHHH
Confidence 2111 2236788999999988889999999999999999998 8999988777666555543 4455566778999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 017994 289 LISRCWSSSPDRRPHFDQIVSIL 311 (362)
Q Consensus 289 li~~~l~~~p~~Rps~~ell~~L 311 (362)
++.+||..+|.+|||+.++++.|
T Consensus 236 ~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 236 LMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHCcCChhhCcCHHHHHhhC
Confidence 99999999999999999999764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=304.59 Aligned_cols=242 Identities=29% Similarity=0.473 Sum_probs=200.6
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|++.+.||+|+||.||+|.+. ++.||+|++....... ....+.+|+.++++++||||+++++.+..++..++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-----LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChH-----HHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence 5788899999999999999985 6789999987543221 13568889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 213 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (362)
||||+++++|..+. .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... .
T Consensus 77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~ 149 (279)
T cd06619 77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-I 149 (279)
T ss_pred EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-c
Confidence 99999999996542 4688899999999999999999999999999999999999999999999998754432 2
Q ss_pred CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCCCC-CCCCCCHH
Q 017994 214 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE-------QAAFAVCQKNARPP-VPPTCPKA 285 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~ 285 (362)
.....++..|+|||++.+..++.++|+||||+++|+|++|..||...... .....+. ....+. .....+++
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 228 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPVLPVGQFSEK 228 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCCCCCCCcCCHH
Confidence 34457899999999999888999999999999999999999999653321 1111111 111122 23457789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
+.+++.+||+.+|.+||++.++++.
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcC
Confidence 9999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=304.37 Aligned_cols=246 Identities=25% Similarity=0.444 Sum_probs=205.9
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEE
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCII 134 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 134 (362)
|++.+.||.|+||.||+|.+. +..+++|.+....... .+.+.+|+.+++.++||||+++++.+..+...++|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE------LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHH------HHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence 677889999999999999986 5678999886543221 35678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-CC
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GS 213 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 213 (362)
+||+++++|..++.... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... ..
T Consensus 81 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~ 159 (282)
T cd06643 81 IEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159 (282)
T ss_pred EEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence 99999999999886533 25899999999999999999999999999999999999999999999999998654322 22
Q ss_pred CCcccccccccChhhhh-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCCHHHH
Q 017994 214 AKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFS 287 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 287 (362)
.....++..|+|||++. +..++.++|+||||+++|+|++|..||...+..+.......... ....+..++..+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence 33456889999999984 34567899999999999999999999988777665555433221 2334567889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~ 309 (362)
++|.+||+.+|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 240 DFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999998874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=300.66 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=208.6
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe--CCe
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK--PPV 130 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~ 130 (362)
.+|...+.||+|+||.||+|.+. +..||+|++.......... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETS-KEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhH-HHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 36888999999999999999875 6789999987654322111 123567889999999999999999998865 467
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
+++++||+++++|.+++.... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 899999999999999998755 478899999999999999999999999999999999999999999999998865432
Q ss_pred CC----CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHH
Q 017994 211 CG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286 (362)
Q Consensus 211 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (362)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..................+..+..+++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHH
Confidence 11 11234578899999999888899999999999999999999999988766665555444444555667778889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+++ +||..+|++||++.++++
T Consensus 239 ~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 239 RDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHH-HHhcCChhhCcCHHHHhc
Confidence 9999 688889999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=303.63 Aligned_cols=247 Identities=29% Similarity=0.493 Sum_probs=210.9
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
..|...+.||.|+||.||+|.+. +..||||++....... ....+.+|+.++++++||||+++++.+.++...+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-----EIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 35778889999999999999985 6889999987643222 1367888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||++|++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 79 IIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999999999998754 47889999999999999999999999999999999999999999999999986543322
Q ss_pred -CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 213 -SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 213 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
......++..|+|||.+.+...+.++|+||||+++|+|++|..||....+......+ .....+..+..++..+.+++.
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEFSKPFKEFID 234 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCCCCCchhhhHHHHHHHH
Confidence 223345788899999998888999999999999999999999999887766554433 223344556677889999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~~ 310 (362)
+||+.+|++||++.++++.
T Consensus 235 ~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 235 ACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHcccCcccCcCHHHHHhC
Confidence 9999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=311.87 Aligned_cols=247 Identities=19% Similarity=0.340 Sum_probs=198.3
Q ss_pred eeeeeccc--CCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEE
Q 017994 59 IGCKFASG--RHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCII 134 (362)
Q Consensus 59 ~~~~lg~G--~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 134 (362)
+.++||+| +|++||++.++ ++.||||++........ ....+.+|+.+++.++||||+++++++..++..++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNE----MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHH----HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEE
Confidence 45789999 68899999886 68899999876543322 235677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC--
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 212 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 212 (362)
|||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.++.+++.||+.........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999999999976554468999999999999999999999999999999999999999999999998643221111
Q ss_pred ------CCCcccccccccChhhhhc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------
Q 017994 213 ------SAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--------- 275 (362)
Q Consensus 213 ------~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--------- 275 (362)
......++..|+|||++.+ ..++.++||||||+++|+|++|..||..................
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 1122345678999999976 45889999999999999999999999876554433222211100
Q ss_pred -----------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 -----------------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 -----------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+....+++.+.+|+.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0112235678999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=305.51 Aligned_cols=249 Identities=25% Similarity=0.436 Sum_probs=208.1
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.+.|++.++||.|+||.||+|.+. +..|++|++....... ...+.+|+.+++.++||||+++++.+..+...
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE------LEDYMVEIEILATCNHPYIVKLLGAFYWDGKL 84 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHH------HHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence 367999999999999999999986 6789999987643321 35678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+++++|..++.+.. ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred EEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999999999998886544 25899999999999999999999999999999999999999999999999987653322
Q ss_pred -CCCCcccccccccChhhhh-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCCH
Q 017994 212 -GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPK 284 (362)
Q Consensus 212 -~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 284 (362)
.......+++.|+|||++. ...++.++|+||||+++|+|++|..||...+............. ....+..++.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM 243 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCH
Confidence 2233456788999999885 34468899999999999999999999988776555444432211 1233556788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
++.+++.+||+.+|++||++.++++
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhc
Confidence 9999999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=304.31 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=202.1
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|.+.+.||.|++|.||+|.+. +..||||++......... ...+.+|+.++++++||||+++++++..+...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGV----PSTAIREISLLKELQHPNIVCLQDVLMQESRLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCc----hHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEE
Confidence 4888999999999999999985 788999998764332211 2566789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 134 ITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
||||++ ++|.+++..... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.+|.++|+|||++.......
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 999996 589988875432 468999999999999999999999999999999999999999999999999986543221
Q ss_pred -CCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------
Q 017994 213 -SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--------------- 275 (362)
Q Consensus 213 -~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--------------- 275 (362)
......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||..................
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 12234568899999988654 4688999999999999999999999876654433322111000
Q ss_pred ------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 ------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 ------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
......+++++.++|.+||+.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0112346889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=301.09 Aligned_cols=252 Identities=27% Similarity=0.484 Sum_probs=210.4
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|+.++.||+|++|.||++.+. ++.||+|++..............+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 3777889999999999999874 78999999876543322222335778899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-ceEEeeeccccccccCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGISCLESQCG 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 212 (362)
|+||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 999999999999998755 588999999999999999999999999999999999998775 69999999987554321
Q ss_pred C-----CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCCCCCCCH
Q 017994 213 S-----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP---EQAAFAVCQKNARPPVPPTCPK 284 (362)
Q Consensus 213 ~-----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... .............+..+..+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 1 2234678899999999888899999999999999999999999975432 2222233333445566777889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+.+++.+||..+|++||++.++++
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhc
Confidence 9999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=304.73 Aligned_cols=248 Identities=26% Similarity=0.443 Sum_probs=209.6
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||.|++|.||++.+. +..||+|++....... .+.+.+|+.++++++||||+++++.+..+...+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE------LEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHH------HHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence 56899999999999999999985 6789999987643321 356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 211 (362)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999999999997654 25899999999999999999999999999999999999999999999999987654332
Q ss_pred CCCCcccccccccChhhhhc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCCHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKA 285 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 285 (362)
.......+++.|+|||.+.. ..++.++|+||||+++|+|++|..||...........+..... ....+..++..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS 237 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHH
Confidence 22234568889999999753 3467899999999999999999999998877665555433221 12335578899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+.+++.+||+.+|.+||++.++++
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhc
Confidence 999999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=297.01 Aligned_cols=246 Identities=32% Similarity=0.616 Sum_probs=208.5
Q ss_pred eeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCC
Q 017994 61 CKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLA 139 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 139 (362)
++||.|++|.||++.+. ++.||+|.+....... ....+.+|+.++++++||||+++++++......++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD-----LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence 36899999999999987 7899999987654431 24678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC---CCc
Q 017994 140 GGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKG 216 (362)
Q Consensus 140 ~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~ 216 (362)
+++|.+++..... .++...+..++.+++.+|.|||+++++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 76 ~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 76 GGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9999999976542 578899999999999999999999999999999999999999999999999875432111 112
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 295 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 295 (362)
...+..|+|||.+.++.++.++|+||||+++|+|++ |..||...........+. .......+..++..+.+++.+||.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 233 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWA 233 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHhc
Confidence 233567999999988889999999999999999999 899998877655544443 334455667788999999999999
Q ss_pred cCCCCCCCHHHHHHHHHh
Q 017994 296 SSPDRRPHFDQIVSILEG 313 (362)
Q Consensus 296 ~~p~~Rps~~ell~~L~~ 313 (362)
.+|.+||++.++++.|++
T Consensus 234 ~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 234 YDPENRPSFSEIYNELQI 251 (251)
T ss_pred cChhhCcCHHHHHHHhhC
Confidence 999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=303.36 Aligned_cols=249 Identities=21% Similarity=0.373 Sum_probs=204.8
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||+|++|.||+|.+. ++.||+|++........ ..+.+.+|+.++++++|||++++++++......+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV----IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLH 76 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc----ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEE
Confidence 36889999999999999999986 68899998865432211 1355778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||+++++|..++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 77 LVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred EEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999999988888776543 58999999999999999999999999999999999999999999999999987654432
Q ss_pred -CCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------
Q 017994 213 -SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--------------- 275 (362)
Q Consensus 213 -~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--------------- 275 (362)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+....+......
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 2234457889999999876 45789999999999999999999999887765544433221000
Q ss_pred ----CC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 ----PP----------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 ----~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+ ..+.++..+.+|+.+||+.+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 01345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=298.58 Aligned_cols=248 Identities=27% Similarity=0.539 Sum_probs=202.6
Q ss_pred eeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE-eCCeEEEE
Q 017994 61 CKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK-KPPVFCII 134 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~-~~~~~~lv 134 (362)
+.||+|+||.||+|.+. ...||||.+....... ..+.+.+|+.+++.++||||+++++++. .+...+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE-----EVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHH-----HHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEE
Confidence 36899999999999863 2479999876432211 1356778999999999999999999765 45678999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC--
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 212 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 212 (362)
+||+.+++|.+++..... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 76 LPYMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred EecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999999999986542 46777888999999999999999999999999999999999999999999986443211
Q ss_pred ---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 213 ---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 213 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
......++..|+|||.+.+..++.++||||||+++|+|++ |.+||......+....+. ....+..+...++.+.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDPLYE 233 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHH
Confidence 1123345678999999988889999999999999999999 577787776665554443 33444556677899999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhh
Q 017994 289 LISRCWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 289 li~~~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
++.+||+.+|++||++.++++.|+.+.
T Consensus 234 li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 234 VMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=302.19 Aligned_cols=247 Identities=23% Similarity=0.329 Sum_probs=211.1
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|++.+.||.|+||.||++.+. ++.||+|++........ ...+.+.+|+.++++++||||+++++.+......++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK---GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcch---hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEE
Confidence 4889999999999999999986 78999999976432211 124678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 213 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (362)
|+||+.|++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EEeCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 999999999999998763 689999999999999999999999999999999999999999999999999876555434
Q ss_pred CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 214 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP--EQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........ .......+..++..+.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ-ETADVLYPATWSTEAIDAIN 234 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh-ccccccCcccCcHHHHHHHH
Confidence 4456688899999999888899999999999999999999999987764 22222221 12455677788999999999
Q ss_pred HhcccCCCCCCCH--HHHH
Q 017994 292 RCWSSSPDRRPHF--DQIV 308 (362)
Q Consensus 292 ~~l~~~p~~Rps~--~ell 308 (362)
+||+.||.+||++ .+++
T Consensus 235 ~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHccCChhHcCCccHHHHh
Confidence 9999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=307.35 Aligned_cols=246 Identities=26% Similarity=0.462 Sum_probs=208.9
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
.+|.+.+.||.|++|.||++.+. ++.||+|.+....... .+.+.+|+.+++.++||||+++++++..++..+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 67999999999999999999974 7899999987644332 256788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||+++++|.+++.+. .+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 93 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred EeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999999999764 47889999999999999999999999999999999999999999999999886543322
Q ss_pred -CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCCHHHHHHH
Q 017994 213 -SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 213 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li 290 (362)
......+++.|+|||.+.+..++.++|+||||+++|++++|..||...++........... .....+..++..+.+++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHH
Confidence 2234567889999999998889999999999999999999999998766544333322211 12234566788999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 017994 291 SRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~ 309 (362)
.+||..+|++||++.++++
T Consensus 250 ~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 250 NRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=298.66 Aligned_cols=249 Identities=29% Similarity=0.534 Sum_probs=210.2
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
.+|++.+.||.|+||.||+|... +..+++|++....... ..+.+.+|+.+++.++||||+++++.+..+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-----SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-----HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEE
Confidence 36899999999999999999875 6789999987644332 1367888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 133 IITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
+++|++++++|.+++..... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 99999999999999987543 46899999999999999999999999999999999999999999999999988654433
Q ss_pred CC-----CCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC-----C
Q 017994 212 GS-----AKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP-----P 280 (362)
Q Consensus 212 ~~-----~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~ 280 (362)
.. .....++..|+|||.+... ..+.++|+||||+++|+|++|..||...+............ ....+ .
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYK 234 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CCCcCCccccc
Confidence 22 2344688899999998777 78999999999999999999999998877665554443322 11111 2
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 281 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+++.+.+++.+||+.||++||++.+|++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 56789999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=299.74 Aligned_cols=246 Identities=28% Similarity=0.476 Sum_probs=210.2
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||.|+||.||+|.+. +..+++|.+..... ...+.+|+++++.++||||+++++.+......+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 74 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW 74 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence 57899999999999999999986 57899999865422 367889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+++||+++++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 75 l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 9999999999999997644 368999999999999999999999999999999999999999999999999987654433
Q ss_pred -CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCCHHHHHHH
Q 017994 213 -SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLI 290 (362)
Q Consensus 213 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 290 (362)
......++..|+|||++.+..++.++||||||+++|+|++|..||....+......+..... ....+..++..+.+++
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence 23345578899999999988899999999999999999999999988766554443322111 1123445778999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 017994 291 SRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~ 309 (362)
.+||+.+|++||++.++++
T Consensus 234 ~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 234 KKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHhcChhhCcCHHHHhc
Confidence 9999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=299.74 Aligned_cols=246 Identities=23% Similarity=0.473 Sum_probs=196.7
Q ss_pred eeecccCCeeEEEEEEC----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEe
Q 017994 61 CKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITE 136 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 136 (362)
+.||+|+||.||+|.+. +..+|+|.+........ ...+.+|+.++++++||||+++++++.+....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-----QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence 35899999999999865 34689998876543221 3467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-
Q 017994 137 YLAGGSLRKYLHQQEP---YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 212 (362)
Q Consensus 137 ~~~~~~L~~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~- 212 (362)
|+++++|.+++..... ...++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 9999999999975332 245667788999999999999999999999999999999999999999999886433221
Q ss_pred --CCCcccccccccChhhhhcC-------CCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC-CC---CCC
Q 017994 213 --SAKGFTGTYRWMAPEMIKEK-------RHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN-AR---PPV 278 (362)
Q Consensus 213 --~~~~~~~~~~~~aPE~~~~~-------~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~-~~---~~~ 278 (362)
......++..|+|||++.+. .++.++|+||||+++|+|++ |..||....+.+......... .. +..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCcc
Confidence 12234567889999998642 35789999999999999997 999998877665543322221 11 122
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 279 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 279 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
....++.+.+++.+|| .+|++||++.+|...|+
T Consensus 236 ~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2356788999999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=300.15 Aligned_cols=253 Identities=29% Similarity=0.493 Sum_probs=208.0
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchH----HHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDAS----LASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~----~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
+|.+.+.||.|+||.||+|... ++.||||.+........ ......+.+.+|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999875 67899998865322111 11223456788999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
..++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 9999999999999999998764 58899999999999999999999999999999999999999999999999987543
Q ss_pred cCC---CCCcccccccccChhhhhcCC--CCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC----C
Q 017994 210 QCG---SAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP----P 280 (362)
Q Consensus 210 ~~~---~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~ 280 (362)
... ......++..|+|||.+.... ++.++|+||||+++|++++|..||.....................+ .
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence 321 123345788999999987654 7899999999999999999999998766555444433333233332 3
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 281 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
.++..+.+++.+||+.+|++||++.++++.
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 240 NLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 468899999999999999999999998853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=318.31 Aligned_cols=260 Identities=30% Similarity=0.619 Sum_probs=226.1
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEECC------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeee
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQ------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~ 122 (362)
+.+++.+...+.+.||.|-||.||.|++.. -.||||..+....... .+.|.+|..+|+.++||||++++
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-----tekflqEa~iMrnfdHphIikLI 457 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-----TEKFLQEASIMRNFDHPHIIKLI 457 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-----HHHHHHHHHHHHhCCCcchhhee
Confidence 455666777778899999999999999862 2599999987443322 47899999999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
|+|.+. ..+||||.++-|.|..|++.+.. .++......++.||+.||.|||+..++||||..+|||+...-.+||+||
T Consensus 458 Gv~~e~-P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 458 GVCVEQ-PMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred eeeecc-ceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeeccc
Confidence 999765 56799999999999999998774 7999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCC--CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 017994 203 GISCLESQCGSA--KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 279 (362)
Q Consensus 203 g~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (362)
|+++.......- ....-...|||||-+.-..++.++|||.||+.|||++. |..||.+..+.+++..+ +.+.+++.|
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-EnGeRlP~P 614 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-ENGERLPCP 614 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-cCCCCCCCC
Confidence 999876554332 22334668999999999999999999999999999998 99999998887766554 467889999
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
+.||+.|..|+.+||+.+|.+||.+.+|...|..+.+
T Consensus 615 ~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 615 PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 9999999999999999999999999999998887654
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=299.05 Aligned_cols=242 Identities=29% Similarity=0.390 Sum_probs=208.8
Q ss_pred ecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCCC
Q 017994 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140 (362)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 140 (362)
||.|++|.||++.+. ++.||+|++........ ...+.+.+|+.+++.++||||+++++.+.++...++++||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET---GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhh---hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence 689999999999997 78999999976432211 1246788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCCCccccc
Q 017994 141 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT 220 (362)
Q Consensus 141 ~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 220 (362)
++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.............++
T Consensus 78 ~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 78 GELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred CcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence 99999998764 4889999999999999999999999999999999999999999999999998766544334445688
Q ss_pred ccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCC
Q 017994 221 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 298 (362)
Q Consensus 221 ~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 298 (362)
..|++||.+.+..++.++|+||||+++|+|++|..||.... +......+.........+...++.+.++|.+||+.+|
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 235 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP 235 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 89999999988889999999999999999999999998776 5555555543355566777778999999999999999
Q ss_pred CCCCC-----HHHHHH
Q 017994 299 DRRPH-----FDQIVS 309 (362)
Q Consensus 299 ~~Rps-----~~ell~ 309 (362)
++||+ +.|+++
T Consensus 236 ~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 236 EERLGNLKGGIKDIKK 251 (262)
T ss_pred hhCcCCcccCHHHHhc
Confidence 99999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=305.16 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=210.4
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|.+.+.||+|+||.||++.+. ++.|+||.+....... ......+.+|+.+++.++||||+++++.+..++..++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLIL---RNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhh---HHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 6888999999999999999987 5789999887543211 1123567789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC--
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-- 211 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~-- 211 (362)
||||++|++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 79 VMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999999998765 5899999999999999999999999999999999999999999999999987531100
Q ss_pred --------------CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-C
Q 017994 212 --------------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-P 276 (362)
Q Consensus 212 --------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~ 276 (362)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....+........... +
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 236 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 0011235678899999998888999999999999999999999999988777666655443322 2
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 017994 277 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 313 (362)
Q Consensus 277 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 313 (362)
.....++..+.++|.+||+.+|++||+..++.+.|+.
T Consensus 237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 2334678999999999999999999997767666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=314.95 Aligned_cols=247 Identities=21% Similarity=0.331 Sum_probs=200.3
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC---
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--- 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--- 128 (362)
.++|.+.+.||.|+||.||+|.+. ++.||||++........ ....+.+|+.++++++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLI----HARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhH----HHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 468999999999999999999885 67899999876432211 134567899999999999999999887543
Q ss_pred ---CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 129 ---PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 129 ---~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
...+++++++ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 4578999988 88999888653 4899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--------- 275 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--------- 275 (362)
..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+......
T Consensus 166 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 166 RQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred eecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 75443 2345578999999999876 56899999999999999999999999876654433332211100
Q ss_pred ------------CC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 276 ------------PP--------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 276 ------------~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
+. .....++.+.+|+.+||..||.+|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 012345678899999999999999999999963
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=300.05 Aligned_cols=245 Identities=24% Similarity=0.513 Sum_probs=197.4
Q ss_pred eecccCCeeEEEEEEC----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEec
Q 017994 62 KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 62 ~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
.||+|+||.||+|... ...+++|.+....... ....+.+|+.+++.++||||+++++.+......++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPD-----EQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChH-----HHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 5899999999999753 3568888776543221 135678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC--
Q 017994 138 LAGGSLRKYLHQQEP---YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 212 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 212 (362)
+++++|.+++..... ...++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999999976542 234677889999999999999999999999999999999999999999999886432211
Q ss_pred -CCCcccccccccChhhhhc-------CCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCC----CCCCC
Q 017994 213 -SAKGFTGTYRWMAPEMIKE-------KRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA----RPPVP 279 (362)
Q Consensus 213 -~~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~----~~~~~ 279 (362)
......++..|+|||++.. ..++.++||||||+++|+|++ |..||....+.+.......... .+..+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD 236 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence 1223345678999999753 346889999999999999999 8899988877665555433322 12334
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
..+++.+.+++..|| .||++||++.+|++.|.
T Consensus 237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 567888999999999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=301.40 Aligned_cols=246 Identities=32% Similarity=0.607 Sum_probs=205.2
Q ss_pred eeecccCCeeEEEEEECC--------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 61 CKFASGRHSRIYRGIYKQ--------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
+.||+|+||.||+|.+.+ ..+|||.+........ ...+.+|+.+++.++||||+++++++...+..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-----KKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhh-----HHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeE
Confidence 358999999999998753 5699998865432111 356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-----ceEEeee
Q 017994 133 IITEYLAGGSLRKYLHQQE-----PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-----CVKVADF 202 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~-----~~kl~Df 202 (362)
++|||+++++|.+++.... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+||
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999999999999997532 22478899999999999999999999999999999999999877 8999999
Q ss_pred ccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 017994 203 GISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 278 (362)
Q Consensus 203 g~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (362)
|++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .......
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~ 234 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQK 234 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCC
Confidence 99865432211 122345678999999998899999999999999999998 999998877666544432 3344556
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 279 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 279 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
+..+|..+.+++.+||..+|.+||++.++++.|+
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 6778899999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=297.42 Aligned_cols=250 Identities=23% Similarity=0.392 Sum_probs=211.6
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe--CCeE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK--PPVF 131 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~ 131 (362)
+|++.+.||.|+||.||++.+. ++.||+|++......... .+.+.+|+.++++++||||+++++++.. ....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE----KQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTL 76 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHH----HHHHHHHHHHHHhcCCCccceeeeeeecCCCCEE
Confidence 4788899999999999999885 678999998764332221 3567889999999999999999997753 4578
Q ss_pred EEEEecCCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 132 CIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLH-----SQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
+++|||+++++|.+++... ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 77 ~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred EEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccc
Confidence 9999999999999999753 1236899999999999999999999 88999999999999999999999999999
Q ss_pred ccccccCCC-CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 017994 205 SCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283 (362)
Q Consensus 205 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (362)
+........ .....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+.......+ .....+..+..++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-KEGKFRRIPYRYS 235 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH-hcCCCCCCccccC
Confidence 876554332 33456889999999998888999999999999999999999999987755544443 3444556777889
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 284 KAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 284 ~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
..+.+++.+||+.+|++||++.+|++.
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=296.75 Aligned_cols=248 Identities=25% Similarity=0.499 Sum_probs=207.9
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|.+.+.||+|+||.||+|.+. ++.|++|++...... ....+.+.+|+.+++.++|+||+++++.+......++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND----PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc----hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEE
Confidence 5888999999999999999875 678999998876543 1224678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 213 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (362)
|+||+++++|.+++.... .+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 77 v~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 77 FMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999999998754 478899999999999999999999999999999999999999999999999876543322
Q ss_pred C-----CcccccccccChhhhhcCC---CCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC--CC
Q 017994 214 A-----KGFTGTYRWMAPEMIKEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT--CP 283 (362)
Q Consensus 214 ~-----~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 283 (362)
. ....++..|+|||++.+.. .+.++||||||++++++++|..||..................+..+.. ++
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLS 234 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccC
Confidence 1 1346788999999998766 789999999999999999999999876433322222222334444444 38
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 284 KAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 284 ~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+.+++.+||+.+|.+||++.+++.
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhc
Confidence 89999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=302.20 Aligned_cols=255 Identities=29% Similarity=0.565 Sum_probs=211.4
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
...|.+.+.||+|+||.||++.+. +..||||++...... .....+.+|+.+++.+.||||+++++++..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~ 77 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-----QHRSDFEREIEILRTLDHENIVKYKGVCEK 77 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-----HHHHHHHHHHHHHHhCCCCChheEEeeeec
Confidence 356788899999999999999864 568999999865543 124678899999999999999999999877
Q ss_pred --CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 128 --PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 128 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
....+++|||+++++|.+++..... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 5689999999999999999987553 5899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCC----CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHH--------------HHH
Q 017994 206 CLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ--------------AAF 267 (362)
Q Consensus 206 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~--------------~~~ 267 (362)
........ .....++..|++||.+.+..++.++|+||||+++|+|++|..|+....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 76542211 112234567999999988889999999999999999999999986533211 122
Q ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 268 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
.........+.+..++.++.+++.+||+.+|.+||++.+++++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 22333344455667789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=302.13 Aligned_cols=254 Identities=22% Similarity=0.392 Sum_probs=205.1
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEE
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACK 126 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~ 126 (362)
+.....+|++.+.||+|+||.||++.+. ++.+|+|++...... ...+..|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-------DEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch-------HHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 3445678999999999999999999885 678999987653221 24567899999998 7999999999874
Q ss_pred -----eCCeEEEEEecCCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEE
Q 017994 127 -----KPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 199 (362)
Q Consensus 127 -----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl 199 (362)
.+...++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEE
Confidence 346789999999999999988632 2235888999999999999999999999999999999999999999999
Q ss_pred eeeccccccccCC-CCCcccccccccChhhhhc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Q 017994 200 ADFGISCLESQCG-SAKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 273 (362)
Q Consensus 200 ~Dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 273 (362)
+|||++....... ......+++.|+|||++.. ..++.++|+||||+++|+|++|..||....+...........
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 9999987543322 2234568899999998753 447889999999999999999999998876644433322211
Q ss_pred -CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 274 -ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 274 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
.....+..++..+.+++.+||+.+|++||++.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1122345567899999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=304.06 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=209.3
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
..+|++.+.||+|+||+||++.+. ++.||+|++....... ..+.+.+|+++++.++||||+++++.+......
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSS-----VRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcch-----HHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence 467899999999999999999986 7889999887543221 246788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
++||||+++++|.+++...+ .+++..+..++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 99999999999999998754 58999999999999999999997 6999999999999999999999999998764432
Q ss_pred CCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhcCCCCCCC
Q 017994 211 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE-----------QAAFAVCQKNARPPVP 279 (362)
Q Consensus 211 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~ 279 (362)
. ......++..|+|||++.+..++.++|+||||+++|++++|..||...... .....+.. ...+..+
T Consensus 157 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 234 (284)
T cd06620 157 S-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRLP 234 (284)
T ss_pred h-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCCCCC
Confidence 2 223457899999999998888999999999999999999999999865442 11222221 1122222
Q ss_pred C-CCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 017994 280 P-TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 313 (362)
Q Consensus 280 ~-~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 313 (362)
. .++..+.+|+.+||+.||++||++.+++++.--
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 2 377889999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=299.68 Aligned_cols=257 Identities=21% Similarity=0.381 Sum_probs=212.7
Q ss_pred CeeeeeeecccCCeeEEEEEEC---CeeEEEEEecCCCcchH----HHHHHHHHHHHHHHHHHc-CCCCceeeeeEEEEe
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDAS----LASMLEKQFTSEVALLFR-LNHPHIITFVAACKK 127 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~----~~~~~~~~~~~Ei~~l~~-l~hp~iv~~~~~~~~ 127 (362)
.|++.+.||+|+||.||++.+. ++.+|+|.+........ ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 3778889999999999999986 47899998865332111 111223556778888875 799999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
++..+++|||++|++|.+++... ....+++..++.++.|++.+|.|||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999999988542 22358999999999999999999996 7899999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCH
Q 017994 205 SCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284 (362)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
+.............++..|++||.+.+..++.++|+||||+++|+|++|..||...........+......+.....+++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE 240 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCH
Confidence 87655443344566888999999999888999999999999999999999999887776665555544444333446789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
.+.+++.+||+.||++||++.|+.+++.
T Consensus 241 ~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 241 DVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 9999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=297.44 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=205.4
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
+++...+.....||+|+||.||+|.+. +..|++|.+....... .+.+.+|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY------VQPLHEEIALHSYLKHRNIVQYLGSDSEN 77 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHH------HHHHHHHHHHHHhcCCCCeeeeeeeeccC
Confidence 344555555678999999999999876 5679999887654322 35678999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCceEEeeecccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFGISC 206 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~ 206 (362)
+..++++||+++++|.+++..... ...++..+..++.|++.||.|||++||+|+||+|+||+++. ++.++|+|||.+.
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 999999999999999999986432 12378889999999999999999999999999999999976 6799999999886
Q ss_pred ccccCC-CCCcccccccccChhhhhcCC--CCCcccchhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCCCCCC
Q 017994 207 LESQCG-SAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVCQKNARPPVPPTC 282 (362)
Q Consensus 207 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~~l~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 282 (362)
...... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...... ............+..+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06624 158 RLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESL 237 (268)
T ss_pred ecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCccc
Confidence 543221 223345788999999986643 788999999999999999999999765432 2222222223345567778
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
++.+.+++.+||+.+|.+||++.++++
T Consensus 238 ~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 238 SAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 899999999999999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=322.43 Aligned_cols=253 Identities=16% Similarity=0.271 Sum_probs=196.4
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC------CCceeeeeEE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN------HPHIITFVAA 124 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~------hp~iv~~~~~ 124 (362)
...+|.+.+.||+|+||+||+|.+. ++.||||++...... ...+..|+.++..++ |+++++++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY-------TRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh-------HHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 3578999999999999999999885 678999998653211 133445666666554 5568899998
Q ss_pred EEeC-CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCC-------
Q 017994 125 CKKP-PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDM------- 195 (362)
Q Consensus 125 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~------- 195 (362)
+..+ ..+++|||++ |++|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccc
Confidence 8764 5789999988 789999987764 58999999999999999999998 5999999999999998765
Q ss_pred ---------ceEEeeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHH
Q 017994 196 ---------CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA 266 (362)
Q Consensus 196 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~ 266 (362)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+..
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 499999998754322 234567899999999999999999999999999999999999999887665443
Q ss_pred HHHHhcCCCC-------------------------CC---------------CCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 017994 267 FAVCQKNARP-------------------------PV---------------PPTCPKAFSYLISRCWSSSPDRRPHFDQ 306 (362)
Q Consensus 267 ~~~~~~~~~~-------------------------~~---------------~~~~~~~l~~li~~~l~~~p~~Rps~~e 306 (362)
..+....... .. ....++.+.+||.+||..||.+|||+.|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 3322111100 00 0011345779999999999999999999
Q ss_pred HHH--HHHhhhhh
Q 017994 307 IVS--ILEGYSES 317 (362)
Q Consensus 307 ll~--~L~~~~~~ 317 (362)
+++ ++..+...
T Consensus 435 ~L~Hp~~~~~~~~ 447 (467)
T PTZ00284 435 MTTHPYVLKYYPE 447 (467)
T ss_pred HhcCccccccCCc
Confidence 997 45444333
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=322.96 Aligned_cols=246 Identities=26% Similarity=0.483 Sum_probs=213.6
Q ss_pred eeeeeeecccCCeeEEEEEECCe--eEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEE
Q 017994 57 LFIGCKFASGRHSRIYRGIYKQR--DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCII 134 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 134 (362)
|.+...||.|+||.||+|..+.. ..|-|++....... ..++.-||.+|..++||+||++++.|..++.++|+
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEE------LEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEE------LEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhH------HhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 55677899999999999988744 34667776543332 46788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc-ccCCC
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE-SQCGS 213 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~-~~~~~ 213 (362)
.|||.||-+..++-..+. .+.+.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+... .....
T Consensus 108 iEFC~GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred EeecCCchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence 999999999998877653 7999999999999999999999999999999999999999999999999987543 23344
Q ss_pred CCcccccccccChhhhh-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCCHHHH
Q 017994 214 AKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-PPVPPTCPKAFS 287 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 287 (362)
...+.|||+|||||+.. ..+|+.++||||||++|.||..+.+|....++..++..+.....+ ...|..++..+.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~ 266 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFS 266 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHH
Confidence 56789999999999875 457899999999999999999999999999999998887654322 235678899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~ 309 (362)
+|+.+||.+||..||++.+|++
T Consensus 267 DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 267 DFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHHHHHHhcCCccCCCHHHHhh
Confidence 9999999999999999999987
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=323.50 Aligned_cols=241 Identities=27% Similarity=0.471 Sum_probs=211.3
Q ss_pred eecccCCeeEEEEEECC--eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCC
Q 017994 62 KFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLA 139 (362)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 139 (362)
+||+|.||+||-|.+.. ..+|||-+....... .+-+..||.+-++++|.|||+++|.+.+++.+-|.||.++
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~------~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE------VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP 655 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchh------hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence 69999999999999874 467999887654433 2456789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-CCCceEEeeeccccccccC-CCCC
Q 017994 140 GGSLRKYLHQQEPYSV--PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-EDMCVKVADFGISCLESQC-GSAK 215 (362)
Q Consensus 140 ~~~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~-~~~~ 215 (362)
||+|.++++..-+ .+ .+.++..+.+||++||.|||.+.|+|||||-+||||+ -.|.+||+|||-+...... ....
T Consensus 656 GGSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred CCcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence 9999999987653 34 7788999999999999999999999999999999996 4689999999988765433 3456
Q ss_pred cccccccccChhhhhcC--CCCCcccchhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 017994 216 GFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVCQKNARPPVPPTCPKAFSYLISR 292 (362)
Q Consensus 216 ~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 292 (362)
+++||..|||||++..+ .|+.++|||||||++.||.||++||...... -..+++-..+..+++|..++.+.++||.+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filr 814 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILR 814 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence 78999999999999765 4899999999999999999999999887544 45567777778899999999999999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 017994 293 CWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 293 ~l~~~p~~Rps~~ell~ 309 (362)
|+.+||..||++++++.
T Consensus 815 cFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 815 CFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HcCCCcccCccHHHhcc
Confidence 99999999999999986
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=303.75 Aligned_cols=255 Identities=28% Similarity=0.597 Sum_probs=211.2
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--Ce----eEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
..+|+..+.||+|+||.||+|.+. +. .||+|.+....... ....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK-----ANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 356888899999999999999874 33 57899887543321 12467889999999999999999999875
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
. ..++++||+++|+|.+++..... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++..
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 4 46789999999999999986542 588999999999999999999999999999999999999999999999999875
Q ss_pred cccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 017994 208 ESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283 (362)
Q Consensus 208 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (362)
...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+... ........+.+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGERLPQPPICT 237 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCCCCCCCCCC
Confidence 443221 122345678999999998889999999999999999998 999998876554433 334455555667788
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 284 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 284 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
..+.+++.+||..+|++||++.++++.|..+..
T Consensus 238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 238 IDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=303.28 Aligned_cols=246 Identities=29% Similarity=0.500 Sum_probs=208.8
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
.|...+.||+|+||.||+|.+. +..||+|.+....... ..+.+.+|+.++++++||||+++++.+..+...++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-----EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH-----HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence 4677788999999999999885 6789999987543322 13578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~- 212 (362)
|+||+++++|.+++... .+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 80 IMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999999998653 48899999999999999999999999999999999999999999999999986544322
Q ss_pred CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 292 (362)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||....+......+ .....+..+..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-PKNSPPTLEGQYSKPFKEFVEA 235 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh-hcCCCCCCCcccCHHHHHHHHH
Confidence 122345788999999999888999999999999999999999999876665544333 2233444556678899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 017994 293 CWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 293 ~l~~~p~~Rps~~ell~~ 310 (362)
||+.+|++||++.++++.
T Consensus 236 ~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 236 CLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HccCCcccCcCHHHHHHh
Confidence 999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=298.92 Aligned_cols=249 Identities=29% Similarity=0.488 Sum_probs=205.6
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCC-
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPP- 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~- 129 (362)
.++|++.+.||+|++|.||+|.+. ++.+++|++...... .+.+.+|+.+++++ +||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-------EEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh-------HHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 478999999999999999999986 578999998765432 35688999999998 7999999999997644
Q ss_pred -----eEEEEEecCCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 130 -----VFCIITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 130 -----~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence 5899999999999999987533 346899999999999999999999999999999999999999999999999
Q ss_pred ccccccccC-CCCCcccccccccChhhhhc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q 017994 203 GISCLESQC-GSAKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 276 (362)
Q Consensus 203 g~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 276 (362)
|++...... .......++..|+|||++.. ..++.++||||||+++|+|++|..||...........+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 988654322 22334568889999998754 246789999999999999999999998766655555443322211
Q ss_pred -CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 -PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+..++..+.+++.+||..||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 222347789999999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=295.18 Aligned_cols=247 Identities=28% Similarity=0.447 Sum_probs=212.9
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|++.+.||.|++|.||++.+. ++.|+||++...... .....+.+|+..+.+++||||+++++++......++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence 5888999999999999999986 788999998875442 124678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
++||+++++|.+++.... .+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 77 VLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999999998764 68999999999999999999999 999999999999999999999999999987654433
Q ss_pred CC-CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCCCCCC-CCHHHH
Q 017994 213 SA-KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQKNARPPVPPT-CPKAFS 287 (362)
Q Consensus 213 ~~-~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~l~ 287 (362)
.. ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+....+. ....+..+.. ++..+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~ 233 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFR 233 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHH
Confidence 22 24567889999999998889999999999999999999999998774 333333333 3444455555 889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~~ 310 (362)
++|.+||+.+|++||++.++++.
T Consensus 234 ~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 234 DFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHccCChhhCCCHHHHHhC
Confidence 99999999999999999999973
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=318.57 Aligned_cols=252 Identities=25% Similarity=0.466 Sum_probs=223.3
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC---C--eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK---Q--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
+..+++.+.++||+|.||.|++|.|+ + -.||||.+....... ....|.+|+.+|.+|+|||+++++|+..
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-----~mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-----IMDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-----hHHHHHHHHHHHHhccCcceeEEeeeec
Confidence 34567788899999999999999997 3 369999998765543 2488999999999999999999999998
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
+ ....+|+|.++.|+|.+.|+......+.......++.||+.|+.||.++++|||||..+|+++-....+||+|||+.+
T Consensus 182 ~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 182 D-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred c-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccccee
Confidence 7 778899999999999999998555578889999999999999999999999999999999999888899999999988
Q ss_pred ccccCCCCC----cccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 207 LESQCGSAK----GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 207 ~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
......... .......|.|||.+....++.++|||++|+++|||++ |+.||.+....+++..+- .+.+.+-|..
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~ 339 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKY 339 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCC
Confidence 655544332 2334668999999999999999999999999999999 999999999988888775 7888889999
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
|++++.+++..||..+|.+||+|..|.+.
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 99999999999999999999999999743
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=302.20 Aligned_cols=249 Identities=23% Similarity=0.410 Sum_probs=207.2
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||+|+||.||++.+. +..||+|.+........ ...+.+|+.++++++||||+++++.+..++..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-----FNQIIMELDILHKAVSPYIVDFYGAFFIEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHH-----HHHHHHHHHHHHhcCCCcHHhhhhheecCCeEE
Confidence 36889999999999999999986 78999998875432221 356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 133 IITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
+||||+++++|..++.... ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 9999999999999987642 2258999999999999999999997 5999999999999999999999999999865433
Q ss_pred CCCCCcccccccccChhhhhcCC------CCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCCCCCCCCCC
Q 017994 211 CGSAKGFTGTYRWMAPEMIKEKR------HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC--QKNARPPVPPTC 282 (362)
Q Consensus 211 ~~~~~~~~~~~~~~aPE~~~~~~------~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~ 282 (362)
. ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||............. .....+..+..+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 156 S-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred C-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 2 233446788999999985543 4889999999999999999999997755544332221 223345566778
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+.++.+||.+||+.+|++||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 999999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=298.19 Aligned_cols=238 Identities=22% Similarity=0.456 Sum_probs=192.7
Q ss_pred eeecccCCeeEEEEEEC--------------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 61 CKFASGRHSRIYRGIYK--------------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
+.||+|+||.||+|+.. ...|++|++.....+ ....+.+|+.++..++||||+++++++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~------~~~~~~~~~~~l~~l~hp~iv~~~~~~~ 74 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRD------ISLAFFETASMMRQVSHKHIVLLYGVCV 74 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhh------HHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 36899999999999853 235889987654322 1356788999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc-------eEE
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-------VKV 199 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~-------~kl 199 (362)
.+...+++|||+++++|..++..... .+++..++.++.||+.||.|||++|++||||||+||+++.++. +++
T Consensus 75 ~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 75 RDVENIMVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred cCCCCEEEEecccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 99999999999999999998876442 5899999999999999999999999999999999999987664 899
Q ss_pred eeeccccccccCCCCCcccccccccChhhhh-cCCCCCcccchhhhHHHHHHH-hCCCCCCCCCHHHHHHHHHhcCCCCC
Q 017994 200 ADFGISCLESQCGSAKGFTGTYRWMAPEMIK-EKRHTKKVDVYSFGIVLWELL-TALTPFDNMTPEQAAFAVCQKNARPP 277 (362)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~~l~ell-~g~~p~~~~~~~~~~~~~~~~~~~~~ 277 (362)
+|||++..... .....++..|+|||.+. +..++.++||||||+++|+|+ +|..||......+... .... ...
T Consensus 154 ~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~--~~~ 227 (262)
T cd05077 154 SDPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG--QCM 227 (262)
T ss_pred CCCCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc--Ccc
Confidence 99998764422 22345778899999886 466899999999999999998 4889987765443322 1111 122
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017994 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 311 (362)
Q Consensus 278 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 311 (362)
.....+.++.+|+.+||+.||.+||++.+|++.+
T Consensus 228 ~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 228 LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 2334467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=294.48 Aligned_cols=251 Identities=27% Similarity=0.447 Sum_probs=211.3
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC--Ce
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--PV 130 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~ 130 (362)
.+|.+.+.||+|+||.||+|.+. +..||+|.+........ .......+.+|+.++++++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQE-TSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccch-hhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 57999999999999999999875 67899998864322111 111246788999999999999999999998664 46
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
+++++||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 889999999999999998755 478899999999999999999999999999999999999999999999999875432
Q ss_pred C----CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHH
Q 017994 211 C----GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286 (362)
Q Consensus 211 ~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (362)
. .......++..|+|||.+.+...+.++|+||||+++|+|++|..||..........++......+..+..+++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 1 112235678899999999888889999999999999999999999988777666666554445566788899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+++.+||. +|..||++.+++.
T Consensus 239 ~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 239 RDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHhc-CcccCccHHHHhc
Confidence 999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=303.41 Aligned_cols=243 Identities=25% Similarity=0.433 Sum_probs=215.2
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEE
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCII 134 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 134 (362)
|.++.+||+|+||.||+|+++ |..+|||.+..+.. ..++..|+.++++++.|++|+++|.+.....+++|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD--------LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD--------LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch--------HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 678899999999999999987 78999999877543 35677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-CCC
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGS 213 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-~~~ 213 (362)
||||..|++.++++.+. +.+++..+..+++..+.||+|||...-+|||||..|||++.+|..||+|||.+..... ...
T Consensus 107 MEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred hhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 99999999999998755 4799999999999999999999999999999999999999999999999999875433 234
Q ss_pred CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCCHHHHHHHH
Q 017994 214 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAFSYLIS 291 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~ 291 (362)
.+...||+.|||||++..-.|..++||||||++..||..|++||.+..+...++.+.. +..+ ..|..++.++-+|++
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT-~PPPTF~KPE~WS~~F~DFi~ 264 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT-KPPPTFKKPEEWSSEFNDFIR 264 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC-CCCCCCCChHhhhhHHHHHHH
Confidence 5678899999999999999999999999999999999999999999888776655432 2222 235678889999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~ 309 (362)
+||-++|++|.++.++++
T Consensus 265 ~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 265 SCLIKKPEERKTALRLCE 282 (502)
T ss_pred HHhcCCHHHHHHHHHHhh
Confidence 999999999999999887
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=314.79 Aligned_cols=242 Identities=24% Similarity=0.424 Sum_probs=197.8
Q ss_pred cCeeeeeeecccCCeeEEEEEEC----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
.+|.+.+.||.|+||.||++... +..||||.+... ....+|+.++++++||||+++++++.....
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----------KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 46999999999999999999764 467999987653 234579999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
.+++||++ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 161 ~~lv~e~~-~~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 161 VCMVMPKY-KCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEEehhc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99999998 568999885543 689999999999999999999999999999999999999999999999999875443
Q ss_pred CCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHhc------------
Q 017994 211 CGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE---QAAFAVCQK------------ 272 (362)
Q Consensus 211 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~---~~~~~~~~~------------ 272 (362)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.... ..+..+...
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 221 23457899999999999999999999999999999999999999764321 111111110
Q ss_pred -------------CCCCC--CC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 273 -------------NARPP--VP-----PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 273 -------------~~~~~--~~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
..+++ .+ ..++.++.++|.+||..||++||++.+++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00010 01 2346678999999999999999999999975
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=298.44 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=199.1
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHH-HHcCCCCceeeeeEEEEeCCeE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVAL-LFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~-l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.+|.+.+.||+|+||.||++.+. ++.||||++........ ...+..|+.. ++.++||||+++++++..++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-----QKRLLMDLDISMRSVDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-----HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcE
Confidence 36889999999999999999986 78999999876533221 2334445554 6667999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 132 CIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
+++|||++ ++|.+++... ....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999995 6898888652 223689999999999999999999997 9999999999999999999999999998765
Q ss_pred ccCCCCCcccccccccChhhhhc----CCCCCcccchhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCC-CCC
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKE----KRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNARPPVP-PTC 282 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slG~~l~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~-~~~ 282 (362)
..........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.... ..+....... ...+..+ ..+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAEKF 233 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCCCcccc
Confidence 44333334567889999998865 446889999999999999999999997533 2233333322 2223332 457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
|.++.++|.+||..+|.+||++.++++
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 899999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=313.07 Aligned_cols=243 Identities=22% Similarity=0.389 Sum_probs=194.1
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
..+|.+.+.||+|+||.||+|.+. ++.||+|+.... ....|+.++++++||||+++++++......
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 132 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------------TTLIEAMLLQNVNHPSVIRMKDTLVSGAIT 132 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------------ccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence 356999999999999999999996 568999985432 234589999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++|+|++ .++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 133 ~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 133 CMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9999999 568988887644 36899999999999999999999999999999999999999999999999998754443
Q ss_pred CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCC-CCCCCCHH---------HHHHHHHhc-CC-CCCC-
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALT-PFDNMTPE---------QAAFAVCQK-NA-RPPV- 278 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~-p~~~~~~~---------~~~~~~~~~-~~-~~~~- 278 (362)
.......|++.|+|||++.+..++.++||||||+++|+|+++.. +|...... ..+..+... .. ...+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 34445678999999999998899999999999999999998544 44432110 011111110 00 0000
Q ss_pred -----------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 279 -----------------------------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 279 -----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
...++.++.+||.+||+.||.+|||+.|+++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 11345667789999999999999999999863
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=300.67 Aligned_cols=237 Identities=24% Similarity=0.454 Sum_probs=192.6
Q ss_pred eecccCCeeEEEEEEC--------------------------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC
Q 017994 62 KFASGRHSRIYRGIYK--------------------------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH 115 (362)
Q Consensus 62 ~lg~G~~g~Vy~~~~~--------------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h 115 (362)
.||+|+||.||+|... ...|++|++...... ....+.+|+.+++.++|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~------~~~~~~~~~~~~~~l~h 75 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRD------IALAFFETASLMSQVSH 75 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHH------HHHHHHHHHHHHhcCCC
Confidence 6999999999999742 135889988653221 23567889999999999
Q ss_pred CceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC
Q 017994 116 PHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM 195 (362)
Q Consensus 116 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~ 195 (362)
|||+++++++......++||||+++++|..++.... ..+++..+..++.|++.||+|||++||+||||||+||+++..+
T Consensus 76 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 76 IHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred CCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 999999999999999999999999999999987643 2688999999999999999999999999999999999997543
Q ss_pred -------ceEEeeeccccccccCCCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHH-hCCCCCCCCCHHHHH
Q 017994 196 -------CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELL-TALTPFDNMTPEQAA 266 (362)
Q Consensus 196 -------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell-~g~~p~~~~~~~~~~ 266 (362)
.++++|||.+..... .....++..|+|||.+.+ ..++.++|+||||+++|+|+ +|..||....+.+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred cccCccceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 489999998754322 123356788999998865 56899999999999999995 699999877665443
Q ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017994 267 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 311 (362)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 311 (362)
... .. ....+...++.+.++|.+||+.+|.+||++.++++.|
T Consensus 232 ~~~-~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 RFY-EK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH-Hh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 222 11 2233445567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=298.83 Aligned_cols=246 Identities=27% Similarity=0.464 Sum_probs=207.3
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|++.+.||.|++|.||++.++ ++.||+|.+....... ....+.+|+.++++++||||+++++.+......++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEA-----IQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChH-----HHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence 5778889999999999999997 7889999987654321 24677889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
++||+++++|.+++.... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999999999998764 368999999999999999999999 999999999999999999999999999886543322
Q ss_pred CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcCCCCCCCCC-CCHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-----PEQAAFAVCQKNARPPVPPT-CPKAF 286 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~-~~~~l 286 (362)
.. ...++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+....+. ....+..+.. ++..+
T Consensus 156 ~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 156 AK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSPDF 233 (265)
T ss_pred hh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhhcCHHH
Confidence 22 2678889999999988899999999999999999999999997642 222222222 2233334443 78899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.++|.+||..+|.+||++.+++.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhh
Confidence 99999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=300.29 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=205.0
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||+|++|.||+|.+. ++.||||++........ ..+.+.+|++++++++||||+++++++..++..+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDED----VKKTALREVKVLRQLRHENIVNLKEAFRRKGRLY 76 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccccc----chhHHHHHHHHHHhcCCCCeeehhheEEECCEEE
Confidence 36899999999999999999986 67899999876433221 2367788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+++||++++.+..+..+.. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 iv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 77 LVFEYVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred EEEecCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9999998876666655433 58999999999999999999999999999999999999999999999999987655433
Q ss_pred --CCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------------
Q 017994 213 --SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-------------- 275 (362)
Q Consensus 213 --~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-------------- 275 (362)
......++..|+|||++.+. .++.++|+||||+++|+|++|..||......+...........
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 23345678899999999888 7899999999999999999999999876654433322211000
Q ss_pred ----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 ----------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...+..++..+.+||.+||..+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0122345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=298.48 Aligned_cols=249 Identities=23% Similarity=0.358 Sum_probs=206.2
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|.+.+.||.|++|.||+|.+. ++.||||++........ ....+.+|+.++++++||||+++++++..+...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG----IPNQALREIKALQACQHPYVVKLLDVFPHGSGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccch----hhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEE
Confidence 4889999999999999999985 78999999887543221 23568889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~- 212 (362)
|+||+ +++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 77 VMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred Eeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99999 999999997654 368999999999999999999999999999999999999999999999999987654432
Q ss_pred -CCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------
Q 017994 213 -SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-------------- 276 (362)
Q Consensus 213 -~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 276 (362)
......++..|+|||.+.+. .++.++||||+|+++|+|++|.+||.+.........+......+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 12345688899999998654 46899999999999999999998887766544433332211110
Q ss_pred --------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 277 --------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 277 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
...+..+..+.++|.+||+.+|++||+++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0113456889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=298.33 Aligned_cols=244 Identities=21% Similarity=0.312 Sum_probs=201.1
Q ss_pred ecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCCC
Q 017994 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140 (362)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 140 (362)
||+|+||+||++.+. ++.||+|++........ .....+.+|+.++++++||||+++++.+...+..++||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKR---KGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhh---hhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence 689999999999876 78899999875322111 1134567899999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCCCccccc
Q 017994 141 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT 220 (362)
Q Consensus 141 ~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 220 (362)
++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.............++
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCC
Confidence 99999998766556899999999999999999999999999999999999999999999999988765443334455678
Q ss_pred ccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCCCCCCCHHHHHHHHHhcccCC
Q 017994 221 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ--KNARPPVPPTCPKAFSYLISRCWSSSP 298 (362)
Q Consensus 221 ~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p 298 (362)
..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.. .......+..+++.+.++|.+||+.+|
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCCh
Confidence 899999999888899999999999999999999999977543211111111 122344566788999999999999999
Q ss_pred CCCC-----CHHHHHH
Q 017994 299 DRRP-----HFDQIVS 309 (362)
Q Consensus 299 ~~Rp-----s~~ell~ 309 (362)
.+|| ++.++++
T Consensus 238 ~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 238 EKRLGCRGGSADEVRE 253 (277)
T ss_pred hHccCCCcccHHHHHh
Confidence 9999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=291.20 Aligned_cols=248 Identities=27% Similarity=0.510 Sum_probs=214.9
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC--CeE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--PVF 131 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~ 131 (362)
+|...+.||+|++|.||+|.+. ++.|++|++....... ...+.+.+|+.++++++||||+++++.+... ...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE----EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTL 76 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccch----HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeE
Confidence 4778899999999999999987 7889999987765421 1246788999999999999999999999988 899
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++++||+++++|.+++.... .+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 77 NIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999999998765 6899999999999999999999999999999999999999999999999998766554
Q ss_pred CC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCCCCCCCHHHH
Q 017994 212 GS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNARPPVPPTCPKAFS 287 (362)
Q Consensus 212 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~ 287 (362)
.. .....++..|+|||.+.+...+.++|+||||+++++|++|..||.... .......+.........+..++..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHH
Confidence 43 445678899999999988889999999999999999999999998866 33333333333455567778899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~ 309 (362)
+++.+||+.+|++||++.++++
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 235 DFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHHhCcCChhhCCCHHHHhh
Confidence 9999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=299.67 Aligned_cols=239 Identities=23% Similarity=0.470 Sum_probs=196.1
Q ss_pred eeecccCCeeEEEEEECC---------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 61 CKFASGRHSRIYRGIYKQ---------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
+.||.|+||.||+|.... ..|++|.+...... ..+.+.+|+.+++.++||||+++++++..++..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRN------YSESFFEAASMMSQLSHKHLVLNYGVCVCGDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHH------HHHHHHHHHHHHHhCCCCChhheeeEEEeCCCc
Confidence 368999999999998742 24888887543211 235678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc--------eEEeeec
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC--------VKVADFG 203 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~--------~kl~Dfg 203 (362)
++||||+++|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++.++. ++++|||
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999999999987553 6889999999999999999999999999999999999987664 6999999
Q ss_pred cccccccCCCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 204 ISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
.+..... .....++..|+|||++.+. .++.++|+||||+++|+|++| ..||....+...... . ......+..
T Consensus 154 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~--~~~~~~~~~ 227 (258)
T cd05078 154 ISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-Y--EDRHQLPAP 227 (258)
T ss_pred cccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-H--HccccCCCC
Confidence 8764432 2335678889999999764 579999999999999999998 577766655443222 2 223455666
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
.+.++.+++.+||+.+|++||++.++++.|+
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 228 KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 6789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=296.13 Aligned_cols=246 Identities=29% Similarity=0.499 Sum_probs=209.9
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
-|.+.+.||.|+||.||+|.+. +..||||++....... ....+.+|+.++.+++||||+++++.+..+...++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-----EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchH-----HHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence 3667889999999999999875 6789999986543222 13577889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~- 212 (362)
||||+++++|.+++... .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 80 IMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999999999998754 48899999999999999999999999999999999999999999999999886543321
Q ss_pred CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 292 (362)
......++..|+|||.+.+...+.++|+||||+++|+|++|..||...........+ .....+..+..++..+.+++.+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-PKNNPPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH-hcCCCCCCCcccCHHHHHHHHH
Confidence 123346788899999998888899999999999999999999999887765554443 2344455667788999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 017994 293 CWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 293 ~l~~~p~~Rps~~ell~~ 310 (362)
||+.+|.+||++.++++.
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 236 CLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HccCChhhCcCHHHHHhC
Confidence 999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=294.30 Aligned_cols=244 Identities=25% Similarity=0.353 Sum_probs=213.6
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
...++|...+.||+|.||+|-++..+ ++.+|+|+++++-.-.. .--..-..|-++|+..+||++..+-..|...+
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak---dEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK---DEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh---HHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 45688999999999999999999887 78999999987533211 00233456889999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.+++||||..||.|.-.+.... .++++.+..+-.+|+.||.|||+++|++||||.+|+|+|.+|++||.|||++....
T Consensus 242 rlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred eEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999999999998887755 58899999999999999999999999999999999999999999999999998543
Q ss_pred -cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 210 -QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 210 -~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
.......++|||.|+|||++....|+.++|.|.+|++||||++|+.||...+.+.....+... ...+|..++++...
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e--d~kFPr~ls~eAkt 397 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME--DLKFPRTLSPEAKT 397 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh--hccCCccCCHHHHH
Confidence 334567899999999999999999999999999999999999999999988776665555443 45678999999999
Q ss_pred HHHHhcccCCCCCC
Q 017994 289 LISRCWSSSPDRRP 302 (362)
Q Consensus 289 li~~~l~~~p~~Rp 302 (362)
|+..+|.+||.+|.
T Consensus 398 LLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 398 LLSGLLKKDPKKRL 411 (516)
T ss_pred HHHHHhhcChHhhc
Confidence 99999999999996
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=295.77 Aligned_cols=237 Identities=24% Similarity=0.492 Sum_probs=194.4
Q ss_pred eeecccCCeeEEEEEECCe------------eEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 61 CKFASGRHSRIYRGIYKQR------------DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~------------~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
+.||+|+||.||+|.+.+. .|++|++...... ...+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-------SLAFFETASLMSQLSHKHLVKLYGVCVR- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-------HHHHHHHHHHHHcCCCcchhheeeEEec-
Confidence 3689999999999998743 3788876654321 3677889999999999999999999988
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-------ceEEee
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-------CVKVAD 201 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~-------~~kl~D 201 (362)
...++||||+++++|.+++..... .+++..+..++.||+.||.|||++||+|+||||+||+++.++ .++|+|
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 778999999999999999987653 588999999999999999999999999999999999999887 799999
Q ss_pred eccccccccCCCCCcccccccccChhhhhcC--CCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 017994 202 FGISCLESQCGSAKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 278 (362)
Q Consensus 202 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (362)
||++..... .....++..|+|||++... .++.++|+||||+++|+|++ |..||............ .... ..
T Consensus 152 fg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~-~~~~--~~ 225 (259)
T cd05037 152 PGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY-QDQH--RL 225 (259)
T ss_pred CCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-hcCC--CC
Confidence 999875433 2234566789999999876 78999999999999999999 68888776543332222 1222 22
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 279 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 279 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
+......+.+++.+||..+|.+||++.++++.|+
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 226 PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 2223378999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=293.30 Aligned_cols=250 Identities=29% Similarity=0.482 Sum_probs=211.4
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|.+.+.||.|+||.||++.++ +..||+|.+........ ..+.+.+|+.+++.++||||+++++.+......++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK----EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch----hhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEE
Confidence 4788999999999999999986 67899999876422111 13567789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-ceEEeeeccccccccCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGISCLESQCG 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 212 (362)
++||+++++|.+++.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999999999876554689999999999999999999999999999999999998876 46999999887544322
Q ss_pred C-CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 213 S-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 213 ~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
. .....+++.|+|||++.+..++.++|+||||+++++|++|..||...+.......... ......++..+..+.+++.
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~ 235 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-GYFAPISPNFSRDLRSLIS 235 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-ccCCCCCCCCCHHHHHHHH
Confidence 1 2234578899999999888899999999999999999999999988776665555443 3334456678899999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~~ 310 (362)
+||..+|++||++.++++.
T Consensus 236 ~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 236 QLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHhccChhhCcCHHHHhhC
Confidence 9999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=300.59 Aligned_cols=248 Identities=21% Similarity=0.309 Sum_probs=198.1
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|.+.+.||.|+||.||+|.+. ++.||+|.+........ ....+.+|+.++++++||||+++++++.+....++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~----~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLYDVLHSDKKLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc----CccchhHHHHHHHhcCCCCeeeHHHHhccCCceEE
Confidence 4788899999999999999985 78899999876432221 12456789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~- 212 (362)
++||++ ++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 77 VFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred EEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 999996 58888887543 258999999999999999999999999999999999999999999999999987543322
Q ss_pred CCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHhcC-----------------
Q 017994 213 SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPF-DNMTPEQAAFAVCQKN----------------- 273 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~-~~~~~~~~~~~~~~~~----------------- 273 (362)
......++..|+|||++.+. .++.++||||||+++|+|++|..|+ .+.+.......+....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 22334568899999998765 4689999999999999999988875 4333332222211100
Q ss_pred -CCC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 274 -ARP---------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 274 -~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
... ...+.+++++.++|.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 112346788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=290.45 Aligned_cols=249 Identities=29% Similarity=0.493 Sum_probs=216.0
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|.+.+.||.|++|.||++.+. +..|++|++........ ....+.+|+++++.++|||++++.+.+......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK----EREDALNEVKILKKLNHPNIIKYYESFEEKGKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChH----HHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEE
Confidence 4788899999999999999997 78999999987544322 13567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 134 ITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||+++++|.+++.... ...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999999998753 246899999999999999999999999999999999999999999999999998765443
Q ss_pred C-CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 212 G-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 212 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
. ......+++.|+|||...+..++.++|+||+|+++++|++|..||.............. ......+..++..+.+++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i 235 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSELRNLV 235 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-CCCCCCCCCCCHHHHHHH
Confidence 2 23345688899999999888899999999999999999999999988876665555443 345566678899999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 017994 291 SRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~ 309 (362)
.+||..+|++||++.++++
T Consensus 236 ~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 236 SSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHcCCChhhCcCHHHHhc
Confidence 9999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=296.05 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=205.1
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeC-
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKP- 128 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~- 128 (362)
..++|.+.+.||+|+||.||++... ++.+|+|++...... ...+.+|+.++.++ +|||++++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-------DEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH-------HHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3578999999999999999999985 678999998653221 24567899999988 899999999998654
Q ss_pred ----CeEEEEEecCCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 129 ----PVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 129 ----~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
...++|+||+++++|.++++.. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence 3689999999999999998642 2235899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC-CCCcccccccccChhhhhcCC-----CCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-C
Q 017994 203 GISCLESQCG-SAKGFTGTYRWMAPEMIKEKR-----HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-R 275 (362)
Q Consensus 203 g~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~-----~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~ 275 (362)
|++....... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||...........+..... .
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (291)
T cd06639 173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT 252 (291)
T ss_pred ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence 9887543322 223456788999999986432 68899999999999999999999988776655554433221 1
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 276 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 276 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
...+..++..+.++|.+||+.+|++||++.++++.
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 12345567889999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=288.18 Aligned_cols=246 Identities=29% Similarity=0.562 Sum_probs=211.7
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|.+.+.||+|++|.||++.+. ++.+++|++...... ....+.+|+.+++.++|||++++++.+..+...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE------KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchh------HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 4788899999999999999996 788999999875541 13678889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 213 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (362)
++||+++++|.+++.... ..+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 75 ~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999999999998764 3689999999999999999999999999999999999999999999999999876655433
Q ss_pred CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCCHHHHHHHH
Q 017994 214 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLIS 291 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~ 291 (362)
.....++..|++||.+.+...+.++|+||||+++|+|++|..||...+.......... ......+ ..++..+.+++.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHH
Confidence 4456788899999999888899999999999999999999999988766555544433 2222222 234889999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~ 309 (362)
+||+.||++||++.++++
T Consensus 233 ~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHccCChhhCCCHHHHhc
Confidence 999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=314.76 Aligned_cols=243 Identities=23% Similarity=0.356 Sum_probs=194.9
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
...|.+.+.||+|+||.||++.+. ++.||||.... ..+.+|++++++++||||+++++++...+..
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~ 235 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------------ASSVHEARLLRRLSHPAVLALLDVRVVGGLT 235 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence 346999999999999999999997 57899996432 2346799999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++|||++ .++|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 236 ~lv~e~~-~~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 236 CLVLPKY-RSDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEEEEcc-CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 9999999 5699998876442 6899999999999999999999999999999999999999999999999998754332
Q ss_pred C---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCC-CCCC
Q 017994 212 G---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--------PEQAAFAVCQKNAR-PPVP 279 (362)
Q Consensus 212 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~--------~~~~~~~~~~~~~~-~~~~ 279 (362)
. ......||..|+|||++.+..++.++|||||||++|||++|..|+-... ..+....+...... ..++
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 1 1234568999999999999999999999999999999999776543211 11221111111100 0000
Q ss_pred -------------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 280 -------------------------------PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 280 -------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
..++..+.+||.+||+.||.+|||+.|+++.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1234578899999999999999999999864
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=295.96 Aligned_cols=245 Identities=27% Similarity=0.491 Sum_probs=204.2
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC---CCceeeeeEEEEeCCe
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN---HPHIITFVAACKKPPV 130 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~~ 130 (362)
.|++.+.||.|+||.||+|.+. ++.||||.+........ ...+.+|+.+++.++ |||++++++++.....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-----VSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchh-----HHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence 4777889999999999999985 68899999876433221 356778999999986 9999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
.++||||+++++|.++++.. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999999998764 588999999999999999999999999999999999999999999999998875443
Q ss_pred CC-CCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCC-CCCHHHH
Q 017994 211 CG-SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP-TCPKAFS 287 (362)
Q Consensus 211 ~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~ 287 (362)
.. ......++..|+|||.+.++ .++.++|+||||+++|+|++|..||...........+.. ...+..+. ..+.++.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 232 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-SKPPRLEDNGYSKLLR 232 (277)
T ss_pred CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc-CCCCCCCcccCCHHHH
Confidence 32 22344688899999998654 468999999999999999999999988766544333221 12223333 3788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~ 309 (362)
+++.+||+.||++||++.++++
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhh
Confidence 9999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=301.97 Aligned_cols=241 Identities=26% Similarity=0.383 Sum_probs=186.5
Q ss_pred eeeecccCCeeEEEEEEC----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe--CCeEEE
Q 017994 60 GCKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK--PPVFCI 133 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~~l 133 (362)
+++||+|+||.||+|.+. ++.||+|.+...... ..+.+|+.++++++||||+++++.+.. +...++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHADRKVWL 77 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc--------HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence 468999999999999864 467999998764332 345689999999999999999998854 467899
Q ss_pred EEecCCCCCHHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----cCCCceEEeee
Q 017994 134 ITEYLAGGSLRKYLHQQE-------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADF 202 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~----~~~~~~kl~Df 202 (362)
++||+ +++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 78 v~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 78 LFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 99998 558988876421 2258899999999999999999999999999999999999 45678999999
Q ss_pred ccccccccCC----CCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHH---------HHHHH
Q 017994 203 GISCLESQCG----SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPE---------QAAFA 268 (362)
Q Consensus 203 g~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~---------~~~~~ 268 (362)
|++....... ......+|+.|+|||++.+. .++.++|+||+|+++|+|++|.+||...... .....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 9987644321 22345789999999998764 5899999999999999999999999643321 11111
Q ss_pred HHhcCCCC------------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 269 VCQKNARP------------------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 269 ~~~~~~~~------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+......+ ......+..+.+||.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11000000 001122456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=292.99 Aligned_cols=245 Identities=24% Similarity=0.480 Sum_probs=195.9
Q ss_pred eecccCCeeEEEEEEC-C---eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEec
Q 017994 62 KFASGRHSRIYRGIYK-Q---RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 62 ~lg~G~~g~Vy~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
.||+|+||.||+|... + ..+++|.+....... ..+.+.+|+.+++.++||||+++++.+......++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSK-----EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChH-----HHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence 5899999999999754 2 245667665543221 146788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC---C
Q 017994 138 LAGGSLRKYLHQQEP--YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC---G 212 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 212 (362)
+++++|.+++..... ...+...+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++...... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999999999986432 24667778899999999999999999999999999999999999999999987532211 1
Q ss_pred CCCcccccccccChhhhhc-------CCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC----CCCCCCC
Q 017994 213 SAKGFTGTYRWMAPEMIKE-------KRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN----ARPPVPP 280 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~----~~~~~~~ 280 (362)
......++..|+|||++.. ..++.++||||||+++|+|++ |..||......+....+.... ..+..+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence 2234567889999998753 235789999999999999997 678998877766555543332 2233445
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 281 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
.+++.+.+++..|| .+|++||++.+|++.|.
T Consensus 237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 237 PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 67889999999999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=301.18 Aligned_cols=246 Identities=24% Similarity=0.394 Sum_probs=205.0
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
.|.....||+|+||.||++.+. +..||||.+...... ..+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ------RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHH------HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 3444567999999999999885 678999998653322 13567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~- 212 (362)
||||+++++|.+++... .+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 97 v~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 97 VMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 99999999999988653 48899999999999999999999999999999999999999999999999886443221
Q ss_pred CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCCHHHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 291 (362)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.... ........++..+.+++.
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 253 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHH
Confidence 2234568889999999988889999999999999999999999998877655544432211 111223356788999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~~ 310 (362)
+||..||.+||++.++++.
T Consensus 254 ~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 254 LMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHccCChhHCcCHHHHhhC
Confidence 9999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=292.97 Aligned_cols=253 Identities=28% Similarity=0.539 Sum_probs=206.5
Q ss_pred eeeeeeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC--
Q 017994 57 LFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP-- 129 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-- 129 (362)
|.+.+.||+|+||.||+|.+. +..||||++......... .+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD----IEEFLREAACMKEFDHPNVIKLIGVSLRSRAK 76 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHH----HHHHHHHHHHHhcCCCCCcceEEEEEccCCCC
Confidence 566788999999999999864 478999998764332221 356788999999999999999999886532
Q ss_pred ----eEEEEEecCCCCCHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEee
Q 017994 130 ----VFCIITEYLAGGSLRKYLHQQE----PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 201 (362)
Q Consensus 130 ----~~~lv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~D 201 (362)
..+++++|+.+++|.+++.... ...+++..++.++.|++.||+|||++||+|+||||+||+++.++.++|+|
T Consensus 77 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECc
Confidence 3478899999999998875321 22578899999999999999999999999999999999999999999999
Q ss_pred eccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC
Q 017994 202 FGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 277 (362)
Q Consensus 202 fg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 277 (362)
||++....... ......+++.|++||.+....++.++||||||+++|+|++ |.+||...+..+....+.. .....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~ 235 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK-GNRLK 235 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-CCcCC
Confidence 99987543221 1223345678999999998889999999999999999999 9999988776655444432 33344
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 278 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
.+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 4566789999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=298.10 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=203.9
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|++.+.||.|++|.||+|.+. ++.||||++........ ....+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 76 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc----cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEE
Confidence 4788999999999999999985 67899998875432221 13567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~- 212 (362)
||||+. ++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 999995 689999987655578999999999999999999999999999999999999999999999999886543322
Q ss_pred CCCcccccccccChhhhhcCC-CCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------------
Q 017994 213 SAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--------------- 276 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 276 (362)
......++..|+|||++.+.. ++.++|+||||+++|+|+||..||...+..............+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 222334678899999886644 5889999999999999999999998776654444332211110
Q ss_pred ------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...+.+++.+.++|.+||+.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 112346788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=299.10 Aligned_cols=248 Identities=28% Similarity=0.417 Sum_probs=206.0
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
..|...+.||+|+||.||+|... ++.||+|++........ ...+.+.+|+.+++.++||||+++.+++..+...+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 55888999999999999999885 78899999865432221 11356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+|+||+. |+|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 92 lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 92 LVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 9999996 58888776543 2589999999999999999999999999999999999999999999999998865433
Q ss_pred CCCcccccccccChhhhh---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
.....++..|+|||++. ...++.++||||||+++|+|++|..||...+.......+.........+..++..+.++
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (307)
T cd06607 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNF 246 (307)
T ss_pred -CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence 23456788999999874 35678899999999999999999999988777665554433322222344578899999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~~ 310 (362)
|.+||+.+|++||++.+++..
T Consensus 247 i~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 247 VDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHhcCChhhCcCHHHHhcC
Confidence 999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=305.46 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=200.8
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC---
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--- 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--- 128 (362)
..+|.+.+.||+|+||.||+|.+. ++.||||++......... ...+.+|+.++++++||||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH----AKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhH----HHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 367999999999999999999985 789999998754332221 24567899999999999999999988543
Q ss_pred ---CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 129 ---PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 129 ---~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
...|+||||+. ++|.+.+... ++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 91 EEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 5888887643 788999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--------- 276 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------- 276 (362)
.............++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+......+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 76554433445567889999999999999999999999999999999999998766543332221110000
Q ss_pred --------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 --------------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 --------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+...++.+.++|.+||+.||++||++.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 001134567899999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=311.70 Aligned_cols=251 Identities=27% Similarity=0.445 Sum_probs=224.0
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
......|.+...||.|.|+.|.+|.+. +..||||++++...+... ...+.+|+++|+.++|||||+++.+.+..
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~----~~k~~rev~imk~l~HPnIvkl~~v~~t~ 127 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK----RQKLGREVDIMKSLNHPNIVKLFSVIETE 127 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH----HHHHHHHHHHHHhcCCcceeeeeeeeeec
Confidence 344678999999999999999999886 889999999987665433 24478999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
..+|+||||+.+|.+.+++.+++ ...+..+..++.|+++|++|||+++|+|||||++||+++.+.++||+|||++..+
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceee
Confidence 99999999999999999999987 4667889999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccChhhhhcCCC-CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHH
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 287 (362)
.........+|++.|.|||++.+..| ++.+|+||+|+++|.|+.|.+||++.+-.+....+...+.+ ++..++.++.
T Consensus 206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r--Ip~~ms~dce 283 (596)
T KOG0586|consen 206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR--IPFYMSCDCE 283 (596)
T ss_pred cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec--ccceeechhH
Confidence 88778889999999999999988765 78999999999999999999999987766665555544444 4556678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~ 309 (362)
++|+++|-.+|.+|++.+++.+
T Consensus 284 ~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 284 DLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred HHHHHhhccCccccCCHHHhhh
Confidence 9999999999999999999986
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=299.80 Aligned_cols=245 Identities=24% Similarity=0.397 Sum_probs=205.8
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEE
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCII 134 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 134 (362)
|.....||.|+||.||++.+. ++.||||++....... .+.+.+|+.++..++||||+++++.+..++..+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR------RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch------HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence 444567999999999999885 7899999986543321 35677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-C
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-S 213 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 213 (362)
+||+++++|..++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 97 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 97 MEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred EecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence 9999999999988653 48899999999999999999999999999999999999999999999999886443322 2
Q ss_pred CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHH
Q 017994 214 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLISR 292 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 292 (362)
.....++..|+|||++.+..++.++|+||||+++|+|++|..||......+....+..... .......++..+.+++.+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 253 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER 253 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence 2345688999999999988899999999999999999999999987776555444322111 112334678899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 017994 293 CWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 293 ~l~~~p~~Rps~~ell~~ 310 (362)
||+.+|.+||++.++++.
T Consensus 254 ~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 254 MLTREPQERATAQELLDH 271 (297)
T ss_pred HhcCCcccCcCHHHHhhC
Confidence 999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=298.06 Aligned_cols=249 Identities=22% Similarity=0.354 Sum_probs=203.3
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||+|+||.||+|.++ ++.||+|++........ ..+.+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 76 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKM----VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLY 76 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcch----hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEE
Confidence 36889999999999999999986 68899999876433221 2356778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+|+||+++++|..+..... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred EEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999998888776543 58999999999999999999999999999999999999999999999999987543322
Q ss_pred -CCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----------------
Q 017994 213 -SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA---------------- 274 (362)
Q Consensus 213 -~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~---------------- 274 (362)
......++..|+|||++.+ ..++.++||||||+++|+|++|.+||......+....+.....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 2234567889999999865 3478899999999999999999999976654333222221000
Q ss_pred ----CC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 275 ----RP---------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 275 ----~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+ ...+.++..+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 012456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=294.81 Aligned_cols=245 Identities=24% Similarity=0.406 Sum_probs=205.3
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
.|.-.+.||.|++|.||++.+. ++.+++|++....... .+.+.+|+.+++.++||||+++++++...+..++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~ 93 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR------RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV 93 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhH------HHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence 3445578999999999999875 6789999886543221 3567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~- 212 (362)
++||+++++|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 94 VMEFLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEeccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999999999999873 58899999999999999999999999999999999999999999999999876443321
Q ss_pred CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCCHHHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-PPVPPTCPKAFSYLIS 291 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~ 291 (362)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++......+...... ...+..++..+.+++.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD 250 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHH
Confidence 223356889999999998888999999999999999999999999887766555544332111 1123347889999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~ 309 (362)
+||+.+|++||++.++++
T Consensus 251 ~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 251 RMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHcccChhhCcCHHHHcc
Confidence 999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=286.89 Aligned_cols=247 Identities=30% Similarity=0.563 Sum_probs=214.0
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|.+.+.||+|++|.||++.+. ++.|++|.+........ ....+.+|+.++.+++|||++++++++......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE----ALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHH----HHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Confidence 4788999999999999999885 67899999987644211 24678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 213 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (362)
++||+++++|.+++.... .+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 77 v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 77 ILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999999999998764 689999999999999999999999999999999999999999999999999876554332
Q ss_pred -CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Q 017994 214 -AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292 (362)
Q Consensus 214 -~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 292 (362)
.....++..|+|||...+...+.++|+|+||+++|+|++|..||............. .......+..++..+.+++.+
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQ 233 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHH
Confidence 234567889999999988888999999999999999999999998877655444443 344556677889999999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 017994 293 CWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 293 ~l~~~p~~Rps~~ell~ 309 (362)
||..+|++||++.+++.
T Consensus 234 ~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 234 CFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHhCChhhCcCHHHHhc
Confidence 99999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=294.16 Aligned_cols=248 Identities=27% Similarity=0.501 Sum_probs=210.9
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
...|.+.+.||+|++|.||++.+. +..|++|++..... ....+.+|+.+++.++|+|++++++.+......
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-------NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 356888899999999999999997 78899999976543 135678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++++||+++++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 99999999999999998765 35899999999999999999999999999999999999999999999999987643322
Q ss_pred C-CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCCCHHHHHH
Q 017994 212 G-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-PVPPTCPKAFSYL 289 (362)
Q Consensus 212 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 289 (362)
. ......++..|++||.+.+..++.++|+||||+++|+|++|..||....+......+....... ..+..++..+.++
T Consensus 170 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence 1 2233457789999999988889999999999999999999999998877765554443322222 2223478999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~ 309 (362)
|.+||+.+|.+||++.++++
T Consensus 250 i~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHhccChhhCcCHHHHhh
Confidence 99999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=294.91 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=203.5
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||.|++|.||+|.++ ++.||+|.+........ ..+.+.+|+.++++++||||+++++++......+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEG----VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLY 77 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccccc----chHHHHHHHHHHHhccCCCEeeEEEEEecCCeEE
Confidence 57999999999999999999986 67899999876433211 1356778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCceEEeeeccccccccC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFGISCLESQC 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~ 211 (362)
+||||++ ++|.+++.......+++..++.++.||+.||.|||++|++|+||+|+||+++. ++.+||+|||++......
T Consensus 78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9999995 58888887666555788899999999999999999999999999999999985 567999999998654322
Q ss_pred -CCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------------
Q 017994 212 -GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------------- 276 (362)
Q Consensus 212 -~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~------------- 276 (362)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+......+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 122334568899999988664 57899999999999999999999998876655544432211100
Q ss_pred --------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 --------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...+.+++.+.+++.+||+.+|.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 012356788999999999999999999999986
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=293.27 Aligned_cols=245 Identities=20% Similarity=0.295 Sum_probs=198.1
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeC--CeE
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKP--PVF 131 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~--~~~ 131 (362)
|.+.+.||+|+||.||+|.+. ++.||+|++........ .....+|+.++.++. |||++++++++.+. +..
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-----QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-----hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence 567889999999999999985 68899999876432221 123346888888885 99999999999887 899
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++|+||++ ++|.+.+.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++......
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 76 ALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 99999996 58888887643 25899999999999999999999999999999999999999 99999999998765544
Q ss_pred CCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------
Q 017994 212 GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--------------- 275 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--------------- 275 (362)
.......++..|+|||.+.. ..++.++|+||||+++|+|++|..||...+..+....+......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 44344567889999997654 55789999999999999999999999887665443332211100
Q ss_pred -CC-----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 -PP-----------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 -~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.. ....++..+.++|.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00 11356789999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=293.56 Aligned_cols=242 Identities=21% Similarity=0.332 Sum_probs=193.6
Q ss_pred eecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHH---HHHcCCCCceeeeeEEEEeCCeEEEEEe
Q 017994 62 KFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVA---LLFRLNHPHIITFVAACKKPPVFCIITE 136 (362)
Q Consensus 62 ~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~---~l~~l~hp~iv~~~~~~~~~~~~~lv~e 136 (362)
.||+|+||.||++.+. ++.+|||.+.......... ...+.+|.. ++...+||||+.+++.+..++..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH---HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 3899999999999985 6889999987643322111 122233433 3444579999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCCCc
Q 017994 137 YLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG 216 (362)
Q Consensus 137 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 216 (362)
|+++++|.+++..+. .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ....
T Consensus 78 ~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~ 154 (279)
T cd05633 78 LMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHA 154 (279)
T ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccC
Confidence 999999999998765 5899999999999999999999999999999999999999999999999998654332 2234
Q ss_pred ccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHhcCCCCCCCCCCCHHHHHHHHHh
Q 017994 217 FTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ--AAFAVCQKNARPPVPPTCPKAFSYLISRC 293 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 293 (362)
..++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||....... .... .........+..++..+.++|.+|
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~ 233 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTVNVELPDSFSPELKSLLEGL 233 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH-HhhcCCcCCccccCHHHHHHHHHH
Confidence 568999999999864 557899999999999999999999997543211 1111 112233456677899999999999
Q ss_pred cccCCCCCC-----CHHHHHHH
Q 017994 294 WSSSPDRRP-----HFDQIVSI 310 (362)
Q Consensus 294 l~~~p~~Rp-----s~~ell~~ 310 (362)
|..||.+|| ++.++++.
T Consensus 234 l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 234 LQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred hcCCHHHhcCCCCCCHHHHHhC
Confidence 999999999 58888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=295.05 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=198.6
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|++.+.||.|++|.||+|.++ ++.||||.+........ ...+.+|+.++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-----PFTAIREASLLKDLKHANIVTLHDIIHTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC-----chhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence 467999999999999999999986 68899999876432211 13456799999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+.+ +|.+++..... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred EEEEecCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 999999964 99999876553 6899999999999999999999999999999999999999999999999988653322
Q ss_pred C-CCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCC-------------
Q 017994 212 G-SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNAR------------- 275 (362)
Q Consensus 212 ~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~-~~~~~~~~~~~~~~------------- 275 (362)
. ......++..|+|||++.+ ..++.++||||+|+++|+|++|..||.... ..+....+......
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 1 1222346788999999875 457899999999999999999999997655 22222111110000
Q ss_pred ------------C---CCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 ------------P---PVPPTCP--KAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 ------------~---~~~~~~~--~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
. .....++ ..+.+++.+||+.+|.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0001233 77889999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=292.04 Aligned_cols=247 Identities=27% Similarity=0.396 Sum_probs=201.2
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC--CeE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--PVF 131 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~ 131 (362)
+|...+.||.|++|.||++.+. ++.+|+|.+....... ....+.+|++++++++||||+++++++... ..+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD-----LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchH-----HHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 5888999999999999999985 6889999987643321 146688899999999999999999988543 478
Q ss_pred EEEEecCCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 132 CIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
++||||+++++|.+++... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999999999987642 22358889999999999999999999999999999999999999999999999986543
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcCCCCCCC-----
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-----PEQAAFAVCQKNARPPVP----- 279 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~----- 279 (362)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+....+. ....+..+
T Consensus 157 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (287)
T cd06621 157 NSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPELKDEPGN 234 (287)
T ss_pred ccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchhhccCCCC
Confidence 322 224457888999999998889999999999999999999999997652 222222221 11111111
Q ss_pred -CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 280 -PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 280 -~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+++.+.+++.+||+.+|.+||++.|+++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 234678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=298.09 Aligned_cols=247 Identities=25% Similarity=0.460 Sum_probs=206.5
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
.+|.+.+.||+|+||.||++... +..||+|.+....... .+.+.+|+.+++.++||||+++++.+......+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK------KELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH------HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 67999999999999999999874 6789999986533221 356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+|+||+++++|.+++.+. .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999999999999764 47889999999999999999999999999999999999999999999999876443322
Q ss_pred -CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCCHHHHHHH
Q 017994 213 -SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 213 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li 290 (362)
......+++.|+|||.+....++.++|+||||+++|++++|..||...+.......+.... .....+..++..+.+++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 249 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHH
Confidence 2234467889999999988889999999999999999999999998766544333222111 11123345678899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 017994 291 SRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~~ 310 (362)
.+||..+|++||++.+++.+
T Consensus 250 ~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 250 NRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=297.52 Aligned_cols=249 Identities=23% Similarity=0.370 Sum_probs=199.5
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCCeE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPPVF 131 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~ 131 (362)
.+|...+.||+|+||.||++.+. ++.||||.+....... ....+.+|+.++.++. ||||+++++++..+...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK-----EQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChH-----HHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence 45777789999999999999986 6889999987643321 2456788999999996 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHh---hcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 132 CIITEYLAGGSLRKYLH---QQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
+++|||+. ++|.++.. ......+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 79 ~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 79 WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 99999984 46655432 22334689999999999999999999975 999999999999999999999999999875
Q ss_pred cccCCCCCcccccccccChhhhhcC---CCCCcccchhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCC----CCC
Q 017994 208 ESQCGSAKGFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVCQKNARP----PVP 279 (362)
Q Consensus 208 ~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~-~~~~~~~~~~~~~----~~~ 279 (362)
...........++..|+|||++.+. .++.++||||||+++|+|++|..||...... +...... ....+ ..+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 236 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPILSNSEE 236 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCcCCCcCC
Confidence 5443333445678899999998776 6899999999999999999999999765421 1111211 11111 122
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
..++..+.+|+.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3478899999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=296.74 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=204.3
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC--C
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--P 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~ 129 (362)
..+|.+.+.||.|+||.||+|.+. ++.+|||.+........ ....+.+|+.++.+++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG----FPITSLREINILLKLQHPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccccc----chhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence 457999999999999999999996 67899999876543311 124567899999999999999999998877 8
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
..++|+||+. ++|.+++..... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~lv~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 80 KIYMVMEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred cEEEEehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 9999999996 599999876543 58999999999999999999999999999999999999999999999999887554
Q ss_pred cC-CCCCcccccccccChhhhhcCC-CCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------------
Q 017994 210 QC-GSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA------------- 274 (362)
Q Consensus 210 ~~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~------------- 274 (362)
.. .......+++.|+|||.+.+.. .+.++|+||||+++|+|++|..||...........+.....
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 43 2223445788899999987644 68999999999999999999999987766554433321100
Q ss_pred ----------------CCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 275 ----------------RPPVPPT-CPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 275 ----------------~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...++.. +++.+.++|.+||+.+|++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0112222 5788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=311.88 Aligned_cols=245 Identities=27% Similarity=0.453 Sum_probs=201.4
Q ss_pred eeeeeecccCCeeEEEEEECCee--EEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe--EEE
Q 017994 58 FIGCKFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV--FCI 133 (362)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~--~~l 133 (362)
.....||+|+|-+||+|.|..+. ||--.+.. .+.........+|..|+.+|+.|+||||+++++++.+... +.+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~--~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKI--RDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhH--HHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence 35678999999999999997544 44222211 1111122234789999999999999999999999987755 889
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCcEEEcCC-CceEEeeecccccccc
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ--GILHRDLKSENLLLGED-MCVKVADFGISCLESQ 210 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~i~H~dlk~~Nil~~~~-~~~kl~Dfg~~~~~~~ 210 (362)
|+|.+..|+|..|+++.+ .+..+.+..|++||+.||.|||++ .|||||||-+||+|+.+ |.|||+|+|+|+....
T Consensus 121 iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 999999999999999887 588899999999999999999998 59999999999999854 8999999999987766
Q ss_pred CCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 211 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM-TPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 211 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
... ....|||.|||||+.. ..|...+||||||+.|+||+|+..||..- ++.++..++..+..+..+..--.+++++|
T Consensus 199 s~a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~f 276 (632)
T KOG0584|consen 199 SHA-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREF 276 (632)
T ss_pred ccc-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHH
Confidence 443 3489999999999987 77999999999999999999999999875 45555555554433334444446889999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~ 309 (362)
|.+||.. ..+|||+.|||+
T Consensus 277 IekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 277 IEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHhcC-chhccCHHHHhh
Confidence 9999999 899999999996
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=296.36 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=210.7
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
..|...+.||+|+||.||++.+. +..||+|++........ .....+.+|+.+++.++|||++++++++..+...+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN---EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCch---HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 34778889999999999999985 67899999875433221 12356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||+. |+|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 102 lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 102 LVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred EEEeCCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9999996 48888776543 2589999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcccccccccChhhhh---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
.....++..|+|||.+. .+.++.++|+||||+++|+|++|..||...........+............+++.+.++
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 23456788999999974 45688999999999999999999999988777666666655444444456678899999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 290 ISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
+.+||+.+|.+||++.++++.+-.+
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred HHHHccCCcccCcCHHHHHhChhhh
Confidence 9999999999999999999866543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=289.54 Aligned_cols=243 Identities=25% Similarity=0.400 Sum_probs=198.5
Q ss_pred eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHH-HHcCCCCceeeeeEEEEeCCeEEEEEec
Q 017994 61 CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVAL-LFRLNHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~-l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
+.||.|+||.||+|.+. ++.||||++........ .. ...+..|..+ ....+|||++++++.+...+..++++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~--~~-~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK--NQ-VTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH--HH-HHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 46899999999999985 67999999875432111 11 1233444444 4456899999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCCCcc
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGF 217 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 217 (362)
+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 79 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~ 153 (260)
T cd05611 79 LNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF 153 (260)
T ss_pred cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccC
Confidence 99999999998765 589999999999999999999999999999999999999999999999998865433 2345
Q ss_pred cccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHhcc
Q 017994 218 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--PPVPPTCPKAFSYLISRCWS 295 (362)
Q Consensus 218 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~ 295 (362)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+...... ......+++.+.+++.+||+
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 233 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC 233 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence 6788999999998888899999999999999999999999888776665554433222 22344678999999999999
Q ss_pred cCCCCCCCHHHHHHHH
Q 017994 296 SSPDRRPHFDQIVSIL 311 (362)
Q Consensus 296 ~~p~~Rps~~ell~~L 311 (362)
.+|++||++.++.+.|
T Consensus 234 ~~p~~R~~~~~~~~~l 249 (260)
T cd05611 234 MDPAKRLGANGYQEIK 249 (260)
T ss_pred CCHHHccCCCcHHHHH
Confidence 9999999776555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=297.52 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=203.6
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC--
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP-- 128 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-- 128 (362)
..++|.+.+.||.|+||.||+|.+. ++.||+|++......... ...+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI----PISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC----cchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 4578999999999999999999986 789999998754332211 13456799999999999999999998755
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
+..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 81 DSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred CeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 56899999995 58998887643 36899999999999999999999999999999999999999999999999998765
Q ss_pred ccCC-CCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------
Q 017994 209 SQCG-SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP---------- 276 (362)
Q Consensus 209 ~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~---------- 276 (362)
.... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+..+....+......+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 4332 2223345778999999865 457899999999999999999999999887766655444321110
Q ss_pred -------CC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 -------PV-----------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 -------~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.. ....++.+.++|.+||+.||.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 1224778899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=296.12 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=203.4
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|.+.+.||.|++|.||+|.+. ++.||||.+........ .......+.+|+.+++.++||||+++++++......++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA-KDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccc-cchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 4788899999999999999985 68999999986543311 11123566789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~- 212 (362)
||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 99999 899999998754 358999999999999999999999999999999999999999999999999987654432
Q ss_pred CCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------------
Q 017994 213 SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--------------- 276 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 276 (362)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||......+....+......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 2223356788999998865 457899999999999999999988887766544333332111000
Q ss_pred -----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 -----------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
......+..+.++|.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 011344678999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=287.85 Aligned_cols=249 Identities=30% Similarity=0.478 Sum_probs=212.8
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|++.+.||.|++|.||++.+. ++.+|+|.+........ ....+.+|+.+++.++||||+++++++......++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK----EREDAVNEIRILASVNHPNIISYKEAFLDGNKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHH----HHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEE
Confidence 4788999999999999999875 67899999876432221 13566789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 134 ITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
|+||+++++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999999999987622 235889999999999999999999999999999999999999999999999998765543
Q ss_pred CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
......+++.|++||.+.+..++.++|+||||+++|+|++|..||...+.......+. ....+..+..++.++.+++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHH
Confidence 3334567889999999998889999999999999999999999999888766555443 34445566678899999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~~ 310 (362)
+||+.+|++||++.++++.
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 235 SMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHcCCCcccCCCHHHHhcC
Confidence 9999999999999999853
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=291.05 Aligned_cols=243 Identities=27% Similarity=0.430 Sum_probs=205.3
Q ss_pred ecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCCC
Q 017994 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140 (362)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 140 (362)
||.|+||.||++.+. ++.+++|++....... ......+.+|+.++++++||||+++++.+......++++||+++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR---KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh---hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence 689999999999996 7899999987643321 12246788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC--------
Q 017994 141 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-------- 212 (362)
Q Consensus 141 ~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-------- 212 (362)
++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 78 GDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99999998765 68999999999999999999999999999999999999999999999999886543321
Q ss_pred -CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC--CCHHHHHH
Q 017994 213 -SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT--CPKAFSYL 289 (362)
Q Consensus 213 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~l 289 (362)
......++..|++||.......+.++|+||||+++|++++|..||......+....+.... ...+.. ++..+.++
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK--IEWPEDVEVSDEAIDL 233 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--cCCCccccCCHHHHHH
Confidence 1233457788999999988889999999999999999999999999888777665554423 233333 48999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~~L~ 312 (362)
+.+||+.+|.+||++.++.+.|+
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhc
Confidence 99999999999999966665553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=294.16 Aligned_cols=256 Identities=24% Similarity=0.435 Sum_probs=205.6
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeE
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVA 123 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~ 123 (362)
...|..+..+|.+.+.||+|++|.||+|.+. ++.||||++........ ...+..|+.++.+. .||||+++++
T Consensus 7 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~e~~~~~~~~~~~~i~~~~~ 81 (296)
T cd06618 7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-----NKRILMDLDVVLKSHDCPYIVKCYG 81 (296)
T ss_pred ceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH-----HHHHHHHHHHHHhccCCCchHhhhe
Confidence 3456677889999999999999999999997 78999999976433221 24455677766666 5999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCceEEeee
Q 017994 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
++..+...+++|||+ +++|.+++..... .+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+||
T Consensus 82 ~~~~~~~~~~v~e~~-~~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 82 YFITDSDVFICMELM-STCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred eeecCCeEEEEeecc-CcCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECcc
Confidence 999999999999998 4588887766432 68999999999999999999997 59999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccChhhhhcCC----CCCcccchhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCC
Q 017994 203 GISCLESQCGSAKGFTGTYRWMAPEMIKEKR----HTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVCQKNARPP 277 (362)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~~l~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~ 277 (362)
|++.............++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...... +....+... ..+.
T Consensus 160 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~ 238 (296)
T cd06618 160 GISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE-EPPS 238 (296)
T ss_pred ccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC-CCCC
Confidence 9987554433333445778999999987553 788999999999999999999999764432 333333322 2222
Q ss_pred CC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 278 VP--PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 278 ~~--~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
.+ ..++.++.+|+.+||+.||.+||++.++++.
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22 3478899999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=291.45 Aligned_cols=243 Identities=21% Similarity=0.314 Sum_probs=194.6
Q ss_pred eecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCC
Q 017994 62 KFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLA 139 (362)
Q Consensus 62 ~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 139 (362)
.||+|+||.||++.+. ++.||+|++................-...+..++..+||+|+++++.+...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999875 67999999876433221111111111123344555689999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCCCcccc
Q 017994 140 GGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 219 (362)
Q Consensus 140 ~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 219 (362)
|++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... ......|
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVG 157 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCC
Confidence 999999997654 5899999999999999999999999999999999999999999999999998654332 2334578
Q ss_pred cccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcc
Q 017994 220 TYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 295 (362)
Q Consensus 220 ~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 295 (362)
+..|+|||++.++ .++.++|+||+|+++|+|++|..||.... ...... .........+..++..+.+++.+||.
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~~~~li~~~l~ 235 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--MTLTMAVELPDSFSPELRSLLEGLLQ 235 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH--HhhccCCCCCCcCCHHHHHHHHHHhh
Confidence 9999999998754 58899999999999999999999998763 222211 12233455667789999999999999
Q ss_pred cCCCCCC-----CHHHHHH
Q 017994 296 SSPDRRP-----HFDQIVS 309 (362)
Q Consensus 296 ~~p~~Rp-----s~~ell~ 309 (362)
.+|.+|| ++.++++
T Consensus 236 ~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 236 RDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred cCHHhccCCCCCCHHHHHh
Confidence 9999999 8888885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=297.26 Aligned_cols=241 Identities=25% Similarity=0.392 Sum_probs=185.9
Q ss_pred eeeecccCCeeEEEEEEC----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE--eCCeEEE
Q 017994 60 GCKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK--KPPVFCI 133 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~--~~~~~~l 133 (362)
+.+||+|+||.||+|... +..||+|.+...... ..+.+|+.+++.++||||+++++++. .+...++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--------MSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc--------HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 468999999999999875 367999998764322 34668999999999999999999884 4567899
Q ss_pred EEecCCCCCHHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----cCCCceEEeee
Q 017994 134 ITEYLAGGSLRKYLHQQ-------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADF 202 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~----~~~~~~kl~Df 202 (362)
|+||+. ++|.+++... ....+++..++.++.|++.||.|||+.||+||||||+||++ +.++.+||+||
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 999985 5888887532 12358889999999999999999999999999999999999 46679999999
Q ss_pred ccccccccCC----CCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHH---------HHHHH
Q 017994 203 GISCLESQCG----SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPE---------QAAFA 268 (362)
Q Consensus 203 g~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~---------~~~~~ 268 (362)
|++....... ......+++.|+|||++.+. .++.++||||||+++|+|++|.+||...... .....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 9997544322 12345678999999998764 5799999999999999999999999653321 00000
Q ss_pred HHhcCC------------------------C------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 269 VCQKNA------------------------R------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 269 ~~~~~~------------------------~------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+..... . .......+..+.+|+.+||..||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 0 0001123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=301.64 Aligned_cols=254 Identities=23% Similarity=0.334 Sum_probs=206.2
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACK 126 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~ 126 (362)
-..+....|++.+.||.||.+.||++... .+.+|+|.+.....+... ..-|.+|+.+|.+| .|.+||++++|-.
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qt----l~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQT----LDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHH----HHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 34556788999999999999999999886 467788777665544332 46788999999999 5999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
.++.+||||||- ..+|.++|++... .++...+..+..||+.++.++|++||||.||||.|+|+ -.|.+||+|||.|.
T Consensus 431 ~d~~lYmvmE~G-d~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 431 TDGYLYMVMECG-DIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIAN 507 (677)
T ss_pred cCceEEEEeecc-cccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhc
Confidence 999999999976 6799999998764 34444788899999999999999999999999999998 56789999999998
Q ss_pred ccccCCC---CCcccccccccChhhhhcCC-----------CCCcccchhhhHHHHHHHhCCCCCCCCCHHHHH-HHHHh
Q 017994 207 LESQCGS---AKGFTGTYRWMAPEMIKEKR-----------HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQ 271 (362)
Q Consensus 207 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~-----------~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~-~~~~~ 271 (362)
....... ....+||+.||+||.+.... .+.++|||||||+||+|+.|++||......... ..+..
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~ 587 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD 587 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC
Confidence 6655433 34678999999999986432 467899999999999999999999886644332 23332
Q ss_pred cCCCCCCCCCCCHH-HHHHHHHhcccCCCCCCCHHHHHH
Q 017994 272 KNARPPVPPTCPKA-FSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 272 ~~~~~~~~~~~~~~-l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
-+...++|..-+.. +.++++.||+.||.+||+..+||+
T Consensus 588 P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 588 PNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred CCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 22333555444444 999999999999999999999996
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=293.08 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=202.8
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEE
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCII 134 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 134 (362)
|++.+.||.|++|.||+|.++ ++.||||++........ ....+.+|+.+++.++|||++++++++..++..+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG----VPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc----chhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEE
Confidence 567789999999999999885 78999999876533221 124567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-C
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-S 213 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 213 (362)
+||+ +++|.+++.......+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....... .
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 77 FEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred Eecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 9999 4699999987664568999999999999999999999999999999999999999999999999986543322 1
Q ss_pred CCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------------
Q 017994 214 AKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR----------------- 275 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~----------------- 275 (362)
.....++..|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+......
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 2233568889999987654 4688999999999999999999999877665443332221100
Q ss_pred ----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 ----------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
......++..+.++|.+||+.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1123456788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=292.94 Aligned_cols=249 Identities=20% Similarity=0.290 Sum_probs=199.4
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCCe--
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPPV-- 130 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~-- 130 (362)
+|++.+.||+|+||.||+|.+. ++.||||++........ ....+.+|+.+++.+. ||||+++++++...+.
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG----IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC----CchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 6889999999999999999985 68899999876432211 1256778999999995 6999999999877665
Q ss_pred ---EEEEEecCCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCceEEeeec
Q 017994 131 ---FCIITEYLAGGSLRKYLHQQE---PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFG 203 (362)
Q Consensus 131 ---~~lv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg 203 (362)
.|++|||+++ +|.+++.... ...+++..++.++.||+.||.|||++|++||||+|+||+++. ++.++|+|||
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 8988886543 235899999999999999999999999999999999999998 8899999999
Q ss_pred cccccccC-CCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----
Q 017994 204 ISCLESQC-GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP----- 276 (362)
Q Consensus 204 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~----- 276 (362)
++...... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 88654322 12223356788999998865 457899999999999999999999998876655443332211000
Q ss_pred ---------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ---------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...+.++..+.+||.+||..||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 011357788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=290.79 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=202.2
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|++.+.||.|++|.||+|.+. ++.||||++........ ...+.+|+.++++++||||+++++++...+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT-----PSTAIREISLMKELKHENIVRLHDVIHTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccc-----hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEE
Confidence 4888999999999999999986 78899999876543221 2456679999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 134 ITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
||||+++ +|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9999975 8998887644 2358999999999999999999999999999999999999999999999999986543321
Q ss_pred -CCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------
Q 017994 213 -SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-------------- 276 (362)
Q Consensus 213 -~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 276 (362)
......++..|++||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+......+
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 22334568889999988654 56889999999999999999999998776655443332211000
Q ss_pred --C-----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 --P-----------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 --~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
. ..+.++..+.+++.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 11345778999999999999999999999885
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=292.01 Aligned_cols=257 Identities=15% Similarity=0.214 Sum_probs=192.6
Q ss_pred cccCeeeeeeecccCCeeEEEEEECC-----eeEEEEEecCCCcchHHHH-----HHHHHHHHHHHHHHcCCCCceeeee
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLAS-----MLEKQFTSEVALLFRLNHPHIITFV 122 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~hp~iv~~~ 122 (362)
...+|.+.+.||+|+||.||+|.+.+ ..+|+|+............ ........+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34689999999999999999999864 3567776544332211110 0011223344556677999999999
Q ss_pred EEEEeCC----eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceE
Q 017994 123 AACKKPP----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 198 (362)
Q Consensus 123 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~k 198 (362)
+.+.... ..+++++++ ..++.+.+.... ..++..+..++.|++.||.|||+.+|+||||||+|||++.++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred EeeeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence 9775543 457888877 457877776543 357888999999999999999999999999999999999999999
Q ss_pred EeeeccccccccCC--------CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH-HHHHH-
Q 017994 199 VADFGISCLESQCG--------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFA- 268 (362)
Q Consensus 199 l~Dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~-~~~~~- 268 (362)
|+|||+++...... ......||+.|+|||+..+..++.++||||||+++|+|++|..||...... .....
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 99999987543211 122346899999999999999999999999999999999999999876322 21111
Q ss_pred ---HHhc-CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 269 ---VCQK-NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 269 ---~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
.... .........+++.+.+++..||..+|.+||++.+|++.++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 247 KCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0000 1111123456889999999999999999999999998763
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=291.08 Aligned_cols=249 Identities=23% Similarity=0.322 Sum_probs=196.7
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
..+|.+.+.||+|+||.||+|.+. +..||+|++........ ...+.+|+.+++.++|+||+++++++..+...
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-----PFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC-----cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeE
Confidence 367999999999999999999875 78999999876432221 23556899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++|+||+. ++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred EEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 99999995 67877776543 25788889999999999999999999999999999999999999999999988653322
Q ss_pred C-CCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCC--------------
Q 017994 212 G-SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVCQKNA-------------- 274 (362)
Q Consensus 212 ~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~-~~~~~~~~~~~-------------- 274 (362)
. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...... +..........
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 1 22334578899999998754 4788999999999999999999999865432 21111111000
Q ss_pred -------CCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 275 -------RPPVP---------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 275 -------~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
....+ ...+..+.+++.+|+..||.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000 112567899999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=292.12 Aligned_cols=248 Identities=27% Similarity=0.445 Sum_probs=210.8
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCCeE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPPVF 131 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~ 131 (362)
++|.+.+.||+|++|.||++.+. ++.||+|++........ ...+.+.+|+.++++++ ||||+++++++...+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 77 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE---KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENL 77 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccch---HHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceE
Confidence 36899999999999999999985 78999999876322111 11356788999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+++++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999999998765 5899999999999999999999999999999999999999999999999988754332
Q ss_pred C---------------------CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 017994 212 G---------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 270 (362)
Q Consensus 212 ~---------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~ 270 (362)
. ......++..|+|||.......+.++|+||||++++++++|..||.............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 2 1123456789999999988889999999999999999999999999877555444433
Q ss_pred hcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 017994 271 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF----DQIVS 309 (362)
Q Consensus 271 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~----~ell~ 309 (362)
......+..+++.+.+++.+||+.+|.+||++ .++++
T Consensus 236 --~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 --KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 34445677889999999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=289.57 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=202.1
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC---CCCceeeeeEEEEeCCe-
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL---NHPHIITFVAACKKPPV- 130 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~~~~~- 130 (362)
|.+.+.||+|+||.||+|.++ ++.||||++......... ...+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI----PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchh----hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence 577889999999999999986 689999999865433221 23455677766655 69999999999988776
Q ss_pred ----EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 131 ----FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 131 ----~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
.+++|||+. ++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 77 RELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred CCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 999999996 589999887654468999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------
Q 017994 207 LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP---------- 276 (362)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~---------- 276 (362)
............++..|+|||.+.+..++.++|+||||+++|+|++|.+||......+....+......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 6544433344557889999999998889999999999999999999999998877665544443211100
Q ss_pred ---------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ---------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...+.++..+.+++.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 001234567889999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=298.91 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=196.9
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC----
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP---- 128 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~---- 128 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++....... ....+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-----FCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccch-----hHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 57999999999999999999885 6889999986432221 135567899999999999999999887544
Q ss_pred -CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 129 -PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 129 -~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
...++++||+. ++|.+++... .+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 80 FNDVYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred cceEEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 35899999995 5888888654 589999999999999999999999999999999999999999999999999865
Q ss_pred cccCCC----CCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--------
Q 017994 208 ESQCGS----AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-------- 274 (362)
Q Consensus 208 ~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-------- 274 (362)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.......+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 433211 123467889999998754 4688999999999999999999999977554332221111000
Q ss_pred ----------------CCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 275 ----------------RPP-----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 275 ----------------~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
... ..+..+..+.+++.+||+.+|.+||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 113457789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=291.84 Aligned_cols=246 Identities=28% Similarity=0.426 Sum_probs=204.3
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEE
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCII 134 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 134 (362)
|...+.||+|+||.||+|.+. ++.|++|++......... ....+.+|+.+++.++|||++++++++.+....++|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE---KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 555678999999999999885 788999998764332211 135677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCC
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 214 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 214 (362)
|||+. ++|.+++.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.... ..
T Consensus 100 ~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~ 174 (313)
T cd06633 100 MEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PA 174 (313)
T ss_pred EecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CC
Confidence 99995 58888876544 358999999999999999999999999999999999999999999999999875432 23
Q ss_pred CcccccccccChhhhh---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 215 KGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 215 ~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
....++..|+|||++. ...++.++|+||||+++|+|++|..||...........+............++..+.+|+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 3456888999999974 3567889999999999999999999998877666665554433333334567788999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~~ 310 (362)
+||+.+|.+||++.+++..
T Consensus 255 ~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 255 YCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=298.50 Aligned_cols=249 Identities=19% Similarity=0.294 Sum_probs=215.7
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
.....|..-++||+||||.||-++-. |+-+|.|.+.+....... -+....+|-.+|.+++.++||.+-..|+..+
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~---ge~maLnEk~iL~kV~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRK---GETMALNEKQILEKVSSPFIVSLAYAFETKD 258 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhh---hhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence 44577888899999999999988765 777899887664333222 2355678999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.+++|+..|+||+|.-.|.+.++..+++..+..++.+|+.||++||+.+|++||+||+|||+|+.|+++|+|+|+|....
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCCCCCCCCCCHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE----QAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
........+||.+|||||++.++.|+...|.|||||++|||+.|+.||...... ++...+ ......++...+++
T Consensus 339 ~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~--~~~~~ey~~kFS~e 416 (591)
T KOG0986|consen 339 EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT--LEDPEEYSDKFSEE 416 (591)
T ss_pred CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH--hcchhhcccccCHH
Confidence 888888889999999999999999999999999999999999999999764432 222222 22334567888999
Q ss_pred HHHHHHHhcccCCCCCCCHH
Q 017994 286 FSYLISRCWSSSPDRRPHFD 305 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ 305 (362)
.++|.+.+|++||.+|....
T Consensus 417 akslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHHHHccCHHHhccCC
Confidence 99999999999999996543
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=336.87 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=216.0
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
++.-+..||.|.||.||.|+.. |...|+|-+........ ..+.+.+|..++..++|||+|+++|+=.+.+..+|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k----~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHK----TFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccc----cCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 4555778999999999999875 77789998776443321 13567789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~- 212 (362)
.||||+||+|.+.+.... ..++.....+..|++.|+.|||++|||||||||.||+++.+|.+|++|||.|.......
T Consensus 1312 FMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999999999998765 46777788899999999999999999999999999999999999999999987654432
Q ss_pred ----CCCcccccccccChhhhhcC---CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 213 ----SAKGFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 213 ----~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
.-....||+.|||||++.+. ....++|||||||++.||+||+.||...+.+..+...+..+..|.+|..++++
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 22456799999999999764 45789999999999999999999999998887776666678889999999999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
-++||..||..||..|.++.||++.
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHh
Confidence 9999999999999999988888753
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=307.72 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=230.3
Q ss_pred ccccCeeeeeeecccCCeeEEEEEECCee--EEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
...+++.....||-||||.|-++..+++. +|+|++++...-... ..+.+..|-.+|..++.|+||+++..|.+..
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtk---QqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTK---QQEHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchh---HHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 44677888889999999999999988655 788888764322111 1467788999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
+.|++||-|-||.|+..++.++ ++++.++..++..+++|++|||++|||+|||||+|++++.+|-+||.|||++....
T Consensus 494 yvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 9999999999999999999887 68999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
......+++|||.|.|||++.++..+.++|.||||+++|||++|.+||.+.++......+...-....+|..++....++
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence 98899999999999999999999999999999999999999999999999999999999998888889999999999999
Q ss_pred HHHhcccCCCCCCC-----HHHHHH
Q 017994 290 ISRCWSSSPDRRPH-----FDQIVS 309 (362)
Q Consensus 290 i~~~l~~~p~~Rps-----~~ell~ 309 (362)
|+++...+|.+|.. +.+|.+
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHh
Confidence 99999999999975 455554
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=292.49 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=198.6
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
.+.++|.+.+.||+|+||.||+|.+. ++.||||.+......... ...+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF----PITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCc----hhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 34678999999999999999999986 789999998754322211 234567999999999999999999986654
Q ss_pred --------eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEee
Q 017994 130 --------VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 201 (362)
Q Consensus 130 --------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~D 201 (362)
..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred ccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECc
Confidence 4599999995 58888887654 3589999999999999999999999999999999999999999999999
Q ss_pred eccccccccCCC-----CCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Q 017994 202 FGISCLESQCGS-----AKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 275 (362)
Q Consensus 202 fg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 275 (362)
||++........ .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999875433221 1234567889999988664 3688999999999999999999999877655433322221100
Q ss_pred C-----------------CC-------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 P-----------------PV-------------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 ~-----------------~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
. .. +...+..+.+||.+||..||.+||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 00 0112456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=290.65 Aligned_cols=241 Identities=23% Similarity=0.388 Sum_probs=202.1
Q ss_pred eeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEec
Q 017994 60 GCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
..+||+|+||.||++... ++.||||++...... ....+.+|+.+++.++||||+++++.+...+..+++|||
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ------RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchh------HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 467999999999999885 789999988653322 146688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-CCCc
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SAKG 216 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 216 (362)
+++++|.+++... .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 99 LEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 9999999988654 47889999999999999999999999999999999999999999999999876443221 2234
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHhcc
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARPPVPPTCPKAFSYLISRCWS 295 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~ 295 (362)
..++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+.... ........++..+.+++.+||+
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 567889999999988888999999999999999999999998776655443332211 1112334578899999999999
Q ss_pred cCCCCCCCHHHHHH
Q 017994 296 SSPDRRPHFDQIVS 309 (362)
Q Consensus 296 ~~p~~Rps~~ell~ 309 (362)
.+|.+||++.++++
T Consensus 256 ~~P~~R~~~~~ll~ 269 (292)
T cd06657 256 RDPAQRATAAELLK 269 (292)
T ss_pred CCcccCcCHHHHhc
Confidence 99999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=295.45 Aligned_cols=252 Identities=24% Similarity=0.411 Sum_probs=198.5
Q ss_pred eeeccc--CCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEe
Q 017994 61 CKFASG--RHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITE 136 (362)
Q Consensus 61 ~~lg~G--~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 136 (362)
..||.| +||+||++.+. ++.||||++........ ..+.+.+|+.+++.++||||+++++++..++..++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEE----HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHH----HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence 346666 89999999984 78999999876543322 13677889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC---
Q 017994 137 YLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS--- 213 (362)
Q Consensus 137 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 213 (362)
|+.+++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999999999876555689999999999999999999999999999999999999999999999985432221111
Q ss_pred -----CCcccccccccChhhhhcC--CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------
Q 017994 214 -----AKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA------------ 274 (362)
Q Consensus 214 -----~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~------------ 274 (362)
.....++..|+|||++.+. .++.++|+||||+++|+|++|..||.................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 1112345679999998764 478999999999999999999999987665443322211100
Q ss_pred ---------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhhh
Q 017994 275 ---------------------------------RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSE 316 (362)
Q Consensus 275 ---------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~~ 316 (362)
..+.+..+++.+.+|+.+||+.||++|||+.++++ .+..+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 01112335677999999999999999999999985 4554444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=291.51 Aligned_cols=249 Identities=27% Similarity=0.405 Sum_probs=205.9
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
..|...+.||.|+||.||+|++. +..+|||.+........ .....+.+|+.+++.++|||++++++++......+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccCh---HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 44777889999999999999985 67899999875322211 11356778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+|+||+. ++|.+++.... ..+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence 9999995 58888776543 2588999999999999999999999999999999999999999999999998865433
Q ss_pred CCCcccccccccChhhhh---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
.....++..|+|||.+. ...++.++||||||+++|+|++|..||...........+.........+..++..+.++
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 23456788999999975 34578899999999999999999999988776665555544333333445688899999
Q ss_pred HHHhcccCCCCCCCHHHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVSIL 311 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~~L 311 (362)
|.+||+.+|.+||++.++++..
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhCc
Confidence 9999999999999999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=288.73 Aligned_cols=247 Identities=24% Similarity=0.376 Sum_probs=201.9
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCCeEEE
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~l 133 (362)
|.+.+.||.|++|.||+|.+. ++.|+||.+........ .....+|+..+.+++ ||||+++++++..++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-----ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-----HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence 567889999999999999985 67899999876433211 123456899999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 213 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (362)
||||+ +++|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 99999 78999999876545689999999999999999999999999999999999999999999999999876554444
Q ss_pred CCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------------
Q 017994 214 AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP---------------- 276 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 276 (362)
.....++..|+|||++.. ..++.++|+||||+++++|++|.+||......+...........+
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 445667889999998754 457899999999999999999999998766544433322111100
Q ss_pred ------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
......+..+.++|.+||+.+|++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 001223678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=294.64 Aligned_cols=249 Identities=23% Similarity=0.380 Sum_probs=198.8
Q ss_pred eeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEe
Q 017994 57 LFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITE 136 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 136 (362)
+.+++.+|.|+++.||++..+++.||||++........ ..+.+.+|+.+++.++||||+++++++......+++||
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e 79 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKE----DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP 79 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchh----HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEe
Confidence 44566677777777777777789999999976532221 13678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC----
Q 017994 137 YLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG---- 212 (362)
Q Consensus 137 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 212 (362)
|+++++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999999999987655568999999999999999999999999999999999999999999999999876432211
Q ss_pred ----CCCcccccccccChhhhhcC--CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------
Q 017994 213 ----SAKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR----------- 275 (362)
Q Consensus 213 ----~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~----------- 275 (362)
......++..|+|||++.+. .++.++|+||||+++|+|++|..||..................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 12234567789999998763 5789999999999999999999999876654433222111100
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 ---------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
......++.++.+|+.+||+.||++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0011223457889999999999999999999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=276.90 Aligned_cols=253 Identities=23% Similarity=0.413 Sum_probs=214.2
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAAC 125 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~ 125 (362)
....+..+++....||.|.-|+|+++.+. +.-+|||.+.......+ .+++...+.++... ++|+||+.+|+|
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee-----~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE-----NKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH-----HHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 34456777888889999999999999997 58899999988655433 35667778877766 499999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
..+...++.||.| +..+..+++... ..+|+..+-++...++.||.||.. +||+|||+||+|||+|..|++||||||.
T Consensus 161 i~n~dV~IcMelM-s~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 161 ITNTDVFICMELM-STCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred eeCchHHHHHHHH-HHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccc
Confidence 9999999999988 667778777654 369999999999999999999986 5899999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccChhhhhcC---CCCCcccchhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCCC-
Q 017994 205 SCLESQCGSAKGFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNM-TPEQAAFAVCQKNARPPVP- 279 (362)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~~l~ell~g~~p~~~~-~~~~~~~~~~~~~~~~~~~- 279 (362)
+.............|.+.|||||.+.-. .|+.++||||||++++||.||+.||.+. ...+++..+.. ...+..+
T Consensus 239 sGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~ 317 (391)
T KOG0983|consen 239 SGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPG 317 (391)
T ss_pred cceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCc
Confidence 9988877777788899999999988643 5899999999999999999999999984 44566666655 3334433
Q ss_pred -CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 280 -PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 280 -~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...++.+.+|+..||.+|+.+||.+.+|++
T Consensus 318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 347899999999999999999999999986
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=296.81 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=202.1
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC----
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP---- 128 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~---- 128 (362)
.+|.+.+.||.|+||.||++.+. ++.||||.+......... ...+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID----AKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch----hHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 46999999999999999999986 689999998764322111 24566899999999999999999987544
Q ss_pred -CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 129 -PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 129 -~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
...++++||+ +++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 81 FNDVYIVYELM-DTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred cCcEEEEEeCC-CCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 3589999999 469999987654 589999999999999999999999999999999999999999999999999876
Q ss_pred cccC-CCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------
Q 017994 208 ESQC-GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA----------- 274 (362)
Q Consensus 208 ~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~----------- 274 (362)
.... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 5433 22234567889999998865 4688999999999999999999999977653322211111000
Q ss_pred ---------------C---CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhh
Q 017994 275 ---------------R---PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI--LEGY 314 (362)
Q Consensus 275 ---------------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~--L~~~ 314 (362)
. ....+.+++.+.++|.+||+.+|.+||++.++++. +..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 01124578889999999999999999999999975 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=297.36 Aligned_cols=248 Identities=22% Similarity=0.340 Sum_probs=199.7
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe----C
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK----P 128 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----~ 128 (362)
.+|.+.+.||.|++|.||+|.+. ++.||+|++........ ....+.+|+.++++++||||+++++++.. .
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT----LAKRTLRELKILRHFKHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccccc----chHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence 67899999999999999999886 78999999876432211 13566789999999999999999988753 3
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
...++|+||+. ++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 57899999995 68999987654 4899999999999999999999999999999999999999999999999998654
Q ss_pred ccCCC-----CCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---------
Q 017994 209 SQCGS-----AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN--------- 273 (362)
Q Consensus 209 ~~~~~-----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~--------- 273 (362)
..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 32211 123467889999999865 457899999999999999999999998765433222111100
Q ss_pred ---------------CCCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 274 ---------------ARPP-----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 274 ---------------~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.... ..+..+.++.++|.+||+.+|++||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0011 11446889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=295.86 Aligned_cols=246 Identities=25% Similarity=0.371 Sum_probs=201.6
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe-
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV- 130 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~- 130 (362)
.++|.+.+.||.|++|.||+|.+. ++.||||++........ ....+.+|+.+++.++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI----HAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhh----HHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 467999999999999999999986 67899999876432221 13556789999999999999999988766554
Q ss_pred -----EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 131 -----FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 131 -----~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
.++|+||+ +++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 77999998763 5899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-------- 276 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-------- 276 (362)
...... .....++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+......+
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 755432 3344678889999998653 67899999999999999999999998776655444332211110
Q ss_pred ---------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ---------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
......++.+.++|.+||+.+|.+||++.+|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 011245788999999999999999999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=290.52 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=201.8
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC-
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP- 129 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~- 129 (362)
..++|++.+.||.|+||.||+|.++ ++.||||++........ ....+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG----FPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC----chHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 3567999999999999999999986 67899999876432211 1245678999999999999999999987654
Q ss_pred ---------eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEe
Q 017994 130 ---------VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 200 (362)
Q Consensus 130 ---------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~ 200 (362)
.+++|+||+++ ++.+.+.... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeC
Confidence 79999999965 7878776643 368999999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCC--CCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-
Q 017994 201 DFGISCLESQCGS--AKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP- 276 (362)
Q Consensus 201 Dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~- 276 (362)
|||.+........ .....++..|+|||.+.+. .++.++||||||+++++|++|.+||......+....+......+
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9999875443221 1223457789999988653 46899999999999999999999998766555443333211110
Q ss_pred ---------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ---------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.....+|..+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 012246889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=291.41 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=196.1
Q ss_pred CeeeeeeecccCCeeEEEEEEC----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC--C
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--P 129 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~ 129 (362)
+|.+.+.||+|++|.||+|.+. +..||||.+........ .....+.+|+.+++.++||||+++++++... .
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT---GISQSACREIALLRELKHENVVSLVEVFLEHADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccccc---CccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence 4788899999999999999984 57899999987431100 0124567899999999999999999999888 8
Q ss_pred eEEEEEecCCCCCHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC----CCceEEeee
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEP---YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE----DMCVKVADF 202 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~----~~~~kl~Df 202 (362)
.+++||||++ ++|.+++..... ..+++..++.++.|++.||.|||+.+++||||||+||+++. ++.+||+||
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 78 SVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred eEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 8999999995 478777754321 25889999999999999999999999999999999999999 999999999
Q ss_pred ccccccccCCC----CCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHH---------HHHH
Q 017994 203 GISCLESQCGS----AKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ---------AAFA 268 (362)
Q Consensus 203 g~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~---------~~~~ 268 (362)
|++........ .....++..|+|||++.+. .++.++|+||||+++|+|++|..||....... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99875433222 2344678889999988764 57899999999999999999999997654321 0000
Q ss_pred HHh------------------------cCCCCCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 269 VCQ------------------------KNARPPVP-----------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 269 ~~~------------------------~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+.. .......+ ...+..+.+++.+||+.||.+|||+.++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 00111111 145678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=288.53 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=201.6
Q ss_pred CeeeeeeecccCCeeEEEEEE-----CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCC
Q 017994 56 QLFIGCKFASGRHSRIYRGIY-----KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPP 129 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 129 (362)
+|++.+.||.|+||.||++.+ ++..||+|++....... .....+.+.+|+.++.++ +||||+++++.+..+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ--KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh--cchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence 478899999999999999987 46789999987532211 111235677899999999 5999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
..++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999999998764 58899999999999999999999999999999999999999999999999887543
Q ss_pred cCC--CCCcccccccccChhhhhcC--CCCCcccchhhhHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCCCCCCC
Q 017994 210 QCG--SAKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMTP----EQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 210 ~~~--~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~ 281 (362)
... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||..... ....... ....++.+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 234 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQE 234 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCCcc
Confidence 321 22345688899999998753 467899999999999999999999974322 2222222 2234456677
Q ss_pred CCHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017994 282 CPKAFSYLISRCWSSSPDRRP-----HFDQIVS 309 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 309 (362)
+++.+.+++.+||+.+|.+|| ++.++++
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 889999999999999999997 6666664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=287.84 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=203.7
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEE
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCII 134 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 134 (362)
|.+.+.||.|++|.||++... ++.+++|.+........ ....+.+|+.++++++||||+++++++..+...+++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG----IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccch----hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEE
Confidence 566788999999999999985 78899999876543321 235677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-C
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-S 213 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 213 (362)
+||+++ +|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 77 ~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 77 FEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred EeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 999965 8888887644 368999999999999999999999999999999999999999999999999887654433 2
Q ss_pred CCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------------
Q 017994 214 AKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP---------------- 276 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 276 (362)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2334577889999998776 78999999999999999999999998877655443332211110
Q ss_pred ------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...+.++..+.++|.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 012346788999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=281.18 Aligned_cols=237 Identities=27% Similarity=0.371 Sum_probs=204.4
Q ss_pred ecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCCC
Q 017994 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140 (362)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 140 (362)
||.|+||.||++.+. ++.+|+|++........ .....+..|+.++++++||||+++++.+..+...+++|||+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR---KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch---HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence 689999999999986 68899999876533221 1245778899999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-CCCCcccc
Q 017994 141 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GSAKGFTG 219 (362)
Q Consensus 141 ~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 219 (362)
++|.+++.... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......+
T Consensus 78 ~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 78 GELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence 99999998765 5899999999999999999999999999999999999999999999999998765443 23345567
Q ss_pred cccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCC
Q 017994 220 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 299 (362)
Q Consensus 220 ~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 299 (362)
+..|++||...+...+.++|+||||+++|++++|..||...+.......+.. .....+...+..+.+++.+||..||+
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~ 233 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPT 233 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHh
Confidence 8899999999888889999999999999999999999988776554444433 44567778899999999999999999
Q ss_pred CCCCHHH
Q 017994 300 RRPHFDQ 306 (362)
Q Consensus 300 ~Rps~~e 306 (362)
+||++.+
T Consensus 234 ~R~~~~~ 240 (250)
T cd05123 234 KRLGSGG 240 (250)
T ss_pred hCCCccc
Confidence 9999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=287.99 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=205.6
Q ss_pred CeeeeeeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCC
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPP 129 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 129 (362)
+|.+.+.||+|++|.||++.+. ++.||||++....... .....+.+.+|+.++.++ +||||+++++.+..+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~--~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQ--KAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHh--hhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence 4788899999999999999753 5679999987532211 111245678899999999 6999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
..++||||+.+++|.+++.... .+++..+..++.|++.+|.|||+.|++|+||+|.||+++.++.++|+|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999999997654 58899999999999999999999999999999999999999999999999886543
Q ss_pred cCC--CCCcccccccccChhhhhcCC--CCCcccchhhhHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCCCCCCC
Q 017994 210 QCG--SAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMTP----EQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 210 ~~~--~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~~l~ell~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~ 281 (362)
... ......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||..... ....... .....+.+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 234 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFPKT 234 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCCcc
Confidence 322 122346788999999987654 78899999999999999999999964322 1222222 2233456677
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 313 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 313 (362)
++..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 88999999999999999999999888777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=286.19 Aligned_cols=247 Identities=24% Similarity=0.341 Sum_probs=201.6
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC--CeEE
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--PVFC 132 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~ 132 (362)
|.+.+.||.|++|.||+|.+. ++.+|+|++........ ....+.+|+.+++.++|||++++++++... +..+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 76 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEG----FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY 76 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccccccc----chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEE
Confidence 567889999999999999986 58899999987642211 135677899999999999999999999888 8999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+|+||++ ++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 77 MVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred EEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9999996 48999887653 368999999999999999999999999999999999999999999999999987654432
Q ss_pred --CCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------------
Q 017994 213 --SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------------- 276 (362)
Q Consensus 213 --~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~------------- 276 (362)
......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+......+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 1233456788999998765 457899999999999999999999998877655444332211100
Q ss_pred ----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ----------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.....+++.+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 001113788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=295.33 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=208.4
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC----
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP---- 129 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~---- 129 (362)
+|.+.+.||.|++|.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI----DAKRILREIKLLRHLRHENIIGLLDILRPPSPEDF 76 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccch----hhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccc
Confidence 4888999999999999999986 68899999876432111 1366788999999999999999999987775
Q ss_pred -eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 130 -VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 130 -~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
..|++|||++ ++|.+++.... .+++..++.++.|++.||.+||+.|++|+||||.||+++.++.++|+|||++...
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 77 NDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred cceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 8899999996 58999987654 6899999999999999999999999999999999999999999999999998865
Q ss_pred ccCC----CCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------
Q 017994 209 SQCG----SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------ 277 (362)
Q Consensus 209 ~~~~----~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------ 277 (362)
.... ......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||.+.+..+....+......+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 5432 23345678899999999887 789999999999999999999999988776554444332211110
Q ss_pred -----------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhh
Q 017994 278 -----------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI--LEGY 314 (362)
Q Consensus 278 -----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~--L~~~ 314 (362)
..+.++..+.++|.+||+.+|.+||++.+++.. ++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 123467889999999999999999999999973 5444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=293.66 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=198.9
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeC--C
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKP--P 129 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~--~ 129 (362)
.+|.+.+.||+|+||.||+|.+. ++.+|||.+......... ...+.+|+.++.++ +||||+++++++... .
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~----~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD----AQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchh----hhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 57889999999999999999985 688999988653222111 24566899999999 999999999988643 4
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
..++||||+. ++|..++... .+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 6899999996 5999988764 47888999999999999999999999999999999999999999999999887543
Q ss_pred cCC------CCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------
Q 017994 210 QCG------SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR------- 275 (362)
Q Consensus 210 ~~~------~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~------- 275 (362)
... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 321 1223457889999998754 45788999999999999999999999876654433222111100
Q ss_pred ----------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 276 ----------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 276 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
....+.++.++.++|.+||+.+|++||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 01123368899999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=292.36 Aligned_cols=246 Identities=22% Similarity=0.362 Sum_probs=200.4
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC--
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP-- 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-- 129 (362)
..+|.+.+.||.|+||.||++.+. +..||||++........ ....+.+|+.+++.++||||+++++++..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchH----HHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 467999999999999999999885 68899999865432211 2356778999999999999999999987554
Q ss_pred ----eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 130 ----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 130 ----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
.+++||||+ +++|.+++... .+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 468999999 78999888753 5899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--------- 275 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--------- 275 (362)
..... ......+++.|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......+......
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 166 RQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred ccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 75433 2234467889999999876 45789999999999999999999999876654333322211100
Q ss_pred --------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 --------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
......++..+.++|.+|++.||.+||++.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0112456778999999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=320.57 Aligned_cols=255 Identities=21% Similarity=0.310 Sum_probs=220.4
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
.+....++|.+.+.||+|+||.|..+.++ ++.+|.|++.+-.- +...-...|..|-.+|...+.+=|+.++..|.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eM---lKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEM---LKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHH---hhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 34456789999999999999999999997 67899999876211 10111356778999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
++.++|+||||++||+|..++.+.. .+|++.+..++..|+.||..||+.|+|||||||+|||+|..|++||+|||.+-
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence 9999999999999999999999876 69999999999999999999999999999999999999999999999999887
Q ss_pred ccccCCC--CCcccccccccChhhhhc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 017994 207 LESQCGS--AKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP 279 (362)
Q Consensus 207 ~~~~~~~--~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (362)
.+...+. ....+|||.|.+||++.. +.|+..+|.||+|+++|||+.|..||...+-.++...+........+|
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP 303 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence 6654433 456789999999999853 468999999999999999999999999988888888888776666666
Q ss_pred --CCCCHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 017994 280 --PTCPKAFSYLISRCWSSSPDRRPH---FDQIVS 309 (362)
Q Consensus 280 --~~~~~~l~~li~~~l~~~p~~Rps---~~ell~ 309 (362)
..+|+..++||.+.+. +|..|.+ ++++..
T Consensus 304 ~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 304 DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 6689999999999987 6788877 777775
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=283.52 Aligned_cols=239 Identities=20% Similarity=0.331 Sum_probs=193.1
Q ss_pred cCeeeeeee--cccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCC
Q 017994 55 SQLFIGCKF--ASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPP 129 (362)
Q Consensus 55 ~~~~~~~~l--g~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 129 (362)
.+|.+.+.+ |+|+||.||++..+ +..+|+|++....... .|+.....+ +||||+++++.+...+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----------~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----------IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 456665555 99999999999986 6789999986542211 122222222 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-ceEEeeecccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGISCLE 208 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg~~~~~ 208 (362)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999999998765 689999999999999999999999999999999999999988 9999999988654
Q ss_pred ccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHH-H-HhcCCCCCCCCCCCHHH
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-V-CQKNARPPVPPTCPKAF 286 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~l 286 (362)
.. .....++..|+|||++.+..++.++|+||||+++|+|++|..||........... . .........+..+++.+
T Consensus 161 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T PHA03390 161 GT---PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA 237 (267)
T ss_pred CC---CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence 32 2344678899999999988899999999999999999999999986543322111 1 11123334556789999
Q ss_pred HHHHHHhcccCCCCCCC-HHHHHH
Q 017994 287 SYLISRCWSSSPDRRPH-FDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps-~~ell~ 309 (362)
.++|.+||+.+|.+||+ ++++++
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhc
Confidence 99999999999999995 688874
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=312.52 Aligned_cols=262 Identities=29% Similarity=0.573 Sum_probs=227.8
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC---------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCce
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~i 118 (362)
.|+++.+++.+.+.||.|.||+|++|... ...||||.+.......+ .+.+..|+.+|+.+ .||||
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~-----~~~~~~El~~m~~~g~H~ni 364 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSE-----KKDLMSELNVLKELGKHPNI 364 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHH-----HHHHHHHHHHHHHhcCCcch
Confidence 79999999999999999999999999754 35799999987665532 47788999999998 59999
Q ss_pred eeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcC------C--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 017994 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQE------P--------YSVPLNLVLKLALDIARGMQYLHSQGILHRDL 184 (362)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~--------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dl 184 (362)
+.++|.+...+.+++|+||+..|+|.++++... . ..++....+.++.||+.|++||++.+++||||
T Consensus 365 v~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDL 444 (609)
T KOG0200|consen 365 VNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDL 444 (609)
T ss_pred hhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhh
Confidence 999999999999999999999999999998765 0 13888999999999999999999999999999
Q ss_pred CCCcEEEcCCCceEEeeeccccccccCCCC--Cccc--ccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCC
Q 017994 185 KSENLLLGEDMCVKVADFGISCLESQCGSA--KGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 259 (362)
Q Consensus 185 k~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~--~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~ 259 (362)
..+|||++.+..+||+|||+++........ .... -...|||||.+....++.++||||+|++|||+++ |..||.+
T Consensus 445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 445 AARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999853332211 1111 3456999999999999999999999999999999 9999999
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 017994 260 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
......+......+.+...|..+++++.+++..||+.+|++||++.++.+.++...
T Consensus 525 ~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 525 IPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 77344445567788888999999999999999999999999999999999999854
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=292.40 Aligned_cols=252 Identities=19% Similarity=0.264 Sum_probs=200.8
Q ss_pred cCee-eeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHH--------HHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 55 SQLF-IGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLA--------SMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 55 ~~~~-~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~--------~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
.+|. +.+.||.|+||.||+|.+. ++.||||++.......... ......+.+|+.++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4555 4577999999999999976 7889999987643321100 001135678999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
++...+..+++|||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999999996 69999997654 58999999999999999999999999999999999999999999999999
Q ss_pred cccccccC---------------CCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHH
Q 017994 204 ISCLESQC---------------GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF 267 (362)
Q Consensus 204 ~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~ 267 (362)
++...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 88654311 111223457789999998764 46899999999999999999999998877665544
Q ss_pred HHHhcCCCCC--------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 268 AVCQKNARPP--------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 268 ~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+......+. .....+..+.++|.+||+.+|.+||++.+++.
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 4332111110 11345778999999999999999999999995
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=283.06 Aligned_cols=251 Identities=27% Similarity=0.453 Sum_probs=203.9
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|.+.+.||+|+||.||++.+. +..+++|++........ .......+..|+.+++.++||||+++++++.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL-NPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEecccccccc-CcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 4888999999999999999886 34566666654221100 00012346678999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 134 ITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
|+||+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||.+......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 99999999999998642 2236899999999999999999999999999999999999975 56999999988654332
Q ss_pred -CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 212 -GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 212 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+. ....+..+..++.++.++|
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 237 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSIM 237 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHHH
Confidence 22334567889999999988888999999999999999999999998766655544443 2344555677889999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 017994 291 SRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~ 309 (362)
.+||..+|++||++.++++
T Consensus 238 ~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 238 QSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHhcCChhhCcCHHHHhh
Confidence 9999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=278.12 Aligned_cols=245 Identities=23% Similarity=0.363 Sum_probs=206.1
Q ss_pred ccCeeee-eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEe--
Q 017994 54 MSQLFIG-CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKK-- 127 (362)
Q Consensus 54 ~~~~~~~-~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~-- 127 (362)
+++|.+. ++||-|-.|.|-.+..+ ++.+|+|++... ....+|+++-... .|||||.++++|+.
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----------~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----------PKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----------HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 4566664 57999999999999887 789999998753 3345788887766 69999999998853
Q ss_pred --CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCceEEeee
Q 017994 128 --PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADF 202 (362)
Q Consensus 128 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~---~~~~kl~Df 202 (362)
...+.+|||.++||.|...++.++...+++.++..|+.||..|+.|||+.+|.||||||+|+|.+. +..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 467889999999999999999999888999999999999999999999999999999999999964 457999999
Q ss_pred ccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCC--
Q 017994 203 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP----EQAAFAVCQKNARP-- 276 (362)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~----~~~~~~~~~~~~~~-- 276 (362)
|++..........+.+.|+.|.|||++....|+...|+||+|++||-|++|.+||....- ......+.......
T Consensus 209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 209 GFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred ccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 999887766677788899999999999999999999999999999999999999976432 12223333222222
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+-...+|++.+++|+.+|..+|.+|.++.++++
T Consensus 289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 222457888999999999999999999999885
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=291.90 Aligned_cols=245 Identities=20% Similarity=0.337 Sum_probs=196.4
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC----
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP---- 128 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~---- 128 (362)
++|.+.+.||.|+||.||+|.+. +..||+|++....... .+.+.+|+.++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~------~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS------VKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCch------HHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 68999999999999999999986 6789999987654422 35677899999999999999998766543
Q ss_pred ----------CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCce
Q 017994 129 ----------PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCV 197 (362)
Q Consensus 129 ----------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~-~~~~ 197 (362)
...++|+||++ ++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||+++. ++.+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence 36799999996 5898888653 4889999999999999999999999999999999999974 5678
Q ss_pred EEeeeccccccccCCC----CCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 017994 198 KVADFGISCLESQCGS----AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 272 (362)
Q Consensus 198 kl~Dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 272 (362)
+|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....+..........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999875432211 123356888999998754 45788999999999999999999999876654433332211
Q ss_pred C-----------------------CCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 273 N-----------------------ARP-----PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 273 ~-----------------------~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
. ... ...+.++.++.+|+.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 000 012356788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.54 Aligned_cols=255 Identities=18% Similarity=0.285 Sum_probs=189.0
Q ss_pred ccCeeeeeeecccCCeeEEEEEECC---eeEEEEEecCCCcc-----------hHHHHHHHHHHHHHHHHHHcCCCCcee
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYKQ---RDVAIKLVSQPEED-----------ASLASMLEKQFTSEVALLFRLNHPHII 119 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~vavK~~~~~~~~-----------~~~~~~~~~~~~~Ei~~l~~l~hp~iv 119 (362)
..+|.+.+.||+|+||+||++..+. ..+++|.+...... ..........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987642 22222211111000 000111245678999999999999999
Q ss_pred eeeEEEEeCCeEEEEEecCCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc
Q 017994 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQE---PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 196 (362)
Q Consensus 120 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~ 196 (362)
++++++...+..|++++++ +++|.+++.... ........+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999998 568888775432 112345678889999999999999999999999999999999999
Q ss_pred eEEeeeccccccccCC--CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCC-CCCCC--CHHHHHHHHHh
Q 017994 197 VKVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALT-PFDNM--TPEQAAFAVCQ 271 (362)
Q Consensus 197 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~-p~~~~--~~~~~~~~~~~ 271 (362)
+||+|||++....... ......|+..|+|||++.+..++.++|||||||++|||++|.. |+... .+......+..
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~ 385 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence 9999999997654322 2334679999999999999999999999999999999999765 44332 22222221111
Q ss_pred cCC---------------------CC----C-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 272 KNA---------------------RP----P-----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 272 ~~~---------------------~~----~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
... .. . ....++.++.++|.+||+.||.+||++.|+++
T Consensus 386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00 0 01134567888899999999999999999986
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=288.58 Aligned_cols=247 Identities=23% Similarity=0.365 Sum_probs=198.9
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe-CCe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK-PPV 130 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~~ 130 (362)
..+|.+.+.||.|+||.||++.+. ++.||||++........ ..+.+.+|+.+++.++||||+++.+++.. ...
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV----LAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccc----hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 367999999999999999999876 67899998865432211 13567789999999999999999999865 567
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
.++++||+ +++|.++++.. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 89999998 67999888754 478888999999999999999999999999999999999999999999999875433
Q ss_pred CCCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----------------
Q 017994 211 CGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK----------------- 272 (362)
Q Consensus 211 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~----------------- 272 (362)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+...
T Consensus 161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 2234467888999998765 56899999999999999999999999876653322111110
Q ss_pred -------CCCCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 273 -------NARPP-----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 273 -------~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
..... ..+.++..+.++|.+||+.+|++||++.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00001 113467899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=290.30 Aligned_cols=247 Identities=24% Similarity=0.329 Sum_probs=198.9
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC---
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--- 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--- 128 (362)
.++|.+.+.||+|+||.||++.+. ++.||+|++........ ..+.+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----HAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhH----HHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 478999999999999999999875 78899999876432211 135577899999999999999999988543
Q ss_pred ---CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 129 ---PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 129 ---~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
...+++++++ +++|.+++... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~ 167 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence 3478888887 88999888754 4899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--------- 275 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--------- 275 (362)
..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+......
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 168 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 75432 2334567889999999866 46789999999999999999999999876654433322211100
Q ss_pred ---------------C-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 276 ---------------P-----PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 276 ---------------~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
+ ......++.+.++|.+||+.||.+||++.+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 0112357789999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=287.11 Aligned_cols=250 Identities=21% Similarity=0.318 Sum_probs=196.6
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC---
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--- 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--- 128 (362)
..+|.+.+.||.|+||.||+|.+. ++.+|||++......... ...+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF----PITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc----chhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 578999999999999999999986 678999988654322111 13456799999999999999999887443
Q ss_pred -----CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 129 -----PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 129 -----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
..+++|+||+. ++|...+.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 83 ~~~~~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 83 SKRKRGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ccccCceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 35799999995 47877776543 369999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCC------------CcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 017994 204 ISCLESQCGSA------------KGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 270 (362)
Q Consensus 204 ~~~~~~~~~~~------------~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~ 270 (362)
++......... ....+++.|+|||.+.+. .++.++||||||+++|+|++|.+||.+.+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 98754332211 123457889999987654 57899999999999999999999998776655443332
Q ss_pred hcCCCC---------------------CC-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 271 QKNARP---------------------PV-------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 271 ~~~~~~---------------------~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.....+ .. ...+++.+.+++.+||+.+|.+||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 211100 00 0234467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=290.09 Aligned_cols=255 Identities=24% Similarity=0.385 Sum_probs=202.0
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
.|.+ ..+|.+.+.||+|+||.||+|.+. ++.||||++........ ....+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 10 VWEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI----FAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred hhcc-ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccccc----chhHHHHHHHHHHhcCCCCccchhheec
Confidence 3444 357999999999999999999875 78999999876432211 1345778999999999999999999986
Q ss_pred eC------CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEe
Q 017994 127 KP------PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 200 (362)
Q Consensus 127 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~ 200 (362)
.. ...++|+||+. .+|..++. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~ 159 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKIL 159 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEe
Confidence 54 34699999995 47777653 248899999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----
Q 017994 201 DFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR---- 275 (362)
Q Consensus 201 Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~---- 275 (362)
|||++..... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.......+......
T Consensus 160 dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 160 DFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred eCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999865432 2234567889999999876 45889999999999999999999999887655444332221100
Q ss_pred -----------------CC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhh
Q 017994 276 -----------------PP--------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYS 315 (362)
Q Consensus 276 -----------------~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 315 (362)
+. ..+..++.+.++|.+||+.||.+||++.+++. .++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00 01246678999999999999999999999995 365543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=301.23 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=200.6
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC------
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP------ 128 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------ 128 (362)
+...+.||+|+||.||+|..+ |+.||||.++....... .+...+|+++|++++|||||++.++=+..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~-----~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP-----RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccch-----HHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 445567999999999999976 89999999987542221 46677899999999999999999875443
Q ss_pred CeEEEEEecCCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc--CCC--ceEEeeec
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG--EDM--CVKVADFG 203 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~--~~~--~~kl~Dfg 203 (362)
....+|||||.||+|...+++-. ..++++..++.++.++..||.|||++||+||||||.||++- .+| ..||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 35689999999999999998532 25799999999999999999999999999999999999983 323 58999999
Q ss_pred cccccccCCCCCcccccccccChhhhh-cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCC----
Q 017994 204 ISCLESQCGSAKGFTGTYRWMAPEMIK-EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE----QAAFAVCQKNA---- 274 (362)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~----~~~~~~~~~~~---- 274 (362)
.|+............||..|.+||+.. .+.|+..+|.||||+++|+++||..||...... +....+...+.
T Consensus 170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 999888877788899999999999998 488999999999999999999999999653222 23332222111
Q ss_pred ---------------CCCCCCCCCHH----HHHHHHHhcccCCCCCC--CHHHHHHHHHhhh
Q 017994 275 ---------------RPPVPPTCPKA----FSYLISRCWSSSPDRRP--HFDQIVSILEGYS 315 (362)
Q Consensus 275 ---------------~~~~~~~~~~~----l~~li~~~l~~~p~~Rp--s~~ell~~L~~~~ 315 (362)
..+++..++.. +-..+..+|..+|.+|- .+.+....++.+.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 11234444444 33567778888888887 6666666665544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=315.33 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=190.8
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC--
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP-- 128 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-- 128 (362)
...+|+....||+||||.||+++.+ |+.+|||++.....+.. ...+.+|+.++.+|+|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~-----~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKL-----YSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHH-----HHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 4567778899999999999999886 89999999988753222 35678899999999999999987533110
Q ss_pred --------------------------------------------------------------------------------
Q 017994 129 -------------------------------------------------------------------------------- 128 (362)
Q Consensus 129 -------------------------------------------------------------------------------- 128 (362)
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence
Q ss_pred -------------------------------------CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHH
Q 017994 129 -------------------------------------PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGM 171 (362)
Q Consensus 129 -------------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l 171 (362)
-.+||-||||+..+|.++++.+.... ....+|+++++|++||
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGL 710 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHH
Confidence 12789999999988888888765321 4678999999999999
Q ss_pred HHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc-------------------cCCCCCcccccccccChhhhhcC
Q 017994 172 QYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES-------------------QCGSAKGFTGTYRWMAPEMIKEK 232 (362)
Q Consensus 172 ~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~~ 232 (362)
.|+|+.|||||||||.||+++.++.|||+|||+++... ......+.+||.-|+|||++.+.
T Consensus 711 aYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 711 AYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99999999999999999999999999999999998611 00122456799999999999765
Q ss_pred C---CCCcccchhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 017994 233 R---HTKKVDVYSFGIVLWELLTALTPFDNM-TPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRCWSSSPDRRPHFDQ 306 (362)
Q Consensus 233 ~---~~~~~Dv~slG~~l~ell~g~~p~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~e 306 (362)
. |+.|+|+||||++++||+ .||... .....+........+.+ +...--+.-..+|.+|++.||++|||+.|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 4 999999999999999998 456542 22233333221111111 01111234567999999999999999999
Q ss_pred HHH
Q 017994 307 IVS 309 (362)
Q Consensus 307 ll~ 309 (362)
|+.
T Consensus 868 LL~ 870 (1351)
T KOG1035|consen 868 LLN 870 (1351)
T ss_pred Hhh
Confidence 986
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=286.08 Aligned_cols=247 Identities=22% Similarity=0.289 Sum_probs=194.7
Q ss_pred CeeeeeeecccCCeeEEEEEEC----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEe---
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKK--- 127 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~--- 127 (362)
+|.+.+.||+|+||.||++.+. +..||||++........ ..+.+.+|+.+++++ +||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 76 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKI----LAKRALRELKLLRHFRGHKNITCLYDMDIVFPG 76 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccch----hHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence 4788899999999999999986 45899999875322211 135677899999999 59999999987543
Q ss_pred -CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 128 -PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 128 -~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
....+++++|+ +++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 77 ~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 77 NFNELYLYEELM-EADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred cCCcEEEEEecc-cCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 24678999988 469999987654 58999999999999999999999999999999999999999999999999987
Q ss_pred ccccCC-----CCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------
Q 017994 207 LESQCG-----SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA------ 274 (362)
Q Consensus 207 ~~~~~~-----~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~------ 274 (362)
...... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+.......+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 543221 1233568899999998765 4689999999999999999999999987654333222111100
Q ss_pred --------------------CC---CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 275 --------------------RP---PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 275 --------------------~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.. ...+..+..+.+++.+||+.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 112345788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=281.10 Aligned_cols=247 Identities=26% Similarity=0.369 Sum_probs=201.9
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEE
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCII 134 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 134 (362)
|++.+.||+|++|.||+|+.. ++.||+|++........ ..+.+.+|+.+++.++|||++++++++...+..++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG----IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccccc----ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEE
Confidence 556788999999999999986 68999999987542211 135667899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-C
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-S 213 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 213 (362)
+||++ ++|.+++.... ..+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||.+....... .
T Consensus 77 ~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 77 FEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred ecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 99996 59999998763 258999999999999999999999999999999999999999999999999887554332 2
Q ss_pred CCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------------
Q 017994 214 AKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR----------------- 275 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~----------------- 275 (362)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2334557789999998776 7899999999999999999999999887655443332211000
Q ss_pred --C--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 --P--------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 --~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+ ...+..+..+.++|.+||..+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 011234778999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=293.24 Aligned_cols=244 Identities=25% Similarity=0.397 Sum_probs=207.1
Q ss_pred eeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEe
Q 017994 59 IGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITE 136 (362)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 136 (362)
..+.||.|-||+||-|++. |+.||||++.+....... +..+.+|+.+|+++.||+||.+.-.|+..+..+.|||
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq----esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME 643 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ----ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME 643 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCch----HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence 3578999999999999986 899999999885443322 3677889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CceEEeeeccccccccCCC
Q 017994 137 YLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---MCVKVADFGISCLESQCGS 213 (362)
Q Consensus 137 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~---~~~kl~Dfg~~~~~~~~~~ 213 (362)
.+.| +..++|-......+++.....++.||+.||.|||-++|+|+||||+|||+... -.+||||||+++......-
T Consensus 644 Kl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 644 KLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 9955 66666654444579999999999999999999999999999999999999644 3799999999999888777
Q ss_pred CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--CCCCCCCCCHHHHHHHH
Q 017994 214 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA--RPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~ 291 (362)
....+|||.|+|||++.++.|...-|+||+|+++|--++|..||..... ...++....+ .+.....++....+||.
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~PW~eis~~AidlIn 800 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNPWSEISPEAIDLIN 800 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCchhhcCHHHHHHHH
Confidence 8889999999999999999999999999999999999999999976432 3333333222 23334567889999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~ 309 (362)
.+|+..-.+|.|..+-++
T Consensus 801 ~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 801 NLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred HHHHHHHHHhcchHhhcc
Confidence 999999999999887765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=307.31 Aligned_cols=148 Identities=26% Similarity=0.464 Sum_probs=132.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
+.+|.+.++||.|+||.||+|.+. ++.||||++....... ......+..|+.++..++||||+++++.+......
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~---~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN---KNMVHQVQAERDALALSKSPFIVHLYYSLQSANNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC---HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEE
Confidence 467999999999999999999997 7899999997643221 11246678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
|+||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 80 ~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999998654 58889999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=284.56 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=211.7
Q ss_pred cccccCeeeeeeecccCCeeEEEEEECC--eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEe
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKK 127 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~ 127 (362)
.+...+|....+||.|+||+|-+|..++ +.+|||++++.-.-.... .+--..|-++|..- +-|+++.++..|..
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDD---vectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDD---VECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCc---ccceehhhhheecCCCCchHHHHHHHhhh
Confidence 4557889999999999999999998874 579999988753211100 01123466777655 57899999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
-+.+|+||||+.||+|--.+++-+ .+.+..+..++.+|+.||-+||++||++||||.+|||++.+|++||.|||++..
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence 999999999999999999998877 577888999999999999999999999999999999999999999999999975
Q ss_pred ccc-CCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHH
Q 017994 208 ESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286 (362)
Q Consensus 208 ~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (362)
... .......+|||.|+|||++...+|+.++|.||+|++||||+.|++||++.+.+++...+...+ -.+|..+|.+.
T Consensus 500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn--vsyPKslSkEA 577 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN--VSYPKSLSKEA 577 (683)
T ss_pred cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc--CcCcccccHHH
Confidence 443 345678999999999999999999999999999999999999999999999999888886544 46788899999
Q ss_pred HHHHHHhcccCCCCCCC
Q 017994 287 SYLISRCWSSSPDRRPH 303 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps 303 (362)
.++....|.+.|.+|..
T Consensus 578 v~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 578 VAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHHHhhcCCccccC
Confidence 99999999999999953
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=279.59 Aligned_cols=250 Identities=32% Similarity=0.571 Sum_probs=207.3
Q ss_pred cCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHc--CCCCceeeeeEEEEeC----
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR--LNHPHIITFVAACKKP---- 128 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hp~iv~~~~~~~~~---- 128 (362)
.+..+.+.||+|.||.||+|.|.|+.||||++...++ +.+.+|.++++. |+|+||+.+++.-..+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE---------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE---------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccch---------hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 6788999999999999999999999999999987554 456677777775 5999999999877554
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCcEEEcCCCceEEe
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ--------GILHRDLKSENLLLGEDMCVKVA 200 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~i~H~dlk~~Nil~~~~~~~kl~ 200 (362)
..++||.+|.+.|||.|||... .++.+...+++.-++.||++||.. .|.|||||+.||||..+|...|+
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 3789999999999999999985 489999999999999999999964 49999999999999999999999
Q ss_pred eeccccccccC-----CCCCcccccccccChhhhhcCC------CCCcccchhhhHHHHHHHhC----------CCCCCC
Q 017994 201 DFGISCLESQC-----GSAKGFTGTYRWMAPEMIKEKR------HTKKVDVYSFGIVLWELLTA----------LTPFDN 259 (362)
Q Consensus 201 Dfg~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~------~~~~~Dv~slG~~l~ell~g----------~~p~~~ 259 (362)
|+|+|...... -..+..+||.+|||||++...- .-..+||||||+++||++.. ++||.+
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99999754443 2245678999999999997542 12368999999999998752 668865
Q ss_pred CC-----HHHHHHHHHhcCCCCCCCCCCCH-----HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 260 MT-----PEQAAFAVCQKNARPPVPPTCPK-----AFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 260 ~~-----~~~~~~~~~~~~~~~~~~~~~~~-----~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
.- .++...-+...+.++.+|..+.. .+.++++.||..+|.-|.++-.|.+.|..+.+
T Consensus 439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 43 23444455667778888776643 47789999999999999999999999988754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=292.47 Aligned_cols=239 Identities=22% Similarity=0.347 Sum_probs=204.6
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCC
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPP 129 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 129 (362)
..++|.+...+|.|+|+.|-++.+. ++..++|++.....+. .+|+.++... +||||+++.+.+.+..
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~----------~~e~~~~~~~~~h~niv~~~~v~~~~~ 389 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDN----------QDEIPISLLVRDHPNIVKSHDVYEDGK 389 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccccc----------ccccchhhhhcCCCcceeecceecCCc
Confidence 3678999999999999999999886 6789999998864332 3477666555 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE-cCCCceEEeeecccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL-GEDMCVKVADFGISCLE 208 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~-~~~~~~kl~Dfg~~~~~ 208 (362)
..|+|||.+.|+-|.+.+...+. ....+..|+.+|+.|+.|||++|++||||||+|||+ +..|+++|+|||.+...
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eeeeeehhccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 99999999999999998887652 226788899999999999999999999999999999 68899999999999876
Q ss_pred ccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
... ....+-|..|.|||++....+++++|+||||++||+|++|..||..-.... .+...-..+.+...+|...++
T Consensus 467 ~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~---ei~~~i~~~~~s~~vS~~AKd 541 (612)
T KOG0603|consen 467 ERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI---EIHTRIQMPKFSECVSDEAKD 541 (612)
T ss_pred chh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH---HHHHhhcCCccccccCHHHHH
Confidence 554 334466889999999999999999999999999999999999998766552 223334455566889999999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 017994 289 LISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 289 li~~~l~~~p~~Rps~~ell~ 309 (362)
|+.+||+.||.+||++.++..
T Consensus 542 Ll~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 542 LLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHHHhccCChhhCcChhhhcc
Confidence 999999999999999999985
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=272.43 Aligned_cols=263 Identities=22% Similarity=0.294 Sum_probs=210.7
Q ss_pred ccCCCcccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHH-cCCCCce
Q 017994 42 IKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLF-RLNHPHI 118 (362)
Q Consensus 42 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~-~l~hp~i 118 (362)
.......-|.+...+++-...||.|+||+|++-.++ ++..|||.++....+.+ .+++..|..... .-++|||
T Consensus 51 ~~p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke-----q~rll~e~d~~mks~~cp~I 125 (361)
T KOG1006|consen 51 KLPDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE-----QKRLLMEHDTVMKSSNCPNI 125 (361)
T ss_pred ecCCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH-----HHHHHHHHHHHHhhcCCcHH
Confidence 334455667777788888889999999999999997 78999999998766443 356666776544 4589999
Q ss_pred eeeeEEEEeCCeEEEEEecCCCCCHHHHHh---hcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCC
Q 017994 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLH---QQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGED 194 (362)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dlk~~Nil~~~~ 194 (362)
|+++|.+..++..++-||.| ..+|..+-+ ......+++..+..|..-.+.||.||-.. .|||||+||+|||++..
T Consensus 126 VkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~ 204 (361)
T KOG1006|consen 126 VKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH 204 (361)
T ss_pred HHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC
Confidence 99999999999999999998 557765543 22233699999999999999999999875 89999999999999999
Q ss_pred CceEEeeeccccccccCCCCCcccccccccChhhhhc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCH-HHHHHHHHh
Q 017994 195 MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTP-EQAAFAVCQ 271 (362)
Q Consensus 195 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~-~~~~~~~~~ 271 (362)
|.+||||||.+......-......|...|||||.+.. ..|+.++||||||++|||+.||..|+..-+. .+.+..+..
T Consensus 205 G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~ 284 (361)
T KOG1006|consen 205 GDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI 284 (361)
T ss_pred CCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc
Confidence 9999999999987666555566678899999998854 3589999999999999999999999988544 233333333
Q ss_pred cCCCC-CCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 272 KNARP-PVP---PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 272 ~~~~~-~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
...+. ..+ ..++..+..+|.-||.+|-+.||.+.+|+++
T Consensus 285 gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 285 GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22221 112 3367889999999999999999999999864
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=269.51 Aligned_cols=242 Identities=21% Similarity=0.343 Sum_probs=197.9
Q ss_pred eeeecccCCeeEEEEEE--CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCeEEEEEe
Q 017994 60 GCKFASGRHSRIYRGIY--KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITE 136 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 136 (362)
.+.||+|+|+.|-.++. ++.++|||++.+..... +.++.+|+.++.++ .|+||+.++++|+++..+|||||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHs------R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE 156 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHS------RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE 156 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchH------HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe
Confidence 46799999999998865 48899999998864432 57889999999999 59999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---ceEEeeeccccccccCCC
Q 017994 137 YLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM---CVKVADFGISCLESQCGS 213 (362)
Q Consensus 137 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~---~~kl~Dfg~~~~~~~~~~ 213 (362)
-+.||+|...|+++. .+++..+.++..+|+.||.+||.+||.|||+||+|||..... -+|||||++.........
T Consensus 157 Km~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred cccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 999999999999876 689999999999999999999999999999999999996443 589999998764322111
Q ss_pred --------CCcccccccccChhhhh-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCH---------------HHH
Q 017994 214 --------AKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTP---------------EQA 265 (362)
Q Consensus 214 --------~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~---------------~~~ 265 (362)
-.+.+|+..|||||+.. ...|+.+.|+||||+++|-|++|.+||.+... ...
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 12456888999999863 23589999999999999999999999976432 122
Q ss_pred HHHHHhcCCCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 266 AFAVCQKNARPP--VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 266 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...+.+.....+ ....++.+.+++++.+|-.|+.+|.++.+++.
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 333333322221 12457888999999999999999999988886
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=293.89 Aligned_cols=253 Identities=27% Similarity=0.544 Sum_probs=220.6
Q ss_pred CeeeeeeecccCCeeEEEEEEC------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
.....++||+|+||+||+|.+- +-+||||++........ ..++.+|+.+|.+++|||++++++++....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~-----s~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA-----SIELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh-----hHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 3445678999999999999984 34799999877554332 367889999999999999999999998776
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
+.||++|+++|+|.++++.+.. .+-.+..+.|..||+.||.|||.++++||||-.+||||..-..+||.|||++....
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 7799999999999999998764 68888999999999999999999999999999999999999999999999998766
Q ss_pred cCCCCC---cccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 210 QCGSAK---GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 210 ~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
...... .....+.|+|-|.+....++.++||||||+++||++| |..|+.+...+++-. ..+...+.+.|+.++.+
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d-lle~geRLsqPpiCtiD 928 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD-LLEKGERLSQPPICTID 928 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH-HHhccccCCCCCCccHH
Confidence 544332 3334678999999999999999999999999999999 999999988876544 45567778999999999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
+..++.+||..|+..||+++++...+..+..
T Consensus 929 Vy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 929 VYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 9999999999999999999999999987754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=270.29 Aligned_cols=218 Identities=18% Similarity=0.265 Sum_probs=181.8
Q ss_pred cCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCCCCCH
Q 017994 66 GRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSL 143 (362)
Q Consensus 66 G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 143 (362)
|.+|.||++.+. ++.||+|++.... .+..|...+....||||+++++++......+++|||++|++|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence 899999999986 7889999987642 123355555566799999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCCCcccccccc
Q 017994 144 RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW 223 (362)
Q Consensus 144 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 223 (362)
.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++++|||.+...... .....++..|
T Consensus 73 ~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y 148 (237)
T cd05576 73 WSHISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMY 148 (237)
T ss_pred HHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccc
Confidence 99997764 5899999999999999999999999999999999999999999999999987554332 2234456789
Q ss_pred cChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 017994 224 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH 303 (362)
Q Consensus 224 ~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 303 (362)
+|||...+..++.++|+||+|+++|+|++|..|+...... .........+..+++.+.++|.+||+.||++||+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~ 222 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLG 222 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHhcC
Confidence 9999998888899999999999999999999887643221 0112223456678899999999999999999998
Q ss_pred H
Q 017994 304 F 304 (362)
Q Consensus 304 ~ 304 (362)
+
T Consensus 223 ~ 223 (237)
T cd05576 223 A 223 (237)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=267.97 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=200.5
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
+...|+....||+|.||.||+|.-+ ...+|||.+..+....... ...-+|+.+++.++|||++.+..++.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS----~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS----MSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC----HHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 3467889999999999999999664 1368999998765433322 34567999999999999999999987
Q ss_pred e-CCeEEEEEecCCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC----CceE
Q 017994 127 K-PPVFCIITEYLAGGSLRKYLHQQE---PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED----MCVK 198 (362)
Q Consensus 127 ~-~~~~~lv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~----~~~k 198 (362)
. +...++++||.+. +|.++|+.+. ...++...+..|++||++|+.|||++.|+||||||.||||..+ |.+|
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 7 8899999999966 9999997432 2469999999999999999999999999999999999999877 8999
Q ss_pred EeeeccccccccC----CCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHH---------H
Q 017994 199 VADFGISCLESQC----GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPE---------Q 264 (362)
Q Consensus 199 l~Dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~---------~ 264 (362)
|+|+|+++..... ......+.|..|.|||++.+. .||.+.|||++||++.||++-.+.|.+.... +
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 9999999876543 234567789999999998875 5899999999999999999998888653221 1
Q ss_pred HHHHHHhcCCCCC-------------------------CC----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 265 AAFAVCQKNARPP-------------------------VP----------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 265 ~~~~~~~~~~~~~-------------------------~~----------~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+..+..-...+. .+ ..-++...+|+.++|..||.+|.|+++.++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 1222221111110 00 011234678999999999999999999887
Q ss_pred HHH
Q 017994 310 ILE 312 (362)
Q Consensus 310 ~L~ 312 (362)
..-
T Consensus 337 h~y 339 (438)
T KOG0666|consen 337 HPY 339 (438)
T ss_pred ccc
Confidence 543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=293.81 Aligned_cols=250 Identities=27% Similarity=0.471 Sum_probs=215.1
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEe--
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKK-- 127 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~-- 127 (362)
....+++...+|.|.+|.||++... ++.+|+|+.+...... +++..|..+++.. +|||++.++|++..
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-------eEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-------EEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-------HHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3466888999999999999998765 7899999998865442 5566788888876 79999999999853
Q ss_pred ---CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 128 ---PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 128 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
++.++||||||.|||+.|+++...+..+.|..+..|++.++.||.+||++.++|||||-.|||++.+|.+||+|||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 57899999999999999999988778899999999999999999999999999999999999999999999999998
Q ss_pred cccc-ccCCCCCcccccccccChhhhhcC-----CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-
Q 017994 205 SCLE-SQCGSAKGFTGTYRWMAPEMIKEK-----RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP- 277 (362)
Q Consensus 205 ~~~~-~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~- 277 (362)
+... .........+||+.|||||++... .|+..+|+||||++..||.-|.+|+.++.+...++.+........
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLk 249 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 249 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcccc
Confidence 7644 344566788999999999998654 367889999999999999999999999999888777643211111
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
-+..+++.+-+||..||.+|..+||+..++++
T Consensus 250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 25667889999999999999999999999886
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=273.37 Aligned_cols=251 Identities=30% Similarity=0.541 Sum_probs=205.9
Q ss_pred ccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHc--CCCCceeeeeEEEEeCC--
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR--LNHPHIITFVAACKKPP-- 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hp~iv~~~~~~~~~~-- 129 (362)
...+.+.+.+|+|+||.||+|.++++.||||++.... .+.|.+|-.+.+. +.|+||+++++.-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~---------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE---------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCHHH---------HHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 4556777899999999999999999999999987633 3566777777765 58999999998865554
Q ss_pred --eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCcEEEcCCCceE
Q 017994 130 --VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ---------GILHRDLKSENLLLGEDMCVK 198 (362)
Q Consensus 130 --~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~i~H~dlk~~Nil~~~~~~~k 198 (362)
.+.||++|.+.|+|.+||..+. +++....+++.-++.||+|||+. +|+|||||+.||||.++++..
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 8999999999999999999875 89999999999999999999973 599999999999999999999
Q ss_pred EeeeccccccccC---CCCCcccccccccChhhhhcCCC-C-----CcccchhhhHHHHHHHhCCC------------CC
Q 017994 199 VADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRH-T-----KKVDVYSFGIVLWELLTALT------------PF 257 (362)
Q Consensus 199 l~Dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~-~-----~~~Dv~slG~~l~ell~g~~------------p~ 257 (362)
|+|||+|...... +.....+||.+|||||++.+.-. . .+.||||+|.++|||++.-. ||
T Consensus 357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 9999999765543 23345789999999999976532 1 36899999999999998422 33
Q ss_pred C-----CCCHHHHHHHHHhcCCCCCCCCCC-----CHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 258 D-----NMTPEQAAFAVCQKNARPPVPPTC-----PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 258 ~-----~~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
. ..+.++....++..+.++.++..+ ...+++.+..||..|++.|.|+.=+.+.+..+..
T Consensus 437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 2 122345556667778888777554 3468899999999999999999999998887654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=261.17 Aligned_cols=236 Identities=31% Similarity=0.497 Sum_probs=200.3
Q ss_pred CCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCCCCCHH
Q 017994 67 RHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLR 144 (362)
Q Consensus 67 ~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 144 (362)
+||.||+|.+. ++.+|+|++........ .+.+.+|++.+++++|+|++++++.+......++++||+.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHH
Confidence 58999999996 58899999987544321 367889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCCCccccccccc
Q 017994 145 KYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWM 224 (362)
Q Consensus 145 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 224 (362)
+++.... .++...++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+.............++..|+
T Consensus 76 ~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 76 DLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred HHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence 9998765 38899999999999999999999999999999999999999999999999988766544455667888999
Q ss_pred ChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC--CCHHHHHHHHHhcccCCCCCC
Q 017994 225 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT--CPKAFSYLISRCWSSSPDRRP 302 (362)
Q Consensus 225 aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rp 302 (362)
+||.+.....+.++|+|+||++++++++|..||.....................+.. ++..+.+++.+||..+|++||
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence 999998888899999999999999999999999874333333333332222222222 889999999999999999999
Q ss_pred CHHHHHH
Q 017994 303 HFDQIVS 309 (362)
Q Consensus 303 s~~ell~ 309 (362)
++.++++
T Consensus 234 ~~~~~~~ 240 (244)
T smart00220 234 TAEEALQ 240 (244)
T ss_pred CHHHHhh
Confidence 9999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=266.67 Aligned_cols=250 Identities=20% Similarity=0.355 Sum_probs=212.6
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeE
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVA 123 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~ 123 (362)
...|....++|.+.++||+|+|++|.++.++ ++-+|+|+++++-..... ..+.++.|-.+..+. +||++|.++.
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndde---didwvqtek~vfe~asn~pflvglhs 318 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDE---DIDWVQTEKHVFEQASNNPFLVGLHS 318 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcc---cchhHHhhHHHHHhccCCCeEEehhh
Confidence 3567778899999999999999999999886 678999999875322211 145667788888876 7999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
+|..+..+++|.||++||+|--.++++. .+|++.+..+..+|+.||.|||++|||+||||.+|+|+|..|++||.|+|
T Consensus 319 cfqtesrlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdyg 396 (593)
T KOG0695|consen 319 CFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG 396 (593)
T ss_pred hhcccceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccc
Confidence 9999999999999999999987777665 69999999999999999999999999999999999999999999999999
Q ss_pred ccccc-ccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCC-------CCHHHHHHHHHhcCCC
Q 017994 204 ISCLE-SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN-------MTPEQAAFAVCQKNAR 275 (362)
Q Consensus 204 ~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~-------~~~~~~~~~~~~~~~~ 275 (362)
++... .+.....+++|||.|.|||++++..|+...|.|+||++|+||+.|+.||+- .+.++.++++... ..
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile-kq 475 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE-KQ 475 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh-hc
Confidence 99754 344567789999999999999999999999999999999999999999963 2334445544332 23
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCC
Q 017994 276 PPVPPTCPKAFSYLISRCWSSSPDRRP 302 (362)
Q Consensus 276 ~~~~~~~~~~l~~li~~~l~~~p~~Rp 302 (362)
..+|..++-....+++..|++||.+|.
T Consensus 476 iriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 IRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ccccceeehhhHHHHHHhhcCCcHHhc
Confidence 456777888888999999999999984
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.76 Aligned_cols=245 Identities=23% Similarity=0.353 Sum_probs=190.9
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
.+...+.||+|+||.||+|.+. +..||||.+...... ...|+..+++++||||+++++++.+++..++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence 4555678999999999999974 789999998653321 1246888999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH---SQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
||||+++|+|.++++. +++..+..++.|++.||+||| +.+++||||||+||+++.++..++. |+.......
T Consensus 761 v~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 761 IHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 9999999999999963 788999999999999999999 6699999999999999988877765 554432211
Q ss_pred CCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCH-----HHHHHHHH-----hcCCCCCC--
Q 017994 211 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP-----EQAAFAVC-----QKNARPPV-- 278 (362)
Q Consensus 211 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~-----~~~~~~~~-----~~~~~~~~-- 278 (362)
.....+++.|+|||++.+..++.++||||||+++|||++|+.||+.... .+...... .....+..
T Consensus 835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 2233678999999999999999999999999999999999999854211 01000000 00001111
Q ss_pred ----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 279 ----PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 279 ----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
+.....++.+++.+||+.||++||++.|+++.|+.+...-.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 11112356789999999999999999999999998766433
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=239.27 Aligned_cols=248 Identities=21% Similarity=0.328 Sum_probs=205.8
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
+|.-.++||+|.||+||+|... .+-||+|.++....+.... ....+||-+++.++|.|||++++....+..+.+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvp----ssalreicllkelkhknivrl~dvlhsdkkltl 78 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVP----SSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCc----HHHHHHHHHHHHhhhcceeehhhhhccCceeEE
Confidence 4666789999999999999876 6789999999876655433 456789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~- 212 (362)
|+||| ..+|..+..+..+ .++.+.+..++.|++.||.++|++++.|||+||.|.+|+.+|.+|+.|||+++.+..+.
T Consensus 79 vfe~c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 79 VFEFC-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred eHHHh-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 99999 5599999987654 68999999999999999999999999999999999999999999999999998665433
Q ss_pred CCCcccccccccChhhhhcCC-CCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC-------------
Q 017994 213 SAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP------------- 277 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~------------- 277 (362)
-....+.|..|.+|.++.+.. |+...|+||-||++.|+.. |.+.|++.+-.+.+..+......+.
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 234556799999999988765 7999999999999999998 8889999887777666544322221
Q ss_pred -----CC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 -----VP---------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 -----~~---------~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
++ +.++..-++++.+++.-+|.+|.++++.++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11 112223567999999999999999887664
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=269.84 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=205.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHH-HHHHHHHHHHHHHHHcCCCCceeeeeEEEE-eCC
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLA-SMLEKQFTSEVALLFRLNHPHIITFVAACK-KPP 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~-~~~ 129 (362)
..+|-+.+.||+|||+.||+|.+- .+.||||+-.......... +..-+...+|.++-+.|+||.||++++++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 467888999999999999999875 6789999877654433322 233456678999999999999999999995 557
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCcEEEc---CCCceEEeeecc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ--GILHRDLKSENLLLG---EDMCVKVADFGI 204 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~i~H~dlk~~Nil~~---~~~~~kl~Dfg~ 204 (362)
.++-|+|||+|.+|.-|++.+. .++++.+..|+.||+.||.||... .|||-||||.|||+- .-|.+||.|||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 8999999999999999999886 699999999999999999999986 699999999999994 457899999999
Q ss_pred ccccccCCC--------CCcccccccccChhhhhcC----CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHh
Q 017994 205 SCLESQCGS--------AKGFTGTYRWMAPEMIKEK----RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA-AFAVCQ 271 (362)
Q Consensus 205 ~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~-~~~~~~ 271 (362)
+..+..... .....||.+|++||.+.-+ ..+.++||||+|+++|.++.|+.||......+. +.....
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 987654332 2456799999999987543 368899999999999999999999987544332 222111
Q ss_pred ---cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 272 ---KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 272 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.....+..+.++.+..+||++||+..-++|.+..+|..
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11122344668899999999999999999988888764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=275.16 Aligned_cols=245 Identities=21% Similarity=0.315 Sum_probs=202.5
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
.+-+-|...+.||-|+||.|.++.-. ...+|.|.+.+.+.- .......++.|-.||...+.+-||+|+..|.+.+
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl---~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL---MRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 702 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHH---hhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence 34567888899999999999998643 557899988764332 2222356677999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.+|+||||++||++-.+|-+.+ -++++.+..++.++..|+++.|..|+|||||||+|||||.+|+|||.|||+++-+.
T Consensus 703 nLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred ceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence 9999999999999999998877 68999999999999999999999999999999999999999999999999986321
Q ss_pred c--------CCC-----------------------------------CCcccccccccChhhhhcCCCCCcccchhhhHH
Q 017994 210 Q--------CGS-----------------------------------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIV 246 (362)
Q Consensus 210 ~--------~~~-----------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~ 246 (362)
- .+. ....+||+.|+|||++....++..+|.||.|++
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 0 000 012458999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHH--HhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 017994 247 LWELLTALTPFDNMTPEQAAFAV--CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 302 (362)
Q Consensus 247 l~ell~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 302 (362)
||||+.|++||...++.+....+ +...+..+....++++..++|.+++. +++.|.
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 99999999999988877665543 33444556678899999998888654 456664
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=263.97 Aligned_cols=246 Identities=22% Similarity=0.323 Sum_probs=200.3
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC--CC----ceeeeeEEE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN--HP----HIITFVAAC 125 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hp----~iv~~~~~~ 125 (362)
..+|.+...+|+|.||.|-.+.+. +..||||+++.-... ++...-|+.++.++. .| -++.+.++|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-------reAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-------REAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-------hhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 688999999999999999999987 578999998764332 455667999999994 22 367788889
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-------------
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG------------- 192 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~------------- 192 (362)
+-.++.+||+|.+ |.++.+++..+...+++...+..+++|++.++++||+.+++|-||||+||++.
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999988 88999999998877899999999999999999999999999999999999983
Q ss_pred -------CCCceEEeeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHH
Q 017994 193 -------EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA 265 (362)
Q Consensus 193 -------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~ 265 (362)
.+..++|+|||.++.... .....+.|..|.|||++.+-.++..+||||+||+|+|+.+|...|..-++.+.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred cceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 134599999999987655 33677889999999999999999999999999999999999999987664442
Q ss_pred HHHHHhcCCCC-------------------CCC-------------------------CCCCHHHHHHHHHhcccCCCCC
Q 017994 266 AFAVCQKNARP-------------------PVP-------------------------PTCPKAFSYLISRCWSSSPDRR 301 (362)
Q Consensus 266 ~~~~~~~~~~~-------------------~~~-------------------------~~~~~~l~~li~~~l~~~p~~R 301 (362)
+........+. ..+ ......|.+||.+||..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 21110000000 000 0001258899999999999999
Q ss_pred CCHHHHHH
Q 017994 302 PHFDQIVS 309 (362)
Q Consensus 302 ps~~ell~ 309 (362)
+|+.|++.
T Consensus 398 iTl~EAL~ 405 (415)
T KOG0671|consen 398 ITLREALS 405 (415)
T ss_pred ccHHHHhc
Confidence 99999885
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=252.15 Aligned_cols=255 Identities=21% Similarity=0.341 Sum_probs=201.9
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe-
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK- 127 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~- 127 (362)
....+.|+-..++|+|.||.||+|..+ ++.||+|++..++..... .....+|+.+|..+.|+|++.++..|..
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGf----pitalreikiL~~lkHenv~nliEic~tk 88 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGF----PITALREIKILQLLKHENVVNLIEICRTK 88 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCC----cHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence 345677888889999999999999886 677999887664433222 2455789999999999999999887743
Q ss_pred -------CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEe
Q 017994 128 -------PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 200 (362)
Q Consensus 128 -------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~ 200 (362)
...+|+|+++|+. +|.-++.+.. ..++...+.+++.++.+||.|+|+..|+|||+|+.|+||+.+|.++|+
T Consensus 89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred cCCcccccceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEee
Confidence 3469999999965 8988887654 368889999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCC-----CCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhc--
Q 017994 201 DFGISCLESQCGS-----AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK-- 272 (362)
Q Consensus 201 Dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~-- 272 (362)
|||+++.+..... -...+.|..|.+||.+.+ ..|+++.|+|.-||+|.+|+++.+-+.+.+..+.+..+..-
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 9999975543321 123456899999999876 46899999999999999999999999988876655443221
Q ss_pred CCCCC------------------CCC-------------CCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017994 273 NARPP------------------VPP-------------TCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 311 (362)
Q Consensus 273 ~~~~~------------------~~~-------------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 311 (362)
...+. .+. .-+++..+|+.+++..||.+|+++++++..-
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 11111 110 0123677899999999999999999988643
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=236.65 Aligned_cols=218 Identities=24% Similarity=0.370 Sum_probs=180.4
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEE--CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIY--KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAAC 125 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~ 125 (362)
.++..-.++..+..||+|++|.|-+-.+ .|+-.|+|.+...-.... .++...|+.+..+. .+|++|.++|..
T Consensus 40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~-----q~r~L~dldi~~r~~~CPf~V~FyGa~ 114 (282)
T KOG0984|consen 40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQE-----QKRLLMDLDIIMRTVDCPFTVHFYGAL 114 (282)
T ss_pred ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHH-----HHHHHHhhhhhccCCCCCeEEEeehhh
Confidence 3566667788888999999999765555 589999999987655433 35667788887765 799999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCceEEeee
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
..+...++.||.+ ..+|..+-++ ..+..+++..+-+|+..++.||.|||++ .++|||+||+|||++.+|++|+|||
T Consensus 115 ~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 115 FREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred hccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccc
Confidence 9999999999999 5688877653 2334799999999999999999999986 8999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccChhhhhc----CCCCCcccchhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhc
Q 017994 203 GISCLESQCGSAKGFTGTYRWMAPEMIKE----KRHTKKVDVYSFGIVLWELLTALTPFDN-MTPEQAAFAVCQK 272 (362)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slG~~l~ell~g~~p~~~-~~~~~~~~~~~~~ 272 (362)
|.+......-...-..|...|+|||.+.. ..|+.++||||||+++.||.+++.||+. .++.+.+.+++..
T Consensus 194 GIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 194 GISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred ccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 99876655444444678889999998753 4689999999999999999999999987 5677777776654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=268.86 Aligned_cols=258 Identities=18% Similarity=0.195 Sum_probs=184.0
Q ss_pred ccccCeeeeeeecccCCeeEEEEEE------------------CCeeEEEEEecCCCcchHHH--------HHHHHHHHH
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIY------------------KQRDVAIKLVSQPEEDASLA--------SMLEKQFTS 105 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~------------------~~~~vavK~~~~~~~~~~~~--------~~~~~~~~~ 105 (362)
...++|.+.++||+|+||.||+|.+ .++.||||.+.......... ....+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3467899999999999999999974 23579999987643221100 001123345
Q ss_pred HHHHHHcCCCCce-----eeeeEEEEe--------CCeEEEEEecCCCCCHHHHHhhcCC--------------------
Q 017994 106 EVALLFRLNHPHI-----ITFVAACKK--------PPVFCIITEYLAGGSLRKYLHQQEP-------------------- 152 (362)
Q Consensus 106 Ei~~l~~l~hp~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~-------------------- 152 (362)
|+.++.+++|.++ ++++++|.. .+..++|+||+++++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777766544 667777643 3568999999999999999874211
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCCC--cccccccccChhh
Q 017994 153 --YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTYRWMAPEM 228 (362)
Q Consensus 153 --~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~aPE~ 228 (362)
..+++..+..++.|++.+|.|||+.+|+||||||+||+++.++.++|+|||++.......... ...+++.|+|||.
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 124567789999999999999999999999999999999999999999999986543322222 2234789999998
Q ss_pred hhcCCC----------------------CCcccchhhhHHHHHHHhCCC-CCCCCCHHHHHH-----------HHHhcCC
Q 017994 229 IKEKRH----------------------TKKVDVYSFGIVLWELLTALT-PFDNMTPEQAAF-----------AVCQKNA 274 (362)
Q Consensus 229 ~~~~~~----------------------~~~~Dv~slG~~l~ell~g~~-p~~~~~~~~~~~-----------~~~~~~~ 274 (362)
+..... ..+.|+||+||++|+|++|.. ||.......... .......
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 754321 234699999999999999875 775432111110 0111111
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 017994 275 RPPVPPTCPKAFSYLISRCWSSSP---DRRPHFDQIVS 309 (362)
Q Consensus 275 ~~~~~~~~~~~l~~li~~~l~~~p---~~Rps~~ell~ 309 (362)
........++...+|+.+||..+| .+|+|+.|+++
T Consensus 462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 222335567889999999999866 68999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=281.46 Aligned_cols=238 Identities=29% Similarity=0.431 Sum_probs=190.2
Q ss_pred eeeecccCCee-EEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCeEEEEEec
Q 017994 60 GCKFASGRHSR-IYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 60 ~~~lg~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
.+.+|.|+.|+ ||+|.+.++.||||.+-.+.. +...+||+.|+.- +|||||++++.-.+....||..|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~---------~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEEFF---------DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhHhH---------HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 45789999987 999999999999999866432 4567899999988 599999999999999999999999
Q ss_pred CCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---C--CceEEeeecccccccc
Q 017994 138 LAGGSLRKYLHQQEP--YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---D--MCVKVADFGISCLESQ 210 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~---~--~~~kl~Dfg~~~~~~~ 210 (362)
| ..+|.+++..... ........+.+..|++.||++||+.+|+||||||.||||+. + ..++|+|||++.....
T Consensus 585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9 6799999987411 01111345788999999999999999999999999999975 3 4789999999986554
Q ss_pred CCC----CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCCH
Q 017994 211 CGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP-VPPTCPK 284 (362)
Q Consensus 211 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 284 (362)
... .....||.+|+|||++....-+.++|+|||||++|+.++ |.+||.+....+. .+........ ..+....
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDC 741 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchH
Confidence 432 346679999999999999988999999999999999999 5999987654432 1221111111 1111112
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+..+||.+|++++|..||++.+++.
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 7889999999999999999999985
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=251.05 Aligned_cols=262 Identities=24% Similarity=0.498 Sum_probs=218.6
Q ss_pred cccccCeeeeeeecccCCeeEEEEEECC-------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
.....++++...+-+|.||.||+|++.+ +.|.+|.++....+-+ -..+..|--++..+.|||+..+.+
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQ-----v~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQ-----VNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHH-----HHHHHHHHHHHhcCcCCCccceeE
Confidence 3445667777889999999999998753 3577777766444332 466788999999999999999999
Q ss_pred EEEe-CCeEEEEEecCCCCCHHHHHhh------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc
Q 017994 124 ACKK-PPVFCIITEYLAGGSLRKYLHQ------QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 196 (362)
Q Consensus 124 ~~~~-~~~~~lv~e~~~~~~L~~~l~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~ 196 (362)
++.. ....+.++.+..-|+|+.++.. .....+...+...++.|++.|++|||++|+||.||..+|++|++.-.
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee
Confidence 8855 4577888899988999999972 22235777888999999999999999999999999999999999999
Q ss_pred eEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 017994 197 VKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK 272 (362)
Q Consensus 197 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~ 272 (362)
+||+|=.+++..-+... .........||+||.+....|+.++|+||||++||||+| |+.|+...++.+....+ .+
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl-kd 513 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL-KD 513 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH-hc
Confidence 99999998875433222 122334668999999999999999999999999999999 99999999998876665 46
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 017994 273 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318 (362)
Q Consensus 273 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l 318 (362)
+.+...|.++|+++..++.-||+..|++||+++|+..-|..+-..+
T Consensus 514 GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 514 GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 7888899999999999999999999999999999999988775543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=271.33 Aligned_cols=249 Identities=18% Similarity=0.206 Sum_probs=169.1
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
.....++|.+.+.||+|+||.||+|.+. +..||||++........ ...+ .+....+.++..+..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~--------~~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI--------WMNE--RVRRACPNSCADFVY 196 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH--------HHHH--HHHhhchhhHHHHHH
Confidence 3456789999999999999999999985 46899998765322110 0111 111111222222111
Q ss_pred E------EEeCCeEEEEEecCCCCCHHHHHhhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 017994 124 A------CKKPPVFCIITEYLAGGSLRKYLHQQEPY------------------SVPLNLVLKLALDIARGMQYLHSQGI 179 (362)
Q Consensus 124 ~------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------~l~~~~~~~i~~~i~~~l~~LH~~~i 179 (362)
. ...+...++|+||+.+++|.+++...... ......+..++.||+.||.|||++||
T Consensus 197 ~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gI 276 (566)
T PLN03225 197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276 (566)
T ss_pred hhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCE
Confidence 1 24567899999999999999998754310 11234567899999999999999999
Q ss_pred cccCCCCCcEEEcC-CCceEEeeeccccccccC--CCCCcccccccccChhhhhcCC----------------------C
Q 017994 180 LHRDLKSENLLLGE-DMCVKVADFGISCLESQC--GSAKGFTGTYRWMAPEMIKEKR----------------------H 234 (362)
Q Consensus 180 ~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~----------------------~ 234 (362)
+||||||+|||++. ++.+||+|||++...... .......+++.|+|||.+.... +
T Consensus 277 iHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred EeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 99999999999985 579999999999754322 2234567899999999764321 3
Q ss_pred CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------CCCCCC----------CCCCHHHHHHHHHhc
Q 017994 235 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN----------ARPPVP----------PTCPKAFSYLISRCW 294 (362)
Q Consensus 235 ~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~----------~~~~~~----------~~~~~~l~~li~~~l 294 (362)
+.++|||||||++|||+++..+++... .......... ...... ...+....+||.+||
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDSNL--IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCchHH--HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 345699999999999999776654321 1111111100 000000 111234558999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 017994 295 SSSPDRRPHFDQIVSI 310 (362)
Q Consensus 295 ~~~p~~Rps~~ell~~ 310 (362)
+.||.+|||+.++++.
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999963
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=233.72 Aligned_cols=246 Identities=18% Similarity=0.349 Sum_probs=198.3
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEE--CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIY--KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAAC 125 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~ 125 (362)
+|. ..++|++.+++|+|.++.||.|.. +++.++||++++-. .+.+.+|+.+|..+. ||||++++++.
T Consensus 33 ~wg-~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---------kkKIkREikIL~nL~gg~NIi~L~DiV 102 (338)
T KOG0668|consen 33 DWG-NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---------KKKIKREIKILQNLRGGPNIIKLLDIV 102 (338)
T ss_pred ecc-ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---------HHHHHHHHHHHHhccCCCCeeehhhhh
Confidence 344 578999999999999999999984 57899999997643 367889999999996 99999999998
Q ss_pred EeC--CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CceEEeee
Q 017994 126 KKP--PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADF 202 (362)
Q Consensus 126 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~-~~~kl~Df 202 (362)
.++ ....+++||+++.+...+-. .++...+...+.+++.||.|+|+.||+|||+||.|+|+|.. -.++|+|+
T Consensus 103 ~Dp~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 103 KDPESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred cCccccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeec
Confidence 665 46789999998877766554 36677899999999999999999999999999999999865 47999999
Q ss_pred ccccccccCCCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHhc--------
Q 017994 203 GISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPF-DNMTPEQAAFAVCQK-------- 272 (362)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~-~~~~~~~~~~~~~~~-------- 272 (362)
|+|.+..+...-+-.+.+..|--||++.. ..|+..-|+|||||++..|+..+.|| .+.++.+.+..+..-
T Consensus 178 GLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 178 GLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred chHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 99988877666666778888999999865 45899999999999999999987776 344433333222110
Q ss_pred -------------------CCC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 273 -------------------NAR--------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 273 -------------------~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+ .......+++..+|+.++|..|-.+|+|+.|...
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 000 0111234578899999999999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=263.25 Aligned_cols=204 Identities=24% Similarity=0.382 Sum_probs=175.7
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcch--HHHHHHHHHHHHHHHHHHcCC---CCceeeeeEEE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDA--SLASMLEKQFTSEVALLFRLN---HPHIITFVAAC 125 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~--~~~~~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~ 125 (362)
.+++|...+.+|.|+||.|++|+++ ...|+||.+.++..-. ..+..-.-.+..||++|..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 4788999999999999999999998 5689999998764211 111100123556999999997 99999999999
Q ss_pred EeCCeEEEEEec-CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 126 KKPPVFCIITEY-LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 126 ~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
++++.+||+||- -+|-+|.++|..++ .+++..+..|++|++.|+++||+.||+|||||-+||.++.+|.+||+|||.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 999999999995 46789999999887 699999999999999999999999999999999999999999999999998
Q ss_pred ccccccCCCCCcccccccccChhhhhcCCC-CCcccchhhhHHHHHHHhCCCCCCC
Q 017994 205 SCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDN 259 (362)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~ 259 (362)
+..... +....+.||..|.|||++.+..| +..-|||+||+++|.++....||..
T Consensus 717 aa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 866544 45667899999999999998876 6778999999999999998888854
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-31 Score=228.95 Aligned_cols=209 Identities=34% Similarity=0.606 Sum_probs=184.8
Q ss_pred ecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCCC
Q 017994 63 FASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140 (362)
Q Consensus 63 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 140 (362)
||+|++|.||++... ++.+++|++....... ....+.+|+..++.+.|++++++++++......++++||+.|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCC
Confidence 689999999999998 7899999998765432 236788999999999999999999999999999999999998
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCceEEeeeccccccccCC-CCCccc
Q 017994 141 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFGISCLESQCG-SAKGFT 218 (362)
Q Consensus 141 ~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~~-~~~~~~ 218 (362)
++|.+++.... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......
T Consensus 76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 99999998753 25889999999999999999999999999999999999999 8999999999987554432 133455
Q ss_pred ccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccC
Q 017994 219 GTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 297 (362)
Q Consensus 219 ~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 297 (362)
+...|++||..... ..+.++|+|++|+++++| ..+.+++.+|++.+
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~ 201 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKD 201 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCC
Confidence 78889999999877 788999999999999999 57899999999999
Q ss_pred CCCCCCHHHHHHH
Q 017994 298 PDRRPHFDQIVSI 310 (362)
Q Consensus 298 p~~Rps~~ell~~ 310 (362)
|++||++.++++.
T Consensus 202 p~~R~~~~~l~~~ 214 (215)
T cd00180 202 PEKRPSAKEILEH 214 (215)
T ss_pred cccCcCHHHHhhC
Confidence 9999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=265.04 Aligned_cols=248 Identities=27% Similarity=0.465 Sum_probs=217.8
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
..+|++..++|.|.||.||++++. ++..|||+++.+..+. -.-+.+|+-+++.++||||+.+++.+...+.+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd------~~~iqqei~~~~dc~h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD------FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL 87 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc------ccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence 367999999999999999999987 7889999999876654 25567899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ- 210 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~- 210 (362)
++.||||.||+|.+.-+-.+ .+++.++...+++.+.+|+|||+.|-+|||||-.||+++..|.+|+.|||.+.....
T Consensus 88 wicMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EEEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999999999877665 699999999999999999999999999999999999999999999999998765433
Q ss_pred CCCCCcccccccccChhhh---hcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---CCCCCCH
Q 017994 211 CGSAKGFTGTYRWMAPEMI---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---VPPTCPK 284 (362)
Q Consensus 211 ~~~~~~~~~~~~~~aPE~~---~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 284 (362)
......+.||+.|||||+- +.+.|...+|+|++|++..|+-.-++|.-...+...++........++ .+..+++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 3445788999999999975 456789999999999999999998899888888888777655555443 3456788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+.+|++.++.++|.+||+++.++.
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhhee
Confidence 9999999999999999999998775
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=237.31 Aligned_cols=246 Identities=22% Similarity=0.306 Sum_probs=199.2
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC----
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP---- 128 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~---- 128 (362)
.+|.-.+.+|.|.- .|.-+-+. +++||+|++..+...... .++..+|..++..++|+||++++.++.-.
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~----akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTH----AKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCcc----chhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 45666778888887 66667665 889999998887444322 36678899999999999999999998533
Q ss_pred --CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 129 --PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 129 --~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
...|+|||++ ..+|...+.. .++-+.+..|+.|++.|+.+||+.||+||||||+||++..++.+||.|||++.
T Consensus 92 ~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 92 EFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence 4689999999 5599999883 36778999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---------
Q 017994 207 LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--------- 277 (362)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 277 (362)
..........++.+..|.|||++.+-.+...+||||+||++.||++|..-|.+.+.-+...++......+.
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 77766566788899999999999988899999999999999999999999987654433333222111110
Q ss_pred --------------------C-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 278 --------------------V-----------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 278 --------------------~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
+ ++.-+..+++++.+||-.||++|.|++++++.
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 11112347899999999999999999999854
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=255.33 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=202.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC------CCceeeeeEEE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN------HPHIITFVAAC 125 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~------hp~iv~~~~~~ 125 (362)
-.+|.+....|+|-|++|.+|.+. +..||||++.....- -+.=+.|+++|++|+ .-|+++++..|
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-------~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-------HKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-------hhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 367888888999999999999997 779999999874321 244567999999995 36899999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CceEEeeec
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFG 203 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~-~~~kl~Dfg 203 (362)
....++|||+|-+ .-+|.+.+++.+. -+|....+..++.|++.||..|-..||+|.||||+||||++. ..+||||||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 9999999999988 6699999986543 358888999999999999999999999999999999999865 579999999
Q ss_pred cccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------
Q 017994 204 ISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------ 277 (362)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------ 277 (362)
.|....... ...+..+..|.|||++.+..|+...|+||+||+||||.||+..|++.++.+.+..........+
T Consensus 583 SA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 583 SASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred ccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 987665533 3445567889999999999999999999999999999999999999887765543322211111
Q ss_pred ----------------------------------CC-----------CCCC-------HHHHHHHHHhcccCCCCCCCHH
Q 017994 278 ----------------------------------VP-----------PTCP-------KAFSYLISRCWSSSPDRRPHFD 305 (362)
Q Consensus 278 ----------------------------------~~-----------~~~~-------~~l~~li~~~l~~~p~~Rps~~ 305 (362)
.| +.++ ..|.+|+.+||..||.+|.+..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 00 1112 3578899999999999999999
Q ss_pred HHHH
Q 017994 306 QIVS 309 (362)
Q Consensus 306 ell~ 309 (362)
|.|+
T Consensus 742 qAL~ 745 (752)
T KOG0670|consen 742 QALK 745 (752)
T ss_pred HHhc
Confidence 8875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=238.75 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=196.5
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC----
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP---- 128 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~---- 128 (362)
.+.+..+.||.|+||.||...+. ++.||+|++..-... -...+.+.+|+.+|..++|.|++..+++..-.
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~----L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~df 128 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN----LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSF 128 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHH----HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchH
Confidence 45666789999999999999986 789999987653322 22357889999999999999999999887544
Q ss_pred -CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 129 -PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 129 -~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
..+|.+.|.+ ..+|.++|-+-. .++.+.+.-++.||+.||.|||+.+|.||||||.|.+++.+..+||||||+++.
T Consensus 129 FqEiYV~TELm-QSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 129 FQELYVLTELM-QSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHHHHH-HhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccc
Confidence 2467778877 457877776533 688889999999999999999999999999999999999999999999999986
Q ss_pred cccCCC--CCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------
Q 017994 208 ESQCGS--AKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------- 277 (362)
Q Consensus 208 ~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------- 277 (362)
...... ....+.|-.|.|||++.+. .|+.+.||||+||++.|++..+..|..-++-+.+..+......+.
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 554332 2345678899999999875 589999999999999999999999988777665544433222111
Q ss_pred -------------CCCC------------CCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 278 -------------VPPT------------CPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 278 -------------~~~~------------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
.++. -..+...++.+++..||+.|.+..+.+..+.
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1111 1124567888999999999998888776543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=243.04 Aligned_cols=131 Identities=27% Similarity=0.466 Sum_probs=115.9
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC--------CCceeeee
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN--------HPHIITFV 122 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--------hp~iv~~~ 122 (362)
...+|.+.++||-|.|++||++.+. .+.||+|+.+..... .+....||.+|++++ ..+||+++
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-------tEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-------TEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-------HHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 3589999999999999999999997 688999999874433 356678999999883 25899999
Q ss_pred EEEEe----CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEE
Q 017994 123 AACKK----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLL 191 (362)
Q Consensus 123 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dlk~~Nil~ 191 (362)
+.|.. +.+++||+|++ |.+|..+|.....++++...+.+|++||+.||.|||+. ||||-||||+|||+
T Consensus 149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 99854 46899999999 88999999988878899999999999999999999985 99999999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=226.35 Aligned_cols=209 Identities=31% Similarity=0.499 Sum_probs=178.2
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEE
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCII 134 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv 134 (362)
|.+.+.||.|++|.||++... ++.+++|.+...... ...+.+.+|+..+..++|+|++++++++......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEE
Confidence 467788999999999999996 588999999875443 1246788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC--
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-- 212 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 212 (362)
+||+++++|.+++..... .+++..++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999999999987652 27889999999999999999999999999999999999999999999999887655432
Q ss_pred CCCcccccccccChhhh-hcCCCCCcccchhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHh
Q 017994 213 SAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLTALTPFDN-MTPEQAAFAVCQ 271 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~~l~ell~g~~p~~~-~~~~~~~~~~~~ 271 (362)
......++..|++||.+ ....++.++|+|+||+++++|++|+.||.. ..+.....+...
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 33455678889999998 666778899999999999999999999977 455544444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=217.14 Aligned_cols=246 Identities=21% Similarity=0.352 Sum_probs=191.6
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEE-EEeCCe
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAA-CKKPPV 130 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~-~~~~~~ 130 (362)
+.|.+.+.||+|.||.+-++.++ ++.+++|.++.+... .++|.+|..---.| .|.||+.-++. |+..+.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt-------~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT-------QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh-------HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 56888999999999999999998 578999999887554 36788887765555 58999987764 677789
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc--CCCceEEeeecccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG--EDMCVKVADFGISCLE 208 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~--~~~~~kl~Dfg~~~~~ 208 (362)
+++++||++.|+|..-+... ++-+.....++.|+++|+.|+|+++++|||||.+||||- +.-++||||||..+..
T Consensus 97 YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred EEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999999999877664 588889999999999999999999999999999999993 2348999999987654
Q ss_pred ccCCCCCcccccccccChhhhhcC-----CCCCcccchhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCCCC-
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEK-----RHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQKNARPPVP- 279 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~slG~~l~ell~g~~p~~~~~---~~~~~~~~~~~~~~~~~~- 279 (362)
.. .-.....+..|.+||+.... ...+.+|+|.||+++|.++||.+||.... +....+..+.....+..|
T Consensus 174 g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 174 GT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred Cc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 33 12223345678999987532 24778999999999999999999997532 222333333344444443
Q ss_pred --CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 280 --PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 280 --~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
..+++.+..+.++-|..++++|--..+..++..
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 446778888999999999999966666665543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=224.48 Aligned_cols=255 Identities=21% Similarity=0.309 Sum_probs=205.0
Q ss_pred CeeeeeeecccCCeeEEEEEECC---eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC----CCceeeeeEEE-Ee
Q 017994 56 QLFIGCKFASGRHSRIYRGIYKQ---RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN----HPHIITFVAAC-KK 127 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~----hp~iv~~~~~~-~~ 127 (362)
+|.+.++||+|+||.||.+.+.. ..+|+|+......... ..+..|+.++..+. .+++..+++.+ ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC------ccchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence 79999999999999999999874 3699998877533221 24566888888886 36899999999 58
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-----CceEEeee
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-----MCVKVADF 202 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~-----~~~kl~Df 202 (362)
+...++||+.+ |.+|.++....+...++..++..|+.|++.+|++||+.|++||||||.|+++... ..+.|.||
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 88999999988 9999999977776689999999999999999999999999999999999999754 46999999
Q ss_pred cccc--ccccCC--------C-CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 017994 203 GISC--LESQCG--------S-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 271 (362)
Q Consensus 203 g~~~--~~~~~~--------~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~ 271 (362)
|+++ ...... . .....||..|.++....+...+.+.|+||+++++.+++.|..||..............
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~ 251 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK 251 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence 9998 311111 1 2235599999999999999999999999999999999999999977654322222211
Q ss_pred ---cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 272 ---KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 272 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
...........+..+..+...+-..+...+|.+..+...+......
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 1111113445667888898888889999999999999998776554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=203.34 Aligned_cols=265 Identities=20% Similarity=0.302 Sum_probs=218.4
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCCe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPPV 130 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~ 130 (362)
..+|.++++||.|+||.+|.|..- +..||||+....... .++.-|..+...++ ..+|..+..++.+..+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--------pqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--------PQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--------cchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 578999999999999999999874 899999998776554 34566888888886 5788888888889999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCceEEeeeccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADFGISCL 207 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~---~~~~kl~Dfg~~~~ 207 (362)
-.+|||.+ |.+|.++++--. ..++..+++-++.|++.-++|+|.++++||||||+|+|+.- ...+.++|||++..
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ceeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 99999988 999999997544 26888999999999999999999999999999999999953 34699999999975
Q ss_pred cccCC--------CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHhcCCCC
Q 017994 208 ESQCG--------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ---AAFAVCQKNARP 276 (362)
Q Consensus 208 ~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~---~~~~~~~~~~~~ 276 (362)
.-... .....+||..|.+-....+...+...|+-|+|+++.++.-|..||.+..+.. ....+.+.....
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 43322 2345679999999988888888999999999999999999999999976543 333444444433
Q ss_pred C---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCCCCccccc
Q 017994 277 P---VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSF 328 (362)
Q Consensus 277 ~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~~~~~~~~ 328 (362)
+ .....|.++.-.+..|-..--.+-|++.-|.+.+.-+-.++.....+..+|
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW 298 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDW 298 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeH
Confidence 3 346788999999999999999999999999999988877777665554443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=210.34 Aligned_cols=258 Identities=18% Similarity=0.304 Sum_probs=215.7
Q ss_pred cCeeeeeeecccCCeeEEEEEE--CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCeE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIY--KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVF 131 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~ 131 (362)
-.|.++++||+|+||.++.|.. +++.||||........ .++..|.+..+.| ..++|..++.+..++.+-
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--------PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--------PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCc--------chHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 4599999999999999999975 5899999987764432 4566788888888 579999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-----CceEEeeecccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-----MCVKVADFGISC 206 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~-----~~~kl~Dfg~~~ 206 (362)
.||+|.+ |.+|.|+..-.+. .++.+++..++.|++.-++|+|++.+|+|||||+|+||... ..+.++|||++.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 9999988 9999999986553 69999999999999999999999999999999999999643 469999999998
Q ss_pred ccccCCC--------CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHhcCCC
Q 017994 207 LESQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ---AAFAVCQKNAR 275 (362)
Q Consensus 207 ~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~---~~~~~~~~~~~ 275 (362)
....+.. .....||.+||+-....+...+.+.|+-|||-++++++-|.+||.+..... -..++-+.+..
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 6544333 356789999999999999999999999999999999999999999875543 33333333333
Q ss_pred CC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCCC
Q 017994 276 PP---VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 322 (362)
Q Consensus 276 ~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~~ 322 (362)
.+ ....+|.++..-+...-..+-.+-|+++-+...+..+.+.+..-.
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~ 307 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETD 307 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcc
Confidence 22 346678899999999889999999999999999998888765443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=221.81 Aligned_cols=243 Identities=22% Similarity=0.383 Sum_probs=190.3
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKK 127 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~ 127 (362)
...|.+.++||.|.|+.||++.+. ++.||+|.+...... ..+..|+++|..+ .+.||+++.+.+..
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--------~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--------SRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--------hHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 356888999999999999999764 468999998875543 5678899999998 59999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCceEEeeecccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFGISC 206 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~ 206 (362)
.+...+|+||++..+..++... ++...+..+++.++.||.++|.+|||||||||+|++.+. .+.-.|+|||++.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 9999999999999999998875 567889999999999999999999999999999999974 4789999999987
Q ss_pred ccc-----------------c-CCC---------------------------CCcccccccccChhhhhc-CCCCCcccc
Q 017994 207 LES-----------------Q-CGS---------------------------AKGFTGTYRWMAPEMIKE-KRHTKKVDV 240 (362)
Q Consensus 207 ~~~-----------------~-~~~---------------------------~~~~~~~~~~~aPE~~~~-~~~~~~~Dv 240 (362)
... . .+. .....||++|.|||++.. ...+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 100 0 000 012348999999999754 557899999
Q ss_pred hhhhHHHHHHHhCCCCCCCCCHH-HHHHHHH------------h--cC---------------------C----------
Q 017994 241 YSFGIVLWELLTALTPFDNMTPE-QAAFAVC------------Q--KN---------------------A---------- 274 (362)
Q Consensus 241 ~slG~~l~ell~g~~p~~~~~~~-~~~~~~~------------~--~~---------------------~---------- 274 (362)
||.|++++.++++..||-....+ +.+.++. . +. .
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999999998432110 0000000 0 00 0
Q ss_pred ----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 275 ----RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 275 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
........+..+.+++.+|++.||.+|.++++.|+
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 00011223457889999999999999999999986
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=255.22 Aligned_cols=192 Identities=17% Similarity=0.202 Sum_probs=140.4
Q ss_pred CCC-CceeeeeEEE-------EeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 017994 113 LNH-PHIITFVAAC-------KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 184 (362)
Q Consensus 113 l~h-p~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dl 184 (362)
+.| +||.++++++ .....+++++||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 345 5777777776 3335678889987 669999997543 35899999999999999999999999999999
Q ss_pred CCCcEEEcCCC-------------------ceEEeeeccccccccCC-----------------CCCcccccccccChhh
Q 017994 185 KSENLLLGEDM-------------------CVKVADFGISCLESQCG-----------------SAKGFTGTYRWMAPEM 228 (362)
Q Consensus 185 k~~Nil~~~~~-------------------~~kl~Dfg~~~~~~~~~-----------------~~~~~~~~~~~~aPE~ 228 (362)
||+||||+..| .+|++|||+++...... ......+|+.|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996544 45555666554211100 0011357888999999
Q ss_pred hhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q 017994 229 IKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 308 (362)
Q Consensus 229 ~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 308 (362)
+.+..++.++|||||||++|||++|.+|+..... ......... .++...........++.+||+.+|.+||++.|++
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-LPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-cChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 9999999999999999999999999888754221 111221111 1111111234567899999999999999999998
Q ss_pred H
Q 017994 309 S 309 (362)
Q Consensus 309 ~ 309 (362)
+
T Consensus 264 ~ 264 (793)
T PLN00181 264 Q 264 (793)
T ss_pred h
Confidence 6
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=204.30 Aligned_cols=162 Identities=24% Similarity=0.291 Sum_probs=129.1
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCCCccccc
Q 017994 141 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT 220 (362)
Q Consensus 141 ~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 220 (362)
|+|.+++...+ ..+++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||++...... ...|+
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~ 67 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVD 67 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCc
Confidence 68999998654 36999999999999999999999998 999999999999999 9988754432 22678
Q ss_pred ccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCCC-----CCCCCCCH--HHHHHHHH
Q 017994 221 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA-AFAVCQKNARP-----PVPPTCPK--AFSYLISR 292 (362)
Q Consensus 221 ~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~--~l~~li~~ 292 (362)
+.|+|||++.+..++.++||||||+++|+|++|..||........ ...+....... ..+..++. .+.+++.+
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 999999999999999999999999999999999999976543222 22222111111 11122333 68999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhh
Q 017994 293 CWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 293 ~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
||..+|.+||++.++++.+....
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-29 Score=210.50 Aligned_cols=253 Identities=32% Similarity=0.608 Sum_probs=217.4
Q ss_pred ccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
++.+++.+..+|.....|..|+|.+.+..++.|++....-... ..++|..|.-.|+-+.||||..+++.|..+..+
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~r----isrdfneefp~lrifshpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTAR----ISRDFNEEFPALRIFSHPNILPVLGACNSPPNL 262 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchh----hcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence 4667788888999999999999999999999999876443322 246788899899999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCceEEe--eeccccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVA--DFGISCL 207 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dlk~~Nil~~~~~~~kl~--Dfg~~~~ 207 (362)
.++..|++.|+|+..++.....-.+..++.+++.+++.|++|||+.. |.---|.+..+++|++.+.+|. |--++.
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf- 341 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF- 341 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-
Confidence 99999999999999999887767888999999999999999999974 4444688999999998776654 322221
Q ss_pred cccCCCCCcccccccccChhhhhcCCC---CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCH
Q 017994 208 ESQCGSAKGFTGTYRWMAPEMIKEKRH---TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284 (362)
Q Consensus 208 ~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
...+....|.|++||.+...+. -.++|+|||++++||+.|...||.+.++.+.-.++...+.+..+|+.++.
T Consensus 342 -----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~ 416 (448)
T KOG0195|consen 342 -----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISR 416 (448)
T ss_pred -----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccH
Confidence 1223445789999999987664 35799999999999999999999999999998899999999999999999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
.+..++.-|+..||.+||.+..|+-.|+++
T Consensus 417 hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 999999999999999999999999888865
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-24 Score=196.32 Aligned_cols=250 Identities=30% Similarity=0.466 Sum_probs=202.8
Q ss_pred eeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCC-ceeeeeEEEEeCCeEEEEE
Q 017994 57 LFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP-HIITFVAACKKPPVFCIIT 135 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp-~iv~~~~~~~~~~~~~lv~ 135 (362)
|.+.+.||.|+||.||++.+. ..+++|.+........ .....+.+|+.++..+.|+ +++++.+.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS---KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch---hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 677889999999999999998 7889999887654432 1246788999999999988 7999999998888889999
Q ss_pred ecCCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-ceEEeeeccccccccCC-
Q 017994 136 EYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGISCLESQCG- 212 (362)
Q Consensus 136 e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~- 212 (362)
+++.++++.+++..... ..++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.+.......
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999999977776532 1588899999999999999999999999999999999999988 79999999987444332
Q ss_pred ------CCCcccccccccChhhhhc---CCCCCcccchhhhHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCC-C--
Q 017994 213 ------SAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMTP----EQAAFAVCQKNAR-P-- 276 (362)
Q Consensus 213 ------~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~----~~~~~~~~~~~~~-~-- 276 (362)
......++..|++||.+.+ ...+...|+|++|++++++++|..||..... ......+...... .
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 2356789999999999987 5789999999999999999999999887763 3333333322222 1
Q ss_pred CCCCCC----CHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 277 PVPPTC----PKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 277 ~~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
...... ...+.+++..++..+|..|.+..+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111211 1578999999999999999988887764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=205.24 Aligned_cols=166 Identities=17% Similarity=0.191 Sum_probs=126.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC---CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
..+|.+.+.||+|+||+||+|.+. ++.||||++...... .........+.+|+.+|++++|+|++..+.. .+.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPW-WSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccc-cccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 467999999999999999999874 567899987633110 0011124668899999999999999853332 245
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCcEEEcCCCceEEeeeccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL-KSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dl-k~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.|+||||++|++|.. +. . .. ...++.+++.+|.|||++||+|||| ||+|||++.++.++|+|||++....
T Consensus 93 ~~LVmE~~~G~~L~~-~~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-AR--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred cEEEEEccCCCCHHH-hC--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 799999999999963 21 1 11 1467889999999999999999999 9999999999999999999998654
Q ss_pred cCCCC---------CcccccccccChhhhhcC
Q 017994 210 QCGSA---------KGFTGTYRWMAPEMIKEK 232 (362)
Q Consensus 210 ~~~~~---------~~~~~~~~~~aPE~~~~~ 232 (362)
..... ....+++.|.|||.+...
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 43221 234567789999988643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=187.04 Aligned_cols=176 Identities=11% Similarity=0.116 Sum_probs=136.0
Q ss_pred ccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHH---HHHHHHHHHHHHHcCCCCceeeeeEEEEeC--
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASM---LEKQFTSEVALLFRLNHPHIITFVAACKKP-- 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~---~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-- 128 (362)
..+|.+.+.||.|+||.||++..++..+|||+++........... ..+.+.+|+..+.++.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 478999999999999999998777789999999865443322110 023368999999999999999999886543
Q ss_pred ------CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 129 ------PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 129 ------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
...+++|||++|.+|.++.. +++ ....+++.+|..+|+.|++|||++|+||+++.+| ++|+||
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 35889999999999988732 333 2456999999999999999999999999999988 999999
Q ss_pred ccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHH
Q 017994 203 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 251 (362)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell 251 (362)
|........... ..+.....+..++|+|+||+++..+.
T Consensus 179 g~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 977543221111 11334455668999999999987664
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=190.24 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=186.2
Q ss_pred cccccCeeeeeeecccCCeeEEEEEECC--e-----------------------------------eEEEEEecCCCcch
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYKQ--R-----------------------------------DVAIKLVSQPEEDA 93 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~-----------------------------------~vavK~~~~~~~~~ 93 (362)
.+..++|+++..||+|....||.+.... . +.|||.+..-..+.
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 3457889999999999999999886531 0 14566554432221
Q ss_pred HHHHHHHHHHHHHHH------H-----------HH----c-CCCCceeeeeEEEEe------------------------
Q 017994 94 SLASMLEKQFTSEVA------L-----------LF----R-LNHPHIITFVAACKK------------------------ 127 (362)
Q Consensus 94 ~~~~~~~~~~~~Ei~------~-----------l~----~-l~hp~iv~~~~~~~~------------------------ 127 (362)
. ...+.+.+.+|.- . +. + -+|||||++.+.|.+
T Consensus 233 ~-~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g 311 (598)
T KOG4158|consen 233 G-DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG 311 (598)
T ss_pred c-hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence 1 1122233333321 1 11 1 259999999887743
Q ss_pred ---CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE--cCCC--ceEEe
Q 017994 128 ---PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL--GEDM--CVKVA 200 (362)
Q Consensus 128 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~--~~~~--~~kl~ 200 (362)
...+|+||... ..+|..++..+. .+.....-++.|+++|+.|||++|+.|||+|++|||+ ++++ .+.|.
T Consensus 312 ~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 312 AGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred cCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 23689999987 459999998764 5667888899999999999999999999999999998 3443 68999
Q ss_pred eeccccccccCCC-------CCcccccccccChhhhhcCCC------CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHH
Q 017994 201 DFGISCLESQCGS-------AKGFTGTYRWMAPEMIKEKRH------TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF 267 (362)
Q Consensus 201 Dfg~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~------~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~ 267 (362)
|||++--...-+. .-..-|....||||+....+- -.++|.|+.|.+.||+++...||..........
T Consensus 388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~ 467 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT 467 (598)
T ss_pred ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech
Confidence 9998743222111 123346778999999865432 357999999999999999999998744433333
Q ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 268 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
........+..|..+|+.+++++..+|+.||++|++..=....|.
T Consensus 468 r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 468 RTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 334455667889999999999999999999999999876666654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-25 Score=215.38 Aligned_cols=237 Identities=19% Similarity=0.223 Sum_probs=184.3
Q ss_pred CeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIIT 135 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 135 (362)
++...+.||.++|=+|.+|++..-.|+||++.+......+... .+-..|++ ...+++||.+++.-+...+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~--~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPF--KQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHH--HHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6888899999999999999998666999999887655444322 22233444 55568999999998888889999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCCC
Q 017994 136 EYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK 215 (362)
Q Consensus 136 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (362)
+|.. -+|+|.+..++ -+..-....|+.|++.||..+|..||+|||||.+||||+.-+.+.|.||........+....
T Consensus 101 qyvk-hnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHh-hhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9995 49999998776 47777788899999999999999999999999999999999999999998654322211111
Q ss_pred --------cccccccccChhhhhcC----------C-CCCcccchhhhHHHHHHHh-CCCCCCC-----------CCHHH
Q 017994 216 --------GFTGTYRWMAPEMIKEK----------R-HTKKVDVYSFGIVLWELLT-ALTPFDN-----------MTPEQ 264 (362)
Q Consensus 216 --------~~~~~~~~~aPE~~~~~----------~-~~~~~Dv~slG~~l~ell~-g~~p~~~-----------~~~~~ 264 (362)
+...-.+|.|||.+... . .+++.||||+||+++||++ |++||.- ..++.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~ 257 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ 257 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence 11123479999988642 1 4788999999999999999 8999852 11111
Q ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 265 AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
.+.++ -+..++++|..|++.||.+|.++++.++.
T Consensus 258 ~Le~I------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 258 LLEKI------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHhC------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11111 12469999999999999999999999985
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-25 Score=215.31 Aligned_cols=246 Identities=24% Similarity=0.328 Sum_probs=186.5
Q ss_pred eeeeeecccCCeeEEEEEEC--CeeEEEEEecC---CCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 58 FIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQ---PEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~---~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
.....+|.|++|.|+..... ....+.|.... +..... .....+..|.-+-..+.|||++..+..+.+.....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~---~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~ 397 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESER---KYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL 397 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHH---HHhhhhhhheeecccccCCchhhhHHHHhhcccch
Confidence 35678999999977777654 23334443321 111111 11122667888888899999998888777766666
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
-.||||++ +|..++.... .+....+-.++.|++.|+.|+|..||.|||+|++|++++.+|.+||+|||.+..+....
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hhhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 66999999 9999998763 47778899999999999999999999999999999999999999999999887554432
Q ss_pred C-----CCcccccccccChhhhhcCCCC-CcccchhhhHHHHHHHhCCCCCCCCCHHHHHH--HHHhc-----CCCCCCC
Q 017994 213 S-----AKGFTGTYRWMAPEMIKEKRHT-KKVDVYSFGIVLWELLTALTPFDNMTPEQAAF--AVCQK-----NARPPVP 279 (362)
Q Consensus 213 ~-----~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~--~~~~~-----~~~~~~~ 279 (362)
. ....+|+..|+|||++.+..|. ...||||.|+++..|++|+.||......+..+ ..... .......
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 2 3567899999999999988875 57899999999999999999997655443321 10000 1111233
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+|...+.+|.+||+.+|.+|.++++|++
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 556778899999999999999999999985
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=177.71 Aligned_cols=144 Identities=18% Similarity=0.170 Sum_probs=109.9
Q ss_pred eeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchH--------------------HHHHHHHHHHHHHHHHHcCCCCce
Q 017994 60 GCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDAS--------------------LASMLEKQFTSEVALLFRLNHPHI 118 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~--------------------~~~~~~~~~~~Ei~~l~~l~hp~i 118 (362)
...||+|++|.||+|.+. ++.||||+++....... ...........|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357999999999999985 88999999986532110 011223344569999999988776
Q ss_pred eeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCcEEEcCCCce
Q 017994 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYL-HSQGILHRDLKSENLLLGEDMCV 197 (362)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~i~H~dlk~~Nil~~~~~~~ 197 (362)
.....+... ..++||||++|+++........ .++...+..++.|++.+|.++ |+.||+||||||+||+++ ++.+
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~--~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA--PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 443332222 2379999998887765543332 588899999999999999999 799999999999999998 4789
Q ss_pred EEeeecccccc
Q 017994 198 KVADFGISCLE 208 (362)
Q Consensus 198 kl~Dfg~~~~~ 208 (362)
+|+|||++...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.3e-24 Score=186.89 Aligned_cols=235 Identities=20% Similarity=0.262 Sum_probs=151.8
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC----------Cceeeee
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH----------PHIITFV 122 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h----------p~iv~~~ 122 (362)
..+..++.||.|+++.||.+++. ++++|||+......... .. .+.+.+|......+.+ -.++-.+
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~-~~--~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~ 88 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASA-NE--YEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL 88 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHT-TH--HHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccch-HH--HHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence 45777889999999999999997 59999999887662221 11 3455556554444322 1222222
Q ss_pred EEEE---------eC---C-----eEEEEEecCCCCCHHHHHhh---cCCC--CCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 017994 123 AACK---------KP---P-----VFCIITEYLAGGSLRKYLHQ---QEPY--SVPLNLVLKLALDIARGMQYLHSQGIL 180 (362)
Q Consensus 123 ~~~~---------~~---~-----~~~lv~e~~~~~~L~~~l~~---~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~ 180 (362)
+... .. . ..+++|+-+ .++|.+++.. .... .+.......+..|++..+++||+.|++
T Consensus 89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV 167 (288)
T PF14531_consen 89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLV 167 (288)
T ss_dssp EEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence 2221 11 1 336778877 5699888652 2211 123334566778999999999999999
Q ss_pred ccCCCCCcEEEcCCCceEEeeeccccccccCCCCCcccccccccChhhhhcC--------CCCCcccchhhhHHHHHHHh
Q 017994 181 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK--------RHTKKVDVYSFGIVLWELLT 252 (362)
Q Consensus 181 H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~Dv~slG~~l~ell~ 252 (362)
|+||+|+|++++.+|.+.|+||+........... ...+..|.+||..... .++.+.|.|+||+++|.|++
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999999977654442222 3445789999987543 46889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 017994 253 ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 301 (362)
Q Consensus 253 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 301 (362)
|..||....+...... .......+|+.++.||..+|+.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999987654322111 111223788999999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=173.09 Aligned_cols=145 Identities=15% Similarity=0.153 Sum_probs=112.7
Q ss_pred eeeecccCCeeEEEEEEC-CeeEEEEEecCCCcch--------------------HHHHHHHHHHHHHHHHHHcCCCCce
Q 017994 60 GCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDA--------------------SLASMLEKQFTSEVALLFRLNHPHI 118 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~--------------------~~~~~~~~~~~~Ei~~l~~l~hp~i 118 (362)
...||+|++|+||+|.+. |+.||||+++...... .........+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999986 8999999998753211 0111223345689999999999987
Q ss_pred eeeeEEEEeCCeEEEEEecCCCCCHHHH-HhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCc
Q 017994 119 ITFVAACKKPPVFCIITEYLAGGSLRKY-LHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMC 196 (362)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~~ 196 (362)
.....+.... .++||||++|+++... +.. . .++...+..++.|++.++.++|+ .||+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-~--~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-V--PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh-c--cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 5544443332 4799999988765443 433 2 47788999999999999999999 9999999999999998 789
Q ss_pred eEEeeecccccccc
Q 017994 197 VKVADFGISCLESQ 210 (362)
Q Consensus 197 ~kl~Dfg~~~~~~~ 210 (362)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-24 Score=203.04 Aligned_cols=225 Identities=24% Similarity=0.340 Sum_probs=187.9
Q ss_pred ecccCCeeEEEEE-----ECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCCeEEEEEe
Q 017994 63 FASGRHSRIYRGI-----YKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPPVFCIITE 136 (362)
Q Consensus 63 lg~G~~g~Vy~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e 136 (362)
+|+|+||.|+++. +.+.-+|.|+..+........ .....|-.++..++ ||.+++++..+..+...+++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~----~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR----THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccc----cccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 7899999999753 346778888887754433322 13345778888886 9999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCCCc
Q 017994 137 YLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG 216 (362)
Q Consensus 137 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 216 (362)
+..||.|...+.+.. .+.+.....+...++.+++.+|+.+|+|+|+|++||+++.+|++++.|||++.........
T Consensus 78 ~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred hcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 999999999887765 4666777788889999999999999999999999999999999999999998765443322
Q ss_pred ccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhccc
Q 017994 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296 (362)
Q Consensus 217 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 296 (362)
+||..|||||++. ....++|.||+|+++++|+||..||.. ++...+. .....+|..++...++++..++..
T Consensus 154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il--~~~~~~p~~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL--KAELEMPRELSAEARSLFRQLFKR 224 (612)
T ss_pred -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh--hhccCCchhhhHHHHHHHHHHHhh
Confidence 9999999999998 678889999999999999999999998 4444443 334667888889999999999999
Q ss_pred CCCCCCCH
Q 017994 297 SPDRRPHF 304 (362)
Q Consensus 297 ~p~~Rps~ 304 (362)
+|.+|...
T Consensus 225 ~p~nrLg~ 232 (612)
T KOG0603|consen 225 NPENRLGA 232 (612)
T ss_pred CHHHHhcc
Confidence 99999755
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-22 Score=167.68 Aligned_cols=187 Identities=18% Similarity=0.089 Sum_probs=140.1
Q ss_pred eeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCCeEEEEEec
Q 017994 59 IGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~ 137 (362)
+...|++|+||+||.+...+.+++.+.+.....-. .......+.+|+++|+++. |+++++++++ ...+++|||
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~--~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWL--RGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhh--hhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 45689999999999888888888877776543321 1111235789999999995 5889999886 446899999
Q ss_pred CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCcEEEcCCCceEEeeeccccccccCCCC--
Q 017994 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL-KSENLLLGEDMCVKVADFGISCLESQCGSA-- 214 (362)
Q Consensus 138 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dl-k~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 214 (362)
+.|.+|.+.+.. ....++.|++.+|.++|++||+|||| ||.||+++.+|.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 999998754321 11357789999999999999999999 799999999999999999999754432210
Q ss_pred ------------CcccccccccChhhhhcC-CCC-CcccchhhhHHHHHHHhCCCCCCCC
Q 017994 215 ------------KGFTGTYRWMAPEMIKEK-RHT-KKVDVYSFGIVLWELLTALTPFDNM 260 (362)
Q Consensus 215 ------------~~~~~~~~~~aPE~~~~~-~~~-~~~Dv~slG~~l~ell~g~~p~~~~ 260 (362)
.-...++.+++|+...-- ..+ .+.+.++.|+-+|.++|+..++-+.
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 011246777777754321 223 5678999999999999988877553
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=199.08 Aligned_cols=247 Identities=19% Similarity=0.238 Sum_probs=186.9
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC---CCceeeeeE
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN---HPHIITFVA 123 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hp~iv~~~~ 123 (362)
.+.+.....|.+.+.||.|+||+||+|... ++.||||+-+.+....- .=-.+++.+|+ -+.|..+..
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---------YI~~q~~~RLk~~~~~~~~~~~~ 761 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---------YICLQVMERLKPQMLPSIMHISS 761 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---------eehHHHHHhhchhhhcchHHHHH
Confidence 344556788999999999999999999886 78999999888765421 11233334443 245555655
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-------CCCc
Q 017994 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-------EDMC 196 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~-------~~~~ 196 (362)
.+.-.+..++|+||.+.|||.++++..+ .+++..+..++.|++..++.||..+||||||||+|+|+. ..-.
T Consensus 762 a~~~~~~S~lv~ey~~~Gtlld~~N~~~--~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 762 AHVFQNASVLVSEYSPYGTLLDLINTNK--VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred HHccCCcceeeeeccccccHHHhhccCC--CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence 5666777889999999999999999544 699999999999999999999999999999999999994 2346
Q ss_pred eEEeeeccccccc---cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Q 017994 197 VKVADFGISCLES---QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 273 (362)
Q Consensus 197 ~kl~Dfg~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 273 (362)
++|+|||.+..+. ........++|-.+-.+|+..+..++..+|.|.|+.+++.|+.|+.-= ...+.
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~~g~ 908 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------VKNGS 908 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------hcCCc
Confidence 9999999886433 333445677889999999999999999999999999999999995421 11111
Q ss_pred CCC---CCCCCCCHH-HHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 274 ARP---PVPPTCPKA-FSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 274 ~~~---~~~~~~~~~-l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
.+. .++..+..+ ..+|+..+|+.|-..=|...+|...|+....
T Consensus 909 ~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 909 SWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred ceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 111 122222233 4568888999666666888888888776544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-20 Score=161.13 Aligned_cols=140 Identities=24% Similarity=0.371 Sum_probs=117.0
Q ss_pred eeecccCCeeEEEEEECCeeEEEEEecCCCcc-hHH-HHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecC
Q 017994 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEED-ASL-ASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYL 138 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~-~~~-~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 138 (362)
+.||+|++|.||+|.+.+..|+||+....... ... .......+.+|+.++..+.|++++....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 56899999999999999999999987653321 111 1222356788999999999999888777777778889999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 139 ~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
+|++|.+++.... . ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999987543 1 7889999999999999999999999999999999 78899999998754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.6e-21 Score=162.70 Aligned_cols=132 Identities=17% Similarity=0.276 Sum_probs=102.9
Q ss_pred eeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-----CCCceeeeeEEEEeCC---e-
Q 017994 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-----NHPHIITFVAACKKPP---V- 130 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-----~hp~iv~~~~~~~~~~---~- 130 (362)
...||+|+||.||.-..... .+||++....... .+.+.+|+.+++.+ +||||++++++++++. .
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~~------~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDGG------DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEECCCCcC-eEEEEEeccccch------HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 45799999999996222233 4799887643321 35688999999999 6799999999998874 4
Q ss_pred EEEEEec--CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHH-HHHHHCCccccCCCCCcEEEcCC----CceEEeeec
Q 017994 131 FCIITEY--LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGM-QYLHSQGILHRDLKSENLLLGED----MCVKVADFG 203 (362)
Q Consensus 131 ~~lv~e~--~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~i~H~dlk~~Nil~~~~----~~~kl~Dfg 203 (362)
+.+|+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++|+||||||+||+++.. +.++|+||+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3378999 5579999999763 35555 35678888777 99999999999999999999743 379999954
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.9e-21 Score=177.98 Aligned_cols=206 Identities=32% Similarity=0.592 Sum_probs=165.4
Q ss_pred HHcCCCCceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-cccCCCCCc
Q 017994 110 LFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI-LHRDLKSEN 188 (362)
Q Consensus 110 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i-~H~dlk~~N 188 (362)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.... ..+++.....++++++.||.|||...| .|+.+++.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 356889999999999999999999999999999999998844 468888899999999999999999876 999999999
Q ss_pred EEEcCCCceEEeeecccccccc---CCCCCcccccccccChhhhhcCC-------CCCcccchhhhHHHHHHHhCCCCCC
Q 017994 189 LLLGEDMCVKVADFGISCLESQ---CGSAKGFTGTYRWMAPEMIKEKR-------HTKKVDVYSFGIVLWELLTALTPFD 258 (362)
Q Consensus 189 il~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~Dv~slG~~l~ell~g~~p~~ 258 (362)
++++....+||.|||+...... ........-..-|.|||.+.... .+.+.|+||+|++++|+++...||+
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 9999999999999999776532 11122223456799999997641 4678999999999999999999997
Q ss_pred CC----CHHHHHHHHHhcCC---CCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 259 NM----TPEQAAFAVCQKNA---RPPVP--PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 259 ~~----~~~~~~~~~~~~~~---~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
.. .+.+....+..... ++... ...++.+..++.+||..+|..||++.++...++.+..
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 62 33345555443122 22221 1345578999999999999999999999998876654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-21 Score=190.09 Aligned_cols=205 Identities=28% Similarity=0.399 Sum_probs=158.3
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|..++.+..|+||.||...++ .+.+|+|+=+. ..+.+. ++.....|++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq------------~lilRn--ilt~a~npfvv------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ------------NLILRN--ILTFAGNPFVV------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc------------chhhhc--cccccCCccee------------
Confidence 467888999999999999999887 67888854221 111111 33334455554
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
|+=...++..+ .++.+ ++.+++|||+.||+|||+||+|.+|+.-|++|+.|||++...-..
T Consensus 136 ---------gDc~tllk~~g--~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ---------GDCATLLKNIG--PLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ---------chhhhhcccCC--CCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 34444454443 34443 378899999999999999999999999999999999987632111
Q ss_pred ----------------CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-C
Q 017994 212 ----------------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-A 274 (362)
Q Consensus 212 ----------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~-~ 274 (362)
....+.+||+.|.|||++....|+..+|+|++|+++|+++.|..||.+.++++....++... .
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~ 276 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 276 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence 11346789999999999999999999999999999999999999999999998877665543 2
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 017994 275 RPPVPPTCPKAFSYLISRCWSSSPDRRPH 303 (362)
Q Consensus 275 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps 303 (362)
.+.-...++++.+++|.++|+.+|..|-.
T Consensus 277 wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 277 WPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred ccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 33445678899999999999999999963
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=163.92 Aligned_cols=146 Identities=20% Similarity=0.237 Sum_probs=112.6
Q ss_pred CeeeeeeecccCCeeEEEEE-E--CCeeEEEEEecCCCcch------------------HHHHHHHHHHHHHHHHHHcCC
Q 017994 56 QLFIGCKFASGRHSRIYRGI-Y--KQRDVAIKLVSQPEEDA------------------SLASMLEKQFTSEVALLFRLN 114 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~-~--~~~~vavK~~~~~~~~~------------------~~~~~~~~~~~~Ei~~l~~l~ 114 (362)
-|.+.+.||+|++|.||+|. + .++.||||+++...... .........+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 3 47899999998653211 111223345678999999997
Q ss_pred CC--ceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCcEEE
Q 017994 115 HP--HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG-ILHRDLKSENLLL 191 (362)
Q Consensus 115 hp--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-i~H~dlk~~Nil~ 191 (362)
+. .++++++. ...++||||++|.+|........ .+....+..++.|++.++.+||+.| ++||||||+||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 53 33444443 23589999999988877653332 3556677899999999999999999 9999999999999
Q ss_pred cCCCceEEeeecccccc
Q 017994 192 GEDMCVKVADFGISCLE 208 (362)
Q Consensus 192 ~~~~~~kl~Dfg~~~~~ 208 (362)
+ ++.++|+|||.+...
T Consensus 183 ~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred E-CCCEEEEEChhhhcc
Confidence 9 889999999987643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=155.13 Aligned_cols=135 Identities=26% Similarity=0.355 Sum_probs=109.8
Q ss_pred ecccCCeeEEEEEECCeeEEEEEecCCCc-chHH-HHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCCC
Q 017994 63 FASGRHSRIYRGIYKQRDVAIKLVSQPEE-DASL-ASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140 (362)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-~~~~-~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 140 (362)
||+|++|.||+|.+.+..|++|+...... .... .......+.+|+.++..+.|+++.....++......+++|||++|
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 79999999999999999999998654321 1111 112236678899999999988766655566667778899999999
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 141 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 141 ~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
++|.+++.... . .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 82 ~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 82 KPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999876532 1 7889999999999999999999999999999 78999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.9e-19 Score=174.38 Aligned_cols=141 Identities=23% Similarity=0.303 Sum_probs=115.1
Q ss_pred CeeeeeeecccCCeeEEEEEECCeeEEEEEecCCC-cchH-HHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPE-EDAS-LASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~-~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
.|...+.||+|+||.||+|.+.+..+++|+..... .... ........+.+|+.++..++|++++....++......++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 34557899999999999999987777776543321 1111 112224678899999999999999988888777778899
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+||++ .++.++|+|||++..
T Consensus 414 v~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 414 VMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999999886 346788999999999999999999999999999 677899999998865
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-20 Score=171.11 Aligned_cols=167 Identities=28% Similarity=0.473 Sum_probs=131.5
Q ss_pred CeEEEEEecCCCCCHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQ-QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
.++||.|++|.-.+|.+++.. ......+......++.|++.|++| +|.+|+|+||.||+...+..+||+|||+.+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 468999999999999999974 333457778899999999999999 9999999999999999999999999999876
Q ss_pred cccCC-------CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC-CC
Q 017994 208 ESQCG-------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP-PV 278 (362)
Q Consensus 208 ~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~-~~ 278 (362)
..... ......||..||+||.+.+..|+.++||||||++++|++. =..++.. .........+..+ .+
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDGIIPPEF 481 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCCCChHH
Confidence 55544 4556789999999999999999999999999999999997 2233322 1112222222222 22
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCC
Q 017994 279 PPTCPKAFSYLISRCWSSSPDRRPH 303 (362)
Q Consensus 279 ~~~~~~~l~~li~~~l~~~p~~Rps 303 (362)
...+ +.-..|+.+++.+.|.+||+
T Consensus 482 ~~d~-p~e~~ll~~lls~~p~~RP~ 505 (516)
T KOG1033|consen 482 LQDY-PEEYTLLQQLLSPSPEERPS 505 (516)
T ss_pred hhcC-cHHHHHHHHhcCCCcccCch
Confidence 2333 33457999999999999993
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.6e-19 Score=150.05 Aligned_cols=141 Identities=18% Similarity=0.181 Sum_probs=109.0
Q ss_pred eeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHH----------------HHHHHHHHHHHHHHHHcCCCCc--
Q 017994 57 LFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASL----------------ASMLEKQFTSEVALLFRLNHPH-- 117 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~----------------~~~~~~~~~~Ei~~l~~l~hp~-- 117 (362)
|.+.+.||+|+||.||++... ++.||||++......... .......+..|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 777889999999999999885 889999997764311100 0112234677899999987773
Q ss_pred eeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCce
Q 017994 118 IITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 197 (362)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~ 197 (362)
++..++ ....+++|||++|++|..+... .....++.+++.++.++|+.|++|+||+|+||+++.++.+
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 444443 2345899999999999775431 2356788999999999999999999999999999999999
Q ss_pred EEeeeccccccc
Q 017994 198 KVADFGISCLES 209 (362)
Q Consensus 198 kl~Dfg~~~~~~ 209 (362)
+|+|||++....
T Consensus 165 ~liDfg~~~~~~ 176 (198)
T cd05144 165 YIIDWPQMVSTD 176 (198)
T ss_pred EEEECCccccCC
Confidence 999999985443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-17 Score=145.16 Aligned_cols=140 Identities=17% Similarity=0.144 Sum_probs=107.4
Q ss_pred eeec-ccCCeeEEEEEECCeeEEEEEecCCCcchH-------HHHHHHHHHHHHHHHHHcCCCCce--eeeeEEEEeC-C
Q 017994 61 CKFA-SGRHSRIYRGIYKQRDVAIKLVSQPEEDAS-------LASMLEKQFTSEVALLFRLNHPHI--ITFVAACKKP-P 129 (362)
Q Consensus 61 ~~lg-~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~~~~Ei~~l~~l~hp~i--v~~~~~~~~~-~ 129 (362)
..|| .||.|+||.+...+..++||.+.....-.. ........+.+|+.++..+.|++| +..+++.... .
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4687 899999999999899999998864321000 011224567889999999998875 6677664332 2
Q ss_pred ---eEEEEEecCCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 130 ---VFCIITEYLAG-GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 130 ---~~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
..++|+|+++| .+|.+++... .++.. .+.+++.+|.+||++||+|+||||.|||++.++.++|+|||.+
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 23599999997 6999988653 35543 3568999999999999999999999999999889999999987
Q ss_pred cc
Q 017994 206 CL 207 (362)
Q Consensus 206 ~~ 207 (362)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 54
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=139.43 Aligned_cols=141 Identities=18% Similarity=0.198 Sum_probs=98.7
Q ss_pred eeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHH------------------HHHHHHHHHHHHHcCCCCc--e
Q 017994 60 GCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASM------------------LEKQFTSEVALLFRLNHPH--I 118 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~------------------~~~~~~~Ei~~l~~l~hp~--i 118 (362)
.+.||+|+||+||+|.+. ++.||||++............ .......|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999987 889999998764322111100 0111235666666664432 4
Q ss_pred eeeeEEEEeCCeEEEEEecCCCCCHHH-HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCc
Q 017994 119 ITFVAACKKPPVFCIITEYLAGGSLRK-YLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMC 196 (362)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~~ 196 (362)
.+.++. ...++||||++++++.. .+.... .. ..+..++.+++.++.++|. .|++|+||||+||+++ ++.
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 444443 23589999998854321 111111 11 5678899999999999999 9999999999999999 889
Q ss_pred eEEeeeccccccc
Q 017994 197 VKVADFGISCLES 209 (362)
Q Consensus 197 ~kl~Dfg~~~~~~ 209 (362)
++|+|||.+....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999886443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.7e-19 Score=173.70 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=197.8
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC---CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCC
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPP 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~ 129 (362)
...|.+.+.||+|+|+.|-..... ...+|+|.+......... ......|..+-+.+. |+|++.+++......
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~----~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~ 94 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDS----SEHIDTETDIQKKLSKHSNTVHMIEPSSSPR 94 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccch----hhhcCccccccccccccccccccCCccCCCc
Confidence 356788888999999999887664 346777777765422211 244455888888886 999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEEEcCCC-ceEEeeeccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH-SQGILHRDLKSENLLLGEDM-CVKVADFGISCL 207 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg~~~~ 207 (362)
..++.++|..|+++.+.+........+...+..++.|+..++.|+| ..++.|+|+||+|.+++..+ .+++.|||+++.
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999999999984222225667788889999999999999 99999999999999999999 999999999986
Q ss_pred ccc-CC---CCCcccc-cccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCC--CCCC
Q 017994 208 ESQ-CG---SAKGFTG-TYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-VCQKNA--RPPV 278 (362)
Q Consensus 208 ~~~-~~---~~~~~~~-~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~-~~~~~~--~~~~ 278 (362)
... .+ .....+| ++.|+|||...+ .......|+||.|+++.-+++|..||........... ...... ....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 544 22 2345567 999999999988 4568899999999999999999999987554432221 111111 2344
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 279 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 279 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...++....+++.+++..+|..|.+.+++..
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccc
Confidence 5667788899999999999999999888764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.1e-17 Score=130.95 Aligned_cols=132 Identities=20% Similarity=0.226 Sum_probs=112.5
Q ss_pred eeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC--CceeeeeEEEEeCCeEEEEEe
Q 017994 59 IGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH--PHIITFVAACKKPPVFCIITE 136 (362)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--p~iv~~~~~~~~~~~~~lv~e 136 (362)
+.+.||.|.++.||++...+..++||....... ...+.+|+..+..+.+ .++++++.+....+..++++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc--------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence 356799999999999999888999999866433 2467789999999976 589999998888889999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 137 YLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ---GILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 137 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
|++|+++..+ +......++.+++.++.+||.. +++|+|++|+||+++..+.++++|||.+..
T Consensus 74 ~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9988777654 4456677889999999999985 799999999999999989999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.9e-14 Score=130.06 Aligned_cols=281 Identities=18% Similarity=0.248 Sum_probs=189.9
Q ss_pred eeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEE------E-EeC
Q 017994 57 LFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAA------C-KKP 128 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~------~-~~~ 128 (362)
...++.||+|+.+.+|..-.-+.. +-|+++.+...... +-+..|... .||-+-.-+.| . ...
T Consensus 13 i~~gr~LgqGgea~ly~l~e~~d~-VAKIYh~Pppa~~a---------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~ 82 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEVRDQ-VAKIYHAPPPAAQA---------QKVAELAATPDAPLLNYRVAWPQATLHGGRRG 82 (637)
T ss_pred cCCCccccCCccceeeecchhhch-hheeecCCCchHHH---------HHHHHhccCCCCcchhhhhcccHHHhhCCCcc
Confidence 345678999999999966443433 44999887654321 122223322 45543331111 1 122
Q ss_pred CeEEEEEecCCCCCHHHHH-h----hcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 129 PVFCIITEYLAGGSLRKYL-H----QQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l-~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
..+.++|..+.|..--..+ + .+.-....+.-..+.++.++.+...||..|.+-||+.++|+|+++++.+.|+|-+
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc
Confidence 3477888888775332222 2 1111246788899999999999999999999999999999999999999999976
Q ss_pred cccccccCCCCCcccccccccChhhhh-----cCCCCCcccchhhhHHHHHHHhC-CCCCCCCCH-------HH--HHH-
Q 017994 204 ISCLESQCGSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTA-LTPFDNMTP-------EQ--AAF- 267 (362)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g-~~p~~~~~~-------~~--~~~- 267 (362)
..............+|...|.+||... +..-+...|.|.||+++++++.| ++||.+... .+ +..
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 544444444556778999999999875 33457789999999999999995 999976431 11 100
Q ss_pred --HHHhcCCC--CCCC-----CCCCHHHHHHHHHhcccC--CCCCCCHHHHHHHHHhhhhhccCCCCcccccCCCCCccc
Q 017994 268 --AVCQKNAR--PPVP-----PTCPKAFSYLISRCWSSS--PDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTI 336 (362)
Q Consensus 268 --~~~~~~~~--~~~~-----~~~~~~l~~li~~~l~~~--p~~Rps~~ell~~L~~~~~~l~~~~~~~~~~~~~~~~~~ 336 (362)
.......+ .+-| .-+++++..+..+|+... +.-||+++..+..|.++.+.|..+...-....+. .
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H~y~~----h 318 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMHVYPV----H 318 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccccccC----C
Confidence 00011111 1111 335788999999999654 6789999999999999999999887644443333 3
Q ss_pred cccccccccccccch
Q 017994 337 LRCLPTCIARHCCAH 351 (362)
Q Consensus 337 ~~~~p~~~~~~~~~~ 351 (362)
...+|+|...++...
T Consensus 319 l~~CPwCa~~~~g~~ 333 (637)
T COG4248 319 LTDCPWCALDNQGVI 333 (637)
T ss_pred CCCCchhhhcccCcc
Confidence 446788888666543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.7e-15 Score=140.62 Aligned_cols=144 Identities=21% Similarity=0.254 Sum_probs=99.1
Q ss_pred eeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHH----------------------------HHHHH------HHHHH
Q 017994 61 CKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASL----------------------------ASMLE------KQFTS 105 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~----------------------------~~~~~------~~~~~ 105 (362)
+.||.|++|+||+|+.. |+.||||+.+......-. ..+.. -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999985 899999998764321110 00111 13455
Q ss_pred HHHHHHcCC-----CCceeeeeEEE-EeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 017994 106 EVALLFRLN-----HPHIITFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR-GMQYLHSQG 178 (362)
Q Consensus 106 Ei~~l~~l~-----hp~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~~ 178 (362)
|...+.++. ++++ .+-..+ ......++||||++|++|.++...... ..+ ...++..++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCC
Confidence 666555552 3433 222222 223456899999999999988754321 222 2345555555 478899999
Q ss_pred ccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 179 ILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 179 i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
++|+|++|+||+++.+|.++++|||++....
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999986544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.3e-14 Score=113.24 Aligned_cols=146 Identities=23% Similarity=0.258 Sum_probs=114.5
Q ss_pred eeeeecccCCeeEEEEEECCeeEEEEE-----ecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 59 IGCKFASGRHSRIYRGIYKQRDVAIKL-----VSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~vavK~-----~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
....+-+|+-+.|+++.+.|+...||. ++.+..+.. ..+.+..+|++.+.++.--+|.-..-++.+.....|
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~k---Ltr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQK---LTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHH---HHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE
Confidence 345688999999999999998888874 333333333 336788899999999876566655556677777889
Q ss_pred EEecCCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---ceEEeeeccccc
Q 017994 134 ITEYLAG-GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM---CVKVADFGISCL 207 (362)
Q Consensus 134 v~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~---~~kl~Dfg~~~~ 207 (362)
+|||++| .++.+++...............++..|-+.+.-||.++|+||||..+||++..+| .+.++|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999977 5889999876654444455578999999999999999999999999999997554 358999998754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=7.1e-14 Score=113.82 Aligned_cols=136 Identities=21% Similarity=0.289 Sum_probs=106.2
Q ss_pred eecccCCeeEEEEEECCeeEEEEEecC-CCcchHHH-HHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCC
Q 017994 62 KFASGRHSRIYRGIYKQRDVAIKLVSQ-PEEDASLA-SMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLA 139 (362)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~~~vavK~~~~-~~~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 139 (362)
.+++|+-+.+|.+.+.+.++++|.-.+ .-....+. ........+|.+++.++.--+|.-..-+..+.+...|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 578999999999988887777774322 22222222 2234677789999999876666665666677788889999999
Q ss_pred CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 140 GGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 140 ~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
|..|.+.+... ...++..+-..+.-||..||+||||+++||++..++ +.++|||++..
T Consensus 83 G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999865 145777888888999999999999999999997765 99999999864
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.8e-14 Score=118.04 Aligned_cols=128 Identities=20% Similarity=0.171 Sum_probs=96.3
Q ss_pred eeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCcee-eeeEEEEeCCeEEEEEecC
Q 017994 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII-TFVAACKKPPVFCIITEYL 138 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv-~~~~~~~~~~~~~lv~e~~ 138 (362)
.+.|+.|.++.||++...+..+++|+....... ...+..|+.+++.+.+.+++ +++... ....++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~-------~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL-------LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc-------ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEec
Confidence 356889999999999999999999998654321 12346788888888654544 454443 23457999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----cccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI-----LHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 139 ~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i-----~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
+|.++.+. . . ....++.+++.+|..||+.++ +|+|++|.||+++ ++.++++||+.+..
T Consensus 74 ~G~~l~~~----~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE----D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc----c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 99887653 0 1 112456789999999999985 9999999999999 66899999998743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=8.6e-15 Score=141.13 Aligned_cols=149 Identities=16% Similarity=0.158 Sum_probs=93.8
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcch----------------------------HHHHHHHHHH
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDA----------------------------SLASMLEKQF 103 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~----------------------------~~~~~~~~~~ 103 (362)
+.+|.. +.||+|++|+||+|+.+ |+.||||+.++..... ....+..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455666 78999999999999985 7899999998652111 0111222233
Q ss_pred ------HHHHHHHHcC----CCCceeeeeEEEE-eCCeEEEEEecCCCCCHHHHHh--hcCC--CCCCHHHHHHHHHHHH
Q 017994 104 ------TSEVALLFRL----NHPHIITFVAACK-KPPVFCIITEYLAGGSLRKYLH--QQEP--YSVPLNLVLKLALDIA 168 (362)
Q Consensus 104 ------~~Ei~~l~~l----~hp~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~--~~~~--~~l~~~~~~~i~~~i~ 168 (362)
.+|+..+.++ .+.+.+.+-.++. -....+|||||+.|+++.++-. ..+. ..+....+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 3344333333 1333233222222 2345679999999999987532 2210 01222223333333
Q ss_pred HHHHHHHHCCccccCCCCCcEEEcCCC----ceEEeeecccccccc
Q 017994 169 RGMQYLHSQGILHRDLKSENLLLGEDM----CVKVADFGISCLESQ 210 (362)
Q Consensus 169 ~~l~~LH~~~i~H~dlk~~Nil~~~~~----~~kl~Dfg~~~~~~~ 210 (362)
+...|++|+|+||+||+++.+| .++++|||++.....
T Consensus 276 -----if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -----VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4569999999999999999888 999999999865433
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.5e-13 Score=115.75 Aligned_cols=142 Identities=15% Similarity=0.148 Sum_probs=102.1
Q ss_pred eeecccCCeeEEEEEECC--------eeEEEEEecCCCcch--------------------HHHHHHHHHHHHHHHHHHc
Q 017994 61 CKFASGRHSRIYRGIYKQ--------RDVAIKLVSQPEEDA--------------------SLASMLEKQFTSEVALLFR 112 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~--------~~vavK~~~~~~~~~--------------------~~~~~~~~~~~~Ei~~l~~ 112 (362)
..||.|.-+.||.|...+ ..+|||+.+...... ...........+|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998652 689999887542111 1122333444589999998
Q ss_pred CCC--CceeeeeEEEEeCCeEEEEEecCCCCCHHH-HHhhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCc
Q 017994 113 LNH--PHIITFVAACKKPPVFCIITEYLAGGSLRK-YLHQQEPYSVPLNLVLKLALDIARGMQYL-HSQGILHRDLKSEN 188 (362)
Q Consensus 113 l~h--p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~i~H~dlk~~N 188 (362)
+.. -+++..+++ ...++||||+.++.+.. .++.. .++......+..+++.+|..| |+.|++||||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 853 455556654 56679999996643322 22221 355566778889999999999 89999999999999
Q ss_pred EEEcCCCceEEeeecccccccc
Q 017994 189 LLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 189 il~~~~~~~kl~Dfg~~~~~~~ 210 (362)
|+++ ++.+.|+|||.+.....
T Consensus 156 IL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred EEEE-CCcEEEEECCCceeCCC
Confidence 9997 46799999998765443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.6e-15 Score=138.01 Aligned_cols=246 Identities=21% Similarity=0.238 Sum_probs=185.1
Q ss_pred cCeeeeeeecc--cCCeeEEEEEE--C--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEe
Q 017994 55 SQLFIGCKFAS--GRHSRIYRGIY--K--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKK 127 (362)
Q Consensus 55 ~~~~~~~~lg~--G~~g~Vy~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~ 127 (362)
..+.+...+|. |.+|.||.+.. . +..+|+|.-+.+...... ...=.+|+...+.++ |++.++....++.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~----~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD----SKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc----cccccchhhcccccCccccccccCccccc
Confidence 34455678999 99999999987 3 578899885443321111 122245777777774 9999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHHHHCCccccCCCCCcEEEcCC-CceEEeee
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR----GMQYLHSQGILHRDLKSENLLLGED-MCVKVADF 202 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~i~H~dlk~~Nil~~~~-~~~kl~Df 202 (362)
.+..|+-+|++ +.+|..+..... ..++...++..+.+... ||..+|+.+++|.|++|.||+...+ ...+++||
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred CCcceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 99999999998 689999887654 25888999999999999 9999999999999999999999988 88999999
Q ss_pred ccccccccCCCC------CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCC
Q 017994 203 GISCLESQCGSA------KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM-TPEQAAFAVCQKNAR 275 (362)
Q Consensus 203 g~~~~~~~~~~~------~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~-~~~~~~~~~~~~~~~ 275 (362)
|+.......... ....+...|++||... +-++.+.|+|++|.+..+..++....... ..... ++-.....
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~--~~r~~~ip 344 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS--QLRQGYIP 344 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcc--ccccccCc
Confidence 998876654422 2225778899999875 44788899999999999999986665432 11110 10011122
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+....+.++...+..|++.+|..|++.+.+..
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 3344455677888999999999999998776654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.1e-12 Score=125.17 Aligned_cols=161 Identities=17% Similarity=0.271 Sum_probs=124.6
Q ss_pred CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCH
Q 017994 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPL 157 (362)
Q Consensus 78 ~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~ 157 (362)
+.+|.|.+++...... .....+.+.-|+.++||||+++++.++.++.+|+|+|.+ ..|..++++.+ .
T Consensus 37 ~~~vsVF~~~~~~~~~------~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~ 103 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEV------TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----K 103 (690)
T ss_pred CCceEEEEEeCCCchh------hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----H
Confidence 5678888877765511 244567888999999999999999999999999999987 47888887754 4
Q ss_pred HHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC-CCcccccccccChhhhhcCCCC
Q 017994 158 NLVLKLALDIARGMQYLH-SQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHT 235 (362)
Q Consensus 158 ~~~~~i~~~i~~~l~~LH-~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~ 235 (362)
..+...+.||+.||.+|| ..+++|++|....|+|+..|..||++|.++........ ......--.|..|+.+....
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--
Confidence 566677899999999998 56899999999999999999999999998765443221 11222223456666443222
Q ss_pred CcccchhhhHHHHHHHhC
Q 017994 236 KKVDVYSFGIVLWELLTA 253 (362)
Q Consensus 236 ~~~Dv~slG~~l~ell~g 253 (362)
-..|.|.||+++++++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 456999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.7e-14 Score=124.18 Aligned_cols=196 Identities=19% Similarity=0.286 Sum_probs=137.3
Q ss_pred HHcCCCCceeeeeEEEEeCC-----eEEEEEecCCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC--Ccc
Q 017994 110 LFRLNHPHIITFVAACKKPP-----VFCIITEYLAGGSLRKYLHQQEP--YSVPLNLVLKLALDIARGMQYLHSQ--GIL 180 (362)
Q Consensus 110 l~~l~hp~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~--~i~ 180 (362)
|-++.|.||++++.|+.+.+ ...++.||+..|+|..+|++... ..+....-.+|+.||++||.|||+. -|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 34457999999999986543 57889999999999999986432 3577777889999999999999998 599
Q ss_pred ccCCCCCcEEEcCCCceEEeeeccccccccC-----CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCC
Q 017994 181 HRDLKSENLLLGEDMCVKVADFGISCLESQC-----GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALT 255 (362)
Q Consensus 181 H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~ 255 (362)
|+++..+.|++..+|-+|++--.-....... .......+-++|.+||.=.....+-++|||++|+...+|..+..
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 9999999999999998888643221111110 01123346788999997666667788999999999999988755
Q ss_pred CCC-CCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 256 PFD-NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 256 p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
--. +......-..+.... .... ..--+.++.+|++..|+.||++.+++-.
T Consensus 281 q~tnseS~~~~ee~ia~~i--~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 281 QSTNSESKVEVEENIANVI--IGLE---NGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred ccCCCcceeehhhhhhhhe--eecc---CccccCcCcccccCCCCCCcchhhhhcC
Confidence 321 111111101110000 0000 1123568999999999999999998763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.7e-13 Score=125.82 Aligned_cols=251 Identities=19% Similarity=0.199 Sum_probs=178.3
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC---CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEe
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKK 127 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~ 127 (362)
....+|..+..||.|.|+.|+..... +..+++|-+......... ...-..|+.+...+ .|.+++++...+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~----di~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS----DIFSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh----hhcchhhhhHhhHhhcccccCCCCCCccc
Confidence 34677888899999999999987654 456788876654332211 12233566666666 48899998888888
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CceEEeeecccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISC 206 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~-~~~kl~Dfg~~~ 206 (362)
....|+-.|||+++++...+.-. ..+.+...+++..|++.++.++|+..++|+|++|.||++.++ +..+++|||..+
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence 88888999999999887776322 247778899999999999999999999999999999999886 788999999876
Q ss_pred ccccCCCCCcccccccc-cChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 207 LESQCGSAKGFTGTYRW-MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 207 ~~~~~~~~~~~~~~~~~-~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
...- ........+..| .++.......+..++|+++||..+.+.+++..--..... ...+ .....+..+.....
T Consensus 416 ~~~~-~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i--~~~~~p~~~~~~~~ 489 (524)
T KOG0601|consen 416 RLAF-SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTI--RSGDTPNLPGLKLQ 489 (524)
T ss_pred ccce-ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceee--ecccccCCCchHHh
Confidence 4211 111111223333 355556666788899999999999999998542221111 0111 11222333444477
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
+..+...+...++..||.+.++..+.+.+
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhh
Confidence 88899999999999999998887665543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.9e-13 Score=133.55 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=182.6
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
..+..+.+.+.+-.|.++.++.+.-. +...++|+......-.... .+....+-.++-.-.+|.++.....+....
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~---~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs 877 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTND---YESIRSKSNILITPRSPAVVRSFPSFPCRS 877 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhcccc---ccccCCccCccccCCCCceecccCCCCCCC
Confidence 34567777888899999999988665 3333444333211100000 011112222222234577776666666778
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
..+++++|..+++|...+++.+ ..+.+-+......+..++++||...+.|+|++|.|++...+|+.++.||+......
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence 8999999999999999998876 35666677788889999999999999999999999999999999999997332111
Q ss_pred cC--------------------------------CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCC
Q 017994 210 QC--------------------------------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257 (362)
Q Consensus 210 ~~--------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~ 257 (362)
.. .......+|+.|.+||.+.+......+|.|++|+++++.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0012345789999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 017994 258 DNMTPEQAAFAVCQKNAR-PPVPPTCPKAFSYLISRCWSSSPDRRPHFD 305 (362)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 305 (362)
....+.++...+...... +..+...+...++++...+..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999988887666544333 234566788899999999999999997665
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.31 E-value=6.4e-11 Score=105.28 Aligned_cols=144 Identities=23% Similarity=0.160 Sum_probs=101.4
Q ss_pred ecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHH-----HHHHHHHHHHHHHcCCCCce--eeeeEEEEe-----CCe
Q 017994 63 FASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASM-----LEKQFTSEVALLFRLNHPHI--ITFVAACKK-----PPV 130 (362)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~-----~~~~~~~Ei~~l~~l~hp~i--v~~~~~~~~-----~~~ 130 (362)
+-......|+++...|+.+.||......-....... -...+.+|...+.+|..-+| +..+++++. ...
T Consensus 30 v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~ 109 (268)
T PRK15123 30 FRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT 109 (268)
T ss_pred EecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence 333444457788888999999977443211101100 01146788888888743333 344555543 235
Q ss_pred EEEEEecCCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-------CCceEEeee
Q 017994 131 FCIITEYLAGG-SLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-------DMCVKVADF 202 (362)
Q Consensus 131 ~~lv~e~~~~~-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~-------~~~~kl~Df 202 (362)
.++|+|++++. +|.+++........+......++.+++..+.-||..||+|+|+++.|||++. ++.+.|+||
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 78999999886 8999986432224566778899999999999999999999999999999975 468999999
Q ss_pred cccc
Q 017994 203 GISC 206 (362)
Q Consensus 203 g~~~ 206 (362)
+.+.
T Consensus 190 ~r~~ 193 (268)
T PRK15123 190 HRAQ 193 (268)
T ss_pred Cccc
Confidence 9774
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=3e-11 Score=104.90 Aligned_cols=139 Identities=21% Similarity=0.260 Sum_probs=103.7
Q ss_pred eeecccCCeeEEEEEECC-eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCC--ceeeeeEEEEeC---CeEEEE
Q 017994 61 CKFASGRHSRIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP--HIITFVAACKKP---PVFCII 134 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp--~iv~~~~~~~~~---~~~~lv 134 (362)
+.|+.|.++.||++...+ ..+++|+........ ....+..|+.+++.+.+. .+.+++.+.... +..++|
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~-----~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v 78 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLP-----SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV 78 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCc-----ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence 468999999999998875 899999987643311 124567899999998653 456777776654 366899
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-------------------------------------- 176 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-------------------------------------- 176 (362)
|||++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 79 ~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 79 MERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 999999888775532 135666666677777777777763
Q ss_pred ------------------CCccccCCCCCcEEEcC--CCceEEeeeccccc
Q 017994 177 ------------------QGILHRDLKSENLLLGE--DMCVKVADFGISCL 207 (362)
Q Consensus 177 ------------------~~i~H~dlk~~Nil~~~--~~~~kl~Dfg~~~~ 207 (362)
..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23689999999999998 66789999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.3e-10 Score=106.47 Aligned_cols=214 Identities=13% Similarity=0.226 Sum_probs=152.4
Q ss_pred CCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE----eCCeEEEEEecCCC
Q 017994 67 RHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK----KPPVFCIITEYLAG 140 (362)
Q Consensus 67 ~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~----~~~~~~lv~e~~~~ 140 (362)
...+.|++... |..|++|+++....... .....-++.++++.|+|+|++..++. .+..+++|++|.++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~ 361 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPS 361 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCC
Confidence 34678999775 78899999955332221 12234688999999999999998875 45688999999875
Q ss_pred -CCHHHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 141 -GSLRKYLHQQE-------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 141 -~~L~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
++|.++.-... +...++..+|.++.|+..||.++|+.|+.-+-|.+.+|+++.+.+++|..+|...
T Consensus 362 s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 362 SPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred CchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEeccccee
Confidence 78877653221 1247889999999999999999999999999999999999999899998877654
Q ss_pred ccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCC-CCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 207 LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP-FDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
...... .+| +. --.+-|.-.||.+++-|.||..- +......... ...+...++.+
T Consensus 442 vl~~d~-----------~~~--le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~--------~~~I~~~yS~D 497 (655)
T KOG3741|consen 442 VLQEDP-----------TEP--LE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSH--------LTRITTTYSTD 497 (655)
T ss_pred eecCCC-----------Ccc--hh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHH--------HHHhhhhhhHH
Confidence 333321 011 11 12346888999999999998432 2222211110 11223567788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHH
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSIL 311 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~L 311 (362)
+++++......++++ -++.+++.++
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 999999999888886 4677777644
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.2e-10 Score=97.79 Aligned_cols=130 Identities=23% Similarity=0.286 Sum_probs=84.0
Q ss_pred eEEEEEEC-CeeEEEEEecCCCcch--------------------HHHHHHHHHHHHHHHHHHcCCCC--ceeeeeEEEE
Q 017994 70 RIYRGIYK-QRDVAIKLVSQPEEDA--------------------SLASMLEKQFTSEVALLFRLNHP--HIITFVAACK 126 (362)
Q Consensus 70 ~Vy~~~~~-~~~vavK~~~~~~~~~--------------------~~~~~~~~~~~~Ei~~l~~l~hp--~iv~~~~~~~ 126 (362)
.||.|... +..+|||+.+...... ...........+|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999885 7899999877642111 11233456778899999999765 455665442
Q ss_pred eCCeEEEEEecCC--CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-HHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 127 KPPVFCIITEYLA--GGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQY-LHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 127 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
..++||||++ |..+..+.... ++......++.+++..+.. +|..||+|||+++.||+++.+ .+.|+|||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~ 151 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG 151 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence 3469999998 65565544332 1123456677777775554 589999999999999999887 89999999
Q ss_pred ccccc
Q 017994 204 ISCLE 208 (362)
Q Consensus 204 ~~~~~ 208 (362)
.+...
T Consensus 152 qav~~ 156 (188)
T PF01163_consen 152 QAVDS 156 (188)
T ss_dssp TEEET
T ss_pred cceec
Confidence 87544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.9e-10 Score=98.38 Aligned_cols=142 Identities=24% Similarity=0.247 Sum_probs=103.1
Q ss_pred eeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcc----------------hHHHHHHHHHHHHHHHHHHcCCCC--c
Q 017994 57 LFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEED----------------ASLASMLEKQFTSEVALLFRLNHP--H 117 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~----------------~~~~~~~~~~~~~Ei~~l~~l~hp--~ 117 (362)
..++..||-|.-+.||.|.+. +.++|||.=+..... .+.....+....+|...|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 346789999999999999997 899999964432111 111122345677899999998544 5
Q ss_pred eeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCce
Q 017994 118 IITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 197 (362)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~ 197 (362)
+++.+++ +...+|||+++|..|...-- +.+..-.++..|+.-+.-+-..|++|||+++-||+++++|.+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence 6666554 56779999999977755431 233344555566666666668999999999999999999999
Q ss_pred EEeeeccccccc
Q 017994 198 KVADFGISCLES 209 (362)
Q Consensus 198 kl~Dfg~~~~~~ 209 (362)
.++||-.+....
T Consensus 242 ~vIDwPQ~v~~~ 253 (304)
T COG0478 242 VVIDWPQAVPIS 253 (304)
T ss_pred EEEeCcccccCC
Confidence 999998765433
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.9e-09 Score=91.19 Aligned_cols=142 Identities=13% Similarity=0.052 Sum_probs=103.6
Q ss_pred cccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCc--eeeeeEEEE-e----CCeEEEEEe
Q 017994 64 ASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH--IITFVAACK-K----PPVFCIITE 136 (362)
Q Consensus 64 g~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~--iv~~~~~~~-~----~~~~~lv~e 136 (362)
|.||.+.|++....|..+-+|.-...-...-....-+..|.+|+..+.++..-+ +++.. ++. . ....+||+|
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEE
Confidence 678999999999888888888754110000000112477889999999885322 44444 322 1 235789999
Q ss_pred cCCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc--eEEeeecccc
Q 017994 137 YLAG-GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC--VKVADFGISC 206 (362)
Q Consensus 137 ~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~--~kl~Dfg~~~ 206 (362)
-+.| .+|.+++........+......++.+++..+.-||+.|+.|+|+.+.||+++.+|. +.++||.-++
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 7743 78999987654334677778899999999999999999999999999999986677 9999998654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=9.2e-11 Score=112.69 Aligned_cols=145 Identities=15% Similarity=0.260 Sum_probs=106.6
Q ss_pred HHHHHHHHHHHHC-CccccCCCCCcEEEcCCCceEEeeeccccccccCCC----------CCcccccccccChhhhhcCC
Q 017994 165 LDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS----------AKGFTGTYRWMAPEMIKEKR 233 (362)
Q Consensus 165 ~~i~~~l~~LH~~-~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~~~ 233 (362)
.+++.|+.|+|+. ++||++|.|++|.++.+|.+||+.|+++........ .....-...|.|||++.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 3455999999986 899999999999999999999999998754333111 11112356799999999988
Q ss_pred CCCcccchhhhHHHHHHHh-CCCCCCCCCHHHH--HHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 234 HTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQA--AFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 234 ~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+.++|+||+|+++|.+.. |+.-+........ ................+|.++.+=+.+++..++.-||++.++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 8999999999999999994 6555544322111 11111111222345788999999999999999999997777654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.2e-09 Score=90.49 Aligned_cols=105 Identities=29% Similarity=0.271 Sum_probs=82.9
Q ss_pred HHHHHHHHHHHcCCCCc--eeeeeEEEEeC----CeEEEEEecCCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 017994 101 KQFTSEVALLFRLNHPH--IITFVAACKKP----PVFCIITEYLAG-GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQY 173 (362)
Q Consensus 101 ~~~~~Ei~~l~~l~hp~--iv~~~~~~~~~----~~~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~ 173 (362)
....+|...+..+..-+ .++.+++.+.. ...++|+|++++ .+|.+++..... .+......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 45677888777774333 34556665543 245899999988 489999987442 5667788999999999999
Q ss_pred HHHCCccccCCCCCcEEEcCCC---ceEEeeeccccc
Q 017994 174 LHSQGILHRDLKSENLLLGEDM---CVKVADFGISCL 207 (362)
Q Consensus 174 LH~~~i~H~dlk~~Nil~~~~~---~~kl~Dfg~~~~ 207 (362)
||.+||+|+|+++.|||++.++ .+.++||+-+..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999887 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=7.2e-09 Score=99.72 Aligned_cols=147 Identities=18% Similarity=0.222 Sum_probs=95.1
Q ss_pred eeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHH----------------------------HHH------HHHHHH
Q 017994 61 CKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLA----------------------------SML------EKQFTS 105 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~----------------------------~~~------~~~~~~ 105 (362)
..|+.++-|+||+|+.. |+.||||+.++.-...-.. .+. +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57999999999999998 8999999987643211100 111 122333
Q ss_pred HHHHHHcC-----CCCceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 017994 106 EVALLFRL-----NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 180 (362)
Q Consensus 106 Ei~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~ 180 (362)
|..-+.++ +.|++.=-.-+++-...-.|+|||++|-.+.+...... .+++.+.+.....++ -+..+=..|++
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgff 287 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCcc
Confidence 44444443 23443322223333456679999999999998854322 245544443333322 22334458999
Q ss_pred ccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 181 HRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 181 H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
|.|.+|.||+++.+|.+.+.|||+......
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999998865443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.86 E-value=7.9e-08 Score=81.69 Aligned_cols=141 Identities=14% Similarity=0.196 Sum_probs=91.7
Q ss_pred cCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHH--HHH-HHHHHHHHHHHHcCCC---CceeeeeEEE---
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLA--SML-EKQFTSEVALLFRLNH---PHIITFVAAC--- 125 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~--~~~-~~~~~~Ei~~l~~l~h---p~iv~~~~~~--- 125 (362)
.+|.+.+.+-......|.+-..++..+++|.........+.. ... .....+.+..+..+.. -....++...
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk 110 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK 110 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence 567777788887778888888889999999877654322111 000 0112233333333322 2222222222
Q ss_pred --EeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 126 --KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 126 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
.-....+++|||++|..|.++.. +++ .+...+.+++.-||+.|+.|||.+|+|++++.++ ++++||+
T Consensus 111 ~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 111 IFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 22345678999999988876642 222 2445677889999999999999999999998665 9999998
Q ss_pred ccc
Q 017994 204 ISC 206 (362)
Q Consensus 204 ~~~ 206 (362)
...
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.1e-07 Score=82.70 Aligned_cols=135 Identities=14% Similarity=0.146 Sum_probs=83.9
Q ss_pred eeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCc--eeeeeEEEEeCCeEEEEEecC
Q 017994 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH--IITFVAACKKPPVFCIITEYL 138 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~--iv~~~~~~~~~~~~~lv~e~~ 138 (362)
..||+|..+.||+. .+..+++|....... .....+|.++++.+..-+ +.+.+++....+...+|||++
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~--------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFD--------KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCC--------HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence 46899999999984 355678898865332 234577999998885433 467788887788889999999
Q ss_pred CCCC-HHHHH---------------------hhcCCCCCCHHHHH-HHHH----------HHHH-HHHHHHH----CCcc
Q 017994 139 AGGS-LRKYL---------------------HQQEPYSVPLNLVL-KLAL----------DIAR-GMQYLHS----QGIL 180 (362)
Q Consensus 139 ~~~~-L~~~l---------------------~~~~~~~l~~~~~~-~i~~----------~i~~-~l~~LH~----~~i~ 180 (362)
+|.+ +...+ +.......+..... .+.. .+.. ...+|.+ ..++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 8864 21111 11100111111111 1100 0111 1222221 2478
Q ss_pred ccCCCCCcEEEcCCCceEEeeecccc
Q 017994 181 HRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 181 H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
|+|++|.||+++.++ +.|+||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.5e-07 Score=80.83 Aligned_cols=142 Identities=18% Similarity=0.170 Sum_probs=94.5
Q ss_pred eeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHH------------------HHHHHHHHHHHHHHHHcCC--CCcee
Q 017994 61 CKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASL------------------ASMLEKQFTSEVALLFRLN--HPHII 119 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~------------------~~~~~~~~~~Ei~~l~~l~--hp~iv 119 (362)
..|.+|.-+.||+|... +..+|||++......... ..........|..-|+++. +=.++
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 36778888899999875 789999999876543322 1222334445666676663 22333
Q ss_pred eeeEEEEeCCeEEEEEecCCCCC-HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCce
Q 017994 120 TFVAACKKPPVFCIITEYLAGGS-LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCV 197 (362)
Q Consensus 120 ~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~~~ 197 (362)
+-+++. ...|||||+.... -.-.|+.. .+....+..+..+++..+.-|-. .+++|+||+.-|||+. ++.+
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 333332 3469999984421 11111111 23334677788888888888877 8999999999999999 7889
Q ss_pred EEeeecccccccc
Q 017994 198 KVADFGISCLESQ 210 (362)
Q Consensus 198 kl~Dfg~~~~~~~ 210 (362)
.|+|++.+....+
T Consensus 206 ~iID~~QaV~~~h 218 (268)
T COG1718 206 YIIDVSQAVTIDH 218 (268)
T ss_pred EEEECccccccCC
Confidence 9999998765443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.2e-07 Score=75.60 Aligned_cols=131 Identities=22% Similarity=0.262 Sum_probs=96.7
Q ss_pred eeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceee-eeEEEEeCCeEEEEE
Q 017994 57 LFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-FVAACKKPPVFCIIT 135 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~-~~~~~~~~~~~~lv~ 135 (362)
....+.||+|++|.||++.+.+..+|+|+-..+.. +..+..|+++|..+.-.++.+ ++.+..+ ++.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~--------r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~m 91 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP--------RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRM 91 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCcc--------hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhh
Confidence 44557799999999999999999999999887655 366788999999998777754 4444332 3559
Q ss_pred ecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC-CCcEEEcCCCceEEeeecccccc
Q 017994 136 EYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK-SENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 136 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk-~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
||+.|..|.+.-... +.+ -...+++.---|-..||-|+.|+ |...++.+++.+.|+||.-|+..
T Consensus 92 e~i~G~~L~~~~~~~-----~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 92 EYIDGRPLGKLEIGG-----DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhcCcchhhhhhcc-----cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 999998888766532 122 23355666666778899999987 45555555558999999988743
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=4.3e-07 Score=87.34 Aligned_cols=146 Identities=17% Similarity=0.202 Sum_probs=91.1
Q ss_pred eeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHH-------------------------HHHHHH------HHHHHH
Q 017994 60 GCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASL-------------------------ASMLEK------QFTSEV 107 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~-------------------------~~~~~~------~~~~Ei 107 (362)
.+.||..+.|+||+|+.+ |+.||||+-++.-..... ..++.+ +|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 357999999999999997 788999998765332211 011122 233333
Q ss_pred HHH----HcCCCCc------eeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 017994 108 ALL----FRLNHPH------IITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 177 (362)
Q Consensus 108 ~~l----~~l~hp~------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 177 (362)
+-. +.+.|-+ |++++-.+ ...-.|+|||++|..+.+.-.-.. .+++...+..-+.+... +.+=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHH--HHHHhc
Confidence 322 2233444 33333322 345679999999987766533221 14666644444333322 223346
Q ss_pred CccccCCCCCcEEEc----CCCceEEeeecccccccc
Q 017994 178 GILHRDLKSENLLLG----EDMCVKVADFGISCLESQ 210 (362)
Q Consensus 178 ~i~H~dlk~~Nil~~----~~~~~kl~Dfg~~~~~~~ 210 (362)
|++|+|-+|.||+++ .++.+.+.|||+......
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 899999999999998 367899999998765443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.3e-06 Score=76.29 Aligned_cols=139 Identities=20% Similarity=0.235 Sum_probs=82.6
Q ss_pred eeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCC--ceeeeeEEE---EeCCeEEEE
Q 017994 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP--HIITFVAAC---KKPPVFCII 134 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp--~iv~~~~~~---~~~~~~~lv 134 (362)
.+.|+.|..+.||+....+..+++|+.... . ....+..|..++..+... .+.+++... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~------~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP--D------AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH--H------HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC--C------CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 357899999999999998889999997664 1 135566788888777422 345666543 334467999
Q ss_pred EecCCCCCHHH----------------HHh---hc--CCCCCCHHH---------HHHH------------HHHHHH-HH
Q 017994 135 TEYLAGGSLRK----------------YLH---QQ--EPYSVPLNL---------VLKL------------ALDIAR-GM 171 (362)
Q Consensus 135 ~e~~~~~~L~~----------------~l~---~~--~~~~l~~~~---------~~~i------------~~~i~~-~l 171 (362)
|++++|.++.. .+. .. ......... .... ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 99999988877 111 11 101111100 0000 011222 23
Q ss_pred HHHHH-------CCccccCCCCCcEEEc-CCCceEEeeecccc
Q 017994 172 QYLHS-------QGILHRDLKSENLLLG-EDMCVKVADFGISC 206 (362)
Q Consensus 172 ~~LH~-------~~i~H~dlk~~Nil~~-~~~~~kl~Dfg~~~ 206 (362)
..+++ ..++|+|+.|.||+++ .++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 33332 3599999999999999 66667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.6e-06 Score=76.64 Aligned_cols=135 Identities=14% Similarity=0.085 Sum_probs=83.5
Q ss_pred ecccCC-eeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCCeEEEEEecCCC
Q 017994 63 FASGRH-SRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPPVFCIITEYLAG 140 (362)
Q Consensus 63 lg~G~~-g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~ 140 (362)
|..|.+ ..||+....+..++||+..... . ..+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-~--------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-T--------YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-c--------cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 445555 7799998777788889876543 1 23456888887773 33456777777766778999999999
Q ss_pred CCHHHHH-------------------hhcCC--CCCCHH--HHHHHHH--------------------HHHHHHHHHH--
Q 017994 141 GSLRKYL-------------------HQQEP--YSVPLN--LVLKLAL--------------------DIARGMQYLH-- 175 (362)
Q Consensus 141 ~~L~~~l-------------------~~~~~--~~l~~~--~~~~i~~--------------------~i~~~l~~LH-- 175 (362)
.+|.... +..+. ...... ....... .+...+..|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 8876432 11110 011100 0000000 0111122221
Q ss_pred -----HCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 176 -----SQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 176 -----~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
...++|+|+.|.||++++++.+.|+||+.+.
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 1248999999999999998778899999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.41 E-value=9.8e-06 Score=68.23 Aligned_cols=132 Identities=20% Similarity=0.292 Sum_probs=92.8
Q ss_pred ccCeeeeeeecccCC-eeEEEEEECCeeEEEEE---ecCCCcchH---H---------HHHHHHHHHHHHHHHHcC---C
Q 017994 54 MSQLFIGCKFASGRH-SRIYRGIYKQRDVAIKL---VSQPEEDAS---L---------ASMLEKQFTSEVALLFRL---N 114 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~-g~Vy~~~~~~~~vavK~---~~~~~~~~~---~---------~~~~~~~~~~Ei~~l~~l---~ 114 (362)
..+++..+.||.|.. |.||++...+..+|+|+ ......... . ......-|..|.+...+| .
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 378999999999999 99999999999999999 222211110 0 012234677888887776 4
Q ss_pred CCce--eeeeEEEEeC------------------CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 017994 115 HPHI--ITFVAACKKP------------------PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYL 174 (362)
Q Consensus 115 hp~i--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~L 174 (362)
+.++ ++++||..-. ....||-||++... .+.... +.+|.+-+..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHHHH
Confidence 5566 8999987322 13467777775533 123333 34666778889
Q ss_pred HHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 175 HSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 175 H~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
|..||+-+|+++.|.. .-+|+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999985 2588999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=7.5e-08 Score=92.22 Aligned_cols=185 Identities=20% Similarity=0.184 Sum_probs=137.5
Q ss_pred eeeeeeecccCCeeEEEEEECC-eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCc-eeeeeEEEEeCCeEEEE
Q 017994 57 LFIGCKFASGRHSRIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH-IITFVAACKKPPVFCII 134 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~-iv~~~~~~~~~~~~~lv 134 (362)
+..-+.+++|+++++++..... +....+++... ....-++++|.+++||| .+..++-++.++...++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 4444567899999999998763 33345666543 11234889999999999 77777888888899999
Q ss_pred EecCCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC
Q 017994 135 TEYLAGG-SLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 213 (362)
Q Consensus 135 ~e~~~~~-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (362)
++++.++ +........ ...+..-+...+.+.-+.+++++|+.-=+|+| ||+..+ +..+..||+..........
T Consensus 313 ~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~ 386 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK 386 (829)
T ss_pred hhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccc
Confidence 9999776 222211110 11244455677788888999999998778888 776654 6789999998776655555
Q ss_pred CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCC
Q 017994 214 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 258 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~ 258 (362)
.....+++.++|||+.....+....|+|++|.-..++.-|.+|-.
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 667889999999999999999999999999987777777766653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.8e-06 Score=85.57 Aligned_cols=79 Identities=16% Similarity=0.218 Sum_probs=56.4
Q ss_pred eeeecccCCeeEEEEEECC----eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCce--eeeeEEEEeC---C
Q 017994 60 GCKFASGRHSRIYRGIYKQ----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHI--ITFVAACKKP---P 129 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~i--v~~~~~~~~~---~ 129 (362)
.+.++.|.+..+|+....+ ..+++|+......... ...+.+|.++++.+. |+++ ++++.++.+. +
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~-----~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G 117 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS-----AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIG 117 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc-----HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCC
Confidence 4678999999999987764 4678887654321111 245778999999985 6665 7778877654 4
Q ss_pred eEEEEEecCCCCCH
Q 017994 130 VFCIITEYLAGGSL 143 (362)
Q Consensus 130 ~~~lv~e~~~~~~L 143 (362)
..|+||||++|..+
T Consensus 118 ~~flVME~v~G~~~ 131 (822)
T PLN02876 118 TAFYIMEYLEGRIF 131 (822)
T ss_pred CceEEEEecCCccc
Confidence 67899999988653
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.30 E-value=9.7e-06 Score=68.36 Aligned_cols=98 Identities=23% Similarity=0.287 Sum_probs=78.6
Q ss_pred HHHHHHHcCCC-CceeeeeEEEEeCCeEEEEEecCCCCCHHHH---HhhcCCCCCCHHHHHHHHHHHHHHHHHHHH---C
Q 017994 105 SEVALLFRLNH-PHIITFVAACKKPPVFCIITEYLAGGSLRKY---LHQQEPYSVPLNLVLKLALDIARGMQYLHS---Q 177 (362)
Q Consensus 105 ~Ei~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~ 177 (362)
.|.-+++.+.+ +++++++|+|- .+++.||...+++... +.+. ...++..+.+|+.++++.+++|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 48888888865 69999999992 2578899977666432 1111 136899999999999999999998 4
Q ss_pred CccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 178 GILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 178 ~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
.+.-.|++++|+-++++|++|++|.+.+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5889999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.26 E-value=4.9e-06 Score=85.10 Aligned_cols=197 Identities=17% Similarity=0.178 Sum_probs=141.2
Q ss_pred HHHHHHHHHHcCCCCceeeeeEEEEeCCeE----EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 017994 102 QFTSEVALLFRLNHPHIITFVAACKKPPVF----CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 177 (362)
Q Consensus 102 ~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 177 (362)
...-|+..+..+.|+|++.++.|....... .+..+++...++...+.... .++..+...+..++..||.|+|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHh
Confidence 334567778888999999999988655433 34457888899999888776 588899999999999999999999
Q ss_pred CccccCCCCC---cEEEcCCCceEEe--eeccccccccCCCCCcccccccccChhhhhcCCCCC--cccchhhhHHHHHH
Q 017994 178 GILHRDLKSE---NLLLGEDMCVKVA--DFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTK--KVDVYSFGIVLWEL 250 (362)
Q Consensus 178 ~i~H~dlk~~---Nil~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~--~~Dv~slG~~l~el 250 (362)
...|.-+..+ +--++..+.+.+. ||+.+.................+.++|.......+. ..|+|++|.+...+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 6666555544 3444556666666 888777666555555555667788888877665544 47999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 017994 251 LTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 311 (362)
Q Consensus 251 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 311 (362)
..|..+-...... ....+......+.+...+|+..++++|+++.+++...
T Consensus 386 ~~~~~i~~~~~~~-----------~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 386 SQGEDISEKSAVP-----------VSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhcCcccccccch-----------hhhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 9875432211100 0011112222678899999999999999999999754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.25 E-value=5.7e-06 Score=72.61 Aligned_cols=73 Identities=19% Similarity=0.182 Sum_probs=45.1
Q ss_pred eeecccCCee-EEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCC---ceeeeeEEEEeC---CeEEE
Q 017994 61 CKFASGRHSR-IYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP---HIITFVAACKKP---PVFCI 133 (362)
Q Consensus 61 ~~lg~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp---~iv~~~~~~~~~---~~~~l 133 (362)
+.|+.|+... ||+. +..+++|+.+.... ...+.+|..++..+... -+.++++..... ...++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~~--------~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAGY--------AGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccch--------HHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 4577777764 9976 34577887554221 24577888888877421 234444443332 24578
Q ss_pred EEecCCCCCHH
Q 017994 134 ITEYLAGGSLR 144 (362)
Q Consensus 134 v~e~~~~~~L~ 144 (362)
+|++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.20 E-value=4e-05 Score=64.98 Aligned_cols=133 Identities=18% Similarity=0.230 Sum_probs=90.8
Q ss_pred eeecccCCeeEEEEEECCeeEEEEEecCCCcchHH----------HHHHHHHHHHHHHHHHcCC------CCceeeeeEE
Q 017994 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASL----------ASMLEKQFTSEVALLFRLN------HPHIITFVAA 124 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~----------~~~~~~~~~~Ei~~l~~l~------hp~iv~~~~~ 124 (362)
..||+|+.-.||.--+ +....||+.......... .....++..+|+.-...+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 4699999999986533 345688998876600000 0001244455555544444 8999999999
Q ss_pred EEeCCeEEEEEecCC------CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC--C-
Q 017994 125 CKKPPVFCIITEYLA------GGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED--M- 195 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~------~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~--~- 195 (362)
.+++....+|+|.+. +.||.+++.... ++. . +...+-+-..||-+++|+.+|++|.||++... +
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999998642 367888886543 554 3 33344455678899999999999999999533 2
Q ss_pred -ceEEee
Q 017994 196 -CVKVAD 201 (362)
Q Consensus 196 -~~kl~D 201 (362)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=2e-06 Score=76.69 Aligned_cols=139 Identities=21% Similarity=0.257 Sum_probs=98.0
Q ss_pred CeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCc----------------chHHHHHHHHHHHHHHHHHHcCC-C-C
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEE----------------DASLASMLEKQFTSEVALLFRLN-H-P 116 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~----------------~~~~~~~~~~~~~~Ei~~l~~l~-h-p 116 (362)
=+.+++.||-|.-+.||.+-+. |++.++|+-+.... ...+.-..+-...+|...|+.|. | -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4567899999999999999987 88888885433211 11111222345567888888773 2 2
Q ss_pred ceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc
Q 017994 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 196 (362)
Q Consensus 117 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~ 196 (362)
-+++.++ ....++|||.+.|..|...-+-.. ...+...+..-+--|..+|+||||..--||+++.++.
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~d--------~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHVED--------PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeecCC--------hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 2334433 356789999999988876543322 2334556666677789999999999999999999999
Q ss_pred eEEeeecccc
Q 017994 197 VKVADFGISC 206 (362)
Q Consensus 197 ~kl~Dfg~~~ 206 (362)
++++||-...
T Consensus 241 i~vIDFPQmv 250 (465)
T KOG2268|consen 241 IVVIDFPQMV 250 (465)
T ss_pred EEEeechHhh
Confidence 9999997543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.4e-05 Score=70.17 Aligned_cols=79 Identities=14% Similarity=-0.012 Sum_probs=57.5
Q ss_pred eeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC---CceeeeeEEEEe---CCe
Q 017994 57 LFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH---PHIITFVAACKK---PPV 130 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h---p~iv~~~~~~~~---~~~ 130 (362)
..-.+.||.|..+.||+....+..+++|..+.... ...+..|...++.+.. -.++++++.+.. .+.
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~--------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~ 87 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGNPMPLMARSFST--------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP 87 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCCEEEEEeccccc--------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence 33456799999999999987666778888543111 1467789988888743 357788887754 367
Q ss_pred EEEEEecCCCCCH
Q 017994 131 FCIITEYLAGGSL 143 (362)
Q Consensus 131 ~~lv~e~~~~~~L 143 (362)
.++|||+++|.++
T Consensus 88 ~~LVmE~i~G~~~ 100 (297)
T PRK10593 88 DVLLLERLRGVSV 100 (297)
T ss_pred eEEEEeccCCEec
Confidence 8999999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.15 E-value=3e-05 Score=67.94 Aligned_cols=72 Identities=18% Similarity=0.255 Sum_probs=46.4
Q ss_pred eeecccCCeeEEEEEEC---CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCce-eeeeEEEEeCCeEEEEEe
Q 017994 61 CKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI-ITFVAACKKPPVFCIITE 136 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e 136 (362)
+.|..|-...+|+.... +..|++|+........ -...+|+.++..+...++ +++++... + .++||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-------~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-------IDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-------ecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEE
Confidence 46778888899999876 4688999776432211 122368888887743333 44444332 2 37999
Q ss_pred cCCCCCH
Q 017994 137 YLAGGSL 143 (362)
Q Consensus 137 ~~~~~~L 143 (362)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998776
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.03 E-value=6.5e-05 Score=66.82 Aligned_cols=134 Identities=19% Similarity=0.210 Sum_probs=78.0
Q ss_pred ecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCce-eeeeEEEEeCCeEEEEEecCCCC
Q 017994 63 FASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI-ITFVAACKKPPVFCIITEYLAGG 141 (362)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~~ 141 (362)
+..|-.+.+|+....+..+++|+......... -...+|..+++.+...++ .+++.... -++|+||++|.
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~------~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALG------VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccccccc------CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 56677889999987788899998654322110 123568888888754333 34444332 36899999987
Q ss_pred CHHHH-----------------HhhcCC--CCCCHH-HHHHHHHHH---------HHHHHHHHH--------CCccccCC
Q 017994 142 SLRKY-----------------LHQQEP--YSVPLN-LVLKLALDI---------ARGMQYLHS--------QGILHRDL 184 (362)
Q Consensus 142 ~L~~~-----------------l~~~~~--~~l~~~-~~~~i~~~i---------~~~l~~LH~--------~~i~H~dl 184 (362)
++... ++.... ..++.. .+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 65321 111111 111111 111211111 111222222 14899999
Q ss_pred CCCcEEEcCCCceEEeeeccccc
Q 017994 185 KSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 185 k~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
.|.||+++.++ +.|+||+.+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.96 E-value=8.2e-05 Score=67.64 Aligned_cols=138 Identities=19% Similarity=0.217 Sum_probs=82.9
Q ss_pred eeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCc--eeeeeE------EEEeCCeE
Q 017994 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH--IITFVA------ACKKPPVF 131 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~--iv~~~~------~~~~~~~~ 131 (362)
.+.|..|....+|+....+..+++|+.... . ...+..|+.++..+.+.+ +++++. +....+..
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~-~--------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV-S--------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC-C--------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 446777888899998877778999987641 1 134556777777664322 344433 12334567
Q ss_pred EEEEecCCCCCHHH----HH----------hhcC-CCC--------CCHHHH----------HHHHHHHHHHHHHHHH--
Q 017994 132 CIITEYLAGGSLRK----YL----------HQQE-PYS--------VPLNLV----------LKLALDIARGMQYLHS-- 176 (362)
Q Consensus 132 ~lv~e~~~~~~L~~----~l----------~~~~-~~~--------l~~~~~----------~~i~~~i~~~l~~LH~-- 176 (362)
+++++|++|.++.. .. +... ... ..+... ......+..++.++.+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999998876522 11 1100 000 000000 0011123334445543
Q ss_pred -----CCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 177 -----QGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 177 -----~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
.+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 379999999999999988778899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00014 Score=66.46 Aligned_cols=142 Identities=20% Similarity=0.297 Sum_probs=81.0
Q ss_pred eeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCc--eeeeeEE------EEeC
Q 017994 57 LFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH--IITFVAA------CKKP 128 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~--iv~~~~~------~~~~ 128 (362)
....+.++.|....+|+....+..+++|+.+..... +.+..|+.++..|...+ +++++.. ....
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~~--------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~ 95 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRVKA--------EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA 95 (307)
T ss_pred ceeccccCCccccceEEEEeCCCcEEEEEecCCCCH--------HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence 334556777877899998776667889987653221 22334555555553211 3343332 1234
Q ss_pred CeEEEEEecCCCCCHH-----------HHH---hhc-CCCC--------CC-HHHHH------------HHHHHHHHHHH
Q 017994 129 PVFCIITEYLAGGSLR-----------KYL---HQQ-EPYS--------VP-LNLVL------------KLALDIARGMQ 172 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~-----------~~l---~~~-~~~~--------l~-~~~~~------------~i~~~i~~~l~ 172 (362)
+..+++++|++|.++. ..+ +.. .... .+ +.... .....+...++
T Consensus 96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 5678999999885432 111 110 0000 00 00000 00112333455
Q ss_pred HHHH-------CCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 173 YLHS-------QGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 173 ~LH~-------~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
++.. .+++|+|+++.||+++.++...|+||+.+.
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5543 589999999999999988877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00014 Score=66.24 Aligned_cols=74 Identities=18% Similarity=0.272 Sum_probs=46.5
Q ss_pred eeecccCCeeEEEEEECC--------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCce-eeeeEEEEeCCeE
Q 017994 61 CKFASGRHSRIYRGIYKQ--------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI-ITFVAACKKPPVF 131 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~ 131 (362)
+.|..|-...+|+....+ +.+++|+....... .....+|..++..+...++ .++++.+..
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~-------~~~r~~E~~~~~~l~~~g~~P~~~~~~~~---- 72 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL-------LIDRERELVVFARLSERNLGPKLYGIFPN---- 72 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc-------eechHHHHHHHHHHHhCCCCCceEEEeCC----
Confidence 456667777899887653 68999997654321 1234568777777743333 455555532
Q ss_pred EEEEecCCCCCHHH
Q 017994 132 CIITEYLAGGSLRK 145 (362)
Q Consensus 132 ~lv~e~~~~~~L~~ 145 (362)
.+|+||++|.++..
T Consensus 73 ~~v~e~i~G~~l~~ 86 (302)
T cd05156 73 GRIEEFIPSRTLTT 86 (302)
T ss_pred CchhheeCCCcCCH
Confidence 35899998877643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00086 Score=63.08 Aligned_cols=80 Identities=10% Similarity=0.009 Sum_probs=51.0
Q ss_pred eeecccCCeeEEEEEECC--eeEEEEEecCCCcc-hHHHHHHHHHHHHHHHHHHcCC---CCceeeeeEEEEeCCeEEEE
Q 017994 61 CKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEED-ASLASMLEKQFTSEVALLFRLN---HPHIITFVAACKKPPVFCII 134 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~-~~~~~~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~~~~lv 134 (362)
+.||.|.+..||++...+ +.|+||.-...... ...-....++...|...|..+. ..++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 578999999999999874 48999985421110 0000011245556777777652 3456677766 34567899
Q ss_pred EecCCCCC
Q 017994 135 TEYLAGGS 142 (362)
Q Consensus 135 ~e~~~~~~ 142 (362)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99997644
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00048 Score=62.87 Aligned_cols=143 Identities=20% Similarity=0.204 Sum_probs=97.0
Q ss_pred eeeecccCCeeEEEEEEC-CeeEEEEEecCCCc--------------------chHHHHHHHHHHHHHHHHHHcCCCCce
Q 017994 60 GCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEE--------------------DASLASMLEKQFTSEVALLFRLNHPHI 118 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~--------------------~~~~~~~~~~~~~~Ei~~l~~l~hp~i 118 (362)
-..|..|.-+.||.+.-. |..+|||+++.+-. ....+++.+-....|++-|++++..+|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 346888999999999876 78899998765311 111235556667778888888865554
Q ss_pred eeeeEEEEeCCeEEEEEecCCCCCH-HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCcEEEcCCCc
Q 017994 119 ITFVAACKKPPVFCIITEYLAGGSL-RKYLHQQEPYSVPLNLVLKLALDIARGMQYL-HSQGILHRDLKSENLLLGEDMC 196 (362)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~i~H~dlk~~Nil~~~~~~ 196 (362)
.-.--+.. ....|||+++..... .-.|+. ..++...+..+-.+++.-+.-| |..++||.||.--|+|+ .+|.
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence 32111111 245699999843222 112222 2467777888888888877777 45799999999999998 5668
Q ss_pred eEEeeecccccc
Q 017994 197 VKVADFGISCLE 208 (362)
Q Consensus 197 ~kl~Dfg~~~~~ 208 (362)
+.|+|.+.+...
T Consensus 303 lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 303 LYIIDVSQSVEH 314 (520)
T ss_pred EEEEEccccccC
Confidence 999998876543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.001 Score=61.19 Aligned_cols=138 Identities=19% Similarity=0.250 Sum_probs=74.8
Q ss_pred eeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-----CCCceeeee---EEEEeCCeEE
Q 017994 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-----NHPHIITFV---AACKKPPVFC 132 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-----~hp~iv~~~---~~~~~~~~~~ 132 (362)
+.|+.|....+|+....+..+++|+...... ..+..|+.++..| ..|.++.-. .+....+..+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~~~~~---------~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQGEYVLTLFERLTA---------EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred chhccccccceEEEEeCCCcEEEEEeccCCh---------HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 4567788789999887766899998762111 2222344444444 233333211 0123356678
Q ss_pred EEEecCCCCCHH-----------HHHh---hc-CCC--------CCCH-HHHH-H-----------HHHH-HHHHHHHHH
Q 017994 133 IITEYLAGGSLR-----------KYLH---QQ-EPY--------SVPL-NLVL-K-----------LALD-IARGMQYLH 175 (362)
Q Consensus 133 lv~e~~~~~~L~-----------~~l~---~~-~~~--------~l~~-~~~~-~-----------i~~~-i~~~l~~LH 175 (362)
++++|++|..+. ..+. .. ... .+.+ ...+ . .+.+ +...+..+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999886431 1111 10 000 0111 0100 0 1111 111222332
Q ss_pred -------HCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 176 -------SQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 176 -------~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
..++||+|+++.||+++.+....|+||+.+..
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 23799999999999998766668999997743
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0022 Score=59.31 Aligned_cols=142 Identities=19% Similarity=0.233 Sum_probs=79.3
Q ss_pred cCeeeeeeecccCCeeEEEEEECC-----eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCce-eeeeEEEEeC
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI-ITFVAACKKP 128 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~ 128 (362)
+.+.+. .|..|=...+|+....+ ..|++|+........ -.-.+|..+++.+..-++ +++++++. .
T Consensus 15 ~~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-------IdR~~E~~il~~l~~~gl~P~~l~~~~-~ 85 (330)
T PLN02421 15 SDFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-------IDRERELQAIKYLSAAGFGAKLLGVFG-N 85 (330)
T ss_pred CceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-------echHHHHHHHHHHHhcCCCCceeEEeC-C
Confidence 344443 45557778899987653 278999876533211 112468888888754444 35565553 2
Q ss_pred CeEEEEEecCCCCCHHH-------HH----------hhcC-C--CCC-CHHHHHHHHHHH--------------------
Q 017994 129 PVFCIITEYLAGGSLRK-------YL----------HQQE-P--YSV-PLNLVLKLALDI-------------------- 167 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~-------~l----------~~~~-~--~~l-~~~~~~~i~~~i-------------------- 167 (362)
+ +|.+|++|.+|.. .+ +... + ... .+..+..+..++
T Consensus 86 G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~ 162 (330)
T PLN02421 86 G---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFE 162 (330)
T ss_pred c---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHH
Confidence 2 5889988776522 11 1111 0 001 122222222221
Q ss_pred --HHHHHHHH----HC----CccccCCCCCcEEEcC-CCceEEeeecccccc
Q 017994 168 --ARGMQYLH----SQ----GILHRDLKSENLLLGE-DMCVKVADFGISCLE 208 (362)
Q Consensus 168 --~~~l~~LH----~~----~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~~ 208 (362)
..-+..+. .. -++|+|+.+.||+++. ++.++++||+.+...
T Consensus 163 ~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 163 ELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred HHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 11122221 11 2799999999999975 578999999987543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0025 Score=57.98 Aligned_cols=147 Identities=12% Similarity=0.153 Sum_probs=82.5
Q ss_pred eeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC--CceeeeeEEEEeCC--eEEEE
Q 017994 59 IGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH--PHIITFVAACKKPP--VFCII 134 (362)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--p~iv~~~~~~~~~~--~~~lv 134 (362)
+.+.+-.|..-.+|.....++.++++ ......... ......+|..+++.+.- --+...++.|..+. ..|.|
T Consensus 29 ~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~----~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVE----SAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred eeeeccCCcccceEEEecCCceEEEe-cCCccccch----hhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 33444445555688887778888888 332111111 12445568888887643 22344556665554 77999
Q ss_pred EecCCCCCHHHHHhhcC---------------------C-----CC----CCHHHHHHHHHH--------------HHHH
Q 017994 135 TEYLAGGSLRKYLHQQE---------------------P-----YS----VPLNLVLKLALD--------------IARG 170 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~---------------------~-----~~----l~~~~~~~i~~~--------------i~~~ 170 (362)
|+|++|..+.+.+.... . .. ....++..+..+ ...-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 99998843222111100 0 00 000111111111 1222
Q ss_pred HHHHHHC--------CccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 171 MQYLHSQ--------GILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 171 l~~LH~~--------~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
..+|+.+ .++|||+++.|++++.++-+-++||+++....+
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 3444432 489999999999999998899999999876444
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0028 Score=58.94 Aligned_cols=141 Identities=12% Similarity=0.214 Sum_probs=80.5
Q ss_pred cCeeeeeeecccCCeeEEEEEEC------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCce-eeeeEEEEe
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI-ITFVAACKK 127 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~ 127 (362)
+.+.+. .|-.|-.-.+|+.... ++.|++|+........ .+ -.+|..+++.+..-++ .++++.+..
T Consensus 37 ~~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~------id-R~~E~~~~~~l~~~gl~P~~~~~~~~ 108 (344)
T PLN02236 37 EALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF------FD-RDDEIRTFECMSRHGQGPRLLGRFPN 108 (344)
T ss_pred CcEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee------ec-hHHHHHHHHHHHHcCCCCceEEEECC
Confidence 334443 5555888889998753 2578999876543211 11 2568888888754333 355565533
Q ss_pred CCeEEEEEecCCCCCHHHH-----------------HhhcC-C--C-CCCHHHHHHHHHHH-----------------HH
Q 017994 128 PPVFCIITEYLAGGSLRKY-----------------LHQQE-P--Y-SVPLNLVLKLALDI-----------------AR 169 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~-----------------l~~~~-~--~-~l~~~~~~~i~~~i-----------------~~ 169 (362)
. .|.+|++|.+|... ++... + . ....+.+..+..++ ..
T Consensus 109 g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~ 184 (344)
T PLN02236 109 G----RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLED 184 (344)
T ss_pred c----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHH
Confidence 2 57899888776421 11111 0 0 01122232332211 11
Q ss_pred HHHHHH--------HCCccccCCCCCcEEEcC-CCceEEeeeccccc
Q 017994 170 GMQYLH--------SQGILHRDLKSENLLLGE-DMCVKVADFGISCL 207 (362)
Q Consensus 170 ~l~~LH--------~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~ 207 (362)
.+..|. ...++|+|+++.||++++ ++.+.++||.++..
T Consensus 185 ~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 185 EINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 122221 125899999999999986 46899999998753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.011 Score=54.00 Aligned_cols=29 Identities=34% Similarity=0.501 Sum_probs=25.3
Q ss_pred CCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 177 QGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 177 ~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
.+++|||+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0015 Score=60.97 Aligned_cols=79 Identities=13% Similarity=0.130 Sum_probs=46.8
Q ss_pred eeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC--CC-ceeeeeEEEEeCCeEEEE
Q 017994 60 GCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN--HP-HIITFVAACKKPPVFCII 134 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hp-~iv~~~~~~~~~~~~~lv 134 (362)
.+.||.|.-.-||++.+. ++.|+||.-..--.-...-....++..-|...|+... .| ++++++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 457899999999999985 5689999644311100000111244455667777653 34 34445443 45556688
Q ss_pred EecCCC
Q 017994 135 TEYLAG 140 (362)
Q Consensus 135 ~e~~~~ 140 (362)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888743
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.009 Score=56.22 Aligned_cols=86 Identities=17% Similarity=0.034 Sum_probs=52.0
Q ss_pred eeeecccCCeeEEEEEECCeeEEEEEecCCCcchHH-HHHHHHHHHHHHHHHHcCC---CCceeeeeEEEEeCCeEEEEE
Q 017994 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASL-ASMLEKQFTSEVALLFRLN---HPHIITFVAACKKPPVFCIIT 135 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~~~~lv~ 135 (362)
.+.||.|....||+....+..++||.-.....-... -.....+-..|...|+.+. ..++++++.++. +..+++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 567899999999999887778999976621110000 0000122233455555543 347778888776 4467889
Q ss_pred ecCCC--CCHHHHH
Q 017994 136 EYLAG--GSLRKYL 147 (362)
Q Consensus 136 e~~~~--~~L~~~l 147 (362)
||+++ ..+.+.+
T Consensus 115 E~L~~~~~ilr~~L 128 (418)
T PLN02756 115 RYLEPPHIILRKGL 128 (418)
T ss_pred eecCCcceehhhhh
Confidence 99976 3454443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0042 Score=55.83 Aligned_cols=30 Identities=23% Similarity=0.401 Sum_probs=25.1
Q ss_pred CccccCCCCCcEEEcCCCc-eEEeeeccccc
Q 017994 178 GILHRDLKSENLLLGEDMC-VKVADFGISCL 207 (362)
Q Consensus 178 ~i~H~dlk~~Nil~~~~~~-~kl~Dfg~~~~ 207 (362)
.++|+|+++.||+++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987555 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0032 Score=58.11 Aligned_cols=77 Identities=12% Similarity=0.087 Sum_probs=44.1
Q ss_pred eecccCCeeEEEEEECC--eeEEEEEecCCCcc-hHHHHHHHHHHHHHHHHHHcCC--CC-ceeeeeEEEEeCCeEEEEE
Q 017994 62 KFASGRHSRIYRGIYKQ--RDVAIKLVSQPEED-ASLASMLEKQFTSEVALLFRLN--HP-HIITFVAACKKPPVFCIIT 135 (362)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~-~~~~~~~~~~~~~Ei~~l~~l~--hp-~iv~~~~~~~~~~~~~lv~ 135 (362)
.||.|...-||++...+ +.|+||.-..--.- ...-....++..-|...|+... .| .+++++. .++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 47899999999999874 57999964421110 0000001233345666666553 34 3444443 3455566899
Q ss_pred ecCCC
Q 017994 136 EYLAG 140 (362)
Q Consensus 136 e~~~~ 140 (362)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0039 Score=57.04 Aligned_cols=105 Identities=16% Similarity=0.233 Sum_probs=72.5
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCceEEeeecc
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
.+..+.|++|++. |++|.-. . ....+++..++++.+..+.-+..+ ..-|||+...||+|+ +|++.|+||-+
T Consensus 296 de~~y~yl~~kdh-gt~is~i-k-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 296 DETLYLYLHFKDH-GTPISII-K-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred CCceEEEEEEecC-Cceeeee-e-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeee
Confidence 3445778889976 5555332 2 134578889999988888777765 689999999999999 99999999999
Q ss_pred ccccccCCCCCcccccccccChhhhhcCCCCCcccchhh
Q 017994 205 SCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSF 243 (362)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~sl 243 (362)
++..... .......+--|-.+. +..+..-|||-+
T Consensus 368 sRl~~~q----~~isy~rldhp~lF~-G~dd~QFeIYrl 401 (488)
T COG5072 368 SRLSYSQ----GIISYNRLDHPDLFN-GVDDYQFEIYRL 401 (488)
T ss_pred eecccCC----ceeeccccCchhhhc-CccceeeeHHHH
Confidence 9854332 222233344555555 334666677754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.01 E-value=8.4e-05 Score=78.35 Aligned_cols=177 Identities=14% Similarity=-0.001 Sum_probs=122.7
Q ss_pred EEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE--eCCeEEEEEecCCCCCHHHHHhhcCCCC--CC
Q 017994 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK--KPPVFCIITEYLAGGSLRKYLHQQEPYS--VP 156 (362)
Q Consensus 81 vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~--l~ 156 (362)
+-+|+......+. +.+-.++-...|...++...|+++.....-.. .....+..++|+.+|.+.+.|-+..... +.
T Consensus 1255 Fk~~I~ke~d~e~-LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld 1333 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFEN-LSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLD 1333 (2724)
T ss_pred eEEEeehhhhHHH-HhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcch
Confidence 4556654432221 22223344445666666678888877655442 3346678899999999999987644322 23
Q ss_pred HHHHHHHHHHHHHHHHHHHHC-----CccccCCCCCcEEEcCCCceEEeeecccc-ccccCCCCCcccccccccChhhhh
Q 017994 157 LNLVLKLALDIARGMQYLHSQ-----GILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIK 230 (362)
Q Consensus 157 ~~~~~~i~~~i~~~l~~LH~~-----~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~-~~~~~~~~~~~~~~~~~~aPE~~~ 230 (362)
..-+.....+.+.+..-.|+. --+|+++++.|.+|..+-.++++++|+.+ ............+++.|+.|++..
T Consensus 1334 ~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N 1413 (2724)
T KOG1826|consen 1334 RSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN 1413 (2724)
T ss_pred hchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH
Confidence 333444444446666666654 16899999999999999999999999998 333333345567788899999988
Q ss_pred cCCCCCcccchhhhHHHHHHHhCCCCCC
Q 017994 231 EKRHTKKVDVYSFGIVLWELLTALTPFD 258 (362)
Q Consensus 231 ~~~~~~~~Dv~slG~~l~ell~g~~p~~ 258 (362)
.-.++.++|+|..|+.+|..-.|..+|.
T Consensus 1414 ~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1414 EIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 8888888999999999999988877764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0028 Score=57.11 Aligned_cols=75 Identities=19% Similarity=0.114 Sum_probs=48.5
Q ss_pred eeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC---CCCceeeeeEEEEeCCeEEEE
Q 017994 58 FIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL---NHPHIITFVAACKKPPVFCII 134 (362)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~~~~~~~lv 134 (362)
.-.+.|+.|....+|+....++.+.||+-..... ..|..|..-|+.| ..-.+++++++....+..+|+
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~---------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGR---------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp -EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGC---------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeEecCCCChhheEEEECCCccEEEEecChhhH---------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3456789999999999997789999999773222 3466677777776 345677889988887788999
Q ss_pred EecCCCC
Q 017994 135 TEYLAGG 141 (362)
Q Consensus 135 ~e~~~~~ 141 (362)
+||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9998766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0034 Score=59.81 Aligned_cols=154 Identities=18% Similarity=0.210 Sum_probs=93.2
Q ss_pred HHHHHHHHHHHcCCCCceeeeeEEEEe-CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 017994 101 KQFTSEVALLFRLNHPHIITFVAACKK-PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 179 (362)
Q Consensus 101 ~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i 179 (362)
.++.-..+.++.+.|+|...++++-.. .....+|+|++ +.+|.+++..+... .. .+. .+|+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~---~~---s~~-----------~~~~ 88 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLK---DE---SLL-----------AHGV 88 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccc---hh---hhc-----------cccc
Confidence 344556788899999999999887743 34588999999 77999999876411 11 110 2222
Q ss_pred cccCCCCCcEEEcCCCceEEeeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 017994 180 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 259 (362)
Q Consensus 180 ~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~ 259 (362)
.|- |+ ++.+| -+.+.. ... ..+++|||++|.++.++..|..-+..
T Consensus 89 ~~~-----~~-------~~~td-~~~t~~------~~~----------------~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 89 LHL-----NI-------IYITD-HFLTKY------PSP----------------IGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred cee-----hh-------hhccc-cccccC------CCC----------------CCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 221 11 22333 111000 011 12489999999999999999877776
Q ss_pred CCHHHHHHHHHhcCCCCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 017994 260 MTPEQAAFAVCQKNARPP----------VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307 (362)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~el 307 (362)
....+....+..-...+. +-..+++.+.++..+|+-..|..||...++
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 665554444332221111 112345567778889999999887754444
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.028 Score=51.38 Aligned_cols=31 Identities=16% Similarity=0.213 Sum_probs=28.1
Q ss_pred CccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 178 GILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 178 ~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
+++|+|+.++||+++.++.+.++||..++..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 7999999999999999999999999987543
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0035 Score=58.17 Aligned_cols=60 Identities=22% Similarity=0.319 Sum_probs=45.6
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEEEc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH-SQGILHRDLKSENLLLG 192 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~i~H~dlk~~Nil~~ 192 (362)
...++-+|..|-++..+++... .+++...+++.-.+.|+-.+= -.+++|.|++|.||++.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 3456777899999999998654 466667777776666665544 35899999999999995
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.01 Score=50.61 Aligned_cols=101 Identities=13% Similarity=0.105 Sum_probs=66.4
Q ss_pred eEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHH
Q 017994 80 DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNL 159 (362)
Q Consensus 80 ~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~ 159 (362)
+..+|++....-... -..|..+.+++.++. +|+++..- ..-.+.++.|+|.... ..
T Consensus 87 ~L~lKKi~slp~~~~-----~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~---------------i~ 142 (308)
T PF07387_consen 87 PLFLKKIRSLPCCIN-----DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK---------------IN 142 (308)
T ss_pred hhhhhhccCCCcccc-----hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc---------------cc
Confidence 456666655433211 145567788888763 57777632 4456778999883210 11
Q ss_pred HHHHHHHHHHHHHHHHHC--CccccCCCCCcEEEcCCCceEEeeecc
Q 017994 160 VLKLALDIARGMQYLHSQ--GILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 160 ~~~i~~~i~~~l~~LH~~--~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
...++.-=+.+|.-.|+. +.+|||..|+|||-|..|.+||.|-+.
T Consensus 143 ~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 143 FSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred hhHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 122222225678888954 699999999999999999999999764
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.031 Score=52.63 Aligned_cols=78 Identities=15% Similarity=0.158 Sum_probs=45.6
Q ss_pred cCeeeeeeecccCCeeEEEEEECC---ee-----EEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCC-ceeeeeEEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYKQ---RD-----VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP-HIITFVAAC 125 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~~---~~-----vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp-~iv~~~~~~ 125 (362)
+.+.+ +.|..|-...+|++...+ .. |.+++........ -.-.+|+.+++.+... .-.++++.+
T Consensus 51 ~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~-------IdR~~E~~i~~~Ls~~glgP~l~~~f 122 (383)
T PTZ00384 51 EFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLV-------IDNDLQYNIAKLLGDNNFGPKIIGRF 122 (383)
T ss_pred ccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceE-------eccHHHHHHHHHHHhCCCCCeEEEec
Confidence 33443 456568888999987542 12 4444432211110 1124588888888544 445566666
Q ss_pred EeCCeEEEEEecCCCCCHH
Q 017994 126 KKPPVFCIITEYLAGGSLR 144 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~ 144 (362)
.. +++.||++|.+|.
T Consensus 123 ~~----g~l~efIeGr~l~ 137 (383)
T PTZ00384 123 GD----FTIQEWVEGNTMG 137 (383)
T ss_pred CC----EEEEEEeccccCC
Confidence 42 5899999987764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.042 Score=50.57 Aligned_cols=135 Identities=22% Similarity=0.301 Sum_probs=80.3
Q ss_pred ecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC---Cc---eeeeeE----EEEeCCeEE
Q 017994 63 FASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH---PH---IITFVA----ACKKPPVFC 132 (362)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h---p~---iv~~~~----~~~~~~~~~ 132 (362)
|.+ .-..||+....+..+++|+.... .. ..++..|+..+..+.- |= +...-| ........+
T Consensus 34 l~s-~eN~~f~~~~~~g~~iLki~~~~-~~-------~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRYILKIYRPG-WT-------RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred ccc-ccCceEEEEecCCCeEEEEecCC-CC-------HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 444 55679999888777799999886 22 2455567777776631 11 222222 112224788
Q ss_pred EEEecCCCCCHHH-H-----------H---hh--------cCC-C-CCCHH-------------HHHHHHHHHHHHHHHH
Q 017994 133 IITEYLAGGSLRK-Y-----------L---HQ--------QEP-Y-SVPLN-------------LVLKLALDIARGMQYL 174 (362)
Q Consensus 133 lv~e~~~~~~L~~-~-----------l---~~--------~~~-~-~l~~~-------------~~~~i~~~i~~~l~~L 174 (362)
-+++|++|..+.. . + +. ++. . ...+. .-.....++...+..+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 8999999887772 1 1 10 000 0 11111 0111333444555555
Q ss_pred HHC--------C--ccccCCCCCcEEEcCCCc-eEEeeecccc
Q 017994 175 HSQ--------G--ILHRDLKSENLLLGEDMC-VKVADFGISC 206 (362)
Q Consensus 175 H~~--------~--i~H~dlk~~Nil~~~~~~-~kl~Dfg~~~ 206 (362)
.+. + +||+|+.|.||+++.+.. ..++||+.+.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 542 3 999999999999998874 8899999764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.015 Score=50.02 Aligned_cols=76 Identities=20% Similarity=0.174 Sum_probs=56.3
Q ss_pred eeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC---CCCceeeeeEEEEeCCeEEEEEe
Q 017994 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL---NHPHIITFVAACKKPPVFCIITE 136 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~~~~~~~lv~e 136 (362)
.+.+..|.--..|...+...++.||+-..+. ...|..|+.-|..+ +.-.+.+++.+..+.++.|+|+|
T Consensus 21 r~~v~gG~inea~~v~dg~~~~FvK~n~~~~---------~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle 91 (286)
T COG3001 21 REEVSGGDINEAWRLRDGTDPFFVKCNQREQ---------LSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLE 91 (286)
T ss_pred ccccCCccccceeEeecCCcceEEEecchhh---------HHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEe
Confidence 3456667777788888888899999854321 35566777766665 34567888999999999999999
Q ss_pred cCCCCCHH
Q 017994 137 YLAGGSLR 144 (362)
Q Consensus 137 ~~~~~~L~ 144 (362)
|++-+.+.
T Consensus 92 ~L~~~~~d 99 (286)
T COG3001 92 YLPTGPLD 99 (286)
T ss_pred eccCCCCC
Confidence 99876665
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.16 Score=46.86 Aligned_cols=28 Identities=25% Similarity=0.198 Sum_probs=23.7
Q ss_pred CCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 177 QGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 177 ~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
.+++|+|+.++||+++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3689999999999995 4 57899999764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.14 Score=54.56 Aligned_cols=31 Identities=26% Similarity=0.463 Sum_probs=25.8
Q ss_pred CCccccCCCCCcEEEcCCC--ceE-Eeeeccccc
Q 017994 177 QGILHRDLKSENLLLGEDM--CVK-VADFGISCL 207 (362)
Q Consensus 177 ~~i~H~dlk~~Nil~~~~~--~~k-l~Dfg~~~~ 207 (362)
.++||+|+++.||+++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999998775 455 999997643
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.14 Score=49.14 Aligned_cols=77 Identities=17% Similarity=0.219 Sum_probs=46.5
Q ss_pred cCeeeeeeecccCCeeEEEEEEC----------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCcee-eeeE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK----------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII-TFVA 123 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv-~~~~ 123 (362)
+++ -.+.|..|=.-.+|+.... ++.|.+|+.-...... . .-.+|..+++.+..-+|- ++++
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l------I-dR~~E~~v~~~ls~~gi~P~l~~ 177 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL------Y-NPISEFEVYKTMSKYRIAPQLLN 177 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce------e-CHHHHHHHHHHHHHCCCCCceEE
Confidence 344 4556777777889998754 3578889876543221 1 123577777766443443 4555
Q ss_pred EEEeCCeEEEEEecCCCCCH
Q 017994 124 ACKKPPVFCIITEYLAGGSL 143 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L 143 (362)
.+. -+.+.+|++|.+|
T Consensus 178 ~f~----gg~I~efi~g~~l 193 (442)
T PTZ00296 178 TFS----GGRIEEWLYGDPL 193 (442)
T ss_pred EeC----CCEEEEeeCCccC
Confidence 443 2457899988644
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 362 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-45 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-45 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-40 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-39 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-39 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-39 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-39 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-39 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-39 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-38 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-38 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-38 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-38 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-38 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-38 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-38 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-38 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-37 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-37 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-37 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-37 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-37 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-37 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-37 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-37 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-37 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-37 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-37 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-37 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-37 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-37 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-37 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-37 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-37 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-36 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-36 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-36 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-36 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-36 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-36 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-36 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-36 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-36 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-35 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-35 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-35 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-34 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-34 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-34 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-34 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-34 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-34 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-34 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-34 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-34 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-34 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-34 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-34 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-34 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-34 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-34 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-34 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-34 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-34 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-34 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-34 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-34 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-34 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-34 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-34 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-34 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-34 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-33 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-33 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-33 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-33 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-33 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-33 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-33 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-33 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-33 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-33 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-33 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-33 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-33 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-33 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-33 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-33 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-33 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-33 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-33 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-33 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-33 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-33 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-33 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-33 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-33 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-33 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-33 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-32 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-32 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-32 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-32 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-32 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-32 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-32 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-32 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-32 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-32 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-32 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-32 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-32 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-32 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-32 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-32 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-32 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-31 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-31 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-31 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-31 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-31 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-31 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-31 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-31 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-31 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-31 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-31 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-31 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-30 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-30 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-30 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-30 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-30 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-30 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-30 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-30 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-30 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-30 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-30 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-30 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-30 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-30 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-30 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-30 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-30 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-30 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-30 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-30 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-30 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-30 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-30 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-30 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-30 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-30 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-30 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-30 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-29 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-29 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-29 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-29 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-29 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-29 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-29 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-29 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-29 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-29 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-29 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-29 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-29 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-29 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-29 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-29 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-29 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-29 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-29 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-29 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-29 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-29 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-29 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-29 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-29 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-29 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-29 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-29 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-29 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-29 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-29 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-29 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-29 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-28 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-28 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-28 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-28 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-28 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-28 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-28 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-28 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-28 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-28 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-27 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-27 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-27 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-27 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-27 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-27 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-26 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-26 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-26 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-26 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-26 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-26 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-26 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-26 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-26 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-26 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-26 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-26 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-26 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-26 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-26 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-26 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-26 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-26 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-26 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-26 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-26 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-26 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-26 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-26 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-26 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-26 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-26 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-26 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-26 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-25 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-25 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-25 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-25 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-25 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-25 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-25 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-25 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-25 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-25 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-25 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-25 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-25 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-25 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-25 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-25 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-25 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-25 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-25 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-25 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-25 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-25 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-25 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-24 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-24 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-24 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-24 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-24 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-24 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-24 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-24 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-24 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-24 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-24 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-24 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-24 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-24 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-24 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-24 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-24 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-24 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-24 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-24 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-24 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-24 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-24 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-23 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-23 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-23 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-23 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-23 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-23 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-23 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-23 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-23 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-23 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-23 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-23 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-23 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-23 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-23 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-23 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-23 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-23 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-23 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-23 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-23 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-23 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-23 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-23 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-23 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-23 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-23 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-23 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-23 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-23 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-23 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-23 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-23 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-23 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-23 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-23 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-23 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-23 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-22 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-22 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-22 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-22 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-22 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-22 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-22 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-22 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-22 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-22 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-22 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-22 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-22 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-22 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-22 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-22 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-22 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-22 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-22 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-22 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-22 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-22 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-22 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-22 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-22 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-22 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-22 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-22 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-22 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-21 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-21 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-21 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-21 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-21 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-21 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-21 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-21 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-21 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-21 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-21 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-21 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-21 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-21 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-21 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-21 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-21 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-21 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-20 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-20 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-20 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-20 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-20 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-20 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-20 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-20 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-20 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-20 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-20 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-20 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-20 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-20 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-20 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-20 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-20 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-20 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-20 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-20 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-20 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-20 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-19 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-19 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-19 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-19 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-19 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-19 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-19 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-19 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-19 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-19 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-19 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-19 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-18 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-18 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-18 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-18 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-18 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-18 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-18 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-18 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-18 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-18 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-18 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-18 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-18 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-17 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-17 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-17 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-17 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-17 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-17 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-17 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-17 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-17 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-17 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-17 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-17 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-17 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-17 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-17 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-17 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-16 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-16 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-16 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-16 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-15 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-14 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-14 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-14 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-14 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-13 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-11 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-08 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 393 bits (1012), Expect = e-138
Identities = 100/280 (35%), Positives = 155/280 (55%), Gaps = 8/280 (2%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEV 107
++ L I K +G ++R + DVA+K++ + + A +F EV
Sbjct: 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER----VNEFLREV 85
Query: 108 ALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALD 166
A++ RL HP+I+ F+ A +PP I+TEYL+ GSL + LH+ + L +A D
Sbjct: 86 AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 167 IARGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SAKGFTGTYRW 223
+A+GM YLH++ I+HR+LKS NLL+ + VKV DFG+S L++ S+K GT W
Sbjct: 146 VAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW 205
Query: 224 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283
MAPE+++++ +K DVYSFG++LWEL T P+ N+ P Q AV K R +P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN 265
Query: 284 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 323
+ +I CW++ P +RP F I+ +L +S P
Sbjct: 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 371 bits (954), Expect = e-129
Identities = 86/274 (31%), Positives = 135/274 (49%), Gaps = 17/274 (6%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVAL 109
D ++L + G ++YR + +VA+K ++ S + E L
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDE--DISQTIENVRQEAKL 59
Query: 110 LFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR 169
L HP+II C K P C++ E+ GG L + L + +P ++++ A+ IAR
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIAR 116
Query: 170 GMQYLHSQG---ILHRDLKSENLLLGE--------DMCVKVADFGISCLESQCGSAKGFT 218
GM YLH + I+HRDLKS N+L+ + + +K+ DFG++ +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAA 175
Query: 219 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 278
G Y WMAPE+I+ +K DV+S+G++LWELLT PF + A+ V P+
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235
Query: 279 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
P TCP+ F+ L+ CW+ P RP F I+ L
Sbjct: 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 368 bits (946), Expect = e-128
Identities = 74/276 (26%), Positives = 133/276 (48%), Gaps = 15/276 (5%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEV 107
+ D QL K +++G ++ D+ +K++ + ++ + F E
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRD----WSTRKSRDFNEEC 58
Query: 108 ALLFRLNHPHIITFVAACKKPPV--FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLAL 165
L +HP+++ + AC+ PP +IT ++ GSL LH+ + V + +K AL
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 166 DIARGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW 223
D+ARGM +LH+ I L S ++++ EDM +++ + G W
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAW 174
Query: 224 MAPEMIKEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP 280
+APE +++K + + D++SF ++LWEL+T PF +++ + V + RP +PP
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234
Query: 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316
S L+ C + P +RP FD IV ILE +
Sbjct: 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 360 bits (925), Expect = e-125
Identities = 85/278 (30%), Positives = 145/278 (52%), Gaps = 17/278 (6%)
Query: 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFT 104
+ ++W Q+ +G + SG +Y+G + DVA+K+++ + F
Sbjct: 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ----LQAFK 68
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
+EV +L + H +I+ F+ P I+T++ G SL +LH E + ++ +A
Sbjct: 69 NEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIA 126
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA---KGFTGTY 221
ARGM YLH++ I+HRDLKS N+ L ED VK+ DFG++ +S+ + + +G+
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 222 RWMAPEMIKEKRH---TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP- 277
WMAPE+I+ + + + DVY+FGIVL+EL+T P+ N+ + + + P
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246
Query: 278 ---VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
V CPK L++ C D RP F +I++ +E
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 358 bits (922), Expect = e-124
Identities = 87/280 (31%), Positives = 141/280 (50%), Gaps = 19/280 (6%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQR--DVAIK-LVSQPEEDASLASMLEKQF 103
+ +++ + G +++G + VAIK L+ E + ++F
Sbjct: 11 SRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70
Query: 104 TSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL 163
EV ++ LNHP+I+ PP ++ E++ G L L + + + ++ L+L
Sbjct: 71 QREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRL 127
Query: 164 ALDIARGMQYLHSQG--ILHRDLKSENLLLGE-----DMCVKVADFGISCLESQCGSAKG 216
LDIA G++Y+ +Q I+HRDL+S N+ L +C KVADFG+S S G
Sbjct: 128 MLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSG 185
Query: 217 FTGTYRWMAPEMI--KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF--AVCQK 272
G ++WMAPE I +E+ +T+K D YSF ++L+ +LT PFD + + F + ++
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245
Query: 273 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
RP +P CP +I CWS P +RPHF IV L
Sbjct: 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 355 bits (912), Expect = e-122
Identities = 86/314 (27%), Positives = 134/314 (42%), Gaps = 36/314 (11%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTS 105
S L G G + + +++ + +K + + +E ++ F
Sbjct: 3 PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE------ETQRTFLK 56
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLAL 165
EV ++ L HP+++ F+ K ITEY+ GG+LR + + P + + A
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAK 115
Query: 166 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-------------- 211
DIA GM YLHS I+HRDL S N L+ E+ V VADFG++ L
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 212 -GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV- 269
G WMAPEMI + + +KVDV+SFGIVL E++ + + P F +
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235
Query: 270 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE---------- 319
+ PP CP +F + RC P++RP F ++ LE L
Sbjct: 236 VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLE 295
Query: 320 -QDPEFFSSFIPSP 332
D F+ ++
Sbjct: 296 QLDRGFWETYRRGE 309
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 353 bits (909), Expect = e-122
Identities = 74/281 (26%), Positives = 129/281 (45%), Gaps = 24/281 (8%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEV 107
+EW QL IG GR ++Y G + +VAI+L+ ++ K F EV
Sbjct: 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ----LKAFKREV 80
Query: 108 ALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDI 167
+ H +++ F+ AC PP IIT G +L + + + +N ++A +I
Sbjct: 81 MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI-VLDVNKTRQIAQEI 139
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC------GSAKGFTGTY 221
+GM YLH++GILH+DLKS+N+ ++ V + DFG+ + + G
Sbjct: 140 VKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 222 RWMAPEMIK---------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 272
+APE+I+ + +K DV++ G + +EL PF E + +
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM-GT 257
Query: 273 NARPPVPP-TCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
+P + K S ++ CW+ + RP F +++ +LE
Sbjct: 258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 349 bits (897), Expect = e-120
Identities = 91/295 (30%), Positives = 136/295 (46%), Gaps = 23/295 (7%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR 112
D ++ + G + + ++ +DVAIK + E K F E+ L R
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE--------RKAFIVELRQLSR 57
Query: 113 LNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGM 171
+NHP+I+ AC P C++ EY GGSL LH EP + L ++G+
Sbjct: 58 VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 172 QYLHS---QGILHRDLKSENLLLGEDM-CVKVADFGISCLESQCGSAKGFTGTYRWMAPE 227
YLHS + ++HRDLK NLLL +K+ DFG +C G+ WMAPE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAPE 173
Query: 228 MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM-TPEQAAFAVCQKNARPPVPPTCPKAF 286
+ + +++K DV+S+GI+LWE++T PFD + P RPP+ PK
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 287 SYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE-----FFSSFIPSPDHTI 336
L++RCWS P +RP ++IV I+ E S P D +
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRV 288
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = e-103
Identities = 77/300 (25%), Positives = 131/300 (43%), Gaps = 53/300 (17%)
Query: 56 QLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH 115
+ + GR+ ++RG ++ +VA+K+ S +E +E+ L H
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEK-------SWFRETELYNTVMLRH 61
Query: 116 PHIITFVAACKK----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGM 171
+I+ F+A+ +IT Y GSL YL ++ L++ L IA G+
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGL 118
Query: 172 QYLHSQ--------GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-----AKGFT 218
+LH + I HRDLKS+N+L+ ++ +AD G++ + SQ +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 219 GTYRWMAPEMIKEK------RHTKKVDVYSFGIVLWELLTALT----------PFDNMTP 262
GT R+MAPE++ E K+VD+++FG+VLWE+ + PF ++ P
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 263 EQAAF-----AVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
+F VC RP +P + + L+ CW +P R +I L
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = e-102
Identities = 77/319 (24%), Positives = 131/319 (41%), Gaps = 53/319 (16%)
Query: 44 GEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQF 103
G Q+ + + GR+ ++ G ++ VA+K+ EE
Sbjct: 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA-------SWFR 78
Query: 104 TSEVALLFRLNHPHIITFVAACKKPPV----FCIITEYLAGGSLRKYLHQQEPYSVPLNL 159
+E+ + H +I+ F+AA K +IT+Y GSL YL ++
Sbjct: 79 ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKS 135
Query: 160 VLKLALDIARGMQYLHSQ--------GILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211
+LKLA G+ +LH++ I HRDLKS+N+L+ ++ +AD G++
Sbjct: 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195
Query: 212 G-----SAKGFTGTYRWMAPEMIKEKRH------TKKVDVYSFGIVLWELLTALT----- 255
GT R+M PE++ E + D+YSFG++LWE+
Sbjct: 196 TNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255
Query: 256 -----PFDNMTPEQAAF-----AVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDR 300
P+ ++ P ++ VC K RP P C + L++ CW+ +P
Sbjct: 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPAS 315
Query: 301 RPHFDQIVSILEGYSESLE 319
R ++ L SES +
Sbjct: 316 RLTALRVKKTLAKMSESQD 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 4e-99
Identities = 74/312 (23%), Positives = 134/312 (42%), Gaps = 53/312 (16%)
Query: 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
+ + GR ++RG ++ +VA+K+ S EE + E E+
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFR---EA----EIY 88
Query: 109 LLFRLNHPHIITFVAACKK----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
L H +I+ F+AA K ++++Y GSL YL++ Y+V + ++KLA
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLA 145
Query: 165 LDIARGMQYLHSQ--------GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS--- 213
L A G+ +LH + I HRDLKS+N+L+ ++ +AD G++
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205
Query: 214 --AKGFTGTYRWMAPEMIKE------KRHTKKVDVYSFGIVLWELLTALT---------- 255
GT R+MAPE++ + K+ D+Y+ G+V WE+ +
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265
Query: 256 PFDNMTPEQAAF-----AVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRRPHFD 305
P+ ++ P + VC++ RP +P + + ++ CW ++ R
Sbjct: 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325
Query: 306 QIVSILEGYSES 317
+I L S+
Sbjct: 326 RIKKTLSQLSQQ 337
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 1e-92
Identities = 75/336 (22%), Positives = 132/336 (39%), Gaps = 68/336 (20%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSE- 106
E S D+ L + GR+ +Y+G +R VA+K+ S + F +E
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---------QNFINEK 56
Query: 107 -VALLFRLNHPHIITFVAACKKPPV-----FCIITEYLAGGSLRKYLHQQEPYSVPLNLV 160
+ + + H +I F+ ++ + ++ EY GSL KYL +
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSS 113
Query: 161 LKLALDIARGMQYLHSQ---------GILHRDLKSENLLLGEDMCVKVADFGISCLES-- 209
+LA + RG+ YLH++ I HRDL S N+L+ D ++DFG+S +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 210 -------QCGSAKGFTGTYRWMAPEMIKE-------KRHTKKVDVYSFGIVLWELLTALT 255
+ +A GT R+MAPE+++ + K+VD+Y+ G++ WE+ T
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 256 ---PFDNMTPEQAAFA---------------VCQKNARPPVPPTC------PKAFSYLIS 291
P +++ Q AF V ++ RP P ++ I
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 292 RCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSS 327
CW + R + E++ +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 3e-88
Identities = 79/319 (24%), Positives = 124/319 (38%), Gaps = 56/319 (17%)
Query: 37 SSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLA 96
SSG ++ G E L + A GR +++ VA+K+ ++
Sbjct: 9 SSGVDL---GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQ---- 61
Query: 97 SMLEKQFTSEVALLFRLNHPHIITFVAACKKPP----VFCIITEYLAGGSLRKYLHQQEP 152
Q EV L + H +I+ F+ A K+ +IT + GSL +L
Sbjct: 62 ---SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-- 116
Query: 153 YSVPLNLVLKLALDIARGMQYLHSQ----------GILHRDLKSENLLLGEDMCVKVADF 202
V N + +A +ARG+ YLH I HRD+KS+N+LL ++ +ADF
Sbjct: 117 -VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 203 GISCL---ESQCGSAKGFTGTYRWMAPEMI-----KEKRHTKKVDVYSFGIVLWELLTAL 254
G++ G G GT R+MAPE++ ++ ++D+Y+ G+VLWEL +
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 255 TPFDNMTPE-QAAF---------------AVCQKNARPPVPPTCPK-----AFSYLISRC 293
T D E F V K RP + K I C
Sbjct: 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295
Query: 294 WSSSPDRRPHFDQIVSILE 312
W + R + +
Sbjct: 296 WDHDAEARLSAGCVGERIT 314
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 2e-70
Identities = 82/278 (29%), Positives = 140/278 (50%), Gaps = 13/278 (4%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSE 106
+EW L + + +G+ ++ G Y VA+K + Q SM F +E
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-------GSMSPDAFLAE 58
Query: 107 VALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALD 166
L+ +L H ++ A + P++ IITEY+ GSL +L + +N +L +A
Sbjct: 59 ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 167 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWM 224
IA GM ++ + +HRDL++ N+L+ + + K+ADFG++ +++ + +G +W
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 225 APEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283
APE I T K DV+SFGI+L E++T P+ MT + + ++ R P CP
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPDNCP 236
Query: 284 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 321
+ L+ CW P+ RP FD + S+LE + + E
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 4e-70
Identities = 79/283 (27%), Positives = 133/283 (46%), Gaps = 13/283 (4%)
Query: 37 SSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLA 96
S A W+ +M +L + G + G Y+ VA+K + DA+
Sbjct: 3 GSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK---NDAT-- 57
Query: 97 SMLEKQFTSEVALLFRLNHPHIITFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSV 155
+ F +E +++ +L H +++ + ++ I+TEY+A GSL YL + +
Sbjct: 58 ---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 114
Query: 156 PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK 215
+ +LK +LD+ M+YL +HRDL + N+L+ ED KV+DFG++ S
Sbjct: 115 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174
Query: 216 GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 274
+W APE ++EK+ + K DV+SFGI+LWE+ + P+ + + V +K
Sbjct: 175 KL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGY 231
Query: 275 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317
+ P CP A ++ CW RP F Q+ LE
Sbjct: 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 1e-69
Identities = 78/280 (27%), Positives = 132/280 (47%), Gaps = 13/280 (4%)
Query: 40 AEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASML 99
A W+ +M +L + G + G Y+ VA+K + DA+
Sbjct: 178 AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK---NDAT----- 229
Query: 100 EKQFTSEVALLFRLNHPHIITFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLN 158
+ F +E +++ +L H +++ + ++ I+TEY+A GSL YL + + +
Sbjct: 230 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 289
Query: 159 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT 218
+LK +LD+ M+YL +HRDL + N+L+ ED KV+DFG++ S
Sbjct: 290 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL- 348
Query: 219 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 277
+W APE ++EK+ + K DV+SFGI+LWE+ + P+ + + V +K +
Sbjct: 349 -PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMD 406
Query: 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317
P CP A ++ CW RP F Q+ LE
Sbjct: 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 1e-69
Identities = 86/290 (29%), Positives = 144/290 (49%), Gaps = 16/290 (5%)
Query: 43 KGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEK 101
+G ++ W L + K G ++ G + VAIK + +M +
Sbjct: 172 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-------GTMSPE 224
Query: 102 QFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVL 161
F E ++ +L H ++ A + P++ I+TEY++ GSL +L + + L ++
Sbjct: 225 AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLV 283
Query: 162 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTG 219
+A IA GM Y+ +HRDL++ N+L+GE++ KVADFG++ +++ + +G
Sbjct: 284 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343
Query: 220 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 278
+W APE R T K DV+SFGI+L EL T P+ M + V ++ R P
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPC 402
Query: 279 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY---SESLEQDPEFF 325
PP CP++ L+ +CW P+ RP F+ + + LE Y +E Q E
Sbjct: 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 452
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 5e-69
Identities = 82/291 (28%), Positives = 146/291 (50%), Gaps = 17/291 (5%)
Query: 43 KGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQR--DVAIKLVSQPEEDASLASMLE 100
++W + + + + K G++ +Y G++K+ VA+K + + +M
Sbjct: 208 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-------DTMEV 260
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV 160
++F E A++ + HP+++ + C + P F IITE++ G+L YL + V ++
Sbjct: 261 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 320
Query: 161 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFT 218
L +A I+ M+YL + +HR+L + N L+GE+ VKVADFG+S + G
Sbjct: 321 LYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 380
Query: 219 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 277
+W APE + + + K DV++FG++LWE+ T ++P+ + Q + +K+ R
Sbjct: 381 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRME 439
Query: 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY----SESLEQDPEF 324
P CP+ L+ CW +P RP F +I E S S E + E
Sbjct: 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 490
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 1e-68
Identities = 81/283 (28%), Positives = 145/283 (51%), Gaps = 17/283 (6%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQR--DVAIKLVSQPEEDASLASMLEKQFTS 105
++W + + + + K G++ +Y G++K+ VA+K + + +M ++F
Sbjct: 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-------DTMEVEEFLK 58
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLAL 165
E A++ + HP+++ + C + P F IITE++ G+L YL + V ++L +A
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 166 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---Y 221
I+ M+YL + +HRDL + N L+GE+ VKVADFG+S + +A G
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH--AGAKFPI 176
Query: 222 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 280
+W APE + + + K DV++FG++LWE+ T ++P+ + Q + +K+ R P
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPE 235
Query: 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 323
CP+ L+ CW +P RP F +I E + E
Sbjct: 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 278
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 5e-68
Identities = 80/279 (28%), Positives = 141/279 (50%), Gaps = 13/279 (4%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTS 105
++ W L + K +G+ ++ Y VA+K + SM + F +
Sbjct: 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-------GSMSVEAFLA 232
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLAL 165
E ++ L H ++ A K P++ IITE++A GSL +L E PL ++ +
Sbjct: 233 EANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291
Query: 166 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRW 223
IA GM ++ + +HRDL++ N+L+ + K+ADFG++ +++ + +G +W
Sbjct: 292 QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 351
Query: 224 MAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 282
APE I T K DV+SFGI+L E++T P+ M+ + A+ ++ R P P C
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENC 410
Query: 283 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 321
P+ ++ RCW + P+ RP F+ I S+L+ + + E
Sbjct: 411 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 222 bits (566), Expect = 5e-68
Identities = 86/294 (29%), Positives = 146/294 (49%), Gaps = 13/294 (4%)
Query: 32 SKYLVSSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPE 90
+ +S + +G ++ W L + K G ++ G + VAIK +
Sbjct: 244 TTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-- 301
Query: 91 EDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQ 150
+M + F E ++ +L H ++ A + P++ I+TEY++ GSL +L +
Sbjct: 302 -----GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGE 355
Query: 151 EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLE 208
+ L ++ +A IA GM Y+ +HRDL++ N+L+GE++ KVADFG++ +
Sbjct: 356 TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415
Query: 209 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAF 267
++ + +G +W APE R T K DV+SFGI+L EL T P+ M +
Sbjct: 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 475
Query: 268 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 321
V ++ R P PP CP++ L+ +CW P+ RP F+ + + LE Y S E
Sbjct: 476 QV-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 6e-68
Identities = 79/277 (28%), Positives = 137/277 (49%), Gaps = 13/277 (4%)
Query: 42 IKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASML 99
+ +++W + L +G + G ++ G + VA+K E L
Sbjct: 101 HRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC---RETLP--PDL 155
Query: 100 EKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNL 159
+ +F E +L + +HP+I+ + C + I+ E + GG +L + E + +
Sbjct: 156 KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKT 214
Query: 160 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFT 218
+L++ D A GM+YL S+ +HRDL + N L+ E +K++DFG+S +A G
Sbjct: 215 LLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL 274
Query: 219 GT--YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 275
+W APE + R++ + DV+SFGI+LWE + +P+ N++ +Q V +K R
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-EKGGR 333
Query: 276 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
P P CP A L+ +CW+ P +RP F I L+
Sbjct: 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-66
Identities = 76/287 (26%), Positives = 128/287 (44%), Gaps = 19/287 (6%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEK 101
+ + G +Y G Y + AIK +S +
Sbjct: 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITE--MQQVE 67
Query: 102 QFTSEVALLFRLNHPHIITFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV 160
F E L+ LNHP+++ + + ++ Y+ G L +++ + + + +
Sbjct: 68 AFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR-NPTVKDL 126
Query: 161 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFT 218
+ L +ARGM+YL Q +HRDL + N +L E VKVADFG++ L+ + S +
Sbjct: 127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186
Query: 219 GT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 274
+W A E ++ R T K DV+SFG++LWELLT P+ ++ P + +
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-AQGR 245
Query: 275 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 321
R P P CP + ++ +CW + P RP F +V +E +L D
Sbjct: 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-66
Identities = 71/275 (25%), Positives = 113/275 (41%), Gaps = 15/275 (5%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQ 102
L + K G + RG + VA+K + D
Sbjct: 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK---PDVLSQPEAMDD 67
Query: 103 FTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLK 162
F EV + L+H ++I PP+ ++TE GSL L + + L + +
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQG-HFLLGTLSR 125
Query: 163 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT- 220
A+ +A GM YL S+ +HRDL + NLLL VK+ DFG+ L
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 221 --YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 277
+ W APE +K + + D + FG+ LWE+ T P+ + Q + ++ R P
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
P CP+ ++ +CW+ P+ RP F + L
Sbjct: 246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-66
Identities = 78/287 (27%), Positives = 136/287 (47%), Gaps = 20/287 (6%)
Query: 44 GEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASM 98
G ++ ++ +G G+ +++GIY + VAIK S
Sbjct: 4 GSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTS--DS 58
Query: 99 LEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLN 158
+ ++F E + + +HPHI+ + + PV+ II E G LR +L ++ S+ L
Sbjct: 59 VREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKY-SLDLA 116
Query: 159 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGF 217
++ A ++ + YL S+ +HRD+ + N+L+ + CVK+ DFG+S +E
Sbjct: 117 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS- 175
Query: 218 TGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 273
+WMAPE I +R T DV+ FG+ +WE+L + PF + + +
Sbjct: 176 -KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENG 233
Query: 274 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 320
R P+PP CP L+++CW+ P RRP F ++ + L E +
Sbjct: 234 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 280
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 3e-66
Identities = 69/262 (26%), Positives = 127/262 (48%), Gaps = 22/262 (8%)
Query: 72 YRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125
Y+G++ VAIK + E S + E E ++ +++PH+ + C
Sbjct: 32 YKGLWIPEGEKVKIPVAIKEL---REATSPKANKE--ILDEAYVMASVDNPHVCRLLGIC 86
Query: 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 185
V +IT+ + G L Y+ + + ++ +L + IA+GM YL + ++HRDL
Sbjct: 87 LTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 186 SENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY--RWMAPEMIKEKRHTKKVDVYS 242
+ N+L+ VK+ DFG++ L ++ G +WMA E I + +T + DV+S
Sbjct: 145 ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 204
Query: 243 FGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 301
+G+ +WEL+T P+D + + + + +K R P PP C ++ +CW D R
Sbjct: 205 YGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVYMIMRKCWMIDADSR 263
Query: 302 PHFDQIVSILEGYSESLEQDPE 323
P F +++ + +DP+
Sbjct: 264 PKFRELIIEF----SKMARDPQ 281
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 3e-66
Identities = 76/273 (27%), Positives = 137/273 (50%), Gaps = 13/273 (4%)
Query: 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEV 107
+W D S+L + SG+ ++ G + + VAIK + + +M E+ F E
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-------GAMSEEDFIEEA 54
Query: 108 ALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDI 167
++ +L+HP ++ C + C++TE++ G L YL Q +L + LD+
Sbjct: 55 EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDV 113
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMA 225
GM YL ++HRDL + N L+GE+ +KV+DFG++ L+ Q S+ G +W +
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 173
Query: 226 PEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284
PE+ R++ K DV+SFG+++WE+ + P++N + + + R P
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLAST 232
Query: 285 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317
+++ CW P+ RP F +++ L +ES
Sbjct: 233 HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 5e-66
Identities = 75/283 (26%), Positives = 131/283 (46%), Gaps = 17/283 (6%)
Query: 41 EIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASML 99
G G W D L + +G+ + G ++ Q DVAIK++ + SM
Sbjct: 10 STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-------GSMS 62
Query: 100 EKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNL 159
E +F E ++ L+H ++ C K IITEY+A G L YL +
Sbjct: 63 EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQ 121
Query: 160 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFT 218
+L++ D+ M+YL S+ LHRDL + N L+ + VKV+DFG+S + ++
Sbjct: 122 LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-- 179
Query: 219 GT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 274
G+ RW PE++ + + K D+++FG+++WE+ + P++ T + A + +
Sbjct: 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGL 238
Query: 275 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317
R P + ++ CW D RP F ++S + +
Sbjct: 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 208 bits (533), Expect = 6e-66
Identities = 80/272 (29%), Positives = 141/272 (51%), Gaps = 15/272 (5%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
++ + + SG+ + G +K Q DVA+K++ + SM E +F E
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKE-------GSMSEDEFFQEAQ 55
Query: 109 LLFRLNHPHIITFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDI 167
+ +L+HP ++ F C K+ P++ I+TEY++ G L YL + + + +L++ D+
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYPIY-IVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDV 113
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMA 225
GM +L S +HRDL + N L+ D+CVKV+DFG++ + Q S+ G +W A
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA 173
Query: 226 PEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284
PE+ +++ K DV++FGI++WE+ + P+D T + V + R P
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-SQGHRLYRPHLASD 232
Query: 285 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316
++ CW P++RP F Q++S +E E
Sbjct: 233 TIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 8e-66
Identities = 85/283 (30%), Positives = 134/283 (47%), Gaps = 17/283 (6%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQR-----DVAIKLVSQPEEDASLASMLEK 101
+ S++ I SG + G + VAIK + + +
Sbjct: 41 SFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYT--ERQRR 95
Query: 102 QFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVL 161
F SE +++ + +HP+II + + I+TEY+ GSL +L + + ++
Sbjct: 96 DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLV 154
Query: 162 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT 220
+ + GM+YL G +HRDL + N+L+ ++ KV+DFG+S LE +A TG
Sbjct: 155 GMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG 214
Query: 221 ---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 276
RW APE I + + DV+SFG+V+WE+L P+ NMT +V ++ R
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-EEGYRL 273
Query: 277 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319
P P CP A L+ CW +RP F QIVS+L+ S E
Sbjct: 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-65
Identities = 78/282 (27%), Positives = 132/282 (46%), Gaps = 20/282 (7%)
Query: 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLE 100
G ++ + + G +Y G+Y VA+K +D +L + +
Sbjct: 3 GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDN--K 57
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV 160
++F SE ++ L+HPHI+ + ++ P + II E G L YL + + S+ + +
Sbjct: 58 EKFMSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKN-SLKVLTL 115
Query: 161 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTG 219
+ +L I + M YL S +HRD+ N+L+ CVK+ DFG+S +E +
Sbjct: 116 VLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--V 173
Query: 220 T---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 275
T +WM+PE I +R T DV+ F + +WE+L+ PF + + + +K R
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-EKGDR 232
Query: 276 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317
P P CP L++RCW P RP F ++V L +
Sbjct: 233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-65
Identities = 68/288 (23%), Positives = 127/288 (44%), Gaps = 21/288 (7%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEK 101
+ G +Y G D A+K ++
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITD--IGEVS 71
Query: 102 QFTSEVALLFRLNHPHIITFVAAC--KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNL 159
QF +E ++ +HP++++ + C + ++ Y+ G LR ++ + + +
Sbjct: 72 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETH-NPTVKD 129
Query: 160 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGF 217
++ L +A+GM+YL S+ +HRDL + N +L E VKVADFG++ + + S
Sbjct: 130 LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 218 TGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 273
TG +WMA E ++ ++ T K DV+SFG++LWEL+T P+ ++ + +
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQG 248
Query: 274 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 321
R P CP ++ +CW + RP F ++VS + + +
Sbjct: 249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 6e-65
Identities = 86/307 (28%), Positives = 140/307 (45%), Gaps = 22/307 (7%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLE 100
+ S + +G +Y+G+ K + VAIK + +
Sbjct: 36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYT--EKQR 90
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV 160
F E ++ + +H +II K IITEY+ G+L K+L +++ + +
Sbjct: 91 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQL 149
Query: 161 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTG 219
+ + IA GM+YL + +HRDL + N+L+ ++ KV+DFG+S LE + +G
Sbjct: 150 VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209
Query: 220 T---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 275
RW APE I ++ T DV+SFGIV+WE++T P+ ++ + A+ R
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFR 268
Query: 276 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHT 335
P P CP A L+ +CW RRP F IVSIL + L + P+ +
Sbjct: 269 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL----DKLIRAPDSLKTLADFDPRV 324
Query: 336 ILRCLPT 342
+R T
Sbjct: 325 SIRLPST 331
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 7e-65
Identities = 88/306 (28%), Positives = 142/306 (46%), Gaps = 23/306 (7%)
Query: 32 SKYLVSSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLV 86
S LV G+E E+ D + L +G G + G KQ D VA+K +
Sbjct: 11 SSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM 70
Query: 87 SQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK-----PPVFCIITEYLAGG 141
+++S + E F SE A + +HP++I + C + P +I ++ G
Sbjct: 71 --KLDNSSQREIEE--FLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYG 126
Query: 142 SLRKYLHQQEPYSVPLNLVLK----LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 197
L YL + P ++ L+ +DIA GM+YL ++ LHRDL + N +L +DM V
Sbjct: 127 DLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186
Query: 198 KVADFGIS-CLESQCGSAKGFTGTY--RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-A 253
VADFG+S + S +G +W+A E + ++ +T K DV++FG+ +WE+ T
Sbjct: 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRG 246
Query: 254 LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 313
+TP+ + + + R P C ++ CW + P RP F + LE
Sbjct: 247 MTPYPGVQNHEMYDYL-LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305
Query: 314 YSESLE 319
ESL
Sbjct: 306 LLESLP 311
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 8e-65
Identities = 73/288 (25%), Positives = 135/288 (46%), Gaps = 18/288 (6%)
Query: 47 EEEWSADMSQLFIGCKF-ASGRHSRIYRGIYKQR----DVAIKLVSQPEEDASLASMLEK 101
+E D L + K SG + +G Y+ + VA+K++ + +A+ ++ ++
Sbjct: 8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL---KNEANDPALKDE 64
Query: 102 QFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVL 161
+E ++ +L++P+I+ + C+ ++ E G L KYL Q+ V ++
Sbjct: 65 -LLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL--QQNRHVKDKNII 120
Query: 162 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT 220
+L ++ GM+YL +HRDL + N+LL K++DFG+S L + K T
Sbjct: 121 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180
Query: 221 ---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 276
+W APE I + + K DV+SFG+++WE + P+ M + + +K R
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGERM 239
Query: 277 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEF 324
P CP+ L++ CW+ + RP F + L Y + +
Sbjct: 240 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH 287
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-64
Identities = 88/296 (29%), Positives = 137/296 (46%), Gaps = 21/296 (7%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEK 101
E D + + I +G + G K VAIK + + +
Sbjct: 37 EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYT--EKQRR 91
Query: 102 QFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVL 161
F E +++ + +HP+II K I+TEY+ GSL +L + + + LV
Sbjct: 92 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV- 150
Query: 162 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT 220
+ IA GM+YL G +HRDL + N+L+ ++ KV+DFG+ LE +A G
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210
Query: 221 ---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 276
RW +PE I ++ T DV+S+GIVLWE+++ P+ M+ + AV + R
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-DEGYRL 269
Query: 277 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSP 332
P P CP A L+ CW + RP F+QIVSIL + L ++P +
Sbjct: 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL----DKLIRNPGSLKIITSAA 321
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-64
Identities = 86/312 (27%), Positives = 144/312 (46%), Gaps = 30/312 (9%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQ 102
E+ Q +G G + KQ D VA+K++ D +S +E+
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK---ADIIASSDIEE- 71
Query: 103 FTSEVALLFRLNHPHIITFVAAC------KKPPVFCIITEYLAGGSLRKYL----HQQEP 152
F E A + +HPH+ V + P+ +I ++ G L +L + P
Sbjct: 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 153 YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQC 211
+++PL +++ +DIA GM+YL S+ +HRDL + N +L EDM V VADFG+S + S
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 212 GSAKGFTGTY--RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 268
+G +W+A E + + +T DV++FG+ +WE++T TP+ + +
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 269 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE-----QDPE 323
+ R PP C + L+ +CWS+ P +RP F + LE L QDP
Sbjct: 252 L-IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310
Query: 324 FFSSFIPSPDHT 335
+ + + H
Sbjct: 311 YI-NIERAHHHH 321
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-64
Identities = 70/287 (24%), Positives = 130/287 (45%), Gaps = 18/287 (6%)
Query: 47 EEEWSADMSQLFIG-CKFASGRHSRIYRGIYKQR----DVAIKLVSQPEEDASLASMLEK 101
+++ L I + G + +G+Y+ R DVAIK++ + +
Sbjct: 1 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTE--KADTE 55
Query: 102 QFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVL 161
+ E ++ +L++P+I+ + C+ + ++ E GG L K+L + N+
Sbjct: 56 EMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVA- 113
Query: 162 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT 220
+L ++ GM+YL + +HRDL + N+LL K++DFG+S L + +
Sbjct: 114 ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 173
Query: 221 ---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 276
+W APE I ++ + + DV+S+G+ +WE L+ P+ M + + ++ R
Sbjct: 174 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRM 232
Query: 277 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 323
PP CP L+S CW + RP F + + SL E
Sbjct: 233 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-64
Identities = 67/288 (23%), Positives = 127/288 (44%), Gaps = 21/288 (7%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEK 101
+ G +Y G D A+K ++
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITD--IGEVS 135
Query: 102 QFTSEVALLFRLNHPHIITFVAAC--KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNL 159
QF +E ++ +HP++++ + C + ++ Y+ G LR ++ + + +
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETH-NPTVKD 193
Query: 160 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGF 217
++ L +A+GM++L S+ +HRDL + N +L E VKVADFG++ + + S
Sbjct: 194 LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253
Query: 218 TGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 273
TG +WMA E ++ ++ T K DV+SFG++LWEL+T P+ ++ + +
Sbjct: 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQG 312
Query: 274 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 321
R P CP ++ +CW + RP F ++VS + + +
Sbjct: 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-64
Identities = 72/303 (23%), Positives = 132/303 (43%), Gaps = 22/303 (7%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRD------VAIKLVSQPEEDASLASMLEKQF 103
++L SG +++G++ V IK++ E+ + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI---EDKSG--RQSFQAV 62
Query: 104 TSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL 163
T + + L+H HI+ + C + ++T+YL GSL ++ Q ++ L+L
Sbjct: 63 TDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRG-ALGPQLLLNW 120
Query: 164 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT--- 220
+ IA+GM YL G++HR+L + N+LL V+VADFG++ L ++
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 221 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 279
+WMA E I ++T + DV+S+G+ +WEL+T P+ + + + +K R P
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-EKGERLAQP 239
Query: 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY----SESLEQDPEFFSSFIPSPDHT 335
C ++ +CW + RP F ++ + L E P P+
Sbjct: 240 QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPH 299
Query: 336 ILR 338
L
Sbjct: 300 GLT 302
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-63
Identities = 70/281 (24%), Positives = 128/281 (45%), Gaps = 21/281 (7%)
Query: 72 YRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125
Y+G++ VAIK + E S + E E ++ +++PH+ + C
Sbjct: 32 YKGLWIPEGEKVKIPVAIKEL---REATSPKANKE--ILDEAYVMASVDNPHVCRLLGIC 86
Query: 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 185
V +IT+ + G L Y+ + + ++ +L + IA+GM YL + ++HRDL
Sbjct: 87 LTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 186 SENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY--RWMAPEMIKEKRHTKKVDVYS 242
+ N+L+ VK+ DFG++ L ++ G +WMA E I + +T + DV+S
Sbjct: 145 ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 204
Query: 243 FGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 301
+G+ +WEL+T P+D + + + + +K R P PP C ++ +CW D R
Sbjct: 205 YGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVYMIMVKCWMIDADSR 263
Query: 302 PHFDQIVSILEGY---SESLEQDPEFFSSFIPSPDHTILRC 339
P F +++ + +PSP +
Sbjct: 264 PKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYR 304
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 4e-63
Identities = 86/307 (28%), Positives = 141/307 (45%), Gaps = 41/307 (13%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASMLE 100
+EW ++ + + G +Y G+ K VAIK V+ E AS+ +E
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIE 74
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYL------HQQEPYS 154
F +E +++ N H++ + + +I E + G L+ YL P
Sbjct: 75 --FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 155 VPLNLV--LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQC 211
P +L +++A +IA GM YL++ +HRDL + N ++ ED VK+ DFG++ +
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-- 190
Query: 212 GSAKGFTGTY----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 260
T Y RWM+PE +K+ T DV+SFG+VLWE+ T A P+ +
Sbjct: 191 ------TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 261 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 320
+ EQ V + P CP L+ CW +P RP F +I+S ++ E +
Sbjct: 245 SNEQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303
Query: 321 DPEFFSS 327
+ F+ S
Sbjct: 304 EVSFYYS 310
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 3e-62
Identities = 77/314 (24%), Positives = 130/314 (41%), Gaps = 45/314 (14%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASML 99
+ + + G +Y G VA+K + E S L
Sbjct: 63 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDEL 119
Query: 100 EKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYL-----HQQEPYS 154
+ F E ++ + NH +I+ + + I+ E +AGG L+ +L +P S
Sbjct: 120 D--FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 155 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGIS-CLESQ 210
+ + +L +A DIA G QYL +HRD+ + N LL G K+ DFG++ +
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR- 236
Query: 211 CGSAKGFTGTY----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 259
G Y +WM PE E T K D +SFG++LWE+ + P+ +
Sbjct: 237 -------AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
Query: 260 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319
+ ++ V R P CP ++++CW P+ RP+F I+ + E
Sbjct: 290 KSNQEVLEFV-TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI----EYCT 344
Query: 320 QDPEFFSSFIPSPD 333
QDP+ ++ +P
Sbjct: 345 QDPDVINTALPIEY 358
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 4e-62
Identities = 76/313 (24%), Positives = 129/313 (41%), Gaps = 45/313 (14%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASMLE 100
+ + + G +Y G VA+K + E S L+
Sbjct: 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELD 79
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYL-----HQQEPYSV 155
F E ++ + NH +I+ + + I+ E +AGG L+ +L +P S+
Sbjct: 80 --FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL 137
Query: 156 PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGIS-CLESQC 211
+ +L +A DIA G QYL +HRD+ + N LL G K+ DFG++ +
Sbjct: 138 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-- 195
Query: 212 GSAKGFTGTY----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 260
Y +WM PE E T K D +SFG++LWE+ + P+ +
Sbjct: 196 ------ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 261 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 320
+ ++ V R P CP ++++CW P+ RP+F I+ + E Q
Sbjct: 250 SNQEVLEFV-TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI----EYCTQ 304
Query: 321 DPEFFSSFIPSPD 333
DP+ ++ +P
Sbjct: 305 DPDVINTALPIEY 317
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 6e-62
Identities = 75/299 (25%), Positives = 126/299 (42%), Gaps = 49/299 (16%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASMLEKQ 102
+S + + R ++Y+G VAIK + + A E
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREE-- 58
Query: 103 FTSEVALLFRLNHPHIITFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV- 160
F E L RL HP+++ + K P+ +I Y + G L ++L + P+S +
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117
Query: 161 -------------LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-C 206
+ L IA GM+YL S ++H+DL + N+L+ + + VK++D G+
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 207 LESQCGSAKGFTGTY----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALT 255
+ + Y RWMAPE I + + D++S+G+VLWE+ + L
Sbjct: 178 VYA--------ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229
Query: 256 PFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314
P+ + + + + P P CP L+ CW+ P RRP F I S L +
Sbjct: 230 PYCGYSNQDVVEMI-RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 1e-61
Identities = 76/278 (27%), Positives = 132/278 (47%), Gaps = 20/278 (7%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEK 101
++ ++ +G G+ +++GIY + VAIK S + +
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREK- 437
Query: 102 QFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVL 161
F E + + +HPHI+ + + PV+ II E G LR +L ++ S+ L ++
Sbjct: 438 -FLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKF-SLDLASLI 494
Query: 162 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT 220
A ++ + YL S+ +HRD+ + N+L+ + CVK+ DFG+S +E
Sbjct: 495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KG 552
Query: 221 ---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 276
+WMAPE I +R T DV+ FG+ +WE+L + PF + + + R
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERL 611
Query: 277 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314
P+PP CP L+++CW+ P RRP F ++ + L
Sbjct: 612 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 4e-61
Identities = 71/293 (24%), Positives = 119/293 (40%), Gaps = 34/293 (11%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD------VAIKLVSQPEEDASLASMLE 100
+ + L G ++ Y VA+K + + ++
Sbjct: 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL---KPESG--GNHI 67
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKPPV--FCIITEYLAGGSLRKYLHQQEPYSVPLN 158
E+ +L L H +I+ + C + +I E+L GSL++YL + + + L
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLK 126
Query: 159 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGF 217
LK A+ I +GM YL S+ +HRDL + N+L+ + VK+ DFG++ +E+
Sbjct: 127 QQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 186
Query: 218 TGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT---------------ALTPFDN 259
W APE + + + DV+SFG+ L ELLT
Sbjct: 187 DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 246
Query: 260 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
MT + + ++ R P PP CP L+ +CW P R F ++ E
Sbjct: 247 MTVTRLVNTL-KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 9e-61
Identities = 70/319 (21%), Positives = 126/319 (39%), Gaps = 38/319 (11%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD------VAIKLVSQPEEDASLASMLE 100
++ + L + G + Y VA+K + +
Sbjct: 15 QDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS------GPDQQ 68
Query: 101 KQFTSEVALLFRLNHPHIITFVAAC---KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPL 157
+ F E+ +L L+ I+ + + + ++ EYL G LR +L + +
Sbjct: 69 RDFQREIQILKALHSDFIVKYRGVSYGPGRQSL-RLVMEYLPSGCLRDFLQRHRA-RLDA 126
Query: 158 NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKG 216
+ +L + I +GM+YL S+ +HRDL + N+L+ + VK+ADFG++ L
Sbjct: 127 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 186
Query: 217 FTGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT---------------ALTPFD 258
W APE + + +++ DV+SFG+VL+EL T D
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246
Query: 259 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318
+ + ++ R P PP CP L+ CW+ SP RP F + L+
Sbjct: 247 VPALSRLLELL-EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305
Query: 319 E-QDPEFFSSFIPSPDHTI 336
+ F++ H++
Sbjct: 306 RGCETHAFTAHPEGKHHSL 324
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 1e-60
Identities = 71/302 (23%), Positives = 124/302 (41%), Gaps = 36/302 (11%)
Query: 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD------VAIKLVSQPEEDASLASML 99
G + + L + G + Y VA+K + E+
Sbjct: 1 GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----- 55
Query: 100 EKQFTSEVALLFRLNHPHIITFVAACKKPPV--FCIITEYLAGGSLRKYLHQQEPYSVPL 157
+ F E+ +L L H +I+ + C +I EYL GSLR YL + + +
Sbjct: 56 -RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDH 113
Query: 158 NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKG 216
+L+ I +GM+YL ++ +HRDL + N+L+ + VK+ DFG++ L K
Sbjct: 114 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 217 FTGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT----------------ALTPF 257
W APE + E + + DV+SFG+VL+EL T
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233
Query: 258 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317
M + + N R P P CP +++ CW+++ ++RP F + ++ ++
Sbjct: 234 GQMIVFHLIELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292
Query: 318 LE 319
+
Sbjct: 293 MA 294
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-60
Identities = 61/261 (23%), Positives = 111/261 (42%), Gaps = 34/261 (13%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF- 121
SG ++++ ++ + IK V E A EV L +L+H +I+ +
Sbjct: 21 SGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----------EREVKALAKLDHVNIVHYN 70
Query: 122 ---------------VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALD 166
++ K I E+ G+L +++ ++ + L L+L
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 167 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP 226
I +G+ Y+HS+ +++RDLK N+ L + VK+ DFG+ G GT R+M+P
Sbjct: 131 ITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSP 190
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286
E I + + K+VD+Y+ G++L ELL + + K
Sbjct: 191 EQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------KFFTDLRDGIISDIFDKKE 244
Query: 287 SYLISRCWSSSPDRRPHFDQI 307
L+ + S P+ RP+ +I
Sbjct: 245 KTLLQKLLSKKPEDRPNTSEI 265
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-60
Identities = 76/306 (24%), Positives = 125/306 (40%), Gaps = 49/306 (16%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASML 99
+ + + G +++ VA+K + + AS
Sbjct: 33 ACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-------ASES 85
Query: 100 EKQ-FTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSV--- 155
+Q F E LL L H HI+ F C + ++ EY+ G L ++L P +
Sbjct: 86 ARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLA 145
Query: 156 --------PLNLV--LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205
PL L L +A +A GM YL +HRDL + N L+G+ + VK+ DFG+S
Sbjct: 146 GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
Query: 206 -CLESQCGSAKGFTGTY----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-A 253
+ S T Y RWM PE I ++ T + DV+SFG+VLWE+ T
Sbjct: 206 RDIYS--------TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257
Query: 254 LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 313
P+ ++ +A + + P CP ++ CW P +R + + L+
Sbjct: 258 KQPWYQLSNTEAIDCI-TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316
Query: 314 YSESLE 319
+++
Sbjct: 317 LAQAPP 322
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-60
Identities = 76/304 (25%), Positives = 124/304 (40%), Gaps = 50/304 (16%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASMLE 100
+ + + G +++ VA+K + ++
Sbjct: 8 HVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-------PTLAA 60
Query: 101 KQ-FTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNL 159
++ F E LL L H HI+ F C ++ EY+ G L K+L P ++ L
Sbjct: 61 RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 160 V--------------LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205
L +A IA GM YL SQ +HRDL + N L+G ++ VK+ DFG+S
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 206 -CLESQCGSAKGFTGTY----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-A 253
+ S T Y RWM PE I ++ T + DV+SFG++LWE+ T
Sbjct: 181 RDVYS--------TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 232
Query: 254 LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 313
P+ ++ + + + P CPK ++ CW P +R + +I IL
Sbjct: 233 KQPWFQLSNTEVIECI-TQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHA 291
Query: 314 YSES 317
++
Sbjct: 292 LGKA 295
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 5e-60
Identities = 80/299 (26%), Positives = 123/299 (41%), Gaps = 36/299 (12%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD------VAIKLVSQPEEDASLASMLEK 101
+ L G ++ Y + VA+K + DA
Sbjct: 24 DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---ADAG--PQHRS 78
Query: 102 QFTSEVALLFRLNHPHIITFVAACKKP--PVFCIITEYLAGGSLRKYLHQQEPYSVPLNL 159
+ E+ +L L H HII + C+ ++ EY+ GSLR YL + S+ L
Sbjct: 79 GWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQ 135
Query: 160 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFT 218
+L A I GM YLH+Q +HRDL + N+LL D VK+ DFG++ + +
Sbjct: 136 LLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 195
Query: 219 GT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT---------------ALTPFDNM 260
W APE +KE + DV+SFG+ L+ELLT M
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255
Query: 261 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319
T + + ++ R P P CP +L+ CW + RP F+ ++ IL+ E +
Sbjct: 256 TVLRLTELL-ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-59
Identities = 85/313 (27%), Positives = 132/313 (42%), Gaps = 55/313 (17%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASMLE 100
+ + G R+++ VA+K++ E+AS +
Sbjct: 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQAD 96
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV 160
F E AL+ ++P+I+ + C C++ EY+A G L ++L P++V
Sbjct: 97 --FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 154
Query: 161 ----------------------LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 198
L +A +A GM YL + +HRDL + N L+GE+M VK
Sbjct: 155 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVK 214
Query: 199 VADFGIS-CLESQCGSAKGFTGTY----------RWMAPEMIKEKRHTKKVDVYSFGIVL 247
+ADFG+S + S Y RWM PE I R+T + DV+++G+VL
Sbjct: 215 IADFGLSRNIYS--------ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266
Query: 248 WELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQ 306
WE+ + L P+ M E+ + V + P CP L+ CWS P RP F
Sbjct: 267 WEIFSYGLQPYYGMAHEEVIYYV-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 325
Query: 307 IVSILEGYSESLE 319
I IL+ E E
Sbjct: 326 IHRILQRMCERAE 338
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-59
Identities = 67/261 (25%), Positives = 124/261 (47%), Gaps = 17/261 (6%)
Query: 72 YRGIYKQR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127
+G+Y+ R DVAIK++ ++ E ++ +L++P+I+ + C+
Sbjct: 353 RQGVYRMRKKQIDVAIKVLK-----QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407
Query: 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 187
+ ++ E GG L K+L + +P++ V +L ++ GM+YL + +HR+L +
Sbjct: 408 EAL-MLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAAR 465
Query: 188 NLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKRHTKKVDVYSF 243
N+LL K++DFG+S L + + +W APE I ++ + + DV+S+
Sbjct: 466 NVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY 525
Query: 244 GIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 302
G+ +WE L+ P+ M + + ++ R PP CP L+S CW + RP
Sbjct: 526 GVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPPECPPELYALMSDCWIYKWEDRP 584
Query: 303 HFDQIVSILEGYSESLEQDPE 323
F + + SL E
Sbjct: 585 DFLTVEQRMRACYYSLASKVE 605
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-59
Identities = 70/301 (23%), Positives = 122/301 (40%), Gaps = 36/301 (11%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD------VAIKLVSQPEEDASLASMLE 100
+ + L + G + Y VA+K + E+
Sbjct: 33 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL------ 86
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKPPV--FCIITEYLAGGSLRKYLHQQEPYSVPLN 158
+ F E+ +L L H +I+ + C +I EYL GSLR YL + + +
Sbjct: 87 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHI 145
Query: 159 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGF 217
+L+ I +GM+YL ++ +HRDL + N+L+ + VK+ DFG++ L K
Sbjct: 146 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK 205
Query: 218 TGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT----------------ALTPFD 258
W APE + E + + DV+SFG+VL+EL T
Sbjct: 206 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 265
Query: 259 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318
M + + N R P P CP +++ CW+++ ++RP F + ++ + +
Sbjct: 266 QMIVFHLIELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
Query: 319 E 319
Sbjct: 325 A 325
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 5e-59
Identities = 82/338 (24%), Positives = 132/338 (39%), Gaps = 52/338 (15%)
Query: 32 SKYLVSSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD----VAIKLVS 87
K+ + + D + + G ++ + K+ AIK +
Sbjct: 2 KKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM- 60
Query: 88 QPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEYLAGGSLRKY 146
+E AS + F E+ +L +L +HP+II + AC+ + EY G+L +
Sbjct: 61 --KEYASKDDHRD--FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116
Query: 147 LHQQEPYSVPLNLV--------------LKLALDIARGMQYLHSQGILHRDLKSENLLLG 192
L + L A D+ARGM YL + +HRDL + N+L+G
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176
Query: 193 EDMCVKVADFGISCLESQCGSAKGFTGTY----------RWMAPEMIKEKRHTKKVDVYS 242
E+ K+ADFG+S Y RWMA E + +T DV+S
Sbjct: 177 ENYVAKIADFGLS----------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 226
Query: 243 FGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 301
+G++LWE+++ TP+ MT + + + R P C L+ +CW P R
Sbjct: 227 YGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYER 285
Query: 302 PHFDQIVSILEGYSES------LEQDPEFFSSFIPSPD 333
P F QI+ L E +F + I
Sbjct: 286 PSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSA 323
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-58
Identities = 64/249 (25%), Positives = 119/249 (47%), Gaps = 14/249 (5%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEK---QFTSEVALLFRLNHPHII 119
G + R IK ++ ++ M K + EVA+L + HP+I+
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEIN-------ISRMSSKEREESRREVAVLANMKHPNIV 86
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 179
+ + ++ I+ +Y GG L K ++ Q+ + +L + I ++++H + I
Sbjct: 87 QYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKI 146
Query: 180 LHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 238
LHRD+KS+N+ L +D V++ DFGI+ L S A+ GT +++PE+ + K + K
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKS 206
Query: 239 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 298
D+++ G VL+EL T F+ + + + + PPV L+S+ + +P
Sbjct: 207 DIWALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYDLRSLVSQLFKRNP 265
Query: 299 DRRPHFDQI 307
RP + I
Sbjct: 266 RDRPSVNSI 274
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 6e-58
Identities = 84/319 (26%), Positives = 138/319 (43%), Gaps = 55/319 (17%)
Query: 35 LVSSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVS 87
L S K + +W L +G G ++ + VA+K++
Sbjct: 3 LSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK 62
Query: 88 QPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYL 147
E+AS + + + SE +L ++NHPH+I AC + +I EY GSLR +L
Sbjct: 63 ---ENASPSELRD--LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL 117
Query: 148 --------------------HQQEPYSVPLNLV--LKLALDIARGMQYLHSQGILHRDLK 185
P L + + A I++GMQYL ++HRDL
Sbjct: 118 RESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177
Query: 186 SENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY----------RWMAPEMIKEKRH 234
+ N+L+ E +K++DFG+S + +Y +WMA E + + +
Sbjct: 178 ARNILVAEGRKMKISDFGLSRDVYE--------EDSYVKRSQGRIPVKWMAIESLFDHIY 229
Query: 235 TKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 293
T + DV+SFG++LWE++T P+ + PE+ + + R P C + L+ +C
Sbjct: 230 TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL-KTGHRMERPDNCSEEMYRLMLQC 288
Query: 294 WSSSPDRRPHFDQIVSILE 312
W PD+RP F I LE
Sbjct: 289 WKQEPDKRPVFADISKDLE 307
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-57
Identities = 70/301 (23%), Positives = 130/301 (43%), Gaps = 34/301 (11%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASMLE 100
+W +L +G G ++ D VA+K++ E A+ +
Sbjct: 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRA 76
Query: 101 KQFTSEVALLFRL-NHPHIITFVAAC--KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPL 157
SE+ +L + +H +++ + AC P +I E+ G+L YL + VP
Sbjct: 77 --LMSELKILIHIGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 158 NLV--------------LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203
+ + + +A+GM++L S+ +HRDL + N+LL E VK+ DFG
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 193
Query: 204 ISCLESQCGSAKGFTGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 259
++ + +WMAPE I ++ +T + DV+SFG++LWE+ + +P+
Sbjct: 194 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 260 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319
+ ++ ++ R P + CW P +RP F ++V L ++
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313
Query: 320 Q 320
Q
Sbjct: 314 Q 314
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-57
Identities = 73/276 (26%), Positives = 134/276 (48%), Gaps = 30/276 (10%)
Query: 71 IYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAA 124
GI K + VA+K++ +DA+ + + SE+ ++ + H +II + A
Sbjct: 55 EAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSD--LVSEMEMMKMIGKHKNIINLLGA 109
Query: 125 CKKPPVFCIITEYLAGGSLRKYL--------------HQQEPYSVPLNLVLKLALDIARG 170
C + +I EY + G+LR+YL ++ + ++ +ARG
Sbjct: 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 169
Query: 171 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT---YRWMAPE 227
M+YL SQ +HRDL + N+L+ E+ +K+ADFG++ + K T +WMAPE
Sbjct: 170 MEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE 229
Query: 228 MIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286
+ ++ +T + DV+SFG+++WE+ T +P+ + E+ + ++ R P C
Sbjct: 230 ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMDKPANCTNEL 288
Query: 287 SYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 322
++ CW + P +RP F Q+V L+ +
Sbjct: 289 YMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-57
Identities = 76/283 (26%), Positives = 138/283 (48%), Gaps = 31/283 (10%)
Query: 71 IYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAA 124
G+ K + VA+K++ DA+ + + SE+ ++ + H +II + A
Sbjct: 89 EAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSD--LISEMEMMKMIGKHKNIINLLGA 143
Query: 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV--------------LKLALDIARG 170
C + +I EY + G+LR+YL + P + + + A +ARG
Sbjct: 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARG 203
Query: 171 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT---YRWMAPE 227
M+YL S+ +HRDL + N+L+ ED +K+ADFG++ K T +WMAPE
Sbjct: 204 MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 263
Query: 228 MIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286
+ ++ +T + DV+SFG++LWE+ T +P+ + E+ + ++ R P C
Sbjct: 264 ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNEL 322
Query: 287 SYLISRCWSSSPDRRPHFDQIVSILEGY-SESLEQDPEFFSSF 328
++ CW + P +RP F Q+V L+ + + Q+ ++
Sbjct: 323 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHH 365
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-57
Identities = 79/348 (22%), Positives = 155/348 (44%), Gaps = 34/348 (9%)
Query: 2 KNFHWFKQISINAKPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLFIGC 61
+ + S + L R + + +++ +E + + +W +L +G
Sbjct: 28 RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGK 87
Query: 62 KFASGRHSRIYRGIYKQRD---------VAIKLVSQPEEDASLASMLEKQFTSEVALLFR 112
G ++ D VA+K++ +DA+ + + SE+ ++
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSD--LVSEMEMMKM 142
Query: 113 L-NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYL--------------HQQEPYSVPL 157
+ H +II + AC + +I EY + G+LR+YL ++ +
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 158 NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGF 217
++ +ARGM+YL SQ +HRDL + N+L+ E+ +K+ADFG++ + K
Sbjct: 203 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 218 TGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 273
T +WMAPE + ++ +T + DV+SFG+++WE+ T +P+ + E+ + ++
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEG 321
Query: 274 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 321
R P C ++ CW + P +RP F Q+V L+ +
Sbjct: 322 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 369
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-56
Identities = 72/268 (26%), Positives = 119/268 (44%), Gaps = 29/268 (10%)
Query: 71 IYRGIYKQRD---VAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACK 126
G+ K VA+K++ A L SE+ +L L NH +I+ + AC
Sbjct: 43 TAYGLIKSDAAMTVAVKMLK---PSAHLTEREA--LMSELKVLSYLGNHMNIVNLLGACT 97
Query: 127 KPPVFCIITEYLAGGSLRKYL----------------HQQEPYSVPLNLVLKLALDIARG 170
+ITEY G L +L + + ++ L +L + +A+G
Sbjct: 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 157
Query: 171 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT---YRWMAPE 227
M +L S+ +HRDL + N+LL K+ DFG++ + +WMAPE
Sbjct: 158 MAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE 217
Query: 228 MIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286
I +T + DV+S+GI LWEL + +P+ M + + + ++ R P P
Sbjct: 218 SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEM 277
Query: 287 SYLISRCWSSSPDRRPHFDQIVSILEGY 314
++ CW + P +RP F QIV ++E
Sbjct: 278 YDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-55
Identities = 60/307 (19%), Positives = 118/307 (38%), Gaps = 47/307 (15%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRD---------VAIKLVSQPEEDASLASMLE 100
L G ++I++G+ ++ V +K++ + +
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY------S 56
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV 160
+ F +++ +L+H H++ C ++ E++ GSL YL + + + +
Sbjct: 57 ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-CINILWK 115
Query: 161 LKLALDIARGMQYLHSQGILHRDLKSENLLL--------GEDMCVKVADFGIS--CLESQ 210
L++A +A M +L ++H ++ ++N+LL G +K++D GIS L
Sbjct: 116 LEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 211 CGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 268
+ W+ PE I+ ++ D +SFG LWE+ + P + ++
Sbjct: 176 ILQER-----IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230
Query: 269 VCQKNARPPVPPTCPKAFSY-LISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSS 327
+ + P P LI+ C PD RP F I+ L F
Sbjct: 231 Y-EDRHQLPAPKAAE---LANLINNCMDYEPDHRPSFRAIIRDLNSL---------FTPD 277
Query: 328 FIPSPDH 334
+P H
Sbjct: 278 LVPRGSH 284
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-55
Identities = 69/301 (22%), Positives = 124/301 (41%), Gaps = 29/301 (9%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASML 99
E+W + L G +G ++ VA+K++ A
Sbjct: 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKE 94
Query: 100 EKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLN 158
SE+ ++ L H +I+ + AC +ITEY G L +L ++
Sbjct: 95 A--LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 159 LV------------LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206
L + +A+GM +L S+ +HRD+ + N+LL K+ DFG++
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 207 LESQCGSAKGFTGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 262
+ +WMAPE I + +T + DV+S+GI+LWE+ + L P+ +
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272
Query: 263 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 322
+ + + + P PK ++ CW+ P RP F QI S L+ ++ ++
Sbjct: 273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRER 332
Query: 323 E 323
+
Sbjct: 333 D 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-55
Identities = 64/241 (26%), Positives = 112/241 (46%), Gaps = 18/241 (7%)
Query: 72 YRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF----VAAC 125
Y+G+ + +VA + D L ++F E +L L HP+I+ F +
Sbjct: 43 YKGLDTETTVEVAWCELQ----DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98
Query: 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRD 183
K ++TE + G+L+ YL + + + ++ I +G+Q+LH++ I+HRD
Sbjct: 99 KGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRD 156
Query: 184 LKSENLLL-GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYS 242
LK +N+ + G VK+ D G++ L+ AK GT +MAPEM +EK + + VDVY+
Sbjct: 157 LKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEK-YDESVDVYA 214
Query: 243 FGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP-TCPKAFSYLISRCWSSSPDRR 301
FG+ + E+ T+ P+ + +P +I C + D R
Sbjct: 215 FGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 274
Query: 302 P 302
Sbjct: 275 Y 275
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 5e-55
Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 14/255 (5%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFT-SEVALLFRLNHPHIITF 121
G+ S +YR VA+K V L + E+ LL +LNHP++I +
Sbjct: 42 RGQFSEVYRAACLLDGVPVALKKVQ----IFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 122 VAACKKPPVFCIITEYLAGGSLRKYL--HQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 179
A+ + I+ E G L + + +++ +P V K + + ++++HS+ +
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV 157
Query: 180 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 238
+HRD+K N+ + VK+ D G+ S+ +A GT +M+PE I E + K
Sbjct: 158 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 217
Query: 239 DVYSFGIVLWELLTALTPF--DNMTPEQAAFAVCQKNARPPVPPTC-PKAFSYLISRCWS 295
D++S G +L+E+ +PF D M + Q + PP+P + L++ C +
Sbjct: 218 DIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-YPPLPSDHYSEELRQLVNMCIN 276
Query: 296 SSPDRRPHFDQIVSI 310
P++RP + +
Sbjct: 277 PDPEKRPDVTYVYDV 291
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 3e-54
Identities = 74/344 (21%), Positives = 133/344 (38%), Gaps = 46/344 (13%)
Query: 5 HWFKQISINAKPERMLSLREYRRAVSWS-KYLVSSGAEIKGEGEEEWSADMSQLFIGCKF 63
H +K+ + L+ + S +Y E E + +W L G
Sbjct: 1 HKYKK-----QFRYESQLQMVQVTGSSDNEYFYVDFREY--EYDLKWEFPRENLEFGKVL 53
Query: 64 ASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NH 115
SG ++ VA+K++ E A + SE+ ++ +L +H
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREA--LMSELKMMTQLGSH 108
Query: 116 PHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV--------------- 160
+I+ + AC +I EY G L YL + +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 161 ------LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 214
L A +A+GM++L + +HRDL + N+L+ VK+ DFG++ +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 215 KGFTGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVC 270
+WMAPE + E +T K DV+S+GI+LWE+ + + P+ + + + +
Sbjct: 229 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 288
Query: 271 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314
Q + P + ++ CW+ +RP F + S L
Sbjct: 289 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 4e-53
Identities = 52/246 (21%), Positives = 97/246 (39%), Gaps = 13/246 (5%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITF 121
G + +++ K+ R A+K P + +EV ++ HP +
Sbjct: 67 HGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD----RARKLAEVGSHEKVGQHPCCVRL 122
Query: 122 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILH 181
A ++ + + TE G SL+++ + S+P V D + +LHSQG++H
Sbjct: 123 EQAWEEGGILYLQTEL-CGPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVH 180
Query: 182 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVY 241
D+K N+ LG K+ DFG+ G+ + G R+MAPE+++ + DV+
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS-YGTAADVF 239
Query: 242 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 301
S G+ + E+ + Q + Q P ++ P R
Sbjct: 240 SLGLTILEVACNMELPHGGEGWQ---QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLR 296
Query: 302 PHFDQI 307
+ +
Sbjct: 297 ATAEAL 302
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 5e-53
Identities = 61/255 (23%), Positives = 101/255 (39%), Gaps = 34/255 (13%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC------------K 126
+ AIK + P + + ++ EV L +L HP I+ + A
Sbjct: 31 CNYAIKRIRLPNRELA-----REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85
Query: 127 KPPVFCIITEYLAGGSLRKYLHQQEPYS-VPLNLVLKLALDIARGMQYLHSQGILHRDLK 185
I + +L+ +++ + ++ L + L IA +++LHS+G++HRDLK
Sbjct: 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLK 145
Query: 186 SENLLLGEDMCVKVADFGISCL-------------ESQCGSAKGFTGTYRWMAPEMIKEK 232
N+ D VKV DFG+ G GT +M+PE I
Sbjct: 146 PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN 205
Query: 233 RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292
++ KVD++S G++L+EL L PF + PP+ ++
Sbjct: 206 SYSHKVDIFSLGLILFEL---LYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQD 262
Query: 293 CWSSSPDRRPHFDQI 307
S SP RP I
Sbjct: 263 MLSPSPMERPEAINI 277
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-52
Identities = 62/276 (22%), Positives = 112/276 (40%), Gaps = 28/276 (10%)
Query: 59 IGCKFASGRHSRIY--RGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
K G S + G++ A+K + E+ ++ E + NHP
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD------REEAQREADMHRLFNHP 86
Query: 117 HIITFVAACKKPPV----FCIITEYLAGGSLRKYL--HQQEPYSVPLNLVLKLALDIARG 170
+I+ VA C + ++ + G+L + + + + + +L L L I RG
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 171 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES----------QCGSAKGFTGT 220
++ +H++G HRDLK N+LLG++ + D G T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 221 YRWMAPEMIKEKRH---TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-VCQKNARP 276
+ APE+ + H ++ DV+S G VL+ ++ P+D + + + A Q
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 277 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
P P A L++ + P +RPH ++S LE
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-51
Identities = 60/243 (24%), Positives = 95/243 (39%), Gaps = 23/243 (9%)
Query: 70 RIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127
++R KQ A+K V LE E+ L+ P I+ A ++
Sbjct: 73 EVHRMKDKQTGFQCAVKKVR-----------LEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 187
P I E L GGSL + + Q P + L G++YLH++ ILH D+K++
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCL--PEDRALYYLGQALEGLEYLHTRRILHGDVKAD 179
Query: 188 NLLLGED-MCVKVADFGIS------CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 240
N+LL D + DFG + L + GT MAPE++ K KVD+
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDI 239
Query: 241 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLISRCWSSSPD 299
+S ++ +L P+ + + +PP+C + I P
Sbjct: 240 WSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPV 299
Query: 300 RRP 302
R
Sbjct: 300 HRA 302
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 6e-51
Identities = 64/258 (24%), Positives = 110/258 (42%), Gaps = 23/258 (8%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEK---QFTSEVALLFRLNHPHII 119
+G + R + K + + K + SM E SEV LL L HP+I+
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELD-------YGSMTEAEKQMLVSEVNLLRELKHPNIV 68
Query: 120 TFVAA--CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPL--NLVLKLALDIARGMQYLH 175
+ + I+ EY GG L + + L VL++ + ++ H
Sbjct: 69 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 176 SQG-----ILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMI 229
+ +LHRDLK N+ L VK+ DFG++ L AK F GT +M+PE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 230 KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289
+ +K D++S G +L+EL + PF + ++ A + + +P + +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDELNEI 247
Query: 290 ISRCWSSSPDRRPHFDQI 307
I+R + RP ++I
Sbjct: 248 ITRMLNLKDYHRPSVEEI 265
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-50
Identities = 72/266 (27%), Positives = 121/266 (45%), Gaps = 18/266 (6%)
Query: 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQ 102
E + E+ + ++ +G G + +Y G Q +AIK + + + S +
Sbjct: 16 EYDYEYDENGDRVVLG----KGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS------QP 65
Query: 103 FTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQE-PYSVPLNLVL 161
E+AL L H +I+ ++ + + I E + GGSL L + P +
Sbjct: 66 LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125
Query: 162 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGIS-CLESQCGSAKGFTG 219
I G++YLH I+HRD+K +N+L+ +K++DFG S L + FTG
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTG 185
Query: 220 TYRWMAPEMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNARP 276
T ++MAPE+I + + K D++S G + E+ T PF + QAA F V P
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP 245
Query: 277 PVPPTCPKAFSYLISRCWSSSPDRRP 302
+P + I +C+ PD+R
Sbjct: 246 EIPESMSAEAKAFILKCFEPDPDKRA 271
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 8e-50
Identities = 63/263 (23%), Positives = 101/263 (38%), Gaps = 45/263 (17%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF-------------VAA 124
R AIK + EE SEV LL LNH +++ + + A
Sbjct: 31 SRYYAIKKIRHTEEK-------LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83
Query: 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 184
KK I EY G+L +H + + +L I + Y+HSQGI+HRDL
Sbjct: 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQ-QRDEYWRLFRQILEALSYIHSQGIIHRDL 142
Query: 185 KSENLLLGEDMCVKVADFGIS---------------CLESQCGSAKGFTGTYRWMAPEMI 229
K N+ + E VK+ DFG++ L + GT ++A E++
Sbjct: 143 KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL 202
Query: 230 KEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288
H +K+D+YS GI+ +E++ M + ++ PP
Sbjct: 203 DGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKL--RSVSIEFPPDFDDNKMK 258
Query: 289 ----LISRCWSSSPDRRPHFDQI 307
+I P++RP +
Sbjct: 259 VEKKIIRLLIDHDPNKRPGARTL 281
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-48
Identities = 55/274 (20%), Positives = 104/274 (37%), Gaps = 36/274 (13%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NH 115
K SG +++ + + AIK +P S+ E+ EV L H
Sbjct: 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG----SVDEQNALREVYAHAVLGQH 70
Query: 116 PHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPL--NLVLKLALDIARGMQY 173
H++ + +A + I EY GGSL + + + L L + RG++Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 174 LHSQGILHRDLKSENLLLGED-------------------MCVKVADFGISCLESQCGSA 214
+HS ++H D+K N+ + + K+ D G ++ S
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSP 187
Query: 215 KGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 273
+ G R++A E+++E H K D+++ + + A N + ++
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEIRQG 243
Query: 274 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307
P +P + F+ L+ P+RRP +
Sbjct: 244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-48
Identities = 56/264 (21%), Positives = 101/264 (38%), Gaps = 40/264 (15%)
Query: 69 SRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP--HIITFVAAC 125
S++++ + + ++ AIK V+ E D E+A L +L II
Sbjct: 23 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN----EIAYLNKLQQHSDKIIRLYDYE 78
Query: 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 185
++ E L +L +++ ++ + +H GI+H DLK
Sbjct: 79 ITDQYIYMVMEC-GNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQHGIVHSDLK 135
Query: 186 SENLLLGEDMCVKVADFGIS----------CLESQCGSAKGFTGTYRWMAPEMIKEK--- 232
N L+ + M +K+ DFGI+ +SQ GT +M PE IK+
Sbjct: 136 PANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-------GTVNYMPPEAIKDMSSS 187
Query: 233 --------RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNARPPVPPTCP 283
+ + K DV+S G +L+ + TPF + + + A+ N P
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 247
Query: 284 KAFSYLISRCWSSSPDRRPHFDQI 307
K ++ C P +R ++
Sbjct: 248 KDLQDVLKCCLKRDPKQRISIPEL 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-47
Identities = 56/264 (21%), Positives = 101/264 (38%), Gaps = 40/264 (15%)
Query: 69 SRIYRGIYKQRD-VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP--HIITFVAAC 125
S++++ + +++ AIK V+ E D + +E+A L +L II
Sbjct: 42 SKVFQVLNEKKQIYAIKYVNLEEADNQTL----DSYRNEIAYLNKLQQHSDKIIRLYDYE 97
Query: 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 185
++ E L +L +++ ++ + +H GI+H DLK
Sbjct: 98 ITDQYIYMVMEC-GNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQHGIVHSDLK 154
Query: 186 SENLLLGEDMCVKVADFGIS----------CLESQCGSAKGFTGTYRWMAPEMIKEK--- 232
N L+ + M +K+ DFGI+ +SQ GT +M PE IK+
Sbjct: 155 PANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-------GTVNYMPPEAIKDMSSS 206
Query: 233 --------RHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNARPPVPPTCP 283
+ + K DV+S G +L+ + TPF + A+ N P
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 266
Query: 284 KAFSYLISRCWSSSPDRRPHFDQI 307
K ++ C P +R ++
Sbjct: 267 KDLQDVLKCCLKRDPKQRISIPEL 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-47
Identities = 57/268 (21%), Positives = 101/268 (37%), Gaps = 40/268 (14%)
Query: 65 SGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP--HIITF 121
SG S++++ + + ++ AIK V+ E D + +E+A L +L II
Sbjct: 66 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL----DSYRNEIAYLNKLQQHSDKIIRL 121
Query: 122 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILH 181
++ E L +L +++ ++ + +H GI+H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQHGIVH 178
Query: 182 RDLKSENLLLGEDMCVKVADFGIS----------CLESQCGSAKGFTGTYRWMAPEMIKE 231
DLK N L+ D +K+ DFGI+ +SQ G +M PE IK+
Sbjct: 179 SDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV-------GAVNYMPPEAIKD 230
Query: 232 K-----------RHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNARPPVP 279
+ + K DV+S G +L+ + TPF + A+ N P
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290
Query: 280 PTCPKAFSYLISRCWSSSPDRRPHFDQI 307
K ++ C P +R ++
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-44
Identities = 69/265 (26%), Positives = 127/265 (47%), Gaps = 27/265 (10%)
Query: 70 RIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128
++Y+G+ + VA+K + ++F +E+ L HPH+++ + C +
Sbjct: 54 KVYKGVLRDGAKVALKRRTPESSQG------IEEFETEIETLSFCRHPHLVSLIGFCDER 107
Query: 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPL--NLVLKLALDIARGMQYLHSQGILHRDLKS 186
+I +Y+ G+L+++L+ + ++ + L++ + ARG+ YLH++ I+HRD+KS
Sbjct: 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKS 167
Query: 187 ENLLLGEDMCVKVADFGISCLESQCGSAKGFT---GTYRWMAPEMIKEKRHTKKVDVYSF 243
N+LL E+ K+ DFGIS ++ T GT ++ PE + R T+K DVYSF
Sbjct: 168 INILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227
Query: 244 GIVLWELLTALTPFDNMTPEQAAFAV-----CQKNARPP----------VPPTCPKAFSY 288
G+VL+E+L A + P + N + + P + F
Sbjct: 228 GVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGD 287
Query: 289 LISRCWSSSPDRRPHFDQIVSILEG 313
+C + S + RP ++ LE
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKLEY 312
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-43
Identities = 45/216 (20%), Positives = 88/216 (40%), Gaps = 17/216 (7%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVP-LNLVLKLA 164
++ + + + + + I + +L+ +++++ + L +
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFT----- 218
+ IA +++LHS+G++HRDLK N+ D VKV DFG+ ++ T
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 219 -------GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 271
GT +M+PE I ++ KVD++S G++L+ELL + + +
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---RIITDVR 287
Query: 272 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307
P + ++ S SP RP I
Sbjct: 288 NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-43
Identities = 79/269 (29%), Positives = 124/269 (46%), Gaps = 27/269 (10%)
Query: 45 EGEEEWSADMSQLF-IGCKFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEK 101
G + AD +LF K G +++GI + VAIK++ E + + + +
Sbjct: 11 PGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ- 69
Query: 102 QFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQ---QEPYSVPLN 158
E+ +L + + P++ + + K II EYL GGS L E +
Sbjct: 70 ----EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ---IA 122
Query: 159 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGF 217
+L+ L +G+ YLHS+ +HRD+K+ N+LL E VK+ADFG++ L F
Sbjct: 123 TILREIL---KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 179
Query: 218 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 277
GT WMAPE+IK+ + K D++S GI EL P + P + F + + N
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---- 235
Query: 278 VPPTCPKAFSYL----ISRCWSSSPDRRP 302
PPT +S + C + P RP
Sbjct: 236 -PPTLEGNYSKPLKEFVEACLNKEPSFRP 263
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 67/294 (22%), Positives = 117/294 (39%), Gaps = 39/294 (13%)
Query: 59 IGCKFASGRHSRIY--RGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NH 115
+ A G + +Y + + R+ A+K + EE+ + EV + +L H
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK------NRAIIQEVCFMKKLSGH 85
Query: 116 PHIITFVAACKKPP--------VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDI 167
P+I+ F +A F ++TE G + + + + VLK+
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 168 ARGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVADFGISCLES----QCGSAKGFT--- 218
R +Q++H Q I+HRDLK ENLLL +K+ DFG + S SA+
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 219 ------GTYRWMAPEMI---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV 269
T + PE+I +K D+++ G +L+ L PF+ + A +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE----DGAKLRI 261
Query: 270 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 323
P T F LI +P+ R ++V L+ + + +P+
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 61/238 (25%), Positives = 107/238 (44%), Gaps = 24/238 (10%)
Query: 78 QRDVAIK-LVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITE 136
VAIK + P E K+F EV +L+H +I++ + ++ + ++ E
Sbjct: 36 NIKVAIKAIFIPPREKEETL----KRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91
Query: 137 YLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 196
Y+ G +L +Y+ P + ++ + I G+++ H I+HRD+K +N+L+ +
Sbjct: 92 YIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT 149
Query: 197 VKVADFGISCLESQCGSAKGFT------GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 250
+K+ DFGI ++ S T GT ++ +PE K + + D+YS GIVL+E+
Sbjct: 150 LKIFDFGI----AKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEM 205
Query: 251 LTALTPFDNMTPEQAAFAVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRRPH 303
L PF+ T A P T P++ S +I R R
Sbjct: 206 LVGEPPFNGETAVSIAIK--HIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK 261
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-42
Identities = 66/280 (23%), Positives = 115/280 (41%), Gaps = 50/280 (17%)
Query: 70 RIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129
+Y+G VA+K ++ + + L++QF E+ ++ + H +++ +
Sbjct: 46 VVYKGYVNNTTVAVKKLAAMVDITTEE--LKQQFDQEIKVMAKCQHENLVELLGFSSDGD 103
Query: 130 VFCIITEYLAGGSLRKYLHQQEPYSVPL--NLVLKLALDIARGMQYLHSQGILHRDLKSE 187
C++ Y+ GSL L + PL ++ K+A A G+ +LH +HRD+KS
Sbjct: 104 DLCLVYVYMPNGSLLDRLSCLDGTP-PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSA 162
Query: 188 NLLLGEDMCVKVADFGISCLESQCGSAKGFT-------GTYRWMAPEMIKEKRHTKKVDV 240
N+LL E K++DFG++ T GT +MAPE ++ + T K D+
Sbjct: 163 NILLDEAFTAKISDFGLARA----SEKFAQTVMTSRIVGTTAYMAPEALRGEI-TPKSDI 217
Query: 241 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN----ARPPVPPTCPKAFSYLI------ 290
YSFG+VL E++T L D Q K I
Sbjct: 218 YSFGVVLLEIITGLPAVDEHREPQ--------LLLDIKEEIE--DEEKTIEDYIDKKMND 267
Query: 291 -------------SRCWSSSPDRRPHFDQIVSILEGYSES 317
S+C ++RP ++ +L+ + S
Sbjct: 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-41
Identities = 72/277 (25%), Positives = 127/277 (45%), Gaps = 27/277 (9%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
IG G+ +Y KQ +A+K++ + + +E Q EV + L HP
Sbjct: 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFK---AQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 117 HII---TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQY 173
+I+ + + V+ +I EY G++ + L + + ++A + Y
Sbjct: 70 NILRLYGYFHDATR--VY-LILEYAPLGTVYRELQKLSKFDEQR--TATYITELANALSY 124
Query: 174 LHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR 233
HS+ ++HRD+K ENLLLG +K+ADFG S + GT ++ PEMI+ +
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 234 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY----L 289
H +KVD++S G++ +E L PF+ T ++ ++ +R V T P + L
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----TYKRISR--VEFTFPDFVTEGARDL 237
Query: 290 ISRCWSSSPDRRPHFDQIVS---ILEGYSESLEQDPE 323
ISR +P +RP +++ I S+ +
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNK 274
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-41
Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 25/240 (10%)
Query: 78 QRDVAIK-LVSQPEEDASLASMLEKQFTSE---VALLFRLNHPHIIT-----FVAACKKP 128
RDVA+K L + D S +F E A LNHP I+ P
Sbjct: 37 HRDVAVKVLRADLARDPSFY----LRFRREAQNAA---ALNHPAIVAVYDTGEAETPAGP 89
Query: 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 188
+ I+ EY+ G +LR +H + P + +++ D + + + H GI+HRD+K N
Sbjct: 90 LPY-IVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPAN 146
Query: 189 LLLGEDMCVKVADFGISCLESQCGSAKGFT----GTYRWMAPEMIKEKRHTKKVDVYSFG 244
+++ VKV DFGI+ + G++ T GT ++++PE + + DVYS G
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206
Query: 245 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRCWSSSPDRRP 302
VL+E+LT PF +P A+ +++ PP ++ + + +P+ R
Sbjct: 207 CVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY 266
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 4e-41
Identities = 58/277 (20%), Positives = 103/277 (37%), Gaps = 29/277 (10%)
Query: 69 SRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF--VAA 124
+ ++RG +K+ AIK+ + S ++ Q E +L +LNH +I+ +
Sbjct: 23 ANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQM-REFEVLKKLNHKNIVKLFAIEE 77
Query: 125 CKKPPVFCIITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQGILHRD 183
+I E+ GSL L + Y +P + L + D+ GM +L GI+HR+
Sbjct: 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN 137
Query: 184 LKSENLLLG----EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK--------E 231
+K N++ K+ DFG + GT ++ P+M + +
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQ 197
Query: 232 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291
K++ VD++S G+ + T PF + V K P+ +
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPSGAISGVQKAE 255
Query: 292 RCWSSSPDRRPHFDQIVSILEGYSES-----LEQDPE 323
P + L+ LE D E
Sbjct: 256 NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 62/251 (24%), Positives = 100/251 (39%), Gaps = 34/251 (13%)
Query: 69 SRIYRG--IYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126
+Y ++R VA+KL+ E +S + E RL PH++
Sbjct: 48 GDVYEAEDTVRERIVALKLM--SETLSSDPVFRTR-MQREARTAGRLQEPHVV------- 97
Query: 127 KPPVF---------CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 177
P+ + + G L L +Q P + + + I + H+
Sbjct: 98 --PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAA 153
Query: 178 GILHRDLKSENLLLGEDMCVKVADFGI--SCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 235
G HRD+K EN+L+ D + DFGI + + + GT +MAPE E T
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHAT 213
Query: 236 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP----PTCPKAFSYLIS 291
+ D+Y+ VL+E LT P+ +Q + N P P P P AF +I+
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQG---DQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIA 270
Query: 292 RCWSSSPDRRP 302
R + +P+ R
Sbjct: 271 RGMAKNPEDRY 281
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-40
Identities = 67/262 (25%), Positives = 122/262 (46%), Gaps = 24/262 (9%)
Query: 51 SADMSQLF-IGCKFASGRHSRIYRGIYKQ--RDVAIKLVS-QPEEDASLASMLEKQFTSE 106
D + + K G +Y + ++VAI+ ++ Q + L +E
Sbjct: 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-------IINE 67
Query: 107 VALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQ---QEPYSVPLNLVLKL 163
+ ++ +P+I+ ++ + ++ EYLAGGSL + + E + V +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCRE 124
Query: 164 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYR 222
L + +++LHS ++HRD+KS+N+LLG D VK+ DFG + + GT
Sbjct: 125 CL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 223 WMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PP 280
WMAPE++ K + KVD++S GI+ E++ P+ N P +A + + N P + P
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPELQNPE 240
Query: 281 TCPKAFSYLISRCWSSSPDRRP 302
F ++RC ++R
Sbjct: 241 KLSAIFRDFLNRCLEMDVEKRG 262
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 68/265 (25%), Positives = 115/265 (43%), Gaps = 23/265 (8%)
Query: 79 RDVAIKLVSQPEEDASLASM-LEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEY 137
A K+V + + L ++ + E+++ L H H++ F + ++ E
Sbjct: 41 EVFAGKIVPK----SLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96
Query: 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 197
SL + +++ + P I G QYLH ++HRDLK NL L ED+ V
Sbjct: 97 CRRRSLLELHKRRKALTEPE--ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEV 154
Query: 198 KVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALT 255
K+ DFG++ G K GT ++APE++ +K H+ +VDV+S G +++ LL
Sbjct: 155 KIGDFGLATKVEYDGERK-KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213
Query: 256 PFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS---ILE 312
PF+ T + K +P + LI + + P RP +++++
Sbjct: 214 PFE--TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271
Query: 313 GY------SESLEQDPEFFSSFIPS 331
GY L P F S PS
Sbjct: 272 GYIPARLPITCLTIPPRF--SIAPS 294
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 65/254 (25%), Positives = 112/254 (44%), Gaps = 19/254 (7%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYL 138
A K+V + L ++ + E+++ L H H++ F + ++ E
Sbjct: 67 EVFAGKIVPK---SLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 123
Query: 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 198
SL + +++ + P I G QYLH ++HRDLK NL L ED+ VK
Sbjct: 124 RRRSLLELHKRRKALTEPE--ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVK 181
Query: 199 VADFGISCLESQCGSAKG-FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
+ DFG++ G K GT ++APE++ +K H+ +VDV+S G +++ LL PF
Sbjct: 182 IGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 241
Query: 258 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317
+ T + K +P + LI + + P RP ++++
Sbjct: 242 E--TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL--------- 290
Query: 318 LEQDPEFFSSFIPS 331
D F S +IP+
Sbjct: 291 --NDEFFTSGYIPA 302
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 2e-39
Identities = 58/277 (20%), Positives = 103/277 (37%), Gaps = 29/277 (10%)
Query: 69 SRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF--VAA 124
+ ++RG +K+ AIK+ + S ++ Q E +L +LNH +I+ +
Sbjct: 23 ANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQM-REFEVLKKLNHKNIVKLFAIEE 77
Query: 125 CKKPPVFCIITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQGILHRD 183
+I E+ GSL L + Y +P + L + D+ GM +L GI+HR+
Sbjct: 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN 137
Query: 184 LKSENLLLG----EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK--------E 231
+K N++ K+ DFG + GT ++ P+M + +
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQ 197
Query: 232 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291
K++ VD++S G+ + T PF + V K P+ +
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG--KPSGAISGVQKAE 255
Query: 292 RCWSSSPDRRPHFDQIVSILEGYSES-----LEQDPE 323
P + L+ LE D E
Sbjct: 256 NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 69/268 (25%), Positives = 125/268 (46%), Gaps = 28/268 (10%)
Query: 47 EEEWSADMSQLF-IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQF 103
E+ + ++F + K G + +Y+ I+K+ + VAIK V E D ++
Sbjct: 20 EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESD-------LQEI 71
Query: 104 TSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLN----- 158
E++++ + + PH++ + + K I+ EY GS+ + + L
Sbjct: 72 IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIA 128
Query: 159 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGF 217
+L+ L +G++YLH +HRD+K+ N+LL + K+ADFG++ L
Sbjct: 129 TILQSTL---KGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV 185
Query: 218 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 277
GT WMAPE+I+E + D++S GI E+ P+ ++ P +A F + PP
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--PP 243
Query: 278 V---PPTCPKAFSYLISRCWSSSPDRRP 302
P F+ + +C SP++R
Sbjct: 244 TFRKPELWSDNFTDFVKQCLVKSPEQRA 271
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-39
Identities = 74/278 (26%), Positives = 129/278 (46%), Gaps = 32/278 (11%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRD--VAIKLVSQPEEDASLASMLEKQFTSEV 107
WS + + SG + + + VAIK ++ + S+ +L+ E+
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK-----EI 64
Query: 108 ALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLK----- 162
+ + +HP+I+++ + ++ + L+GGS+ + + VL
Sbjct: 65 QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124
Query: 163 -LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKG---- 216
+ ++ G++YLH G +HRD+K+ N+LLGED V++ADFG+S L + +
Sbjct: 125 TILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 217 -FTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 274
F GT WMAPE++++ R + K D++SFGI EL T P+ P + Q +
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND- 243
Query: 275 RPPVPPTCP----------KAFSYLISRCWSSSPDRRP 302
PP T K+F +IS C P++RP
Sbjct: 244 -PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-39
Identities = 52/310 (16%), Positives = 108/310 (34%), Gaps = 20/310 (6%)
Query: 45 EGEEEWSADMSQLFIGCKFASGRHS--RIYRGIYKQRD--VAIKLVSQPEEDASLASMLE 100
+G + + + G + YK V ++ ++ + + L+
Sbjct: 15 QGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQ 74
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV 160
E+ + NHP+I+ + A ++T ++A GS + + + +
Sbjct: 75 G----ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAI 130
Query: 161 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS------- 213
+ + + + Y+H G +HR +K+ ++L+ D V ++ + G
Sbjct: 131 AYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 214 -AKGFTGTYRWMAPEMIKEKRH--TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 270
K W++PE++++ K D+YS GI EL PF +M Q
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250
Query: 271 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIP 330
P + ++ S S D + + S + +F P
Sbjct: 251 NGT--VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP 308
Query: 331 SPDHTILRCL 340
H + +CL
Sbjct: 309 HFHHFVEQCL 318
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-39
Identities = 60/242 (24%), Positives = 105/242 (43%), Gaps = 27/242 (11%)
Query: 72 YRGIYKQ--RDVAIK---LVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126
K R VA+K L Q + +EV ++ H +++ +
Sbjct: 62 CLAREKHSGRQVAVKMMDLRKQQRRE---------LLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 127 KPPVFCIITEYLAGGSLRKYLHQ---QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRD 183
++ E+L GG+L + Q E + V + L + + YLH+QG++HRD
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLNEEQ---IATVCEAVL---QALAYLHAQGVIHRD 166
Query: 184 LKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYS 242
+KS+++LL D VK++DFG + K GT WMAPE+I + +VD++S
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWS 226
Query: 243 FGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDR 300
GI++ E++ P+ + +P QA + + + P + + R P
Sbjct: 227 LGIMVIEMVDGEPPYFSDSPVQAMKRL-RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQE 285
Query: 301 RP 302
R
Sbjct: 286 RA 287
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 63/293 (21%), Positives = 121/293 (41%), Gaps = 18/293 (6%)
Query: 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQ 102
+ ++ + +G +++ +K +A KL+ + A Q
Sbjct: 23 QKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR-----NQ 77
Query: 103 FTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLK 162
E+ +L N P+I+ F A I E++ GGSL + L + +P ++ K
Sbjct: 78 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGK 135
Query: 163 LALDIARGMQYLHSQG-ILHRDLKSENLLLGEDMCVKVADFGISC--LESQCGSAKGFTG 219
+++ + +G+ YL + I+HRD+K N+L+ +K+ DFG+S ++S A F G
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVG 192
Query: 220 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF-DNMTPEQAAFAVCQKNARPPV 278
T +M+PE ++ ++ + D++S G+ L E+ P E CQ
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252
Query: 279 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD--PEFFSSFI 329
P P+ +++ S F+ + I+ L F F+
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 305
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 59/253 (23%), Positives = 94/253 (37%), Gaps = 42/253 (16%)
Query: 64 ASGRHSRIYRG---IYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
A G IY R V +K + DA +E L + HP I+
Sbjct: 89 AHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQ----AMAMAERQFLAEVVHPSIVQ 143
Query: 121 ---FV--AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH 175
FV PV I+ EY+ G SL++ Q+ +P+ + L+I + YLH
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLH 199
Query: 176 SQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT------GTYRWMAPEMI 229
S G+++ DLK EN++L E+ +K+ D G GT + APE++
Sbjct: 200 SIGLVYNDLKPENIMLTEEQ-LKLIDLGA---------VSRINSFGYLYGTPGFQAPEIV 249
Query: 230 KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289
+ T D+Y+ G L L L + + ++ L
Sbjct: 250 RT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------PEDDPVLKTYDSYGRL 300
Query: 290 ISRCWSSSPDRRP 302
+ R P +R
Sbjct: 301 LRRAIDPDPRQRF 313
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 64/249 (25%), Positives = 104/249 (41%), Gaps = 18/249 (7%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII---TFVAACKKPPVFCIITEY 137
VAIK++ + A + + ++ +EV + +L HP I+ + V+ ++ E
Sbjct: 39 VAIKMIDK---KAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY--VY-LVLEM 92
Query: 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 197
G + +YL + N I GM YLHS GILHRDL NLLL +M +
Sbjct: 93 CHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNI 151
Query: 198 KVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALT 255
K+ADFG++ +T GT +++PE+ H + DV+S G + + LL
Sbjct: 152 KIADFGLATQLKMPHEKH-YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRP 210
Query: 256 PFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS---ILE 312
PFD T A +P LI + +P R ++ +
Sbjct: 211 PFD--TDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268
Query: 313 GYSESLEQD 321
S + +
Sbjct: 269 NSSTKSKDE 277
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 3e-38
Identities = 66/252 (26%), Positives = 108/252 (42%), Gaps = 26/252 (10%)
Query: 71 IYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPP 129
+YRG++ RDVA+K + E S A EV LL + HP++I + K
Sbjct: 41 VYRGMFDNRDVAVKRILP--ECFSFAD-------REVQLLRESDEHPNVIRYFCTEKDRQ 91
Query: 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 189
I E L +L++Y+ Q++ ++ + L G+ +LHS I+HRDLK N+
Sbjct: 92 FQYIAIE-LCAATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149
Query: 190 LLGE-----DMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMIKE---KRHTKK 237
L+ + ++DFG+ G GT W+APEM+ E + T
Sbjct: 150 LISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT 209
Query: 238 VDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVP-PTCPKAFSYLISRCWS 295
VD++S G V + +++ PF QA + + P LI + +
Sbjct: 210 VDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIA 269
Query: 296 SSPDRRPHFDQI 307
P +RP +
Sbjct: 270 MDPQKRPSAKHV 281
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-38
Identities = 58/234 (24%), Positives = 108/234 (46%), Gaps = 22/234 (9%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII---TFVAACKKPPVFCIITEY 137
+A+K++ + + +E Q E+ + L HP+I+ + K+ ++ ++ E+
Sbjct: 42 MALKVLFKSQ---LEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR--IY-LMLEF 95
Query: 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 197
G L K L + + ++A + Y H + ++HRD+K ENLL+G +
Sbjct: 96 APRGELYKELQKHGRFDEQR--SATFMEELADALHYCHERKVIHRDIKPENLLMGYKGEL 153
Query: 198 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
K+ADFG S + + + GT ++ PEMI+ K H +KVD++ G++ +E L + PF
Sbjct: 154 KIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212
Query: 258 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSY----LISRCWSSSPDRRPHFDQI 307
D+ + ++ V P S LIS+ P +R +
Sbjct: 213 DSPSHT----ETHRRIVN--VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 77/269 (28%), Positives = 110/269 (40%), Gaps = 28/269 (10%)
Query: 47 EEEWSADMSQLF-IGCKFASGRHSRIYRGIYKQ--RDVAIKLVS----QPEEDASLASML 99
E + D +LF + G +Y + VAIK +S Q E
Sbjct: 45 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD---- 100
Query: 100 EKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVP-LN 158
EV L +L HP+ I + + ++ EY G + ++P +
Sbjct: 101 ---IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 157
Query: 159 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT 218
V AL +G+ YLHS ++HRD+K+ N+LL E VK+ DFG + S A F
Sbjct: 158 AVTHGAL---QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA---SIMAPANSFV 211
Query: 219 GTYRWMAPEMI---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 275
GT WMAPE+I E ++ KVDV+S GI EL P NM A + + Q
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-- 269
Query: 276 PPV--PPTCPKAFSYLISRCWSSSPDRRP 302
P + F + C P RP
Sbjct: 270 SPALQSGHWSEYFRNFVDSCLQKIPQDRP 298
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-38
Identities = 60/248 (24%), Positives = 109/248 (43%), Gaps = 32/248 (12%)
Query: 72 YRGIYKQ--RDVAIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128
Y+ K+ A K++ + EE+ + E+ +L +HP+I+ + A
Sbjct: 36 YKAKNKETGALAAAKVIETKSEEELED-------YIVEIEILATCDHPYIVKLLGAYYHD 88
Query: 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLN-----LVLKLALDIARGMQYLHSQGILHRD 183
I+ E+ GG++ + + + L +V + L + +LHS+ I+HRD
Sbjct: 89 GKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQML---EALNFLHSKRIIHRD 142
Query: 184 LKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMI-----KEKRHTKK 237
LK+ N+L+ + +++ADFG+S F GT WMAPE++ K+ + K
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYK 202
Query: 238 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV---PPTCPKAFSYLISRCW 294
D++S GI L E+ P + P + + + + PP P F +
Sbjct: 203 ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--PPTLLTPSKWSVEFRDFLKIAL 260
Query: 295 SSSPDRRP 302
+P+ RP
Sbjct: 261 DKNPETRP 268
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 64/249 (25%), Positives = 108/249 (43%), Gaps = 20/249 (8%)
Query: 72 YRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA------ 123
R I++ VAIK Q E+ E+ ++ +LNHP++++
Sbjct: 31 LRWIHQDTGEQVAIKQCRQ----ELSPKNRERWC-LEIQIMKKLNHPNVVSAREVPDGLQ 85
Query: 124 ACKKPPVFCIITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
+ + EY GG LRKYL+Q E + + L DI+ ++YLH I+HR
Sbjct: 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHR 145
Query: 183 DLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVD 239
DLK EN++L + + K+ D G + Q F GT +++APE++++K++T VD
Sbjct: 146 DLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVD 205
Query: 240 VYSFGIVLWELLTALTPF-DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 298
+SFG + +E +T PF N P Q + + + +P
Sbjct: 206 YWSFGTLAFECITGFRPFLPNWQPVQ--WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTP 263
Query: 299 DRRPHFDQI 307
+
Sbjct: 264 NHLSGILAG 272
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-38
Identities = 47/214 (21%), Positives = 89/214 (41%), Gaps = 21/214 (9%)
Query: 66 GRHSRIYRGIYKQRDVAIKLVS-----------QPEEDASLASMLEKQFTSEVALLFRLN 114
G+ ++I + A+K + D F +E+ ++ +
Sbjct: 42 GKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101
Query: 115 HPHIITFVAACKKPPVFCIITEYLAGGSLRKYL------HQQEPYSVPLNLVLKLALDIA 168
+ + +T II EY+ S+ K+ + +P+ ++ + +
Sbjct: 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVL 161
Query: 169 RGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE 227
Y+H++ I HRD+K N+L+ ++ VK++DFG S KG GTY +M PE
Sbjct: 162 NSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD-KKIKGSRGTYEFMPPE 220
Query: 228 MIKEKR--HTKKVDVYSFGIVLWELLTALTPFDN 259
+ + KVD++S GI L+ + + PF
Sbjct: 221 FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 71/278 (25%), Positives = 116/278 (41%), Gaps = 48/278 (17%)
Query: 70 RIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128
++Y+G VA+K + E QF +EV ++ H +++ C P
Sbjct: 45 KVYKGRLADGTLVAVKRLK-----EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99
Query: 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV--LKLALDIARGMQYLHSQG---ILHRD 183
++ Y+A GS+ L ++ PL+ ++AL ARG+ YLH I+HRD
Sbjct: 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRD 159
Query: 184 LKSENLLLGEDMCVKVADFGISCLESQCGSAK----GFT-------GTYRWMAPEMIKEK 232
+K+ N+LL E+ V DFG+ AK T GT +APE +
Sbjct: 160 VKAANILLDEEFEAVVGDFGL---------AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 210
Query: 233 RHTKKVDVYSFGIVLWELLTALTPFDNMTP---------EQAAFAVCQKNARPPVPPTCP 283
+ ++K DV+ +G++L EL+T FD + + +K V
Sbjct: 211 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ 270
Query: 284 KAFSY--------LISRCWSSSPDRRPHFDQIVSILEG 313
+ + C SSP RP ++V +LEG
Sbjct: 271 GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 27/268 (10%)
Query: 53 DMSQLF-IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVAL 109
D + +F + +G + ++Y+G + + + AIK++ ++ E++ E+ +
Sbjct: 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINM 73
Query: 110 LFRL-NHPHIITFVAACKKPPVFC------IITEYLAGGSLRKYLHQQEPYSVPLNLVLK 162
L + +H +I T+ A K ++ E+ GS+ + + ++ +
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133
Query: 163 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTY 221
+ +I RG+ +LH ++HRD+K +N+LL E+ VK+ DFG+S L+ G F GT
Sbjct: 134 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 193
Query: 222 RWMAPEMIKEKRHTK-----KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 276
WMAPE+I + K D++S GI E+ P +M P +A F + +
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--A 251
Query: 277 PV--PPTCPKAFSYLISRCWSSSPDRRP 302
P K F I C + +RP
Sbjct: 252 PRLKSKKWSKKFQSFIESCLVKNHSQRP 279
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 5e-37
Identities = 45/173 (26%), Positives = 83/173 (47%), Gaps = 4/173 (2%)
Query: 144 RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203
+ + L ++ + +A+GM++L S+ +HRDL + N+LL E VK+ DFG
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 238
Query: 204 ISCLESQCGSAKGFTGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 259
++ + +WMAPE I ++ +T + DV+SFG++LWE+ + +P+
Sbjct: 239 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298
Query: 260 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
+ ++ ++ R P + CW P +RP F ++V L
Sbjct: 299 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 7e-07
Identities = 27/129 (20%), Positives = 47/129 (36%), Gaps = 10/129 (7%)
Query: 72 YRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAAC-KKPP 129
GI K V +E A+ + + SE+ +L + +H +++ + AC K
Sbjct: 43 AFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLNVVNLLGACTKPGG 100
Query: 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 189
+I E+ G+L YL + VP +G Y+ G + DLK
Sbjct: 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKT---KGARFRQGKDYV---GAIPVDLKRRLD 154
Query: 190 LLGEDMCVK 198
+
Sbjct: 155 SITSSQSSA 163
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-36
Identities = 66/253 (26%), Positives = 114/253 (45%), Gaps = 18/253 (7%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
K SG + + K + AIK++ + S+++ + EVA+L L+HP
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRK----TSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+I+ + + ++ E GG L + + ++ + + G+ YLH
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE--VDAAVIIKQVLSGVTYLHK 154
Query: 177 QGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR 233
I+HRDLK ENLLL +D +K+ DFG+S + K GT ++APE+++ K+
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KK 213
Query: 234 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY----L 289
+ +K DV+S G++L+ LL PF T ++ V + + K S L
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--EKGKYTFDSPEWKNVSEGAKDL 271
Query: 290 ISRCWSSSPDRRP 302
I + RR
Sbjct: 272 IKQMLQFDSQRRI 284
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-36
Identities = 61/268 (22%), Positives = 114/268 (42%), Gaps = 18/268 (6%)
Query: 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQF 103
G + + A+++ L + SG ++++ +++ +A+K + S K+
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-----RRSGNKEENKRI 70
Query: 104 TSEVALLFRL-NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLK 162
++ ++ + + P+I+ I E + + + Q P +P ++ K
Sbjct: 71 LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP--IPERILGK 128
Query: 163 LALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY 221
+ + I + + YL + G++HRD+K N+LL E +K+ DFGIS + G
Sbjct: 129 MTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCA 188
Query: 222 RWMAPEMIKEKRHTK-----KVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVCQKNA- 274
+MAPE I TK + DV+S GI L EL T P+ N + + V Q+
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP 248
Query: 275 RPPVPPTCPKAFSYLISRCWSSSPDRRP 302
P F + C + +RP
Sbjct: 249 LLPGHMGFSGDFQSFVKDCLTKDHRKRP 276
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 8e-36
Identities = 59/277 (21%), Positives = 113/277 (40%), Gaps = 55/277 (19%)
Query: 71 IYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTS----EVALLFRL-NHPHIITFVAAC 125
+++G ++ R VA+K + F E+ LL +HP++I + +
Sbjct: 32 VFQGSFQGRPVAVK-------------RMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE 78
Query: 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV-----LKLALDIARGMQYLHSQGIL 180
I E +L+ + + L L + L IA G+ +LHS I+
Sbjct: 79 TTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKII 137
Query: 181 HRDLKSENLLL-------------GEDMCVKVADFGISCL-----ESQCGSAKGFTGTYR 222
HRDLK +N+L+ E++ + ++DFG+ S + +GT
Sbjct: 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSG 197
Query: 223 WMAPEMIKE-------KRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNA 274
W APE+++E +R T+ +D++S G V + +L+ PF + ++ +
Sbjct: 198 WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL 257
Query: 275 RPPVPPTCPKAFSY----LISRCWSSSPDRRPHFDQI 307
+ ++ LIS+ P +RP ++
Sbjct: 258 -DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 25/236 (10%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VAIK++ + L ++ EV ++ LNHP+I+ + +I EY +G
Sbjct: 43 VAIKII----DKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98
Query: 141 GSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDLKSENLLLG 192
G + YL ++ AR +QY H + I+HRDLK+ENLLL
Sbjct: 99 GEVFDYLVAHG----------RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD 148
Query: 193 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT-KKVDVYSFGIVLWELL 251
DM +K+ADFG S + G F G + APE+ + K++ +VDV+S G++L+ L+
Sbjct: 149 ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 208
Query: 252 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307
+ PFD + +P L+ R +P +R +QI
Sbjct: 209 SGSLPFDGQN--LKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 34/266 (12%), Positives = 80/266 (30%), Gaps = 26/266 (9%)
Query: 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
I + ++ ++L + + +F L+ +I
Sbjct: 103 VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 162
Query: 121 FVAACKKPPVFCI-ITEYLAGGSLRKYL-----HQQEPYSVPLNLVLKLALDIARGMQYL 174
+ V +L+ + H S+ + L+L L + R + L
Sbjct: 163 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222
Query: 175 HSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK---- 230
H G++H L+ +++L + V + F + G+ + + + PE+
Sbjct: 223 HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD---GARVVSSVSRGFEPPELEARRAT 279
Query: 231 -------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283
T D ++ G+V++ + A P + + + P
Sbjct: 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS------CKNIP 333
Query: 284 KAFSYLISRCWSSSPDRRPHFDQIVS 309
+ L+ + R Q +
Sbjct: 334 QPVRALLEGFLRYPKEDRLLPLQAME 359
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-35
Identities = 64/289 (22%), Positives = 123/289 (42%), Gaps = 27/289 (9%)
Query: 36 VSSGAEIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDA 93
+ S ++K E+ W L + G + + + ++K + +A+K + +
Sbjct: 3 IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-----RS 57
Query: 94 SLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEYLAGGSLR--KYLHQQ 150
++ +KQ ++ ++ R + P+I+ F A + I E ++ + KY++
Sbjct: 58 TVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSV 117
Query: 151 EPYSVPLNLVLKLALDIARGMQYLHSQG-ILHRDLKSENLLLGEDMCVKVADFGIS-CLE 208
+P ++ K+ L + + +L I+HRD+K N+LL +K+ DFGIS L
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177
Query: 209 SQCGSAKGFT-GTYRWMAPEMIKEKRHTK----KVDVYSFGIVLWELLTALTPFDNM-TP 262
AK G +MAPE I + + DV+S GI L+EL T P+ +
Sbjct: 178 DS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235
Query: 263 EQAAFAVCQKNARPPVPPTCP-----KAFSYLISRCWSSSPDRRPHFDQ 306
V + + PP +F ++ C + +RP + +
Sbjct: 236 FDQLTQVVKGD--PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 63/259 (24%), Positives = 114/259 (44%), Gaps = 19/259 (7%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVS-------QPEEDASLASMLEKQFTSEVAL 109
K SG + + K + AIK++ + +D ++ +E++L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 110 LFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR 169
L L+HP+II + F ++TE+ GG L + + + + + I
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDE--CDAANIMKQILS 157
Query: 170 GMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP 226
G+ YLH I+HRD+K EN+LL + +K+ DFG+S S+ + GT ++AP
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN---ARPPVPPTCP 283
E++K K++ +K DV+S G++++ LL PF + V +
Sbjct: 218 EVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISD 276
Query: 284 KAFSYLISRCWSSSPDRRP 302
+A LI + ++R
Sbjct: 277 EAKE-LIKLMLTYDYNKRC 294
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 65/252 (25%), Positives = 113/252 (44%), Gaps = 16/252 (6%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
I C G + + + ++ A+K++++ AS + EV LL +L+HP
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINK----ASAKNKDTSTILREVELLKKLDHP 81
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+I+ + F I+ E GG L + +++ +S + ++ + G+ Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE--HDAARIIKQVFSGITYMHK 139
Query: 177 QGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR 233
I+HRDLK EN+LL +D +K+ DFG+S Q K GT ++APE+++
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GT 198
Query: 234 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN---ARPPVPPTCPKAFSYLI 290
+ +K DV+S G++L+ LL+ PF V P A LI
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD-LI 257
Query: 291 SRCWSSSPDRRP 302
+ + P R
Sbjct: 258 RKMLTFHPSLRI 269
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-34
Identities = 39/286 (13%), Positives = 76/286 (26%), Gaps = 46/286 (16%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
G S ++ + D A+K+ + E++ ++ RL
Sbjct: 72 VGDRSVVFLVRDVERLEDFALKVFTMGAENSRSE---LERLHEATFAAARLLGESPEEAR 128
Query: 123 AACK------------KPPVFCIITEY-------------LAGGSLRKYLHQ-----QEP 152
+ +PP + A L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 153 YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212
+ + L + R L S+G++H +NL + D + + D G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG 248
Query: 213 SAKGFTGTYRWMAPEMI--KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 270
A TY E + T ++ + G+ ++ + PF +TP
Sbjct: 249 PASSVPVTY--APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR 306
Query: 271 QKNARPPVPPTCPKAFSY-------LISRCWSSSPDRRPHFDQIVS 309
P + + LI R + RR + +
Sbjct: 307 PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 61/252 (24%), Positives = 107/252 (42%), Gaps = 15/252 (5%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
G + K ++ A+K++S+ ++ EV LL +L+HP
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISK---RQVKQKTDKESLLREVQLLKQLDHP 86
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+I+ + F ++ E GG L + ++ +S ++ + G+ Y+H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE--VDAARIIRQVLSGITYMHK 144
Query: 177 QGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR 233
I+HRDLK ENLLL +D +++ DFG+S K GT ++APE++
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GT 203
Query: 234 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN---ARPPVPPTCPKAFSYLI 290
+ +K DV+S G++L+ LL+ PF+ V + P A LI
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD-LI 262
Query: 291 SRCWSSSPDRRP 302
+ + P R
Sbjct: 263 RKMLTYVPSMRI 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 1e-33
Identities = 40/286 (13%), Positives = 90/286 (31%), Gaps = 41/286 (14%)
Query: 59 IGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
+ G +++Y ++ +K+ +F L+
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---------WEFYIGTQLME 119
Query: 112 RLN---HPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYS---VPLNLVLKLAL 165
RL + F +A ++ E + G+L ++ + +P LV+ A+
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 166 DIARGMQYLHSQGILHRDLKSENLLLGEDMC-----------VKVADFGISC---LESQC 211
+ ++ +H I+H D+K +N +LG + + D G S L +
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 271
T + EM+ K ++D + ++ +L +
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 272 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317
+ R P + F +++ P D + L+ +
Sbjct: 300 R--RLPHLDMWNEFFHVMLN---IPDCHHLPSLDLLRQKLKKVFQQ 340
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 18/214 (8%)
Query: 100 EKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYS----V 155
+K +E+ +L RL+HP+II + P ++ E + GG L + ++ YS
Sbjct: 92 KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA 151
Query: 156 PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCG 212
I + YLH GI+HRDLK ENLL D +K+ADFG+S +
Sbjct: 152 ------DAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205
Query: 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 272
K GT + APE+++ + +VD++S GI+ + LL PF + +Q F
Sbjct: 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN 265
Query: 273 NA----RPPVPPTCPKAFSYLISRCWSSSPDRRP 302
P A L+ + P +R
Sbjct: 266 CEYYFISPWWDEVSLNAKD-LVRKLIVLDPKKRL 298
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-33
Identities = 35/248 (14%), Positives = 65/248 (26%), Gaps = 44/248 (17%)
Query: 64 ASGRHSRIYRG--IYKQRDVAIKLV-SQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
+ ++ R VA+ V Q + + S L R++ P +
Sbjct: 40 GGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQ----ETLSRTLRLSRIDKPGVAR 95
Query: 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQ-EPYSVPLNLVLKLALDIARGMQYLHSQGI 179
+ ++ E++ GGSL++ P ++ +A H G+
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA-----IRAMQSLAAAADAAHRAGV 150
Query: 180 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVD 239
+ + D V +A M + D
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPAT-------------------MPDA-------NPQDD 184
Query: 240 VYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP-----TCPKAFSYLISRCW 294
+ G L+ LL P + A P+ P P S + +R
Sbjct: 185 IRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSV 244
Query: 295 SSSPDRRP 302
R
Sbjct: 245 QGDGGIRS 252
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 55/203 (27%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
G S + R ++K + A K+++ L++ ++ E + +L HP+I+
Sbjct: 16 KGAFSVVRRCVHKTTGLEFAAKIINT----KKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR----GMQYLHSQG 178
+ ++ ++ + + GG L + + +E YS A + + Y HS G
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSE------ADASHCIQQILESIAYCHSNG 125
Query: 179 ILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 235
I+HR+LK ENLLL + VK+ADFG++ + + GF GT +++PE++K+ ++
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 236 KKVDVYSFGIVLWELLTALTPFD 258
K VD+++ G++L+ LL PF
Sbjct: 186 KPVDIWACGVILYILLVGYPPFW 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-32
Identities = 54/213 (25%), Positives = 104/213 (48%), Gaps = 9/213 (4%)
Query: 52 ADMSQLF-IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
+ + + +G + SG+ + + + K ++ A K + + +S + ++ EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
+L + HP+IIT + +I E ++GG L +L ++E + + I
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE--ATQFLKQIL 118
Query: 169 RGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADFGISCLESQCGSAKGFTGTYRWM 224
G+ YLHS+ I H DLK EN++L + +K+ DFGI+ K GT ++
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178
Query: 225 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
APE++ + + D++S G++ + LL+ +PF
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSGASPF 211
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 35/283 (12%), Positives = 81/283 (28%), Gaps = 47/283 (16%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT-- 120
++ + + E S A K+ + LL + +
Sbjct: 88 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147
Query: 121 --------FVAACKKPPVF---------CIITEYLA-----------GGSLRKYLHQQEP 152
V +K + +++ + G L + +
Sbjct: 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 207
Query: 153 YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212
+ + L+L L + R + LH G++H L+ +++L + V + F +
Sbjct: 208 --LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASA 265
Query: 213 SAKG--FTGTYRWMAPEMIKEKRH-----TKKVDVYSFGIVLWELLTALTPFDNMTPEQA 265
+ A M+ +H T D ++ G+ ++ + A P +
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG 325
Query: 266 AFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 308
+ + + P P L+ + R Q +
Sbjct: 326 SEWIFRSCKNIPQP------VRALLEGFLRYPKEDRLLPLQAM 362
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-32
Identities = 60/246 (24%), Positives = 115/246 (46%), Gaps = 17/246 (6%)
Query: 72 YRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVA-LLFRLNHPHIITFVAACKKP 128
+ + + +A+K + A++ S +K+ ++ + ++ P +TF A +
Sbjct: 24 EKMRHVPSGQIMAVKRI-----RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE 78
Query: 129 PVFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQG-ILHRDLK 185
I E + SL K+ Q + ++P +++ K+A+ I + +++LHS+ ++HRD+K
Sbjct: 79 GDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVK 137
Query: 186 SENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK----EKRHTKKVDVY 241
N+L+ VK+ DFGIS + G +MAPE I +K ++ K D++
Sbjct: 138 PSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIW 197
Query: 242 SFGIVLWELLTALTPFDNM-TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 300
S GI + EL P+D+ TP Q V ++ + F S+C +
Sbjct: 198 SLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKE 257
Query: 301 RPHFDQ 306
RP + +
Sbjct: 258 RPTYPE 263
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-32
Identities = 51/203 (25%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
SG S ++ + + A+K + + + + +E+A+L ++ H +I+T
Sbjct: 19 SGAFSEVFLVKQRLTGKLFALKCIKK----SPAFR--DSSLENEIAVLKKIKHENIVTLE 72
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYS----VPLNLVLKLALDIARGMQYLHSQG 178
+ + ++ + ++GG L + ++ Y+ + + ++YLH G
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS------LVIQQVLSAVKYLHENG 126
Query: 179 ILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 235
I+HRDLK ENLL E+ + + DFG+S +E G GT ++APE++ +K ++
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMSTACGTPGYVAPEVLAQKPYS 185
Query: 236 KKVDVYSFGIVLWELLTALTPFD 258
K VD +S G++ + LL PF
Sbjct: 186 KAVDCWSIGVITYILLCGYPPFY 208
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVS--QPEEDASLASMLEKQFTSEVALLFRLN 114
+ SG + ++ + VAI+++S + ++ + +E+ +L +LN
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 115 HPHIITFVAACKKPPVFCIITEYLAGGSL------RKYLHQQEPYSVPLNLVLKLALDIA 168
HP II + I+ E + GG L K L + +
Sbjct: 199 HPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEAT--------CKLYFYQML 249
Query: 169 RGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMA 225
+QYLH GI+HRDLK EN+LL ED +K+ DFG S + + + GT ++A
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309
Query: 226 PEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFD 258
PE++ + + VD +S G++L+ L+ PF
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 56/279 (20%), Positives = 110/279 (39%), Gaps = 51/279 (18%)
Query: 79 RDVAIKLV--SQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITE 136
++V +K + + ED + + T E+A+L R+ H +II + + F ++ E
Sbjct: 50 KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVME 109
Query: 137 -YLAGGSL---------------RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 180
+ +G L Q + + YL + I+
Sbjct: 110 KHGSGLDLFAFIDRHPRLDEPLASYIFRQ-----------------LVSAVGYLRLKDII 152
Query: 181 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT-KKVD 239
HRD+K EN+++ ED +K+ DFG + + F GT + APE++ + +++
Sbjct: 153 HRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELE 212
Query: 240 VYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYLISRCWSSS 297
++S G+ L+ L+ PF + ++ A P K L+S
Sbjct: 213 MWSLGVTLYTLVFEENPFCEL----------EETVEAAIHPPYLVSKELMSLVSGLLQPV 262
Query: 298 PDRRPHFDQIVS---ILEGYSESLEQDPEFFSSFIPSPD 333
P+RR +++V+ + + + + E F P
Sbjct: 263 PERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESG 301
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEK---QFTSEVALLFRLN-HPHI 118
G S + R I+K ++ A+K++ + A +++ EV +L +++ HP+I
Sbjct: 27 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86
Query: 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR----GMQYL 174
I + F ++ + + G L YL ++ S K I R + L
Sbjct: 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE------KETRKIMRALLEVICAL 140
Query: 175 HSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK---- 230
H I+HRDLK EN+LL +DM +K+ DFG SC + GT ++APE+I+
Sbjct: 141 HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN 200
Query: 231 --EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 264
+ K+VD++S G++++ LL PF +
Sbjct: 201 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 12/205 (5%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
I C G + + + ++ A+K++++ AS + EV LL +L+HP
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINK----ASAKNKDTSTILREVELLKKLDHP 81
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+I+ + F I+ E GG L + +++ +S + ++ + G+ Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE--HDAARIIKQVFSGITYMHK 139
Query: 177 QGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR 233
I+HRDLK EN+LL +D +K+ DFG+S Q K GT ++APE+++
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GT 198
Query: 234 HTKKVDVYSFGIVLWELLTALTPFD 258
+ +K DV+S G++L+ LL+ PF
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFY 223
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 59/235 (25%), Positives = 114/235 (48%), Gaps = 23/235 (9%)
Query: 37 SSGAEIKGEGEEEWSADMSQLF----IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPE 90
+G + G G E ++ + + G S + R ++K + A K+++
Sbjct: 7 MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-- 64
Query: 91 EDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQ 150
L++ ++ E + +L HP+I+ + ++ ++ + + GG L + + +
Sbjct: 65 --KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122
Query: 151 EPYSVPLNLVLKLALDIAR----GMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFG 203
E YS A + + Y HS GI+HR+LK ENLLL + VK+ADFG
Sbjct: 123 EFYSE------ADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG 176
Query: 204 ISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 258
++ + + GF GT +++PE++K+ ++K VD+++ G++L+ LL PF
Sbjct: 177 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 37/162 (22%), Positives = 75/162 (46%), Gaps = 6/162 (3%)
Query: 100 EKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNL 159
+F E+ ++ L+HP+II + ++ E GG L + + + + +
Sbjct: 50 VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE--SD 107
Query: 160 VLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKG 216
++ D+ + Y H + HRDLK EN L D +K+ DFG++ +
Sbjct: 108 AARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 217 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 258
GT +++P++++ + + D +S G++++ LL PF
Sbjct: 168 KVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFS 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 8/205 (3%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
IG + SG+ + + + K + A K + + + AS + ++ EV++L ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
++IT + +I E ++GG L +L Q+E S I G+ YLH+
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--EEATSFIKQILDGVNYLHT 133
Query: 177 QGILHRDLKSENLLL----GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK 232
+ I H DLK EN++L +K+ DFG++ K GT ++APE++ +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 233 RHTKKVDVYSFGIVLWELLTALTPF 257
+ D++S G++ + LL+ +PF
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPF 218
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 61/274 (22%), Positives = 104/274 (37%), Gaps = 48/274 (17%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH--PHIITFVAACKKPPVFCIITEYL 138
VAIK V + + EV LL +++ +I + ++P F +I E
Sbjct: 71 VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 130
Query: 139 AG-----------GSL-----RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
G+L R + Q + +++ H+ G+LHR
Sbjct: 131 EPVQDLFDFITERGALQEELARSFFWQ-----------------VLEAVRHCHNCGVLHR 173
Query: 183 DLKSENLLL-GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDV 240
D+K EN+L+ +K+ DFG L F GT + PE I+ R H + V
Sbjct: 174 DIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAV 232
Query: 241 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 300
+S GI+L++++ PF++ E+ + +LI C + P
Sbjct: 233 WSLGILLYDMVCGDIPFEH--DEEI------IRGQVFFRQRVSSECQHLIRWCLALRPSD 284
Query: 301 RPHFDQIVSI--LEGYSESLEQDPEFFSSFIPSP 332
RP F++I + ++ E S P P
Sbjct: 285 RPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGP 318
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-31
Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 8/205 (3%)
Query: 59 IGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
IG + SG+ + + + K + A K + + + AS + ++ EV++L ++ HP
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+IIT + +I E ++GG L +L Q+E S I G+ YLH+
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE--ATSFIKQILDGVNYLHT 133
Query: 177 QGILHRDLKSENLLL----GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK 232
+ I H DLK EN++L +K+ DFG++ K GT ++APE++ +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 233 RHTKKVDVYSFGIVLWELLTALTPF 257
+ D++S G++ + LL+ +PF
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPF 218
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-31
Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 8/205 (3%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
G + SG+ + + + K A K + + +S + + EV++L + HP
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
++IT + +I E +AGG L +L ++E + + I G+ YLHS
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE--ATEFLKQILNGVYYLHS 132
Query: 177 QGILHRDLKSENLLL----GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK 232
I H DLK EN++L +K+ DFG++ K GT ++APE++ +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 233 RHTKKVDVYSFGIVLWELLTALTPF 257
+ D++S G++ + LL+ +PF
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 60/247 (24%), Positives = 105/247 (42%), Gaps = 13/247 (5%)
Query: 69 SRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF--VAACK 126
++ R R + +Q E+A+L +L+HP+++ V
Sbjct: 49 KKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDP 108
Query: 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLN--LVLKLALDIARGMQYLHSQGILHRDL 184
++ E + G + + + PL+ D+ +G++YLH Q I+HRD+
Sbjct: 109 NEDHLYMVFELVNQGPVMEVPTLK-----PLSEDQARFYFQDLIKGIEYLHYQKIIHRDI 163
Query: 185 KSENLLLGEDMCVKVADFGISCL-ESQCGSAKGFTGTYRWMAPEMIKEKRHT---KKVDV 240
K NLL+GED +K+ADFG+S + GT +MAPE + E R K +DV
Sbjct: 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDV 223
Query: 241 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 300
++ G+ L+ + PF + + + P P + LI+R +P+
Sbjct: 224 WAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPES 283
Query: 301 RPHFDQI 307
R +I
Sbjct: 284 RIVVPEI 290
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-31
Identities = 56/218 (25%), Positives = 103/218 (47%), Gaps = 42/218 (19%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITF 121
G +S R I+K + A+K++ + + D + E+ +L R HP+IIT
Sbjct: 32 VGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT----------EEIEILLRYGQHPNIITL 81
Query: 122 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYS----VPLNLVLKLALDIARGMQYLHSQ 177
++TE + GG L + +Q+ +S + I + ++YLH+Q
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS------AVLFTITKTVEYLHAQ 135
Query: 178 GILHRDLKSENLLL----GEDMCVKVADFGIS--------CLESQCGSAKGFTGTYRWMA 225
G++HRDLK N+L G +++ DFG + L + C +A + +A
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA-----NF--VA 188
Query: 226 PEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE 263
PE+++ + + D++S G++L+ +LT TPF N +
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD 226
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-31
Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 9/202 (4%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
G S + R I ++ + A+K+V + +S E E ++ L HPHI+ +
Sbjct: 34 KGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED-LKREASICHMLKHPHIVELL 92
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLN--LVLKLALDIARGMQYLHSQGIL 180
+ ++ E++ G L + ++ + + I ++Y H I+
Sbjct: 93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNII 152
Query: 181 HRDLKSENLLL---GEDMCVKVADFGISCLESQCGSA-KGFTGTYRWMAPEMIKEKRHTK 236
HRD+K +LL VK+ FG++ + G G GT +MAPE++K + + K
Sbjct: 153 HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGK 212
Query: 237 KVDVYSFGIVLWELLTALTPFD 258
VDV+ G++L+ LL+ PF
Sbjct: 213 PVDVWGCGVILFILLSGCLPFY 234
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 62/273 (22%), Positives = 107/273 (39%), Gaps = 39/273 (14%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF--VAACKKPPVFCIITEYL 138
VA+K+V E E+ + LNH +++ F + + EY
Sbjct: 35 VAVKIVDM----KRAVDCPENIKK-EICINKMLNHENVVKFYGHRREGN--IQYLFLEYC 87
Query: 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDLKSENLL 190
+GG L + + A+ G+ YLH GI HRD+K ENLL
Sbjct: 88 SGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL 137
Query: 191 LGEDMCVKVADFGISCLESQCGSAKGF--T--GTYRWMAPEMIKEKR-HTKKVDVYSFGI 245
L E +K++DFG++ + + + + GT ++APE++K + H + VDV+S GI
Sbjct: 138 LDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 246 VLWELLTALTPFDNMTPEQAAFA--VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH 303
VL +L P+D + ++ +K P + L+ + +P R
Sbjct: 197 VLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA-LLHKILVENPSARIT 255
Query: 304 FDQIVS---ILEGYSESLEQDPEFFSSFIPSPD 333
I + + ++ SP
Sbjct: 256 IPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPS 288
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 36/244 (14%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF--VAACKKPPVFCIITEYL 138
VA+K+V E E+ + LNH +++ F + + EY
Sbjct: 35 VAVKIVDM----KRAVDCPENIKK-EICINKMLNHENVVKFYGHRREGN--IQYLFLEYC 87
Query: 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDLKSENLL 190
+GG L + + A+ G+ YLH GI HRD+K ENLL
Sbjct: 88 SGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL 137
Query: 191 LGEDMCVKVADFGISCLESQCGSAKGF--T--GTYRWMAPEMIKEKR-HTKKVDVYSFGI 245
L E +K++DFG++ + + + + GT ++APE++K + H + VDV+S GI
Sbjct: 138 LDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 246 VLWELLTALTPFDNMTPEQAAFA--VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH 303
VL +L P+D + ++ +K P + L+ + +P R
Sbjct: 197 VLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA-LLHKILVENPSARIT 255
Query: 304 FDQI 307
I
Sbjct: 256 IPDI 259
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 55/223 (24%), Positives = 104/223 (46%), Gaps = 37/223 (16%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASM--LEKQFTSEVALLFRL-NHPHII 119
G S + R +++ + A+K++ E S + + + E +L ++ HPHII
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYS-----VPLNLVLKLALDIARGMQYL 174
T + + + ++ + + G L YL ++ S + + + +L
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR-------SIMRSLLEAVSFL 216
Query: 175 HSQGILHRDLKSENLLLGEDMCVKVADFGISC-------LESQCGSAKGFTGTYRWMAPE 227
H+ I+HRDLK EN+LL ++M ++++DFG SC L CG+ Y +APE
Sbjct: 217 HANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTP-----GY--LAPE 269
Query: 228 MIK------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 264
++K + K+VD+++ G++L+ LL PF +
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL 312
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 8/202 (3%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL- 163
E+ ++ L HP ++ + + ++ + L GG LR +L Q + +KL
Sbjct: 64 KELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKLF 120
Query: 164 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW 223
++ + YL +Q I+HRD+K +N+LL E V + DF I+ + + GT +
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPY 180
Query: 224 MAPEMIKEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ-KNARPPVP 279
MAPEM ++ ++ VD +S G+ +ELL P+ + + V + P
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP 240
Query: 280 PTCPKAFSYLISRCWSSSPDRR 301
+ L+ + +PD+R
Sbjct: 241 SAWSQEMVSLLKKLLEPNPDQR 262
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 7/164 (4%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL- 163
E ++ RL+HP + + Y G L KY+ + + +
Sbjct: 79 RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---CTRFY 135
Query: 164 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG---ISCLESQCGSAKGFTGT 220
+I ++YLH +GI+HRDLK EN+LL EDM +++ DFG + ES+ A F GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 221 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 264
++++PE++ EK K D+++ G ++++L+ L PF
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLV--SQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
SG ++ + + IK + + + +Q +E+ +L L+HP+II
Sbjct: 32 SGAFGDVHLVEERSSGLERVIKTINKDRSQVP-------MEQIEAEIEVLKSLDHPNIIK 84
Query: 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLN--LVLKLALDIARGMQYLHSQG 178
+ I+ E GG L + + + L+ V +L + + Y HSQ
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 179 ILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 235
++H+DLK EN+L +K+ DFG++ L + GT +MAPE+ K + T
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVT 203
Query: 236 KKVDVYSFGIVLWELLTALTPFD 258
K D++S G+V++ LLT PF
Sbjct: 204 FKCDIWSAGVVMYFLLTGCLPFT 226
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 60/251 (23%), Positives = 95/251 (37%), Gaps = 52/251 (20%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN----HPHIITFVAACKKPPVFCIITE 136
VAIK++ + EVALL+++ HP +I + + F ++ E
Sbjct: 59 VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLE 118
Query: 137 Y-LAGGSL---------------RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 180
L L R + Q + +Q+ HS+G++
Sbjct: 119 RPLPAQDLFDYITEKGPLGEGPSRCFFGQ-----------------VVAAIQHCHSRGVV 161
Query: 181 HRDLKSENLLL-GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKV 238
HRD+K EN+L+ C K+ DFG L F GT + PE I + H
Sbjct: 162 HRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEPYTDFDGTRVYSPPEWISRHQYHALPA 220
Query: 239 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYLISRCWSS 296
V+S GI+L++++ PF+ Q+ A P LI RC +
Sbjct: 221 TVWSLGILLYDMVCGDIPFERD----------QEILEAELHFPAHVSPDCCALIRRCLAP 270
Query: 297 SPDRRPHFDQI 307
P RP ++I
Sbjct: 271 KPSSRPSLEEI 281
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 57/196 (29%), Positives = 86/196 (43%), Gaps = 31/196 (15%)
Query: 81 VAIK------LVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCII 134
VAIK +A A +E E+ +L +LNHP II + I+
Sbjct: 38 VAIKIISKRKFAIGSAREADPALNVET----EIEILKKLNHPCIIKIKNFFDAEDYY-IV 92
Query: 135 TEYLAGGSL------RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 188
E + GG L K L + + +QYLH GI+HRDLK EN
Sbjct: 93 LELMEGGELFDKVVGNKRLKEATCK--------LYFYQMLLAVQYLHENGIIHRDLKPEN 144
Query: 189 LLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE---KRHTKKVDVYS 242
+LL ED +K+ DFG S + + + GT ++APE++ + + VD +S
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 204
Query: 243 FGIVLWELLTALTPFD 258
G++L+ L+ PF
Sbjct: 205 LGVILFICLSGYPPFS 220
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 44/162 (27%), Positives = 88/162 (54%), Gaps = 6/162 (3%)
Query: 98 MLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPL 157
+ EKQ +L ++N +++ A + C++ + GG L+ +++ P
Sbjct: 232 LNEKQ------ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE 285
Query: 158 NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGF 217
+ A +I G++ LH + I++RDLK EN+LL + ++++D G++ + + KG
Sbjct: 286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 345
Query: 218 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 259
GT +MAPE++K +R+T D ++ G +L+E++ +PF
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-30
Identities = 55/259 (21%), Positives = 93/259 (35%), Gaps = 62/259 (23%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF--VAACKKPPVFCIITEYL 138
A+K++ + + E E+ LL RL H ++I V ++ ++ EY
Sbjct: 33 RAVKILKK--KKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC 90
Query: 139 AGGSL----------------RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
G Y Q + G++YLHSQGI+H+
Sbjct: 91 VCGMQEMLDSVPEKRFPVCQAHGYFCQ-----------------LIDGLEYLHSQGIVHK 133
Query: 183 DLKSENLLLGEDMCVKVADFGIS----------CLESQCGSAKGFTGTYRWMAPEMIKEK 232
D+K NLLL +K++ G++ + GS + PE+
Sbjct: 134 DIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP-----AF--QPPEIANGL 186
Query: 233 R--HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSY 288
KVD++S G+ L+ + T L PF+ + + + +P C S
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGLYPFE----GDNIYKLFENIGKGSYAIPGDCGPPLSD 242
Query: 289 LISRCWSSSPDRRPHFDQI 307
L+ P +R QI
Sbjct: 243 LLKGMLEYEPAKRFSIRQI 261
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 54/190 (28%), Positives = 87/190 (45%), Gaps = 22/190 (11%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEY 137
VA+K++ + + + E+ L HPHII P F ++ EY
Sbjct: 36 GHKVAVKIL---NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92
Query: 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDLKSENL 189
++GG L Y+ + ++ AR + Y H ++HRDLK EN+
Sbjct: 93 VSGGELFDYICKHG----------RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENV 142
Query: 190 LLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLW 248
LL M K+ADFG+S + S + G+ + APE+I + +VD++S G++L+
Sbjct: 143 LLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILY 202
Query: 249 ELLTALTPFD 258
LL PFD
Sbjct: 203 ALLCGTLPFD 212
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-30
Identities = 51/204 (25%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
G S + R + ++ A +++ L++ ++ E + L HP+I+
Sbjct: 21 KGAFSVVRRCVKVLAGQEYAAMIINT----KKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR----GMQYLHSQG 178
+ + +I + + GG L + + +E YS A + + + H G
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSE------ADASHCIQQILEAVLHCHQMG 130
Query: 179 ILHRDLKSENLLL---GEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRH 234
++HR+LK ENLLL + VK+ADFG++ +E + + GF GT +++PE++++ +
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 235 TKKVDVYSFGIVLWELLTALTPFD 258
K VD+++ G++L+ LL PF
Sbjct: 191 GKPVDLWACGVILYILLVGYPPFW 214
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 9e-30
Identities = 63/301 (20%), Positives = 106/301 (35%), Gaps = 54/301 (17%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+ G + + I Q AIK++++ + +E+ +EV L+ +L+HP
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER-IKTEVRLMKKLHHP 88
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVL--------------- 161
+I + C++ E GG L L+ S +
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 162 -----------------------KLALDIARGMQYLHSQGILHRDLKSENLLLG--EDMC 196
+ I + YLH+QGI HRD+K EN L +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208
Query: 197 VKVADFGISCL-----ESQCGSAKGFTGTYRWMAPEMIK--EKRHTKKVDVYSFGIVLWE 249
+K+ DFG+S + GT ++APE++ + + K D +S G++L
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 250 LLTALTPFDNMTPEQAAFAVCQKN---ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQ 306
LL PF + V K P P A L+S + + D R +
Sbjct: 269 LLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARD-LLSNLLNRNVDERFDAMR 327
Query: 307 I 307
Sbjct: 328 A 328
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-30
Identities = 77/272 (28%), Positives = 117/272 (43%), Gaps = 31/272 (11%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VA+K +S+ S M + E++ L L HPHII P ++ EY AG
Sbjct: 37 VALKFISRQLLKKS--DMHMRVER-EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AG 92
Query: 141 GSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDLKSENLLLG 192
G L Y+ +++ ++ D R ++Y H I+HRDLK ENLLL
Sbjct: 93 GELFDYIVEKK----------RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD 142
Query: 193 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELL 251
+++ VK+ADFG+S + + K G+ + APE+I K +VDV+S GIVL+ +L
Sbjct: 143 DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVML 202
Query: 252 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS-- 309
PFD+ V + +P LI R + P +R +I
Sbjct: 203 VGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260
Query: 310 -ILEGYSESLEQDPEFFSSFIPSPDHTILRCL 340
+ L E S+ D I+ L
Sbjct: 261 WFNVNLPDYLRPMEEVQGSYA---DSRIVSKL 289
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 37/208 (17%), Positives = 78/208 (37%), Gaps = 22/208 (10%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
I G ++R + + K V D + E+++L H
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVLVKKEISILNIARHR 61
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSL-----RKYLHQQEPYSVPLNLVLKLALDIARGM 171
+I+ + + +I E+++G + E V + +
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV------SYVHQVCEAL 115
Query: 172 QYLHSQGILHRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI 229
Q+LHS I H D++ EN++ +K+ +FG + + + + APE+
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175
Query: 230 KEKRHTKKVDVYSFGIVLWELLTALTPF 257
+ + D++S G +++ LL+ + PF
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPF 203
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 45/207 (21%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVS-QPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT 120
G S + ++K+ + A+K++S + E + E+ L HP+I+
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ----------KEITALKLCEGHPNIVK 70
Query: 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYS-----VPLNLVLKLALDIARGMQYLH 175
++ E L GG L + + +++ +S + + + ++H
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS-------YIMRKLVSAVSHMH 123
Query: 176 SQGILHRDLKSENLLL---GEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKE 231
G++HRDLK ENLL +++ +K+ DFG + K T + APE++ +
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183
Query: 232 KRHTKKVDVYSFGIVLWELLTALTPFD 258
+ + D++S G++L+ +L+ PF
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQ 210
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 54/189 (28%), Positives = 82/189 (43%), Gaps = 28/189 (14%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAG 140
VA+K + + + +++ E+ L HP+I+ F P II EY +G
Sbjct: 48 VAVKYIER-------GAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100
Query: 141 GSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDLKSENLLLG 192
G L + + + + D AR G+ Y HS I HRDLK EN LL
Sbjct: 101 GELYERICNAG----------RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD 150
Query: 193 ED--MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWE 249
+K+ DFG S K GT ++APE++ + K DV+S G+ L+
Sbjct: 151 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYV 210
Query: 250 LLTALTPFD 258
+L PF+
Sbjct: 211 MLVGAYPFE 219
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 52/230 (22%), Positives = 98/230 (42%), Gaps = 46/230 (20%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITF 121
G + ++ +++ + A+KL+ + EV ++ PHI+
Sbjct: 39 LGVNGKVLECFHRRTGQKCALKLLYD-----------SPKARQEVDHHWQASGGPHIVCI 87
Query: 122 VAAC----KKPPVFCIITEYLAGGSL------RKYLHQQEPYSVPLNLVLKLALDIARGM 171
+ II E + GG L R E + ++ DI +
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA------EIMRDIGTAI 141
Query: 172 QYLHSQGILHRDLKSENLLL---GEDMCVKVADFGIS------CLESQCGSAKGFTGTYR 222
Q+LHS I HRD+K ENLL +D +K+ DFG + L++ C + Y
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP-----YY- 195
Query: 223 WMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 272
+APE++ +++ K D++S G++++ LL PF + T + + + ++
Sbjct: 196 -VAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR 244
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 55/190 (28%), Positives = 91/190 (47%), Gaps = 22/190 (11%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEY 137
VA+K++++ + + ++ K E+ L HPHII P ++ EY
Sbjct: 41 GHKVAVKILNRQKIRSL--DVVGKIRR-EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97
Query: 138 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDLKSENL 189
++GG L Y+ + +L +R G+ Y H ++HRDLK EN+
Sbjct: 98 VSGGELFDYICKNG----------RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENV 147
Query: 190 LLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLW 248
LL M K+ADFG+S + S + G+ + APE+I + +VD++S G++L+
Sbjct: 148 LLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILY 207
Query: 249 ELLTALTPFD 258
LL PFD
Sbjct: 208 ALLCGTLPFD 217
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 50/212 (23%), Positives = 87/212 (41%), Gaps = 22/212 (10%)
Query: 58 FIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH 115
+ G+ + + + I K ++ A K + + + + E+A+L
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH----EIAVLELAKS 87
Query: 116 -PHIITFVAACKKPPVFCIITEYLAGGSL------RKYLHQQEPYSVPLNLVLKLALDIA 168
P +I + +I EY AGG + E + +L I
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI------RLIKQIL 141
Query: 169 RGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMA 225
G+ YLH I+H DLK +N+LL +K+ DFG+S + GT ++A
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLA 201
Query: 226 PEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257
PE++ T D+++ GI+ + LLT +PF
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 43/165 (26%), Positives = 88/165 (53%), Gaps = 9/165 (5%)
Query: 98 MLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQ--QEPYSV 155
M+EK+ +L +++ I++ A + C++ + GG +R +++ ++
Sbjct: 233 MVEKK------ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF 286
Query: 156 PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-A 214
+ I G+++LH + I++RDLK EN+LL +D V+++D G++ +
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 215 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 259
KG+ GT +MAPE++ + + VD ++ G+ L+E++ A PF
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-28
Identities = 47/209 (22%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 59 IGCKFASGRHSRIYRGIYK--QRDVAIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNH 115
I + SG ++R + K R K ++ D + +E++++ +L+H
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-------KYTVKNEISIMNQLHH 107
Query: 116 PHIITFVAACKKPPVFCIITEYLAGGSL-----RKYLHQQEPYSVPLNLVLKLALDIARG 170
P +I A + +I E+L+GG L + E + G
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI------NYMRQACEG 161
Query: 171 MQYLHSQGILHRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 228
++++H I+H D+K EN++ + VK+ DFG++ + K T T + APE+
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221
Query: 229 IKEKRHTKKVDVYSFGIVLWELLTALTPF 257
+ + D+++ G++ + LL+ L+PF
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPF 250
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNH 115
I + +G ++R + + A K V E D ++ E+ + L H
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD-------KETVRKEIQTMSVLRH 213
Query: 116 PHIITFVAACKKPPVFCIITEYLAGGSL-RKYLHQQEPYSVPLNLVLKLALDIARGMQYL 174
P ++ A + +I E+++GG L K + S + ++ + +G+ ++
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE--DEAVEYMRQVCKGLCHM 271
Query: 175 HSQGILHRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK 232
H +H DLK EN++ +K+ DFG++ S K TGT + APE+ + K
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 233 RHTKKVDVYSFGIVLWELLTALTPF 257
D++S G++ + LL+ L+PF
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLSPF 356
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 5/158 (3%)
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
L NHP + + P + E++ GG L ++ + + A +I
Sbjct: 77 LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR--ARFYAAEII 134
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAP 226
+ +LH +GI++RDLK +N+LL + K+ADFG+ C E C T GT ++AP
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM-CKEGICNGVTTATFCGTPDYIAP 193
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 264
E+++E + VD ++ G++L+E+L PF+ +
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 51/225 (22%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVS-QPEEDASLASMLEKQFTSEVALLFRL-NHPHIIT 120
G H+R+ I ++ A+K++ QP + EV +L++ H +++
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIEKQPGHI-------RSRVFREVEMLYQCQGHRNVLE 75
Query: 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYS----VPLNLVLKLALDIARGMQYLHS 176
+ ++ F ++ E + GGS+ ++H++ ++ + D+A + +LH+
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS------VVVQDVASALDFLHN 129
Query: 177 QGILHRDLKSENLLL---GEDMCVKVADFGIS---------------CLESQCGSAKGFT 218
+GI HRDLK EN+L + VK+ DF + L + CGSA
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA---- 185
Query: 219 GTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFD 258
Y MAPE+++ + K+ D++S G++L+ LL+ PF
Sbjct: 186 -EY--MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 48/161 (29%), Positives = 81/161 (50%), Gaps = 6/161 (3%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL- 163
+E +L +N P ++ + K ++ EY+AGG + +L + +S P +
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFY 146
Query: 164 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW 223
A I +YLHS +++RDLK ENLL+ + ++V DFG + G GT
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF-AKRVK-GRTWTLCGTPEA 204
Query: 224 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 264
+APE+I K + K VD ++ G++++E+ PF P Q
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL-ALDI 167
L HP + + + EYL GG L ++ + + A +I
Sbjct: 71 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFYAAEI 127
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMA 225
G+Q+LHS+GI++RDLK +N+LL +D +K+ADFG+ C E+ G AK T GT ++A
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGM-CKENMLGDAKTNTFCGTPDYIA 186
Query: 226 PEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCP 283
PE++ +++ VD +SFG++L+E+L +PF E+ + P P
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----LFHSIRMDNPFYPRWLE 242
Query: 284 KAFSYLISRCWSSSPDRR 301
K L+ + + P++R
Sbjct: 243 KEAKDLLVKLFVREPEKR 260
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 52/196 (26%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 110 LFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR 169
L HP + A + C + EY GG L +L ++ ++ +I
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER--ARFYGAEIVS 116
Query: 170 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE--SQCGSAKGFTGTYRWMAPE 227
++YLHS+ +++RD+K ENL+L +D +K+ DFG+ C E S + K F GT ++APE
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-CKEGISDGATMKTFCGTPEYLAPE 175
Query: 228 MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKA 285
++++ + + VD + G+V++E++ PF N E+ + + P T
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFELILMEEIRFPRTLSPE 231
Query: 286 FSYLISRCWSSSPDRR 301
L++ P +R
Sbjct: 232 AKSLLAGLLKKDPKQR 247
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 7e-27
Identities = 45/161 (27%), Positives = 82/161 (50%), Gaps = 7/161 (4%)
Query: 98 MLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPL 157
+ E+ S V+ + P I+ A P I + + GG L +L Q +S
Sbjct: 237 LNERIMLSLVS---TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD 293
Query: 158 NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGF 217
+ A +I G++++H++ +++RDLK N+LL E V+++D G++C +
Sbjct: 294 --MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHAS 350
Query: 218 TGTYRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLTALTPF 257
GT+ +MAPE++ K + D +S G +L++LL +PF
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 40/158 (25%), Positives = 80/158 (50%), Gaps = 5/158 (3%)
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
NHP ++ + + + EY+ GG L ++ +Q + +I+
Sbjct: 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH--ARFYSAEIS 120
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAP 226
+ YLH +GI++RDLK +N+LL + +K+ D+G+ C E T GT ++AP
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNYIAP 179
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 264
E+++ + + VD ++ G++++E++ +PFD +
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 45/199 (22%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNHPHIITF 121
GR ++++ +A K++ + +D +++ +E++++ +L+H ++I
Sbjct: 99 GGRFGQVHKCEETATGLKLAAKIIKTRGMKD-------KEEVKNEISVMNQLDHANLIQL 151
Query: 122 VAACKKPPVFCIITEYLAGGSL-RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 180
A + ++ EY+ GG L + + + + + I G++++H IL
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTE--LDTILFMKQICEGIRHMHQMYIL 209
Query: 181 HRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 238
H DLK EN+L + +K+ DFG++ K GT ++APE++ +
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPT 269
Query: 239 DVYSFGIVLWELLTALTPF 257
D++S G++ + LL+ L+PF
Sbjct: 270 DMWSVGVIAYMLLSGLSPF 288
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 6/161 (3%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL- 163
E +L + HP II + +I +Y+ GG L L + + + P V K
Sbjct: 55 DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---VAKFY 111
Query: 164 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW 223
A ++ ++YLHS+ I++RDLK EN+LL ++ +K+ DFG + GT +
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVTYTLCGTPDY 169
Query: 224 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 264
+APE++ K + K +D +SFGI+++E+L TPF + +
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 47/153 (30%), Positives = 82/153 (53%), Gaps = 5/153 (3%)
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
L P + + + + EY+ GG L ++ Q + P + A +IA
Sbjct: 74 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH--AVFYAAEIA 131
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAP 226
G+ +L S+GI++RDLK +N++L + +K+ADFG+ C E+ T GT ++AP
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM-CKENIWDGVTTKTFCGTPDYIAP 190
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 259
E+I + + K VD ++FG++L+E+L PF+
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 40/162 (24%), Positives = 80/162 (49%), Gaps = 5/162 (3%)
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
NHP ++ + + + EY+ GG L ++ +Q + +I+
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH--ARFYSAEIS 163
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAP 226
+ YLH +GI++RDLK +N+LL + +K+ D+G+ C E T GT ++AP
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNYIAP 222
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 268
E+++ + + VD ++ G++++E++ +PFD +
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 33/209 (15%)
Query: 65 SGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITF 121
G + ++ + K Q A+K++ + EV L +R PHI+
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKMLQD-----------CPKARREVELHWRASQCPHIVRI 120
Query: 122 VAAC----KKPPVFCIITEYLAGGSL------RKYLHQQEPYSVPLNLVLKLALDIARGM 171
V I+ E L GG L R E + ++ I +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS------EIMKSIGEAI 174
Query: 172 QYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 228
QYLHS I HRD+K ENLL + +K+ DFG + + S T ++APE+
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234
Query: 229 IKEKRHTKKVDVYSFGIVLWELLTALTPF 257
+ +++ K D++S G++++ LL PF
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPF 263
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 6e-26
Identities = 47/153 (30%), Positives = 82/153 (53%), Gaps = 5/153 (3%)
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
L P + + + + EY+ GG L ++ Q + P + A +IA
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH--AVFYAAEIA 452
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAP 226
G+ +L S+GI++RDLK +N++L + +K+ADFG+ C E+ T GT ++AP
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM-CKENIWDGVTTKTFCGTPDYIAP 511
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 259
E+I + + K VD ++FG++L+E+L PF+
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 50/160 (31%), Positives = 82/160 (51%), Gaps = 21/160 (13%)
Query: 110 LFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR 169
L +NHP I+ A + +I ++L GG L L ++ + +
Sbjct: 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV----------MFTEEDVK 129
Query: 170 --------GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--G 219
+ +LHS GI++RDLK EN+LL E+ +K+ DFG+ ES K ++ G
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL-SKESIDHEKKAYSFCG 188
Query: 220 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 259
T +MAPE++ + HT+ D +SFG++++E+LT PF
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-26
Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 21/160 (13%)
Query: 110 LFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR 169
L + HP I+ + A + +I EYL+GG L L ++ D A
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG----------IFMEDTAC 124
Query: 170 --------GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--G 219
+ +LH +GI++RDLK EN++L VK+ DFG+ C ES T G
Sbjct: 125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL-CKESIHDGTVTHTFCG 183
Query: 220 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 259
T +MAPE++ H + VD +S G +++++LT PF
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 46/157 (29%), Positives = 83/157 (52%), Gaps = 4/157 (2%)
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
+E +L HP + + + C + EY GG L +L ++ +S
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR--ARFYG 254
Query: 165 LDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGTYR 222
+I + YLHS+ +++RDLK ENL+L +D +K+ DFG+ + G+ K F GT
Sbjct: 255 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 314
Query: 223 WMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 259
++APE++++ + + VD + G+V++E++ PF N
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 7/159 (4%)
Query: 109 LLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL-ALDI 167
LL + HP ++ + + + +Y+ GG L +L ++ + P + A +I
Sbjct: 92 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEI 148
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMA 225
A + YLHS I++RDLK EN+LL + + DFG+ C E+ ++ T GT ++A
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL-CKENIEHNSTTSTFCGTPEYLA 207
Query: 226 PEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 264
PE++ ++ + + VD + G VL+E+L L PF + +
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 52/177 (29%), Positives = 93/177 (52%), Gaps = 10/177 (5%)
Query: 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL-ALDIARGMQYLHSQGILHRDLKSENLL 190
+I +Y+ GG L +L Q+E ++ +++ +I +++LH GI++RD+K EN+L
Sbjct: 135 HLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191
Query: 191 LGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIV 246
L + V + DFG+S + + A F GT +MAP++++ H K VD +S G++
Sbjct: 192 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251
Query: 247 LWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYLISRCWSSSPDRR 301
++ELLT +PF + + + ++ + PP P LI R P +R
Sbjct: 252 MYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 11/169 (6%)
Query: 103 FTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLK 162
F E ++ N P ++ A + ++ EY+ GG L ++ Y VP
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARF 172
Query: 163 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTG 219
++ + +HS G +HRD+K +N+LL + +K+ADFG +C++ G
Sbjct: 173 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNKEGMVRCDTAVG 231
Query: 220 TYRWMAPEMIKEK----RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 264
T +++PE++K + + ++ D +S G+ L+E+L TPF +
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-23
Identities = 39/182 (21%), Positives = 76/182 (41%), Gaps = 28/182 (15%)
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV 160
F E +L + I A + ++ EY GG L L +
Sbjct: 106 SCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE-------- 157
Query: 161 LKLALDIAR--------GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212
++ ++AR + +H G +HRD+K +N+LL +++ADFG SCL+ +
Sbjct: 158 -RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG-SCLKLRAD 215
Query: 213 S---AKGFTGTYRWMAPEMIKEK-------RHTKKVDVYSFGIVLWELLTALTPFDNMTP 262
+ GT +++PE+++ + + D ++ G+ +E+ TPF +
Sbjct: 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275
Query: 263 EQ 264
+
Sbjct: 276 AE 277
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 9e-23
Identities = 42/197 (21%), Positives = 82/197 (41%), Gaps = 24/197 (12%)
Query: 103 FTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLK 162
F E +L + I T A + ++ +Y GG L L + E +
Sbjct: 121 FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFED---------R 171
Query: 163 LALDIAR--------GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 214
L ++AR + +H +HRD+K +N+L+ + +++ADFG + G+
Sbjct: 172 LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231
Query: 215 KGFT--GTYRWMAPEMIKEK-----RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF 267
+ GT +++PE+++ R+ + D +S G+ ++E+L TPF + +
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 291
Query: 268 AVCQKNARPPVPPTCPK 284
+ R P
Sbjct: 292 KIMNHKERFQFPTQVTD 308
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-22
Identities = 50/205 (24%), Positives = 79/205 (38%), Gaps = 46/205 (22%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITF 121
G + ++ + K+ A+K++ + EV L +R PHI+
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKMLQD-----------CPKARREVELHWRASQCPHIVRI 76
Query: 122 VAAC----KKPPVFCIITEYLAGGSL--RKYLHQQEPYSVPLNLVLKLALDIARGMQYLH 175
V I+ E L GG L R + ++ ++ I +QYLH
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE--REASEIMKSIGEAIQYLH 134
Query: 176 SQGILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK 232
S I HRD+K ENLL + +K+ DFG A E EK
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETTGEK 174
Query: 233 RHTKKVDVYSFGIVLWELLTALTPF 257
+ K D++S G++++ LL PF
Sbjct: 175 -YDKSCDMWSLGVIMYILLCGYPPF 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 72/274 (26%), Positives = 111/274 (40%), Gaps = 74/274 (27%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFTS-EVALLFRLNHPHIIT----FVAACKKPPVFCI 133
VAIK V Q +K+F + E+ ++ +L+H +I+ F ++ +K +
Sbjct: 80 ELVAIKKVLQ-----------DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128
Query: 134 --ITEYLAGGSLRKYL--HQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 189
+ +Y+ ++ + + + ++P+ V + R + Y+HS GI HRD+K +NL
Sbjct: 129 NLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 187
Query: 190 LLGEDMCV-KVADFGISCLESQCGSAKGFTGT-----------YRWMAPE-MIKEKRHTK 236
LL D V K+ DF GSAK YR APE + +T
Sbjct: 188 LLDPDTAVLKLCDF---------GSAKQLVRGEPNVSYICSRYYR--APELIFGATDYTS 236
Query: 237 KVDVYSFGIVLWELLT--AL------------------TP----FDNMTPEQAAFAVCQK 272
+DV+S G VL ELL + TP M P F Q
Sbjct: 237 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 296
Query: 273 NARPP----VPPTCPKAFSYLISRCWSSSPDRRP 302
A P P T P+A + L SR +P R
Sbjct: 297 KAHPWTKVFRPRTPPEAIA-LCSRLLEYTPTARL 329
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 6e-21
Identities = 49/194 (25%), Positives = 92/194 (47%), Gaps = 22/194 (11%)
Query: 76 YKQRD------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHIITFVAACKK 127
+K ++ VA+K V ++D + S ++ E+ LL L H +I+
Sbjct: 19 FKAKNRETHEIVALKRVRLDDDDEGVPS------SALREICLLKELKHKNIVRLHDVLHS 72
Query: 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 187
++ E+ L+KY + +V + +G+ + HS+ +LHRDLK +
Sbjct: 73 DKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQ 130
Query: 188 NLLLGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSF 243
NLL+ + +K+A+FG++ + +C SA+ T YR P+ + K ++ +D++S
Sbjct: 131 NLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDVLFGAKLYSTSIDMWSA 188
Query: 244 GIVLWELLTALTPF 257
G + EL A P
Sbjct: 189 GCIFAELANAGRPL 202
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-20
Identities = 52/188 (27%), Positives = 97/188 (51%), Gaps = 21/188 (11%)
Query: 76 YKQRD-----VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHIITFVAACKKP 128
YK +D VA+K + ED + S T+ E++LL L+HP+I++ +
Sbjct: 38 YKAKDSQGRIVALKRIRLDAEDEGIPS------TAIREISLLKELHHPNIVSLIDVIHSE 91
Query: 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 188
++ E++ L+K L + + + + + RG+ + H ILHRDLK +N
Sbjct: 92 RCLTLVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQN 149
Query: 189 LLLGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFG 244
LL+ D +K+ADFG++ + + + + T YR AP+ ++ K+++ VD++S G
Sbjct: 150 LLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDVLMGSKKYSTSVDIWSIG 207
Query: 245 IVLWELLT 252
+ E++T
Sbjct: 208 CIFAEMIT 215
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 30/198 (15%)
Query: 76 YKQRD------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLN---HPHIIT---- 120
YK RD VA+K V P + ++ EVALL RL HP+++
Sbjct: 26 YKARDPHSGHFVALKSVRVPNGGGGGGGL---PISTVREVALLRRLEAFEHPNVVRLMDV 82
Query: 121 -FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 179
+ + ++ E++ LR YL + P +P + L RG+ +LH+ I
Sbjct: 83 CATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCI 141
Query: 180 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT-----YRWMAPEMIKEKRH 234
+HRDLK EN+L+ VK+ADFG L T YR APE++ + +
Sbjct: 142 VHRDLKPENILVTSGGTVKLADFG---LARIYSYQMALTPVVVTLWYR--APEVLLQSTY 196
Query: 235 TKKVDVYSFGIVLWELLT 252
VD++S G + E+
Sbjct: 197 ATPVDMWSVGCIFAEMFR 214
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 41/208 (19%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
SG + R+VAIK +S+P ++ + A K+ E+ L+ +NH +II
Sbjct: 72 SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMKCVNHKNII--- 124
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVP------LNLVLKLALD---------- 166
++ + +L ++ Q+ Y V L V+++ LD
Sbjct: 125 ---------SLLNVFTPQKTLEEF---QDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 172
Query: 167 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT--YRWM 224
+ G+++LHS GI+HRDLK N+++ D +K+ DFG++ + T YR
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR-- 230
Query: 225 APEMIKEKRHTKKVDVYSFGIVLWELLT 252
APE+I + + VD++S G ++ E++
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVR 258
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 2e-20
Identities = 46/188 (24%), Positives = 90/188 (47%), Gaps = 21/188 (11%)
Query: 76 YKQRD-----VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHIITFVAACKKP 128
YK ++ A+K + +ED + S T+ E+++L L H +I+
Sbjct: 19 YKAQNNYGETFALKKIRLEKEDEGIPS------TTIREISILKELKHSNIVKLYDVIHTK 72
Query: 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 188
++ E+L L+K L + L + G+ Y H + +LHRDLK +N
Sbjct: 73 KRLVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQN 130
Query: 189 LLLGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFG 244
LL+ + +K+ADFG++ + + + + T YR AP+ ++ K+++ +D++S G
Sbjct: 131 LLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDVLMGSKKYSTTIDIWSVG 188
Query: 245 IVLWELLT 252
+ E++
Sbjct: 189 CIFAEMVN 196
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 52/192 (27%), Positives = 96/192 (50%), Gaps = 37/192 (19%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEY 137
+R+VAIK +S+P ++ + A K+ E+ L+ +NH +II ++ +
Sbjct: 50 ERNVAIKKLSRPFQNQTHA----KRAYRELVLMKCVNHKNII------------GLLNVF 93
Query: 138 LAGGSLRKYLHQQEPYSVP------LNLVLKLALD----------IARGMQYLHSQGILH 181
SL ++ Q+ Y V L V+++ LD + G+++LHS GI+H
Sbjct: 94 TPQKSLEEF---QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 150
Query: 182 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWM-APEMIKEKRHTKKVDV 240
RDLK N+++ D +K+ DFG++ + T R+ APE+I + + VD+
Sbjct: 151 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT-RYYRAPEVILGMGYKENVDI 209
Query: 241 YSFGIVLWELLT 252
+S G ++ E++
Sbjct: 210 WSVGCIMGEMIK 221
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 6e-20
Identities = 49/194 (25%), Positives = 87/194 (44%), Gaps = 45/194 (23%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTS-EVALLFRLNHPHIIT----FVAACKKPPVFCI-- 133
VAIK V + +K+F + E+ ++ + HP+++ F + K +
Sbjct: 67 VAIKKV-----------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115
Query: 134 ITEYLAGGSLRKYL--HQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 191
+ EY+ ++ + + + ++P+ L+ + R + Y+HS GI HRD+K +NLLL
Sbjct: 116 VLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL 174
Query: 192 -GEDMCVKVADFGISCLESQCGSAKGFTGT-----------YRWMAPE-MIKEKRHTKKV 238
+K+ DF GSAK YR APE + +T +
Sbjct: 175 DPPSGVLKLIDF---------GSAKILIAGEPNVSYICSRYYR--APELIFGATNYTTNI 223
Query: 239 DVYSFGIVLWELLT 252
D++S G V+ EL+
Sbjct: 224 DIWSTGCVMAELMQ 237
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 7e-20
Identities = 48/196 (24%), Positives = 90/196 (45%), Gaps = 36/196 (18%)
Query: 76 YKQRD------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHIITFVAACKK 127
+K R+ VAIK + E+D + + E+ +L +L HP+++ + ++
Sbjct: 20 FKCRNRDTGQIVAIKKFLESEDDPVIKK------IALREIRMLKQLKHPNLVNLLEVFRR 73
Query: 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 187
++ EY ++ L + VP +LV + + + + H +HRD+K E
Sbjct: 74 KRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPE 131
Query: 188 NLLLGEDMCVKVADFGISCLESQCGSAKGFTG---TY------RWM-APEMI-KEKRHTK 236
N+L+ + +K+ DFG A+ TG Y RW +PE++ + ++
Sbjct: 132 NILITKHSVIKLCDFGF---------ARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGP 182
Query: 237 KVDVYSFGIVLWELLT 252
VDV++ G V ELL+
Sbjct: 183 PVDVWAIGCVFAELLS 198
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 8e-20
Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 34/199 (17%)
Query: 76 YKQRD-------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLN---HPHIIT--- 120
+K RD VA+K V + + ++ EVA+L L HP+++
Sbjct: 28 FKARDLKNGGRFVALKRVRVQTGEEGMPL------STIREVAVLRHLETFEHPNVVRLFD 81
Query: 121 --FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 178
V+ + ++ E++ L YL + VP + + + RG+ +LHS
Sbjct: 82 VCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR 140
Query: 179 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT-----YRWMAPEMIKEKR 233
++HRDLK +N+L+ +K+ADFG L T YR APE++ +
Sbjct: 141 VVHRDLKPQNILVTSSGQIKLADFG---LARIYSFQMALTSVVVTLWYR--APEVLLQSS 195
Query: 234 HTKKVDVYSFGIVLWELLT 252
+ VD++S G + E+
Sbjct: 196 YATPVDLWSVGCIFAEMFR 214
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 42/239 (17%)
Query: 41 EIKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ----RDVAIKLVSQPEEDASLA 96
++K E E D+ + + GCK G + +Y+ K +D A+K + S++
Sbjct: 8 KVKLSSERERVEDLFE-YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMS 64
Query: 97 SMLEKQFTSEVALLFRLNHPHIITF--VAACKKPPVFCIITEYLAGGSLRKYLH------ 148
+ E+ALL L HP++I+ V ++ +Y L +
Sbjct: 65 AC------REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASK 117
Query: 149 -QQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM----CVKVADFG 203
++P +P +V L I G+ YLH+ +LHRDLK N+L+ + VK+AD G
Sbjct: 118 ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177
Query: 204 ISCLESQCGS-AKGFTGT--------YRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT 252
S K YR APE ++ + +TK +D+++ G + ELLT
Sbjct: 178 ---FARLFNSPLKPLADLDPVVVTFWYR--APELLLGARHYTKAIDIWAIGCIFAELLT 231
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 77 KQRDVAIKLVSQPEEDASLASMLEKQFTS-----EVALLFRLNHPHIITF--VAACKKPP 129
+ VAIK V D ++L F E+ LL +HP+I+ + + P
Sbjct: 45 EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP 104
Query: 130 VFC---IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALD--------IARGMQYLHSQG 178
++TE + L + +H Q + ++ I G+ LH G
Sbjct: 105 AMHKLYLVTELM-RTDLAQVIHDQR---------IVISPQHIQYFMYHILLGLHVLHEAG 154
Query: 179 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT--YRWMAPE-MIKEKRHT 235
++HRDL N+LL ++ + + DF ++ ++ + + YR APE +++ K T
Sbjct: 155 VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR--APELVMQFKGFT 212
Query: 236 KKVDVYSFGIVLWELLT 252
K VD++S G V+ E+
Sbjct: 213 KLVDMWSAGCVMAEMFN 229
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 39/209 (18%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
G + + VAIK +S P E + ++ E+ +L R H +II
Sbjct: 37 EGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYC----QRTLREIKILLRFRHENIIGIN 91
Query: 123 AACKKPPVFC------IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALD--------IA 168
+ P I+ + + L K L Q L+ D I
Sbjct: 92 DIIR-APTIEQMKDVYIVQDLM-ETDLYKLLKTQ-----------HLSNDHICYFLYQIL 138
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RWM- 224
RG++Y+HS +LHRDLK NLLL +K+ DFG++ + GF Y RW
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 225 APE-MIKEKRHTKKVDVYSFGIVLWELLT 252
APE M+ K +TK +D++S G +L E+L+
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLS 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 35/191 (18%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC----- 132
VAIK + +P + A K+ E+ LL + H ++I +
Sbjct: 50 GAKVAIKKLYRPFQSELFA----KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105
Query: 133 -IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALD--------IARGMQYLHSQGILHRD 183
++ ++ G L K + + KL D + +G++Y+H+ GI+HRD
Sbjct: 106 YLVMPFM-GTDLGKLMKHE-----------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRD 153
Query: 184 LKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWM-APE-MIKEKRHTKKVDVY 241
LK NL + ED +K+ DFG++ G+ T RW APE ++ R+T+ VD++
Sbjct: 154 LKPGNLAVNEDCELKILDFGLA--RQADSEMTGYVVT-RWYRAPEVILNWMRYTQTVDIW 210
Query: 242 SFGIVLWELLT 252
S G ++ E++T
Sbjct: 211 SVGCIMAEMIT 221
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 24/199 (12%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
SG + + I K+ VAIK +S+P + A K+ E+ LL + H ++I +
Sbjct: 34 SGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA----KRAYRELLLLKHMQHENVIGLL 89
Query: 123 AACKKPPVFC------IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLAL-DIARGMQYLH 175
++ ++ L+K + + ++ + + +G++Y+H
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK-----FSEEKIQYLVYQMLKGLKYIH 143
Query: 176 SQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW-MAPE-MIKEKR 233
S G++HRDLK NL + ED +K+ DFG++ G+ T RW APE ++
Sbjct: 144 SAGVVHRDLKPGNLAVNEDCELKILDFGLA--RHADAEMTGYVVT-RWYRAPEVILSWMH 200
Query: 234 HTKKVDVYSFGIVLWELLT 252
+ + VD++S G ++ E+LT
Sbjct: 201 YNQTVDIWSVGCIMAEMLT 219
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 5e-19
Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 36/196 (18%)
Query: 76 YKQRD------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHIITFVAACKK 127
K R+ VAIK + ++D + + E+ LL +L H +++ + CKK
Sbjct: 42 MKCRNKDTGRIVAIKKFLESDDDKMVKK------IAMREIKLLKQLRHENLVNLLEVCKK 95
Query: 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 187
+ ++ E++ ++ L + P + +V K I G+ + HS I+HRD+K E
Sbjct: 96 KKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPE 153
Query: 188 NLLLGEDMCVKVADFGISCLESQCGSAKGFTG---TY------RWM-APEMI-KEKRHTK 236
N+L+ + VK+ DFG A+ Y RW APE++ + ++ K
Sbjct: 154 NILVSQSGVVKLCDFGF---------ARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGK 204
Query: 237 KVDVYSFGIVLWELLT 252
VDV++ G ++ E+
Sbjct: 205 AVDVWAIGCLVTEMFM 220
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 7e-19
Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 62 KFASGRHSRIYRGIYKQ--RDVAIKLVS-QPEEDASLASMLEKQFTS--EVALLFRLNHP 116
K G ++ +Y+G K VA+K + + EE A T+ EV+LL L H
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP--------CTAIREVSLLKDLKHA 60
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+I+T ++ EYL L++YL + ++ V + RG+ Y H
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIKEK 232
Q +LHRDLK +NLL+ E +K+ADFG++ + ++ + T YR P+ ++
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--PPDILLGST 176
Query: 233 RHTKKVDVYSFGIVLWELLT 252
++ ++D++ G + +E+ T
Sbjct: 177 DYSTQIDMWGVGCIFYEMAT 196
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 9e-19
Identities = 59/302 (19%), Positives = 97/302 (32%), Gaps = 102/302 (33%)
Query: 81 VAIKLVSQPEEDASLASMLEKQFTS-EVALLFRLNHPHIIT----FVAACKKPPVFCIIT 135
A+K V Q + ++ + E+ ++ L+H +II F + P
Sbjct: 35 FALKKVLQ-----------DPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83
Query: 136 EYLAGGSLRKYLHQQEPYSVP--------LNLVL-------------------KLALD-- 166
+ + SV LN+++ + ++
Sbjct: 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLI 143
Query: 167 ------IARGMQYLHSQGILHRDLKSENLLLGEDMCV-KVADFGISCLESQCGSAKGFTG 219
+ R + ++HS GI HRD+K +NLL+ K+ DF GSAK
Sbjct: 144 SIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF---------GSAKKLIP 194
Query: 220 T-----------YRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT--AL----------- 254
+ YR APE M+ +T +D++S G V EL+ L
Sbjct: 195 SEPSVAYICSRFYR--APELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLV 252
Query: 255 -------TP----FDNMTPEQAAFAVCQKNARP---PVPPTCPKAFSYLISRCWSSSPDR 300
TP M P A+ +P P L+ + PD
Sbjct: 253 RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312
Query: 301 RP 302
R
Sbjct: 313 RI 314
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 37/206 (17%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
SG + + + VA+K +S+P + A K+ E+ LL + H ++I +
Sbjct: 39 SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA----KRTYRELRLLKHMKHENVIGLL 94
Query: 123 AACKKPPVFC------IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALD--------IA 168
++T + G L + Q KL D I
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----------KLTDDHVQFLIYQIL 142
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW-MAPE 227
RG++Y+HS I+HRDLK NL + ED +K+ DFG++ G+ T RW APE
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTADEMTGYVAT-RWYRAPE 199
Query: 228 -MIKEKRHTKKVDVYSFGIVLWELLT 252
M+ + + VD++S G ++ ELLT
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLT 225
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 62/269 (23%), Positives = 100/269 (37%), Gaps = 51/269 (18%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC----- 132
+R VAIK + + ED K+ E+A+L RLNH H++ + V
Sbjct: 78 KRVVAIKKILRVFEDLIDC----KRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133
Query: 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 192
++ E +K + + L ++ G++Y+HS GILHRDLK N L+
Sbjct: 134 VVLEIA-DSDFKKLFRTPVYLTE--LHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN 190
Query: 193 EDMCVKVADFG----ISCLESQCGSAKGFTGTY-----------------------RWM- 224
+D VKV DFG + E+ RW
Sbjct: 191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR 250
Query: 225 APE-MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283
APE ++ ++ +T+ +DV+S G + ELL + ++ P P +
Sbjct: 251 APELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR----------GPLFPGSSC 300
Query: 284 KAFSYLISRCWSSSPDRRPHFDQIVSILE 312
S R + DQ+ I
Sbjct: 301 FPLSPDQKAGNDFKFHTRGNRDQLNVIFN 329
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 40/155 (25%), Positives = 79/155 (50%), Gaps = 11/155 (7%)
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNL----VL 161
E++L+ L H +I+ ++ E++ L+KY+ + + P L V
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111
Query: 162 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS---CLESQCGSAKGFT 218
+ +G+ + H ILHRDLK +NLL+ + +K+ DFG++ + S++ T
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 219 GTYRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT 252
YR AP+ ++ + ++ +D++S G +L E++T
Sbjct: 172 LWYR--APDVLMGSRTYSTSIDIWSCGCILAEMIT 204
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 59/196 (30%), Positives = 90/196 (45%), Gaps = 33/196 (16%)
Query: 76 YKQRD------VAIK---LVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHIITFVAA 124
YK RD VAIK L + E + T+ E+ LL L+HP+II + A
Sbjct: 27 YKARDKNTNQIVAIKKIKLGHRSEAKDGINR------TALREIKLLQELSHPNIIGLLDA 80
Query: 125 CKKPPVFCIITEYLAGGSLRKYL-HQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRD 183
++ +++ L + + + L +G++YLH ILHRD
Sbjct: 81 FGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSH--IKAYMLMTLQGLEYLHQHWILHRD 137
Query: 184 LKSENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGT-----YRWMAPEMI-KEKRHTK 236
LK NLLL E+ +K+ADFG L GS + +T YR APE++ + +
Sbjct: 138 LKPNNLLLDENGVLKLADFG---LAKSFGSPNRAYTHQVVTRWYR--APELLFGARMYGV 192
Query: 237 KVDVYSFGIVLWELLT 252
VD+++ G +L ELL
Sbjct: 193 GVDMWAVGCILAELLL 208
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 8e-18
Identities = 55/194 (28%), Positives = 84/194 (43%), Gaps = 30/194 (15%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH------PHIITFVAACKKPPVF 131
+ VA+K+V + +Q E+ +L L ++I + F
Sbjct: 122 HQHVALKMV------RNEKRFH-RQAAEEIRILEHLRKQDKDNTMNVIHMLEN------F 168
Query: 132 ------CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 185
C+ E L +L + + + + L LV K A I + + LH I+H DLK
Sbjct: 169 TFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLK 227
Query: 186 SENLLLGE--DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSF 243
EN+LL + +KV DFG SC E Q + YR APE+I R+ +D++S
Sbjct: 228 PENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--APEVILGARYGMPIDMWSL 285
Query: 244 GIVLWELLTALTPF 257
G +L ELLT
Sbjct: 286 GCILAELLTGYPLL 299
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 8e-18
Identities = 47/204 (23%), Positives = 87/204 (42%), Gaps = 32/204 (15%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-----------HPHII----TFV 122
VA+K+V + + E+ LL R+N HI+ F
Sbjct: 44 NTHVAMKIVRG-------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILH 181
++ E L G +L + + E +PL V +++ + G+ Y+H + GI+H
Sbjct: 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIH 155
Query: 182 RDLKSENLLLGE------DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 235
D+K EN+L+ + +K+AD G +C + + T YR +PE++
Sbjct: 156 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR--SPEVLLGAPWG 213
Query: 236 KKVDVYSFGIVLWELLTALTPFDN 259
D++S +++EL+T F+
Sbjct: 214 CGADIWSTACLIFELITGDFLFEP 237
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 8e-18
Identities = 57/283 (20%), Positives = 96/283 (33%), Gaps = 83/283 (29%)
Query: 79 RDVAIKLVSQPEEDASLASMLEKQFT----SEVALLFRLNHPHIIT----FVAACKKPPV 130
VAIK V Q + +F + L L+HP+I+ F ++
Sbjct: 49 MSVAIKKVIQ-----------DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97
Query: 131 ---FCIITEYLAGGSLRKYLHQQEPYSVPLNLVL-KLAL-DIARGMQYLH--SQGILHRD 183
++ EY+ +L + V +L K+ L + R + LH S + HRD
Sbjct: 98 DIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRD 156
Query: 184 LKSENLLLGEDMCV-KVADFGISCLESQCGSAKGFTGT-----------YRWMAPE-MIK 230
+K N+L+ E K+ DF GSAK + + YR APE +
Sbjct: 157 IKPHNVLVNEADGTLKLCDF---------GSAKKLSPSEPNVAYICSRYYR--APELIFG 205
Query: 231 EKRHTKKVDVYSFGIVLWELLT--AL------------------TP----FDNMTPEQAA 266
+ +T VD++S G + E++ + P + P
Sbjct: 206 NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTD 265
Query: 267 FAVCQKNARP-------PVPPTCPKAFSYLISRCWSSSPDRRP 302
+ P +A+ L+S P+ R
Sbjct: 266 VDLYNSKGIPWSNVFSDHSLKDAKEAYD-LLSALLQYLPEERM 307
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 60/271 (22%), Positives = 98/271 (36%), Gaps = 62/271 (22%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC----- 132
+++VAIK V++ ED K+ E+ +L RL +II +
Sbjct: 51 EKNVAIKKVNRMFEDLIDC----KRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106
Query: 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALD--------IARGMQYLHSQGILHRDL 184
I+ E L+K L + + G ++H GI+HRDL
Sbjct: 107 IVLEIA-DSDLKKLFKTPIF----------LTEEHIKTILYNLLLGENFIHESGIIHRDL 155
Query: 185 KSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY---------------------R 222
K N LL +D VKV DFG++ + S+ + R
Sbjct: 156 KPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR 215
Query: 223 WM-APE-MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP 280
W APE ++ ++ +TK +D++S G + ELL L N + P P
Sbjct: 216 WYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR----------FPLFPG 265
Query: 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 311
+ S + R + I +I+
Sbjct: 266 SSCFPLSPDRNSKKVHEKSNRDQLNIIFNII 296
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 53/272 (19%), Positives = 94/272 (34%), Gaps = 56/272 (20%)
Query: 78 QRDVAIKLVS-QPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITE 136
+ VAIK + + K E+ ++ RL+H +I+
Sbjct: 36 DKRVAIKKIVLTDPQSV-------KHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88
Query: 137 YLAGGSLRKYLHQQEPYSVPLNLVLK---LALD--------IARGMQYLHSQGILHRDLK 185
Y+ QE L VL+ L + + RG++Y+HS +LHRDLK
Sbjct: 89 GSLTELNSVYI-VQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLK 147
Query: 186 SENLLLGEDMC-VKVADFGISCLESQCGSAKGFTGTY---RWM-APE-MIKEKRHTKKVD 239
NL + + +K+ DFG++ + S KG +W +P ++ +TK +D
Sbjct: 148 PANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAID 207
Query: 240 VYSFGIVLWELLTALTPF---DNM-----------TPEQAAFAVCQKNAR------PPVP 279
+++ G + E+LT T F + + P
Sbjct: 208 MWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEP 267
Query: 280 P---------TCPKAFSYLISRCWSSSPDRRP 302
+A + + + SP R
Sbjct: 268 HKPLTQLLPGISREAVD-FLEQILTFSPMDRL 298
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-17
Identities = 41/202 (20%), Positives = 85/202 (42%), Gaps = 36/202 (17%)
Query: 76 YKQRD------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHIIT------- 120
+K R VA+K V E T+ E+ +L L H +++
Sbjct: 34 FKARHRKTGQKVALKKVLMENEKEGFP------ITALREIKILQLLKHENVVNLIEICRT 87
Query: 121 -FVAACKKPPVFCIITEYLAGGSLRKYL-HQQEPYSVPLNLVLKLALDIARGMQYLHSQG 178
+ ++ ++ L L + +++ + ++ + G+ Y+H
Sbjct: 88 KASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSE--IKRVMQMLLNGLYYIHRNK 144
Query: 179 ILHRDLKSENLLLGEDMCVKVADFGI--SCLESQCGSAKGFTGT-----YRWMAPEMI-K 230
ILHRD+K+ N+L+ D +K+ADFG+ + ++ +T YR PE++
Sbjct: 145 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR--PPELLLG 202
Query: 231 EKRHTKKVDVYSFGIVLWELLT 252
E+ + +D++ G ++ E+ T
Sbjct: 203 ERDYGPPIDLWGAGCIMAEMWT 224
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 28/194 (14%)
Query: 76 YKQRD------VAIKLVSQPEEDASLASMLEKQFTS--EVALLFRLNHPHIITFVAACKK 127
YK D VAIK + E+ + T+ EV+LL L H +II +
Sbjct: 51 YKAIDTVTNETVAIKRIRLEHEEEGVPG------TAIREVSLLKELQHRNIIELKSVIHH 104
Query: 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 187
+I EY L+KY+ + S + ++ + G+ + HS+ LHRDLK +
Sbjct: 105 NHRLHLIFEYAEN-DLKKYMDKNPDVS--MRVIKSFLYQLINGVNFCHSRRCLHRDLKPQ 161
Query: 188 NLLL-----GEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKV 238
NLLL E +K+ DFG++ + + + + T YR PE ++ + ++ V
Sbjct: 162 NLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR--PPEILLGSRHYSTSV 219
Query: 239 DVYSFGIVLWELLT 252
D++S + E+L
Sbjct: 220 DIWSIACIWAEMLM 233
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 51/201 (25%), Positives = 81/201 (40%), Gaps = 44/201 (21%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC----- 132
VAIK + P + A + E+ +L H +IIT + P F
Sbjct: 36 GEIVAIKKIE-PFDKPLFA----LRTLREIKILKHFKHENIITIFNIQR-PDSFENFNEV 89
Query: 133 -IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALD--------IARGMQYLHSQGILHRD 183
II E + L + + Q L+ D R ++ LH ++HRD
Sbjct: 90 YIIQELM-QTDLHRVISTQ-----------MLSDDHIQYFIYQTLRAVKVLHGSNVIHRD 137
Query: 184 LKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWM----------APE-MIKE 231
LK NLL+ + +KV DFG++ ++ TG M APE M+
Sbjct: 138 LKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS 197
Query: 232 KRHTKKVDVYSFGIVLWELLT 252
++++ +DV+S G +L EL
Sbjct: 198 AKYSRAMDVWSCGCILAELFL 218
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 46/210 (21%), Positives = 84/210 (40%), Gaps = 52/210 (24%)
Query: 78 QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPPVFC---I 133
VA+K + ++++ A ++ E+ +L L+ H +I+ + + +
Sbjct: 34 GEVVAVKKIFDAFQNSTDA----QRTFREIMILTELSGHENIVNLLNVLR-ADNDRDVYL 88
Query: 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALD--------IARGMQYLHSQGILHRDLK 185
+ +Y+ L + L + + ++YLHS G+LHRD+K
Sbjct: 89 VFDYM-ETDLHAVIRAN-----------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMK 136
Query: 186 SENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---------------------RWM 224
N+LL + VKVADFG+S RW
Sbjct: 137 PSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWY 196
Query: 225 -APE-MIKEKRHTKKVDVYSFGIVLWELLT 252
APE ++ ++TK +D++S G +L E+L
Sbjct: 197 RAPEILLGSTKYTKGIDMWSLGCILGEILC 226
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 38/206 (18%), Positives = 88/206 (42%), Gaps = 27/206 (13%)
Query: 62 KFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118
K G++S ++ I V +K++ +P + +K+ E+ +L L P+I
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKIL-KPVK--------KKKIKREIKILENLRGGPNI 93
Query: 119 I----TFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYL 174
I + P + E++ ++ ++ + +I + + Y
Sbjct: 94 ITLADIVKDPVSRTPAL--VFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYC 146
Query: 175 HSQGILHRDLKSENLLLGEDMC-VKVADFGISCLESQCGSAKGFTGTYRWM-APE-MIKE 231
HS GI+HRD+K N+++ + +++ D+G++ + R+ PE ++
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGPELLVDY 205
Query: 232 KRHTKKVDVYSFGIVLWELLTALTPF 257
+ + +D++S G +L ++ PF
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 52/197 (26%), Positives = 81/197 (41%), Gaps = 34/197 (17%)
Query: 78 QRDVAIKLV-SQPEEDASLASMLEKQFTSEVALLFRLNHP------HIITFVAACKKPPV 130
Q VAIK++ ++ Q EV LL +N +I+
Sbjct: 79 QEWVAIKIIKNKK--------AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH------ 124
Query: 131 F------CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ--GILHR 182
F C++ E L +L L V LNL K A + + +L + I+H
Sbjct: 125 FMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHC 183
Query: 183 DLKSENLLL--GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 240
DLK EN+LL + +K+ DFG SC Q + YR +PE++ + +D+
Sbjct: 184 DLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPEVLLGMPYDLAIDM 241
Query: 241 YSFGIVLWELLTALTPF 257
+S G +L E+ T F
Sbjct: 242 WSLGCILVEMHTGEPLF 258
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 39/146 (26%), Positives = 61/146 (41%), Gaps = 22/146 (15%)
Query: 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 190
CI E L G + ++L + PL V +A + +++LH + H DLK EN+L
Sbjct: 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENIL 155
Query: 191 LGEDMC-------------------VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE 231
++VADFG + + + + T YR PE+I E
Sbjct: 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYR--PPEVILE 213
Query: 232 KRHTKKVDVYSFGIVLWELLTALTPF 257
+ DV+S G +L+E T F
Sbjct: 214 LGWAQPCDVWSIGCILFEYYRGFTLF 239
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 63/274 (22%), Positives = 105/274 (38%), Gaps = 30/274 (10%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH- 115
+G K SG IY G +VAIKL + L E + +
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL--------HIESKIYKMMQGG 64
Query: 116 PHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH 175
I T + ++ E L G SL + L L VL LA + ++Y+H
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 176 SQGILHRDLKSENLLLGEDMC---VKVADFGISC--LESQCGS------AKGFTGTYRWM 224
S+ +HRD+K +N L+G V + DFG++ +++ K TGT R+
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 225 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM---TPEQAAFAVCQKNARPPVPPT 281
+ +++ D+ S G VL P+ + T Q + +K P+
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
Query: 282 C---PKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
C P F+ ++ C S D +P + + +
Sbjct: 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 39/183 (21%), Positives = 71/183 (38%), Gaps = 53/183 (28%)
Query: 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLL 190
C++ E + G L K++ + +PL V K+ + +G+ YLH++ I+H D+K EN+L
Sbjct: 121 CMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179
Query: 191 LG-------------------------------------------------EDMCVKVAD 201
L E + VK+AD
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 202 FGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT 261
G +C + + T YR + E++ + D++S + +EL T F+ +
Sbjct: 240 LGNACWVHKHFTEDIQTRQYR--SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297
Query: 262 PEQ 264
E+
Sbjct: 298 GEE 300
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 22/146 (15%)
Query: 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 190
CI+ E L G S ++ + L+ + K+A I + + +LHS + H DLK EN+L
Sbjct: 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENIL 150
Query: 191 LGEDMC-------------------VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE 231
+ +KV DFG + + + S T YR APE+I
Sbjct: 151 FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR--APEVILA 208
Query: 232 KRHTKKVDVYSFGIVLWELLTALTPF 257
++ DV+S G +L E T F
Sbjct: 209 LGWSQPCDVWSIGCILIEYYLGFTVF 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 39/146 (26%), Positives = 60/146 (41%), Gaps = 28/146 (19%)
Query: 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 191
C+I E L G SL + + + + + ++I + + YL + H DLK EN+LL
Sbjct: 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL 170
Query: 192 GEDMC-------------------------VKVADFGISCLESQCGSAKGFTGTYRWMAP 226
+ +K+ DFG + +S + T YR AP
Sbjct: 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYR--AP 228
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLT 252
E+I D++SFG VL EL T
Sbjct: 229 EVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-13
Identities = 50/275 (18%), Positives = 99/275 (36%), Gaps = 30/275 (10%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+G + G I+ G + VAIK + + L E +
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL--RDEYRT-----YKLLAGCT 66
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
I ++ ++ + L G SL + L + V A + +Q +H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL-GPSL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 177 QGILHRDLKSENLLLGEDMC-----VKVADFGIS--CLESQCGS------AKGFTGTYRW 223
+ +++RD+K +N L+G + V DFG+ + K +GT R+
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 224 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM---TPEQAAFAVCQKNARPPVPP 280
M+ + +++ D+ + G V L P+ + T +Q + +K P+
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 244
Query: 281 TC---PKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
C P+ F + + + D P +D + +
Sbjct: 245 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 279
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 63/274 (22%), Positives = 105/274 (38%), Gaps = 30/274 (10%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-H 115
+G K SG IY G Q +VAIKL + + L E + L
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL--------LYESKIYRILQGG 62
Query: 116 PHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH 175
I + ++ + L G SL + L + L VL LA + ++++H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 176 SQGILHRDLKSENLLLGEDMC---VKVADFGISCL--ESQCGS------AKGFTGTYRWM 224
S+ LHRD+K +N L+G V + DFG++ ++ K TGT R+
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 225 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM---TPEQAAFAVCQKNARPPVPPT 281
+ +++ D+ S G VL L P+ + T +Q + +K +
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 282 C---PKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
C P F+ C S D +P + + +
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR 274
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 43/181 (23%), Positives = 70/181 (38%), Gaps = 24/181 (13%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+G K G + G VAIKL L LE +F +
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQL--HLEYRF-----YKQLGSGD 65
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
I ++ E L G SL + L + L VL +A+ + M+Y+HS
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL-GPSL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 177 QGILHRDLKSENLLLGEDM-----CVKVADFGIS--CLESQCGS------AKGFTGTYRW 223
+ +++RD+K EN L+G + + DF ++ ++ + K TGT R+
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 224 M 224
M
Sbjct: 184 M 184
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 26/178 (14%), Positives = 58/178 (32%), Gaps = 28/178 (15%)
Query: 75 IYKQRDVAIKLVSQPEEDASLASMLEK---QFTSEVALLFRLNHPHIITFVAACKKPPVF 131
+Y+ + + + L+ + +E R P + P+
Sbjct: 58 LYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117
Query: 132 CIITEY---------------LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
I T G SL+ L + + VL++A + +++LH
Sbjct: 118 AIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE 177
Query: 177 QGILHRDLKSENLLLGEDMCVKV--ADFGISC--------LESQCGSAKGFTGTYRWM 224
+H ++ +EN+ + + +V A +G + + GS G ++
Sbjct: 178 NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 44/190 (23%), Positives = 70/190 (36%), Gaps = 27/190 (14%)
Query: 59 IGCKFASGRHSRIYRG--IYKQRDVAIKLVSQPEEDAS-----------LASMLEKQFTS 105
+G K SG IY K A +V ++ +A +
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 106 EVALLFRLNHPHIITFVAACKKPPVF-CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
E L L P K + ++ E L G L+K Q + + VL+L
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFK--KSTVLQLG 157
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV--ADFGISC--------LESQCGSA 214
+ + ++Y+H +H D+K+ NLLLG +V AD+G+S + Q
Sbjct: 158 IRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR 217
Query: 215 KGFTGTYRWM 224
KG GT +
Sbjct: 218 KGHNGTIEFT 227
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 33/196 (16%), Positives = 56/196 (28%), Gaps = 36/196 (18%)
Query: 59 IGCKFASGRHSRIYRG-IYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH 117
+G G IY + V + +E+ R P
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDA----PCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 118 IITFVAACKKPPVFCI-------------------ITEYLAGGSLRKYLHQQEPYSVPLN 158
I +K + I + G L+K
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRK 152
Query: 159 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV--ADFGISC--------LE 208
VL+L+L I ++Y+H +H D+K+ NLLL +V D+G++
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 209 SQCGSAKGFTGTYRWM 224
+ GT +
Sbjct: 213 YAADPKRCHDGTIEFT 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 1e-06
Identities = 29/191 (15%), Positives = 51/191 (26%), Gaps = 45/191 (23%)
Query: 55 SQLFIGCKFASGRHSRIYRGIYKQRDVAIKLV--SQPEEDASLASMLEKQFTSEVALLFR 112
+L K G +++ I VAIK++ P+ ++ E+ +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 113 L---------NHPHIITFVAAC----KKPPVFC--------------------------I 133
L I + PP+ I
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLG 192
+ E+ GG L Q L + + + + HRDL N+LL
Sbjct: 140 VLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 193 EDMCVKVADFG 203
+ K+
Sbjct: 197 KTSLKKLHYTL 207
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 2e-05
Identities = 62/400 (15%), Positives = 107/400 (26%), Gaps = 123/400 (30%)
Query: 11 SINAKPERMLSLREYRRAVSWSKYLVSSGAEIKGEGEEEWSADMSQLF-IGCK-FASGRH 68
SI A+ R+L + Y LV +A F + CK + R
Sbjct: 229 SIQAELRRLLKSKPYENC-----LLVL---------LNVQNAKAWNAFNLSCKILLTTRF 274
Query: 69 SRIYRGIYKQRDVAIKLVSQP---EEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125
++ + I L D S+L K L P
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTLTPDEVK-SLLLKYLDCRPQDL-----PR-----EVL 323
Query: 126 K-KPPVFCIITEYLAGGSLR--KYLHQQEPYSVPLNLVLKLALDI-----ARGMQYLHSQ 177
P II E + G + H L +++ +L++ R +
Sbjct: 324 TTNPRRLSIIAESIRDGLATWDNWKHVNCD---KLTTIIESSLNVLEPAEYR--KMFDRL 378
Query: 178 GILHRDLKSENLLLG-----------EDMCVKVADFGISCLESQCGSAKGFT----GTYR 222
+ +LL + K+ + S +E Q K T Y
Sbjct: 379 SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKY--SLVEKQ---PKESTISIPSIYL 433
Query: 223 WMAPEMIKEKR-HTKKVDVYSF--GIVLWELLTALTPFDN----------MTPEQA---- 265
+ ++ E H VD Y+ +L+ D E
Sbjct: 434 ELKVKLENEYALHRSIVDHYNIPKTFDSDDLI--PPYLDQYFYSHIGHHLKNIEHPERMT 491
Query: 266 ---------AFAVCQK--------NARPPVPPTCPKAFSYL--ISRCWSSSPDRRPHFDQ 306
F + QK NA + T + Y I D P +++
Sbjct: 492 LFRMVFLDFRF-LEQKIRHDSTAWNASGSILNTLQQLKFYKPYIC-------DNDPKYER 543
Query: 307 IVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTCIAR 346
+V+ + F+P + ++ T + R
Sbjct: 544 LVNAIL--------------DFLPKIEENLICSKYTDLLR 569
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 32/144 (22%), Positives = 50/144 (34%), Gaps = 14/144 (9%)
Query: 64 ASGRHSRIYRGIYKQRDVAIKL-VSQPEEDASLASMLEKQFT-SEVALLFRLNHPHIITF 121
G + I R Y DV IK V + D L + K T E L + I
Sbjct: 345 GKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAP 404
Query: 122 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILH 181
I+ Y+ G + + L +A I + LH ++H
Sbjct: 405 YIFDVDLDNKRIMMSYINGKLAKDVI----------EDNLDIAYKIGEIVGKLHKNDVIH 454
Query: 182 RDLKSENLLLGEDMCVKVADFGIS 205
DL + N + +D+ + DFG+
Sbjct: 455 NDLTTSNFIFDKDLY--IIDFGLG 476
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 362 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.51 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.32 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.16 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.98 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.79 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.78 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.73 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.56 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.53 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.48 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.35 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.23 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.19 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.03 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.91 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.82 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.81 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.79 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.7 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.56 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.56 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.55 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.41 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.26 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.92 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.83 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.57 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.72 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.45 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.43 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 85.91 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 84.29 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-61 Score=434.88 Aligned_cols=267 Identities=32% Similarity=0.587 Sum_probs=224.2
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
....|+++.+++.++++||+|+||+||+|.+++ .||||+++....... ..+.|.+|+.++++++|||||++++++
T Consensus 27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~----~~~~f~~E~~il~~l~HpNIV~l~g~~ 101 (307)
T 3omv_A 27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPE----QFQAFRNEVAVLRKTRHVNILLFMGYM 101 (307)
T ss_dssp --CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHH----HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 456799999999999999999999999999876 599999976544332 246789999999999999999999988
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
.+ +.++||||||+||+|.+++..... .+++.++..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|
T Consensus 102 ~~-~~~~iVmEy~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 102 TK-DNLAIVTQWCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp CS-SSCEEEEECCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred EC-CeEEEEEEcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence 65 568999999999999999976543 6999999999999999999999999999999999999999999999999999
Q ss_pred cccccC---CCCCcccccccccChhhhhc---CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---
Q 017994 206 CLESQC---GSAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--- 276 (362)
Q Consensus 206 ~~~~~~---~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--- 276 (362)
+..... ......+||+.|||||++.+ +.++.++|||||||++|||+||+.||.+.+...............
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~ 259 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL 259 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence 765432 22345689999999999964 358999999999999999999999999877665555544443322
Q ss_pred -CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 277 -PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 277 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
..+..+|+.+.+|+.+||+.||++|||+.||++.|+.+...+.
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 3456789999999999999999999999999999998876543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-60 Score=431.03 Aligned_cols=260 Identities=29% Similarity=0.540 Sum_probs=228.5
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
.++.++|.+.+.||+|+||+||+|.+. +..||||+++..... ..+.|.+|+.+|++++|||||+++|
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~------~~~~f~~E~~il~~l~HpnIV~l~g 82 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN------ARKDFHREAELLTNLQHEHIVKFYG 82 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHH------HHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChH------HHHHHHHHHHHHHhCCCCCCccEEE
Confidence 456788999999999999999999874 567999999764332 2467899999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc
Q 017994 124 ACKKPPVFCIITEYLAGGSLRKYLHQQE-----------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 192 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~ 192 (362)
++.+++.++||||||++|+|.++++... ...+++.++..++.|++.||.|||+++|+||||||+|||++
T Consensus 83 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~ 162 (299)
T 4asz_A 83 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 162 (299)
T ss_dssp EECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred EEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC
Confidence 9999999999999999999999997642 34699999999999999999999999999999999999999
Q ss_pred CCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHH
Q 017994 193 EDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 268 (362)
Q Consensus 193 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~ 268 (362)
.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+....
T Consensus 163 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 242 (299)
T 4asz_A 163 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 242 (299)
T ss_dssp GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999997543322 2234568999999999999999999999999999999999 9999999998888777
Q ss_pred HHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 269 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 269 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
+.. ...++.|..+|+++.+|+.+||+.||++|||+.+|.+.|+.+.+.
T Consensus 243 i~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 243 ITQ-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 655 455677889999999999999999999999999999999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-60 Score=437.29 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=220.2
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|++.+.||+|+||+||+|.+. ++.||||++......... .+.+.+|+.++++++|||||++++++.+++.+
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE----REESRREVAVLANMKHPNIVQYRESFEENGSL 98 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHH----HHHHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence 578999999999999999999986 789999999876543322 46788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
|||||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999999998766556899999999999999999999999999999999999999999999999999865442
Q ss_pred C-CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 212 G-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 212 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
. .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+....+.... .++.+..+|+++.+||
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~li 257 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPPVSLHYSYDLRSLV 257 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCCTTSCHHHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccCCHHHHHHH
Confidence 2 2345679999999999999999999999999999999999999999999888888876644 4566788999999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 017994 291 SRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~ 309 (362)
.+||+.||++|||+.|+++
T Consensus 258 ~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 258 SQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHTCSSGGGSCCHHHHHT
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=431.48 Aligned_cols=262 Identities=27% Similarity=0.526 Sum_probs=225.5
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeee
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF 121 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~ 121 (362)
.+.++.++|.+.++||+|+||+||+|.+. ++.||||+++..... ..+.|.+|+.+|++++|||||++
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~------~~~~f~~E~~il~~l~HpnIV~l 108 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES------ARQDFQREAELLTMLQHQHIVRF 108 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHH------HHHHHHHHHHHHTTCCCTTBCCE
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHH------HHHHHHHHHHHHHhCCCCCCCcE
Confidence 34567789999999999999999999874 578999999764332 24679999999999999999999
Q ss_pred eEEEEeCCeEEEEEecCCCCCHHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 017994 122 VAACKKPPVFCIITEYLAGGSLRKYLHQQEP-------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 188 (362)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~N 188 (362)
+|++.+.+.++||||||++|+|.++++.... ..+++.++..|+.|++.||.|||+++|+||||||+|
T Consensus 109 ~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~N 188 (329)
T 4aoj_A 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN 188 (329)
T ss_dssp EEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred EEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhh
Confidence 9999999999999999999999999976432 358999999999999999999999999999999999
Q ss_pred EEEcCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHH
Q 017994 189 LLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQ 264 (362)
Q Consensus 189 il~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~ 264 (362)
||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+
T Consensus 189 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~ 268 (329)
T 4aoj_A 189 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268 (329)
T ss_dssp EEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred EEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999997543322 2235678999999999999999999999999999999999 999999999888
Q ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 265 AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
....+.. ..+++.|..+|+++.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 269 ~~~~i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 269 AIDCITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 7777654 456778889999999999999999999999999999999988653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-60 Score=428.71 Aligned_cols=258 Identities=28% Similarity=0.522 Sum_probs=227.3
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
+++.+++++.++||+|+||+||+|.+. ++.||||+++....... .+.|.+|+.++++++|||||+++|
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~-----~~~f~~E~~il~~l~HpNIV~l~g 96 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-----REEFRHEAMLRARLQHPNVVCLLG 96 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-C-----HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHH-----HHHHHHHHHHHHhCCCCCCCCcce
Confidence 456788999999999999999999873 47899999976443321 467899999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 017994 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 189 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Ni 189 (362)
++.+++.+++|||||++|+|.+++..... ..+++..+..|+.||+.||.|||+++|+||||||+||
T Consensus 97 ~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NI 176 (308)
T 4gt4_A 97 VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV 176 (308)
T ss_dssp EECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccce
Confidence 99999999999999999999999975421 2589999999999999999999999999999999999
Q ss_pred EEcCCCceEEeeeccccccccC---CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHH
Q 017994 190 LLGEDMCVKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQA 265 (362)
Q Consensus 190 l~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~ 265 (362)
|++.++.+||+|||+++..... .......||+.|+|||++.++.++.++|||||||++|||+| |..||.+.+..+.
T Consensus 177 Ll~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 177 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp EECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred EECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999754332 22345679999999999999999999999999999999999 8999999998887
Q ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 266 AFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
...+.. ...++.|..+|+.+.+|+.+||+.||.+|||+.||++.|+++
T Consensus 257 ~~~i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 776654 556678889999999999999999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-60 Score=427.50 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=222.5
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
..++|++++.||+|+||+||+|.+. ++.||||++.+..... ....+.+.+|+.++++++|||||++++++.+++.
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 106 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 106 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 3468999999999999999999986 7899999997532111 1113678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
+|+|||||+||+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999999998876 699999999999999999999999999999999999999999999999999986543
Q ss_pred C---CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHH
Q 017994 211 C---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287 (362)
Q Consensus 211 ~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 287 (362)
. ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+....+.... ..+|..+++++.
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~ 262 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--YDFPEKFFPKAR 262 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTCCHHHH
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCcccCHHHH
Confidence 2 23456789999999999999999999999999999999999999999998888888776543 566788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~ 309 (362)
+||.+||..||.+|||+.|++.
T Consensus 263 dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 263 DLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHHHHHSCSSGGGSTTSGGGTC
T ss_pred HHHHHHccCCHhHCcChHHHcC
Confidence 9999999999999999999753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=429.08 Aligned_cols=257 Identities=23% Similarity=0.326 Sum_probs=223.7
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
+......|.+.++||+|+||.||+|.++ ++.||||+++.... ..+|+.+++.++|||||++++++.+
T Consensus 53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----------~~~E~~il~~l~HpnIV~l~~~~~~ 121 (336)
T 4g3f_A 53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----------RVEELVACAGLSSPRIVPLYGAVRE 121 (336)
T ss_dssp CCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----------CTHHHHTTTTCCCTTBCCEEEEEEE
T ss_pred hhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----------HHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 3445678999999999999999999987 78999999986432 2369999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-ceEEeeecccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGISC 206 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg~~~ 206 (362)
++.+|||||||+||+|.++++..+ .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+|+
T Consensus 122 ~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 122 GPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred CCEEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 999999999999999999998876 599999999999999999999999999999999999999988 69999999998
Q ss_pred ccccCCC------CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCC
Q 017994 207 LESQCGS------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-PPVP 279 (362)
Q Consensus 207 ~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~ 279 (362)
....... ....+||+.|||||++.+..++.++|||||||++|||++|.+||.+.+..+....+...... ...+
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 279 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP 279 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSC
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcC
Confidence 6543221 23457999999999999999999999999999999999999999987776666666554332 2467
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
+.+++.+.+||.+||+.||.+|||+.||++.|....+.+.
T Consensus 280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 8899999999999999999999999999999988776554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-59 Score=428.31 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=219.8
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.+.|++.++||+|+||+||+|.++ ++.||||++....... .+.+.+|+.+|++++|||||++++++.+++.+
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 146 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR------RELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 146 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS------GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH------HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 356999999999999999999996 7899999997644332 25578899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
|||||||+||+|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 147 ~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 9999999999999999864 4999999999999999999999999999999999999999999999999999865443
Q ss_pred -CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCCHHHHHH
Q 017994 212 -GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYL 289 (362)
Q Consensus 212 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 289 (362)
......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+....+..... ....+..+++++.+|
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 303 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF 303 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 345678899999999999999999999999999999999999999999988887777654322 223445789999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~ 309 (362)
|.+||+.||++|||+.|+++
T Consensus 304 i~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 304 LDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999885
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-59 Score=415.52 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=205.0
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|++.+.||+|+||+||+|.+. ++.||||++........ .....+.+|+.++++++||||+++++++.+++.+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKS---DMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCH---HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 468999999999999999999986 78999999986543221 1246788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
|+||||+ +|+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 9999999 789999998765 6999999999999999999999999999999999999999999999999999876665
Q ss_pred CCCCcccccccccChhhhhcCCC-CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+... ...++..+|+++.+||
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li 243 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--VYTLPKFLSPGAAGLI 243 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHH
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Confidence 55667889999999999998775 68999999999999999999999998887776666543 4566788999999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 017994 291 SRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~ 309 (362)
.+||+.||++|||+.|+++
T Consensus 244 ~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHH
T ss_pred HHHccCChhHCcCHHHHHc
Confidence 9999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-59 Score=429.18 Aligned_cols=266 Identities=25% Similarity=0.510 Sum_probs=232.3
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEECC-------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC-Cce
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-PHI 118 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-p~i 118 (362)
...|+++.++|++++.||+|+||+||+|.+.+ +.||||++........ .+.|.+|+.+|.+++| |||
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~-----~~~~~~E~~il~~l~hhpnI 130 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNV 130 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTTB
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHH-----HHHHHHHHHHHHHcCCCCcE
Confidence 45799999999999999999999999998753 5799999987544332 3678899999999965 999
Q ss_pred eeeeEEEEeC-CeEEEEEecCCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 017994 119 ITFVAACKKP-PVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRD 183 (362)
Q Consensus 119 v~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~d 183 (362)
|+++|+|.++ ..+++|||||++|+|.++|+... ...+++..+..++.||+.||.|||+++|+|||
T Consensus 131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRD 210 (353)
T 4ase_A 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 210 (353)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCc
Confidence 9999999764 57899999999999999997532 13488999999999999999999999999999
Q ss_pred CCCCcEEEcCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCC
Q 017994 184 LKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 259 (362)
Q Consensus 184 lk~~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~ 259 (362)
|||+|||++.++.+||+|||+|+...... ......||+.|||||++.+..++.++|||||||++|||+| |..||.+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998654322 2235578999999999999999999999999999999998 9999998
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 260 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
....+..........+++.|..+++++.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 291 ~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 7766666666667778888999999999999999999999999999999999987654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-59 Score=419.67 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=214.7
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
.++++|++.+.||+|+||+||+|.+. ++.||||+++........ ...+.+|+.++++++|||||++++++.
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~l~~~~~ 96 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD----RVRTKMERDILVEVNHPFIVKLHYAFQ 96 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE----CC------CCCCCCCCTTEECEEEEEE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH----HHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 45688999999999999999999873 568999999864322111 135678999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
+++.+|+|||||+||+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus 97 ~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 97 TEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp ETTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccce
Confidence 9999999999999999999998876 69999999999999999999999999999999999999999999999999997
Q ss_pred cccc-CCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 207 LESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 207 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
.... .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+... ...+|..+|++
T Consensus 175 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~ 252 (304)
T 3ubd_A 175 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--KLGMPQFLSPE 252 (304)
T ss_dssp C-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHH
T ss_pred eccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCcCCHH
Confidence 5433 33445678999999999999999999999999999999999999999999988888877654 45677889999
Q ss_pred HHHHHHHhcccCCCCCCCH-----HHHHH
Q 017994 286 FSYLISRCWSSSPDRRPHF-----DQIVS 309 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~-----~ell~ 309 (362)
+.+||.+||+.||++|||+ +|+++
T Consensus 253 ~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 9999999999999999985 55553
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-58 Score=430.10 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=221.1
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.+.|++.++||+|+||.||+|.+. ++.||||++....... .+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 223 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR------RELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 223 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS------GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH------HHHHHHHHHHHHhCCCCCCCceEEEEEECCEE
Confidence 357999999999999999999997 7899999998754433 25678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
|||||||+||+|.++++.. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 224 ~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 9999999999999999764 4999999999999999999999999999999999999999999999999999865443
Q ss_pred -CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCCHHHHHH
Q 017994 212 -GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYL 289 (362)
Q Consensus 212 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 289 (362)
......+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+....+..... ....+..+++++.+|
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 380 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF 380 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHH
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHH
Confidence 345677899999999999999999999999999999999999999999988887777655422 234456789999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~ 309 (362)
|.+||..||.+|||+.|+++
T Consensus 381 i~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 381 LDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999985
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=410.14 Aligned_cols=245 Identities=25% Similarity=0.479 Sum_probs=209.0
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe----CCe
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK----PPV 130 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----~~~ 130 (362)
|.+.++||+|+||.||+|.+. +..||||++........ ..+.|.+|+.++++++|||||++++++.+ +..
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS----ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH----HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 467889999999999999997 67899999976543322 24678899999999999999999999865 356
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcC-CCceEEeeeccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGE-DMCVKVADFGISCL 207 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~ 207 (362)
+|||||||+||+|.+++.+.. .+++..+..++.||+.||.|||++| |+||||||+|||++. +|.+||+|||+|+.
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 899999999999999998765 6999999999999999999999998 999999999999984 79999999999975
Q ss_pred cccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCCCCCCCCCHHH
Q 017994 208 ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARPPVPPTCPKAF 286 (362)
Q Consensus 208 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 286 (362)
... ......+||+.|+|||++.+ .++.++|||||||++|||+||..||.+......+....... .....+..+++++
T Consensus 182 ~~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (290)
T 3fpq_A 182 KRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred CCC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHH
Confidence 433 33456789999999999865 59999999999999999999999998765554444433333 3334566788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+||.+||+.||++|||+.|+++
T Consensus 260 ~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 260 KEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHccCChhHCcCHHHHhc
Confidence 99999999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-56 Score=402.35 Aligned_cols=252 Identities=28% Similarity=0.516 Sum_probs=203.9
Q ss_pred cCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC----e
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP----V 130 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~----~ 130 (362)
.+|.+.++||+|+||+||+|.++++.||||++...... ...+..|+..+.+++|||||++++++.+++ .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~-------~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-------SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHH-------HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-------hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 46889999999999999999999999999999653221 123345777778899999999999997654 6
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCcEEEcCCCceEEeee
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ--------GILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
+||||||+++|+|.++++.. .++++.+.+++.|++.||.|||++ +|+||||||+|||++.++++||+||
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 89999999999999999875 489999999999999999999987 9999999999999999999999999
Q ss_pred ccccccccCCC-----CCcccccccccChhhhhcC------CCCCcccchhhhHHHHHHHhCCCCCC----------CC-
Q 017994 203 GISCLESQCGS-----AKGFTGTYRWMAPEMIKEK------RHTKKVDVYSFGIVLWELLTALTPFD----------NM- 260 (362)
Q Consensus 203 g~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slG~~l~ell~g~~p~~----------~~- 260 (362)
|+++....... ....+||+.|+|||++.+. .++.++|||||||++|||+||.+||. +.
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 99976544322 2345799999999999764 35779999999999999999976553 21
Q ss_pred ----CHHHHHHHHHhcCCCCCCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 261 ----TPEQAAFAVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 261 ----~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
........+.....++..|.. .++.+.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 123333344444555555543 23578999999999999999999999999998765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=399.13 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=193.2
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC---
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP--- 129 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~--- 129 (362)
++|++.+.||+|+||+||+|.++ ++.||||++.....+. ..+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL-----AREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHH-----HHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHH-----HHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 56999999999999999999987 7899999997654332 2467889999999999999999999986544
Q ss_pred ---------eEEEEEecCCCCCHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEE
Q 017994 130 ---------VFCIITEYLAGGSLRKYLHQQEPY-SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 199 (362)
Q Consensus 130 ---------~~~lv~e~~~~~~L~~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl 199 (362)
.+|+|||||+||+|.+++...... ..++..++.++.||+.||+|||++||+||||||+|||++.+|.+||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 479999999999999999875432 2456778999999999999999999999999999999999999999
Q ss_pred eeeccccccccCCC-------------CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHH-H
Q 017994 200 ADFGISCLESQCGS-------------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-A 265 (362)
Q Consensus 200 ~Dfg~~~~~~~~~~-------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~-~ 265 (362)
+|||+|+....... ....+||+.|+|||++.+..|+.++|||||||++|||++ ||....... .
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 99999976543221 234579999999999999999999999999999999996 776532221 2
Q ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 266 AFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...+ .....++.....++.+.+||.+||+.||.+|||+.|+++
T Consensus 237 ~~~~-~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 LTDV-RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH-HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH-hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2222 222222222344567889999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=398.02 Aligned_cols=248 Identities=21% Similarity=0.311 Sum_probs=211.1
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe-----
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK----- 127 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----- 127 (362)
++|++++.||+|+||+||+|.+. ++.||||++......... .+.+.+|+.+|+.++|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN----AKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHH----HHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHH----HHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 57999999999999999999986 789999999765443322 3567899999999999999999998754
Q ss_pred -CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 128 -PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 128 -~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
.+.+|||||||+ |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred cCCEEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence 367899999995 68999998765 69999999999999999999999999999999999999999999999999997
Q ss_pred ccccC-----CCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---
Q 017994 207 LESQC-----GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--- 277 (362)
Q Consensus 207 ~~~~~-----~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--- 277 (362)
..... ......+||+.|+|||++.+. .++.++||||+||++|||++|.+||.+.+..+....+......++
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 54322 233467899999999998775 569999999999999999999999999988877766654332221
Q ss_pred --------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 --------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 --------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+.+++++.+||.+||..||.+|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 01346889999999999999999999999885
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=409.73 Aligned_cols=249 Identities=21% Similarity=0.330 Sum_probs=222.7
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|++++.||+|+||.||+|.++ ++.||||++....... .+.+.+|+.+|+.++||||+++++++.++..+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~------~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD------KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH------HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh------HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 368999999999999999999996 7899999998754332 36778999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC--CceEEeeeccccccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED--MCVKVADFGISCLES 209 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~--~~~kl~Dfg~~~~~~ 209 (362)
|+|||||+||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ |.+||+|||++....
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99999999999999997543 269999999999999999999999999999999999999854 899999999998776
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCCHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAFS 287 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 287 (362)
........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+....+....... .....+++++.
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 388 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 6555567789999999999999999999999999999999999999999999988888776654433 23467899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~ 309 (362)
+||.+||+.||.+||++.|+++
T Consensus 389 dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 389 DFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=410.58 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=211.7
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
...++|++++.||+|+||+||+|.++ ++.||||++.+.................++.+++.++|||||++++++.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 34688999999999999999999996 7899999997532111111111122234567788889999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.+|+||||++||+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+|....
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999999998876 69999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
.. .....+||+.|+|||++.. ..|+.++|+|||||++|||++|.+||.+.+ .......+. .....+|..+|++
T Consensus 344 ~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~--~~~~~~p~~~S~~ 420 (689)
T 3v5w_A 344 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPE 420 (689)
T ss_dssp SC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH--HCCCCCCTTSCHH
T ss_pred CC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc--CCCCCCCccCCHH
Confidence 43 3456789999999999964 579999999999999999999999997632 233333333 3445678889999
Q ss_pred HHHHHHHhcccCCCCCCC-----HHHHHH
Q 017994 286 FSYLISRCWSSSPDRRPH-----FDQIVS 309 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps-----~~ell~ 309 (362)
+.+||.+||+.||.+|++ +.||++
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 999999999999999998 577765
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=382.29 Aligned_cols=242 Identities=20% Similarity=0.291 Sum_probs=198.7
Q ss_pred cCeeeeeeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeC
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKP 128 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~ 128 (362)
++|++.+.||+|+||+||+|.++ ++.||||++..... ...+.+|+.+++.+ +||||+++++++.+.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--------~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--------PIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--------HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--------HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 56999999999999999999873 57899999876543 24567899999988 699999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CceEEeeeccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISCL 207 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~-~~~kl~Dfg~~~~ 207 (362)
+.+|+||||++||+|.++++ .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999999984 48999999999999999999999999999999999999876 8999999999964
Q ss_pred cccCC-----------------------------CCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCC
Q 017994 208 ESQCG-----------------------------SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPF 257 (362)
Q Consensus 208 ~~~~~-----------------------------~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~ 257 (362)
..... .....+||+.|+|||++.+. .++.++||||+||++|+|++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 33211 12345799999999999775 5899999999999999999999999
Q ss_pred CCCC-HHHHHHHHHhc----------------------------------------------------CCCCCCCCCCCH
Q 017994 258 DNMT-PEQAAFAVCQK----------------------------------------------------NARPPVPPTCPK 284 (362)
Q Consensus 258 ~~~~-~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~ 284 (362)
.... ..+.+..+... .........+|+
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 5433 33322222110 000112345788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
++.+||.+||..||.+|||+.|+++
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhc
Confidence 9999999999999999999999884
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-51 Score=371.34 Aligned_cols=269 Identities=37% Similarity=0.642 Sum_probs=227.5
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
....+.+...+|.+.+.||+|+||.||+|.++++.||||++......... .+.+.+|+.++++++||||+++++++
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER----VNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHH----HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 35667788899999999999999999999999999999999876543321 35688999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCceEEeee
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
...+..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 999999999999999999999986541 13899999999999999999999999 999999999999999999999999
Q ss_pred ccccccccC-CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 203 GISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 203 g~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
|++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.........+..
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263 (309)
T ss_dssp C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence 998754432 2234567899999999999999999999999999999999999999999988887777667777788899
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l 318 (362)
+++.+.+||.+||+.||.+|||+.++++.|+.+....
T Consensus 264 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999999887653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=355.20 Aligned_cols=261 Identities=28% Similarity=0.580 Sum_probs=230.2
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
..|.++.++|.+.+.||+|+||.||+|.+. ++.||||++...... .+.+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 75 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-------EEDFIEEAEVMMKLSHPKLVQLYGVCL 75 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-------HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-------HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 468888999999999999999999999995 788999999876544 256889999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
+....++||||+++++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 76 EQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred cCCceEEEEEeCCCCcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccc
Confidence 99999999999999999999976543 68999999999999999999999999999999999999999999999999987
Q ss_pred ccccC--CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 017994 207 LESQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283 (362)
Q Consensus 207 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (362)
..... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+.. ......+..++
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (269)
T 4hcu_A 155 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLAS 233 (269)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTSC
T ss_pred cccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc-CccCCCCCcCC
Confidence 54332 22334556788999999999999999999999999999999 9999999888777666543 45566677889
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 284 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 284 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
+.+.+++.+||+.||.+||++.++++.|+.+.+.
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 234 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 9999999999999999999999999999988653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=366.83 Aligned_cols=250 Identities=27% Similarity=0.438 Sum_probs=222.8
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
..++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPT----SLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 3578999999999999999999985 78999999976543322 23567899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
.++||||++|++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999999999998765 589999999999999999999999999999999999999999999999999987665
Q ss_pred CCCCCcccccccccChhhhhcCCCC-CcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 211 CGSAKGFTGTYRWMAPEMIKEKRHT-KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 211 ~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
.......+||+.|+|||++.+..++ .++||||||+++|+|++|..||.+.+..+....+... ....|..+++++.+|
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l 244 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFYMSTDCENL 244 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHH
Confidence 5555677899999999999888764 8999999999999999999999999888877776654 345667789999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~~ 310 (362)
+.+||..||.+|||+.|+++.
T Consensus 245 i~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHCCCChhHCcCHHHHhcC
Confidence 999999999999999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=370.23 Aligned_cols=265 Identities=27% Similarity=0.538 Sum_probs=229.3
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEEC---------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCc
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPH 117 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~ 117 (362)
..|.+..++|.+++.||+|+||.||+|.+. +..||||++........ .+.+.+|+.+++.+ +|||
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~hpn 148 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-----LSDLVSEMEMMKMIGKHKN 148 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHH-----HHHHHHHHHHHHHSCCCTT
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHH-----HHHHHHHHHHHHHhcCCCC
Confidence 456777899999999999999999999863 34699999987543322 36788999999999 8999
Q ss_pred eeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 017994 118 IITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRD 183 (362)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~d 183 (362)
|+++++++...+.+|+||||+++|+|.+++..... ..+++..++.++.||+.||.|||++||+|||
T Consensus 149 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 228 (370)
T 2psq_A 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 228 (370)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 99999999999999999999999999999987542 3478999999999999999999999999999
Q ss_pred CCCCcEEEcCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCC
Q 017994 184 LKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 259 (362)
Q Consensus 184 lk~~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~ 259 (362)
|||+|||++.++.+||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 229 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~ 308 (370)
T 2psq_A 229 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308 (370)
T ss_dssp CCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999997544322 2234557789999999999999999999999999999999 9999998
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 017994 260 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318 (362)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l 318 (362)
....+....+ ........+..++.++.++|.+||+.||.+||++.|+++.|+.+....
T Consensus 309 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 309 IPVEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp CCGGGHHHHH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 8776655544 345566778889999999999999999999999999999999887643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=354.10 Aligned_cols=259 Identities=29% Similarity=0.553 Sum_probs=231.0
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC-
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP- 128 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~- 128 (362)
+.++.++|.+.+.||+|+||.||+|.++++.||||++......... .+.+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRK----SRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHH----HHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHH----HHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 4567789999999999999999999999999999999876543322 36788999999999999999999999887
Q ss_pred -CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 129 -PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 129 -~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
...++||||+++++|.+++.......+++..++.++.|++.||.|||++| ++||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 78899999999999999998876556999999999999999999999999 999999999999999999999999886
Q ss_pred cccccCCCCCcccccccccChhhhhcCCCCC---cccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTK---KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC 282 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (362)
... ......+|+.|+|||++.+..++. ++||||||+++|+|++|..||......+....+......+..+..+
T Consensus 161 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3kmu_A 161 FSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI 236 (271)
T ss_dssp CTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTC
T ss_pred eee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCC
Confidence 542 223456899999999998765444 7999999999999999999999999888888887778888888999
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
++.+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 237 SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 9999999999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=377.76 Aligned_cols=259 Identities=29% Similarity=0.547 Sum_probs=228.9
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
...|.++.++|.+.+.||+|+||.||+|.++++.||||+++.... .+.+.+|+.++++++||||+++++++.
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~ 256 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIV 256 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTT--------SHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchH--------HHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence 457889999999999999999999999999999999999987542 256889999999999999999999987
Q ss_pred eCC-eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 127 KPP-VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 127 ~~~-~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
... ..++||||+++|+|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 257 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp CTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 665 7999999999999999999876555899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCH
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
...... .....+++.|+|||++.+..++.++||||||+++|||++ |..||...+..+....+. ...+...+..+|+
T Consensus 337 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~ 413 (450)
T 1k9a_A 337 KEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPP 413 (450)
T ss_dssp EECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCH
T ss_pred cccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCH
Confidence 754332 223366889999999999999999999999999999998 999999887766665543 4556777889999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
.+.+||.+||+.||.+||++.++++.|+.+..
T Consensus 414 ~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=361.96 Aligned_cols=263 Identities=31% Similarity=0.554 Sum_probs=226.7
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
.++..++|.+.+.||+|+||.||+|.+. +..||||++....... ..+.+.+|+.++++++||||++++++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-----QRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHH-----HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHH-----HHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 3456789999999999999999999985 3469999998654332 24678899999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
+.+.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 119 VTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp ECGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCc
Confidence 999999999999999999999997654 3699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC----CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 017994 205 SCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 279 (362)
Q Consensus 205 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (362)
+........ .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+.. ....+.+
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 276 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE-GYRLPAP 276 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCC
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCCCCCC
Confidence 976543221 223345778999999999999999999999999999999 9999999888877666543 4566778
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
..+++.+.+||.+||+.||.+||++.++++.|+.+....+
T Consensus 277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 8899999999999999999999999999999999876533
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=352.54 Aligned_cols=264 Identities=28% Similarity=0.545 Sum_probs=228.2
Q ss_pred CCCcccccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeee
Q 017994 44 GEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122 (362)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~ 122 (362)
+.+...|.++.++|.+.+.||+|+||.||++.+. +..||||++...... .+.+.+|+.++.+++||||++++
T Consensus 13 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~ 85 (283)
T 3gen_A 13 GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-------EDEFIEEAKVMMNLSHEKLVQLY 85 (283)
T ss_dssp ---CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-------HHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-------HHHHHHHHHHHhcCCCCCEeeEE
Confidence 3445788899999999999999999999999987 568999999876544 25678999999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
+++.+....++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Df 164 (283)
T 3gen_A 86 GVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDF 164 (283)
T ss_dssp EEECSSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECST
T ss_pred EEEecCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccc
Confidence 99999999999999999999999998743 25999999999999999999999999999999999999999999999999
Q ss_pred ccccccccC--CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 017994 203 GISCLESQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 279 (362)
Q Consensus 203 g~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (362)
|++...... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+.. ......+
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 243 (283)
T 3gen_A 165 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRP 243 (283)
T ss_dssp TGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCCCCC
T ss_pred cccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc-ccCCCCC
Confidence 998754332 22334456788999999999999999999999999999998 9999999888777666543 4556667
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
..+++.+.+++.+||+.||.+||++.++++.|+.+.+
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 7889999999999999999999999999999998764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=352.40 Aligned_cols=258 Identities=33% Similarity=0.684 Sum_probs=216.5
Q ss_pred cccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
+++.++|.+.+.||+|+||.||+|.+.++.||||++........ ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDI--SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccH--HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 45678999999999999999999999999999999876433221 1113568899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCcEEEcC--------CCceEE
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG---ILHRDLKSENLLLGE--------DMCVKV 199 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~dlk~~Nil~~~--------~~~~kl 199 (362)
.++||||+++++|.+++... .+++..++.++.|++.||.|||++| ++||||||+||+++. ++.++|
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 99999999999999999653 5899999999999999999999999 899999999999985 778999
Q ss_pred eeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 017994 200 ADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP 279 (362)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (362)
+|||++....... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+...............+.+
T Consensus 158 ~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 158 TDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp CCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred ccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence 9999987554432 335578999999999999999999999999999999999999999998888887777777777888
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
..+++.+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=356.85 Aligned_cols=247 Identities=24% Similarity=0.453 Sum_probs=218.0
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
..+|.+.+.||+|+||.||+|.+. ++.||||++....... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH------HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 467999999999999999999875 7899999987644332 35678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||++|++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999999999875 4899999999999999999999999999999999999999999999999998765433
Q ss_pred C-CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCCHHHHHH
Q 017994 212 G-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYL 289 (362)
Q Consensus 212 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 289 (362)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..... ....+..+++.+.+|
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence 2 33456799999999999999999999999999999999999999999887776655544332 344567789999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~ 309 (362)
|.+||+.||.+|||+.|+++
T Consensus 250 i~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHccCChhHCcCHHHHhh
Confidence 99999999999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=372.50 Aligned_cols=265 Identities=29% Similarity=0.573 Sum_probs=231.1
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
..+.|.++.++|.+.+.||+|+||.||+|.+. ++.||||++....... ....+.+|+.++++++||||+++++
T Consensus 105 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~ 179 (377)
T 3cbl_A 105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD-----LKAKFLQEARILKQYSHPNIVRLIG 179 (377)
T ss_dssp CCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHH-----HHTTTTHHHHHHTTCCCTTBCCEEE
T ss_pred cccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHH-----HHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45688999999999999999999999999996 7899999987643221 2356788999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
++...+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 180 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG 258 (377)
T 3cbl_A 180 VCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFG 258 (377)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred EEecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCC
Confidence 9999999999999999999999998654 258999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 017994 204 ISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 279 (362)
Q Consensus 204 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (362)
++........ .....+++.|+|||++.+..++.++||||||+++|||++ |..||......+....+ ......+.+
T Consensus 259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~ 337 (377)
T 3cbl_A 259 MSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-EKGGRLPCP 337 (377)
T ss_dssp GCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH-HTTCCCCCC
T ss_pred CceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCC
Confidence 9875433211 122345778999999999999999999999999999998 99999998887665554 345566778
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
..+|+.+.+||.+||+.||.+|||+.++++.|+.+...
T Consensus 338 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 88999999999999999999999999999999988654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=367.41 Aligned_cols=270 Identities=25% Similarity=0.494 Sum_probs=232.1
Q ss_pred cCCCcccccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-C
Q 017994 43 KGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-N 114 (362)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~ 114 (362)
.......|++..++|.+++.||+|+||.||+|.+. ++.||||++........ .+.+.+|+.++.++ +
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~ 84 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGH 84 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHH-----HHHHHHHHHHHHhhcC
Confidence 33456788899999999999999999999999853 37899999986543322 36788999999999 7
Q ss_pred CCceeeeeEEEEeCC-eEEEEEecCCCCCHHHHHhhcCC-----------------------------------------
Q 017994 115 HPHIITFVAACKKPP-VFCIITEYLAGGSLRKYLHQQEP----------------------------------------- 152 (362)
Q Consensus 115 hp~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~----------------------------------------- 152 (362)
||||+++++++...+ ..++||||+++|+|.+++.....
T Consensus 85 hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (359)
T 3vhe_A 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164 (359)
T ss_dssp CTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------
T ss_pred CcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccc
Confidence 999999999998765 48999999999999999986542
Q ss_pred -----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 153 -----------------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 153 -----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp -------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred cccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 128899999999999999999999999999999999999999999999999997543
Q ss_pred cCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 210 QCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 210 ~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...................+..+++.
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE 324 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHH
T ss_pred ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHH
Confidence 322 2234567889999999999999999999999999999998 999999877666666666667777888889999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
+.+++.+||+.||.+||++.++++.|+.+.+.
T Consensus 325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999988764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=367.01 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=220.1
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
+.|.+++.||+|+||.||++.+. ++.||||++..............+.+.+|+.++++++||||+++++++.+....+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 56999999999999999999996 7899999998754322100011356789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC----ceEEeeecccccc
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM----CVKVADFGISCLE 208 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~----~~kl~Dfg~~~~~ 208 (362)
+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 92 lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 9999999999999998754 699999999999999999999999999999999999998776 7999999999876
Q ss_pred ccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCCHHH
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAF 286 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 286 (362)
..........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.......+ ....+++.+
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 249 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence 665555667899999999999999999999999999999999999999999888877776654433221 235788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+||.+||..||.+|||+.|+++
T Consensus 250 ~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 250 KDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHCCCChhHCcCHHHHhc
Confidence 99999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=376.53 Aligned_cols=266 Identities=29% Similarity=0.568 Sum_probs=233.1
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
....|++..++|.+.+.||+|+||.||+|.++ +..||||++...... .+.+.+|+.++++++||||++++++
T Consensus 179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~l~~~ 251 (454)
T 1qcf_A 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-------VEAFLAEANVMKTLQHDKLVKLHAV 251 (454)
T ss_dssp CTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC-------HHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc-------HHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 35778999999999999999999999999997 788999999875443 3678899999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
+. .+..++||||+++|+|.++++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp EC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred Ee-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 86 66789999999999999999865434588999999999999999999999999999999999999999999999999
Q ss_pred ccccccC--CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 205 SCLESQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 205 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
+...... .......+++.|+|||++....++.++||||||+++|||++ |..||.+.+..+....+. .....+.+..
T Consensus 331 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~ 409 (454)
T 1qcf_A 331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPEN 409 (454)
T ss_dssp GGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTT
T ss_pred ceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Confidence 9764332 12233456788999999999999999999999999999999 999999998887776654 4556677888
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccC
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 320 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~ 320 (362)
+|+.+.+||.+||+.||.+|||+.+|++.|+.+....+.
T Consensus 410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 410 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 999999999999999999999999999999988665443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=349.32 Aligned_cols=260 Identities=29% Similarity=0.581 Sum_probs=227.9
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
.|.+..++|.+.+.||+|+||.||+|.+. +..||||++...... .+.+.+|+.++.+++||||+++++++..
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-------EDEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-------HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-------HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 45667789999999999999999999987 568999999875544 2567899999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 75 EYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153 (268)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred CCceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence 999999999999999999998754 2589999999999999999999999999999999999999999999999999875
Q ss_pred cccCC--CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCH
Q 017994 208 ESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284 (362)
Q Consensus 208 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
..... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...........+. .......+..+++
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 232 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASD 232 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCH
T ss_pred cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChH
Confidence 44322 2234456778999999999899999999999999999999 999999988877766654 3445566777899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
.+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 233 TIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 999999999999999999999999999988654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=356.06 Aligned_cols=268 Identities=27% Similarity=0.496 Sum_probs=233.7
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEE-------CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCc
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIY-------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPH 117 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~ 117 (362)
....|.+..++|.+.+.||+|+||.||+|.+ .++.||||++........ .+.+.+|+.+++++ +|||
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~~ 88 (313)
T 1t46_A 14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-----REALMSELKVLSYLGNHMN 88 (313)
T ss_dssp CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTT
T ss_pred CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHH-----HHHHHHHHHHHhhcccCCC
Confidence 3567888889999999999999999999986 247899999986543221 36788999999999 9999
Q ss_pred eeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 017994 118 IITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP----------------YSVPLNLVLKLALDIARGMQYLHSQGILH 181 (362)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H 181 (362)
|+++++++...+..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++||+|
T Consensus 89 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 168 (313)
T 1t46_A 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH 168 (313)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred eeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 99999999999999999999999999999987542 14899999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCC
Q 017994 182 RDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPF 257 (362)
Q Consensus 182 ~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~ 257 (362)
|||||+||+++.++.+||+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 169 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 248 (313)
T 1t46_A 169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (313)
T ss_dssp SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999876544322 234456788999999999999999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 017994 258 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318 (362)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l 318 (362)
.....................+..+++.+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp TTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 9877666666666666677778889999999999999999999999999999999887653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=360.52 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=219.8
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
..++|.+.+.||+|+||.||++.++ ++.||||++...... .......+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 79 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII---AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh---hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCE
Confidence 4578999999999999999999986 789999999753211 01113567789999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc-
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES- 209 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~- 209 (362)
+++||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999999999998765 58999999999999999999999999999999999999999999999999987533
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
........+||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+.......+... ...++..+++++.+|
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l 235 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSL 235 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHH
Confidence 233445678999999999999999999999999999999999999999998887776666543 345677899999999
Q ss_pred HHHhcccCCCCCC-----CHHHHHHH
Q 017994 290 ISRCWSSSPDRRP-----HFDQIVSI 310 (362)
Q Consensus 290 i~~~l~~~p~~Rp-----s~~ell~~ 310 (362)
|.+||+.||.+|| ++.++++.
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 9999999999999 88888863
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=352.38 Aligned_cols=258 Identities=25% Similarity=0.408 Sum_probs=219.5
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||+|+||.||+|.+. ++.||||++........ ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE---ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCH---HHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccH---HHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 67999999999999999999986 78899999876543322 12467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||++|++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 88 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999999998775 58999999999999999999999999999999999999999999999999987654332
Q ss_pred --CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---CCCCCCCHHHH
Q 017994 213 --SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP---PVPPTCPKAFS 287 (362)
Q Consensus 213 --~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~ 287 (362)
......||+.|+|||++.+..++.++||||||+++|+|++|..||.+................. ..+..+|+.+.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 2334568999999999999999999999999999999999999999988877665554433222 24567899999
Q ss_pred HHHHHhcccCCCCCC-CHHHHHHHHHhhhhh
Q 017994 288 YLISRCWSSSPDRRP-HFDQIVSILEGYSES 317 (362)
Q Consensus 288 ~li~~~l~~~p~~Rp-s~~ell~~L~~~~~~ 317 (362)
++|.+||+.||.+|| ++.++.+.|+.+...
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred HHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 999999999999999 999999999877544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=364.27 Aligned_cols=271 Identities=27% Similarity=0.535 Sum_probs=235.3
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEEC---------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CC
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NH 115 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h 115 (362)
....|++..++|.+++.||+|+||.||+|.+. +..||||++........ ...+.+|+.+++++ +|
T Consensus 60 ~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h 134 (382)
T 3tt0_A 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-----LSDLISEMEMMKMIGKH 134 (382)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCC
T ss_pred cCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHH-----HHHHHHHHHHHHHhcCC
Confidence 34567888899999999999999999999873 25799999987543322 36788999999999 99
Q ss_pred CceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 017994 116 PHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILH 181 (362)
Q Consensus 116 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H 181 (362)
|||+++++++..++..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+|
T Consensus 135 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 214 (382)
T 3tt0_A 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH 214 (382)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred chhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 9999999999999999999999999999999987542 35899999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCC
Q 017994 182 RDLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPF 257 (362)
Q Consensus 182 ~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~ 257 (362)
|||||+||+++.++.+||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 215 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~ 294 (382)
T 3tt0_A 215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294 (382)
T ss_dssp SCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999997654322 2334567889999999999999999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCCC
Q 017994 258 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 322 (362)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~~ 322 (362)
......+....+ ........+..+++.+.+|+.+||+.||.+||++.++++.|+.+........
T Consensus 295 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 295 PGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp TTCCHHHHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred CCCCHHHHHHHH-HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 998877665554 3455667788899999999999999999999999999999999987665443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=374.85 Aligned_cols=266 Identities=31% Similarity=0.580 Sum_probs=228.6
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
....|++..++|.+.+.||+|+||.||+|.++ +..||||++...... .+.+.+|+.++++++||||++++++
T Consensus 175 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~ 247 (452)
T 1fmk_A 175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-------PEAFLQEAQVMKKLRHEKLVQLYAV 247 (452)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC-------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 46789999999999999999999999999998 467999999875433 3568899999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
+.+ +..++||||+++|+|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 248 ~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~ 326 (452)
T 1fmk_A 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 326 (452)
T ss_dssp ECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred EcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcc
Confidence 876 6789999999999999999865434689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC--CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 205 SCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 205 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
+....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+. ...+.+.+..
T Consensus 327 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~ 405 (452)
T 1fmk_A 327 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 405 (452)
T ss_dssp TC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred ceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Confidence 97654322 2233456788999999999999999999999999999999 999999998877766654 4556677889
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccC
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 320 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~ 320 (362)
+|+.+.+||.+||+.||.+|||+.+|++.|+.+....+.
T Consensus 406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 999999999999999999999999999999988765443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=363.11 Aligned_cols=268 Identities=25% Similarity=0.475 Sum_probs=228.4
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEE-------CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCce
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIY-------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~i 118 (362)
...|++..++|.+.+.||+|+||.||+|.+ .+..||||++....... ..+.+.+|+.++.++ +||||
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~i 111 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-----EREALMSELKMMTQLGSHENI 111 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTB
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHH-----HHHHHHHHHHHHHhhcCCCCe
Confidence 356888899999999999999999999997 24579999997543221 136788999999999 89999
Q ss_pred eeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q 017994 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP---------------------YSVPLNLVLKLALDIARGMQYLHSQ 177 (362)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~LH~~ 177 (362)
+++++++...+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++
T Consensus 112 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 191 (344)
T 1rjb_A 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 191 (344)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999986542 2378999999999999999999999
Q ss_pred CccccCCCCCcEEEcCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-C
Q 017994 178 GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-A 253 (362)
Q Consensus 178 ~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g 253 (362)
||+||||||+||+++.++.++|+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 192 ~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 192 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271 (344)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999976544322 234456788999999999999999999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 254 LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 254 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
..||.+...................+..+++.+.+|+.+||+.||.+||++.++++.|+.+....+
T Consensus 272 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 272 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 999998776666666666667777788899999999999999999999999999999998766543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=360.74 Aligned_cols=266 Identities=30% Similarity=0.546 Sum_probs=228.9
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEECC-------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceee
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~ 120 (362)
..+.+..++|.+.+.||+|+||.||+|.+.+ +.||||++....... ..+.+.+|+.++++++||||++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~ 114 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-----MQADFQREAALMAEFDNPNIVK 114 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHH-----HHHHHHHHHHHHHTCCCTTBCC
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHH-----HHHHHHHHHHHHHhCCCCCEEE
Confidence 3466778999999999999999999999864 789999998654322 2467889999999999999999
Q ss_pred eeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 017994 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEP----------------------YSVPLNLVLKLALDIARGMQYLHSQG 178 (362)
Q Consensus 121 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~ 178 (362)
+++++...+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++|
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 194 (343)
T 1luf_A 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 194 (343)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999987431 36899999999999999999999999
Q ss_pred ccccCCCCCcEEEcCCCceEEeeeccccccccC---CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CC
Q 017994 179 ILHRDLKSENLLLGEDMCVKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-AL 254 (362)
Q Consensus 179 i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~ 254 (362)
|+||||||+||+++.++.+||+|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 999999999999999999999999998754332 22334567889999999999999999999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 255 TPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 255 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
.||.+....+....+.. ......+..+++.+.+++.+||+.||.+||++.++++.|+.+.+..+
T Consensus 275 ~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 275 QPYYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp CTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CcCCCCChHHHHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 99999888777666543 44456778899999999999999999999999999999999876654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=361.19 Aligned_cols=259 Identities=32% Similarity=0.520 Sum_probs=219.7
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
.+..++|.+++.||+|+||.||+|.+. ++.||+|++...... ..+.+.+|+.++++++||||+++++++.++
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE------TQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHH------HHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHH------HHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence 456789999999999999999999986 788999988654322 246788999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLM 158 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred CeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence 99999999999999999998754 36999999999999999999999999999999999999999999999999998754
Q ss_pred ccCCCC---------------CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHH-----HHH
Q 017994 209 SQCGSA---------------KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA-----AFA 268 (362)
Q Consensus 209 ~~~~~~---------------~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~-----~~~ 268 (362)
...... ....||+.|+|||++.+..++.++||||||+++|+|++|..||........ ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 238 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence 332221 145789999999999999999999999999999999999999876432110 011
Q ss_pred HHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccC
Q 017994 269 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 320 (362)
Q Consensus 269 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~ 320 (362)
.. ....+..+++.+.+++.+||+.||.+|||+.++++.|+.+...+..
T Consensus 239 ~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 239 FL----DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp HH----HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred cc----cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 11 1124567888999999999999999999999999999999877654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=357.82 Aligned_cols=247 Identities=16% Similarity=0.260 Sum_probs=219.1
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||++.+. ++.||+|++.....+ ...+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-------HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCccc-------HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 67999999999999999999996 789999999765332 356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC--CCceEEeeecccccccc
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE--DMCVKVADFGISCLESQ 210 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~--~~~~kl~Dfg~~~~~~~ 210 (362)
+||||++|++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999999997654 36899999999999999999999999999999999999987 78999999999987655
Q ss_pred CCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCCHHHHH
Q 017994 211 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSY 288 (362)
Q Consensus 211 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ 288 (362)
........+++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.......+. ...++.++.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T 1tki_A 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence 44445667899999999999888999999999999999999999999998888877776654433321 2578899999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 017994 289 LISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 289 li~~~l~~~p~~Rps~~ell~ 309 (362)
||.+||..||.+|||+.|+++
T Consensus 237 li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 237 FVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHhc
Confidence 999999999999999999997
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=344.63 Aligned_cols=259 Identities=28% Similarity=0.585 Sum_probs=228.6
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
.|.++.++|.+.+.||+|+||.||++.+. ++.||||++...... .+.+.+|+.++++++||||+++++++..
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 74 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-------EEDFIEEAEVMMKLSHPKLVQLYGVCLE 74 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-------HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-------HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 57788899999999999999999999985 778999999876544 2567889999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 75 QAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp SSSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred CCCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccc
Confidence 999999999999999999998754 3589999999999999999999999999999999999999999999999999875
Q ss_pred cccC--CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCH
Q 017994 208 ESQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284 (362)
Q Consensus 208 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
.... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+.. ......+..+++
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~ 232 (267)
T 3t9t_A 154 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLAST 232 (267)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTSCH
T ss_pred cccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc-CCcCCCCccCcH
Confidence 4322 12234556788999999999999999999999999999999 9999999888776666543 445566778899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
.+.+++.+||+.||.+||++.++++.|+.+.+
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 233 HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999998865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=348.75 Aligned_cols=263 Identities=29% Similarity=0.590 Sum_probs=215.8
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeee
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF 121 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~ 121 (362)
..+|++..++|.+.+.||+|+||.||+|.+. +..||||++....... ..+.+.+|+.++++++||||+++
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~ 81 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-----VREKFLQEALTMRQFDHPHIVKL 81 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHH-----HHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCccceE
Confidence 3567778899999999999999999999985 3469999987643322 24678899999999999999999
Q ss_pred eEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEee
Q 017994 122 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 201 (362)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~D 201 (362)
++++. ++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|
T Consensus 82 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 159 (281)
T 1mp8_A 82 IGVIT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 159 (281)
T ss_dssp EEEEC-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEc-cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECc
Confidence 99984 567889999999999999998654 3689999999999999999999999999999999999999999999999
Q ss_pred eccccccccCCC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 017994 202 FGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 278 (362)
Q Consensus 202 fg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (362)
||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+. .....+.
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~~~~ 238 (281)
T 1mp8_A 160 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPM 238 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCC
T ss_pred cccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCCCCC
Confidence 999876543322 233456788999999999999999999999999999997 999999887766665554 3445667
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 279 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 279 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
+..+++.+.+++.+||+.||.+||++.++++.|+.+.+.
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 788999999999999999999999999999999988654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=348.77 Aligned_cols=267 Identities=30% Similarity=0.571 Sum_probs=230.0
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
-.++|++..++|.+.+.||+|+||.||+|.+. +..||||++...... .+.+.+|+.+++.++||||++++++
T Consensus 4 ~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~ 76 (279)
T 1qpc_A 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-------PDAFLAEANLMKQLQHQRLVRLYAV 76 (279)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc-------HHHHHHHHHHHHhCCCcCcceEEEE
Confidence 35689999999999999999999999999987 568999999875443 3568899999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
+.. +..++||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 77 ~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 155 (279)
T 1qpc_A 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155 (279)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcc
Confidence 864 5688999999999999999765433589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC--CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 205 SCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 205 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
+....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+. .......+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (279)
T 1qpc_A 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDN 234 (279)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred cccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCCccc
Confidence 87654322 2234456788999999998889999999999999999999 999999988777665554 3445566788
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCC
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 321 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~ 321 (362)
+++.+.+++.+||+.||.+||++.++++.|+.+.......
T Consensus 235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 9999999999999999999999999999999987765543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=360.50 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=219.7
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++......... .+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 57999999999999999999986 789999999875443221 356789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CceEEeeeccccccc
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---MCVKVADFGISCLES 209 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~---~~~kl~Dfg~~~~~~ 209 (362)
+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++....
T Consensus 105 lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999999998765 58999999999999999999999999999999999999765 459999999998766
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCCHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFS 287 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~ 287 (362)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+.......+.+ ..+++.+.
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 5555556789999999999999899999999999999999999999999988877777766554433322 46789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~~ 310 (362)
+||.+||+.||.+||++.++++.
T Consensus 263 ~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999998863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=352.26 Aligned_cols=262 Identities=26% Similarity=0.503 Sum_probs=217.2
Q ss_pred cccccCeeeeeeecccCCeeEEEEEE------CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIY------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
.+...+|++.+.||+|+||.||+|.+ .++.||||++....... .+.+.+|+.++++++||||++++++
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~ 79 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH------LRDFEREIEILKSLQHDNIVKYKGV 79 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHH------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHH------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34568899999999999999999985 36889999998654322 3678899999999999999999999
Q ss_pred EEe--CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 125 CKK--PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 125 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
+.. ....++||||+++++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp ECHHHHTSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred EecCCCCceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccC
Confidence 854 3568999999999999999987542 5899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC----CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHH--------------
Q 017994 203 GISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-------------- 264 (362)
Q Consensus 203 g~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~-------------- 264 (362)
|++....... ......++..|+|||++.+..++.++||||||+++|+|++|..|+.......
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 9997654322 1233456778999999999999999999999999999999999986532211
Q ss_pred -HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 265 -AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 265 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
............+.+..+++.+.+|+.+||+.||.+|||+.++++.|+.+.+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 1222334455667788999999999999999999999999999999999887653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=349.22 Aligned_cols=264 Identities=30% Similarity=0.604 Sum_probs=233.3
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
...|++...+|.+.+.||+|+||.||+|.+. +..||||++...... .+.+.+|+.++++++||||++++++
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~ 77 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLGV 77 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH-------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4578888999999999999999999999997 789999999865443 3678899999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
+.+++..++||||+++++|.+++.......+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||+
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred EccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence 99999999999999999999999887666799999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 205 SCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 205 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
+........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+.......+ ........+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (288)
T 3kfa_A 158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEG 236 (288)
T ss_dssp GGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTT
T ss_pred ceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hccCCCCCCCC
Confidence 876543322 233456788999999999999999999999999999999 99999988776655444 34556677788
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l 318 (362)
+++.+.+|+.+||+.||.+||++.++++.|+.+....
T Consensus 237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999999876643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=362.58 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=213.6
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKP 128 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~ 128 (362)
...++|++.+.||+|+||.||+|.++ ++.||||++...... .......+.+|..++..+ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~---~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL---QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH---HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc---chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 44688999999999999999999986 689999999753211 111235677899999988 799999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
+.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999999998765 5999999999999999999999999999999999999999999999999998753
Q ss_pred c-cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHH
Q 017994 209 S-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287 (362)
Q Consensus 209 ~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 287 (362)
. ........+||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....+... ...++..+++.+.
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~ 252 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLHEDAT 252 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHH
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHH
Confidence 3 223345678999999999999999999999999999999999999999999988887777654 3456778999999
Q ss_pred HHHHHhcccCCCCCCCH------HHHHH
Q 017994 288 YLISRCWSSSPDRRPHF------DQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~------~ell~ 309 (362)
+||.+||+.||.+||++ .++++
T Consensus 253 ~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 253 GILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 99999999999999998 66665
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=361.56 Aligned_cols=264 Identities=28% Similarity=0.418 Sum_probs=216.6
Q ss_pred CCCcccccccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 44 GEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
..+..+|.++..+|++.+.||+|+||.||+|.+.++.||||++...... ......|+.++++++||||+++++
T Consensus 13 ~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~ 85 (322)
T 3soc_A 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQ-------SWQNEYEVYSLPGMKHENILQFIG 85 (322)
T ss_dssp -CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHH-------HHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred ccCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCchH-------HHHHHHHHHHHhcCCCCCchhhcc
Confidence 3456778888999999999999999999999999999999999654322 234556999999999999999999
Q ss_pred EEEeCC----eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CccccCCCCCcE
Q 017994 124 ACKKPP----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ----------GILHRDLKSENL 189 (362)
Q Consensus 124 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~i~H~dlk~~Ni 189 (362)
++.... .+++||||+++|+|.++++.. .+++..++.++.|++.||.|||+. ||+||||||+||
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Ni 162 (322)
T 3soc_A 86 AEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNV 162 (322)
T ss_dssp EEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGE
T ss_pred eeccCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhE
Confidence 998754 479999999999999999875 489999999999999999999999 999999999999
Q ss_pred EEcCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcC-----CCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 017994 190 LLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEK-----RHTKKVDVYSFGIVLWELLTALTPFDNMT 261 (362)
Q Consensus 190 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~slG~~l~ell~g~~p~~~~~ 261 (362)
+++.++.+||+|||++........ .....||+.|+|||++.+. .++.++||||||+++|+|++|..||.+..
T Consensus 163 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 163 LLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp EECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred EECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999999999975443222 3346789999999999863 45678899999999999999999997532
Q ss_pred ----------------HHHHHHHHHhcCCCCCCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 262 ----------------PEQAAFAVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 262 ----------------~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
..............+..+.. .++.+.+||.+||+.||.+|||+.++++.|+.+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 22222223223333332221 235699999999999999999999999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=357.95 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=219.1
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
.+|.+.+.||+|+||.||++.+. ++.||||++..............+.+.+|+.+++.++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56999999999999999999986 7899999998754321110001356889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC----ceEEeeecccccc
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM----CVKVADFGISCLE 208 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~----~~kl~Dfg~~~~~ 208 (362)
+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 91 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 9999999999999998654 689999999999999999999999999999999999998877 7999999999876
Q ss_pred ccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCCHHH
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAF 286 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 286 (362)
..........||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+.......+ ....++..+
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 248 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHH
Confidence 555555567899999999999989999999999999999999999999998888777666654433222 225678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+||.+||+.||.+|||+.++++
T Consensus 249 ~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 249 KDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHhc
Confidence 99999999999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=353.25 Aligned_cols=266 Identities=28% Similarity=0.534 Sum_probs=230.2
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCce
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i 118 (362)
....|.+..++|.+.+.||+|+||.||+|.+. ++.||||++........ .+.+.+|+.++++++||||
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~i 88 (314)
T 2ivs_A 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-----LRDLLSEFNVLKQVNHPHV 88 (314)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHH-----HHHHHHHHHHHTTCCCTTB
T ss_pred CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHH-----HHHHHHHHHHHhhCCCCce
Confidence 34677888899999999999999999999872 37899999986543221 3678899999999999999
Q ss_pred eeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 017994 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP----------------------YSVPLNLVLKLALDIARGMQYLHS 176 (362)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~l~~LH~ 176 (362)
+++++++...+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 168 (314)
T 2ivs_A 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168 (314)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999987542 238899999999999999999999
Q ss_pred CCccccCCCCCcEEEcCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-
Q 017994 177 QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT- 252 (362)
Q Consensus 177 ~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~- 252 (362)
+||+||||||+||+++.++.++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++
T Consensus 169 ~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 248 (314)
T 2ivs_A 169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248 (314)
T ss_dssp TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999987543322 2234457788999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 253 ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 253 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
|..||.+.........+ ........+..+++.+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 249 g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 249 GGNPYPGIPPERLFNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp SCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCCCHHHHHHHh-hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 99999988776655444 34455667788999999999999999999999999999999987653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=361.44 Aligned_cols=263 Identities=26% Similarity=0.479 Sum_probs=225.8
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeee
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~ 122 (362)
+.+..++|.+.+.||+|+||.||+|.+. ++.||||++........ ...+.+|+.++++++||||++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~ 140 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-----ELDFLMEALIISKFNHQNIVRCI 140 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHH-----HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhh-----HHHHHHHHHHHHhCCCCCCCeEE
Confidence 4556789999999999999999999953 45799999975433322 35678899999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC--
Q 017994 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEP-----YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-- 195 (362)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~-- 195 (362)
+++......++||||++||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 220 (367)
T 3l9p_A 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220 (367)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCC
Confidence 999999999999999999999999987542 3589999999999999999999999999999999999999555
Q ss_pred -ceEEeeeccccccccC---CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 017994 196 -CVKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVC 270 (362)
Q Consensus 196 -~~kl~Dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~ 270 (362)
.+||+|||++...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+.
T Consensus 221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 5999999998743222 22334567899999999999999999999999999999998 999999988877766654
Q ss_pred hcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 017994 271 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318 (362)
Q Consensus 271 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l 318 (362)
. ......+..++..+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus 301 ~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 301 S-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp T-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred c-CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 3 4456667889999999999999999999999999999999887643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=365.80 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=218.3
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||++.+. ++.||+|++......... .+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD----HQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHH----HHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 67999999999999999999986 789999999876543321 356889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc---CCCceEEeeeccccccc
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG---EDMCVKVADFGISCLES 209 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~---~~~~~kl~Dfg~~~~~~ 209 (362)
+||||+.||+|.+.+.... .+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++....
T Consensus 87 lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999999998765 599999999999999999999999999999999999998 46789999999997654
Q ss_pred cCC-CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCCHHH
Q 017994 210 QCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAF 286 (362)
Q Consensus 210 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l 286 (362)
... ......||+.|+|||++.+..++.++||||||+++|+|++|.+||.+.+.......+.......+. ...+++.+
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 432 234568999999999999989999999999999999999999999998888877777665544333 25789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+||.+||+.||.+|||+.|+++
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999999999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=375.99 Aligned_cols=262 Identities=30% Similarity=0.612 Sum_probs=232.2
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
...|++...+|.+.+.||+|+||.||+|.+. +..||||++...... .+.+.+|+.++++++||||++++++
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~ 284 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLGV 284 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc-------hHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4678899999999999999999999999997 789999999875443 3678899999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
+...+.+++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 285 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 364 (495)
T 1opk_A 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL 364 (495)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred EecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccc
Confidence 99999999999999999999999876655799999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC--CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 205 SCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 205 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
+....... ......+++.|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+ ........+..
T Consensus 365 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~ 443 (495)
T 1opk_A 365 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEG 443 (495)
T ss_dssp EECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTT
T ss_pred ceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCC
Confidence 97654321 2233456788999999999999999999999999999999 99999988876655443 44566677889
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
+++.+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 444 ~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 444 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999999987643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=352.93 Aligned_cols=248 Identities=24% Similarity=0.390 Sum_probs=218.7
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
..++|.+.+.||+|+||.||++.+. ++.||||++....... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 80 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR---LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ 80 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCE
Confidence 4578999999999999999999986 7899999987532111 0113567789999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
+|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999999998765 589999999999999999999999999999999999999999999999999976443
Q ss_pred CCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 211 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 211 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
.....+||+.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+... ...++..+++++.++|
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li 234 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLL 234 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHH
Confidence 334568999999999999999999999999999999999999999998887777776654 3456778999999999
Q ss_pred HHhcccCCCCCC-----CHHHHHH
Q 017994 291 SRCWSSSPDRRP-----HFDQIVS 309 (362)
Q Consensus 291 ~~~l~~~p~~Rp-----s~~ell~ 309 (362)
.+||..||.+|| ++.++++
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhccCHHHcCCCcCCCHHHHhc
Confidence 999999999999 8888885
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=348.86 Aligned_cols=259 Identities=29% Similarity=0.544 Sum_probs=219.1
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
...|.++.++|.+.+.||+|+||.||++.++++.||||++..... .+.+.+|+.++++++||||+++++++.
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIV 84 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhH--------HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 456788889999999999999999999999999999999976532 366889999999999999999999875
Q ss_pred eC-CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 127 KP-PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 127 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
.. +..++||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred cCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccc
Confidence 44 57899999999999999998764334889999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCH
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
...... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+..+++
T Consensus 165 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 241 (278)
T 1byg_A 165 KEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPP 241 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCH
T ss_pred cccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCCH
Confidence 754432 233457889999999999999999999999999999998 999999877766555443 3445667788999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
.+.++|.+||+.||.+||++.++++.|+.+..
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 242 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 99999999999999999999999999998865
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=355.59 Aligned_cols=266 Identities=26% Similarity=0.507 Sum_probs=231.0
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEECC-------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCce
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~i 118 (362)
...|++..++|.+.+.||+|+||.||+|.+.+ ..||||++........ .+.+.+|+.+++.+ +||||
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~~i 112 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE-----KEALMSELKIMSHLGQHENI 112 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTTB
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHH-----HHHHHHHHHHHHhhcCCCCe
Confidence 45688889999999999999999999999853 3699999987543221 46788999999999 89999
Q ss_pred eeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 017994 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQE------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 186 (362)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~ 186 (362)
+++++++...+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||++||+||||||
T Consensus 113 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 192 (333)
T 2i1m_A 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAA 192 (333)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred eeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCccc
Confidence 999999999999999999999999999997542 23579999999999999999999999999999999
Q ss_pred CcEEEcCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCH
Q 017994 187 ENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 262 (362)
Q Consensus 187 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~ 262 (362)
+||+++.++.++|+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp GGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred ceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 999999999999999999975543222 234456789999999999999999999999999999999 9999998776
Q ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 263 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
................+..+++.+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 6666666666667777888899999999999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=347.32 Aligned_cols=265 Identities=32% Similarity=0.635 Sum_probs=211.2
Q ss_pred CCcccccccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 45 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
...+.+++..++|.+.+.||+|+||.||+|.+.+ .||||++......... .+.+.+|+.++++++||||++++++
T Consensus 14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (289)
T 3og7_A 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILLFMGY 88 (289)
T ss_dssp ----CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHH----HHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHH----HHHHHHHHHHHHhCCCCcEEEEEee
Confidence 3456677888999999999999999999999876 4999999876544322 3678899999999999999999996
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
. .....++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+
T Consensus 89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 89 S-TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL 166 (289)
T ss_dssp E-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred c-cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcccee
Confidence 5 5567899999999999999997654 3689999999999999999999999999999999999999999999999999
Q ss_pred ccccccC---CCCCcccccccccChhhhh---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-C-
Q 017994 205 SCLESQC---GSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-P- 276 (362)
Q Consensus 205 ~~~~~~~---~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~- 276 (362)
+...... .......|++.|+|||++. +..++.++||||||+++|+|++|..||......+........... +
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence 8754331 2233457899999999986 566788999999999999999999999887665554444433322 2
Q ss_pred --CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 277 --PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 277 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
.....+|+.+.+|+.+||+.||.+||++.++++.|+.+.+
T Consensus 247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 2345788999999999999999999999999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=356.56 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=219.7
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
...++|.+.+.||+|+||.||++.+. ++.||||++....... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 114 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK---LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34678999999999999999999986 7899999986532111 011356788999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.+|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 9999999999999999998765 58999999999999999999999999999999999999999999999999997654
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
. .....+||+.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+... ...++..+++.+.++
T Consensus 193 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~l 268 (350)
T 1rdq_E 193 G--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDL 268 (350)
T ss_dssp S--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHH
T ss_pred C--CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHH
Confidence 3 234568999999999999999999999999999999999999999998888777777654 345677899999999
Q ss_pred HHHhcccCCCCCCC-----HHHHHH
Q 017994 290 ISRCWSSSPDRRPH-----FDQIVS 309 (362)
Q Consensus 290 i~~~l~~~p~~Rps-----~~ell~ 309 (362)
|.+||+.||.+||+ +.++++
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHhhcCHHhccCCccCCHHHHHh
Confidence 99999999999998 778775
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=360.88 Aligned_cols=248 Identities=20% Similarity=0.347 Sum_probs=210.4
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEE
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACK 126 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~ 126 (362)
.....++|.+.+.||+|+||.||++.++ ++.||||++........ ...+.+.+|..++.++ +||||+++++++.
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~---~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-------CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH---HHHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 4456789999999999999999999987 67899999986432211 1124567899999877 8999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
+.+.+++||||++||+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence 9999999999999999999998765 59999999999999999999999999999999999999999999999999997
Q ss_pred c-cccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCC---------HHHHHHHHHhcCCCC
Q 017994 207 L-ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT---------PEQAAFAVCQKNARP 276 (362)
Q Consensus 207 ~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~---------~~~~~~~~~~~~~~~ 276 (362)
. ..........+||+.|+|||++.+..++.++|+||||+++|+|++|..||.... .......+. ....
T Consensus 202 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~--~~~~ 279 (396)
T 4dc2_A 202 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQI 279 (396)
T ss_dssp CCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH--HCCC
T ss_pred ecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh--cccc
Confidence 5 333344567789999999999999999999999999999999999999996432 122222332 3445
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 017994 277 PVPPTCPKAFSYLISRCWSSSPDRRPHF 304 (362)
Q Consensus 277 ~~~~~~~~~l~~li~~~l~~~p~~Rps~ 304 (362)
.+|..+++++.+||.+||+.||.+||++
T Consensus 280 ~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 6778899999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=376.68 Aligned_cols=266 Identities=31% Similarity=0.579 Sum_probs=232.8
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
....|++..++|.+.+.||+|+||.||+|.+. +..||||++...... .+.|.+|+.+|++++||||++++++
T Consensus 258 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~ 330 (535)
T 2h8h_A 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-------PEAFLQEAQVMKKLRHEKLVQLYAV 330 (535)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC-------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 46789999999999999999999999999998 468999999875433 3568899999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
+.+ +..++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 331 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp ECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred Eee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccc
Confidence 876 6789999999999999999864434689999999999999999999999999999999999999999999999999
Q ss_pred ccccccC--CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 205 SCLESQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 205 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
+...... .......++..|+|||++.+..++.++||||||+++|||++ |..||.+....+....+. ...+.+.+..
T Consensus 410 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~ 488 (535)
T 2h8h_A 410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPE 488 (535)
T ss_dssp TTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred ceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Confidence 9764332 12234456788999999999999999999999999999999 999999988877766654 4556667788
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccC
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 320 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~ 320 (362)
++..+.+||.+||+.||++||++.+|+++|+.+....+.
T Consensus 489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 999999999999999999999999999999988665443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=361.07 Aligned_cols=261 Identities=31% Similarity=0.564 Sum_probs=215.6
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
.+++..+|.+.+.||+|+||.||+|.+. +..||||++....... ..+.+.+|+.++++++||||++++++
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-----QRRDFLGEASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHH-----HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHH-----HHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3556789999999999999999999875 5679999997653322 24678899999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
+...+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 115 ~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 115 VTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EeeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 999999999999999999999998754 3689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC----CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 017994 205 SCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 279 (362)
Q Consensus 205 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (362)
+........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .....+.+
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~ 272 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPP 272 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCC
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 876543221 122345678999999999999999999999999999998 999999988877666554 34455667
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
..++..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 273 ~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 78899999999999999999999999999999988764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=357.43 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=217.2
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEe
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKK 127 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~ 127 (362)
....++|.+.+.||+|+||.||+|.++ ++.||||++....... ......+..|..++..+ +||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM---DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 89 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh---hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 345688999999999999999999986 7899999997532110 00124567788998876 89999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999999998765 589999999999999999999999999999999999999999999999999875
Q ss_pred ccc-CCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHH
Q 017994 208 ESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286 (362)
Q Consensus 208 ~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (362)
... .......+||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....+... .+.++..+++++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~ 245 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEA 245 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHH
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCCCCcccCHHH
Confidence 432 23345678999999999999999999999999999999999999999998888777766543 355677899999
Q ss_pred HHHHHHhcccCCCCCCCHH-HHHH
Q 017994 287 SYLISRCWSSSPDRRPHFD-QIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~-ell~ 309 (362)
.+||.+||..||.+||++. ++++
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHhcCCHhHcCCChHHHHc
Confidence 9999999999999999997 6653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=360.31 Aligned_cols=254 Identities=20% Similarity=0.348 Sum_probs=216.6
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
...+..++|.+.+.||+|+||.||++.+. ++.||||++....... ....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE---RNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34566789999999999999999999987 6789999986532111 111356788999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
+....|+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++.
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA 163 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceee
Confidence 9999999999999999999998765 59999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCcccccccccChhhhhc---CCCCCcccchhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCCCCC
Q 017994 207 LESQCGSAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQKNARPPVPP 280 (362)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~ 280 (362)
...........+||+.|+|||++.+ ..++.++||||||+++|+|++|..||.... .......+. ......+.
T Consensus 164 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~p~ 241 (384)
T 4fr4_A 164 MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--TTVVTYPS 241 (384)
T ss_dssp ECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH--HCCCCCCT
T ss_pred eccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--hcccCCCC
Confidence 7666556667889999999999864 458999999999999999999999997533 233333322 34456778
Q ss_pred CCCHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 017994 281 TCPKAFSYLISRCWSSSPDRRPH-FDQIVS 309 (362)
Q Consensus 281 ~~~~~l~~li~~~l~~~p~~Rps-~~ell~ 309 (362)
.+++.+.+||.+||+.||.+||+ +.++++
T Consensus 242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 89999999999999999999998 666664
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=351.76 Aligned_cols=245 Identities=20% Similarity=0.361 Sum_probs=210.3
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCC
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPP 129 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 129 (362)
..++|.+.+.||+|+||.||++.++ ++.||||++........ ...+.+.+|+.++.++ +||||+++++++.+..
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSH---HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcch---HHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 4578999999999999999999986 78999999986532221 1235677899999987 8999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999999998765 58999999999999999999999999999999999999999999999999997533
Q ss_pred -cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCC---------CHHHHHHHHHhcCCCCCCC
Q 017994 210 -QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM---------TPEQAAFAVCQKNARPPVP 279 (362)
Q Consensus 210 -~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~---------~~~~~~~~~~~~~~~~~~~ 279 (362)
........+||+.|+|||++.+..++.++|+||||+++|+|++|..||... ........+.. ....++
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p 239 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIP 239 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH--CCCCCC
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc--CCCCCC
Confidence 223445678999999999999999999999999999999999999999752 22222233332 345567
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCH
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHF 304 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~ 304 (362)
..++..+.+||.+||+.||.+||++
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 8899999999999999999999996
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=342.70 Aligned_cols=266 Identities=27% Similarity=0.538 Sum_probs=228.1
Q ss_pred cccccccCeeeee-eecccCCeeEEEEEEC----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 49 EWSADMSQLFIGC-KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 49 ~~~~~~~~~~~~~-~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
.|.+..++|.+.+ .||+|+||.||+|.+. +..||||++....... ..+.+.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~ 77 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-----DTEEMMREAQIMHQLDNPYIVRLIG 77 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH-----HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchh-----HHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 4566678888887 9999999999999863 6789999998754322 2467889999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
++ ..+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||
T Consensus 78 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 78 VC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred Ee-cCCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccc
Confidence 99 5567899999999999999997643 368999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC----CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 017994 204 ISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 278 (362)
Q Consensus 204 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (362)
++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. ....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~~ 234 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMEC 234 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCC
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCCC
Confidence 9876543221 233456889999999998889999999999999999998 999999888776665544 3455677
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCCC
Q 017994 279 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 322 (362)
Q Consensus 279 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~~ 322 (362)
+..+++.+.++|.+||+.||.+||++.++++.|+.+........
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 88999999999999999999999999999999999887766544
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=355.14 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=217.3
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKP 128 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~ 128 (362)
...++|.+.+.||+|+||.||+|.++ ++.||||++....... ......+..|..++..+ +||||+++++++.+.
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~---~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ---DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc---chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 44688999999999999999999997 5789999987532110 01135677899999988 799999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
+.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999999998765 5899999999999999999999999999999999999999999999999998753
Q ss_pred c-cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHH
Q 017994 209 S-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287 (362)
Q Consensus 209 ~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 287 (362)
. ........+||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....+... ...++..+++++.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~ 249 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAV 249 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHH
Confidence 3 223445678999999999999999999999999999999999999999998888877777654 3456788999999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHHH
Q 017994 288 YLISRCWSSSPDRRPH-----FDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps-----~~ell~ 309 (362)
+||.+||+.||.+||+ +.++++
T Consensus 250 ~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 250 AICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 9999999999999995 466654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=355.66 Aligned_cols=250 Identities=25% Similarity=0.330 Sum_probs=203.8
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
.+..+|.+.+.||+|+||.||++.+. ++.||||++....... +.+.+|+.+++.++||||+++++++....
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-------ENVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC-------HHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc-------HHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 34678999999999999999999996 7889999998654332 45778999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc--eEEeeeccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC--VKVADFGISCL 207 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~--~kl~Dfg~~~~ 207 (362)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 9999999999999999998765 5999999999999999999999999999999999999987765 99999999875
Q ss_pred cccCCCCCcccccccccChhhhhcCCCCCc-ccchhhhHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCCCCCCCCCC
Q 017994 208 ESQCGSAKGFTGTYRWMAPEMIKEKRHTKK-VDVYSFGIVLWELLTALTPFDNMTP----EQAAFAVCQKNARPPVPPTC 282 (362)
Q Consensus 208 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~~l~ell~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~ 282 (362)
...........||+.|+|||++.+..++.+ +||||||+++|+|++|..||.+... ......+.......+....+
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (361)
T 3uc3_A 168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI 247 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCC
T ss_pred ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCC
Confidence 544444556789999999999988877655 8999999999999999999987543 33334444444444445578
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
++.+.+||.+||+.||.+|||+.|+++.
T Consensus 248 s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 248 SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 9999999999999999999999999974
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=350.52 Aligned_cols=268 Identities=25% Similarity=0.503 Sum_probs=229.0
Q ss_pred CCcccccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCC
Q 017994 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHP 116 (362)
Q Consensus 45 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp 116 (362)
.....|.+..++|.+.+.||+|+||.||+|.+. ++.||||++........ .+.+.+|+.++.++ +||
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~hp 91 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHL 91 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCT
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHH-----HHHHHHHHHHHHhcccCC
Confidence 345677888899999999999999999999852 47899999987543321 35688999999999 799
Q ss_pred ceeeeeEEEEeCC-eEEEEEecCCCCCHHHHHhhcCCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 017994 117 HIITFVAACKKPP-VFCIITEYLAGGSLRKYLHQQEPY--------------SVPLNLVLKLALDIARGMQYLHSQGILH 181 (362)
Q Consensus 117 ~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~--------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H 181 (362)
||+++++++...+ ..++||||+++++|.+++...... .+++..++.++.|++.||.|||++||+|
T Consensus 92 ~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H 171 (316)
T 2xir_A 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 171 (316)
T ss_dssp TBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred CeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 9999999987654 589999999999999999875421 2789999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCC
Q 017994 182 RDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPF 257 (362)
Q Consensus 182 ~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~ 257 (362)
|||||+||+++.++.+||+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999875543222 234557889999999999999999999999999999998 99999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 258 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
.+...................+..+++.+.+++.+||+.||.+||++.++++.|+.+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 252 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp TTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 887655555555555666677788999999999999999999999999999999988764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=351.05 Aligned_cols=268 Identities=26% Similarity=0.531 Sum_probs=231.3
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEEC---------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CC
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NH 115 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h 115 (362)
....|.+..++|.+++.||+|+||.||+|.+. +..||||++........ .+.+.+|+.+++++ +|
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h 100 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-----LSDLVSEMEMMKMIGKH 100 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHH-----HHHHHHHHHHHHHHCCC
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHH-----HHHHHHHHHHHHHhhcC
Confidence 45678888899999999999999999999874 45799999986543322 36688999999999 89
Q ss_pred CceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 017994 116 PHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILH 181 (362)
Q Consensus 116 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H 181 (362)
|||+++++++...+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+|
T Consensus 101 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 180 (334)
T 2pvf_A 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH 180 (334)
T ss_dssp TTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 9999999999999999999999999999999986542 24889999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCC
Q 017994 182 RDLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPF 257 (362)
Q Consensus 182 ~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~ 257 (362)
|||||+||+++.++.+||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 181 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 260 (334)
T 2pvf_A 181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260 (334)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999999999987554322 2234456788999999999889999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 258 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
.+....+....+. .......+..++..+.++|.+||+.||.+||++.++++.|+.+.....
T Consensus 261 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 261 PGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp TTCCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CcCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 9988776655544 345566778899999999999999999999999999999999876544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=340.88 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=220.3
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||+|.+. ++.||+|++......... .+.+.+|+.++++++||||+++++++......+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHH----HHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 67999999999999999999986 789999999765433221 356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc---eEEeeeccccccc
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC---VKVADFGISCLES 209 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~---~kl~Dfg~~~~~~ 209 (362)
+||||+++++|.+.+.... .+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||++....
T Consensus 82 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999999998765 5899999999999999999999999999999999999986655 9999999998766
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCCCCHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFS 287 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~ 287 (362)
.........+++.|+|||++.+..++.++||||||+++|+|++|..||.+.........+.......+. ...+++.+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 655556678999999999999999999999999999999999999999998888777776655444333 357899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~ 309 (362)
+||.+||+.||.+||++.|+++
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHcccChhhCCCHHHHhc
Confidence 9999999999999999999997
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=346.41 Aligned_cols=259 Identities=33% Similarity=0.625 Sum_probs=214.8
Q ss_pred ccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
++.++|.+.+.||+|+||.||+|.+.++.||||++..... .+.+.+|+.++++++||||+++++++.+ ..
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 74 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE--------RKAFIVELRQLSRVNHPNIVKLYGACLN--PV 74 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTH--------HHHHHHHHHHHHHCCCTTBCCEEEBCTT--TT
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhH--------HHHHHHHHHHHhcCCCCCcCeEEEEEcC--Cc
Confidence 4568899999999999999999999999999999875432 3678899999999999999999998763 47
Q ss_pred EEEEecCCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCCCcEEEcCCCc-eEEeeecccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHS---QGILHRDLKSENLLLGEDMC-VKVADFGISC 206 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~dlk~~Nil~~~~~~-~kl~Dfg~~~ 206 (362)
++||||+++++|.+++..... ..++...++.++.|++.||.|||+ +||+||||||+||+++.++. +||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 899999999999999986542 247889999999999999999999 89999999999999998886 7999999987
Q ss_pred ccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCCCCCCCHH
Q 017994 207 LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
..... .....|++.|+|||++.+..++.++||||||+++|+|++|..||...... ............+..+..+++.
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (307)
T 2eva_A 155 DIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 232 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHH
T ss_pred ccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHH
Confidence 54332 23446899999999999999999999999999999999999999864322 2222223345556677889999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCCC
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 322 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~~ 322 (362)
+.+++.+||+.||.+|||+.++++.|+.+.+.+....
T Consensus 233 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 9999999999999999999999999999987765543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=350.96 Aligned_cols=265 Identities=29% Similarity=0.525 Sum_probs=228.8
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCce
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i 118 (362)
...+|++..++|.+.+.||+|+||.||+|.+. ++.||||++........ ...+.+|+.+++.++||||
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i 90 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-----RIEFLNEASVMKEFNCHHV 90 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHH-----HHHHHHHHHHGGGCCCTTB
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHH-----HHHHHHHHHHHHhcCCCCE
Confidence 45678888899999999999999999999875 46899999986543321 3568899999999999999
Q ss_pred eeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 017994 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 190 (362)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil 190 (362)
+++++++.+....++||||+++++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl 170 (322)
T 1p4o_A 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 170 (322)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEE
Confidence 999999999999999999999999999997532 124789999999999999999999999999999999999
Q ss_pred EcCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHH
Q 017994 191 LGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAA 266 (362)
Q Consensus 191 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~ 266 (362)
++.++.+||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+..
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 250 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence 9999999999999987543322 1223456889999999999999999999999999999999 89999998887766
Q ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 267 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
..+.. ......+..++..+.++|.+||+.||.+||++.++++.|+....
T Consensus 251 ~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 251 RFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 66544 34456678899999999999999999999999999999987654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=343.48 Aligned_cols=265 Identities=26% Similarity=0.518 Sum_probs=222.9
Q ss_pred cccccccccCeeeee-eecccCCeeEEEEEEC----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeee
Q 017994 47 EEEWSADMSQLFIGC-KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF 121 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~-~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~ 121 (362)
..++.++..+|.+.+ .||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||+++
T Consensus 8 ~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~ 83 (291)
T 1xbb_A 8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAEANVMQQLDNPYIVRM 83 (291)
T ss_dssp ---CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH----HHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHH----HHHHHHHHHHHHHhCCCCCEEEE
Confidence 456677788999998 9999999999999653 57899999986543322 24678899999999999999999
Q ss_pred eEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEee
Q 017994 122 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 201 (362)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~D 201 (362)
++++ ..+..++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|
T Consensus 84 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp EEEE-ESSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred EEEE-CCCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEcc
Confidence 9999 5677899999999999999998765 589999999999999999999999999999999999999999999999
Q ss_pred eccccccccCCC----CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCC
Q 017994 202 FGISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 276 (362)
Q Consensus 202 fg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 276 (362)
||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. ....+
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~ 239 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERM 239 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCC
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 999875543222 122345788999999998889999999999999999999 999999988876655544 44556
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 277 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 277 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
..+..+++.+.++|.+||+.||.+||++.++++.|+.+-....
T Consensus 240 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 240 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 6788899999999999999999999999999999998876544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=356.79 Aligned_cols=254 Identities=22% Similarity=0.320 Sum_probs=212.0
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHH-HHcCCCCceeeeeEEEEe
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVAL-LFRLNHPHIITFVAACKK 127 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~-l~~l~hp~iv~~~~~~~~ 127 (362)
....++|.+.+.||+|+||.||++.++ ++.||||++......... ....+.+|..+ ++.++||||+++++++.+
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~---~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~ 110 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK---EEKHIMSERNVLLKNVKHPFLVGLHFSFQT 110 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC----------------CCBCCCCCTTBCCEEEEEEC
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH---HHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence 345688999999999999999999997 678999999765432211 12445667766 567899999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
.+.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 999999999999999999998765 589999999999999999999999999999999999999999999999999875
Q ss_pred cc-cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHH
Q 017994 208 ES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286 (362)
Q Consensus 208 ~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (362)
.. ........+||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....+... ...++..++..+
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~ 266 (373)
T 2r5t_A 189 NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSA 266 (373)
T ss_dssp GBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--CCCCCSSSCHHH
T ss_pred cccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHHH
Confidence 33 333455678999999999999999999999999999999999999999998888777776654 345667899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVSIL 311 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~~L 311 (362)
.+||.+||+.||.+||++.+.++.+
T Consensus 267 ~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 267 RHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp HHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred HHHHHHHcccCHHhCCCCCCCHHHH
Confidence 9999999999999999986444333
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=348.38 Aligned_cols=264 Identities=30% Similarity=0.530 Sum_probs=222.1
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEECC------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeee
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQ------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~ 122 (362)
.+++..++|.+.+.||+|+||.||+|.+.. ..||||++....... ....+.+|+.++++++||||++++
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~ 112 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-----QRVDFLGEAGIMGQFSHHNIIRLE 112 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHH-----HHHHHHHHHHHHHhCCCCCCCcEE
Confidence 346677899999999999999999998752 359999998654322 145788999999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
+++...+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus 113 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 113 GVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp EEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCC
Confidence 99999999999999999999999998754 36899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC----CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC
Q 017994 203 GISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 277 (362)
Q Consensus 203 g~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 277 (362)
|++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .....+
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~ 270 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLP 270 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCC
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CCCcCC
Confidence 99876543221 223345788999999999999999999999999999999 999999888877666554 344566
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 278 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
.+..+++.+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 677899999999999999999999999999999998876533
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=347.46 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=211.2
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHH--------------------HHHHHHHHHHHHHHH
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASL--------------------ASMLEKQFTSEVALL 110 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~--------------------~~~~~~~~~~Ei~~l 110 (362)
..++|.+.+.||+|+||.||+|.+. ++.||||++......... .....+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4578999999999999999999986 789999999765422110 011135688999999
Q ss_pred HcCCCCceeeeeEEEEe--CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 017994 111 FRLNHPHIITFVAACKK--PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 188 (362)
Q Consensus 111 ~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~N 188 (362)
++++||||+++++++.+ ....++||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999999986 57899999999999998865443 58999999999999999999999999999999999
Q ss_pred EEEcCCCceEEeeeccccccccCC-CCCcccccccccChhhhhcCC---CCCcccchhhhHHHHHHHhCCCCCCCCCHHH
Q 017994 189 LLLGEDMCVKVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 264 (362)
Q Consensus 189 il~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~ 264 (362)
|+++.++.+||+|||++....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.......
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 999999999999999987654322 234567899999999997665 3788999999999999999999999888777
Q ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 265 AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
....+.......+....+++.+.+||.+||+.||.+||++.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 666666555555556788999999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=341.87 Aligned_cols=262 Identities=28% Similarity=0.532 Sum_probs=221.5
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEECC-----eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeee
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~ 122 (362)
..|.+..++|.+.+.||+|+||.||+|.+.+ ..||||++....... ..+.+.+|+.+++.++||||++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~ 79 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-----NKEKFMSEAVIMKNLDHPHIVKLI 79 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHH-----HHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCch-----HHHHHHHHHHHHHhCCCCCcceEE
Confidence 4567778999999999999999999998742 359999998754322 146788999999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
+++.++ ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+||
T Consensus 80 ~~~~~~-~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 80 GIIEEE-PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp EEECSS-SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCC
T ss_pred EEEcCC-CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCcc
Confidence 998654 5689999999999999998754 25899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC--CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 017994 203 GISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 279 (362)
Q Consensus 203 g~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (362)
|++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .....+.+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 236 (281)
T 3cc6_A 158 GLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKP 236 (281)
T ss_dssp CGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCC
T ss_pred CCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCC
Confidence 9987654322 1234456789999999999999999999999999999998 999998777666554443 34556677
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
..+++.+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 88999999999999999999999999999999987643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=357.61 Aligned_cols=250 Identities=21% Similarity=0.322 Sum_probs=219.0
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|.+.+.||+|+||.||+|.+. ++.||+|++....... ...+.+|+.+++.++||||+++++++.+....
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD------KYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH------HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh------HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 467999999999999999999986 7889999998754322 35678999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC--CCceEEeeeccccccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE--DMCVKVADFGISCLES 209 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~--~~~~kl~Dfg~~~~~~ 209 (362)
++||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999999999997654 36899999999999999999999999999999999999974 4789999999998765
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCCHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--PPVPPTCPKAFS 287 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~ 287 (362)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+...... ......+++++.
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 544445567999999999999999999999999999999999999999998887777666554332 233457899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~~ 310 (362)
+||.+||+.||.+||++.++++.
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999999863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=351.41 Aligned_cols=256 Identities=20% Similarity=0.283 Sum_probs=215.0
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCeE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVF 131 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~ 131 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++...... +.+.+|+.+++.+ +||||+++++++...+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 67999999999999999999974 789999998765432 3567899999999 999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc-----eEEeeecccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-----VKVADFGISC 206 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~-----~kl~Dfg~~~ 206 (362)
++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EEEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 9999999 999999998753 36999999999999999999999999999999999999998887 9999999997
Q ss_pred ccccCCC--------CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCC
Q 017994 207 LESQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP---EQAAFAVCQKNAR 275 (362)
Q Consensus 207 ~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~---~~~~~~~~~~~~~ 275 (362)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .+....+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 6443222 2456799999999999999999999999999999999999999987543 2222222221111
Q ss_pred CC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCC
Q 017994 276 PP---VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 321 (362)
Q Consensus 276 ~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~ 321 (362)
.+ ....+| .+.+++.+||+.||.+||++.+|.+.|+.+.......
T Consensus 239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 11 123355 9999999999999999999999999999888776543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=345.00 Aligned_cols=259 Identities=19% Similarity=0.281 Sum_probs=219.3
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPV 130 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~ 130 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++...... ..+.+|+.+++.+ +|+|++++++++.....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc--------HHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 467999999999999999999974 889999998765432 3467799999999 79999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc-----eEEeeeccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-----VKVADFGIS 205 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~-----~kl~Dfg~~ 205 (362)
.++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||++
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 99999999 999999998754 25999999999999999999999999999999999999987765 999999999
Q ss_pred cccccCCC--------CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHhcC-
Q 017994 206 CLESQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQKN- 273 (362)
Q Consensus 206 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~---~~~~~~~~~~~~- 273 (362)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 76544322 345578999999999999999999999999999999999999998743 333333322221
Q ss_pred --CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCCC
Q 017994 274 --ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 322 (362)
Q Consensus 274 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~~ 322 (362)
........+|+.+.+++.+||+.||++||++.+|++.|+.+...+....
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 1122345789999999999999999999999999999999988776543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=360.04 Aligned_cols=249 Identities=29% Similarity=0.416 Sum_probs=213.0
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.+++.++||||+++++++......
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK---SDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc---hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 478999999999999999999984 7899999986532111 01124678999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+ +|+|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999999 789999998765 5999999999999999999999999999999999999999999999999999876665
Q ss_pred CCCCcccccccccChhhhhcCCC-CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.........+ .......+..+++.+.+||
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li 239 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLI 239 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHH
Confidence 55667789999999999987775 78999999999999999999999875433221111 1223456777899999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 017994 291 SRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~~ 310 (362)
.+||+.||.+|||+.|+++.
T Consensus 240 ~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp HTTSCSSGGGSCCHHHHTTC
T ss_pred HHHcCCChhHCcCHHHHHhC
Confidence 99999999999999999863
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=348.43 Aligned_cols=252 Identities=21% Similarity=0.342 Sum_probs=209.8
Q ss_pred ccccCeeeeeeecccCCeeEEEEEE-----CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIY-----KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
+..++|.+.+.||+|+||.||++.+ .++.||||++........ ......+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN--AKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC----------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh--hhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 4567899999999999999999987 368899999986532111 111355778999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
..+..++||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999999998765 58999999999999999999999999999999999999999999999999987
Q ss_pred cccc-CCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 207 LESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 207 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
.... ........||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+... ....+..+++.
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~ 247 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--KLNLPPYLTQE 247 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CCCCCTTSCHH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHH
Confidence 5332 22344567999999999999999999999999999999999999999998887777766554 34567788999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHH
Q 017994 286 FSYLISRCWSSSPDRRP-----HFDQIVS 309 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rp-----s~~ell~ 309 (362)
+.++|.+||+.||.+|| ++.++++
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 99999999999999999 6677765
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=350.51 Aligned_cols=264 Identities=26% Similarity=0.467 Sum_probs=219.8
Q ss_pred ccccCeeeeeeecccCCeeEEEEEE------CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIY------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
++..+|.+.+.||+|+||.||++.+ .++.||||++....... .+.+.+|+.++++++||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ------QRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHH------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHH------HHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 4467899999999999999999985 36789999998754332 36688999999999999999999988
Q ss_pred E--eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 126 K--KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 126 ~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
. +....++||||+++++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccc
Confidence 6 55679999999999999999987442 58999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC----CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH--------------HH
Q 017994 204 ISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE--------------QA 265 (362)
Q Consensus 204 ~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~--------------~~ 265 (362)
++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...... ..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 997654322 223455788899999999998999999999999999999999998653322 22
Q ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCCC
Q 017994 266 AFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 322 (362)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~~ 322 (362)
...........+.+..+++.+.+||.+||+.||.+||++.++++.|+.+........
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 334444566677788999999999999999999999999999999999877655443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=349.01 Aligned_cols=267 Identities=28% Similarity=0.510 Sum_probs=211.4
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEECCe-----eEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeee
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQR-----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~ 122 (362)
.++.+..++|.+.+.||+|+||.||+|.+... .||||++........ ..+.+.+|+.++++++||||++++
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~ 91 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS----DIEEFLREAACMKEFDHPHVAKLV 91 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CH----HHHHHHHHHHHHTTCCCTTBCCCC
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHH----HHHHHHHHHHHHHHCCCCceehhh
Confidence 34556678999999999999999999988632 799999976532222 146788999999999999999999
Q ss_pred EEEEeCCeE------EEEEecCCCCCHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc
Q 017994 123 AACKKPPVF------CIITEYLAGGSLRKYLHQQE----PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 192 (362)
Q Consensus 123 ~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~ 192 (362)
+++...... ++||||+++++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+||+++
T Consensus 92 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA 171 (323)
T ss_dssp EEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc
Confidence 999877655 99999999999999996532 12589999999999999999999999999999999999999
Q ss_pred CCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHH
Q 017994 193 EDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 268 (362)
Q Consensus 193 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~ 268 (362)
.++.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 251 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 999999999999976543222 223456778999999999999999999999999999999 9999998887766655
Q ss_pred HHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 269 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 269 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
+. .......+..+++.+.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus 252 ~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 252 LI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred Hh-cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 54 344566778899999999999999999999999999999999877543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=358.57 Aligned_cols=259 Identities=18% Similarity=0.307 Sum_probs=213.6
Q ss_pred ccccccccCeeeeeeeccc--CCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 48 EEWSADMSQLFIGCKFASG--RHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G--~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
..+..+.++|++.+.||+| +||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||+++++
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~ 93 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE----MVTFLQGELHVSKLFNHPNIVPYRA 93 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChH----HHHHHHHHHHHHHhCCCCCCCcEeE
Confidence 3445567899999999999 99999999997 78999999987543322 2467888999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
++...+..++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg 173 (389)
T 3gni_B 94 TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR 173 (389)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGG
T ss_pred EEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccc
Confidence 99999999999999999999999988755579999999999999999999999999999999999999999999999999
Q ss_pred cccccccC--------CCCCcccccccccChhhhhc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Q 017994 204 ISCLESQC--------GSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 273 (362)
Q Consensus 204 ~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 273 (362)
.+...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 253 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 87543221 12233478899999999987 578999999999999999999999998765444333221111
Q ss_pred C--------------------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 274 A--------------------------------------------RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 274 ~--------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
. ..+.+..+++.+.+||.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 11234567889999999999999999999999986
Q ss_pred H
Q 017994 310 I 310 (362)
Q Consensus 310 ~ 310 (362)
.
T Consensus 334 h 334 (389)
T 3gni_B 334 H 334 (389)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=349.99 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=218.8
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++..............+.+.+|+.++++++||||+++++++......+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 57999999999999999999986 7899999998754322111011356889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC----ceEEeeecccccc
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM----CVKVADFGISCLE 208 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~----~~kl~Dfg~~~~~ 208 (362)
+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 9999999999999998754 589999999999999999999999999999999999999887 7999999999876
Q ss_pred ccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCCHHH
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAF 286 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 286 (362)
..........|++.|+|||++.+..++.++||||||+++|+|++|..||.+....+....+.......+ ....+++.+
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred CccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHH
Confidence 655555567799999999999999999999999999999999999999999888777666544332211 225678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+||.+||+.||.+|||+.++++
T Consensus 250 ~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 250 KDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHhc
Confidence 99999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=345.32 Aligned_cols=245 Identities=24% Similarity=0.391 Sum_probs=214.2
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
.|...+.||+|+||.||+|.+. ++.||||++....... .+.+.+|+.+++.++||||+++++++...+..++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR------RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS------HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH------HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 4777789999999999999986 7899999998654433 3567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-C
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-G 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 212 (362)
||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 120 v~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp EECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence 99999999999998754 5899999999999999999999999999999999999999999999999998765433 2
Q ss_pred CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCCCCCCCHHHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-PPVPPTCPKAFSYLIS 291 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~ 291 (362)
......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...... ...+..+++.+.++|.
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 276 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE 276 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHH
Confidence 334567999999999999999999999999999999999999999988887766655443222 1233467899999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~ 309 (362)
+||+.||.+||++.++++
T Consensus 277 ~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 277 RMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHSCSSTTTSCCHHHHHT
T ss_pred HHccCChhhCcCHHHHhc
Confidence 999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=341.37 Aligned_cols=251 Identities=26% Similarity=0.445 Sum_probs=216.0
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
...++|.+.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK---AGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---HTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccch---hhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 34678999999999999999999987 5689999986532111 112466889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999999999998765 58999999999999999999999999999999999999999999999999886543
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
.. ......+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+.. .....+..+++.+.+|
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 161 SS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDL 237 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCCCTTSCHHHHHH
T ss_pred cc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh--CCCCCCCcCCHHHHHH
Confidence 32 23456789999999999999999999999999999999999999999887776666543 3445677889999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~~ 310 (362)
|.+||+.||.+||++.|+++.
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHhccChhhCCCHHHHhhC
Confidence 999999999999999999974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=364.85 Aligned_cols=256 Identities=22% Similarity=0.307 Sum_probs=218.9
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
.+....++|.+.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.+++.++||||+++++++.
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK---RSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh---hHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34556789999999999999999999996 6789999986521100 000234678999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
+...+|+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 999999999999999999999764 48999999999999999999999999999999999999999999999999997
Q ss_pred ccccCC--CCCcccccccccChhhhhcCC----CCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCC
Q 017994 207 LESQCG--SAKGFTGTYRWMAPEMIKEKR----HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN--ARPPV 278 (362)
Q Consensus 207 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~--~~~~~ 278 (362)
...... .....+||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+.......+.... ...+.
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 654432 234678999999999998765 7899999999999999999999999988888777776543 23334
Q ss_pred CCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 017994 279 PPTCPKAFSYLISRCWSSSPDR--RPHFDQIVSI 310 (362)
Q Consensus 279 ~~~~~~~l~~li~~~l~~~p~~--Rps~~ell~~ 310 (362)
...+++++.+||.+||..+|.+ ||++.||++.
T Consensus 297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 4578999999999999999988 9999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=352.77 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=209.9
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|++.+.||+|+||.||+|.+. ++.||||++....... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-----hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 478999999999999999999986 7899999997654322 135678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999999999997654 5899999999999999999999999999999999999999999999999999754322
Q ss_pred ---CCCCcccccccccChhhhhcCCC-CCcccchhhhHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCCCCCCCCCCHHH
Q 017994 212 ---GSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNARPPVPPTCPKAF 286 (362)
Q Consensus 212 ---~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l 286 (362)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......... ...............+++.+
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHH
Confidence 22345679999999999987765 78999999999999999999999876553222 22222233333346688999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
.+||.+||+.||.+|||+.|+++.
T Consensus 239 ~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 239 LALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHccCChhhCcCHHHHhhC
Confidence 999999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=342.31 Aligned_cols=258 Identities=26% Similarity=0.463 Sum_probs=216.2
Q ss_pred ccccCeeeeeeecccCCeeEEEEEE------CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIY------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
+...+|++.+.||+|+||.||+|.+ .++.||||++........ .+.+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-----IADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CC-----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchh-----HHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 4457799999999999999999984 378999999986543221 35678999999999999999999999
Q ss_pred EeC--CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 126 KKP--PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 126 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
... ...++||||+++++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence 876 678999999999999999976543 58999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC----CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCC--------------CHHHH
Q 017994 204 ISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM--------------TPEQA 265 (362)
Q Consensus 204 ~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~--------------~~~~~ 265 (362)
++....... ......++..|+|||++.+..++.++||||||+++|+|++|..|+... .....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 987654432 233456788899999999999999999999999999999998876422 22233
Q ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 017994 266 AFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
...........+.+..+++.+.+||.+||+.||.+|||+.++++.|+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 33444556667778899999999999999999999999999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=339.39 Aligned_cols=246 Identities=20% Similarity=0.313 Sum_probs=216.9
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||+|.+. +..||+|++....... .+.+.+|+.++++++||||+++++++.+....+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED------VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 57999999999999999999997 5689999987643332 366889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCceEEeeeccccccc
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLES 209 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~---~~~~~~kl~Dfg~~~~~~ 209 (362)
+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+|||++....
T Consensus 83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999999999998765 58999999999999999999999999999999999999 788899999999998766
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCCHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFS 287 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~ 287 (362)
.........+++.|+|||++.+. ++.++||||||+++|+|++|..||......+....+.......+.. ..+++.+.
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 65556667899999999998654 8999999999999999999999999988887777766544333221 36889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~ 309 (362)
++|.+||+.||.+||++.++++
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=351.82 Aligned_cols=246 Identities=26% Similarity=0.384 Sum_probs=197.4
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++..... .+.+.+|+.++++++||||+++++++......
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--------KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh--------HHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 467999999999999999999997 57899999986432 25677899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCceEEeeecccccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADFGISCLE 208 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~---~~~~kl~Dfg~~~~~ 208 (362)
++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++...
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999999999999998765 5899999999999999999999999999999999999975 889999999999866
Q ss_pred ccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCCC--CCCCCCCHH
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQKNARP--PVPPTCPKA 285 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~ 285 (362)
..........||+.|+|||++.+..++.++||||||+++|+|++|..||....... ....+....... +....++..
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred CcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 55444556779999999999999899999999999999999999999998766554 333443332222 233578999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+.+||.+||+.||++||++.++++
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=345.83 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=206.9
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
.++|++.+.||+|+||.||+|.+. ++.||||++........ ....+.+|+.++++++||||+++++++.++...+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG----IPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------C----HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccch----hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 478999999999999999999995 78999999976543322 2356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 211 (362)
+||||+++ +|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 96 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEEECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEEcCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99999964 8888887654 36999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------------
Q 017994 212 GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------- 277 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 277 (362)
.......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+......+.
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 23345578999999999876 5689999999999999999999999988766555544433211110
Q ss_pred ---------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 ---------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 ---------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+.+++++.+||.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 12346788999999999999999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=340.29 Aligned_cols=249 Identities=20% Similarity=0.315 Sum_probs=207.5
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||+|+||.||+|.+. ++.||||++......... ...+.+|+.++++++||||+++++++.+++..+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTH----HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCc----chHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEE
Confidence 57999999999999999999996 688999999875543322 356778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 211 (362)
+||||+++ +|.+.+.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 78 lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 78 LVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred EEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99999965 6666665533 36999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccccChhhhhcCC-CCCcccchhhhHHHHHHHhCCCC-CCCCCHHHHHHHHHhcCCCC-------------
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTP-FDNMTPEQAAFAVCQKNARP------------- 276 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p-~~~~~~~~~~~~~~~~~~~~------------- 276 (362)
.......+|+.|+|||++.+.. ++.++||||||+++|+|++|..| |...+..+....+......+
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 2334567899999999997765 79999999999999999987776 56666655555543321111
Q ss_pred --------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 --------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...+.+++.+.+||.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 122457889999999999999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=342.31 Aligned_cols=249 Identities=20% Similarity=0.305 Sum_probs=207.5
Q ss_pred cCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++......... ...+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCC----CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccccc----chhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence 57999999999999999999986 789999999765433221 2567789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-C
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-G 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 212 (362)
||||+++ +|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 78 v~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 9999965 9999998654 36899999999999999999999999999999999999999999999999998754432 2
Q ss_pred CCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------------
Q 017994 213 SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--------------- 276 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 276 (362)
......+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+....+....+......+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 23445789999999999764 58999999999999999999999999988776665544321110
Q ss_pred ------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.....+++.+.+||.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 112457899999999999999999999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=352.90 Aligned_cols=248 Identities=20% Similarity=0.285 Sum_probs=211.7
Q ss_pred eeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEe
Q 017994 59 IGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITE 136 (362)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 136 (362)
..+.||+|+||.||+|.+. ++.||||++....... .+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD------KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHH------HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccccccc------HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3678999999999999986 7899999998754322 3678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE--cCCCceEEeeeccccccccCCCC
Q 017994 137 YLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL--GEDMCVKVADFGISCLESQCGSA 214 (362)
Q Consensus 137 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~ 214 (362)
|+++++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.........
T Consensus 167 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 167 YVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp CCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred CCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 999999999987643 258999999999999999999999999999999999999 56789999999999876655555
Q ss_pred CcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHH
Q 017994 215 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISR 292 (362)
Q Consensus 215 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~ 292 (362)
....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+........ ....+++.+.+||.+
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 566799999999999988999999999999999999999999999888877777765543332 235689999999999
Q ss_pred hcccCCCCCCCHHHHHH--HHHh
Q 017994 293 CWSSSPDRRPHFDQIVS--ILEG 313 (362)
Q Consensus 293 ~l~~~p~~Rps~~ell~--~L~~ 313 (362)
||+.||.+||++.|+++ .+..
T Consensus 326 ~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 326 LLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp TSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HcCCChhhCCCHHHHhcCcCcCC
Confidence 99999999999999997 4544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=357.28 Aligned_cols=276 Identities=14% Similarity=0.187 Sum_probs=216.1
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHH-----HHHHHHHHHHHHHHHcCCCCcee
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLA-----SMLEKQFTSEVALLFRLNHPHII 119 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~-----~~~~~~~~~Ei~~l~~l~hp~iv 119 (362)
...++|.+.+.||+|+||.||+|.+. ++.||||++.......... ......+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 44578999999999999999999885 3679999988754321111 11112344577788889999999
Q ss_pred eeeEEEEeC----CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc--C
Q 017994 120 TFVAACKKP----PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG--E 193 (362)
Q Consensus 120 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~--~ 193 (362)
++++++... ...++||||+ |++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 999998765 5689999999 999999998753 3699999999999999999999999999999999999999 8
Q ss_pred CCceEEeeeccccccccCCC--------CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHH
Q 017994 194 DMCVKVADFGISCLESQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA 265 (362)
Q Consensus 194 ~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~ 265 (362)
++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 89999999999975433221 1344599999999999999999999999999999999999999986322211
Q ss_pred HHHHHhcCCCC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCCCCcccccC
Q 017994 266 AFAVCQKNARP---------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFI 329 (362)
Q Consensus 266 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~~~~~~~~~ 329 (362)
........... .....+|+++.+++..||+.||.+||++.+|++.|+.+...+........++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 342 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLS 342 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceE
Confidence 11111100000 01256789999999999999999999999999999998887765554434443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=348.11 Aligned_cols=261 Identities=29% Similarity=0.501 Sum_probs=222.1
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--Cee--EEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEE
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRD--VAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACK 126 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~ 126 (362)
++.++|.+.+.||+|+||.||+|.+. +.. ||||.+....... ..+.+.+|+.+++++ +||||+++++++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----DHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchH-----HHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 45688999999999999999999875 454 5999987543222 135678899999999 8999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 192 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~ 192 (362)
..+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 9999999999999999999997653 23589999999999999999999999999999999999999
Q ss_pred CCCceEEeeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 017994 193 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ 271 (362)
Q Consensus 193 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~ 271 (362)
.++.+||+|||++.............+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+.
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~- 255 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 255 (327)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-
T ss_pred CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh-
Confidence 999999999999875544444445567889999999998889999999999999999998 999999988776655543
Q ss_pred cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 017994 272 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318 (362)
Q Consensus 272 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l 318 (362)
.......+..+++.+.+||.+||+.||.+||++.++++.|+.+.+..
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 34456677889999999999999999999999999999999887653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=365.90 Aligned_cols=254 Identities=23% Similarity=0.342 Sum_probs=212.2
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
.+....++|.+.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.+++.++||||+++++++.
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC----------------CCCCCSCTTSCCEEEEEE
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh---hHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 34456788999999999999999999986 7899999987532111 111355678999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
..+.+++||||+++++|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred eCCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence 9999999999999999999998765 58999999999999999999998 99999999999999999999999999998
Q ss_pred ccccc-CCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCH
Q 017994 206 CLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284 (362)
Q Consensus 206 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+... ...++..+++
T Consensus 297 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~ 374 (446)
T 4ejn_A 297 KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLGP 374 (446)
T ss_dssp CTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCH
T ss_pred eeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCH
Confidence 75332 23345678999999999999999999999999999999999999999998887777766554 3456778999
Q ss_pred HHHHHHHHhcccCCCCCC-----CHHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRP-----HFDQIVS 309 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rp-----s~~ell~ 309 (362)
.+.+||.+||+.||.+|| ++.|+++
T Consensus 375 ~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 999999999999999999 9999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=345.88 Aligned_cols=261 Identities=29% Similarity=0.501 Sum_probs=220.2
Q ss_pred ccCeeeeeeecccCCeeEEEEEE------CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIY------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
...|.+.+.||+|+||.||++.+ .++.||||++....... ..+.+.+|+.++++++||||+++++++.+
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ-----HRSGWKQEIDILRTLYHEHIIKYKGCCED 104 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChH-----HHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence 34459999999999999998876 36789999998754322 24678899999999999999999999987
Q ss_pred C--CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 128 P--PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 128 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
. ..+++||||+++++|.+++.... +++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred CCCceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccc
Confidence 4 68899999999999999998753 899999999999999999999999999999999999999999999999999
Q ss_pred cccccCC----CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH--------------HHHH
Q 017994 206 CLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE--------------QAAF 267 (362)
Q Consensus 206 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~--------------~~~~ 267 (362)
....... ......++..|+|||++.+..++.++||||||+++|+|++|..||...... ....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 7654432 123455788899999999989999999999999999999999999754321 1122
Q ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCCC
Q 017994 268 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 322 (362)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~~ 322 (362)
.........+.+..+++.+.+||.+||+.||.+||++.++++.|+.+.+.+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 3344556677788899999999999999999999999999999999988876543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=341.48 Aligned_cols=258 Identities=32% Similarity=0.579 Sum_probs=217.0
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHH-HHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLA-SMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
...++|.+.+.||+|+||.||+|.+. ++.||||++.......... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34578999999999999999999995 7889999987654332211 00115688999999999999999999998766
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcCCCc-----eEEee
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMC-----VKVAD 201 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dlk~~Nil~~~~~~-----~kl~D 201 (362)
. ++||||+++++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++. +||+|
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred C--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 5 69999999999999887654 36999999999999999999999999 999999999999988776 99999
Q ss_pred eccccccccCCCCCcccccccccChhhhh--cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHH--HHHHHhcCCCCC
Q 017994 202 FGISCLESQCGSAKGFTGTYRWMAPEMIK--EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA--AFAVCQKNARPP 277 (362)
Q Consensus 202 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~ 277 (362)
||++..... ......+++.|+|||++. ...++.++||||||+++|+|++|..||........ ..........+.
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 999875433 334567899999999984 44578999999999999999999999987654333 445555666777
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 278 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
.+..+++.+.++|.+||+.||.+||++.++++.|+.+
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 8889999999999999999999999999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=342.25 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=211.0
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC---CCCceeeeeEEEEeC
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL---NHPHIITFVAACKKP 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~~~ 128 (362)
.++|++.+.||+|+||.||+|.+. ++.||||++.......... .....+.+|+.+++.+ +||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG-GLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSS-CCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccc-ccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 478999999999999999999975 7899999987533111000 0013445677766665 599999999999876
Q ss_pred C-----eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 129 P-----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 129 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
. ..++||||+. ++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 5 5899999995 599999998776569999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------
Q 017994 204 ISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------ 277 (362)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------ 277 (362)
++.............+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......++
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCS
T ss_pred cccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 99876655556677899999999999999999999999999999999999999999888777666544322111
Q ss_pred -------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 -------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 -------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+.+++.+.+||.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp SCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 12357889999999999999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=365.60 Aligned_cols=250 Identities=25% Similarity=0.421 Sum_probs=219.9
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
..++|.+++.||+|+||.||+|.+. ++.||||++....... ......+.+|+.+++.++||||+++++++...+.
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS---LDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHH---TTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4578999999999999999999986 7899999997532111 1113568899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
.++||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999999998654 599999999999999999999999999999999999999999999999999987665
Q ss_pred CCCCCcccccccccChhhhhcCCC-CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 211 CGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 211 ~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
.......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.........+... ....+..+++.+.+|
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~L 246 (476)
T 2y94_A 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQYLNPSVISL 246 (476)
T ss_dssp TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT--CCCCCTTCCHHHHHH
T ss_pred cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CcCCCccCCHHHHHH
Confidence 555566789999999999988765 78999999999999999999999988877766666543 345667789999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~ 309 (362)
|.+||+.||.+|||+.++++
T Consensus 247 i~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCchhCcCHHHHHh
Confidence 99999999999999999997
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=365.07 Aligned_cols=257 Identities=20% Similarity=0.282 Sum_probs=217.3
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
.+....++|.+.+.||+|+||+||+|.+. ++.||||++....... ......+.+|+.++..++||||+++++++.
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK---RAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH---TTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh---HHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34456789999999999999999999997 6889999986521110 001234778999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
+.+.+|+||||++||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 9999999999999999999998743 369999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCC--CCcccccccccChhhhh-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---C
Q 017994 207 LESQCGS--AKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR---P 276 (362)
Q Consensus 207 ~~~~~~~--~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~---~ 276 (362)
....... ....+||+.|+|||++. ...++.++||||||+++|||++|..||.+.+..+....+...... +
T Consensus 224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 303 (437)
T 4aw2_A 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303 (437)
T ss_dssp ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCC
Confidence 5443322 23468999999999987 456899999999999999999999999998888877776543322 2
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 017994 277 PVPPTCPKAFSYLISRCWSSSPDR--RPHFDQIVS 309 (362)
Q Consensus 277 ~~~~~~~~~l~~li~~~l~~~p~~--Rps~~ell~ 309 (362)
.....+++++.+||.+||..+|++ ||++.|+++
T Consensus 304 ~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 333558999999999999888888 999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=347.67 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=216.2
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
..|.+.+.||+|+||.||+|.+. ++.||||++........ ...+.+.+|+.++++++||||+++++++..++..+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccch---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 55999999999999999999975 78999999986543322 12367889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||+. |+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 131 lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 9999996 68888886544 3689999999999999999999999999999999999999999999999999876543
Q ss_pred CCCcccccccccChhhhh---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
.....||+.|+|||++. ...++.++||||||+++|+|++|..||...+.......+.........+..+++.+.+|
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 33567899999999985 46689999999999999999999999999888777777666555555567889999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~~ 310 (362)
|.+||+.||.+|||+.++++.
T Consensus 286 i~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHcccChhhCcCHHHHhhC
Confidence 999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=347.53 Aligned_cols=257 Identities=26% Similarity=0.531 Sum_probs=214.9
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--Ce----eEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
...+|.+.+.||+|+||.||+|.+. ++ .||+|.+....... ..+.+.+|+.++++++||||+++++++.
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 87 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-----ANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC------------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHH-----HHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 4578999999999999999999985 33 46888876533221 1367889999999999999999999998
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
... .++|+||+.+|+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 88 ~~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 88 TST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp SSS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred cCC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 765 778999999999999998754 369999999999999999999999999999999999999999999999999997
Q ss_pred ccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 017994 207 LESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 282 (362)
Q Consensus 207 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (362)
....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||........... .......+.+..+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-LEKGERLPQPPIC 244 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HHTTCCCCCCTTB
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH-HHcCCCCCCCccC
Confidence 6543322 233456789999999999999999999999999999999 9999998877655444 3445566778889
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 245 ~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999999987653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=343.23 Aligned_cols=268 Identities=29% Similarity=0.505 Sum_probs=217.9
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeee
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF 121 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~ 121 (362)
...+.++.++|.+++.||+|+||.||+|.+. +..||||++......... .+.+.+|+.++++++||||+++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~ 101 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE----IEEFLSEAACMKDFSHPNVIRL 101 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHH----HHHHHHHHHHHHTCCCTTBCCC
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhH----HHHHHHHHHHHhcCCCCCeeee
Confidence 3556677899999999999999999999874 247999999865443221 3568899999999999999999
Q ss_pred eEEEEeCC-----eEEEEEecCCCCCHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc
Q 017994 122 VAACKKPP-----VFCIITEYLAGGSLRKYLHQQ----EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 192 (362)
Q Consensus 122 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~ 192 (362)
++++.... ..++||||+++++|.+++... ....+++..++.++.|++.||.|||++||+||||||+||+++
T Consensus 102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~ 181 (313)
T 3brb_A 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR 181 (313)
T ss_dssp CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC
T ss_pred eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc
Confidence 99997655 459999999999999999532 234699999999999999999999999999999999999999
Q ss_pred CCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHH
Q 017994 193 EDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 268 (362)
Q Consensus 193 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~ 268 (362)
.++.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 261 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 99999999999987554322 1233456789999999999999999999999999999999 9999998877666555
Q ss_pred HHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 269 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 269 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
+. .......+..+++.+.++|.+||+.||.+||++.++++.|+.+.+.++
T Consensus 262 ~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 262 LL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 44 344566778899999999999999999999999999999999887654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=369.84 Aligned_cols=267 Identities=27% Similarity=0.542 Sum_probs=224.6
Q ss_pred cccccccCeeeee-eecccCCeeEEEEEEC----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 49 EWSADMSQLFIGC-KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 49 ~~~~~~~~~~~~~-~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
.|.+...++.+.+ .||+|+||.||+|.+. +..||||+++....... .+.+.+|+.++++++||||+++++
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~E~~il~~l~hpniv~l~~ 403 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-----TEEMMREAQIMHQLDNPYIVRLIG 403 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTT-----HHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHH-----HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 4555667777776 8999999999999874 45799999987533221 367889999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
++.. +..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 404 ~~~~-~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFG 481 (613)
T 2ozo_A 404 VCQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG 481 (613)
T ss_dssp EEES-SSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred Eecc-CCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeecc
Confidence 9976 56899999999999999997654 369999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC----CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 017994 204 ISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 278 (362)
Q Consensus 204 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (362)
++........ .....+++.|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+. .......
T Consensus 482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~ 560 (613)
T 2ozo_A 482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMEC 560 (613)
T ss_dssp TTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCC
T ss_pred CcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCC
Confidence 9976543221 122345688999999999999999999999999999998 999999988877666554 4556677
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCCCC
Q 017994 279 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 323 (362)
Q Consensus 279 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~~~ 323 (362)
+..+++.+.+||.+||+.||.+||++.+|++.|+.+...+....+
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~ 605 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCC
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccC
Confidence 888999999999999999999999999999999998777665443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=347.74 Aligned_cols=256 Identities=24% Similarity=0.413 Sum_probs=209.7
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC--
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP-- 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-- 129 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++........ .....+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSH---HHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCH---HHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 367999999999999999999985 78999999987543321 12467889999999999999999999987654
Q ss_pred --eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 130 --VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 130 --~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
..++||||++|++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred CcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 3499999999999999998765 589999999999999999999999999999999999999999999999999875
Q ss_pred cccCC----CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCC
Q 017994 208 ESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPT 281 (362)
Q Consensus 208 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 281 (362)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+................++ ....
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 44322 22345689999999999999999999999999999999999999999888877766655443332 2356
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHH-HHHHHHhh
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQ-IVSILEGY 314 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~e-ll~~L~~~ 314 (362)
+++++.+||.+||+.||.+||+..+ +...+...
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 8899999999999999999996555 44555544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=345.93 Aligned_cols=256 Identities=20% Similarity=0.320 Sum_probs=212.4
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC--
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP-- 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-- 129 (362)
..+|.+.+.||+|+||.||+|.+. ++.||||++........ .+.+.+|+.++++++||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch-----HHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 367999999999999999999997 78999999976432221 356678999999999999999999998765
Q ss_pred eEEEEEecCCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----cCCCceEEeeecc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADFGI 204 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~----~~~~~~kl~Dfg~ 204 (362)
..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 78999999999999999986542 238999999999999999999999999999999999999 7888899999999
Q ss_pred ccccccCCCCCcccccccccChhhhh--------cCCCCCcccchhhhHHHHHHHhCCCCCCCCCH----HHHHHHHHhc
Q 017994 205 SCLESQCGSAKGFTGTYRWMAPEMIK--------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTP----EQAAFAVCQK 272 (362)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~----~~~~~~~~~~ 272 (362)
+.............||+.|+|||++. +..++.++||||||+++|+|++|..||..... .+....+...
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 98766655556677999999999986 46789999999999999999999999975332 3334444332
Q ss_pred CCCC-----------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 273 NARP-----------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 273 ~~~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
.... ..+..+++.+.++|.+||+.||.+|||+.|+++....-
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 2110 11223456788999999999999999999999988754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=351.50 Aligned_cols=264 Identities=27% Similarity=0.473 Sum_probs=217.3
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
.+.....++|.+.+.||+|+||.||+|.+. ++.||||++....... .+.+.+|+.+++.++||||+++++++.
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG------IEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSH------HHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHH------HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 344456789999999999999999999986 7899999987754432 367889999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEP--YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
..+..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999999975432 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHH------HHHHH-hcC-
Q 017994 205 SCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA------AFAVC-QKN- 273 (362)
Q Consensus 205 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~------~~~~~-~~~- 273 (362)
+....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||....+.+. ..... ...
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 87543221 22345689999999999999999999999999999999999999976443211 00111 000
Q ss_pred -------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 274 -------ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 274 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
.....+..++..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 01112233456789999999999999999999999999987653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=337.56 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=207.8
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||++.+. +..||+|++........ .+.+.+|+.++++++||||+++++++.+....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-----MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC-----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh-----HHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 67999999999999999999986 67899999877543322 366788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCceEEeeeccccc
Q 017994 133 IITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCL 207 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~---~~~~~~kl~Dfg~~~~ 207 (362)
+||||+++++|.+++... ....+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999999998643 12369999999999999999999999999999999999999 4567899999999987
Q ss_pred cccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCCHHH
Q 017994 208 ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-VPPTCPKAF 286 (362)
Q Consensus 208 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l 286 (362)
...........+++.|+|||++. ..++.++||||||+++|+|++|..||.+....+............. ....+++.+
T Consensus 177 ~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (285)
T 3is5_A 177 FKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHH
T ss_pred cCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHH
Confidence 66555556677999999999986 5688999999999999999999999999887776665544333322 224578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+||.+||+.||.+||++.|+++
T Consensus 256 ~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 256 VDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=346.72 Aligned_cols=253 Identities=22% Similarity=0.355 Sum_probs=209.7
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||+|+||.||+|.+. ++.||||++......... ....+.+.+|+.+++.++||||+++++++...+..|
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP-GLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS-SCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc-cchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 57999999999999999999986 789999998642110000 001356889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc---eEEeeeccccc
Q 017994 133 IITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC---VKVADFGISCL 207 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~---~kl~Dfg~~~~ 207 (362)
+||||++|++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999888643 2235899999999999999999999999999999999999986654 99999999976
Q ss_pred cccCCC-CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCCH
Q 017994 208 ESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPK 284 (362)
Q Consensus 208 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 284 (362)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. ......+........ ....+++
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~ 261 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISE 261 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCH
Confidence 554332 345679999999999999999999999999999999999999998753 344444443332221 1256889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+.+||.+||+.||.+||++.++++
T Consensus 262 ~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 262 SAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=338.51 Aligned_cols=266 Identities=23% Similarity=0.377 Sum_probs=210.2
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
...+|.+.+.||+|+||.||+|.+. ++.||||++........ .....+.+|+.++++++||||+++++++...+.
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA---KARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 4578999999999999999999985 78999999986432211 124678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
.++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999999999752 2346899999999999999999999999999999999999999999999999998754
Q ss_pred ccCC-CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 209 SQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--PEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 209 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
.... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.. .......+............+++.
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence 4322 2334568999999999999999999999999999999999999997643 333333433333333334678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCC
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 321 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~ 321 (362)
+.+++.+||+.||.+||++.++++.|+.+.+.....
T Consensus 267 l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 267 LRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 999999999999999999999999999998775543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=341.96 Aligned_cols=252 Identities=22% Similarity=0.447 Sum_probs=213.6
Q ss_pred ccccCeeeeeeecccCCeeEEEEEECC---------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeee
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYKQ---------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~ 122 (362)
+..++|.+.+.||+|+||.||+|.+.. ..||+|++....... .+.+.+|+.++++++||||++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~ 78 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY------SESFFEAASMMSKLSHKHLVLNY 78 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGG------HHHHHHHHHHHHTSCCTTBCCEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHH------HHHHHHHHHHHHhCCCCCEeEEE
Confidence 456789999999999999999998863 469999987643332 36788999999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc------
Q 017994 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC------ 196 (362)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~------ 196 (362)
+++..++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.
T Consensus 79 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 79 GVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp EEECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred EEEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccc
Confidence 99999999999999999999999998754 24899999999999999999999999999999999999998887
Q ss_pred --eEEeeeccccccccCCCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 017994 197 --VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK 272 (362)
Q Consensus 197 --~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~ 272 (362)
++|+|||++..... .....+++.|+|||++.+ ..++.++||||||+++|+|++ +.+||............ .
T Consensus 158 ~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~- 232 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-E- 232 (289)
T ss_dssp CEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-H-
T ss_pred ceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-h-
Confidence 99999999865432 233457889999999987 678999999999999999999 56666666554443332 2
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 273 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 273 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
.....+...++.+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 233 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 -DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2445566678899999999999999999999999999998755
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=359.48 Aligned_cols=256 Identities=20% Similarity=0.272 Sum_probs=214.7
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
++....++|.+.+.||+|+||.||++.++ ++.||||++...... .......+.+|..++..++||||+++++++.
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~---~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML---KRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh---hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34556789999999999999999999986 789999999752211 1111245778999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
+.+.+|+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 9999999999999999999998754 268999999999999999999999999999999999999999999999999997
Q ss_pred ccccCCC--CCcccccccccChhhhh-------cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---C
Q 017994 207 LESQCGS--AKGFTGTYRWMAPEMIK-------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN---A 274 (362)
Q Consensus 207 ~~~~~~~--~~~~~~~~~~~aPE~~~-------~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~---~ 274 (362)
....... ....+||+.|+|||++. ...++.++|+||||+++|||++|..||...+..+....+.... .
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence 6544322 33568999999999997 3568999999999999999999999999988877766665422 2
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 017994 275 RPPVPPTCPKAFSYLISRCWSSSPDRR---PHFDQIVS 309 (362)
Q Consensus 275 ~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~ell~ 309 (362)
.+..+..+++++.+||.+||. +|.+| |++.++++
T Consensus 291 ~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 291 LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 233346789999999999999 99988 58888875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=346.93 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=219.5
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcc--hHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCC
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEED--ASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPP 129 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~--~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~ 129 (362)
.+|.+.+.||+|+||.||+|.+. ++.||||++...... ........+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 67999999999999999999986 789999999875422 222233456788999999999 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
..++||||++|++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+||+++.+|.++|+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999999998765 58999999999999999999999999999999999999999999999999988766
Q ss_pred cCCCCCcccccccccChhhhhcC------CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--CCC
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEK------RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPT 281 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 281 (362)
.........||+.|+|||++.+. .++.++||||||+++|+|++|..||...........+......... ...
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 331 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD 331 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSS
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 55555667899999999998643 5788999999999999999999999988877766666554433322 256
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
++..+.+||.+||+.||.+||++.++++
T Consensus 332 ~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 332 RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 7889999999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=341.19 Aligned_cols=249 Identities=21% Similarity=0.345 Sum_probs=207.2
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.++++++||||+++++++...+..+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV----IKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH 78 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchH----HHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence 67999999999999999999996 78999999877654432 2466788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 211 (362)
+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 79 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999999999887654 5899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---------------
Q 017994 212 GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--------------- 275 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--------------- 275 (362)
.......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 22345678999999999976 56899999999999999999999999998876655443321110
Q ss_pred ----CCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 ----PPV----------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 ----~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+. .+.+++.+.+||.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 011 1457889999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=341.05 Aligned_cols=260 Identities=22% Similarity=0.336 Sum_probs=210.3
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
..++|.+.+.||+|+||.||+|.+. ++.||||++....... ....+.+.+|+.++++++||||+++++++..++.
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD---PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC---HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 3578999999999999999999986 7899999997643322 2234678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999999998765 589999999999999999999999999999999999999999999999999875543
Q ss_pred CC--CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCCCCCHHH
Q 017994 211 CG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--PPVPPTCPKAF 286 (362)
Q Consensus 211 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 286 (362)
.. ......+++.|+|||++.+..++.++||||||+++|+|++|..||...........+ ..... ...+..+|+.+
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGTSTTCCTHH
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCccccCCCCCHHH
Confidence 22 223456899999999999889999999999999999999999999887665333332 22222 13456789999
Q ss_pred HHHHHHhcccCCCCCC-CHHHHHHHHHhhhhhc
Q 017994 287 SYLISRCWSSSPDRRP-HFDQIVSILEGYSESL 318 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rp-s~~ell~~L~~~~~~l 318 (362)
.++|.+||+.||.+|| ++.++++.|+.+....
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 9999999999999999 9999999998775543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=339.07 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=216.4
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||++.+. ++.||||++..............+.+.+|+.++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56999999999999999999996 7899999988654321111011367889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC----ceEEeeecccccc
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM----CVKVADFGISCLE 208 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~----~~kl~Dfg~~~~~ 208 (362)
+||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999999998765 589999999999999999999999999999999999998877 8999999999866
Q ss_pred ccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCCHHH
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAF 286 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 286 (362)
..........+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+........ ....+++.+
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 242 (283)
T ss_dssp C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHH
Confidence 554445566789999999999999999999999999999999999999999887776665543332221 225678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH--HHHhhh
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS--ILEGYS 315 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 315 (362)
.+++.+||+.||.+||++.++++ .++.+.
T Consensus 243 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 243 KDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 99999999999999999999997 455544
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=338.02 Aligned_cols=260 Identities=29% Similarity=0.534 Sum_probs=219.3
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--C---eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--Q---RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
-.|.+.+.||+|+||.||+|.+. + ..||+|++........ .+.+.+|+.+++.++||||+++++++...+
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ-----VEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHH-----HHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHH-----HHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 35667899999999999999873 2 3699999976443322 467889999999999999999999997766
Q ss_pred eE-EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 130 VF-CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 130 ~~-~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
.. ++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred CCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 55 99999999999999998744 36899999999999999999999999999999999999999999999999998754
Q ss_pred ccC-----CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 017994 209 SQC-----GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 282 (362)
Q Consensus 209 ~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (362)
... .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+ ........+..+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 253 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-AQGRRLPQPEYC 253 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH-HTTCCCCCCTTC
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh-hcCCCCCCCccc
Confidence 321 22344567899999999999999999999999999999999 56666666665554444 345556677889
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCC
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 321 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~ 321 (362)
++.+.+++.+||+.||.+|||+.++++.|+.+...+...
T Consensus 254 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 254 PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred hHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 999999999999999999999999999999998876544
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=342.32 Aligned_cols=255 Identities=25% Similarity=0.445 Sum_probs=214.0
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEE
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAA 124 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~ 124 (362)
..+....++|.+.+.||+|+||.||+|.+. ++.||||++...... ...+.+|+.+++++ +||||++++++
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST-------THHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc-------HHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 334445688999999999999999999994 789999999865443 25678899999998 79999999999
Q ss_pred EEe------CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceE
Q 017994 125 CKK------PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 198 (362)
Q Consensus 125 ~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~k 198 (362)
+.. ....++||||+++++|.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEE
Confidence 977 56899999999999999999876545699999999999999999999999999999999999999999999
Q ss_pred EeeeccccccccC-CCCCcccccccccChhhhh-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 017994 199 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 272 (362)
Q Consensus 199 l~Dfg~~~~~~~~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 272 (362)
|+|||++...... .......+++.|+|||++. +..++.++||||||+++|+|++|..||...........+...
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 9999998765432 2234557899999999987 556899999999999999999999999998887777666655
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 273 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 273 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
......+..++..+.+||.+||+.||.+||++.++++
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 5555556778999999999999999999999999987
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=337.13 Aligned_cols=250 Identities=24% Similarity=0.429 Sum_probs=218.7
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
...++|.+.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK---EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch---HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 45678999999999999999999986 6789999986532111 111356889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 9999999999999999998765 58999999999999999999999999999999999999999999999999986544
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
.. ......+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+.. .....+..++..+.++
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l 242 (284)
T 2vgo_A 166 SL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--VDLKFPPFLSDGSKDL 242 (284)
T ss_dssp SS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCCTTSCHHHHHH
T ss_pred cc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc--cccCCCCcCCHHHHHH
Confidence 32 23456789999999999998999999999999999999999999998887766655543 3455678899999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~ 309 (362)
|.+||+.||.+||++.++++
T Consensus 243 i~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhcCHhhCCCHHHHhh
Confidence 99999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=339.16 Aligned_cols=259 Identities=25% Similarity=0.516 Sum_probs=217.9
Q ss_pred ccCeeeeeeecccCCeeEEEEEECC-----eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE-Ee
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC-KK 127 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~-~~ 127 (362)
..+|.+.+.||+|+||.||+|.+.+ ..||||.+........ .+.+.+|+.++++++||||+++++++ ..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHH-----HHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHH-----HHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 4568899999999999999998752 3589999876443322 36788999999999999999999985 45
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence 668899999999999999997644 3689999999999999999999999999999999999999999999999999975
Q ss_pred cccCC-----CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 208 ESQCG-----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 208 ~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
..... ......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......+....+. .......+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 256 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEY 256 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTT
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCcc
Confidence 43322 2234457789999999999999999999999999999999 777887776655555443 3445566778
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
+++.+.+++.+||+.||.+||++.++++.|+.+...+.
T Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 89999999999999999999999999999999877654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=347.36 Aligned_cols=251 Identities=21% Similarity=0.293 Sum_probs=211.5
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-----CCceeee
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-----HPHIITF 121 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----hp~iv~~ 121 (362)
....-.++|.+.+.||+|+||.||+|.+. ++.||||++...... ...+..|+.+++.+. ||||+++
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY-------TRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHH-------HHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhh-------hhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 33344678999999999999999999994 788999999753221 355677999999886 9999999
Q ss_pred eEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC--------
Q 017994 122 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-------- 193 (362)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~-------- 193 (362)
++++...+..++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence 99999999999999999 999999998876567999999999999999999999999999999999999975
Q ss_pred -----------------CCceEEeeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCC
Q 017994 194 -----------------DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP 256 (362)
Q Consensus 194 -----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p 256 (362)
++.+||+|||++..... ......||+.|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 78999999999975443 23456789999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCC------------------------CC--------------------CCCCHHHHHHHHH
Q 017994 257 FDNMTPEQAAFAVCQKNARPP------------------------VP--------------------PTCPKAFSYLISR 292 (362)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~------------------------~~--------------------~~~~~~l~~li~~ 292 (362)
|......+....+.......+ .+ ...++.+.+||.+
T Consensus 259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 338 (360)
T 3llt_A 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338 (360)
T ss_dssp CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence 998877665554433222111 00 1123678899999
Q ss_pred hcccCCCCCCCHHHHHH
Q 017994 293 CWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 293 ~l~~~p~~Rps~~ell~ 309 (362)
||+.||.+|||+.|+++
T Consensus 339 ~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 339 ILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HCCSSGGGSCCHHHHTT
T ss_pred HhcCChhhCCCHHHHhc
Confidence 99999999999999974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=344.85 Aligned_cols=257 Identities=26% Similarity=0.542 Sum_probs=214.1
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--Ce----eEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
...+|.+.+.||+|+||.||+|.+. ++ .||+|.+........ .+.+.+|+.++++++||||+++++++.
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~ 87 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-----NKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCC-----HHHHHHHHHHHTTCCBTTBCCCCEEEE
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHH-----HHHHHHHHHHHHhCCCCCeeEEEEEEe
Confidence 3578999999999999999999985 33 357787765433221 367889999999999999999999998
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
... .+++++|+.+++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 88 ~~~-~~~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 88 TST-VQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp SSS-EEEEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred cCC-ceEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 765 7889999999999999987543 68999999999999999999999999999999999999999999999999997
Q ss_pred ccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 017994 207 LESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 282 (362)
Q Consensus 207 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (362)
....... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+ ......+.+..+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~ 244 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPIC 244 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCCTTB
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCccC
Confidence 6543222 233456788999999999999999999999999999999 99999988776655444 445566778889
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 245 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999988643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=344.20 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=197.4
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++........ ...+.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-----PSTAIREISLMKELKHENIVRLYDVIHTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS-----CHHHHHHHHHHTTCCBTTBCCEEEEECCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEEECCeE
Confidence 367999999999999999999886 78999999976543221 24577899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 132 CIITEYLAGGSLRKYLHQQE----PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
++||||++ ++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99999997 59999987542 23589999999999999999999999999999999999999999999999999876
Q ss_pred cccC-CCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------
Q 017994 208 ESQC-GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--------- 276 (362)
Q Consensus 208 ~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------- 276 (362)
.... .......+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+......+
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 5432 233456789999999999764 68999999999999999999999999988777665554321110
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 -----------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 112357889999999999999999999999885
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=349.50 Aligned_cols=267 Identities=27% Similarity=0.490 Sum_probs=221.2
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
....|.+..++|.+.+.||+|+||.||+|.+.+ .||||++......... .+.+.+|+.++++++||||+++++++
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ----LKAFKREVMAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC----CCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH----HHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 457788899999999999999999999999876 5999998765332211 24466799999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
...+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++ ++.++|+|||++
T Consensus 99 ~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 99 MSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp ECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred ecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999999999998754 3689999999999999999999999999999999999998 679999999987
Q ss_pred cccccC------CCCCcccccccccChhhhhc---------CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 017994 206 CLESQC------GSAKGFTGTYRWMAPEMIKE---------KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 270 (362)
Q Consensus 206 ~~~~~~------~~~~~~~~~~~~~aPE~~~~---------~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~ 270 (362)
...... .......|++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 653211 22234468999999999874 347889999999999999999999999988887776665
Q ss_pred hcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 271 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 271 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
........+..++..+.+++.+||+.||.+||++.+++++|+.+.....
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 5444444445788999999999999999999999999999999876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=348.97 Aligned_cols=257 Identities=26% Similarity=0.474 Sum_probs=215.2
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--Ce----eEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
...+|.+.+.||+|+||.||+|.+. ++ .||+|++........ ...+.+|+.++++++||||+++++++.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-----FQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC-----BCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH-----HHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 4578999999999999999999985 33 388888765432211 134567999999999999999999986
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
+...++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred -CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 456889999999999999998653 258889999999999999999999999999999999999999999999999998
Q ss_pred ccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 017994 207 LESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 282 (362)
Q Consensus 207 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (362)
....... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+. .......+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 242 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQIC 242 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTTB
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCcC
Confidence 6543322 234557789999999999999999999999999999999 999999877666555443 44556667788
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 243 ~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 243 TIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 89999999999999999999999999999987643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=344.28 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=210.5
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC--CceeeeeEEEEe
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH--PHIITFVAACKK 127 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--p~iv~~~~~~~~ 127 (362)
.+...+|.+.+.||+|+||.||++.+. ++.||||++........ ..+.+.+|+.++..++| |||+++++++..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 80 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchH----HHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence 445678999999999999999999886 67899999987554332 13678899999999976 999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
+...++|||+ .+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 81 ~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 81 DQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp SSEEEEEECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred CCEEEEEEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence 9999999995 5889999998865 689999999999999999999999999999999999997 67899999999976
Q ss_pred cccCCC---CCcccccccccChhhhhc-----------CCCCCcccchhhhHHHHHHHhCCCCCCCCCH-HHHHHHHHhc
Q 017994 208 ESQCGS---AKGFTGTYRWMAPEMIKE-----------KRHTKKVDVYSFGIVLWELLTALTPFDNMTP-EQAAFAVCQK 272 (362)
Q Consensus 208 ~~~~~~---~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~-~~~~~~~~~~ 272 (362)
...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ......+...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 236 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence 543322 235679999999999875 6688999999999999999999999987543 3444455445
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 273 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 273 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
......+...+..+.+||.+||+.||.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 55667778888999999999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=336.48 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=219.0
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
..+|.+.+.||+|+||.||++.+. ++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP---HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCH---HHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 478999999999999999999997 67899999876432221 1246788899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999999998765 5899999999999999999999999999999999999999999999999998765432
Q ss_pred -CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 212 -GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 212 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
.......+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+.. .....+..+++.+.+++
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li 246 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK--NEYSIPKHINPVAASLI 246 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCCTTSCHHHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh--ccCCCccccCHHHHHHH
Confidence 233456789999999999988899999999999999999999999998887766555543 34456778899999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 017994 291 SRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~~ 310 (362)
.+||+.||.+||++.++++.
T Consensus 247 ~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 247 QKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHTCSSGGGSCCGGGGGGS
T ss_pred HHHcccChhhCcCHHHHhhC
Confidence 99999999999999999973
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=343.20 Aligned_cols=249 Identities=32% Similarity=0.558 Sum_probs=202.1
Q ss_pred ccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHc--CCCCceeeeeEEEEe----
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR--LNHPHIITFVAACKK---- 127 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hp~iv~~~~~~~~---- 127 (362)
.++|.+.+.||+|+||.||+|.++++.||||++..... ..+..|.+++.. ++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~---------~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE---------KSWFRETELYNTVMLRHENILGFIASDMTSRHS 77 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGH---------HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccc---------hhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence 46899999999999999999999999999999865322 334456666655 799999999998654
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCcEEEcCCCceEE
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH--------SQGILHRDLKSENLLLGEDMCVKV 199 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~i~H~dlk~~Nil~~~~~~~kl 199 (362)
....++||||+++|+|.++++.. .+++..++.++.|++.||.||| +.||+||||||+||+++.++.+||
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 35689999999999999999654 5899999999999999999999 999999999999999999999999
Q ss_pred eeeccccccccCCC-----CCcccccccccChhhhhcC------CCCCcccchhhhHHHHHHHhC----------CCCCC
Q 017994 200 ADFGISCLESQCGS-----AKGFTGTYRWMAPEMIKEK------RHTKKVDVYSFGIVLWELLTA----------LTPFD 258 (362)
Q Consensus 200 ~Dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slG~~l~ell~g----------~~p~~ 258 (362)
+|||++........ .....||+.|+|||++.+. .++.++||||||+++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 99999865433222 2344789999999999876 345789999999999999999 88886
Q ss_pred CCCH-----HHHHHHHHhcCCCCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 259 NMTP-----EQAAFAVCQKNARPPVPP-----TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 259 ~~~~-----~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
.... .............+..+. .+++.+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 5322 222222222233333332 2457899999999999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=336.63 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=200.9
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
|++..++|++.+.||+|+||.||+|.+. ++.||||++......... .+.+.++...++.++||||+++++++.+
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ----KRLLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHH----HHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 4566789999999999999999999994 889999999765433221 2344556666888999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCceEEeeecc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
++..++||||++ ++|.+++.. .....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||+
T Consensus 78 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 78 EGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp SSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred cCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence 999999999996 588888764 2234699999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccChhhh----hcCCCCCcccchhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCCC
Q 017994 205 SCLESQCGSAKGFTGTYRWMAPEMI----KEKRHTKKVDVYSFGIVLWELLTALTPFDNM-TPEQAAFAVCQKNARPPVP 279 (362)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~-~~~~~~~~~~~~~~~~~~~ 279 (362)
+.............+++.|+|||++ .+..++.++||||||+++|+|++|..||... ..................+
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence 9876655555556799999999996 4567899999999999999999999999874 4444445555444444445
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+++.+.+++.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 678999999999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=335.25 Aligned_cols=251 Identities=25% Similarity=0.407 Sum_probs=209.4
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
..++|.+++.||+|+||.||+|.+. ++.||||++....... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRS---LDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccc---hhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 4578999999999999999999986 7899999986532111 1113567889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999999998765 589999999999999999999999999999999999999999999999999987655
Q ss_pred CCCCCcccccccccChhhhhcCCC-CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 211 CGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 211 ~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
........+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+... ....+..++..+.++
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l 241 (276)
T 2h6d_A 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEYLNRSVATL 241 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cccCchhcCHHHHHH
Confidence 444456678999999999987765 68999999999999999999999988777666555432 345667789999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~~ 310 (362)
|.+||+.||.+||++.++++.
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhhCCCHHHHHhC
Confidence 999999999999999999973
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=334.55 Aligned_cols=254 Identities=25% Similarity=0.387 Sum_probs=219.9
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCc---chHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEE---DASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKK 127 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~---~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~ 127 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++..... .........+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999996 68999999987542 11222334577889999999995 9999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
....++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 999999999999999999998765 589999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccccccccChhhhh------cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--
Q 017994 208 ESQCGSAKGFTGTYRWMAPEMIK------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP-- 279 (362)
Q Consensus 208 ~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 279 (362)
...........+++.|+|||++. ...++.++||||||+++|+|++|..||...........+.........+
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccc
Confidence 66555555677899999999985 3457889999999999999999999999888777766665554443332
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..++..+.++|.+||+.||.+||++.++++
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 468899999999999999999999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=366.76 Aligned_cols=253 Identities=21% Similarity=0.313 Sum_probs=217.9
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
+..++|.+.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 45688999999999999999999986 7899999986532111 011356788999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.+|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999999987665569999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT----PEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
........+||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+. .....++..++++
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--~~~~~~p~~~s~~ 415 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EVPEEYSERFSPQ 415 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--HCCCCCCTTSCHH
T ss_pred cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--cccccCCccCCHH
Confidence 5444456689999999999999889999999999999999999999998753 233333332 2345567889999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHH
Q 017994 286 FSYLISRCWSSSPDRRP-----HFDQIVS 309 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rp-----s~~ell~ 309 (362)
+.+||.+||+.||.+|| ++.|+++
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 99999999999999999 6788875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=354.26 Aligned_cols=246 Identities=22% Similarity=0.340 Sum_probs=197.9
Q ss_pred ccCeeee-eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHH-cCCCCceeeeeEEEEe--
Q 017994 54 MSQLFIG-CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLF-RLNHPHIITFVAACKK-- 127 (362)
Q Consensus 54 ~~~~~~~-~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~-~l~hp~iv~~~~~~~~-- 127 (362)
..+|.+. +.||.|+||.||++.+. ++.||||++... ..+.+|+.++. ..+||||+++++++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 4677776 78999999999999986 778999999642 34567888774 4589999999999875
Q ss_pred --CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCceEEeee
Q 017994 128 --PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADF 202 (362)
Q Consensus 128 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~---~~~~kl~Df 202 (362)
...+|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 567899999999999999998766556999999999999999999999999999999999999987 789999999
Q ss_pred ccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCCC-
Q 017994 203 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ----AAFAVCQKNARPP- 277 (362)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~----~~~~~~~~~~~~~- 277 (362)
|++............+||+.|+|||++.+..++.++||||||+++|+|++|..||.+..... ....+.......+
T Consensus 209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 99986655444556788999999999999999999999999999999999999997654321 2223333332222
Q ss_pred -CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 278 -VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 278 -~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
....+++++.+||.+||+.||.+|||+.++++.
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 225689999999999999999999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=361.89 Aligned_cols=249 Identities=26% Similarity=0.405 Sum_probs=215.5
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++........ ....+.+|+.++++++||||+++++++.+...++
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK----DTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch----HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 67999999999999999999986 78999999865321111 1356789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc---CCCceEEeeeccccccc
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG---EDMCVKVADFGISCLES 209 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~---~~~~~kl~Dfg~~~~~~ 209 (362)
+||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++....
T Consensus 98 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999999998765 589999999999999999999999999999999999995 45679999999998766
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCCHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFS 287 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~ 287 (362)
.........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+.........+ ..+++.+.
T Consensus 176 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 254 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (486)
T ss_dssp CC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred CCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence 5555566789999999999875 58999999999999999999999999998888877776655444333 56789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~~ 310 (362)
+||.+||+.||.+|||+.++++.
T Consensus 255 ~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 255 DLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999999973
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=360.95 Aligned_cols=248 Identities=26% Similarity=0.373 Sum_probs=213.2
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||+|.+. +..||||++......... ...+.+|+.+++.++||||+++++++.+....+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS----NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT----THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH----HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 57999999999999999999996 678999999865322111 356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CceEEeeeccccccc
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---MCVKVADFGISCLES 209 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~---~~~kl~Dfg~~~~~~ 209 (362)
+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.. +.+||+|||++....
T Consensus 113 lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999999998765 58999999999999999999999999999999999999764 459999999998766
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCCHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFS 287 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~ 287 (362)
.........||+.|+|||++. ..++.++||||||+++|+|++|.+||.+.+..+....+.........+ ..+++.+.
T Consensus 191 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp TTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred CCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence 655556778999999999986 468999999999999999999999999999888877776655443332 56899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~ 309 (362)
+||.+||+.||.+|||+.++++
T Consensus 270 ~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHCCCChhhCccHHHHhc
Confidence 9999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=338.10 Aligned_cols=260 Identities=27% Similarity=0.484 Sum_probs=214.0
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC---C--eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK---Q--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
+..++|++.+.||+|+||.||+|.+. + ..||||++........ ...+.+.+|+.++++++||||+++++++.
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP---EAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C---HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCH---HHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 44678999999999999999999863 2 3689999876432211 12467889999999999999999999998
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
.+. .++|+||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccc
Confidence 765 789999999999999998753 258999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCC----CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 207 LESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 207 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
....... .....++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+.......+.+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcC
Confidence 6543221 223456778999999998889999999999999999999 99999999988888777766667777888
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
+++.+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 99999999999999999999999999999987653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=342.84 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=219.2
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
...+|.+.+.||+|+||.||++.+. ++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 115 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP---HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 115 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence 3578999999999999999999997 67899999876432211 124678889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 116 ~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp EEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999999999998765 689999999999999999999999999999999999999999999999999876543
Q ss_pred C-CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 211 C-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 211 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
. .......+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+... ....+..+++.+.+|
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 271 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASL 271 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHH
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHH
Confidence 2 2334567899999999999988999999999999999999999999988877666555443 345667889999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~ 309 (362)
|.+||+.||.+||++.++++
T Consensus 272 i~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 272 IQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999997
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=369.04 Aligned_cols=263 Identities=27% Similarity=0.525 Sum_probs=220.7
Q ss_pred ccccccccCeeee-eeecccCCeeEEEEEEC----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeee
Q 017994 48 EEWSADMSQLFIG-CKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122 (362)
Q Consensus 48 ~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~ 122 (362)
..|.++...+.+. +.||+|+||.||+|.+. ++.||||++.....+.. ..+.+.+|+.++++++||||++++
T Consensus 361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~l~ 436 (635)
T 4fl3_A 361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAEANVMQQLDNPYIVRMI 436 (635)
T ss_dssp SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGG----GHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHH----HHHHHHHHHHHHHhCCCCCEeeEE
Confidence 3455566666664 48999999999999763 47899999976433322 136788999999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
+++.. +..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 437 ~~~~~-~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DF 513 (635)
T 4fl3_A 437 GICEA-ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDF 513 (635)
T ss_dssp EEEES-SSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCT
T ss_pred EEEec-CCEEEEEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEc
Confidence 99965 55889999999999999998765 6899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC----CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCC
Q 017994 203 GISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 277 (362)
Q Consensus 203 g~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 277 (362)
|++....... ......+++.|+|||++.+..++.++||||||+++|||++ |..||.+....+....+. ......
T Consensus 514 Gla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~ 592 (635)
T 4fl3_A 514 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMG 592 (635)
T ss_dssp THHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCC
T ss_pred CCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCC
Confidence 9987554322 1223446788999999999999999999999999999998 999999998877666554 455667
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 017994 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318 (362)
Q Consensus 278 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l 318 (362)
.+..+++++.+||.+||+.||.+||++.+|++.|+.+...+
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 78899999999999999999999999999999999876543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=339.40 Aligned_cols=245 Identities=21% Similarity=0.277 Sum_probs=201.1
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCeE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVF 131 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~ 131 (362)
++|++.++||+|+||+||+|.+. ++.||||++......... ......|+..+..+ +||||+++++++.+.+..
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD----RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH----HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 67999999999999999999996 789999998765443322 23344555555554 899999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred EEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999999 779999988765 36999999999999999999999999999999999999999999999999998876655
Q ss_pred CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..|+.... ....+......+..+..+++.+.+||.
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHHH
Confidence 55566679999999999876 68999999999999999999976665422 222332233333445678999999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~ 309 (362)
+||+.||.+|||+.++++
T Consensus 287 ~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 287 MMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHSCSSTTTSCCHHHHHT
T ss_pred HHcCCChhhCcCHHHHHh
Confidence 999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=363.30 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=219.4
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++......... ....+.+|+.++++++||||+++++++.+.+..
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKT---DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSS---CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccch---HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 367999999999999999999996 789999999764322110 136788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCceEEeeecccccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLE 208 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~---~~~~~~kl~Dfg~~~~~ 208 (362)
++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999999998765 58999999999999999999999999999999999999 56789999999999876
Q ss_pred ccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCCHHH
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAF 286 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l 286 (362)
..........||+.|+|||++.+ .++.++||||||+++|+|++|.+||.+.+..+....+.........+ ..+++.+
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 180 EASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp CCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred ccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 65555556679999999999876 68999999999999999999999999999888887777665444333 5688999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+||.+||+.||.+|||+.++++
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHCCCChhHCcCHHHHhh
Confidence 99999999999999999999996
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=336.24 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=213.2
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe-----
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK----- 127 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----- 127 (362)
.+|.+.+.||+|+||.||+|.+. ++.||||++..... .+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----------KAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----------GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----------HHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 57999999999999999999996 78999999986542 34579999999999999999998864
Q ss_pred -----------CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc
Q 017994 128 -----------PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 196 (362)
Q Consensus 128 -----------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~ 196 (362)
....++||||+++++|.+++.......+++..++.++.|++.||.|||++||+|+||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence 456899999999999999998765457999999999999999999999999999999999999999999
Q ss_pred eEEeeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q 017994 197 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 276 (362)
Q Consensus 197 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 276 (362)
++|+|||++.............+++.|+|||++.+..++.++||||||+++|+|++|..|+... ........ ..
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~----~~ 234 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR----DG 234 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH----TT
T ss_pred EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh----cc
Confidence 9999999988766555555667999999999999999999999999999999999998887432 11111211 23
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccC
Q 017994 277 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 320 (362)
Q Consensus 277 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~ 320 (362)
..+..++..+.++|.+||+.||.+||++.++++.|..+....+.
T Consensus 235 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 235 IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 34567889999999999999999999999999999988766543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=343.46 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=203.0
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
..++|.+.+.||+|+||.||+|.+. ++.||||++........ ....+.+|+.++++++||||+++++++.....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG----VPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC------------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccc----cchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 4578999999999999999999886 78999999976543322 23567789999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-----CCCceEEeeeccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-----EDMCVKVADFGIS 205 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~-----~~~~~kl~Dfg~~ 205 (362)
.++||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999999996 59999998776 589999999999999999999999999999999999994 4556999999998
Q ss_pred cccccC-CCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC-----
Q 017994 206 CLESQC-GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV----- 278 (362)
Q Consensus 206 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 278 (362)
...... .......+|+.|+|||++.+. .++.++||||||+++|+|++|..||......+....+......+..
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 765432 233455679999999999874 4899999999999999999999999998887776665543222111
Q ss_pred -----------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 279 -----------------------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 279 -----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0116789999999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=340.35 Aligned_cols=261 Identities=26% Similarity=0.496 Sum_probs=219.8
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
.+..++|.+.+.||+|+||.||+|.+. +..||||++........ ...+.+|+.++++++||||+++++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-----ELDFLMEALIISKFNHQNIVRCIG 100 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHH-----HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhh-----HHHHHHHHHHHhhCCCCCCCeEEE
Confidence 345688999999999999999999843 45799999975433221 356888999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CC
Q 017994 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEP-----YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DM 195 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~---~~ 195 (362)
++......++||||+++++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+||+++. ++
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence 99999999999999999999999987542 34889999999999999999999999999999999999984 44
Q ss_pred ceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 017994 196 CVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ 271 (362)
Q Consensus 196 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~ 271 (362)
.++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+.
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~- 259 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT- 259 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-
Confidence 69999999987433221 2234567889999999999999999999999999999998 999999888776665554
Q ss_pred cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 272 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 272 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
.......+..++..+.++|.+||+.||.+||++.++++.|+.+...
T Consensus 260 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 3445566788999999999999999999999999999999987653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=351.62 Aligned_cols=260 Identities=25% Similarity=0.506 Sum_probs=211.6
Q ss_pred cCeeeeeeecccCCeeEEEEEEC---C--eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE-eC
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK---Q--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK-KP 128 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~-~~ 128 (362)
..|.+.+.||+|+||.||+|.+. + ..||||.+........ .+.+.+|+.++++++||||+++++++. .+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHH-----HHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHH-----HHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 45778899999999999999874 2 3689999876443322 467889999999999999999999875 45
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 68899999999999999998654 35889999999999999999999999999999999999999999999999998754
Q ss_pred ccCC-----CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 017994 209 SQCG-----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 282 (362)
Q Consensus 209 ~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (362)
.... ......+++.|+|||++.+..++.++||||||+++|+|++ |.+||......+....+. .......+..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~ 321 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYC 321 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 3321 1233456788999999999999999999999999999999 788998776655554443 34455667789
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCC
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 321 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~ 321 (362)
+..+.+++.+||+.||.+||++.++++.|+.+...+...
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 999999999999999999999999999999998776543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=341.09 Aligned_cols=262 Identities=26% Similarity=0.501 Sum_probs=219.3
Q ss_pred cccccCeeeeeeecccCCeeEEEEEE------CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIY------KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
.+...+|.+.+.||+|+||.||++.+ .++.||||++....... .+.+.+|+.++++++||||++++++
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH------LRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHH------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHH------HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 34567899999999999999999985 37899999998754322 3678899999999999999999999
Q ss_pred EEeCC--eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 125 CKKPP--VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 125 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
+...+ ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+||
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecC
Confidence 86554 7899999999999999998764 25899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC----CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH---------------
Q 017994 203 GISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE--------------- 263 (362)
Q Consensus 203 g~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~--------------- 263 (362)
|++........ .....++..|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence 99876544322 23345677899999999888999999999999999999999988643111
Q ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 264 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
.............+.+..+++.+.++|.+||+.||.+||++.++++.|+.+.+.+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 01122333445566778899999999999999999999999999999999887653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=344.05 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=212.8
Q ss_pred cCeeee-eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCe
Q 017994 55 SQLFIG-CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPV 130 (362)
Q Consensus 55 ~~~~~~-~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~ 130 (362)
.+|.+. +.||+|+||.||+|.+. ++.||||++......... ...+.+|+.++..+ +||||+++++++.....
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC----RAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH----HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 567776 88999999999999987 789999999864332211 35678899999999 56999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCceEEeeeccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADFGISCL 207 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~---~~~~kl~Dfg~~~~ 207 (362)
.++||||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 999999999999999997665557999999999999999999999999999999999999987 78999999999987
Q ss_pred cccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCCHH
Q 017994 208 ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKA 285 (362)
Q Consensus 208 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 285 (362)
...........+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+....... .....+++.
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 263 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263 (327)
T ss_dssp C---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred cCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHH
Confidence 665555556789999999999999999999999999999999999999999988877766665544333 334678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+.+||.+||+.||.+||++.++++
T Consensus 264 ~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 264 ATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHcCCChhhCcCHHHHhC
Confidence 999999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=337.13 Aligned_cols=246 Identities=23% Similarity=0.373 Sum_probs=214.3
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||++.+. ++.||||++....... ...+.+|+.+++.++||||+++++++.+....+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR------DSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc------hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 57999999999999999999986 7899999998654322 256788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCceEEeeeccccccc
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLES 209 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~---~~~~~~kl~Dfg~~~~~~ 209 (362)
+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999999999998765 58999999999999999999999999999999999999 778899999999986543
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCCHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAFS 287 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 287 (362)
. .......+++.|+|||++.+..++.++||||||+++|+|++|..||...........+....... +....+++.+.
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 161 N-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp C-BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred C-CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence 3 22334568999999999999899999999999999999999999999988877766665544332 34467899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~ 309 (362)
+||.+||+.||.+||++.++++
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCChhHCcCHHHHhc
Confidence 9999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=335.16 Aligned_cols=260 Identities=22% Similarity=0.315 Sum_probs=214.4
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE-EeCCe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC-KKPPV 130 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~-~~~~~ 130 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++...... +.+.+|+.+++.++|++++..+..+ .....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--------hHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence 367999999999999999999974 889999998775543 3577899999999988866655554 67788
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCceEEeeeccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCL 207 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~---~~~~~~kl~Dfg~~~~ 207 (362)
.++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred eEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 89999999 999999998544 369999999999999999999999999999999999999 4888999999999876
Q ss_pred cccCCC--------CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHhc---C
Q 017994 208 ESQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE---QAAFAVCQK---N 273 (362)
Q Consensus 208 ~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~---~~~~~~~~~---~ 273 (362)
...... .....|++.|+|||++.+..++.++||||||+++|+|++|..||...... .....+... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 544322 24567899999999999999999999999999999999999999874321 112221111 1
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCCCC
Q 017994 274 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 323 (362)
Q Consensus 274 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~~~ 323 (362)
.....+..+|+.+.+++.+||+.||.+||++.++++.|+.+........+
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 3uzp_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence 11123467889999999999999999999999999999998877665443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=359.23 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=216.1
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchH-------HHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDAS-------LASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~-------~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
.++|.+++.||+|+||.||+|.+. ++.||||++........ ......+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467999999999999999999986 67899999987542210 001124678899999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---ceEEee
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM---CVKVAD 201 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~---~~kl~D 201 (362)
+.+....++||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999999998765 599999999999999999999999999999999999998776 699999
Q ss_pred eccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--C
Q 017994 202 FGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--P 279 (362)
Q Consensus 202 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~ 279 (362)
||++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+..+....+.......+. .
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence 99998766655556778999999999987 46899999999999999999999999999988887777665443332 2
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+++.+.+||.+||+.||.+|||+.|+++
T Consensus 272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 272 KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 578999999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=334.83 Aligned_cols=248 Identities=28% Similarity=0.490 Sum_probs=219.1
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.+.|.+.+.||+|+||.||+|.+. ++.||||++........ .+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-----IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH-----HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 366999999999999999999986 78999999987543322 36788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+++++|.+++... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 96 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp EEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999999999764 5899999999999999999999999999999999999999999999999998765433
Q ss_pred C-CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 212 G-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 212 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
. ......+++.|+|||++.+..++.++||||||+++|+|++|..||...........+.. ...+..+..++..+.+||
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 251 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-NNPPTLEGNYSKPLKEFV 251 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCCCCSSCCHHHHHHH
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-CCCCCCccccCHHHHHHH
Confidence 2 23456789999999999999999999999999999999999999998887776655543 445567778999999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 017994 291 SRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~~ 310 (362)
.+||+.||.+||++.++++.
T Consensus 252 ~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 252 EACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHCCSSGGGSCCHHHHTTC
T ss_pred HHHcCCChhhCcCHHHHhhC
Confidence 99999999999999999974
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=347.50 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=211.0
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC--CCceeeeeEEEEe
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN--HPHIITFVAACKK 127 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hp~iv~~~~~~~~ 127 (362)
.....+|.+.+.||+|+||.||++.+. ++.||||++........ ..+.+.+|+.++++++ ||||+++++++..
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~ 127 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHH----HHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence 344567999999999999999999886 77899999987544322 2467889999999996 5999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
++.+++||| +.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 128 ~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 128 DQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 203 (390)
T ss_dssp SSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred CCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence 999999999 55889999998765 689999999999999999999999999999999999995 58899999999976
Q ss_pred cccCC---CCCcccccccccChhhhhc-----------CCCCCcccchhhhHHHHHHHhCCCCCCCCCH-HHHHHHHHhc
Q 017994 208 ESQCG---SAKGFTGTYRWMAPEMIKE-----------KRHTKKVDVYSFGIVLWELLTALTPFDNMTP-EQAAFAVCQK 272 (362)
Q Consensus 208 ~~~~~---~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~-~~~~~~~~~~ 272 (362)
..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ......+...
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 54332 2345679999999999875 3688999999999999999999999987543 3444555555
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 273 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 273 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
......+...+..+.+||.+||+.||.+||++.|+++.
T Consensus 284 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 55566777788999999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=343.97 Aligned_cols=244 Identities=25% Similarity=0.400 Sum_probs=208.6
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPV 130 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~ 130 (362)
.++|.+.+.||+|+||.||++.++ ++.||||++...... ..+|+.++.++ +||||+++++++.+...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----------PTEEIEILLRYGQHPNIITLKDVYDDGKY 90 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----------CHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----------hHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence 367999999999999999999996 789999999875433 23588888887 79999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC----CceEEeeecccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED----MCVKVADFGISC 206 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~----~~~kl~Dfg~~~ 206 (362)
.|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||++..+ +.+||+|||++.
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 999999999999999998765 58999999999999999999999999999999999998433 359999999997
Q ss_pred ccccC-CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCC---CCHHHHHHHHHhcCCCCC--CCC
Q 017994 207 LESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN---MTPEQAAFAVCQKNARPP--VPP 280 (362)
Q Consensus 207 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~---~~~~~~~~~~~~~~~~~~--~~~ 280 (362)
..... ......++|+.|+|||++.+..++.++||||||+++|+|++|..||.. ....+....+........ ...
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred cCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 65433 234456789999999999988899999999999999999999999986 345555555554443322 346
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 281 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+++.+.+||.+||+.||.+||++.++++
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 78999999999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=348.86 Aligned_cols=249 Identities=21% Similarity=0.333 Sum_probs=199.2
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCC-
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPP- 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~- 129 (362)
..+|.+.+.||+|+||.||+|.+. ++.||||++......... ...+.+|+.++..+. ||||+++++++..++
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD----AQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHH----HHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHH----HHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 368999999999999999999986 789999998764333221 356778999999997 999999999997554
Q ss_pred -eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 130 -VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 130 -~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
.+|+||||++ ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred CEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 7899999996 5999999874 5899999999999999999999999999999999999999999999999999754
Q ss_pred ccC----------------------CCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHH
Q 017994 209 SQC----------------------GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA 265 (362)
Q Consensus 209 ~~~----------------------~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~ 265 (362)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 221 11234579999999999976 6789999999999999999999999999887766
Q ss_pred HHHHHhcCCCCC---------------------------------------------CCCCCCHHHHHHHHHhcccCCCC
Q 017994 266 AFAVCQKNARPP---------------------------------------------VPPTCPKAFSYLISRCWSSSPDR 300 (362)
Q Consensus 266 ~~~~~~~~~~~~---------------------------------------------~~~~~~~~l~~li~~~l~~~p~~ 300 (362)
...+......+. .+..+++.+.+||.+||..||.+
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 655543221111 12267889999999999999999
Q ss_pred CCCHHHHHHH
Q 017994 301 RPHFDQIVSI 310 (362)
Q Consensus 301 Rps~~ell~~ 310 (362)
|||+.|+++.
T Consensus 320 R~t~~e~l~H 329 (388)
T 3oz6_A 320 RISANDALKH 329 (388)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhCC
Confidence 9999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=336.75 Aligned_cols=251 Identities=26% Similarity=0.416 Sum_probs=191.1
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
..++|.+.+.||+|+||.||+|.+. ++.||||++....... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK---AGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhh---hhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 3568999999999999999999984 7899999986532111 1113568889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999999998753 3689999999999999999999999999999999999999999999999999876543
Q ss_pred C-CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 211 C-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 211 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
. .......+++.|+|||++.+..++.++||||||+++|+|++|..||...........+. ......+..++..+.++
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 242 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSFLSIEAKDL 242 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--SSCCCCCTTSCHHHHHH
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--hcccCCccccCHHHHHH
Confidence 2 22345678999999999998889999999999999999999999998765444333221 22334567789999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~ 309 (362)
|.+||+.||.+||++.++++
T Consensus 243 i~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHcccCHhhCCCHHHHhc
Confidence 99999999999999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=343.50 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=200.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC--
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP-- 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-- 129 (362)
.++|++.+.||+|+||.||+|.+. ++.||||++........ .+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-----REKVMREVKALAKLEHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTH-----HHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence 367999999999999999999996 78999999986543322 467889999999999999999999986543
Q ss_pred -------------------------------------------------------eEEEEEecCCCCCHHHHHhhcCC-C
Q 017994 130 -------------------------------------------------------VFCIITEYLAGGSLRKYLHQQEP-Y 153 (362)
Q Consensus 130 -------------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~-~ 153 (362)
..++||||+++++|.+++..... .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 38999999999999999987543 2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC-------------CCCccccc
Q 017994 154 SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-------------SAKGFTGT 220 (362)
Q Consensus 154 ~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~ 220 (362)
..++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ......||
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 35666789999999999999999999999999999999999999999999987654431 22345799
Q ss_pred ccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCC
Q 017994 221 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 300 (362)
Q Consensus 221 ~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 300 (362)
+.|+|||++.+..++.++||||||+++|+|++|..|+.. ....... ......+......++.+.+||.+||+.||.+
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITD-VRNLKFPLLFTQKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHH-HHTTCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHH-hhccCCCcccccCChhHHHHHHHHccCCCCc
Confidence 999999999999999999999999999999998766432 1111111 1122222222445678899999999999999
Q ss_pred CCCHHHHHH
Q 017994 301 RPHFDQIVS 309 (362)
Q Consensus 301 Rps~~ell~ 309 (362)
||++.|+++
T Consensus 317 Rps~~~~l~ 325 (332)
T 3qd2_B 317 RPEATDIIE 325 (332)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHhh
Confidence 999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=352.37 Aligned_cols=265 Identities=25% Similarity=0.412 Sum_probs=213.2
Q ss_pred CCcccccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 45 EGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 45 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
....++....++|.+.+.||+|+||.||+|.+. ++.||||++........ ...+.+|+.+++.++||||+++++
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG-----ELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C-----CCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH-----HHHHHHHHHHHHhccCCCccceEE
Confidence 344556667789999999999999999999875 78999999976543221 235788999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCcEEEcCCCceE
Q 017994 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEP--YSVPLNLVLKLALDIARGMQYLHSQ---GILHRDLKSENLLLGEDMCVK 198 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~dlk~~Nil~~~~~~~k 198 (362)
++......++||||+++++|.+++..... ..+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999986543 2489999999999999999999999 999999999999999999999
Q ss_pred EeeeccccccccCCC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCC----HHHHHHHHHhc
Q 017994 199 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT----PEQAAFAVCQK 272 (362)
Q Consensus 199 l~Dfg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~----~~~~~~~~~~~ 272 (362)
|+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ...........
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999999976543222 334558999999999999999999999999999999999999995211 00000111110
Q ss_pred CC-------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 273 NA-------------RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 273 ~~-------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
.. ....+...+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 00 0111222346799999999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=346.84 Aligned_cols=256 Identities=15% Similarity=0.238 Sum_probs=212.2
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC----------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceee---
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK----------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT--- 120 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~--- 120 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~ 109 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----------GRLFNEQNFFQRAAKPLQVNKWK 109 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----------chHHHHHHHHHHhcccchhhhhh
Confidence 478999999999999999999985 578999998764 34668999999999999987
Q ss_pred ------------eeEEEEe-CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 017994 121 ------------FVAACKK-PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 187 (362)
Q Consensus 121 ------------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~ 187 (362)
+++++.. +...++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+
T Consensus 110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~ 188 (352)
T 2jii_A 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE 188 (352)
T ss_dssp HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence 6777766 78899999999 999999998763346999999999999999999999999999999999
Q ss_pred cEEEcCCC--ceEEeeeccccccccCC--------CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCC
Q 017994 188 NLLLGEDM--CVKVADFGISCLESQCG--------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 257 (362)
Q Consensus 188 Nil~~~~~--~~kl~Dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~ 257 (362)
||+++.++ .++|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 99999999997544322 123457899999999999999999999999999999999999999
Q ss_pred CCCC--HHHHHHHHHh-cCCCCCCC------CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCC
Q 017994 258 DNMT--PEQAAFAVCQ-KNARPPVP------PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 321 (362)
Q Consensus 258 ~~~~--~~~~~~~~~~-~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~ 321 (362)
.... .......... ........ ..+++.+.+|+.+||+.||.+||++.++++.|+.+.......
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 8764 2222222111 11111111 256899999999999999999999999999999998776644
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=345.51 Aligned_cols=260 Identities=23% Similarity=0.330 Sum_probs=213.1
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
..+|.+.+.||+|+||.||+|.+. +..||||++....... ......+.+.+|+.++++++||||+++++++.+.+..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ-INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC----CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc-cCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 477999999999999999999986 6789999987532110 0011246788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcC--------------------------------------CCCCCHHHHHHHHHHHHHHHHH
Q 017994 132 CIITEYLAGGSLRKYLHQQE--------------------------------------PYSVPLNLVLKLALDIARGMQY 173 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~i~~~l~~ 173 (362)
++||||++|++|.+++.... ...+++..++.++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 99999999999999995211 1124577889999999999999
Q ss_pred HHHCCccccCCCCCcEEEcCCC--ceEEeeeccccccccCC-----CCCcccccccccChhhhhc--CCCCCcccchhhh
Q 017994 174 LHSQGILHRDLKSENLLLGEDM--CVKVADFGISCLESQCG-----SAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFG 244 (362)
Q Consensus 174 LH~~~i~H~dlk~~Nil~~~~~--~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG 244 (362)
||++||+||||||+||+++.++ .+||+|||++....... ......||+.|+|||++.+ ..++.++||||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 9999999999999999998776 89999999987543321 1345678999999999975 6789999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 017994 245 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGY 314 (362)
Q Consensus 245 ~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~ 314 (362)
+++|+|++|..||.+....+....+.........+ ..+++.+.+||.+||+.||.+||++.++++ .++.+
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 99999999999999998888877776655444333 347899999999999999999999999987 44443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=344.88 Aligned_cols=247 Identities=22% Similarity=0.381 Sum_probs=211.2
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHH--HHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASL--ASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
..+|.+.+.||+|+||.||+|.+. ++.||||++......... .......+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 367999999999999999999885 789999999875421100 0000134567999999999999999999999999
Q ss_pred eEEEEEecCCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 130 VFCIITEYLAGG-SLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 130 ~~~lv~e~~~~~-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
..++||||+.+| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 999999998666 9999998765 5999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcccccccccChhhhhcCCC-CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHH
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 287 (362)
..........||+.|+|||++.+..+ +.++||||||+++|+|++|..||..... ........+..+++.+.
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~~l~ 252 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEAAIHPPYLVSKELM 252 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTTCCCCSSCCCHHHH
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhhccCCCcccCHHHH
Confidence 66555566789999999999988776 8899999999999999999999976332 12233445667899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~~ 310 (362)
+||.+||+.||.+||++.++++.
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 253 SLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999974
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=347.55 Aligned_cols=259 Identities=22% Similarity=0.271 Sum_probs=205.6
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHH-----HHHHHHHHHHHHHHHHcCCCCceeeee
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASL-----ASMLEKQFTSEVALLFRLNHPHIITFV 122 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~hp~iv~~~ 122 (362)
..++|.+.+.||+|+||.||+|.+. +..||||+.......... .......+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3578999999999999999999985 468999999876432211 111124467889999999999999999
Q ss_pred EEEEe----CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC--c
Q 017994 123 AACKK----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--C 196 (362)
Q Consensus 123 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~--~ 196 (362)
+++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++ .
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc
Confidence 99988 78999999999 999999998765 689999999999999999999999999999999999998877 9
Q ss_pred eEEeeeccccccccCCC--------CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCC--CHHHHH
Q 017994 197 VKVADFGISCLESQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM--TPEQAA 266 (362)
Q Consensus 197 ~kl~Dfg~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~--~~~~~~ 266 (362)
+||+|||++........ .....|++.|+|||++.+..++.++||||||+++|+|++|..||... ......
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 99999999975433211 13457899999999999999999999999999999999999999652 222211
Q ss_pred HHHHhcCCCCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 267 FAVCQKNARPPV---------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 267 ~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
... ....... ...+++.+.++|.+||+.||.+||++.+|++.|+....
T Consensus 272 ~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 272 TAK--TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHH--HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHH--HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111 1111111 12788999999999999999999999999999987643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=333.45 Aligned_cols=259 Identities=22% Similarity=0.321 Sum_probs=210.8
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE-EeCCeE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC-KKPPVF 131 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~-~~~~~~ 131 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++...... ..+.+|+.+++.++|++++..++.+ ......
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--------CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--------hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 67999999999999999999974 789999987664432 3467899999999888777666555 777889
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCceEEeeecccccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLE 208 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~---~~~~~~kl~Dfg~~~~~ 208 (362)
++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9999999 999999998644 269999999999999999999999999999999999999 78899999999999765
Q ss_pred ccCCC--------CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHhc---CC
Q 017994 209 SQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE---QAAFAVCQK---NA 274 (362)
Q Consensus 209 ~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~---~~~~~~~~~---~~ 274 (362)
..... .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.... .....+... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 44322 23567899999999999999999999999999999999999999874321 111111111 11
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCCCC
Q 017994 275 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 323 (362)
Q Consensus 275 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~~~ 323 (362)
.......+|+.+.+|+.+||+.||.+||++.++++.|+.+......+..
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTT
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCcc
Confidence 1122366789999999999999999999999999999999887665443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=332.15 Aligned_cols=250 Identities=25% Similarity=0.466 Sum_probs=210.3
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe--
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK-- 127 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-- 127 (362)
.+...|.+.+.||+|+||.||+|.+. +..||+|++........ ..+.+.+|+.++++++||||+++++++..
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS----ERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHH----HHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 34566899999999999999999986 67899999876543322 24678899999999999999999999865
Q ss_pred --CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEc-CCCceEEeee
Q 017994 128 --PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLG-EDMCVKVADF 202 (362)
Q Consensus 128 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dlk~~Nil~~-~~~~~kl~Df 202 (362)
....++||||+++++|.+++.... .+++..++.++.|++.||.|||+.| |+||||||+||+++ .++.++|+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred CCCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 456899999999999999998765 5899999999999999999999999 99999999999997 7899999999
Q ss_pred ccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCCCCCCCCC
Q 017994 203 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-VCQKNARPPVPPT 281 (362)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~ 281 (362)
|++..... .......+++.|+|||++. +.++.++||||||+++|+|++|..||........... +.........+..
T Consensus 177 g~~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (290)
T 1t4h_A 177 GLATLKRA-SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp TGGGGCCT-TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred CCcccccc-cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCC
Confidence 99865443 2334567899999999886 4589999999999999999999999988555444433 3333333345667
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.++.+.+||.+||+.||.+|||+.++++
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 7889999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=343.13 Aligned_cols=265 Identities=23% Similarity=0.317 Sum_probs=213.1
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
....+.++.++|.+.+.||+|+||.||++.+. ++.||||++...... ..+.+.+|+.+++.++||||+++++
T Consensus 20 ~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~ 93 (317)
T 2buj_A 20 QGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ------DREEAQREADMHRLFNHPNILRLVA 93 (317)
T ss_dssp EEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHH------HHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred cccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHH------HHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34556677889999999999999999999984 789999998664322 1467889999999999999999999
Q ss_pred EEE----eCCeEEEEEecCCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCce
Q 017994 124 ACK----KPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 197 (362)
Q Consensus 124 ~~~----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~ 197 (362)
++. .....++||||+++++|.+++... ....+++..++.++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~ 173 (317)
T 2buj_A 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQP 173 (317)
T ss_dssp EEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCE
T ss_pred EEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCE
Confidence 986 335789999999999999999763 22368999999999999999999999999999999999999999999
Q ss_pred EEeeeccccccccCCCC----------CcccccccccChhhhhcCC---CCCcccchhhhHHHHHHHhCCCCCCCCCHH-
Q 017994 198 KVADFGISCLESQCGSA----------KGFTGTYRWMAPEMIKEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPE- 263 (362)
Q Consensus 198 kl~Dfg~~~~~~~~~~~----------~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~~l~ell~g~~p~~~~~~~- 263 (362)
+|+|||++......... ....|++.|+|||++.+.. ++.++||||||+++|+|++|..||......
T Consensus 174 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 253 (317)
T 2buj_A 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253 (317)
T ss_dssp EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence 99999987654321111 1234689999999987543 689999999999999999999999542110
Q ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 264 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
.............+.+..+++.+.++|.+||+.||.+||++.++++.|+.+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 254 DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 01112222344445567789999999999999999999999999999998754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=345.72 Aligned_cols=262 Identities=27% Similarity=0.465 Sum_probs=204.9
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHH--HHHHHHHcCCCCceeeeeEEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFT--SEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~--~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
.+.++.++|.+.+.||+|+||.||+|.++++.||||++..... ..+. .|+..+..++||||+++++.+.
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---------~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---------QNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH---------HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch---------hhHHHHHHHHHHHhccCcchhhheeccc
Confidence 4456788999999999999999999999999999999975432 2233 3444455689999999998653
Q ss_pred e-----CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCcEEEc
Q 017994 127 K-----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ---------GILHRDLKSENLLLG 192 (362)
Q Consensus 127 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~i~H~dlk~~Nil~~ 192 (362)
. ...+++||||+++|+|.+++.... .++..++.++.||+.||.|||+. ||+||||||+|||++
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK 154 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence 2 336789999999999999998764 58899999999999999999999 999999999999999
Q ss_pred CCCceEEeeeccccccccC---------CCCCcccccccccChhhhhc-------CCCCCcccchhhhHHHHHHHhCCCC
Q 017994 193 EDMCVKVADFGISCLESQC---------GSAKGFTGTYRWMAPEMIKE-------KRHTKKVDVYSFGIVLWELLTALTP 256 (362)
Q Consensus 193 ~~~~~kl~Dfg~~~~~~~~---------~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~~l~ell~g~~p 256 (362)
.++.+||+|||++...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..|
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence 9999999999999754322 11234568999999999976 4567789999999999999999666
Q ss_pred CCCC-C-----------------HHHHHHHHHhcCCCCCCCCC------CCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 257 FDNM-T-----------------PEQAAFAVCQKNARPPVPPT------CPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 257 ~~~~-~-----------------~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
|... . ..............+.++.. +++.+.+||.+||+.||.+|||+.|+++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 5321 1 11222222233334444443 3447999999999999999999999999999
Q ss_pred hhhhhccCCC
Q 017994 313 GYSESLEQDP 322 (362)
Q Consensus 313 ~~~~~l~~~~ 322 (362)
.+....+.+.
T Consensus 315 ~ll~~~~~~~ 324 (336)
T 3g2f_A 315 ELMMIWERNK 324 (336)
T ss_dssp HHHHCCCC--
T ss_pred HHHHHHHhcc
Confidence 9987766543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=336.34 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=201.6
Q ss_pred cCeeee-eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCe
Q 017994 55 SQLFIG-CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPV 130 (362)
Q Consensus 55 ~~~~~~-~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~ 130 (362)
+.|.+. +.||+|+||.||+|.+. ++.||||++....... ...+.+|+.++.++ +||||+++++++.+.+.
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI------RSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC------HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh------HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 568885 78999999999999975 7899999997754332 35678899999985 79999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc---eEEeeeccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC---VKVADFGISCL 207 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~---~kl~Dfg~~~~ 207 (362)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++..
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999999998765 5899999999999999999999999999999999999988775 99999999875
Q ss_pred cccCC--------CCCcccccccccChhhhhc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCH------------
Q 017994 208 ESQCG--------SAKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTP------------ 262 (362)
Q Consensus 208 ~~~~~--------~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~------------ 262 (362)
..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 43211 1223458999999999875 5578999999999999999999999987542
Q ss_pred ---HHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 263 ---EQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 263 ---~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
......+.......+. ...+++.+.+||.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 2223333332222111 1467899999999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=343.15 Aligned_cols=246 Identities=22% Similarity=0.363 Sum_probs=204.6
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC--
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP-- 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-- 129 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 99 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHH----HHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence 468999999999999999999986 78999999976543322 2467889999999999999999999997663
Q ss_pred ----eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 130 ----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 130 ----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
.+|+||||+ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 100 DDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 88999999874 5899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-------- 276 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-------- 276 (362)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 176 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 176 RQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp EECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred ccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 76543 2345678999999999887 678999999999999999999999999888766555543321111
Q ss_pred ---------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ---------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
......++.+.+||.+||..||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 123467889999999999999999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=333.76 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=216.0
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE--eCC
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK--KPP 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~--~~~ 129 (362)
.++|++.+.||+|+||.||++.+. ++.||+|++........ ..+.+.+|+.++++++||||+++++++. ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA----EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHH----HHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 578999999999999999999996 78899999987544322 2467889999999999999999999874 467
Q ss_pred eEEEEEecCCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCcEEEcCCCceEEeee
Q 017994 130 VFCIITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQG-----ILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~-----i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.| ++||||||+||+++.++.++|+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 8999999999999999997532 234899999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCC-CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 203 GISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 203 g~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
|++........ .....+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+.. ......+..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~ 239 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYR 239 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCCCCCTT
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh-cccccCCcc
Confidence 99875443211 2245689999999999998999999999999999999999999999887766665544 344567778
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 312 (362)
++..+.++|.+||+.||.+||++.++++.+.
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 9999999999999999999999999997654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=343.24 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=206.9
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++........ ...+.+|+.+++.++||||+++++++...+..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc-----chhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEE
Confidence 57999999999999999999996 78899999976433211 123457999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 211 (362)
+||||++ ++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 77 lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp EEEECCS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred EEecccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 9999996 599999987543 6899999999999999999999999999999999999999999999999998754432
Q ss_pred CCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------------
Q 017994 212 GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------- 277 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 277 (362)
.......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+......+.
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 22345578999999999876 5689999999999999999999999999888776665544222111
Q ss_pred ---------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhhhh
Q 017994 278 ---------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSES 317 (362)
Q Consensus 278 ---------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~~~ 317 (362)
..+.+++++.+||.+||+.||.+|||+.|+++ .+..+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 12356789999999999999999999999997 44444433
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=355.32 Aligned_cols=247 Identities=22% Similarity=0.313 Sum_probs=202.2
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC---
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--- 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--- 128 (362)
.++|++.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChH----HHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence 478999999999999999999986 78999999986533222 246778999999999999999999999654
Q ss_pred ---CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 129 ---PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 129 ---~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
...|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 467999999965 57777653 4899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--------
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-------- 277 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 277 (362)
.............||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+......+.
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 876665555667899999999999999999999999999999999999999999887766655543221110
Q ss_pred ------------C---------CCC-----------CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 ------------V---------PPT-----------CPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 ------------~---------~~~-----------~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
. +.. .++.+.+||.+||..||.+|||+.|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 000 1457899999999999999999999997
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=342.93 Aligned_cols=250 Identities=22% Similarity=0.386 Sum_probs=212.0
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
+..++|.+.+.||+|+||.||++.+. ++.||+|++....... ..+.+.+|+.+++.++||||+++++++..++
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 104 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-----IRNQIIRELQVLHECNSPYIVGFYGAFYSDG 104 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHH-----HHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHH-----HHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence 34578999999999999999999997 7899999998754322 2467889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++...
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 9999999999999999998765 589999999999999999999996 9999999999999999999999999998654
Q ss_pred ccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHH---------------------
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF--------------------- 267 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~--------------------- 267 (362)
... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+...
T Consensus 183 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 183 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp HHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 332 2345678999999999999999999999999999999999999998766544321
Q ss_pred ---------------------HHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 268 ---------------------AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 268 ---------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+............++.++.+||.+||+.||.+|||+.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 112222222233457899999999999999999999999997
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=340.27 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=209.5
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
..++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM----VKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchH----HHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence 4688999999999999999999997 78999999877654432 24667889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999999999988876554 589999999999999999999999999999999999999999999999999875443
Q ss_pred C-CCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------------
Q 017994 211 C-GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR------------- 275 (362)
Q Consensus 211 ~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~------------- 275 (362)
. .......+++.|+|||++.+. .++.++||||||+++|+|++|..||......+....+......
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 2 233456789999999999875 6899999999999999999999999988876655544321111
Q ss_pred -------CC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 -------PP---------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 -------~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+. ..+.+++.+.+||.+||+.||.+||++.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 11357899999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=338.72 Aligned_cols=253 Identities=30% Similarity=0.547 Sum_probs=206.3
Q ss_pred ccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHc--CCCCceeeeeEEEEeC---
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR--LNHPHIITFVAACKKP--- 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hp~iv~~~~~~~~~--- 128 (362)
.++|.+.+.||+|+||.||+|.++++.||||++..... ..+..|..++.. ++||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~---------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE---------ASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGH---------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEecccc---------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 36899999999999999999999999999999865322 233445555554 4899999999999887
Q ss_pred -CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCcEEEcCCCceEE
Q 017994 129 -PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ--------GILHRDLKSENLLLGEDMCVKV 199 (362)
Q Consensus 129 -~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~i~H~dlk~~Nil~~~~~~~kl 199 (362)
...++||||+++++|.++++.. .+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 7899999999999999999775 489999999999999999999999 9999999999999999999999
Q ss_pred eeeccccccccCCC-----CCcccccccccChhhhhcCCCCCc------ccchhhhHHHHHHHhC----------CCCCC
Q 017994 200 ADFGISCLESQCGS-----AKGFTGTYRWMAPEMIKEKRHTKK------VDVYSFGIVLWELLTA----------LTPFD 258 (362)
Q Consensus 200 ~Dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~------~Dv~slG~~l~ell~g----------~~p~~ 258 (362)
+|||++........ .....||+.|+|||++.+...+.. +||||||+++|+|++| ..||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 99999865433222 124578999999999988776665 9999999999999999 77776
Q ss_pred CCCH-----HHHHHHHHhcCCCCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 017994 259 NMTP-----EQAAFAVCQKNARPPVPP-----TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318 (362)
Q Consensus 259 ~~~~-----~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l 318 (362)
.... .............+..+. .+++.+.+|+.+||+.||.+||++.++++.|+.+.+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 5322 222222323333444443 45677999999999999999999999999999987753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=359.24 Aligned_cols=253 Identities=21% Similarity=0.325 Sum_probs=214.8
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
...++|.+.+.||+|+||.||++.+. ++.||||++....... ......+.+|+.++++++||||+++++++....
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 258 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK---RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT 258 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh---hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence 44688999999999999999999986 7899999986532111 011356788999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
.+|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 9999999999999999997643 34699999999999999999999999999999999999999999999999999976
Q ss_pred cccCCC-CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCCCCCCCC
Q 017994 208 ESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT----PEQAAFAVCQKNARPPVPPTC 282 (362)
Q Consensus 208 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~ 282 (362)
...... ....+||+.|+|||++.+..++.++|+||||+++|+|++|..||.... .......+.. ....++..+
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~--~~~~~p~~~ 416 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYPDKF 416 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CCCCCCTTS
T ss_pred ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh--cccCCCccc
Confidence 544332 345689999999999999999999999999999999999999998753 3444444433 344567889
Q ss_pred CHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 017994 283 PKAFSYLISRCWSSSPDRRPHF-----DQIVS 309 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~-----~ell~ 309 (362)
++.+.+||.+||+.||.+||++ .+|++
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 9999999999999999999975 55553
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=370.19 Aligned_cols=252 Identities=22% Similarity=0.325 Sum_probs=218.3
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEe
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKK 127 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~ 127 (362)
....++|.+.+.||+|+||.||+|.+. ++.||||++....... ......+..|..++..+ +||+|+++++++.+
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~---~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~ 413 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ---DDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 413 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH---TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc---HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe
Confidence 345789999999999999999999987 5779999987532110 11135667899999987 79999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
.+.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999999998865 599999999999999999999999999999999999999999999999999975
Q ss_pred cc-cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHH
Q 017994 208 ES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286 (362)
Q Consensus 208 ~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (362)
.. ........+||+.|+|||++.+..++.++||||||+++|||++|..||.+.+..+....+.. ....++..+++++
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~ 569 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEA 569 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS--SCCCCCTTSCHHH
T ss_pred cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHH
Confidence 33 33345567899999999999999999999999999999999999999999988888777754 3456778899999
Q ss_pred HHHHHHhcccCCCCCCCH-----HHHHH
Q 017994 287 SYLISRCWSSSPDRRPHF-----DQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~-----~ell~ 309 (362)
.+||.+||+.||.+||++ .+|++
T Consensus 570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 570 VAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 999999999999999997 56654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=331.10 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=212.8
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
.+.+...+|.....||+|+||.||+|.+. ++.||||++....... .+.+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~ 89 (295)
T 2clq_A 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY------SQPLHEEIALHKHLKHKNIVQYLGSFS 89 (295)
T ss_dssp CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---------HHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHH------HHHHHHHHHHHHhCCCCCEeeEeeEEE
Confidence 34455566666679999999999999985 6789999998754322 366889999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCceEEeeecc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFGI 204 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~ 204 (362)
..+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||||+||+++. ++.++|+|||+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp ETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred eCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccc
Confidence 9999999999999999999998753 235678999999999999999999999999999999999987 89999999999
Q ss_pred ccccccC-CCCCcccccccccChhhhhcCC--CCCcccchhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCCCC
Q 017994 205 SCLESQC-GSAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVCQKNARPPVPP 280 (362)
Q Consensus 205 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~~l~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 280 (362)
+...... .......+++.|+|||++.+.. ++.++||||||+++|+|++|..||...... ............+..+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (295)
T 2clq_A 170 SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE 249 (295)
T ss_dssp CEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCT
T ss_pred ccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccc
Confidence 8765432 2234567899999999997654 789999999999999999999999765433 33333334455667788
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 281 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+++.+.++|.+||+.||.+||++.++++
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 89999999999999999999999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=331.63 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=210.1
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++....... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT-----HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh-----hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEE
Confidence 367999999999999999999986 7899999987643322 136778999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999999999997654 5899999999999999999999999999999999999999999999999998754322
Q ss_pred ---CCCCcccccccccChhhhhcCCC-CCcccchhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCCCCCCCCCCCHHH
Q 017994 212 ---GSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQA-AFAVCQKNARPPVPPTCPKAF 286 (362)
Q Consensus 212 ---~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l 286 (362)
.......+++.|+|||++.+..+ +.++||||||+++|+|++|..||........ ................+++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHH
Confidence 22345678999999999987664 7899999999999999999999987654322 222222222223345688999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.++|.+||+.||.+|||+.++++
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 239 LALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHCCCCchhCCCHHHHhc
Confidence 99999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=329.86 Aligned_cols=249 Identities=25% Similarity=0.401 Sum_probs=216.1
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++......... ...+.+|+.++++++||||+++++++......
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH----HHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 367999999999999999999996 789999998764322111 35678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---CceEEeeecccccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---MCVKVADFGISCLE 208 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~---~~~kl~Dfg~~~~~ 208 (362)
++|+||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++...
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999999998765 58999999999999999999999999999999999999754 46999999998876
Q ss_pred ccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--CCCCHHH
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAF 286 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l 286 (362)
..........+++.|+|||.+.+. ++.++||||||+++|+|++|..||.+.+..+....+.........+ ..+++.+
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 2wei_A 175 QQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (287)
T ss_dssp CCCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred cCCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence 555445566789999999998754 8999999999999999999999999988877776666554443333 5789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.++|.+||+.||.+||++.++++
T Consensus 254 ~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 254 KDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcccChhhCcCHHHHhc
Confidence 99999999999999999999997
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=344.55 Aligned_cols=255 Identities=23% Similarity=0.343 Sum_probs=210.2
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe-
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK- 127 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~- 127 (362)
+....+|.+++.||+|+||.||+|.+. ++.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----------~~~E~~il~~l~hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----------KNRELDIMKVLDHVNIIKLVDYFYTT 72 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----------CCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----------HHHHHHHHHHcCCCCccchhheeeec
Confidence 345678999999999999999999985 789999998765332 2369999999999999999999843
Q ss_pred -------------------------------------CCeEEEEEecCCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHH
Q 017994 128 -------------------------------------PPVFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIA 168 (362)
Q Consensus 128 -------------------------------------~~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~~i~ 168 (362)
...+++||||++ ++|.+.+.. .....+++..++.++.||+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 345899999996 588887764 2234699999999999999
Q ss_pred HHHHHHHHCCccccCCCCCcEEEc-CCCceEEeeeccccccccCCCCCcccccccccChhhhhcC-CCCCcccchhhhHH
Q 017994 169 RGMQYLHSQGILHRDLKSENLLLG-EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIV 246 (362)
Q Consensus 169 ~~l~~LH~~~i~H~dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~ 246 (362)
.||.|||++||+||||||+||+++ .++.+||+|||++.............+|+.|+|||++.+. .++.++||||||++
T Consensus 152 ~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 152 RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 999999999999999999999998 6889999999999876665566677889999999998765 48999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHhcccCCC
Q 017994 247 LWELLTALTPFDNMTPEQAAFAVCQKNARP---------------------------PVPPTCPKAFSYLISRCWSSSPD 299 (362)
Q Consensus 247 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~ 299 (362)
+|+|++|..||.+.+..+....+......+ .++..+++++.+||.+||+.||.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999999988877666654321111 13456789999999999999999
Q ss_pred CCCCHHHHHH--HHHhhhh
Q 017994 300 RRPHFDQIVS--ILEGYSE 316 (362)
Q Consensus 300 ~Rps~~ell~--~L~~~~~ 316 (362)
+|||+.|+++ .++.+..
T Consensus 312 ~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GSCCHHHHHTSGGGHHHHH
T ss_pred hCCCHHHHhcCHHHHHHHh
Confidence 9999999995 4444433
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=331.94 Aligned_cols=248 Identities=24% Similarity=0.436 Sum_probs=210.3
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
..++|.+.+.||+|+||.||+|.+. ++.||||++...... +.+.+|+.+++.++||||+++++++.....
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--------QEIIKEISIMQQCDSPHVVKYYGSYFKNTD 98 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCC--------HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHH--------HHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 3467999999999999999999987 789999999875432 567889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
.++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999999999997543 3689999999999999999999999999999999999999999999999999875543
Q ss_pred C-CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCCHHHHH
Q 017994 211 C-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSY 288 (362)
Q Consensus 211 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 288 (362)
. .......+++.|+|||++.+..++.++||||||+++|+|++|..||...........+..... ....+..++..+.+
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 3 223456789999999999998899999999999999999999999998887666555433322 12335567899999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 017994 289 LISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 289 li~~~l~~~p~~Rps~~ell~ 309 (362)
||.+||+.||.+||++.++++
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHccCChhhCcCHHHHHh
Confidence 999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=341.48 Aligned_cols=244 Identities=20% Similarity=0.325 Sum_probs=185.6
Q ss_pred cCeeee---eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeC
Q 017994 55 SQLFIG---CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKP 128 (362)
Q Consensus 55 ~~~~~~---~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~ 128 (362)
.+|.+. +.||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+. ||||+++++++.+.
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---------EANTQKEITALKLCEGHPNIVKLHEVFHDQ 78 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---------HHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh---------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 345553 78999999999999996 7899999996532 255678999999997 99999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---ceEEeeeccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM---CVKVADFGIS 205 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~---~~kl~Dfg~~ 205 (362)
...++||||++|++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred CEEEEEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 99999999999999999998865 699999999999999999999999999999999999998765 8999999999
Q ss_pred cccccC-CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCCCC
Q 017994 206 CLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP-------EQAAFAVCQKNARPP 277 (362)
Q Consensus 206 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~-------~~~~~~~~~~~~~~~ 277 (362)
...... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||..... .+....+........
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 157 RLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp EECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred eecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 754432 223456789999999999999999999999999999999999999986443 233333332222111
Q ss_pred C--CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 V--PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 ~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
. ...+++++.+||.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 1 1357899999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=337.66 Aligned_cols=257 Identities=25% Similarity=0.461 Sum_probs=208.5
Q ss_pred eeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEe
Q 017994 57 LFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITE 136 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 136 (362)
|..++.||+|+||.||+|.++++.||||++........ ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT--EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCT--TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcch--HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 45568999999999999999999999999876432110 1124678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC--
Q 017994 137 YLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-- 213 (362)
Q Consensus 137 ~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 213 (362)
|+++++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 999999999997432 23589999999999999999999999999999999999999999999999999875443221
Q ss_pred -CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHH----HHHHh---------cCCCCCCC
Q 017994 214 -AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA----FAVCQ---------KNARPPVP 279 (362)
Q Consensus 214 -~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~----~~~~~---------~~~~~~~~ 279 (362)
.....|++.|+|||.+.+ .++.++||||||+++|+|++|..||......... ..... .......+
T Consensus 191 ~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD 269 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence 234578999999998865 4789999999999999999999999875432211 11110 01112223
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
...+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 3455779999999999999999999999999998753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=333.29 Aligned_cols=249 Identities=22% Similarity=0.431 Sum_probs=208.8
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|++.+.||+|+||.||+|.+. ++.||+|++....... .+.+.+|+.+++.++||||+++++++..++..
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE------LEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC------HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH------HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 467999999999999999999997 7889999987654332 36678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc-
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ- 210 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~- 210 (362)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999999987644 2699999999999999999999999999999999999999999999999998753222
Q ss_pred CCCCCcccccccccChhhhh-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CCCCCCCH
Q 017994 211 CGSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-PVPPTCPK 284 (362)
Q Consensus 211 ~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 284 (362)
........+++.|+|||++. +..++.++||||||+++|+|++|..||...+.......+....... ..+..++.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 250 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence 12234457899999999984 5668899999999999999999999999988877666655443322 34567889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+.++|.+||+.||.+|||+.++++
T Consensus 251 ~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 251 EFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHcccChhhCCCHHHHhc
Confidence 9999999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=346.35 Aligned_cols=246 Identities=24% Similarity=0.335 Sum_probs=208.7
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC------CCCceeeeeEEE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL------NHPHIITFVAAC 125 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l------~hp~iv~~~~~~ 125 (362)
..+|++.+.||+|+||.||+|.+. ++.||||++...... ...+.+|+.+++.+ +|+||+++++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~-------~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF-------HRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHH-------HHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccch-------HHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 357999999999999999999986 689999999764221 35566788877776 678999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc--eEEeeec
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC--VKVADFG 203 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~--~kl~Dfg 203 (362)
......++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999999995 69999998876667999999999999999999999999999999999999999887 9999999
Q ss_pred cccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------
Q 017994 204 ISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------ 277 (362)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------ 277 (362)
++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+......++
T Consensus 248 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 248 SSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp TCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 9865443 33456789999999999999999999999999999999999999999887766555443211110
Q ss_pred ---------------------------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 017994 278 ---------------------------------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQ 306 (362)
Q Consensus 278 ---------------------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~e 306 (362)
.+...++.+.+||.+||+.||.+|||+.|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 11234788999999999999999999999
Q ss_pred HHH
Q 017994 307 IVS 309 (362)
Q Consensus 307 ll~ 309 (362)
+++
T Consensus 406 ~L~ 408 (429)
T 3kvw_A 406 ALR 408 (429)
T ss_dssp HHT
T ss_pred HhC
Confidence 985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=339.06 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=199.3
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeE
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVA 123 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~ 123 (362)
...+.....+|.+.+.||+|+||.||+|.+. ++.||||++....... .+.+.+|+.++.++. ||||+++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~e~~~l~~l~~h~~iv~~~~ 93 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK------NRAIIQEVCFMKKLSGHPNIVQFCS 93 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHH------HHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHH------HHHHHHHHHHHHHhccCCChhhccc
Confidence 3455666779999999999999999999994 7899999986543322 366788999999995 999999999
Q ss_pred EEE--------eCCeEEEEEecCCCCCHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEc
Q 017994 124 ACK--------KPPVFCIITEYLAGGSLRKYLHQQ-EPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLG 192 (362)
Q Consensus 124 ~~~--------~~~~~~lv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dlk~~Nil~~ 192 (362)
++. ....+++||||+. |+|.+++... ....+++..++.++.||+.||.|||+.| |+||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~ 172 (337)
T 3ll6_A 94 AASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS 172 (337)
T ss_dssp EEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC
T ss_pred cccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC
Confidence 984 3446899999995 6999988752 2235999999999999999999999999 99999999999999
Q ss_pred CCCceEEeeeccccccccCCC-------------CCcccccccccChhhh---hcCCCCCcccchhhhHHHHHHHhCCCC
Q 017994 193 EDMCVKVADFGISCLESQCGS-------------AKGFTGTYRWMAPEMI---KEKRHTKKVDVYSFGIVLWELLTALTP 256 (362)
Q Consensus 193 ~~~~~kl~Dfg~~~~~~~~~~-------------~~~~~~~~~~~aPE~~---~~~~~~~~~Dv~slG~~l~ell~g~~p 256 (362)
.++.+||+|||++........ .....+++.|+|||++ .+..++.++||||||+++|+|++|..|
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 252 (337)
T 3ll6_A 173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252 (337)
T ss_dssp TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 999999999999876543221 1144589999999998 566788999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 257 FDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
|........ .......+.+...+..+.+||.+||+.||.+||++.++++.|+.+.....
T Consensus 253 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 253 FEDGAKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp C----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CcchhHHHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 987544332 22333445566778889999999999999999999999999999877644
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=329.17 Aligned_cols=244 Identities=23% Similarity=0.340 Sum_probs=206.6
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCeE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVF 131 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~ 131 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++......... ...+.+|+..+..+ +||||+++++++.+.+..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH----HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH----HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 67999999999999999999996 789999999875433221 35677899999998 999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC---------------
Q 017994 132 CIITEYLAGGSLRKYLHQQEP--YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED--------------- 194 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~--------------- 194 (362)
++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999999976421 358999999999999999999999999999999999999844
Q ss_pred ----CceEEeeeccccccccCCCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Q 017994 195 ----MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV 269 (362)
Q Consensus 195 ----~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~ 269 (362)
..++|+|||.+...... ....+++.|+|||++.+. .++.++||||||+++|+|++|.+++..... ...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~- 239 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHE- 239 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHH-
T ss_pred cCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHH-
Confidence 47999999998765442 334689999999999766 567899999999999999999877755432 222
Q ss_pred HhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 270 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 270 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
......+..+..+++.+.++|.+||+.||.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 240 IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 2344556677889999999999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=349.79 Aligned_cols=259 Identities=20% Similarity=0.323 Sum_probs=213.8
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC--
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP-- 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-- 129 (362)
..+|.+.+.||+|+||.||+|.+. ++.||||++........ .+.+.+|+.++++++||||+++++++....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch-----HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 367999999999999999999997 78999999975432221 356678999999999999999999998765
Q ss_pred eEEEEEecCCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----cCCCceEEeeecc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADFGI 204 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~----~~~~~~kl~Dfg~ 204 (362)
..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 78999999999999999986442 249999999999999999999999999999999999999 7788899999999
Q ss_pred ccccccCCCCCcccccccccChhhhhc--------CCCCCcccchhhhHHHHHHHhCCCCCCCC----CHHHHHHHHHhc
Q 017994 205 SCLESQCGSAKGFTGTYRWMAPEMIKE--------KRHTKKVDVYSFGIVLWELLTALTPFDNM----TPEQAAFAVCQK 272 (362)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~slG~~l~ell~g~~p~~~~----~~~~~~~~~~~~ 272 (362)
+.............||+.|+|||++.+ ..++.++||||||+++|+|++|..||... ...+....+...
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 987665555556779999999999875 56788999999999999999999999643 223444444432
Q ss_pred CCCC-------------------C----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 273 NARP-------------------P----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 273 ~~~~-------------------~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
.... + .+..+++.+.+++.+||+.||.+||++.++++.++.+...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 2110 1 1123456788999999999999999999999999887653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=340.50 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=206.0
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
..+|.+.+.||+|+||.||+|.+. ++.||||++........ .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA-KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchh-hhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 478999999999999999999986 78899999976432211 111124677899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+++ +|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 999999965 8999987654 35888999999999999999999999999999999999999999999999999765432
Q ss_pred -CCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------------
Q 017994 212 -GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------ 277 (362)
Q Consensus 212 -~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 277 (362)
.......+|+.|+|||++.+. .++.++||||||+++|+|++|.+||.+....+....+......+.
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 233456789999999999764 589999999999999999999999999888777666554322111
Q ss_pred --------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 278 --------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 278 --------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
....+++++.+||.+||+.||.+|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 014567899999999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=335.41 Aligned_cols=256 Identities=26% Similarity=0.492 Sum_probs=196.0
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
.|.+..++|.+.+.||+|+||.||+|.+. ++.||||++....... ..+.+.+|+.++++++||||+++++++.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 83 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT-----SMDELLKEIQAMSQCHHPNIVSYYTSFV 83 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC---------------------CCCCCCCTTBCCEEEEEE
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcch-----hHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence 46677889999999999999999999874 7899999987643221 1356788999999999999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEe
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQ------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 200 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~ 200 (362)
..+..++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEE
Confidence 999999999999999999999741 22358999999999999999999999999999999999999999999999
Q ss_pred eeccccccccCC------CCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Q 017994 201 DFGISCLESQCG------SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 273 (362)
Q Consensus 201 Dfg~~~~~~~~~------~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 273 (362)
|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||................
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence 999986543321 1234568999999999876 568999999999999999999999999877665544433322
Q ss_pred CC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 274 AR--------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 274 ~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.. ......+++.+.++|.+||+.||.+||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11 1233567899999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=339.15 Aligned_cols=252 Identities=29% Similarity=0.551 Sum_probs=210.3
Q ss_pred ccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHc--CCCCceeeeeEEEEeCC--
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR--LNHPHIITFVAACKKPP-- 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~hp~iv~~~~~~~~~~-- 129 (362)
.++|.+.+.||+|+||.||+|.++++.||||++.... ...+.+|+.++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh---------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 3689999999999999999999999999999986532 2456678888887 78999999999998876
Q ss_pred --eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCcEEEcCCCceEE
Q 017994 130 --VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH--------SQGILHRDLKSENLLLGEDMCVKV 199 (362)
Q Consensus 130 --~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~i~H~dlk~~Nil~~~~~~~kl 199 (362)
..++||||+++++|.+++... .+++..++.++.|++.||.||| +.||+||||||+||+++.++.+||
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred cceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 899999999999999999875 4899999999999999999999 899999999999999999999999
Q ss_pred eeeccccccccCC-----CCCcccccccccChhhhhcCC------CCCcccchhhhHHHHHHHhC----------CCCCC
Q 017994 200 ADFGISCLESQCG-----SAKGFTGTYRWMAPEMIKEKR------HTKKVDVYSFGIVLWELLTA----------LTPFD 258 (362)
Q Consensus 200 ~Dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~------~~~~~Dv~slG~~l~ell~g----------~~p~~ 258 (362)
+|||++....... ......+++.|+|||++.+.. ++.++||||||+++|+|++| ..||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 9999987654432 234557899999999997653 33689999999999999999 78887
Q ss_pred CCC-----HHHHHHHHHhcCCCCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 259 NMT-----PEQAAFAVCQKNARPPVPP-----TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 259 ~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
... .......+......+..+. .+++.+.+|+.+||+.||.+||++.++++.|+.+.+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 642 2333333333344444443 2345799999999999999999999999999998764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=359.76 Aligned_cols=263 Identities=29% Similarity=0.587 Sum_probs=224.3
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeee
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITF 121 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~ 121 (362)
...+.+..++|.+++.||+|+||.||+|.+. +..||||++....... ..+.+.+|+.++++++||||+++
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l 456 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS-----VREKFLQEALTMRQFDHPHIVKL 456 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHH-----HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHH-----HHHHHHHHHHHHHhCCCCCCCeE
Confidence 3456777889999999999999999999985 3569999987643322 24678899999999999999999
Q ss_pred eEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEee
Q 017994 122 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 201 (362)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~D 201 (362)
++++. ++..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 457 ~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~D 534 (656)
T 2j0j_A 457 IGVIT-ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 534 (656)
T ss_dssp EEEEC-SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEe-cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEe
Confidence 99985 456899999999999999998654 3689999999999999999999999999999999999999999999999
Q ss_pred eccccccccCCC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 017994 202 FGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 278 (362)
Q Consensus 202 fg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (362)
||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+.. ....+.
T Consensus 535 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~~ 613 (656)
T 2j0j_A 535 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPM 613 (656)
T ss_dssp CCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-TCCCCC
T ss_pred cCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CCCCCC
Confidence 999976543322 223456789999999999999999999999999999997 9999999888777666544 455667
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 279 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 279 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
+..+++.+.+||.+||+.||.+||++.++++.|+.+.+.
T Consensus 614 ~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 888999999999999999999999999999999988653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=349.51 Aligned_cols=249 Identities=25% Similarity=0.337 Sum_probs=189.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe----
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK---- 127 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~---- 127 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||+++++++..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 127 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI----DCKRILREIAILNRLNHDHVVKVLDIVIPKDVE 127 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHH----HHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc
Confidence 378999999999999999999886 78899999976543322 13678899999999999999999999843
Q ss_pred -CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 128 -PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 128 -~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
...+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 128 KFDELYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp TCCCEEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred cCceEEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccch
Confidence 35799999998 679999998754 69999999999999999999999999999999999999999999999999997
Q ss_pred ccccCC----------------------------CCCcccccccccChhhh-hcCCCCCcccchhhhHHHHHHHh-----
Q 017994 207 LESQCG----------------------------SAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLT----- 252 (362)
Q Consensus 207 ~~~~~~----------------------------~~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~~l~ell~----- 252 (362)
...... .....+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 653221 12345689999999986 45679999999999999999998
Q ss_pred ------CCCCCCCCCH--------------------HHHHHHHHhcCCC-----------------------------CC
Q 017994 253 ------ALTPFDNMTP--------------------EQAAFAVCQKNAR-----------------------------PP 277 (362)
Q Consensus 253 ------g~~p~~~~~~--------------------~~~~~~~~~~~~~-----------------------------~~ 277 (362)
|.++|.+... .+.+..+...... ..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 6777765431 1111111110000 01
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+..++++.+||.+||..||.+|||+.|+++
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 12456889999999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=338.08 Aligned_cols=247 Identities=22% Similarity=0.310 Sum_probs=198.3
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC--
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP-- 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-- 129 (362)
..+|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHH----HHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChH----HHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence 478999999999999999999986 78999999986543322 2366788999999999999999999997665
Q ss_pred ----eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 130 ----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 130 ----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
..++||||++ ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 100 ~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 100 EEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp TTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 7899999996 588888863 4889999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--------- 276 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------- 276 (362)
.............||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......+
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 86655444456789999999999999999999999999999999999999999988776655554322111
Q ss_pred -----------CC--------------CC------CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 -----------PV--------------PP------TCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 -----------~~--------------~~------~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.. +. ..+..+.+||.+||..||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00 00 01467899999999999999999999997
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=350.45 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=197.8
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHH--HHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASL--ASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++......... .......+.+|+.++++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 468999999999999999999986 679999998764321110 11112357789999999999999999999754 5
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---ceEEeeecccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM---CVKVADFGISC 206 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~---~~kl~Dfg~~~ 206 (362)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 6789999999999999987654 689999999999999999999999999999999999997544 59999999998
Q ss_pred ccccCCCCCcccccccccChhhhhc---CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---CCC
Q 017994 207 LESQCGSAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---VPP 280 (362)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 280 (362)
............||+.|+|||++.+ ..++.++||||||+++|+|++|..||.................... ...
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 370 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 370 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHT
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhc
Confidence 7665555566789999999999853 5678899999999999999999999987543322222222222221 225
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 281 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+++.+.+||.+||+.||.+||++.|+++
T Consensus 371 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 371 EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 67899999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=336.64 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=207.2
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe---
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK--- 127 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--- 127 (362)
..++|.+.+.||+|+||.||+|.+. ++.||||++......... ...+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF----PITALREIKILQLLKHENVVNLIEICRTKAS 90 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS----CHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc----hHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence 4578999999999999999999985 789999998765433221 2456789999999999999999999977
Q ss_pred -----CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 128 -----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 128 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
.+..++||||+++ +|.+.+.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4578999999965 8888776644 25999999999999999999999999999999999999999999999999
Q ss_pred ccccccccC-----CCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q 017994 203 GISCLESQC-----GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 276 (362)
Q Consensus 203 g~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 276 (362)
|++...... .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+.......
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 998754421 22244568999999999876 458999999999999999999999999988777665554322221
Q ss_pred C--CCCC----------------------------CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 P--VPPT----------------------------CPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ~--~~~~----------------------------~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+ ..+. .++.+.+||.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1 1111 2677999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=333.80 Aligned_cols=252 Identities=21% Similarity=0.333 Sum_probs=211.0
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC---CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC---CCCceeeeeEEEE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL---NHPHIITFVAACK 126 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~ 126 (362)
..++|.+.+.||+|+||.||+|.+. ++.||||++......... ...+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM----PLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC----BCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC----CchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 3478999999999999999999983 688999998754322110 12345677766655 8999999999987
Q ss_pred -----eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEee
Q 017994 127 -----KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 201 (362)
Q Consensus 127 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~D 201 (362)
.....++||||+. ++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp EEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred ecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEec
Confidence 5678999999996 6999999887655699999999999999999999999999999999999999999999999
Q ss_pred eccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------
Q 017994 202 FGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR------ 275 (362)
Q Consensus 202 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~------ 275 (362)
||++.............+++.|+|||++.+..++.++||||||+++|+|++|..||.+.........+......
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 99997665544455667899999999999999999999999999999999999999998877666555432111
Q ss_pred -------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 -------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
......++..+.+||.+||+.||.+||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0123567899999999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=345.83 Aligned_cols=249 Identities=25% Similarity=0.341 Sum_probs=198.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC---
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--- 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--- 128 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI----DCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHH----HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChH----HHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence 478999999999999999999986 68899999976543322 246788999999999999999999999766
Q ss_pred --CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 129 --PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 129 --~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
...|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 101 ~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 101 KFDELYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cCCeEEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 57999999985 69999998754 59999999999999999999999999999999999999999999999999997
Q ss_pred ccccCCC-----------------------CCcccccccccChhhh-hcCCCCCcccchhhhHHHHHHHhC---------
Q 017994 207 LESQCGS-----------------------AKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLTA--------- 253 (362)
Q Consensus 207 ~~~~~~~-----------------------~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~~l~ell~g--------- 253 (362)
....... ....+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 6543221 2456789999999986 556799999999999999999984
Q ss_pred --CCCCCCCCH-----------------HHHHHHHHhc------------------------CCCCC-----CCCCCCHH
Q 017994 254 --LTPFDNMTP-----------------EQAAFAVCQK------------------------NARPP-----VPPTCPKA 285 (362)
Q Consensus 254 --~~p~~~~~~-----------------~~~~~~~~~~------------------------~~~~~-----~~~~~~~~ 285 (362)
.++|.+.+. .+.+..+... ..... ..+.+++.
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 444443320 1111111110 00111 11457899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+.+||.+||..||.+|||+.|+++
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=330.68 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=210.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE--EeCC
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC--KKPP 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~--~~~~ 129 (362)
.++|.+++.||+|+||.||++.+. ++.||||++........ ......+.+|+.++++++||||+++++++ .+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI--PNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHS--TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccccc--chhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 367999999999999999999985 67899999875321110 11246788999999999999999999998 4456
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
..++||||+.++ |.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 899999999765 8888877665679999999999999999999999999999999999999999999999999987654
Q ss_pred cC---CCCCcccccccccChhhhhcCC--CCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCH
Q 017994 210 QC---GSAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284 (362)
Q Consensus 210 ~~---~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
.. .......+++.|+|||++.+.. ++.++||||||+++|+|++|..||...........+... ....+..+++
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~ 238 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGDCGP 238 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCCSSSCH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--CCCCCCccCH
Confidence 32 1223456899999999997654 378999999999999999999999998877766655443 3456778899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
.+.++|.+||+.||.+||++.++++.
T Consensus 239 ~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 239 PLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99999999999999999999999964
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=338.59 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=206.5
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC----
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP---- 128 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~---- 128 (362)
.+|.+.+.||+|+||.||+|.+. ++.||||++....... ..+.+.+|+.++.+++||||+++++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT-----YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHH-----HHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcH-----HHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 68999999999999999999986 7889999997643322 236678999999999999999999999655
Q ss_pred -CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 129 -PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 129 -~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
...++||||+. ++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 47899999996 5999999875 489999999999999999999999999999999999999999999999999976
Q ss_pred cccCCC----CCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-----
Q 017994 208 ESQCGS----AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP----- 277 (362)
Q Consensus 208 ~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~----- 277 (362)
...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+......+.
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 543322 244578999999998754 4589999999999999999999999988776555444432111110
Q ss_pred ------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 ------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+.+++.+.+||.+||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 12457889999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=335.11 Aligned_cols=260 Identities=22% Similarity=0.357 Sum_probs=190.6
Q ss_pred CCCcccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHH-HHHcCCCCceee
Q 017994 44 GEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVA-LLFRLNHPHIIT 120 (362)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~-~l~~l~hp~iv~ 120 (362)
......|.+..++|.+.+.||+|+||.||+|.+. ++.||||++........ ...+..|+. +++.++||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~~~~~~~h~niv~ 85 (327)
T 3aln_A 11 ISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-----QKQLLMDLDVVMRSSDCPYIVQ 85 (327)
T ss_dssp CCCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-----HHHHHHHHHHHHSSCCCTTBCC
T ss_pred CChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-----HHHHHHHHHHHHHcCCCCcEee
Confidence 3456778888999999999999999999999997 88999999987543322 234445555 777789999999
Q ss_pred eeEEEEeCCeEEEEEecCCCCCHHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCc
Q 017994 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQ---QEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMC 196 (362)
Q Consensus 121 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dlk~~Nil~~~~~~ 196 (362)
+++++...+..++||||+++ +|.+++.. .....+++..++.++.|++.||.|||+. ||+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~ 164 (327)
T 3aln_A 86 FYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN 164 (327)
T ss_dssp EEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE
T ss_pred eeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC
Confidence 99999999999999999965 88888763 2234689999999999999999999999 9999999999999999999
Q ss_pred eEEeeeccccccccCCCCCcccccccccChhhh----hcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 017994 197 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMI----KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 272 (362)
Q Consensus 197 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 272 (362)
+||+|||++.............|++.|+|||++ .+..++.++||||||+++|+|++|..||...............
T Consensus 165 ~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (327)
T 3aln_A 165 IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244 (327)
T ss_dssp EEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC
T ss_pred EEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc
Confidence 999999999766554444455789999999998 4566899999999999999999999999875432111111111
Q ss_pred CCCCCC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 273 NARPPV----PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 273 ~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...+.. ...+++.+.+||.+||+.||.+||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111112 2457899999999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=336.75 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=201.6
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchH--HHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDAS--LASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++........ ........+.+|+.++++++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 57999999999999999999986 68999999976432110 01111345788999999999999999999987665
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc---eEEeeeccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC---VKVADFGISCL 207 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~---~kl~Dfg~~~~ 207 (362)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 899999999999999997654 6899999999999999999999999999999999999987654 99999999876
Q ss_pred cccCCCCCcccccccccChhhhh---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCC--CCCCCC
Q 017994 208 ESQCGSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQKNAR--PPVPPT 281 (362)
Q Consensus 208 ~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~-~~~~~~~~~~~--~~~~~~ 281 (362)
...........|++.|+|||++. ...++.++||||||+++|+|++|..||....... ....+...... +.....
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTT
T ss_pred cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhh
Confidence 54433333456899999999974 4568899999999999999999999997654332 22222222111 112356
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+++.+.+||.+||+.||.+||++.++++
T Consensus 247 ~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 247 VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 7899999999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=341.50 Aligned_cols=246 Identities=24% Similarity=0.335 Sum_probs=190.9
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC----
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP---- 128 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~---- 128 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||+++++++...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHH----HHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 78999999999999999999986 78999999976543322 236778999999999999999999998654
Q ss_pred --CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 129 --PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 129 --~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
...++|+|++ +++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred cCCeEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 5689999999 78999998763 59999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------
Q 017994 207 LESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--------- 276 (362)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------- 276 (362)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 181 HTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred cccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 6443 2345678999999999877 678999999999999999999999999988766555443321111
Q ss_pred ------------C--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 277 ------------P--------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 277 ------------~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
. .....++.+.+||.+||..||.+|||+.++++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 113567889999999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=337.15 Aligned_cols=256 Identities=25% Similarity=0.343 Sum_probs=202.9
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcch-----HHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDA-----SLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~-----~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
.-.++|.+.+.||+|+||.||+|.+. ++.||||++....... .......+.+.+|+.++++++||||+++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 34578999999999999999999886 7899999986533221 11122346788999999999999999999998
Q ss_pred Ee-----CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEe
Q 017994 126 KK-----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 200 (362)
Q Consensus 126 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~ 200 (362)
.. ....++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 44 347899999996 68888887543 368999999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---
Q 017994 201 DFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--- 276 (362)
Q Consensus 201 Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--- 276 (362)
|||++.............+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+......+
T Consensus 177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 256 (362)
T 3pg1_A 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256 (362)
T ss_dssp CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence 9999976555555566788999999999877 678999999999999999999999999888766655543321111
Q ss_pred ---------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ---------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...+.+++.+.+||.+||+.||.+|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 112456788999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=330.76 Aligned_cols=242 Identities=16% Similarity=0.279 Sum_probs=203.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEe--C
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKK--P 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~--~ 128 (362)
.++|++.+.||+|+||.||+|.+. ++.||||++.... .+.+.+|+.++++++ ||||+++++++.. .
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---------KKKIKREIKILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence 578999999999999999999885 7899999997543 256788999999997 9999999999987 6
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-ceEEeeeccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGISCL 207 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg~~~~ 207 (362)
...++||||+++++|.+++.. +++..++.++.|++.||.|||++||+||||||+||+++.++ .++|+|||++..
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 789999999999999999853 78899999999999999999999999999999999999776 899999999987
Q ss_pred cccCCCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHh-------------c
Q 017994 208 ESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQ-------------K 272 (362)
Q Consensus 208 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~-~~~~~~~~~~-------------~ 272 (362)
...........+++.|+|||++.+ ..++.++||||||+++|+|++|..||.... ..+....+.. .
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 181 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred cCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 665555566789999999999977 668999999999999999999999995432 2222211111 0
Q ss_pred C----------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 273 N----------------------ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 273 ~----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
. .....+..+++.+.+||.+||+.||.+|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 011112237899999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=335.79 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=206.9
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
..|.+ ..+|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||+++++++
T Consensus 36 ~~~~l-~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~ 110 (371)
T 4exu_A 36 TAWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI----FAKRAYRELLLLKHMQHENVIGLLDVF 110 (371)
T ss_dssp EEEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ceecc-cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchh----HHHHHHHHHHHHHhcCCCCchhhhhhe
Confidence 34444 368999999999999999999986 78999999987544332 246778999999999999999999999
Q ss_pred EeCCeE------EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEE
Q 017994 126 KKPPVF------CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 199 (362)
Q Consensus 126 ~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl 199 (362)
...+.. ++||||+. ++|.+++.. .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||
T Consensus 111 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL 185 (371)
T 4exu_A 111 TPASSLRNFYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKI 185 (371)
T ss_dssp CSCSSSTTCCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred eccCCcccceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEE
Confidence 877654 99999996 688888743 4899999999999999999999999999999999999999999999
Q ss_pred eeeccccccccCCCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--
Q 017994 200 ADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-- 276 (362)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-- 276 (362)
+|||++..... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+......+
T Consensus 186 ~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 186 LDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 263 (371)
T ss_dssp CSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence 99999875443 2345678999999999987 678999999999999999999999999888766655543321111
Q ss_pred ---------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ---------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...+.+++.+.+||.+||+.||.+|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 012457899999999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=351.76 Aligned_cols=255 Identities=16% Similarity=0.148 Sum_probs=199.5
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHH---HHHHcCCCCceeeee-
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEV---ALLFRLNHPHIITFV- 122 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei---~~l~~l~hp~iv~~~- 122 (362)
.|.....+|.+.+.||+|+||.||+|.+. ++.||||++......... ..+.+.+|+ .++++++||||++++
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~~l~hpniv~~~~ 143 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN---AIKQMKEEVLRLRLLRGIKNQKQAKVHL 143 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTT---HHHHHHHHHHGGGGSTTCCSHHHHHHHH
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchH---HHHHHHHHHHHHHhccccCCHHHHHHHh
Confidence 34445678999999999999999999975 789999999753221110 136788899 555666899999998
Q ss_pred ------EEEEeCC-----------------eEEEEEecCCCCCHHHHHhhcCCC-----CCCHHHHHHHHHHHHHHHHHH
Q 017994 123 ------AACKKPP-----------------VFCIITEYLAGGSLRKYLHQQEPY-----SVPLNLVLKLALDIARGMQYL 174 (362)
Q Consensus 123 ------~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~L 174 (362)
+++...+ ..|+||||+ +|+|.+++...... .+++..++.++.||+.||.||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 222 (377)
T 3byv_A 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222 (377)
T ss_dssp CBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 6666553 389999999 67999999865321 123478889999999999999
Q ss_pred HHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCCCcccccccccChhhhhcC-----------CCCCcccchhh
Q 017994 175 HSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-----------RHTKKVDVYSF 243 (362)
Q Consensus 175 H~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~Dv~sl 243 (362)
|++||+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++|||||
T Consensus 223 H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 223 HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred HhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 999999999999999999999999999999875333 2334567 999999999887 89999999999
Q ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhhh
Q 017994 244 GIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSE 316 (362)
Q Consensus 244 G~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~~ 316 (362)
|+++|+|++|..||...........+ ......+++.+.+||.+||+.||.+||++.++++ .++.+.+
T Consensus 300 G~il~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp HHHHHHHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred HHHHHHHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence 99999999999999775543222111 1223678899999999999999999999999996 5555443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=344.89 Aligned_cols=245 Identities=23% Similarity=0.299 Sum_probs=202.9
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC---
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--- 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--- 128 (362)
..+|.+.+.||+|+||.||+|.+. ++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK 122 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----------SCCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----------hHHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence 357999999999999999999995 78999999876432 223699999999999999999988532
Q ss_pred ---CeEEEEEecCCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-CceEEeee
Q 017994 129 ---PVFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADF 202 (362)
Q Consensus 129 ---~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~-~~~kl~Df 202 (362)
..+++||||+++ +|.+.+.. .....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+||
T Consensus 123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccc
Confidence 247799999965 77776653 223469999999999999999999999999999999999999955 67899999
Q ss_pred ccccccccCCCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----
Q 017994 203 GISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP----- 276 (362)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~----- 276 (362)
|++.............+|+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..+......+
T Consensus 202 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 202 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp TTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999866555555567889999999998765 78999999999999999999999999988766655544321100
Q ss_pred ----------C------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ----------P------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ----------~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
. ++..+++++.+||.+||..||.+||++.|+++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0 23467899999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=342.84 Aligned_cols=255 Identities=25% Similarity=0.375 Sum_probs=210.2
Q ss_pred cccccCeeeeeeecccCCeeEEEEEE-----CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEE
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIY-----KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAA 124 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~ 124 (362)
.....+|.+.+.||+|+||.||++.+ .++.||||++......... .....+.+|+.+++.+ +||||++++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE--SSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh--hHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 34568999999999999999999998 4789999998753210000 0023456799999999 69999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
+......++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 999999999999999999999998765 589999999999999999999999999999999999999999999999999
Q ss_pred ccccccC--CCCCcccccccccChhhhhcC--CCCCcccchhhhHHHHHHHhCCCCCCCCC----HHHHHHHHHhcCCCC
Q 017994 205 SCLESQC--GSAKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMT----PEQAAFAVCQKNARP 276 (362)
Q Consensus 205 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~p~~~~~----~~~~~~~~~~~~~~~ 276 (362)
+...... .......||+.|+|||++.+. .++.++||||||+++|+|++|..||.... .......+. ...+
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~ 283 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KSEP 283 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH--HCCC
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh--ccCC
Confidence 8754322 223456799999999999863 47899999999999999999999997532 223333332 2345
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 017994 277 PVPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVSIL 311 (362)
Q Consensus 277 ~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~~L 311 (362)
..+..++..+.+||.+||+.||.+|| ++.++++..
T Consensus 284 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 284 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 67788999999999999999999999 889988743
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=339.75 Aligned_cols=254 Identities=21% Similarity=0.320 Sum_probs=213.1
Q ss_pred cccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHH-----------HHHHHHHHHHHHHHHcCCCCceeee
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLA-----------SMLEKQFTSEVALLFRLNHPHIITF 121 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~-----------~~~~~~~~~Ei~~l~~l~hp~iv~~ 121 (362)
..++|.+.+.||+|+||.||+|.+.++.||||++.......... ....+.+.+|+.++++++||||+++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35789999999999999999999999999999987532211000 0001567899999999999999999
Q ss_pred eEEEEeCCeEEEEEecCCCCCHHHH------HhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCC
Q 017994 122 VAACKKPPVFCIITEYLAGGSLRKY------LHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGED 194 (362)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~ 194 (362)
++++.+.+..++||||+++++|.++ +.......+++..++.++.|++.||.|||+ +|++||||+|+||+++.+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence 9999999999999999999999998 665434579999999999999999999999 999999999999999999
Q ss_pred CceEEeeeccccccccCCCCCcccccccccChhhhhcC-CCCC-cccchhhhHHHHHHHhCCCCCCCCCH-HHHHHHHHh
Q 017994 195 MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTK-KVDVYSFGIVLWELLTALTPFDNMTP-EQAAFAVCQ 271 (362)
Q Consensus 195 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~Dv~slG~~l~ell~g~~p~~~~~~-~~~~~~~~~ 271 (362)
+.++|+|||++...... ......+++.|+|||++.+. .++. ++||||||+++|+|++|..||..... .+....+..
T Consensus 189 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~ 267 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267 (348)
T ss_dssp SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS
T ss_pred CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence 99999999998765432 34456789999999999877 5555 99999999999999999999988766 455444433
Q ss_pred cCCCCCCC-------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 272 KNARPPVP-------------------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 272 ~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.. ...+ ..+++.+.+||.+||+.||.+||++.++++
T Consensus 268 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 268 KN--IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CC--CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cC--cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22 2233 668899999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=337.20 Aligned_cols=255 Identities=15% Similarity=0.202 Sum_probs=210.2
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEE-----E--CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC---CC
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGI-----Y--KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN---HP 116 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-----~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hp 116 (362)
...+.....+|.+.+.||+|+||.||+|. . .++.||||++..... ..+..|+.++..++ |+
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~e~~~~~~l~~~~~~ 127 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---------WEFYIGTQLMERLKPSMQH 127 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---------HHHHHHHHHHHHSCGGGGG
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---------hHHHHHHHHHHHhhhhhhh
Confidence 35566778899999999999999999994 2 368899999976532 45677888888886 99
Q ss_pred ceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC
Q 017994 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQ---EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 193 (362)
Q Consensus 117 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~ 193 (362)
||+++++++...+..++||||+++|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 128 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN 207 (365)
T ss_dssp GBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECG
T ss_pred hhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecc
Confidence 9999999999999999999999999999999752 2346999999999999999999999999999999999999988
Q ss_pred -----------CCceEEeeeccccccc---cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 017994 194 -----------DMCVKVADFGISCLES---QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 259 (362)
Q Consensus 194 -----------~~~~kl~Dfg~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~ 259 (362)
++.+||+|||++.... .........||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 8999999999996433 22233456799999999999999999999999999999999999999965
Q ss_pred CCHHHHHHHHHhcCCCCCC-CCCCCHHHHHHHHHhcccCCCCC-CCHHHHHHHHHhhhhh
Q 017994 260 MTPEQAAFAVCQKNARPPV-PPTCPKAFSYLISRCWSSSPDRR-PHFDQIVSILEGYSES 317 (362)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~R-ps~~ell~~L~~~~~~ 317 (362)
..... ......+ ....++.+.+++..|++.+|.+| |++.++.+.|+.+.+.
T Consensus 288 ~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 288 NEGGE-------CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp EETTE-------EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCCc-------eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 32211 0000111 11236778999999999999988 5888888888877654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=331.98 Aligned_cols=245 Identities=22% Similarity=0.332 Sum_probs=206.2
Q ss_pred cCeeeeeeecccCCeeEEEEEE---CCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCC------ceeeeeEEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIY---KQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP------HIITFVAAC 125 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp------~iv~~~~~~ 125 (362)
++|.+.+.||+|+||.||+|.+ .++.||||++..... ..+.+.+|+.+++.++|+ +++++++++
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR-------YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH-------HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc-------hhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 6899999999999999999988 378999999975322 135677899999888665 499999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC------------
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE------------ 193 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~------------ 193 (362)
...+..++||||+ +++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999999 889999998876556899999999999999999999999999999999999987
Q ss_pred -------CCceEEeeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHH
Q 017994 194 -------DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA 266 (362)
Q Consensus 194 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~ 266 (362)
++.++|+|||++..... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||...+..+..
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 66899999999876443 234567899999999999999999999999999999999999999988776654
Q ss_pred HHHHhcCCCC------------------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 017994 267 FAVCQKNARP------------------------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHF 304 (362)
Q Consensus 267 ~~~~~~~~~~------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~ 304 (362)
..+....... ..+...++.+.+||.+||+.||.+|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 4332211110 0112235678999999999999999999
Q ss_pred HHHHH
Q 017994 305 DQIVS 309 (362)
Q Consensus 305 ~ell~ 309 (362)
.|+++
T Consensus 324 ~ell~ 328 (339)
T 1z57_A 324 REALK 328 (339)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=339.05 Aligned_cols=245 Identities=22% Similarity=0.314 Sum_probs=203.1
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC---
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP--- 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~--- 129 (362)
..+|.+.+.||+|+||.||+|.+. +..||+|++...... ..+|+.+++.++||||+++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----------~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 357999999999999999999996 566999988764322 236999999999999999999985543
Q ss_pred ---eEEEEEecCCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-CCCceEEeeec
Q 017994 130 ---VFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-EDMCVKVADFG 203 (362)
Q Consensus 130 ---~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~-~~~~~kl~Dfg 203 (362)
.+++||||+++ ++...+.. .....+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||
T Consensus 109 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 109 DEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp SCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 38899999976 44444331 1223699999999999999999999999999999999999999 78999999999
Q ss_pred cccccccCCCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------
Q 017994 204 ISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------ 276 (362)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~------ 276 (362)
++.............+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+......+
T Consensus 188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp TCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99876655556677889999999998765 58999999999999999999999999988776665554321111
Q ss_pred ---------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ---------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.++..+++++.+||.+||+.||.+|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 123457889999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=346.89 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=212.7
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC-CceeeeeEEEEeCCeE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-PHIITFVAACKKPPVF 131 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-p~iv~~~~~~~~~~~~ 131 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++...... ..+..|+.+++.+.| +++..+..++...+..
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--------PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 67999999999999999999986 789999998765443 346789999999976 6666777777888999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---cCCCceEEeeecccccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCVKVADFGISCLE 208 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~---~~~~~~kl~Dfg~~~~~ 208 (362)
++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 79 ~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 9999999 999999998644 369999999999999999999999999999999999999 68899999999999765
Q ss_pred ccCCC--------CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHhcC---C
Q 017994 209 SQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP---EQAAFAVCQKN---A 274 (362)
Q Consensus 209 ~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~---~~~~~~~~~~~---~ 274 (362)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .+....+.... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 44322 2256799999999999999999999999999999999999999987543 22222222211 1
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 275 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 275 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
.......+++++.+||.+||+.+|.+||++.+|++.|+.+.....
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 112336778999999999999999999999999999998866543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=326.50 Aligned_cols=256 Identities=22% Similarity=0.376 Sum_probs=195.6
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
...+....++|.+.+.||+|+||.||+|.+. ++.||||++......... .+.+.++..+++.++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~~~~~~~~h~~i~~~~~~ 92 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN----KRILMDLDVVLKSHDCPYIVQCFGT 92 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHH----HHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHH----HHHHHHHHHHHHhcCCCceeeEEEE
Confidence 4566777899999999999999999999996 789999999876543321 2344456667888899999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCCceEEeeec
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
+...+..++||||+ ++.+..+..... ..+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||
T Consensus 93 ~~~~~~~~lv~e~~-~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg 170 (318)
T 2dyl_A 93 FITNTDVFIAMELM-GTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG 170 (318)
T ss_dssp EECSSEEEEEECCC-SEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred EecCCcEEEEEecc-CCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECC
Confidence 99999999999999 666666665433 3689999999999999999999995 99999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccChhhhh-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCC
Q 017994 204 ISCLESQCGSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNARPP 277 (362)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~ 277 (362)
++.............+++.|+|||++. ...++.++||||||+++|+|++|..||.... ..+....+.. ...+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~ 249 (318)
T 2dyl_A 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-EEPPL 249 (318)
T ss_dssp TC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH-SCCCC
T ss_pred CchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc-cCCCC
Confidence 987655544455667899999999994 4568899999999999999999999998744 3344444433 22332
Q ss_pred C--CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 V--PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 ~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
. ...+++.+.++|.+||+.||.+||++.++++
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 2 3468999999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=325.63 Aligned_cols=255 Identities=23% Similarity=0.341 Sum_probs=209.9
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC--CCceeeeeEE
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN--HPHIITFVAA 124 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hp~iv~~~~~ 124 (362)
........+|.+.+.||+|+||.||++.+. ++.||||++........ ..+.+.+|+.++.+++ ||||++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHH----HHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccccc----chHHHHHHHHHHHhccccCCceEEEEEE
Confidence 344556688999999999999999999986 67899999987544322 1367889999999997 5999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
+...+..++||| +.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||++++ +.+||+|||+
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccc
Confidence 999999999999 45889999998765 6899999999999999999999999999999999999964 8999999999
Q ss_pred ccccccCCC---CCcccccccccChhhhhc-----------CCCCCcccchhhhHHHHHHHhCCCCCCCCCH-HHHHHHH
Q 017994 205 SCLESQCGS---AKGFTGTYRWMAPEMIKE-----------KRHTKKVDVYSFGIVLWELLTALTPFDNMTP-EQAAFAV 269 (362)
Q Consensus 205 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~-~~~~~~~ 269 (362)
+........ .....|++.|+|||++.+ ..++.++||||||+++|+|++|..||..... .......
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 876543222 234568999999999875 4678899999999999999999999987643 3344444
Q ss_pred HhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 270 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 270 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
.........+...+..+.++|.+||+.||.+||++.++++.
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 44455556777889999999999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=331.04 Aligned_cols=247 Identities=21% Similarity=0.309 Sum_probs=205.2
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC---
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP--- 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--- 128 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++....... ....+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-----FALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHH-----HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccch-----HHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 368999999999999999999987 7899999997543322 235677899999999999999999988654
Q ss_pred --CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 129 --PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 129 --~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
...++||||+. ++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 85 NFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 68899999996 6999999874 58999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCC-----------CCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Q 017994 207 LESQCGS-----------AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 274 (362)
Q Consensus 207 ~~~~~~~-----------~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 274 (362)
....... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 5443211 123468999999998765 6789999999999999999999999998876655443322111
Q ss_pred CCC------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 275 RPP------------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 275 ~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+. ..+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 110 12467899999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=325.69 Aligned_cols=245 Identities=22% Similarity=0.365 Sum_probs=199.8
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE------
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK------ 126 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~------ 126 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++....... .+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS------VKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHH------HHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHH------HHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 67999999999999999999997 7899999987654321 467789999999999999999999873
Q ss_pred --------eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-CCCce
Q 017994 127 --------KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-EDMCV 197 (362)
Q Consensus 127 --------~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~-~~~~~ 197 (362)
.....++||||++ ++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++ .++.+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence 4478899999996 5999999753 589999999999999999999999999999999999997 56799
Q ss_pred EEeeeccccccccC----CCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 017994 198 KVADFGISCLESQC----GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 272 (362)
Q Consensus 198 kl~Dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 272 (362)
||+|||++...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+....+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999998765432 12234567889999998875 67899999999999999999999999988876655544332
Q ss_pred CCC-----------------------C-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 273 NAR-----------------------P-----PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 273 ~~~-----------------------~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
... + .....++..+.+||.+||+.||.+||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 211 0 112467899999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=330.17 Aligned_cols=244 Identities=24% Similarity=0.373 Sum_probs=203.2
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe--
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV-- 130 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~-- 130 (362)
.+|.+.+.||+|+||.||+|.+. ++.||||++........ ..+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI----FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchH----HHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 67999999999999999999986 78999999977543322 24677899999999999999999999987654
Q ss_pred ----EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 131 ----FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 131 ----~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
.++||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred cceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999996 588887743 48999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------
Q 017994 207 LESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA----------- 274 (362)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~----------- 274 (362)
.... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 175 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 175 HADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp C----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 6443 2345578999999999877 6789999999999999999999999998877665544432110
Q ss_pred ------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 275 ------------------RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 275 ------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.......+++.+.+||.+||+.||.+||++.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11233567899999999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=334.10 Aligned_cols=251 Identities=21% Similarity=0.263 Sum_probs=196.9
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP 128 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 128 (362)
....++|.+.+.||+|+||.||+|.+. ++.||||++....... ....+++..+..++||||+++++++...
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC-------CHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc-------HHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 345688999999999999999999986 7899999987644332 3455678888889999999999998654
Q ss_pred Ce-------EEEEEecCCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCcEEEcC-CCc
Q 017994 129 PV-------FCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLH--SQGILHRDLKSENLLLGE-DMC 196 (362)
Q Consensus 129 ~~-------~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~dlk~~Nil~~~-~~~ 196 (362)
.. .++||||+++ +|...+.. .....+++..++.++.|++.||.||| ++||+||||||+||+++. ++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE
T ss_pred ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc
Confidence 33 8899999966 66555442 22336899999999999999999999 999999999999999996 899
Q ss_pred eEEeeeccccccccCCCCCcccccccccChhhhhcCC-CCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Q 017994 197 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 275 (362)
Q Consensus 197 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 275 (362)
+||+|||++.............+|+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+.......+......
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp EEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 9999999998776655566778899999999986654 899999999999999999999999998877766655432111
Q ss_pred ------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 ------------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 ------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...+...++.+.+||.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1122335788999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=340.56 Aligned_cols=253 Identities=14% Similarity=0.132 Sum_probs=189.0
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHH---HHHHcCCCCceeeee-
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEV---ALLFRLNHPHIITFV- 122 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei---~~l~~l~hp~iv~~~- 122 (362)
.+.....+|.+.+.||+|+||.||+|.+. ++.||||++......... ..+.+.+|+ ..++. +||||++++
T Consensus 56 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~~~~l~~-~hp~iv~~~~ 131 (371)
T 3q60_A 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS---ELERLHEATFAAARLLG-ESPEEARDRR 131 (371)
T ss_dssp TTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHH---HHHHHHHHHHHHHHHHC-----------
T ss_pred cCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccccc---HHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence 34444567999999999999999999986 789999999986543221 235667775 45555 799988755
Q ss_pred ------EEEEeC-----------------CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHH------HHHHHHHHHHHHH
Q 017994 123 ------AACKKP-----------------PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV------LKLALDIARGMQY 173 (362)
Q Consensus 123 ------~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~------~~i~~~i~~~l~~ 173 (362)
+++... ..+++||||++ ++|.+++..... .+++..+ +.++.||+.||.|
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~ 209 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAAN 209 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHH
Confidence 455433 33899999997 899999986432 2444555 6788999999999
Q ss_pred HHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCCCcccccccccChhhhhc--CCCCCcccchhhhHHHHHHH
Q 017994 174 LHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELL 251 (362)
Q Consensus 174 LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~ell 251 (362)
||++||+||||||+|||++.+|.+||+|||++...... .....+++.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 210 LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 210 LQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp HHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred HHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 99999999999999999999999999999999765432 224556799999999987 67999999999999999999
Q ss_pred hCCCCCCCCCHHHHHH-------HHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 252 TALTPFDNMTPEQAAF-------AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 252 ~g~~p~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+|..||....+..... .........+....+++.+.+||.+||+.||++||++.++++
T Consensus 288 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 288 CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999998764321100 000011112233578999999999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=337.71 Aligned_cols=246 Identities=21% Similarity=0.320 Sum_probs=200.7
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC--------CCceeeeeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN--------HPHIITFVA 123 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--------hp~iv~~~~ 123 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++..... ..+.+.+|+.+++.++ ||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH-------YTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-------HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCc-------chHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 378999999999999999999886 78999999975422 1366788999999885 788999999
Q ss_pred EEE----eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEcCCC---
Q 017994 124 ACK----KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDM--- 195 (362)
Q Consensus 124 ~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dlk~~Nil~~~~~--- 195 (362)
++. .....++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 987 556899999999 66777777665545799999999999999999999998 999999999999998776
Q ss_pred ----------------------------------------------ceEEeeeccccccccCCCCCcccccccccChhhh
Q 017994 196 ----------------------------------------------CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI 229 (362)
Q Consensus 196 ----------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~ 229 (362)
.+||+|||++..... ......||+.|+|||++
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhh
Confidence 799999999976544 23455789999999999
Q ss_pred hcCCCCCcccchhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhcCCC----------------------------
Q 017994 230 KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP------EQAAFAVCQKNAR---------------------------- 275 (362)
Q Consensus 230 ~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~------~~~~~~~~~~~~~---------------------------- 275 (362)
.+..++.++||||||+++|+|++|..||...+. ......+......
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 999999999999999999999999999976542 2222221111000
Q ss_pred ------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 ------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 ------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
...+...++.+.+||.+||+.||.+|||+.|+++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0112233467889999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=321.47 Aligned_cols=244 Identities=26% Similarity=0.394 Sum_probs=195.9
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe-----
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK----- 127 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----- 127 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++..... ..+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-------KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHH-------HHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHH-------HHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 57999999999999999999985 78999999864221 13678899999999999999999998865
Q ss_pred --------CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEE
Q 017994 128 --------PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 199 (362)
Q Consensus 128 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl 199 (362)
....++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence 457899999999999999998654 35788999999999999999999999999999999999999999999
Q ss_pred eeeccccccccC---------------CCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCH-
Q 017994 200 ADFGISCLESQC---------------GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTP- 262 (362)
Q Consensus 200 ~Dfg~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~- 262 (362)
+|||++...... .......+++.|+|||++.+. .++.++||||||+++|+|++ ||.....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 999998754321 122345689999999999765 68999999999999999998 5543222
Q ss_pred HHHHHHHHhc--CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 263 EQAAFAVCQK--NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 263 ~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
......+... ......+...+..+.++|.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 2222222221 1223445667788999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=327.34 Aligned_cols=246 Identities=20% Similarity=0.329 Sum_probs=204.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC---CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCc------eeeeeEE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH------IITFVAA 124 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~------iv~~~~~ 124 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++..... ..+.+.+|+.+++.++|++ ++.+.++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK-------YREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH-------HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc-------chhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 368999999999999999999985 36899999975322 1356778999999887665 9999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE-------------
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL------------- 191 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~------------- 191 (362)
+...+..++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 99999999999999 6788888877654579999999999999999999999999999999999999
Q ss_pred ------cCCCceEEeeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHH
Q 017994 192 ------GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA 265 (362)
Q Consensus 192 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~ 265 (362)
+.++.+||+|||++..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+.
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 5678999999999875433 23456789999999999999999999999999999999999999998877655
Q ss_pred HHHHHhcCCCCC------------------------------------------CCCCCCHHHHHHHHHhcccCCCCCCC
Q 017994 266 AFAVCQKNARPP------------------------------------------VPPTCPKAFSYLISRCWSSSPDRRPH 303 (362)
Q Consensus 266 ~~~~~~~~~~~~------------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps 303 (362)
...+.......+ .....+..+.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 443322211110 11122457889999999999999999
Q ss_pred HHHHHH
Q 017994 304 FDQIVS 309 (362)
Q Consensus 304 ~~ell~ 309 (362)
+.|+++
T Consensus 328 ~~e~l~ 333 (355)
T 2eu9_A 328 LAEALL 333 (355)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=325.27 Aligned_cols=248 Identities=25% Similarity=0.407 Sum_probs=199.1
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC----CCCceeeeeEE
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL----NHPHIITFVAA 124 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l----~hp~iv~~~~~ 124 (362)
+.-.++|.+.+.||+|+||.||+|.+. ++.||||++................+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 334578999999999999999999985 778999999765432211111124456789999888 89999999999
Q ss_pred EEeCCeEEEEEec-CCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-CCCceEEeee
Q 017994 125 CKKPPVFCIITEY-LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-EDMCVKVADF 202 (362)
Q Consensus 125 ~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~-~~~~~kl~Df 202 (362)
+...+..++|+|| +.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++ .++.++|+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 9999999999999 78999999998765 589999999999999999999999999999999999999 8899999999
Q ss_pred ccccccccCCCCCcccccccccChhhhhcCCC-CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 203 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
|++...... ......++..|+|||++.+..+ +.++||||||+++|+|++|..||..... +. ......+..
T Consensus 185 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~--~~~~~~~~~ 255 (312)
T 2iwi_A 185 GSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------IL--EAELHFPAH 255 (312)
T ss_dssp SSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH--HTCCCCCTT
T ss_pred chhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hh--hhccCCccc
Confidence 998765442 3345678999999999987665 4589999999999999999999976321 11 223456678
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
++..+.++|.+||+.||.+||++.++++
T Consensus 256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 256 VSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 8999999999999999999999999997
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=335.70 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=185.5
Q ss_pred cCeee-eeeecccCCeeEEEEEEC----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe--
Q 017994 55 SQLFI-GCKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK-- 127 (362)
Q Consensus 55 ~~~~~-~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-- 127 (362)
+.|.+ +++||+|+||.||+|.+. ++.||||++...... ..+.+|+.++++++||||+++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--------HHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--------HHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence 34665 568999999999999965 578999999765433 456789999999999999999999954
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----cCCCc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQE-------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL----GEDMC 196 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~----~~~~~ 196 (362)
....++||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 678999999995 58888886321 1248999999999999999999999999999999999999 67789
Q ss_pred eEEeeeccccccccC----CCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHH--------
Q 017994 197 VKVADFGISCLESQC----GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPE-------- 263 (362)
Q Consensus 197 ~kl~Dfg~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~-------- 263 (362)
+||+|||++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||......
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 999999999765432 223456789999999999874 5899999999999999999999999765432
Q ss_pred -HHHHHHHhcCCCCC------------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 017994 264 -QAAFAVCQKNARPP------------------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQ 306 (362)
Q Consensus 264 -~~~~~~~~~~~~~~------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~e 306 (362)
+.+..+......+. .....++.+.+||.+||+.||.+|||+.|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 22222222111111 01122567899999999999999999999
Q ss_pred HHHH
Q 017994 307 IVSI 310 (362)
Q Consensus 307 ll~~ 310 (362)
+++.
T Consensus 331 ~L~h 334 (405)
T 3rgf_A 331 AMQD 334 (405)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9963
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=326.32 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=177.6
Q ss_pred ccCeeeee-eecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe---
Q 017994 54 MSQLFIGC-KFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK--- 127 (362)
Q Consensus 54 ~~~~~~~~-~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--- 127 (362)
.++|.+.+ .||+|+||.||+|.+. ++.||||++..... ...+....++.++||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----------ARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----------HHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----------HHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 46799854 6999999999999997 78999999975321 11122334566799999999999876
Q ss_pred -CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCceEEeeec
Q 017994 128 -PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADFG 203 (362)
Q Consensus 128 -~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~---~~~~kl~Dfg 203 (362)
....++||||++|++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 456899999999999999999876567999999999999999999999999999999999999976 4559999999
Q ss_pred cccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHH----HHh--cCCCCC
Q 017994 204 ISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA----VCQ--KNARPP 277 (362)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~----~~~--~~~~~~ 277 (362)
++..... .......+++.|+|||++.+..++.++||||||+++|+|++|..||........... +.. .....+
T Consensus 177 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 177 FAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp TCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred cceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 9875543 233456789999999999888899999999999999999999999977654432211 111 111222
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
....+++.+.+||.+||+.||.+|||+.++++
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 33578999999999999999999999999997
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=331.56 Aligned_cols=247 Identities=21% Similarity=0.339 Sum_probs=200.6
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-----------CCcee
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-----------HPHII 119 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------hp~iv 119 (362)
...+|.+.+.||+|+||.||+|.+. ++.||||++...... ...+.+|+.++++++ ||||+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~ 89 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-------TEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH-------HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccc-------hhhhhHHHHHHHHhhcccccchhccccchHH
Confidence 4578999999999999999999985 789999999753321 356778999988876 89999
Q ss_pred eeeEEEEeCC----eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEc--
Q 017994 120 TFVAACKKPP----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLG-- 192 (362)
Q Consensus 120 ~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dlk~~Nil~~-- 192 (362)
++++++...+ ..++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+||+++
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence 9999997654 889999999 89999999886655799999999999999999999998 999999999999995
Q ss_pred ----CCCceEEeeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCH------
Q 017994 193 ----EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP------ 262 (362)
Q Consensus 193 ----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~------ 262 (362)
..+.+||+|||++..... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 344899999999876543 23445789999999999999999999999999999999999999986542
Q ss_pred HHHHHHHHhcCC----------------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 017994 263 EQAAFAVCQKNA----------------------------------------RPPVPPTCPKAFSYLISRCWSSSPDRRP 302 (362)
Q Consensus 263 ~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp 302 (362)
......+..... ...++..+++.+.+||.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 122222211000 1122344567899999999999999999
Q ss_pred CHHHHHH
Q 017994 303 HFDQIVS 309 (362)
Q Consensus 303 s~~ell~ 309 (362)
|+.|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=330.17 Aligned_cols=246 Identities=26% Similarity=0.349 Sum_probs=204.4
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CC-----ceeeeeEEE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HP-----HIITFVAAC 125 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp-----~iv~~~~~~ 125 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++..... ....+..|+.++..++ |+ +|+++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA-------FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH-------HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH-------HHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 578999999999999999999986 78899999975322 1355677888888774 44 599999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCcEEEc--CCCceEEee
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH--SQGILHRDLKSENLLLG--EDMCVKVAD 201 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~dlk~~Nil~~--~~~~~kl~D 201 (362)
...+..++||||+. ++|.+++.......+++..+..++.|++.||.||| +.||+||||||+|||++ .++.+||+|
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999999995 59999998876556999999999999999999999 57999999999999995 477899999
Q ss_pred eccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC----
Q 017994 202 FGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---- 277 (362)
Q Consensus 202 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---- 277 (362)
||++..... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......++
T Consensus 205 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 205 FGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999976543 23456789999999999999999999999999999999999999999887776655543211110
Q ss_pred ------------------------------CCCC----------------------------CCHHHHHHHHHhcccCCC
Q 017994 278 ------------------------------VPPT----------------------------CPKAFSYLISRCWSSSPD 299 (362)
Q Consensus 278 ------------------------------~~~~----------------------------~~~~l~~li~~~l~~~p~ 299 (362)
.++. .++.+.+||.+||+.||.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 0000 013789999999999999
Q ss_pred CCCCHHHHHH
Q 017994 300 RRPHFDQIVS 309 (362)
Q Consensus 300 ~Rps~~ell~ 309 (362)
+|||+.|+++
T Consensus 363 ~Rpta~e~L~ 372 (382)
T 2vx3_A 363 TRIQPYYALQ 372 (382)
T ss_dssp TSCCHHHHTT
T ss_pred hCCCHHHHhc
Confidence 9999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=328.05 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=206.2
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC--CCceeeeeEEEEe
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN--HPHIITFVAACKK 127 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hp~iv~~~~~~~~ 127 (362)
.-.++|.+.+.||+|+||.||+|.+. ++.||||++................+.+|+.++++++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34578999999999999999999985 7899999987643211000000134567999999996 5999999999999
Q ss_pred CCeEEEEEecCCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-CCCceEEeeeccc
Q 017994 128 PPVFCIITEYLAG-GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-EDMCVKVADFGIS 205 (362)
Q Consensus 128 ~~~~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~-~~~~~kl~Dfg~~ 205 (362)
.+..++|+|++.+ ++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 9999999999976 89999998765 589999999999999999999999999999999999999 7899999999998
Q ss_pred cccccCCCCCcccccccccChhhhhcCCC-CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCH
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
...... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||..... +. ......+..+++
T Consensus 198 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~--~~~~~~~~~~~~ 268 (320)
T 3a99_A 198 ALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II--RGQVFFRQRVSS 268 (320)
T ss_dssp EECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH--HCCCCCSSCCCH
T ss_pred cccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hh--cccccccccCCH
Confidence 765442 3345678999999999987665 7889999999999999999999976321 11 223445678899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 285 AFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+.+||.+||+.||.+||++.++++
T Consensus 269 ~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 269 ECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=331.10 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=193.7
Q ss_pred cccccccCeeeeeeecccCCee-EEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEE
Q 017994 49 EWSADMSQLFIGCKFASGRHSR-IYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACK 126 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~ 126 (362)
.+.+...+|.+.+.||+|+||+ ||++...++.||||++...... .+.+|+.+++.+ +||||+++++++.
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---------~~~~E~~~l~~l~~HpnIv~l~~~~~ 88 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---------FADREVQLLRESDEHPNVIRYFCTEK 88 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---------ECHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred cEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---------HHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 3445566799999999999999 5666667899999999765432 245699999999 7999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---C--CceEEee
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---D--MCVKVAD 201 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~---~--~~~kl~D 201 (362)
+....|+||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+||+++. + ..++|+|
T Consensus 89 ~~~~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~D 166 (432)
T 3p23_A 89 DRQFQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD 166 (432)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred cCCEEEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence 9999999999995 699999987553 3555567899999999999999999999999999999953 2 3578999
Q ss_pred eccccccccC----CCCCcccccccccChhhhh---cCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC
Q 017994 202 FGISCLESQC----GSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 273 (362)
Q Consensus 202 fg~~~~~~~~----~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~ 273 (362)
||++...... .......||+.|+|||++. ...++.++|||||||++|+|++ |..||................
T Consensus 167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~ 246 (432)
T 3p23_A 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS 246 (432)
T ss_dssp TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCC
T ss_pred ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCC
Confidence 9999765433 2234567999999999997 4567889999999999999999 999997665544322211111
Q ss_pred CCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 274 ARP-PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 274 ~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
... ..+...+..+.+||.+||+.||.+||++.++++
T Consensus 247 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111 112233456889999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=310.26 Aligned_cols=229 Identities=13% Similarity=0.128 Sum_probs=189.5
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|.+.+.||+|+||.||+|.+. ++.||||++........ ...+.+.+|+.++.+++||||+++++++...+..|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPD---DVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCH---HHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 67999999999999999999997 78999999987544321 12467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+||||++|++|.++++.. .....+..++.|++.||.|||++||+||||||+||+++.+|.++|++++
T Consensus 108 lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999999653 3556788999999999999999999999999999999999999998543
Q ss_pred CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHH---HHHhcCCCC--CCCCCCCHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF---AVCQKNARP--PVPPTCPKAFS 287 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~l~ 287 (362)
|++ .++.++||||||+++|+|++|..||.+.+...... ......... .....+++.+.
T Consensus 175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence 233 26889999999999999999999998755422110 000000000 12357889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 288 YLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
+||.+||+.||.+| |+.++++.|+.+...
T Consensus 238 ~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 238 AVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred HHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 99999999999999 999999999987654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=326.59 Aligned_cols=242 Identities=23% Similarity=0.335 Sum_probs=186.0
Q ss_pred CeeeeeeecccCCeeEEEE-EECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCeEEE
Q 017994 56 QLFIGCKFASGRHSRIYRG-IYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~l 133 (362)
.|.+.+.||+|+||+||.+ ...++.||||++.... .+.+.+|+.++.++ +||||+++++++.+....++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 3556788999999999654 4458999999986532 24567899999876 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC-------------C
Q 017994 134 ITEYLAGGSLRKYLHQQEPYS-----VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-------------M 195 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~-----l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~-------------~ 195 (362)
||||+. |+|.+++....... .++..++.++.||+.||.|||++||+||||||+||+++.+ +
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999995 69999998654211 1223457899999999999999999999999999999754 4
Q ss_pred ceEEeeeccccccccCCC-----CCcccccccccChhhhhc-------CCCCCcccchhhhHHHHHHHh-CCCCCCCCCH
Q 017994 196 CVKVADFGISCLESQCGS-----AKGFTGTYRWMAPEMIKE-------KRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 262 (362)
Q Consensus 196 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~ 262 (362)
.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+|++ |..||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 899999999976544321 234579999999999976 568999999999999999999 9999987654
Q ss_pred HHHHHHHHhcCCCCCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 263 EQAAFAVCQKNARPPV-----PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 263 ~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
... .+.......+. +..+++++.+||.+||+.||.+||++.++++
T Consensus 246 ~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 432 22222222211 1234578999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=307.66 Aligned_cols=224 Identities=22% Similarity=0.366 Sum_probs=182.6
Q ss_pred ccCeeee-eeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHH-HcCCCCceeeeeEEEEe--
Q 017994 54 MSQLFIG-CKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALL-FRLNHPHIITFVAACKK-- 127 (362)
Q Consensus 54 ~~~~~~~-~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l-~~l~hp~iv~~~~~~~~-- 127 (362)
.++|.+. +.||+|+||.||++.+. ++.||||++... ..+.+|+.++ +.++||||+++++++..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 3668776 78999999999999985 789999998642 3456788887 55699999999999987
Q ss_pred --CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCceEEeee
Q 017994 128 --PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADF 202 (362)
Q Consensus 128 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~---~~~~kl~Df 202 (362)
....++||||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++. ++.++|+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 678999999999999999999876567999999999999999999999999999999999999997 788999999
Q ss_pred ccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCCC-
Q 017994 203 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN--ARPPVP- 279 (362)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~--~~~~~~- 279 (362)
|++.... +..++.++||||||+++|+|++|..||................ .....+
T Consensus 165 g~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (299)
T 3m2w_A 165 GFAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223 (299)
T ss_dssp TTCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred ccccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence 9875432 2346778999999999999999999998755433221111111 111122
Q ss_pred ---CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 280 ---PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 280 ---~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+++.+.+||.+||+.||.+||++.++++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 567899999999999999999999999997
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=339.59 Aligned_cols=249 Identities=25% Similarity=0.349 Sum_probs=199.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe----
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK---- 127 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~---- 127 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++....... ..+.+.+|+.++++++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~-----~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-----NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHH-----HHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHH-----HHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 467999999999999999999985 7899999987653322 24678899999999999999999998765
Q ss_pred --CCeEEEEEecCCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCc---eEEee
Q 017994 128 --PPVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC---VKVAD 201 (362)
Q Consensus 128 --~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~---~kl~D 201 (362)
.+..++||||++|++|.+++..... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 6788999999999999999986442 35888999999999999999999999999999999999997664 99999
Q ss_pred eccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHH---------HHHh-
Q 017994 202 FGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF---------AVCQ- 271 (362)
Q Consensus 202 fg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~---------~~~~- 271 (362)
||++.............+++.|+|||++.+..++.++||||||+++|+|++|..||.......... ....
T Consensus 168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred cccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 999987666555566789999999999999999999999999999999999999997653322100 0000
Q ss_pred c--C------C----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 017994 272 K--N------A----RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307 (362)
Q Consensus 272 ~--~------~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 307 (362)
. . . .......+++.+.++|.+||+.||.+||++.++
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0 0 0 001223356889999999999999999999883
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=327.26 Aligned_cols=247 Identities=15% Similarity=0.122 Sum_probs=187.4
Q ss_pred ccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC-Ccee-------
Q 017994 50 WSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-PHII------- 119 (362)
Q Consensus 50 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-p~iv------- 119 (362)
+.....+|..++.||+|+||.||+|.+. ++.||||++........ ...+.+.+|+.+++.+.| +|..
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~ 149 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS---NAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-------CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH---HHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence 3344567889999999999999999987 88999999885433221 113568889999999976 2111
Q ss_pred --------------eeeEEEEe-----CCeEEEEEecCCCCCHHHHHhh-----cCCCCCCHHHHHHHHHHHHHHHHHHH
Q 017994 120 --------------TFVAACKK-----PPVFCIITEYLAGGSLRKYLHQ-----QEPYSVPLNLVLKLALDIARGMQYLH 175 (362)
Q Consensus 120 --------------~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH 175 (362)
.+..++.. ....+++|+++ +++|.++++. .....+++..++.++.||+.||.|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 228 (413)
T 3dzo_A 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 228 (413)
T ss_dssp BCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 11111111 23467788866 7899999952 22234778889999999999999999
Q ss_pred HCCccccCCCCCcEEEcCCCceEEeeeccccccccCCCCCcccccccccChhhh----------hcCCCCCcccchhhhH
Q 017994 176 SQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI----------KEKRHTKKVDVYSFGI 245 (362)
Q Consensus 176 ~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~Dv~slG~ 245 (362)
++||+||||||+|||++.++.+||+|||++...... .....| +.|+|||++ .+..++.++||||||+
T Consensus 229 ~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 229 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred hCCcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999999998765443 344567 999999999 4455788999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 246 VLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 246 ~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
++|+|++|..||...........+ ......+|+.+.+||.+||+.||.+||++.++++
T Consensus 306 il~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHCCCCCCCcchhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999999876543322211 1123467899999999999999999999777754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.97 Aligned_cols=239 Identities=23% Similarity=0.337 Sum_probs=195.1
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC---CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
.++|.+.+.||+|+||.||+|.+. ++.||||++....... ....+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE-----AQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHH-----HHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHH-----HHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence 378999999999999999999984 6899999987643321 24567899999999999999999999987665
Q ss_pred -----EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 131 -----FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 131 -----~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
.|+||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred CCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999988765 58999999999999999999999999999999999999875 8999999998
Q ss_pred cccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-CCCCCCH
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-VPPTCPK 284 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 284 (362)
...... ....||+.|+|||++.+.. +.++||||||+++|+|++|..||.+.... ..... .....++
T Consensus 229 ~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~~~~~~~~~~~ 295 (681)
T 2pzi_A 229 SRINSF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLPEDDPVLKTYD 295 (681)
T ss_dssp EETTCC---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCCTTCHHHHHCH
T ss_pred hhcccC---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------cccccccccccCH
Confidence 765442 4567999999999997764 89999999999999999999888752110 00000 0012357
Q ss_pred HHHHHHHHhcccCCCCCC-CHHHHHHHHHhhh
Q 017994 285 AFSYLISRCWSSSPDRRP-HFDQIVSILEGYS 315 (362)
Q Consensus 285 ~l~~li~~~l~~~p~~Rp-s~~ell~~L~~~~ 315 (362)
.+.+||.+||+.||.+|| +++++...|..+.
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 899999999999999999 5667777776654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=309.94 Aligned_cols=244 Identities=15% Similarity=0.128 Sum_probs=186.4
Q ss_pred ccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchH--HHHHHHHHHHHHHHHHHcCC---------CCceee
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDAS--LASMLEKQFTSEVALLFRLN---------HPHIIT 120 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~Ei~~l~~l~---------hp~iv~ 120 (362)
+..++|.+.+.||+|+||.||+|.++++.||||++........ ......+.+.+|+.+++.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 3457899999999999999999999999999999987532100 00001255677888888775 677766
Q ss_pred eeEEE-----------------Ee-------------CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHH
Q 017994 121 FVAAC-----------------KK-------------PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARG 170 (362)
Q Consensus 121 ~~~~~-----------------~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~ 170 (362)
+.+.+ .+ ....++||||+++|++.+.+.. ..+++..++.++.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 66654 22 7899999999999977776644 258999999999999999
Q ss_pred HHHHH-HCCccccCCCCCcEEEcCCC--------------------ceEEeeeccccccccCCCCCcccccccccChhhh
Q 017994 171 MQYLH-SQGILHRDLKSENLLLGEDM--------------------CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI 229 (362)
Q Consensus 171 l~~LH-~~~i~H~dlk~~Nil~~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~ 229 (362)
|.||| ++||+||||||+|||++.++ .+||+|||+++.... ....||+.|+|||++
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhh
Confidence 99999 99999999999999999887 899999999986543 245799999999999
Q ss_pred hcCCCCCcccchhhhHH-HHHHHhCCCCCCCCCH-HHHHHHHHhcCCCC-CC----CCCCCHHHHHHHHHhcccCCCCCC
Q 017994 230 KEKRHTKKVDVYSFGIV-LWELLTALTPFDNMTP-EQAAFAVCQKNARP-PV----PPTCPKAFSYLISRCWSSSPDRRP 302 (362)
Q Consensus 230 ~~~~~~~~~Dv~slG~~-l~ell~g~~p~~~~~~-~~~~~~~~~~~~~~-~~----~~~~~~~l~~li~~~l~~~p~~Rp 302 (362)
.+.. +.++|||||+++ .+++++|..||..... ......+....... .. +..+++++.+||.+||+.|
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----- 323 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----- 323 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----
T ss_pred cCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----
Confidence 8776 889999998777 7778889999854221 11222222111111 11 2246788999999999976
Q ss_pred CHHHHH
Q 017994 303 HFDQIV 308 (362)
Q Consensus 303 s~~ell 308 (362)
|+.|++
T Consensus 324 sa~e~l 329 (336)
T 2vuw_A 324 SATDLL 329 (336)
T ss_dssp SHHHHH
T ss_pred CHHHHH
Confidence 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=275.33 Aligned_cols=186 Identities=16% Similarity=0.138 Sum_probs=132.2
Q ss_pred eecccCCeeEEEEEE--CCeeEEEEEecCCCc----chHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEEeCCeEEEE
Q 017994 62 KFASGRHSRIYRGIY--KQRDVAIKLVSQPEE----DASLASMLEKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCII 134 (362)
Q Consensus 62 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv 134 (362)
..+.|+.|.+..+.. -++.+|||++..... .....+...++|.+|+.+|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456677766665543 388999999986532 2222333457799999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-CC
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GS 213 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 213 (362)
|||++|++|.++|...+ .+++. +|+.||+.||.|+|++|||||||||+|||++.+|.+||+|||+++..... ..
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence 99999999999998876 46654 58899999999999999999999999999999999999999999765443 33
Q ss_pred CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhC
Q 017994 214 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA 253 (362)
Q Consensus 214 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g 253 (362)
....+||+.|+|||++.+. +..++|+|++|++++++.++
T Consensus 396 ~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp SHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred ccCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence 4567899999999998754 56789999999988777554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-30 Score=248.40 Aligned_cols=189 Identities=16% Similarity=0.156 Sum_probs=149.5
Q ss_pred eeeeeecccCCeeEEEEEECCeeEEEEEecCCCcc-h-HHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEE
Q 017994 58 FIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEED-A-SLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIIT 135 (362)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~-~-~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 135 (362)
...+.||+|+||.||++...++.+++|+....... . .......+.+.+|+.++++++||||+++..++...+..++||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 34678999999999999888999999987653321 1 112233567899999999999999997766666778889999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCCC--
Q 017994 136 EYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-- 213 (362)
Q Consensus 136 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 213 (362)
||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 419 E~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 419 SYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp ECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred ECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 99999999999976 4589999999999999999999999999999998 999999999986654321
Q ss_pred ------CCcccccccccChhhhhc--CCCCCcccchhhhHHHHHHHhCCCCCC
Q 017994 214 ------AKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFD 258 (362)
Q Consensus 214 ------~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~ell~g~~p~~ 258 (362)
.....||+.|+|||++.. ..|+...|+|+..+-..+-+.++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 135679999999999987 567888999999888888877766653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=198.95 Aligned_cols=150 Identities=15% Similarity=0.146 Sum_probs=116.5
Q ss_pred CeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchH------------HHHHHHHHHHHHHHHHHcCCCCceeeee
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDAS------------LASMLEKQFTSEVALLFRLNHPHIITFV 122 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~------------~~~~~~~~~~~Ei~~l~~l~hp~iv~~~ 122 (362)
.|.+++.||+|+||.||+|.+. ++.||||+++....... ........+.+|+.++++++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 4456699999999999999995 78999999975432110 00123467889999999998 4 6666
Q ss_pred EEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
+++.. +..++||||++|++|.+ +.. .....++.|++.||.|||++||+||||||+|||++ +|.++|+||
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 65544 45699999999999988 421 22457999999999999999999999999999999 999999999
Q ss_pred ccccccccCCCCCcccccccccChhhhhc
Q 017994 203 GISCLESQCGSAKGFTGTYRWMAPEMIKE 231 (362)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 231 (362)
|++.. +..+.|||++..
T Consensus 237 G~a~~------------~~~~~a~e~l~r 253 (282)
T 1zar_A 237 PQSVE------------VGEEGWREILER 253 (282)
T ss_dssp TTCEE------------TTSTTHHHHHHH
T ss_pred CCCeE------------CCCCCHHHHHHH
Confidence 98853 334678888753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.5e-22 Score=174.87 Aligned_cols=142 Identities=13% Similarity=0.121 Sum_probs=108.2
Q ss_pred CeeeeeeecccCCeeEEEEEE--CCee--EEEEEecCCCcchHH------------------HHHHHHHHHHHHHHHHcC
Q 017994 56 QLFIGCKFASGRHSRIYRGIY--KQRD--VAIKLVSQPEEDASL------------------ASMLEKQFTSEVALLFRL 113 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~--~~~~--vavK~~~~~~~~~~~------------------~~~~~~~~~~Ei~~l~~l 113 (362)
-|.+.+.||+|+||.||+|.+ .++. ||||+++........ .......+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999998 6888 999997654221100 112234678899999999
Q ss_pred CCCce--eeeeEEEEeCCeEEEEEecCCC-C----CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCC
Q 017994 114 NHPHI--ITFVAACKKPPVFCIITEYLAG-G----SLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH-SQGILHRDLK 185 (362)
Q Consensus 114 ~hp~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~i~H~dlk 185 (362)
.|+++ +.+++. ...++||||+.+ | +|.++... .++..+..++.|++.+|.||| +.||+|||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 88764 334432 356899999932 3 77776543 223467889999999999999 9999999999
Q ss_pred CCcEEEcCCCceEEeeecccccc
Q 017994 186 SENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 186 ~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
|+|||++. .++|+|||++...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999988 8999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.3e-19 Score=163.85 Aligned_cols=142 Identities=15% Similarity=0.148 Sum_probs=102.0
Q ss_pred CeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcc----------------hHHHHHHHHHHHHHHHHHHcCCCCce
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEED----------------ASLASMLEKQFTSEVALLFRLNHPHI 118 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~----------------~~~~~~~~~~~~~Ei~~l~~l~hp~i 118 (362)
=|.+++.||+|++|.||+|.+. |+.||||+++..... .....+.+.....|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3889999999999999999986 789999997643211 11112222334467777777755444
Q ss_pred eeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC---
Q 017994 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--- 195 (362)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~--- 195 (362)
.-..-+... ..+|||||++|++|.++.. . .....++.|++.+|.+||++|||||||||.|||++.+|
T Consensus 176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQS--RHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEEE--TTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeecc--CceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 222111111 2379999999988865432 1 23457889999999999999999999999999998776
Q ss_pred -------ceEEeeeccccc
Q 017994 196 -------CVKVADFGISCL 207 (362)
Q Consensus 196 -------~~kl~Dfg~~~~ 207 (362)
.+.|+||+.+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 389999997644
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=6.5e-14 Score=123.82 Aligned_cols=139 Identities=12% Similarity=0.094 Sum_probs=110.9
Q ss_pred cCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCCeEEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~l 133 (362)
..|.+...++.|+.+.||++...++.+++|+........ ...+.+|+.+++.+. +..++++++++...+..|+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC------HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 457788888889999999998888899999987521111 134677999999884 6778899999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS------------------------------------- 176 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~------------------------------------- 176 (362)
||||++|.+|.+.+.. ......++.+++.+|..||+
T Consensus 88 v~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999999876321 12234678899999999998
Q ss_pred ----------------------CCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 177 ----------------------QGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 177 ----------------------~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
..++|+|++|.||+++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876667799999763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.34 E-value=4.4e-12 Score=111.50 Aligned_cols=134 Identities=13% Similarity=0.070 Sum_probs=97.6
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCc--eeeeeEEEEeCCe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH--IITFVAACKKPPV 130 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~--iv~~~~~~~~~~~ 130 (362)
...+.+....+.|..+.||++... ++.++||+...... ..+.+|+.+++.+.+.+ +.+++++....+.
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~---------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~ 89 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---------NELQDEAARLSWLATTGVPCAAVLDVVTEAGR 89 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccc---------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence 344555444446666999999765 56799999765411 34567888888885434 5668888888888
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG-------------------------------- 178 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------- 178 (362)
.++||||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 90 ~~~v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp EEEEEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred CEEEEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 99999999998884 211 12 1256667777777777643
Q ss_pred --------------------------ccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 179 --------------------------ILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 179 --------------------------i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
++|+|++|.||+++.++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.32 E-value=6.7e-12 Score=116.10 Aligned_cols=140 Identities=15% Similarity=0.206 Sum_probs=106.4
Q ss_pred eeeeecccCCeeEEEEEECCeeEEEEEec--CCCcchHHHHHHHHHHHHHHHHHHcCC--CCceeeeeEEEEeC---CeE
Q 017994 59 IGCKFASGRHSRIYRGIYKQRDVAIKLVS--QPEEDASLASMLEKQFTSEVALLFRLN--HPHIITFVAACKKP---PVF 131 (362)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hp~iv~~~~~~~~~---~~~ 131 (362)
-.+.|+.|.++.||+....+..+++|+.. ...... ....+.+|..+++.+. +..+++++.++.+. +..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~-----~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLP-----SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC---------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCC-----cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 35678999999999999888889999876 321110 0245678999999886 45578888888766 458
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS----------------------------------- 176 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~----------------------------------- 176 (362)
|+||||++|.++.+.. ...++......++.+++..|..||+
T Consensus 117 ~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999999998775411 1246788888999999999999997
Q ss_pred -----------------------CCccccCCCCCcEEEcCCCc--eEEeeeccccc
Q 017994 177 -----------------------QGILHRDLKSENLLLGEDMC--VKVADFGISCL 207 (362)
Q Consensus 177 -----------------------~~i~H~dlk~~Nil~~~~~~--~kl~Dfg~~~~ 207 (362)
..++|||+++.||+++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987653 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.16 E-value=2.6e-11 Score=109.51 Aligned_cols=182 Identities=18% Similarity=0.211 Sum_probs=119.9
Q ss_pred eeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCc--eeeeeEEEEeCC---eEEEE
Q 017994 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPH--IITFVAACKKPP---VFCII 134 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~--iv~~~~~~~~~~---~~~lv 134 (362)
+.++.|.+..||+.. ..+++|+.... . ....+.+|..+++.+. +.. +.+++....... ..|+|
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~--~------~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS--R------GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH--H------HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc--c------hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 458999999999874 57899986532 1 1356778999998873 322 345555543333 45889
Q ss_pred EecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 017994 135 TEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-------------------------------------- 176 (362)
Q Consensus 135 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-------------------------------------- 176 (362)
|++++|.+|.+.... .++..+...++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999999988764332 36777788888888888888886
Q ss_pred --------------------CCccccCCCCCcEEEcC--CCceEEeeeccccccccCCCCCcccccccccChhhhhc---
Q 017994 177 --------------------QGILHRDLKSENLLLGE--DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE--- 231 (362)
Q Consensus 177 --------------------~~i~H~dlk~~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~--- 231 (362)
..++|+|++|.||+++. ++.+.|+||+.+.................-..|+....
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence 13699999999999998 56688999998764322110000000000022222110
Q ss_pred C--CC---------CCcccchhhhHHHHHHHhCCCCC
Q 017994 232 K--RH---------TKKVDVYSFGIVLWELLTALTPF 257 (362)
Q Consensus 232 ~--~~---------~~~~Dv~slG~~l~ell~g~~p~ 257 (362)
. .. ....+.|+++.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 00 12358999999999999997765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=5.4e-08 Score=87.70 Aligned_cols=132 Identities=19% Similarity=0.169 Sum_probs=92.2
Q ss_pred eeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCC---ceeeeeEEEE-eCCeEEEEEe
Q 017994 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP---HIITFVAACK-KPPVFCIITE 136 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp---~iv~~~~~~~-~~~~~~lv~e 136 (362)
+.++.|....||+. +..++||+.... . ....+.+|..++..+.+. .+.+++.++. ..+..++|||
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~~~--~------~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPKSQ--Q------GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEESSH--H------HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eecCCCcceeEEEE---CCEEEEEecCCc--h------HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 45788888899988 678899985321 1 135678899999998642 3566676664 4566789999
Q ss_pred cCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------
Q 017994 137 YLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ--------------------------------------- 177 (362)
Q Consensus 137 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------------- 177 (362)
|++|.+|.+..-. .++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9999888763211 234445555555555555555542
Q ss_pred ---------------------CccccCCCCCcEEEcC---CCc-eEEeeeccccc
Q 017994 178 ---------------------GILHRDLKSENLLLGE---DMC-VKVADFGISCL 207 (362)
Q Consensus 178 ---------------------~i~H~dlk~~Nil~~~---~~~-~kl~Dfg~~~~ 207 (362)
.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999987 355 58999997754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=6.3e-08 Score=85.43 Aligned_cols=130 Identities=20% Similarity=0.197 Sum_probs=94.2
Q ss_pred ecccCCe-eEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCCeEEEEEecC
Q 017994 63 FASGRHS-RIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPPVFCIITEYL 138 (362)
Q Consensus 63 lg~G~~g-~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~ 138 (362)
+..|..| .||+.... +..+++|+-.... ...+.+|...|+.+. +--+.++++++.+++..++|||++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~---------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l 102 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSV---------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI 102 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHH---------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCC---------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence 4455555 58988765 5678999865421 245677888888774 333678889999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 017994 139 AGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ----------------------------------------- 177 (362)
Q Consensus 139 ~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------------- 177 (362)
+|.++.+...... .....+..++...|..||+.
T Consensus 103 ~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 103 PGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9998887664422 12334556666666666631
Q ss_pred -----------------CccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 178 -----------------GILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 178 -----------------~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
.++|+|+++.||+++.++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 168999999999999887778999997643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=1.4e-07 Score=86.70 Aligned_cols=82 Identities=7% Similarity=0.046 Sum_probs=54.4
Q ss_pred eeeeee-cccCCeeEEEEEEC--------CeeEEEEEecCCCc--chHHHHHHHHHHHHHHHHHHcCC-C--CceeeeeE
Q 017994 58 FIGCKF-ASGRHSRIYRGIYK--------QRDVAIKLVSQPEE--DASLASMLEKQFTSEVALLFRLN-H--PHIITFVA 123 (362)
Q Consensus 58 ~~~~~l-g~G~~g~Vy~~~~~--------~~~vavK~~~~~~~--~~~~~~~~~~~~~~Ei~~l~~l~-h--p~iv~~~~ 123 (362)
...+.| +.|....+|+.... +..+++|+...... ... ...+.+|+.+++.+. + -.+.+++.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~-----~~~~~~E~~~l~~L~~~~~vpvP~v~~ 97 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP-----TYRLDHQFEVIRLVGELTDVPVPRVRW 97 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS-----CCCHHHHHHHHHHHHHHCCSCCCCEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc-----hhHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence 334667 88888999998765 67899998654320 000 023456777777773 2 34677787
Q ss_pred EEEeC---CeEEEEEecCCCCCHH
Q 017994 124 ACKKP---PVFCIITEYLAGGSLR 144 (362)
Q Consensus 124 ~~~~~---~~~~lv~e~~~~~~L~ 144 (362)
++.+. +..++||||++|.++.
T Consensus 98 ~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 98 IETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp EECSSTTTSSCEEEEECCCCBCCC
T ss_pred EccCCCccCCceEEEEecCCCChh
Confidence 77655 3568999999886653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.48 E-value=1.9e-06 Score=78.36 Aligned_cols=136 Identities=18% Similarity=0.212 Sum_probs=77.6
Q ss_pred eeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-----CCCceeeee-E--EEEeCCeEE
Q 017994 61 CKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-----NHPHIITFV-A--ACKKPPVFC 132 (362)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-----~hp~iv~~~-~--~~~~~~~~~ 132 (362)
+.|+.|..+.||+....+..+++|+..... ..+..|..++..+ ..|.++... | +....+..+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~~----------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRPE----------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCCH----------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 456667789999998887779999987631 1122344444433 234444311 1 123467789
Q ss_pred EEEecCCCCCHH--------------HHHhh-cCCC----C-------CCHHH---------------------------
Q 017994 133 IITEYLAGGSLR--------------KYLHQ-QEPY----S-------VPLNL--------------------------- 159 (362)
Q Consensus 133 lv~e~~~~~~L~--------------~~l~~-~~~~----~-------l~~~~--------------------------- 159 (362)
++|+|++|.++. ..++. .... . ..+..
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986542 11111 1100 0 01111
Q ss_pred ----HHHHHHHHHHHHHHHHH-------------CCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 160 ----VLKLALDIARGMQYLHS-------------QGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 160 ----~~~i~~~i~~~l~~LH~-------------~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
...+...+..++.+|+. .+++|||+++.||+++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 01111223345666652 579999999999999888889999999753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.1e-06 Score=82.08 Aligned_cols=80 Identities=14% Similarity=0.119 Sum_probs=47.8
Q ss_pred eeeecccCCeeEEEEEE--CCeeEEEEEecCCCc-chHHHHHHHHHHHHHHHHHHcCCC--Cc-eeeeeEEEEeCCeEEE
Q 017994 60 GCKFASGRHSRIYRGIY--KQRDVAIKLVSQPEE-DASLASMLEKQFTSEVALLFRLNH--PH-IITFVAACKKPPVFCI 133 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~~~~Ei~~l~~l~h--p~-iv~~~~~~~~~~~~~l 133 (362)
.+.||.|.++.||++.. .++.++||....... ...........+..|..+++.+.. |. +++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 45789999999999965 357899998654211 000000001345668888877632 33 4455543 3455689
Q ss_pred EEecCCCC
Q 017994 134 ITEYLAGG 141 (362)
Q Consensus 134 v~e~~~~~ 141 (362)
||||++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.23 E-value=1.4e-05 Score=66.91 Aligned_cols=141 Identities=11% Similarity=0.096 Sum_probs=97.0
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCceEEeeeccccccccCCCCCcccc
Q 017994 141 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 219 (362)
Q Consensus 141 ~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 219 (362)
-+|.++|...+. .++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.+.+.+ ..+. ..
T Consensus 33 vSL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~ 99 (229)
T 2yle_A 33 LSLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AG 99 (229)
T ss_dssp EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cc
Confidence 589999987764 79999999999999999877632 2222334567999999999988764 1110 11
Q ss_pred cccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccC--
Q 017994 220 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS-- 297 (362)
Q Consensus 220 ~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~-- 297 (362)
...+.+||... ...+.+.=|||||+++|.-+-- +.....+..+|+.|.+||..|....
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy-------------------gL~e~eE~eLS~~LE~LL~~Mt~~~~d 159 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY-------------------GLKENEERELSPPLEQLIDHMANTVEA 159 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTT-------------------TCCTTEEECCCHHHHHHHHHHTTCCC-
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc-------------------CCCcccchhhCHHHHHHHHHHHhcccc
Confidence 23456777653 3446777899999999999863 2233446778999999999998662
Q ss_pred -----------------------CCCCCCHHHHHHHHHhh
Q 017994 298 -----------------------PDRRPHFDQIVSILEGY 314 (362)
Q Consensus 298 -----------------------p~~Rps~~ell~~L~~~ 314 (362)
+..|+++++|++.-...
T Consensus 160 ~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~h 199 (229)
T 2yle_A 160 DGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAH 199 (229)
T ss_dssp -------------------CCSCCCCCCSHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCcCCHHHHHHHHHhh
Confidence 35778888888777654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.19 E-value=1.4e-05 Score=71.90 Aligned_cols=75 Identities=16% Similarity=0.084 Sum_probs=60.3
Q ss_pred eeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC---CCceeeeeEEEEeCCeEEEEEe
Q 017994 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN---HPHIITFVAACKKPPVFCIITE 136 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~~~~lv~e 136 (362)
.+.|+.|....+|+....+..++||+..... ...+..|...|+.+. ...+++++.++...+..++|||
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~---------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERSY---------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGGG---------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCccc---------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 4678999999999998888889999876421 255678888888773 3668888988888889999999
Q ss_pred cCCCCCH
Q 017994 137 YLAGGSL 143 (362)
Q Consensus 137 ~~~~~~L 143 (362)
|++|.++
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.03 E-value=2.5e-05 Score=73.35 Aligned_cols=76 Identities=13% Similarity=0.059 Sum_probs=45.4
Q ss_pred eeeecccCCeeEEEEEECCeeEEEEEecCC-----Cc-chHHHHHHHHHHHHHHHHHH-cCCCCceeeeeEEEEeCCeEE
Q 017994 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQP-----EE-DASLASMLEKQFTSEVALLF-RLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~-~~~~~~~~~~~~~~Ei~~l~-~l~hp~iv~~~~~~~~~~~~~ 132 (362)
.+.||.|..+.||++...+..++||..... .. ..... ...+..|+..+. ......+++++.+. .+..+
T Consensus 39 i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~---~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKE---RAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTT---HHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchh---HHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 456899999999999877778999943221 00 00000 122333433322 22334566777665 56778
Q ss_pred EEEecC-CC
Q 017994 133 IITEYL-AG 140 (362)
Q Consensus 133 lv~e~~-~~ 140 (362)
+||||+ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 77
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.91 E-value=2.8e-05 Score=69.53 Aligned_cols=71 Identities=11% Similarity=0.231 Sum_probs=43.7
Q ss_pred eeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCce-eeeeEEEEeCCeEEEEEecC
Q 017994 60 GCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI-ITFVAACKKPPVFCIITEYL 138 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~ 138 (362)
.+.|+.|....+|+. ..+++|+........ -...+|..+++.+...++ .++++. +.+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~-------~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY-------INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----C-------CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccce-------eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeec
Confidence 567889999999999 578999886532110 112347766666532222 455554 333456899999
Q ss_pred -CCCCH
Q 017994 139 -AGGSL 143 (362)
Q Consensus 139 -~~~~L 143 (362)
+|.+|
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 76554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.82 E-value=7.5e-05 Score=67.70 Aligned_cols=135 Identities=17% Similarity=0.098 Sum_probs=70.1
Q ss_pred eecccCCee-EEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC--CceeeeeEEEEeCCeEEEEEec
Q 017994 62 KFASGRHSR-IYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH--PHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 62 ~lg~G~~g~-Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--p~iv~~~~~~~~~~~~~lv~e~ 137 (362)
.|+.|+... +|+.... +..+++|....... ..+..|+.++..+.. -.+.+++.+....+ +++||+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 465665554 6677764 66777876554321 112345666655531 23455666543333 689999
Q ss_pred CCCCCHHHHHhhcC---------------------C---CCCCHHHHH-------HH-------------HHHHHHHHHH
Q 017994 138 LAGGSLRKYLHQQE---------------------P---YSVPLNLVL-------KL-------------ALDIARGMQY 173 (362)
Q Consensus 138 ~~~~~L~~~l~~~~---------------------~---~~l~~~~~~-------~i-------------~~~i~~~l~~ 173 (362)
+.+.++.+.+.... . ..++..... .+ ...+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 97777755443110 0 011121110 00 0011122233
Q ss_pred HH------HCCccccCCCCCcEEEcCC----CceEEeeeccccc
Q 017994 174 LH------SQGILHRDLKSENLLLGED----MCVKVADFGISCL 207 (362)
Q Consensus 174 LH------~~~i~H~dlk~~Nil~~~~----~~~kl~Dfg~~~~ 207 (362)
+. ...++|||+++.|||++.+ +.+.|+||+.+..
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 31 2469999999999999874 6899999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00012 Score=64.86 Aligned_cols=79 Identities=10% Similarity=0.042 Sum_probs=54.2
Q ss_pred cCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC---CceeeeeEEEEeCCe
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH---PHIITFVAACKKPPV 130 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h---p~iv~~~~~~~~~~~ 130 (362)
.+..-.+.+|.|..+.||+.... |+.|+||+........ ...|..|...|+.+.. --+++++++. .
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~------~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~ 84 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL------DGLFRAEALGLDWLGRSFGSPVPQVAGWD----D 84 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC------TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----T
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch------hhHHHHHHHHHHHHHhhCCCCcceEEecc----C
Confidence 34556678999999999999986 7899999876543221 1346778888887742 1244555542 2
Q ss_pred EEEEEecCCCCCH
Q 017994 131 FCIITEYLAGGSL 143 (362)
Q Consensus 131 ~~lv~e~~~~~~L 143 (362)
.++||||++++..
T Consensus 85 ~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 85 RTLAMEWVDERPP 97 (288)
T ss_dssp TEEEEECCCCCCC
T ss_pred ceEEEEeecccCC
Confidence 3689999877653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00011 Score=66.16 Aligned_cols=140 Identities=19% Similarity=0.271 Sum_probs=78.3
Q ss_pred eeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-----CCceeeee-E--EEEeCCe
Q 017994 59 IGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-----HPHIITFV-A--ACKKPPV 130 (362)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----hp~iv~~~-~--~~~~~~~ 130 (362)
-.+.|+.|....+|+....+..+++|+....... ..+..|+.++..+. -|.++... | +....+.
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~--------~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEK--------NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEECC---EEEEEEEESSCCEEEEEECC---C--------CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred EeeccCCCcccceEEEEeCCccEEEEEeCCCCCH--------HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 3456788888999999887668999998763111 23345666666553 23333211 1 1123466
Q ss_pred EEEEEecCCCCCHHH--------------HHhhc-CCCCC------C---HHHHHH------------HHHHHHHHHHHH
Q 017994 131 FCIITEYLAGGSLRK--------------YLHQQ-EPYSV------P---LNLVLK------------LALDIARGMQYL 174 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~--------------~l~~~-~~~~l------~---~~~~~~------------i~~~i~~~l~~L 174 (362)
.+++++|++|.++.. .++.. ..... . +...+. +...+...+..+
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 789999998865311 11111 11010 1 111000 001134445555
Q ss_pred HH-------CCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 175 HS-------QGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 175 H~-------~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
+. .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 53 368999999999999887666899999764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.70 E-value=7.6e-05 Score=70.26 Aligned_cols=72 Identities=15% Similarity=0.278 Sum_probs=47.5
Q ss_pred eeeecccCCeeEEEEEEC---------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCce-eeeeEEEEeCC
Q 017994 60 GCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI-ITFVAACKKPP 129 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~ 129 (362)
.+.|+.|....||+.... +..+++|+...... ...+.+|..++..+...++ +++++.+.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--------~~~li~E~~~l~~L~~~g~~P~l~~~~~~-- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--------ESHLVAESVIFTLLSERHLGPKLYGIFSG-- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--------HHHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--------HHHHHHHHHHHHHHHhCCCCCcEEEEeCC--
Confidence 457888889999999875 36899999854311 0223368888877743333 566665532
Q ss_pred eEEEEEecCCCCCH
Q 017994 130 VFCIITEYLAGGSL 143 (362)
Q Consensus 130 ~~~lv~e~~~~~~L 143 (362)
.+|+||++|.+|
T Consensus 148 --g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 --GRLEEYIPSRPL 159 (429)
T ss_dssp --EEEECCCCEEEC
T ss_pred --CEEEEEeCCccc
Confidence 389999987443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00083 Score=60.46 Aligned_cols=73 Identities=14% Similarity=0.186 Sum_probs=45.0
Q ss_pred eecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCc--eeeeeEE-----EEeCCeEEE
Q 017994 62 KFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH--IITFVAA-----CKKPPVFCI 133 (362)
Q Consensus 62 ~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~--iv~~~~~-----~~~~~~~~l 133 (362)
.|+ |....||+.... ++.+++|+....... ...+..|..++..+...+ +++++.. ....+..++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~-------~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWT-------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSC-------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCC-------HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 456 888899998765 557999998743221 134455777666653111 3333332 223566788
Q ss_pred EEecCCCCC
Q 017994 134 ITEYLAGGS 142 (362)
Q Consensus 134 v~e~~~~~~ 142 (362)
+++|++|.+
T Consensus 105 l~~~i~G~~ 113 (328)
T 1zyl_A 105 VFPSVGGRQ 113 (328)
T ss_dssp EEECCCCEE
T ss_pred EEEecCCCC
Confidence 999998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00015 Score=66.89 Aligned_cols=141 Identities=17% Similarity=0.217 Sum_probs=81.4
Q ss_pred cCeeeeeeecccCCeeEEEEEEC---------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAA 124 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~ 124 (362)
+.+. .+.|..|-...+|+.... +..+++|+....... ...+.+|..+++.+. +.-..++++.
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~-------~~~~~rE~~vl~~L~~~gv~P~ll~~ 122 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG-------VDSLVLESVMFAILAERSLGPQLYGV 122 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC-------HHHHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch-------HHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 3444 346777888899999874 367999986332111 134457888888774 2223566666
Q ss_pred EEeCCeEEEEEecCCCCCHHH-----------H---H---hhcC---CCCC--CHHHHHHHHHHHHH-------------
Q 017994 125 CKKPPVFCIITEYLAGGSLRK-----------Y---L---HQQE---PYSV--PLNLVLKLALDIAR------------- 169 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~-----------~---l---~~~~---~~~l--~~~~~~~i~~~i~~------------- 169 (362)
+.+ .+||||++|.+|.. + + +... .... -+.++.++..++-.
T Consensus 123 ~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~ 198 (379)
T 3feg_A 123 FPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLE 198 (379)
T ss_dssp ETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHH
T ss_pred cCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhh
Confidence 543 28999998865431 1 1 1111 0111 13455555544322
Q ss_pred ------HHHHHH----H----CCccccCCCCCcEEEcCC----CceEEeeeccccc
Q 017994 170 ------GMQYLH----S----QGILHRDLKSENLLLGED----MCVKVADFGISCL 207 (362)
Q Consensus 170 ------~l~~LH----~----~~i~H~dlk~~Nil~~~~----~~~kl~Dfg~~~~ 207 (362)
.+..|. . ..++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 199 ~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 199 MYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233333 2 258999999999999876 7899999998754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00013 Score=67.20 Aligned_cols=73 Identities=15% Similarity=0.163 Sum_probs=43.1
Q ss_pred eeeecccCCeeEEEEEECC----------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCc-eeeeeEEEEeC
Q 017994 60 GCKFASGRHSRIYRGIYKQ----------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH-IITFVAACKKP 128 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~-iv~~~~~~~~~ 128 (362)
...|+.|....+|+....+ ..+++|+........ .....|..+++.+...+ ..++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-------~~~~~E~~~l~~L~~~g~~P~~~~~~--~ 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-------YNTISEFEVYKTMSKYKIAPQLLNTF--N 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-------SCHHHHHHHHHHHHHTTSSCCEEEEE--T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-------ecHHHHHHHHHHHHhcCCCCceEEec--C
Confidence 3567888889999998764 688999876532211 01245777777664223 44666544 2
Q ss_pred CeEEEEEecCCCCCH
Q 017994 129 PVFCIITEYLAGGSL 143 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L 143 (362)
-++||+|++|.++
T Consensus 109 --~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 --GGRIEEWLYGDPL 121 (369)
T ss_dssp --TEEEEECCCSEEC
T ss_pred --CcEEEEEecCCcC
Confidence 2689999988543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0012 Score=59.99 Aligned_cols=30 Identities=23% Similarity=0.494 Sum_probs=26.7
Q ss_pred CccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 178 GILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 178 ~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 689999999999999888899999987654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0017 Score=61.40 Aligned_cols=73 Identities=14% Similarity=0.073 Sum_probs=47.4
Q ss_pred eeeecccCCeeEEEEEECC--eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCce-eeeeEEEEeCCeEEEEEe
Q 017994 60 GCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI-ITFVAACKKPPVFCIITE 136 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e 136 (362)
.+.|+.|-...+|+....+ ..+++|+........ -...+|..++..+...++ +++++.+. + .+|+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-------idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e 181 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-------INREREKKISCILYNKNIAKKIYVFFT--N--GRIEE 181 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-------SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-------cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEE
Confidence 4568888889999999876 889999875432111 011468888888864444 56777663 2 35999
Q ss_pred cCCCCCH
Q 017994 137 YLAGGSL 143 (362)
Q Consensus 137 ~~~~~~L 143 (362)
|++|.+|
T Consensus 182 ~I~G~~l 188 (458)
T 2qg7_A 182 FMDGYAL 188 (458)
T ss_dssp CCCSEEC
T ss_pred eeCCccC
Confidence 9987544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0015 Score=61.08 Aligned_cols=73 Identities=14% Similarity=0.141 Sum_probs=46.6
Q ss_pred eeeecccCCeeEEEEEEC---------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCC
Q 017994 60 GCKFASGRHSRIYRGIYK---------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPP 129 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~ 129 (362)
.+.|..|-...+|+.... +..+++|+........ -...+|..+++.+. +.-..++++.+ .
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-------idR~~E~~~l~~L~~~gi~P~l~~~~--~- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-------YDSKVELDVFRYLSNINIAPNIIADF--P- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-------CCHHHHHHHHHHHHHTTSSCCEEEEE--T-
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-------cCHHHHHHHHHHHHhcCCCCCEEEEc--C-
Confidence 456777888899999886 5789999865432111 11245777777763 22234555533 2
Q ss_pred eEEEEEecCCCCCH
Q 017994 130 VFCIITEYLAGGSL 143 (362)
Q Consensus 130 ~~~lv~e~~~~~~L 143 (362)
-++|++|++|.+|
T Consensus 145 -~~~I~efI~G~~l 157 (424)
T 3mes_A 145 -EGRIEEFIDGEPL 157 (424)
T ss_dssp -TEEEEECCCSEEC
T ss_pred -CCEEEEEeCCccC
Confidence 2689999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.57 E-value=0.038 Score=51.21 Aligned_cols=30 Identities=30% Similarity=0.445 Sum_probs=25.2
Q ss_pred ccccCCCCCcEEE------cCCCceEEeeecccccc
Q 017994 179 ILHRDLKSENLLL------GEDMCVKVADFGISCLE 208 (362)
Q Consensus 179 i~H~dlk~~Nil~------~~~~~~kl~Dfg~~~~~ 208 (362)
++|+|+.+.||++ +.++.+.++||.++...
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 6899999999999 34567999999988643
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.72 E-value=1.8 Score=36.07 Aligned_cols=115 Identities=11% Similarity=0.016 Sum_probs=73.9
Q ss_pred CCCceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHH-HHHHCCccccCCCCCcEEEc
Q 017994 114 NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQ-YLHSQGILHRDLKSENLLLG 192 (362)
Q Consensus 114 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~i~H~dlk~~Nil~~ 192 (362)
.||++ -..+-.+++.+.+.++.-+++.=...++ .++....++++.+|+.... ++ ..-+|--|+|+||+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence 57888 3444477778777777543333333343 3677888888888777554 33 4457788999999999
Q ss_pred CCCceEEeeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCC
Q 017994 193 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 258 (362)
Q Consensus 193 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~ 258 (362)
.++.+++.-.|.-....+ .=+.+|.+ +-.+=+++..++.++..|.
T Consensus 119 ~~~~p~i~hRGi~~~lpP-----------~e~~ee~f----------l~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 119 RALEPFFLHVGVKESLPP-----------DEWDDERL----------LREVKATVLALTEGEYRFD 163 (219)
T ss_dssp TTCCEEESCCEETTTBSS-----------CSCCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred CCCcEEEEEcCCcccCCC-----------CCCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 999999998885322111 11223322 2245677788888877664
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.45 E-value=0.066 Score=50.58 Aligned_cols=61 Identities=10% Similarity=-0.099 Sum_probs=17.3
Q ss_pred eeeeecccCCeeEEEEEECC--eeEEE------EEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEE
Q 017994 59 IGCKFASGRHSRIYRGIYKQ--RDVAI------KLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACK 126 (362)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~--~~vav------K~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~ 126 (362)
+.+.|| ||.||+|.+.+ .+||| |........ ......+.+|..+++.++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~----~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS----EKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC---------------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCcccccccccc----ccccccccccccccccccccccCCCcceEE
Confidence 345666 99999999974 57888 655432211 111345778889999999999999888664
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.43 E-value=0.75 Score=38.25 Aligned_cols=122 Identities=14% Similarity=0.095 Sum_probs=78.1
Q ss_pred HHHHHHcCCCCceeeeeEEEEeCCeEEEEEecCC-CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 017994 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLA-GGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 184 (362)
Q Consensus 106 Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dl 184 (362)
|+.+|.. .||+.+.. .+-..++.+.+.++.-+ +.++.. ++ .++....++++.+|+....++ ..-+|--|
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L 105 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVN--RTRYTFVL 105 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGG--GSSEECCC
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHh--cCceEEEE
Confidence 3444442 68888876 46666777766666433 222222 32 367788999999988877444 33467889
Q ss_pred CCCcEEEcCCCceEEeeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCC
Q 017994 185 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 258 (362)
Q Consensus 185 k~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~ 258 (362)
+|+||+++.++.+++.-.|+-....+. =..+|.+ +-.+=+++..+++++..|.
T Consensus 106 ~P~NL~f~~~~~p~i~~RGik~~l~P~-----------~~~ee~f----------L~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 106 APDELFFTRDGLPIAKTRGLQNVVDPL-----------PVSEAEF----------LTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp SGGGEEECTTSCEEESCCEETTTBSCC-----------CCCHHHH----------HHHHHHHHHHHHCTTCCHH
T ss_pred ecceEEEcCCCCEEEEEccCccCCCCC-----------CCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 999999999999999987753222111 0122222 2345678888888887775
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=85.91 E-value=12 Score=36.15 Aligned_cols=25 Identities=32% Similarity=0.299 Sum_probs=23.1
Q ss_pred cCCCCCcEEEcCCCceEEeeecccc
Q 017994 182 RDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 182 ~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
+|=+++|||++.+|++.=+|||.+-
T Consensus 477 gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 477 GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred cCCCCcceeEcCCCCEeeeehHHhh
Confidence 6889999999999999999999874
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=84.29 E-value=17 Score=35.90 Aligned_cols=25 Identities=32% Similarity=0.311 Sum_probs=23.3
Q ss_pred cCCCCCcEEEcCCCceEEeeecccc
Q 017994 182 RDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 182 ~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
+|-+++||||+.+|.+.-+|||.+-
T Consensus 551 GDRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 551 GDRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred CCCCCcceEEeCCCCEEEEeehhhh
Confidence 6999999999999999999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 362 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-77 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-71 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-67 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-64 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-63 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-63 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-62 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-62 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-60 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-58 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-57 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-55 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-55 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-53 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-51 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-51 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-50 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-50 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-47 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-46 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 2e-77
Identities = 88/283 (31%), Positives = 149/283 (52%), Gaps = 17/283 (6%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEV 107
++W Q+ +G + SG +Y+G + DVA+K+++ + F +EV
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH-GDVAVKMLNVTAPTPQQ----LQAFKNEV 55
Query: 108 ALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDI 167
+L + H +I+ F+ P + I+T++ G SL +LH E + ++ +A
Sbjct: 56 GVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQT 113
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWM 224
A+GM YLH++ I+HRDLKS N+ L ED+ VK+ DFG++ + S + +G+ WM
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 225 APEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---- 277
APE+I+ + ++ + DVY+FGIVL+EL+T P+ N+ + + P
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 320
V CPKA L++ C D RP F QI++ +E + SL +
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 5e-73
Identities = 74/264 (28%), Positives = 126/264 (47%), Gaps = 11/264 (4%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVAL 109
W+ +M +L + G + G Y+ VA+K + + F +E ++
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASV 53
Query: 110 LFRLNHPHIITFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
+ +L H +++ + ++ I+TEY+A GSL YL + + + +LK +LD+
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 228
M+YL +HRDL + N+L+ ED KV+DFG++ S + +W APE
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--TQDTGKLPVKWTAPEA 171
Query: 229 IKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288
++EK+ + K DV+SFGI+LWE+ + P + +K + P CP A
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231
Query: 289 LISRCWSSSPDRRPHFDQIVSILE 312
++ CW RP F Q+ LE
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 1e-71
Identities = 81/276 (29%), Positives = 136/276 (49%), Gaps = 11/276 (3%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTS 105
E+EW L + + +G+ ++ G Y VA+K + Q SM F +
Sbjct: 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-------GSMSPDAFLA 57
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLAL 165
E L+ +L H ++ A + P++ IITEY+ GSL +L + +N +L +A
Sbjct: 58 EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 166 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRW 223
IA GM ++ + +HRDL++ N+L+ + + K+ADFG++ L +++ + +G +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 224 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283
APE I T K DV+SFGI+L E++T ++ R P CP
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP 236
Query: 284 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319
+ L+ CW P+ RP FD + S+LE + + E
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-67
Identities = 83/283 (29%), Positives = 138/283 (48%), Gaps = 11/283 (3%)
Query: 44 GEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQ 102
G ++ W L + K G ++ G + VAIK + +M +
Sbjct: 6 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-------GTMSPEA 58
Query: 103 FTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLK 162
F E ++ +L H ++ A + P+ I+TEY++ GSL +L + + L ++
Sbjct: 59 FLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 117
Query: 163 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGT 220
+A IA GM Y+ +HRDL++ N+L+GE++ KVADFG++ L +++ + +G
Sbjct: 118 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 221 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP 280
+W APE R T K DV+SFGI+L EL T + ++ R P PP
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 237
Query: 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 323
CP++ L+ +CW P+ RP F+ + + LE Y S E +
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 7e-66
Identities = 72/271 (26%), Positives = 129/271 (47%), Gaps = 17/271 (6%)
Query: 62 KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH 117
+ G + +G+Y+ Q DVAIK++ Q E A ++ E ++ +L++P+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-----EEMMREAQIMHQLDNPY 70
Query: 118 IITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 177
I+ + C+ ++ E GG L K+L + +P++ V +L ++ GM+YL +
Sbjct: 71 IVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEK 128
Query: 178 GILHRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMIKEKR 233
+HRDL + N+LL K++DFG+S +S + +W APE I ++
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 234 HTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292
+ + DV+S+G+ +WE L+ P+ M + + ++ R PP CP L+S
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPPECPPELYALMSD 247
Query: 293 CWSSSPDRRPHFDQIVSILEGYSESLEQDPE 323
CW + RP F + + SL E
Sbjct: 248 CWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 4e-65
Identities = 70/268 (26%), Positives = 127/268 (47%), Gaps = 11/268 (4%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYKQRD-VAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
D S+L + SG+ ++ G + +D VAIK + + +M E+ F E ++
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-------GAMSEEDFIEEAEVMM 55
Query: 112 RLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGM 171
+L+HP ++ C + C++ E++ G L Y + + +L + LD+ GM
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGM 114
Query: 172 QYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMI 229
YL ++HRDL + N L+GE+ +KV+DFG++ + Q S+ G +W +PE+
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 230 KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289
R++ K DV+SFG+++WE+ + R P +
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 234
Query: 290 ISRCWSSSPDRRPHFDQIVSILEGYSES 317
++ CW P+ RP F +++ L +ES
Sbjct: 235 MNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (524), Expect = 5e-65
Identities = 81/279 (29%), Positives = 141/279 (50%), Gaps = 12/279 (4%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTS 105
++W + + + + K G++ +Y G++K+ VA+K + + +M ++F
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-------DTMEVEEFLK 62
Query: 106 EVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLAL 165
E A++ + HP+++ + C + P F IITE++ G+L YL + V ++L +A
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 166 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRW 223
I+ M+YL + +HRDL + N L+GE+ VKVADFG+S L + G +W
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 224 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283
APE + + + K DV++FG++LWE+ T + + +K+ R P CP
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 242
Query: 284 KAFSYLISRCWSSSPDRRPHFDQIVSILEG-YSESLEQD 321
+ L+ CW +P RP F +I E + ES D
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 4e-64
Identities = 67/263 (25%), Positives = 120/263 (45%), Gaps = 12/263 (4%)
Query: 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSE 106
+W+ + IG G+ +Y KQ +A+K++ + + + + +E Q E
Sbjct: 2 QWA--LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA---GVEHQLRRE 56
Query: 107 VALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALD 166
V + L HP+I+ +I EY G++ + L + + +
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR--TATYITE 114
Query: 167 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP 226
+A + Y HS+ ++HRD+K ENLLLG +K+ADFG S + GT ++ P
Sbjct: 115 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPP 173
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286
EMI+ + H +KVD++S G++ +E L PF+ T ++ + P +
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGA 231
Query: 287 SYLISRCWSSSPDRRPHFDQIVS 309
LISR +P +RP +++
Sbjct: 232 RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 7e-64
Identities = 74/264 (28%), Positives = 127/264 (48%), Gaps = 13/264 (4%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLF 111
D L + +G+ + G ++ Q DVAIK++ + SM E +F E ++
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-------GSMSEDEFIEEAKVMM 54
Query: 112 RLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGM 171
L+H ++ C K IITEY+A G L YL + +L++ D+ M
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAM 113
Query: 172 QYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMI 229
+YL S+ LHRDL + N L+ + VKV+DFG+S + + S+ G RW PE++
Sbjct: 114 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 230 KEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288
+ + K D+++FG+++WE+ + P++ T + A + Q R P +
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYT 232
Query: 289 LISRCWSSSPDRRPHFDQIVSILE 312
++ CW D RP F ++S +
Sbjct: 233 IMYSCWHEKADERPTFKILLSNIL 256
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-63
Identities = 67/257 (26%), Positives = 122/257 (47%), Gaps = 17/257 (6%)
Query: 65 SGRHSRIYRGIYKQ----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120
SG + +G Y+ + VA+K++ D +L + + +E ++ +L++P+I+
Sbjct: 17 SGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL----KDELLAEANVMQQLDNPYIVR 72
Query: 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 180
+ C+ + ++ E G L KYL Q V +++L ++ GM+YL +
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 181 HRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMIKEKRHTK 236
HRDL + N+LL K++DFG+S E+ + +W APE I + +
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 237 KVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 295
K DV+SFG+++WE + P+ M + + +K R P CP+ L++ CW+
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGERMGCPAGCPREMYDLMNLCWT 248
Query: 296 SSPDRRPHFDQIVSILE 312
+ RP F + L
Sbjct: 249 YDVENRPGFAAVELRLR 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (514), Expect = 3e-63
Identities = 66/250 (26%), Positives = 106/250 (42%), Gaps = 13/250 (5%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
G +Y + VAIK +S ++ + EV L +L HP+ I +
Sbjct: 25 HGSFGAVYFARDVRNSEVVAIKKMSY---SGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
+ ++ EY G + ++P + + +G+ YLHS ++HR
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHKKPL--QEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 183 DLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI---KEKRHTKKVD 239
D+K+ N+LL E VK+ DFG + + + S F GT WMAPE+I E ++ KVD
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPANS---FVGTPYWMAPEVILAMDEGQYDGKVD 196
Query: 240 VYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 299
V+S GI EL P NM A + + Q + + F + C P
Sbjct: 197 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQ 256
Query: 300 RRPHFDQIVS 309
RP + ++
Sbjct: 257 DRPTSEVLLK 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 3e-62
Identities = 65/299 (21%), Positives = 123/299 (41%), Gaps = 38/299 (12%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-------VAIKLVSQPEEDASLASML 99
+ +W L G SG ++ VA+K++ + + +
Sbjct: 29 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE----- 83
Query: 100 EKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQ-------- 150
+ SE+ ++ +L +H +I+ + AC +I EY G L YL +
Sbjct: 84 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 143
Query: 151 -------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 197
+ + +L A +A+GM++L + +HRDL + N+L+ V
Sbjct: 144 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV 203
Query: 198 KVADFGISCLESQCGSAK---GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA- 253
K+ DFG++ + +WMAPE + E +T K DV+S+GI+LWE+ +
Sbjct: 204 KICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263
Query: 254 LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
+ P+ + + + + Q + P + ++ CW+ +RP F + S L
Sbjct: 264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 3e-62
Identities = 62/262 (23%), Positives = 114/262 (43%), Gaps = 17/262 (6%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+ +G + R + K + + K + S+ ++ SEV LL L HP
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDY----GSMTEAEKQMLVSEVNLLRELKHP 63
Query: 117 HIITFVAAC--KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLN--LVLKLALDIARGMQ 172
+I+ + + I+ EY GG L + + L+ VL++ + ++
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 173 YLHSQG-----ILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAP 226
H + +LHRDLK N+ L VK+ DFG++ L AK F GT +M+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 227 EMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286
E + + +K D++S G +L+EL + PF + ++ A + + +P
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDEL 242
Query: 287 SYLISRCWSSSPDRRPHFDQIV 308
+ +I+R + RP ++I+
Sbjct: 243 NEIITRMLNLKDYHRPSVEEIL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 7e-62
Identities = 62/258 (24%), Positives = 110/258 (42%), Gaps = 16/258 (6%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
I + G ++Y+ K+ A K++ E+ + + E+ +L +HP
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE------LEDYMVEIDILASCDHP 69
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+I+ + A I+ E+ AGG++ + + E + + + + + YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHD 128
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMI-----K 230
I+HRDLK+ N+L D +K+ADFG+S F GT WMAPE++ K
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 231 EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYL 289
++ + K DV+S GI L E+ P + P + + + P F
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 290 ISRCWSSSPDRRPHFDQI 307
+ +C + D R Q+
Sbjct: 249 LKKCLEKNVDARWTTSQL 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-61
Identities = 59/247 (23%), Positives = 117/247 (47%), Gaps = 13/247 (5%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
G +Y + ++VAI+ ++ ++ ++ +E+ ++ +P+I+ ++
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYL 83
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
+ ++ EYLAGGSL + + + + + + + +++LHS ++HR
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 183 DLKSENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVY 241
D+KS+N+LLG D VK+ DFG + S GT WMAPE++ K + KVD++
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 242 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLISRCWSSSPDR 300
S GI+ E++ P+ N P +A + + P F ++RC ++
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260
Query: 301 RPHFDQI 307
R ++
Sbjct: 261 RGSAKEL 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (497), Expect = 8e-61
Identities = 83/286 (29%), Positives = 137/286 (47%), Gaps = 23/286 (8%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQFT 104
D+S + I +G + G K VAIK + + + F
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-----KSGYTEKQRRDFL 75
Query: 105 SEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLA 164
SE +++ + +HP++I K IITE++ GSL +L Q + + ++ +
Sbjct: 76 SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-FTVIQLVGML 134
Query: 165 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS------AKGFT 218
IA GM+YL +HRDL + N+L+ ++ KV+DFG+S S A G
Sbjct: 135 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194
Query: 219 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 277
RW APE I+ ++ T DV+S+GIV+WE+++ P+ +MT + A+ +++ R P
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-EQDYRLP 253
Query: 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 323
P CP A L+ CW + RP F QIV+ L + + ++P
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL----DKMIRNPN 295
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-60
Identities = 77/298 (25%), Positives = 129/298 (43%), Gaps = 28/298 (9%)
Query: 53 DMSQLFIGCKFASGRHSRIYRGIYKQ----RDVAIKLVSQPEEDASLASMLEKQFTSEVA 108
D + + G ++ + K+ D AIK + + + F E+
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----HRDFAGELE 62
Query: 109 LLFRL-NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPY-------------- 153
+L +L +HP+II + AC+ + EY G+L +L +
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 154 SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS 213
++ +L A D+ARGM YL + +HRDL + N+L+GE+ K+ADFG+S +
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182
Query: 214 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTAL-TPFDNMTPEQAAFAVCQK 272
RWMA E + +T DV+S+G++LWE+++ TP+ MT + + +
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQ 241
Query: 273 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ--DPEFFSSF 328
R P C L+ +CW P RP F QI+ L E + + + F
Sbjct: 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKF 299
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 5e-60
Identities = 69/264 (26%), Positives = 112/264 (42%), Gaps = 15/264 (5%)
Query: 59 IGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQFTSEVALLFRL 113
+ K G + RG + VA+K + D F EV + L
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK---PDVLSQPEAMDDFIREVNAMHSL 68
Query: 114 NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQY 173
+H ++I PP ++TE GSL L + + L + + A+ +A GM Y
Sbjct: 69 DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGY 126
Query: 174 LHSQGILHRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMI 229
L S+ +HRDL + NLLL VK+ DFG+ + + + W APE +
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 230 KEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288
K + + D + FG+ LWE+ T P+ + Q + ++ R P P CP+
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 246
Query: 289 LISRCWSSSPDRRPHFDQIVSILE 312
++ +CW+ P+ RP F + L
Sbjct: 247 VMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 6e-60
Identities = 75/271 (27%), Positives = 127/271 (46%), Gaps = 14/271 (5%)
Query: 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQF 103
++ ++ +G G+ +++GIY + VAIK D+ + ++F
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-----VREKF 55
Query: 104 TSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL 163
E + + +HPHI+ + + PV+ II E G LR + Q YS+ L ++
Sbjct: 56 LQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSF-LQVRKYSLDLASLILY 113
Query: 164 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTY 221
A ++ + YL S+ +HRD+ + N+L+ + CVK+ DFG+S K
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 222 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 281
+WMAPE I +R T DV+ FG+ +WE+L + R P+PP
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 233
Query: 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
CP L+++CW+ P RRP F ++ + L
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-59
Identities = 65/261 (24%), Positives = 118/261 (45%), Gaps = 18/261 (6%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+ G +Y+G+ + +VA + D L ++F E +L L HP
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQ----DRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 117 HIITFVAAC----KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQ 172
+I+ F + K ++TE + G+L+ YL + + + ++ I +G+Q
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM--KIKVLRSWCRQILKGLQ 126
Query: 173 YLHSQG--ILHRDLKSENLLL-GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI 229
+LH++ I+HRDLK +N+ + G VK+ D G++ L+ AK GT +MAPEM
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMY 185
Query: 230 KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-VPPTCPKAFSY 288
+EK + + VDVY+FG+ + E+ T+ P+ + +P
Sbjct: 186 EEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244
Query: 289 LISRCWSSSPDRRPHFDQIVS 309
+I C + D R +++
Sbjct: 245 IIEGCIRQNKDERYSIKDLLN 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-59
Identities = 80/273 (29%), Positives = 126/273 (46%), Gaps = 19/273 (6%)
Query: 65 SGRHSRIYRGIYK------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118
+G +Y+G+ K + VAIK + + F E ++ + +H +I
Sbjct: 17 AGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-----RVDFLGEAGIMGQFSHHNI 71
Query: 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 178
I K IITEY+ G+L K+L +++ + ++ + IA GM+YL +
Sbjct: 72 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANMN 130
Query: 179 ILHRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMIKEKRH 234
+HRDL + N+L+ ++ KV+DFG+S + + G RW APE I ++
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 190
Query: 235 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 294
T DV+SFGIV+WE++T R P P CP A L+ +CW
Sbjct: 191 TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCW 250
Query: 295 SSSPDRRPHFDQIVSILEGY---SESLEQDPEF 324
RRP F IVSIL+ +SL+ +F
Sbjct: 251 QQERARRPKFADIVSILDKLIRAPDSLKTLADF 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 5e-59
Identities = 70/276 (25%), Positives = 130/276 (47%), Gaps = 20/276 (7%)
Query: 65 SGRHSRIYRGIYKQRD------VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI 118
SG +Y+G++ VAIK + + + K+ E ++ +++PH+
Sbjct: 19 SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-----NKEILDEAYVMASVDNPHV 73
Query: 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 178
+ C V +IT+ + G L Y+ + + + +L + IA+GM YL +
Sbjct: 74 CRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 179 ILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHT 235
++HRDL + N+L+ VK+ DFG++ L E + A+G +WMA E I + +T
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 191
Query: 236 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 295
+ DV+S+G+ +WEL+T + + P ++ +K R P PP C ++ +CW
Sbjct: 192 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWM 251
Query: 296 SSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPS 331
D RP F +++ + +DP+ +
Sbjct: 252 IDADSRPKFRELIIEF----SKMARDPQRYLVIQGD 283
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 8e-59
Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 34/300 (11%)
Query: 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASML 99
+ +W ++L G +G ++ VA+K++
Sbjct: 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE----- 69
Query: 100 EKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQ-------- 150
+ SE+ +L L NH +I+ + AC +ITEY G L +L ++
Sbjct: 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 151 --------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202
+ ++ L +L + +A+GM +L S+ +HRDL + N+LL K+ DF
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDF 189
Query: 203 GISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP-FD 258
G++ +S +WMAPE I +T + DV+S+GI LWEL + + +
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249
Query: 259 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY-SES 317
M + + + ++ R P P ++ CW + P +RP F QIV ++E SES
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (482), Expect = 1e-58
Identities = 80/302 (26%), Positives = 129/302 (42%), Gaps = 39/302 (12%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLE 100
+ + G R+++ VA+K++ + ++ ++
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-----EASADMQ 60
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSV----- 155
F E AL+ ++P+I+ + C C++ EY+A G L ++L P++V
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 156 -----------------PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 198
L +A +A GM YL + +HRDL + N L+GE+M VK
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVK 180
Query: 199 VADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-AL 254
+ADFG+S + RWM PE I R+T + DV+++G+VLWE+ + L
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 255 TPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314
P+ M E+ + V N P CP L+ CWS P RP F I IL+
Sbjct: 241 QPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
Query: 315 SE 316
E
Sbjct: 300 CE 301
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 191 bits (485), Expect = 2e-58
Identities = 59/286 (20%), Positives = 117/286 (40%), Gaps = 18/286 (6%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
I + SG ++R + K R K ++ P + +E++++ +L+HP
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD------KYTVKNEISIMNQLHHP 86
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+I A + +I E+L+GG L + + Y + V+ G++++H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE 145
Query: 177 QGILHRDLKSENLLL--GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH 234
I+H D+K EN++ + VK+ DFG++ + K T T + APE++ +
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 205
Query: 235 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISR 292
D+++ G++ + LL+ L+PF + V + + + I
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 265
Query: 293 CWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILR 338
P +R + L+ D +S IPS + +R
Sbjct: 266 LLQKEPRKRLTVHDALE-----HPWLKGDHSNLTSRIPSSRYNKIR 306
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-58
Identities = 66/268 (24%), Positives = 123/268 (45%), Gaps = 17/268 (6%)
Query: 65 SGRHSRIYRGIYKQRD-----VAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119
G +Y G D A+K +++ + + QF +E ++ +HP+++
Sbjct: 37 RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPNVL 91
Query: 120 TFVAACKKPP-VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 178
+ + C + ++ Y+ G LR + + E ++ + ++ L +A+GM++L S+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 179 ILHRDLKSENLLLGEDMCVKVADFGISCL-----ESQCGSAKGFTGTYRWMAPEMIKEKR 233
+HRDL + N +L E VKVADFG++ + G +WMA E ++ ++
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210
Query: 234 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 293
T K DV+SFG++LWEL+T P + R P CP ++ +C
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 270
Query: 294 WSSSPDRRPHFDQIVSILEGYSESLEQD 321
W + RP F ++VS + + +
Sbjct: 271 WHPKAEMRPSFSELVSRISAIFSTFIGE 298
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 190 bits (484), Expect = 3e-58
Identities = 52/255 (20%), Positives = 105/255 (41%), Gaps = 13/255 (5%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
I + +G ++R + + A K V P E ++ E+ + L HP
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD------KETVRKEIQTMSVLRHP 83
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
++ A + +I E+++GG L + + + + + ++ + +G+ ++H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 177 QGILHRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH 234
+H DLK EN++ +K+ DFG++ S K TGT + APE+ + K
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 202
Query: 235 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISR 292
D++S G++ + LL+ L+PF ++ V + + I +
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262
Query: 293 CWSSSPDRRPHFDQI 307
+ P+ R Q
Sbjct: 263 LLLADPNTRMTIHQA 277
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-57
Identities = 63/281 (22%), Positives = 116/281 (41%), Gaps = 19/281 (6%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
+G +++ +K +A KL+ + A + Q E+ +L N P+I+ F
Sbjct: 16 AGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-----IRNQIIRELQVLHECNSPYIVGFY 70
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILH 181
A I E++ GGSL + L + P ++ K+++ + +G+ YL + I+H
Sbjct: 71 GAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLREKHKIMH 128
Query: 182 RDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVY 241
RD+K N+L+ +K+ DFG+S A F GT +M+PE ++ ++ + D++
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIW 187
Query: 242 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 301
S G+ L E+ P ++ P S D R
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKELELMF--GCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245
Query: 302 PHFDQIVSILEGYSESLEQDPEFFSSFIPSPD--HTILRCL 340
P +I E + + P S + S + + +CL
Sbjct: 246 PPM----AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 4e-57
Identities = 62/258 (24%), Positives = 109/258 (42%), Gaps = 14/258 (5%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+ G + + + + VA+K+V D A + E+ + LNH
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNHE 63
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+++ F ++ + + EY +GG L + P + + G+ YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLMAGVVYLHG 121
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKR 233
GI HRD+K ENLLL E +K++DFG++ + ++ GT ++APE++K +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 234 -HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-VCQKNARPPVPPTCPKAFSYLIS 291
H + VDV+S GIVL +L P+D + ++ +K A L+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 292 RCWSSSPDRRPHFDQIVS 309
+ +P R I
Sbjct: 242 KILVENPSARITIPDIKK 259
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 4e-57
Identities = 79/299 (26%), Positives = 137/299 (45%), Gaps = 25/299 (8%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLE 100
+EW ++ + + G +Y G+ K + VAIK V++
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-----R 67
Query: 101 KQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSV----- 155
+F +E +++ N H++ + + +I E + G L+ YL P
Sbjct: 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 156 ---PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212
L+ ++++A +IA GM YL++ +HRDL + N ++ ED VK+ DFG++ +
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187
Query: 213 SAKGFT---GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 268
+ RWM+PE +K+ T DV+SFG+VLWE+ T A P+ ++ EQ
Sbjct: 188 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247
Query: 269 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSS 327
V + P CP L+ CW +P RP F +I+S ++ E ++ F+ S
Sbjct: 248 VMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 305
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 182 bits (464), Expect = 3e-56
Identities = 63/257 (24%), Positives = 113/257 (43%), Gaps = 16/257 (6%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEK---QFTSEVALLFRLN-HPHI 118
G S + R I+K ++ A+K++ + A +++ EV +L +++ HP+I
Sbjct: 13 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72
Query: 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 178
I + F ++ + + G L YL ++ K+ + + LH
Sbjct: 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL--SEKETRKIMRALLEVICALHKLN 130
Query: 179 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI------KEK 232
I+HRDLK EN+LL +DM +K+ DFG SC + GT ++APE+I
Sbjct: 131 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 190
Query: 233 RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLI 290
+ K+VD++S G++++ LL PF + + N + P L+
Sbjct: 191 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 250
Query: 291 SRCWSSSPDRRPHFDQI 307
SR P +R ++
Sbjct: 251 SRFLVVQPQKRYTAEEA 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 4e-56
Identities = 72/296 (24%), Positives = 129/296 (43%), Gaps = 53/296 (17%)
Query: 65 SGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124
GR ++RG ++ +VA+K+ S EE +E+ L H +I+ F+AA
Sbjct: 13 KGRFGEVWRGKWRGEEVAVKIFSSREER-------SWFREAEIYQTVMLRHENILGFIAA 65
Query: 125 CKKP----PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ--- 177
K ++++Y GSL YL++ Y+V + ++KLAL A G+ +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 178 -----GILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-----SAKGFTGTYRWMAPE 227
I HRDLKS+N+L+ ++ +AD G++ + GT R+MAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 228 MIKEKRH------TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF-------------- 267
++ + + K+ D+Y+ G+V WE+ + Q +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 268 -AVCQKNARPPVP-----PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317
VC++ RP +P + + ++ CW ++ R +I L S+
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-55
Identities = 64/275 (23%), Positives = 112/275 (40%), Gaps = 18/275 (6%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
G G S + R+ AIK++ + + T E ++ RL+HP
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEK---RHIIKENKVPYVTRERDVMSRLDHP 68
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+ + Y G L KY+ + + +I ++YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLHG 126
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKR 233
+GI+HRDLK EN+LL EDM +++ DFG + + ES+ A F GT ++++PE++ EK
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 234 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 293
K D+++ G ++++L+ L PF + P L+ +
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKL 244
Query: 294 WSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSF 328
+R +++ L+ P FF S
Sbjct: 245 LVLDATKRLGCEEMEGYGP-----LKAHP-FFESV 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-55
Identities = 39/255 (15%), Positives = 91/255 (35%), Gaps = 14/255 (5%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
I G ++R + + K V D + E+++L H
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVLVKKEISILNIARHR 61
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+I+ + + +I E+++G + + ++ + + ++ + +Q+LHS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS 120
Query: 177 QGILHRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH 234
I H D++ EN++ +K+ +FG + + + + APE+ +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 235 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISR 292
+ D++S G +++ LL+ + PF T +Q + + R
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 293 CWSSSPDRRPHFDQI 307
R +
Sbjct: 241 LLVKERKSRMTASEA 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (461), Expect = 2e-55
Identities = 61/250 (24%), Positives = 113/250 (45%), Gaps = 14/250 (5%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
+G S + K+ + VAIK +++ + E +E+A+L ++ HP+I+
Sbjct: 19 TGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-----EGSMENEIAVLHKIKHPNIVALD 73
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
+ +I + ++GG L + ++ Y +L + ++YLH GI+HR
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 183 DLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVD 239
DLK ENLL ED + ++DFG+S +E GT ++APE++ +K ++K VD
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVD 191
Query: 240 VYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLISRCWSSS 297
+S G++ + LL PF + + + + P + I
Sbjct: 192 CWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKD 251
Query: 298 PDRRPHFDQI 307
P++R +Q
Sbjct: 252 PEKRFTCEQA 261
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 3e-55
Identities = 75/291 (25%), Positives = 130/291 (44%), Gaps = 32/291 (10%)
Query: 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQRD---------VAIKLVSQPEEDASLASML 99
W +L +G G ++ D VA+K++ + L
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL---- 62
Query: 100 EKQFTSEVALLFRL-NHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLN 158
SE+ ++ + H +II + AC + +I EY + G+LR+YL + P + +
Sbjct: 63 -SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121
Query: 159 L--------------VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204
++ A +ARGM+YL S+ +HRDL + N+L+ ED +K+ADFG+
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 181
Query: 205 SCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT 261
+ +WMAPE + ++ +T + DV+SFG++LWE+ T
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 262 PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
P + F + ++ R P C ++ CW + P +RP F Q+V L+
Sbjct: 242 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-54
Identities = 61/247 (24%), Positives = 113/247 (45%), Gaps = 9/247 (3%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+ G +++ +K+ + AIK + + + + +E + L HP
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
+ + + EYL GG L ++ + L+ A +I G+Q+LHS
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF--DLSRATFYAAEIILGLQFLHS 121
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHT 235
+GI++RDLK +N+LL +D +K+ADFG+ F GT ++APE++ +++
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 236 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 295
VD +SFG++L+E+L +PF E+ + P P K L+ + +
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH--SIRMDNPFYPRWLEKEAKDLLVKLFV 239
Query: 296 SSPDRRP 302
P++R
Sbjct: 240 REPEKRL 246
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 175 bits (445), Expect = 2e-53
Identities = 63/256 (24%), Positives = 112/256 (43%), Gaps = 17/256 (6%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+G G S ++ + RDVA+K++ D + +F E LNHP
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRA---DLARDPSFYLRFRREAQNAAALNHP 67
Query: 117 HIITFVAAC----KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQ 172
I+ P+ I+ EY+ G +LR +H + P + +++ D + +
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR--AIEVIADACQALN 125
Query: 173 YLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEM 228
+ H GI+HRD+K N+++ VKV DFGI+ + GT ++++PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 229 IKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAF 286
+ + DVYS G VL+E+LT PF +P A+ +++ PP
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 287 SYLISRCWSSSPDRRP 302
++ + + +P+ R
Sbjct: 246 DAVVLKALAKNPENRY 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 174 bits (441), Expect = 9e-52
Identities = 58/274 (21%), Positives = 112/274 (40%), Gaps = 14/274 (5%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+ G +Y + A+K + + L ++L+ + P
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
I+ A P I + + GG L +L Q +S + A +I G++++H+
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD--MRFYAAEIILGLEHMHN 125
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI-KEKRHT 235
+ +++RDLK N+LL E V+++D G++C S+ GT+ +MAPE++ K +
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYD 184
Query: 236 KKVDVYSFGIVLWELLTALTPFDNMTP-EQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 294
D +S G +L++LL +PF ++ +P + L+
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244
Query: 295 SSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSF 328
+RR L ++ +++ P FF S
Sbjct: 245 QRDVNRRL------GCLGRGAQEVKESP-FFRSL 271
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-51
Identities = 67/297 (22%), Positives = 125/297 (42%), Gaps = 32/297 (10%)
Query: 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLE 100
+W +L +G G ++ R VA+K++ + +
Sbjct: 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----H 60
Query: 101 KQFTSEVALLFRLNHPHIITFV--AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVP-- 156
+ SE+ +L + H + + A K +I E+ G+L YL + VP
Sbjct: 61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 157 ------------LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204
L ++ + +A+GM++L S+ +HRDL + N+LL E VK+ DFG+
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 180
Query: 205 SCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 260
+ + +WMAPE I ++ +T + DV+SFG++LWE+ + +P+ +
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240
Query: 261 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317
++ ++ R P + CW P +RP F ++V L ++
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-51
Identities = 60/257 (23%), Positives = 106/257 (41%), Gaps = 10/257 (3%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
G + SG+ + + + K A K + + +S + + EV++L + HP
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
++IT + +I E +AGG L +L ++E + I G+ YLHS
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESL--TEEEATEFLKQILNGVYYLHS 131
Query: 177 QGILHRDLKSENLLLGEDMC----VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK 232
I H DLK EN++L + +K+ DFG++ K GT ++APE++ +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 233 RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLI 290
+ D++S G++ + LL+ +PF T ++ V N I
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 291 SRCWSSSPDRRPHFDQI 307
R P +R
Sbjct: 252 RRLLVKDPKKRMTIQDS 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-50
Identities = 55/259 (21%), Positives = 101/259 (38%), Gaps = 27/259 (10%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITF 121
G + ++ + K+ A+K++ + EV L +R PHI+
Sbjct: 22 LGINGKVLQIFNKRTQEKFALKMLQD-----------CPKARREVELHWRASQCPHIVRI 70
Query: 122 VAACK----KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 177
V + I+ E L GG L + + + ++ I +QYLHS
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 178 GILHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH 234
I HRD+K ENLL + +K+ DFG + + S T ++APE++ +++
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 190
Query: 235 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------PVPPTCPKAFSY 288
K D++S G++++ LL PF + + + + P +
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 250
Query: 289 LISRCWSSSPDRRPHFDQI 307
LI + P +R +
Sbjct: 251 LIRNLLKTEPTQRMTITEF 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (424), Expect = 8e-50
Identities = 64/259 (24%), Positives = 118/259 (45%), Gaps = 13/259 (5%)
Query: 50 WSADMSQLFIGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEV 107
+S + I +G R++ + R A+K++ + + + + E
Sbjct: 1 YS--LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK---EIVVRLKQVEHTNDER 55
Query: 108 ALLFRLNHPHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDI 167
+L + HP II + +I +Y+ GG L L + + + P + A ++
Sbjct: 56 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEV 113
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE 227
++YLHS+ I++RDLK EN+LL ++ +K+ DFG + GT ++APE
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPE 171
Query: 228 MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287
++ K + K +D +SFGI+++E+L TPF + + + NA PP +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--NAELRFPPFFNEDVK 229
Query: 288 YLISRCWSSSPDRRPHFDQ 306
L+SR + +R Q
Sbjct: 230 DLLSRLITRDLSQRLGNLQ 248
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-47
Identities = 58/255 (22%), Positives = 102/255 (40%), Gaps = 16/255 (6%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+G SG +Y GI VAIK V + + EV LL +++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 117 H--IITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYL 174
+I + ++P F +I E + ++ L + +++
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHC 126
Query: 175 HSQGILHRDLKSENLLLGED-MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK-EK 232
H+ G+LHRD+K EN+L+ + +K+ DFG L F GT + PE I+ +
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHR 185
Query: 233 RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 292
H + V+S GI+L++++ PF++ + +LI
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------IIRGQVFFRQRVSSECQHLIRW 237
Query: 293 CWSSSPDRRPHFDQI 307
C + P RP F++I
Sbjct: 238 CLALRPSDRPTFEEI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 2e-47
Identities = 55/273 (20%), Positives = 97/273 (35%), Gaps = 28/273 (10%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+G K SG IY G +VAIKL + Q E + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGG 62
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
I + C + ++ L G SL + L VL LA + ++Y+HS
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHS 121
Query: 177 QGILHRDLKSENLL---LGEDMCVKVADFGISCLESQCGS--------AKGFTGTYRWMA 225
+ +HRD+K +N L + V + DFG++ + K TGT R+ +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 226 PEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR------PPVP 279
+++ D+ S G VL P+ + + + + +
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 312
P F+ ++ C S D +P + + +
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 159 bits (404), Expect = 4e-47
Identities = 52/281 (18%), Positives = 97/281 (34%), Gaps = 30/281 (10%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
+G + G I+ G + VAIK + + Q E L
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGC 60
Query: 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
I V + + ++ L G SL L + V A + +Q +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHE 119
Query: 177 QGILHRDLKSENLLLGEDMC-----VKVADFGISCLESQCGS--------AKGFTGTYRW 223
+ +++RD+K +N L+G + V DFG+ + K +GT R+
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 224 MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE---QAAFAVCQKNARPPV-- 278
M+ + +++ D+ + G V L P+ + Q + +K P+
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239
Query: 279 -PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 318
P+ F + + + D P +D + + E L
Sbjct: 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-46
Identities = 57/241 (23%), Positives = 107/241 (44%), Gaps = 10/241 (4%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
G ++ K R A+K++ + + +A +E +L HP +
Sbjct: 15 KGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
A + C + EY GG L +L ++ + +I ++YLHS+ +++R
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVF--TEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 183 DLKSENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVY 241
D+K ENL+L +D +K+ DFG+ G+ K F GT ++APE++++ + + VD +
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 242 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 301
G+V++E++ PF N E+ + P T L++ P +R
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 302 P 302
Sbjct: 248 L 248
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (375), Expect = 2e-42
Identities = 56/240 (23%), Positives = 103/240 (42%), Gaps = 11/240 (4%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
+G R+ +K+ A+K++ + + + +E +L +N P ++
Sbjct: 51 TGSFGRVMLVKHKESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
+ K ++ EY+AGG + +L + +S P A I +YLHS +++R
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYR 165
Query: 183 DLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYS 242
DLK ENLL+ + ++V DFG + G GT +APE+I K + K VD ++
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWA 223
Query: 243 FGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 302
G++++E+ PF P Q + + + P L+ +R
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIV--SGKVRFPSHFSSDLKDLLRNLLQVDLTKRF 281
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-41
Identities = 57/273 (20%), Positives = 101/273 (36%), Gaps = 33/273 (12%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
G+ + +Y+ K + VAIK + + + + E+ LL L+HP+II +
Sbjct: 8 EGQFATVYKARDKNTNQIVAIKKIK-LGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 66
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
A ++ +++ + + L +G++YLH ILHR
Sbjct: 67 DAFGHKSNISLVFDFMETDLEVIIKDNSLVL--TPSHIKAYMLMTLQGLEYLHQHWILHR 124
Query: 183 DLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDV 240
DLK NLLL E+ +K+ADFG++ S + T + APE++ R + VD+
Sbjct: 125 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDM 184
Query: 241 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP----------------------- 277
++ G +L ELL + + + + P
Sbjct: 185 WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP 244
Query: 278 ---VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307
+ LI + +P R Q
Sbjct: 245 LHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 4e-41
Identities = 52/285 (18%), Positives = 103/285 (36%), Gaps = 41/285 (14%)
Query: 59 IGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-- 113
+ G + ++++ R VA+K V + + EVA+L L
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE----EGMPLSTIREVAVLRHLET 66
Query: 114 -NHPHIITFVAACKKPPV-----FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDI 167
HP+++ C ++ E++ YL + VP + + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQL 125
Query: 168 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE 227
RG+ +LHS ++HRDLK +N+L+ +K+ADFG++ + S + T + APE
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185
Query: 228 MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---------- 277
++ + + VD++S G + E+ F + + P
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 278 ---------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307
+ L+ +C + +P +R
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 9e-41
Identities = 61/256 (23%), Positives = 117/256 (45%), Gaps = 16/256 (6%)
Query: 59 IGCKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL 113
+ +G + +++ + A+K++ + + + +E +L +
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL--KKATIVQKAKTTEHTRTERQVLEHI 85
Query: 114 NH-PHIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQ 172
P ++T A + +I +Y+ GG L +L Q+E + + V +I ++
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF--TEHEVQIYVGEIVLALE 143
Query: 173 YLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS--AKGFTGTYRWMAPEMI- 229
+LH GI++RD+K EN+LL + V + DFG+S + A F GT +MAP+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 230 -KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAF 286
+ H K VD +S G++++ELLT +PF + + + ++ + PP P
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263
Query: 287 SYLISRCWSSSPDRRP 302
LI R P +R
Sbjct: 264 KDLIQRLLMKDPKKRL 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-39
Identities = 59/274 (21%), Positives = 107/274 (39%), Gaps = 36/274 (13%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
G + +Y+ K VA+K + E + E++LL LNHP+I+ +
Sbjct: 12 EGTYGVVYKARNKLTGEVVALKKIRLDTETEGV----PSTAIREISLLKELNHPNIVKLL 67
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
++ E+L L+K++ +PL L+ + +G+ + HS +LHR
Sbjct: 68 DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 183 DLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW-MAPEMI-KEKRHTKKVDV 240
DLK +NLL+ + +K+ADFG++ W APE++ K ++ VD+
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 241 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP----------------------- 277
+S G + E++T F + F + + P
Sbjct: 187 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 246
Query: 278 ----VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307
V P + L+S+ P++R
Sbjct: 247 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-38
Identities = 61/283 (21%), Positives = 104/283 (36%), Gaps = 48/283 (16%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
G + + VAIK +S E ++ E+ +L R H +II
Sbjct: 18 EGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-----QRTLREIKILLRFRHENIIGIN 72
Query: 123 AACKKPPVF----CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 178
+ P + + +L G L K L Q + + + I RG++Y+HS
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN 129
Query: 179 ILHRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMI-KEKR 233
+LHRDLK NLLL +K+ DFG++ + G + T + APE++ K
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 234 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---------------- 277
+TK +D++S G +L E+L+ F + P
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 278 -------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307
+ P L+ + + +P +R +Q
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 134 bits (337), Expect = 2e-37
Identities = 44/273 (16%), Positives = 92/273 (33%), Gaps = 36/273 (13%)
Query: 65 SGRHSRIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123
G + +Y+ A+K + +ED + E+++L L H +I+
Sbjct: 12 EGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTIREISILKELKHSNIVKLYD 67
Query: 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRD 183
++ E+L + + L + G+ Y H + +LHRD
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGL--ESVTAKSFLLQLLNGIAYCHDRRVLHRD 125
Query: 184 LKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI--KEKRHTKKVDVY 241
LK +NLL+ + +K+ADFG++ W + K+++ +D++
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 242 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------------------ 277
S G + E++ F ++ + + P
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP 245
Query: 278 ---VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307
++ L+S+ P++R Q
Sbjct: 246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 4e-37
Identities = 49/296 (16%), Positives = 102/296 (34%), Gaps = 54/296 (18%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
K G +++ +++ + VA+K V E E+ +L L H
Sbjct: 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF----PITALREIKILQLLKHE 69
Query: 117 HIITFVAACKKPPV--------FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIA 168
+++ + C+ ++ ++ + +++ + ++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLL 127
Query: 169 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL-----ESQCGSAKGFTGTYRW 223
G+ Y+H ILHRD+K+ N+L+ D +K+ADFG++ SQ T +
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 224 MAPEMI-KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC 282
PE++ E+ + +D++ G ++ E+ T T + + Q P
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT-PEVW 246
Query: 283 PKAFSY-------------------------------LISRCWSSSPDRRPHFDQI 307
P +Y LI + P +R D
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 6e-37
Identities = 58/281 (20%), Positives = 99/281 (35%), Gaps = 48/281 (17%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
+G +Y+ VAIK V Q + + E+ ++ +L+H +I+
Sbjct: 30 NGSFGVVYQAKLCDSGELVAIKKVLQDK----------RFKNRELQIMRKLDHCNIVRLR 79
Query: 123 AAC------KKPPVFCIITEYLAGGSLRKYLH-QQEPYSVPLNLVLKLALDIARGMQYLH 175
K ++ +Y+ R H + ++P+ V + R + Y+H
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 176 SQGILHRDLKSENLLLGED-MCVKVADFGISCLESQCGSAKGFTGTYRWMAP-EMIKEKR 233
S GI HRD+K +NLLL D +K+ DFG + + + + + AP +
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 199
Query: 234 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---------------- 277
+T +DV+S G VL ELL F + + + P
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 259
Query: 278 -----------VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307
P P L SR +P R +
Sbjct: 260 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 3e-35
Identities = 46/275 (16%), Positives = 92/275 (33%), Gaps = 38/275 (13%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
G + +++ ++ VA+K V ++D + E+ LL L H +I+
Sbjct: 12 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKELKHKNIVRLH 67
Query: 123 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 182
++ E+ + + +V + +G+ + HS+ +LHR
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL--DPEIVKSFLFQLLKGLGFCHSRNVLHR 125
Query: 183 DLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP--EMIKEKRHTKKVDV 240
DLK +NLL+ + +K+A+FG++ W P + K ++ +D+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 241 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP----------------------- 277
+S G + EL A P + P
Sbjct: 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT 245
Query: 278 -----VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307
V P L+ +P +R ++
Sbjct: 246 TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 1e-34
Identities = 56/281 (19%), Positives = 109/281 (38%), Gaps = 48/281 (17%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
SG + + + + VAIK + +P + + K+ E+ LL + H ++I +
Sbjct: 28 SGAYGAVCSAVDGRTGAKVAIKKLYRPFQS----ELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 123 AACKKPPV------FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
F ++ ++ G+ L + E + + L + +G++Y+H+
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKL--GEDRIQFLVYQMLKGLRYIHA 139
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI-KEKRHT 235
GI+HRDLK NL + ED +K+ DFG++ G+ T + APE+I R+T
Sbjct: 140 AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYT 197
Query: 236 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------------ 277
+ VD++S G ++ E++T T F + + PP
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257
Query: 278 -----------VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 307
+ L+ + ++R +
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (309), Expect = 5e-33
Identities = 41/252 (16%), Positives = 96/252 (38%), Gaps = 21/252 (8%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-H 115
+ K G++S ++ I V +K++ ++ K+ E+ +L L
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---------KKIKREIKILENLRGG 89
Query: 116 PHIITFVAACKKPP--VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQY 173
P+IIT K P ++ E++ ++ ++ + +I + + Y
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDY 144
Query: 174 LHSQGILHRDLKSENLLLG-EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE-MIKE 231
HS GI+HRD+K N+++ E +++ D+G++ + + PE ++
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 232 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291
+ + +D++S G +L ++ PF + K ++ +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 292 RCWSSSPDRRPH 303
++ R
Sbjct: 265 PRFNDILGRHSR 276
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-32
Identities = 55/284 (19%), Positives = 107/284 (37%), Gaps = 23/284 (8%)
Query: 65 SGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFV 122
SG + R+VAIK +S+P ++ + A K+ E+ L+ +NH +II+ +
Sbjct: 27 SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMKCVNHKNIISLL 82
Query: 123 AACKKPPVF------CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 176
++ E + + + + L + G+++LHS
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHS 137
Query: 177 QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTK 236
GI+HRDLK N+++ D +K+ DFG++ + T + APE+I + +
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197
Query: 237 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 296
VD++S G ++ E++ F V ++ P F + +
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP------CPEFMKKLQPTVRN 251
Query: 297 SPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCL 340
+ RP + + D E + + L
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-31
Identities = 63/317 (19%), Positives = 109/317 (34%), Gaps = 47/317 (14%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHP 116
SG + + + VA+K +S+P + A K+ E+ LL + H
Sbjct: 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA----KRTYRELRLLKHMKHE 77
Query: 117 HIITFVAACKKPPVFC-----IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGM 171
++I + + +L G L + Q+ + V L I RG+
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT---DDHVQFLIYQILRGL 134
Query: 172 QYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE 231
+Y+HS I+HRDLK NL + ED +K+ DFG++ + T Y M+
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWY-RAPEIMLNW 193
Query: 232 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-------------- 277
+ + VD++S G ++ ELLT T F + + P
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 278 ---------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS---ILEGYSESLE 319
V L+ + D+R Q ++ + + E
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313
Query: 320 QDPEFFSSFIPSPDHTI 336
+ + S D I
Sbjct: 314 PVADPYDQSFESRDLLI 330
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 96.6 bits (239), Expect = 4e-23
Identities = 47/296 (15%), Positives = 100/296 (33%), Gaps = 14/296 (4%)
Query: 59 IGCKFASGRHSRIYRGIYKQ--RDVAIKLVSQPEEDASLA----SMLEKQFTSEVALLFR 112
+ K G S ++ VA+K+V + A +L++ ++
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 113 LNHPHIITFVAACKKPP---VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR 169
+ HI+ + V ++ + G +L + + E +PL V +++ +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 170 GMQYLH-SQGILHRDLKSENLLL-GEDMCVKVADFGISCLESQCGSAKG---FTGTYRWM 224
G+ Y+H GI+H D+K EN+L+ D + I+ L + C + T +
Sbjct: 137 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 225 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 284
+PE++ D++S +++EL+T F+ + P
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 285 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCL 340
+ R + + L + +F + L
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.1 bits (176), Expect = 1e-15
Identities = 25/195 (12%), Positives = 62/195 (31%), Gaps = 25/195 (12%)
Query: 59 IGCKFASGRHSRIYRGIYKQ-RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPH 117
IG G+ S ++ ++ + +K ++L + +
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 118 IITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 177
+ + V + + L + + +E Y V + ++ I + + +
Sbjct: 64 EFRALQKLQGLAVPKVY-AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR 122
Query: 178 GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK------- 230
GI+H DL N+L+ + + + DF S E+++
Sbjct: 123 GIVHGDLSQYNVLVS-EEGIWIIDFPQS------------VEVGEEGWREILERDVRNII 169
Query: 231 ---EKRHTKKVDVYS 242
+ + + D+ S
Sbjct: 170 TYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 362 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.76 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.35 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.93 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.4 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.26 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-59 Score=418.76 Aligned_cols=265 Identities=33% Similarity=0.622 Sum_probs=223.9
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
++|+++.++|.+++.||+|+||+||+|.+++ .||||+++........ .+.|.+|+.++++++||||+++++++.+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILLFMGYSTA 75 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTH----HHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence 5799999999999999999999999998776 5999999765433322 3678899999999999999999998754
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
+.+++||||+++|+|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 76 -~~~~lv~Ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 76 -PQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp -SSCEEEEECCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred -cEEEEEEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceee
Confidence 567999999999999999976543 599999999999999999999999999999999999999999999999999976
Q ss_pred cccCC---CCCcccccccccChhhhhcC---CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----C
Q 017994 208 ESQCG---SAKGFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP----P 277 (362)
Q Consensus 208 ~~~~~---~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~----~ 277 (362)
..... ......||+.|+|||++.+. .++.++||||||+++|||+||..||.+.+............... .
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 233 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchh
Confidence 54322 23456799999999998643 47899999999999999999999999887666555544444332 3
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 278 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
.+..+|+++.+|+.+||+.||++|||+.||++.|+.+.++++
T Consensus 234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 467789999999999999999999999999999999887654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.1e-59 Score=417.27 Aligned_cols=262 Identities=30% Similarity=0.599 Sum_probs=230.7
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
..+.|+++.++|++.+.||+|+||+||+|.+. ++.||||+++..... .+.|.+|+.++++++||||+++++
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~E~~il~~l~HpnIv~~~~ 80 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLG 80 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC-------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch-------HHHHHHHHHHHHhCCCCCEecCCc
Confidence 34679999999999999999999999999996 788999999765544 356889999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
++.+++..++||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 81 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred cEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccc
Confidence 99999999999999999999999987766679999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCC-CCCCCHHHHHHHHHhcCCCCCCCC
Q 017994 204 ISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP-FDNMTPEQAAFAVCQKNARPPVPP 280 (362)
Q Consensus 204 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~ 280 (362)
+++....... .....|++.|+|||++.+..++.++||||||+++|||++|..| |...+... ..........++.+.
T Consensus 161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~ 239 (287)
T d1opja_ 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERPE 239 (287)
T ss_dssp CTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHTTCCCCCCT
T ss_pred ceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHHHhcCCCCCCCc
Confidence 9986544322 2334578899999999999999999999999999999996555 45555544 445555667788889
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 017994 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 281 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
.+|+.+.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 99999999999999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-58 Score=407.87 Aligned_cols=248 Identities=26% Similarity=0.457 Sum_probs=221.1
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|++++.||+|+||+||+|.++ ++.||||++....... ....+.+.+|+.++++++||||+++++++.+++.+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 81 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK---AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 81 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC---hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence 468999999999999999999996 6789999987532111 11246788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~- 158 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 158 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred EEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC-
Confidence 99999999999999998765 599999999999999999999999999999999999999999999999999976544
Q ss_pred CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.. ....+|..+|+++.+||.
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLIS 236 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCCTTSCHHHHHHHH
T ss_pred CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCccCCHHHHHHHH
Confidence 234466799999999999999999999999999999999999999999888887776654 445677889999999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 017994 292 RCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 292 ~~l~~~p~~Rps~~ell~ 309 (362)
+||+.||++|||+.|+++
T Consensus 237 ~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHTCSSGGGSCCHHHHHT
T ss_pred HHccCCHhHCcCHHHHHc
Confidence 999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-58 Score=410.61 Aligned_cols=261 Identities=31% Similarity=0.586 Sum_probs=228.1
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
-.++|+++.++|++.+.||+|+||.||+|.++ ++.||||++...... .+.|.+|+.++++++|||||+++++
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-------PDAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC-------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC-------HHHHHHHHHHHHhCCCCCEeEEEee
Confidence 46889999999999999999999999999997 578999999865443 3678899999999999999999998
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
+.+ +..++||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred ecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccc
Confidence 754 5678999999999999988765544699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC--CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 205 SCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 205 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
++...... ......+++.|+|||++.++.++.++||||||+++|||+| |.+|+...+..+....+ .....+..+..
T Consensus 156 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i-~~~~~~~~p~~ 234 (272)
T d1qpca_ 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPDN 234 (272)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTT
T ss_pred eEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH-HhcCCCCCccc
Confidence 98654332 2345678999999999999999999999999999999999 55666666666655554 45567778889
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
+|+++.+|+.+||+.||++|||+.+|++.|+.+-
T Consensus 235 ~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 9999999999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=404.79 Aligned_cols=257 Identities=28% Similarity=0.569 Sum_probs=218.6
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCe
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPV 130 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~ 130 (362)
++.++|++.+.||+|+||+||+|.+. ++.||||++...... .+.|.+|+.++++++||||++++|++..++.
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 74 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC-------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc-------HHHHHHHHHHHHhcCCCCcccccceeccCCc
Confidence 45788999999999999999999996 678999999865443 3678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 210 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (362)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred eEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence 999999999999999987654 3689999999999999999999999999999999999999999999999999976544
Q ss_pred CC--CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHH
Q 017994 211 CG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287 (362)
Q Consensus 211 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 287 (362)
.. ......||+.|+|||++.+..++.++||||||+++|||+| |.+||...+..+....+. .......|..+++++.
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~ 232 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVY 232 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCCCTTSCHHHH
T ss_pred CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHH
Confidence 32 2334678999999999999999999999999999999999 677777777766666554 4566777888999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 288 YLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
+|+.+||+.||++|||+++|++.|+.+.++
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999988764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-57 Score=407.11 Aligned_cols=246 Identities=24% Similarity=0.459 Sum_probs=219.4
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
.+|++.+.||+|+||+||+|.+. ++.||||++....... .+.+.+|+.++++++||||+++++++.+++.+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH------HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence 47999999999999999999986 7899999987644332 356889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 211 (362)
+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999999999998765 4899999999999999999999999999999999999999999999999999865433
Q ss_pred CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCCHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLI 290 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 290 (362)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..... ....+..+++.+.+||
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 250 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHH
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHH
Confidence 344566799999999999999999999999999999999999999999888777766655433 3455678899999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 017994 291 SRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~ell~ 309 (362)
.+||+.||.+|||+.|+++
T Consensus 251 ~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 251 NRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHTCSSTTTSCCHHHHTT
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-57 Score=404.07 Aligned_cols=267 Identities=31% Similarity=0.580 Sum_probs=226.1
Q ss_pred ccCCCcccccccccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceee
Q 017994 42 IKGEGEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120 (362)
Q Consensus 42 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~ 120 (362)
..+...++|+++.++|++++.||+|+||+||+|.++ ++.||||++...... .+.|.+|+.++++++|||||+
T Consensus 4 ~~~~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~-------~~~~~~E~~~l~~l~h~nIv~ 76 (285)
T d1fmka3 4 TQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-------PEAFLQEAQVMKKLRHEKLVQ 76 (285)
T ss_dssp CSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC-------HHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC-------HHHHHHHHHHHHhcccCCEeE
Confidence 345567899999999999999999999999999997 568999999865544 267889999999999999999
Q ss_pred eeEEEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEe
Q 017994 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 200 (362)
Q Consensus 121 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~ 200 (362)
+++++.+ +.+++||||+++|+|..++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 77 ~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~ 155 (285)
T d1fmka3 77 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 155 (285)
T ss_dssp EEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEc
Confidence 9999854 567899999999999999976544469999999999999999999999999999999999999999999999
Q ss_pred eeccccccccCC--CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCC
Q 017994 201 DFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPP 277 (362)
Q Consensus 201 Dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~ 277 (362)
|||+++...... ......+|+.|+|||++.++.++.++||||||+++|||++| .+|+......+....+. .....+
T Consensus 156 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~ 234 (285)
T d1fmka3 156 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMP 234 (285)
T ss_dssp CCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCC
T ss_pred ccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCC
Confidence 999997654322 23346689999999999999999999999999999999995 55566666655555544 456677
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 278 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 278 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
.+..+++++.+||.+||+.||++||++++|+++|+.+...
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 8899999999999999999999999999999999886554
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.2e-57 Score=406.94 Aligned_cols=260 Identities=32% Similarity=0.559 Sum_probs=218.3
Q ss_pred cccccCeeeeeeecccCCeeEEEEEEC--C---eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYK--Q---RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
+++.++|++.+.||+|+||+||+|.+. + ..||||.+........ .+.|.+|+.+|++++|||||++++++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ-----RRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHH-----HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHH-----HHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 456788999999999999999999985 2 2588998876544322 46789999999999999999999999
Q ss_pred EeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccc
Q 017994 126 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 205 (362)
Q Consensus 126 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 205 (362)
..++.+++||||+++|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eeCCEEEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccc
Confidence 999999999999999999999887543 5899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC------CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 017994 206 CLESQCGS------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 278 (362)
Q Consensus 206 ~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (362)
+....... .....+|+.|+|||++.++.++.++|||||||++|||+| |..||.+.+..+....+. ...+++.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~ 254 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPP 254 (299)
T ss_dssp --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCC
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCC
Confidence 76543222 123457899999999999999999999999999999998 899999998887776664 4556777
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 279 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 279 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
+..+|+.+.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 255 ~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 888999999999999999999999999999999987653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-57 Score=414.14 Aligned_cols=262 Identities=25% Similarity=0.484 Sum_probs=228.6
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEECC-------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCce
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~i 118 (362)
...|+++.++|++++.||+|+||+||+|.+.+ ..||||++....... ....+.+|+.++.++ +||||
T Consensus 29 ~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~HpnI 103 (325)
T d1rjba_ 29 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-----EREALMSELKMMTQLGSHENI 103 (325)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTB
T ss_pred CccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHH-----HHHHHHHHHHHHHHhcCCCcE
Confidence 45688999999999999999999999998752 369999987643322 135688899999998 89999
Q ss_pred eeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q 017994 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP---------------------YSVPLNLVLKLALDIARGMQYLHSQ 177 (362)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~LH~~ 177 (362)
|++++++.+.+.+++||||+++|+|.++++.... ..+++..++.++.|++.||.|||++
T Consensus 104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~ 183 (325)
T d1rjba_ 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 183 (325)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999976532 2488999999999999999999999
Q ss_pred CccccCCCCCcEEEcCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-C
Q 017994 178 GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-A 253 (362)
Q Consensus 178 ~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g 253 (362)
||+||||||+||+++.++.+||+|||+++....... .....||+.|+|||++.++.++.++|||||||++|||+| |
T Consensus 184 ~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g 263 (325)
T d1rjba_ 184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263 (325)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence 999999999999999999999999999976554332 234567999999999999999999999999999999998 8
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 017994 254 LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 313 (362)
Q Consensus 254 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 313 (362)
..||.+.+.......+.....+++.|..+|+++.+||.+||+.||++|||++||+++|..
T Consensus 264 ~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 999998877777777777788888899999999999999999999999999999999863
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=404.34 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=210.6
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|++.+.||+|+||+||+|.+. ++.||||++....... ..+.+.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-----HHHHHHHHHHHHHhCCCCCEeeEeeeeccCcee
Confidence 367999999999999999999986 7899999998654322 135688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 99999999999999997654 6999999999999999999999999999999999999999999999999999865432
Q ss_pred ---CCCCcccccccccChhhhhcCCC-CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHH-HHHhcCCCCCCCCCCCHHH
Q 017994 212 ---GSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF-AVCQKNARPPVPPTCPKAF 286 (362)
Q Consensus 212 ---~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 286 (362)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......... ..............+++++
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHH
Confidence 23456789999999999988775 678999999999999999999998765433332 2222233333346789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+||.+||+.||++|||+.|+++
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-56 Score=394.93 Aligned_cols=252 Identities=28% Similarity=0.540 Sum_probs=225.9
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
+.++|+++++||+|+||+||+|+++ ++.||||+++..... .+.|.+|+.++++++||||++++|++.+++.+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~ 74 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 74 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-------HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-------HHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Confidence 5678999999999999999999997 678999999876544 36788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+++|+|.+++..... .+++..+++++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEEEECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred EEEEEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 999999999999999776543 5889999999999999999999999999999999999999999999999999754433
Q ss_pred CC--CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 212 GS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 212 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
.. .....+|+.|+|||.+.+..++.++||||||+++|||+| |..||...+..+....+.. ..+...|..+++.+.+
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~ 232 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYT 232 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHH
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh-CCCCCCcccccHHHHH
Confidence 22 334668999999999999999999999999999999998 8999999998887776654 5567788899999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHh
Q 017994 289 LISRCWSSSPDRRPHFDQIVSILEG 313 (362)
Q Consensus 289 li~~~l~~~p~~Rps~~ell~~L~~ 313 (362)
||.+||+.||++|||+++|++.|..
T Consensus 233 li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 233 IMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHccCCHhHCcCHHHHHHHhhC
Confidence 9999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-57 Score=400.42 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=208.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe--CC
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK--PP 129 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~ 129 (362)
.++|++.+.||+|+||+||+|.++ ++.||||++......... .+.+.+|+.++++++||||+++++++.+ +.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 78 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHH----HHHHHHHHHHTTSCCCTTBCCEEEEEEC----
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHH----HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCC
Confidence 367999999999999999999986 788999999876543322 4668899999999999999999999864 46
Q ss_pred eEEEEEecCCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCcEEEcCCCceEEeee
Q 017994 130 VFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQG-----ILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
.+|+||||++||+|.+++... ....+++..++.++.||+.||.|||+.| |+||||||+|||++.+|.+||+||
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 789999999999999999642 2236999999999999999999999976 999999999999999999999999
Q ss_pred ccccccccC-CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 017994 203 GISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 281 (362)
Q Consensus 203 g~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (362)
|++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+... .....+..
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 237 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRRIPYR 237 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTT
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCcc
Confidence 999865443 2345678999999999999999999999999999999999999999998888877776554 34467788
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 282 CPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 282 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+|+++.+||.+||+.||.+|||+.|+++
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 9999999999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-56 Score=406.28 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=203.8
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
+.|++.+.||+|+||+||+|.++ ++.||||++........ ...+.+|+.++++++||||+++++++.+++.+|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-----EGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC---------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45999999999999999999986 78899999986543321 356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc---CCCceEEeeeccccccc
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG---EDMCVKVADFGISCLES 209 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~---~~~~~kl~Dfg~~~~~~ 209 (362)
+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||++. .++.+||+|||++....
T Consensus 84 lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999999998765 699999999999999999999999999999999999995 57899999999998766
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCCHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAFS 287 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 287 (362)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....... +.+..+|+++.
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 6555667789999999999999999999999999999999999999999988888777776654443 34467899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~ 309 (362)
+||.+||+.||++|||+.|+++
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHhc
Confidence 9999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-56 Score=398.80 Aligned_cols=264 Identities=27% Similarity=0.540 Sum_probs=226.3
Q ss_pred ccccccCeeeee-eecccCCeeEEEEEEC----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 50 WSADMSQLFIGC-KFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 50 ~~~~~~~~~~~~-~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
|-+..++|.+.+ +||+|+||.||+|.+. +..||||+++...... ..+.|.+|+.++++++|||||+++++
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-----DTEEMMREAQIMHQLDNPYIVRLIGV 77 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH-----HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHH-----HHHHHHHHHHHHHhCCCCCEeeEeee
Confidence 344567788888 4999999999999875 3479999997654332 24678899999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
+.+ +.+++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 78 ~~~-~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 78 CQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EES-SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred ecc-CeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchh
Confidence 865 46789999999999999986544 2699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC----CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 017994 205 SCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 279 (362)
Q Consensus 205 ~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (362)
++...... ......||+.|+|||++.++.++.++||||||+++|||+| |..||.+.+..+....+. ...+++.|
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p 234 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECP 234 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCC
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 97654322 2234568899999999999999999999999999999998 999999988777665554 45667788
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCC
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 321 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~ 321 (362)
..+|+++.+||.+||+.||++|||+.+|.+.|+....++...
T Consensus 235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 999999999999999999999999999999999876655544
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-57 Score=405.40 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=218.3
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
+++|++++.||+|+||+||+|.+. ++.||||++....... ....+.+.+|+.++++++||||+++++++.+++.+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC---HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 467999999999999999999986 7899999987532111 11136788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
|+||||++||+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999999999998776 6999999999999999999999999999999999999999999999999999865432
Q ss_pred ---CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 212 ---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 212 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+... ...++..+++++.+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 239 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPEKFFPKARD 239 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--CCCCCTTCCHHHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--CCCCCccCCHHHHH
Confidence 2234567999999999999999999999999999999999999999998888877776543 45677889999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 017994 289 LISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 289 li~~~l~~~p~~Rps~~ell~~ 310 (362)
||.+||+.||.+|||++|+++.
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHHccCCHhHCcCHHHHcCC
Confidence 9999999999999999998653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-57 Score=398.79 Aligned_cols=257 Identities=29% Similarity=0.550 Sum_probs=221.7
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe-
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK- 127 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~- 127 (362)
.|+++.++|++++.||+|+||.||+|.++++.||||+++.+.. .+.+.+|+.++++++||||++++|++.+
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~--------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH--------HHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 3899999999999999999999999999999999999976432 3568899999999999999999999854
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
.+.+++||||+++|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+||+++.+|.+||+|||++..
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 152 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccccee
Confidence 46789999999999999999765433589999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHH
Q 017994 208 ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286 (362)
Q Consensus 208 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (362)
... ......+++.|+|||++.+..++.++||||||+++|||+| |.+||...+..+....+. ...+++.+..+++++
T Consensus 153 ~~~--~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~ 229 (262)
T d1byga_ 153 ASS--TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAV 229 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHH
T ss_pred cCC--CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHH
Confidence 443 2334567899999999999999999999999999999998 899999888877766654 456778889999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
.+||.+||+.||.+|||+.+|+++|+.++.
T Consensus 230 ~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 230 YEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-56 Score=401.97 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=219.3
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
..|+..+.||+|+||.||+|.+. ++.||||++......... ..+.+.+|+.++++++|||||++++++.+++..|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHH---HHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence 35999999999999999999986 788999999875543321 2467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+|||||.+|+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 92 iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 9999999999987776654 699999999999999999999999999999999999999999999999999976543
Q ss_pred CCCcccccccccChhhhhc---CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHH
Q 017994 213 SAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 289 (362)
.....||+.|+|||++.+ +.++.++|||||||++|+|++|..||.+.+..+....+.........+..+|+.+.+|
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~l 246 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHH
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 345689999999999864 4588999999999999999999999999988888888777666666667899999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 017994 290 ISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 290 i~~~l~~~p~~Rps~~ell~ 309 (362)
|.+||+.||.+|||+.|+++
T Consensus 247 i~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 247 VDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCcCChhHCcCHHHHHh
Confidence 99999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=402.87 Aligned_cols=248 Identities=25% Similarity=0.442 Sum_probs=216.8
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
+.|++.+.||+|+||.||+|.+. ++.||||++....... .+.+.+|+.++++++||||+++++++.+++.++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE------LEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG------GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH------HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence 45899999999999999999986 6789999998754432 256788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 211 (362)
+||||++||+|.+++.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 86 lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 9999999999999987654 25999999999999999999999999999999999999999999999999998754332
Q ss_pred CCCCcccccccccChhhhh-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CCCCCCCCCHH
Q 017994 212 GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKA 285 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 285 (362)
.......||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+..... ....+..+|++
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHH
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHH
Confidence 2234568999999999984 45678999999999999999999999999888887777765443 23445778999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
+.+||.+||+.||.+|||+.|+++
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-56 Score=396.65 Aligned_cols=259 Identities=31% Similarity=0.541 Sum_probs=217.9
Q ss_pred cccccCeeeeeeecccCCeeEEEEEECC------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEE
Q 017994 51 SADMSQLFIGCKFASGRHSRIYRGIYKQ------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAA 124 (362)
Q Consensus 51 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~ 124 (362)
+++++.|...+.||+|+||.||+|.+++ ..||||++.....+.. ...|.+|+.++++++|||||+++|+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-----RVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHH-----HHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 4567889999999999999999998753 3699999976544322 3568899999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecc
Q 017994 125 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 204 (362)
Q Consensus 125 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 204 (362)
+.+.+..++||||+.++++.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 78 ISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EecCCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccch
Confidence 999999999999999999999887654 3699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC----CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCC
Q 017994 205 SCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVP 279 (362)
Q Consensus 205 ~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (362)
++...... ......||+.|+|||++.++.++.++||||||+++|||++| .+|+...+..+.... .....+++.+
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~-i~~~~~~~~~ 235 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-INDGFRLPTP 235 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCC
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH-HhccCCCCCc
Confidence 97644322 22345689999999999999999999999999999999995 555666666555544 4556777888
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
..+|+.+.+||.+||+.||++||++.||+++|+.+.+
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 8999999999999999999999999999999988765
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-56 Score=395.40 Aligned_cols=261 Identities=29% Similarity=0.597 Sum_probs=218.7
Q ss_pred cccccccCeeeeeeecccCCeeEEEEEECC-----eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 49 EWSADMSQLFIGCKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 49 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
+|+++.++|++++.||+|+||.||+|.+.. ..||||++.....+. ..+.+.+|+.++++++||||+++++
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~ 75 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-----VREKFLQEALTMRQFDHPHIVKLIG 75 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHH-----HHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHH-----HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 588999999999999999999999998852 458889886544332 2467889999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
++. ++.+++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 76 ~~~-~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 76 VIT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp EEC-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEe-cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccch
Confidence 986 467899999999999999887654 368999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC--CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 017994 204 ISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 280 (362)
Q Consensus 204 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (362)
++....... ......+|+.|+|||++.+..++.++||||||+++|||++ |.+||.+.+..+....+. ....++.++
T Consensus 154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~ 232 (273)
T d1mp8a_ 154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPP 232 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCT
T ss_pred hheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence 997654322 2344567899999999999999999999999999999998 999999988877776665 455667888
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 281 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 281 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
.+|+.+.+||.+||+.||++|||+.||++.|+.+.+.
T Consensus 233 ~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999987653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-56 Score=400.82 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=222.6
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++++.||+|+||+||+|.++ ++.||||++..............+.+.+|+.++++++||||+++++++.+++.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46999999999999999999986 7899999997643322111112467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC----ceEEeeecccccc
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM----CVKVADFGISCLE 208 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~----~~kl~Dfg~~~~~ 208 (362)
+|||||+||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 90 iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999998765 699999999999999999999999999999999999998776 4999999999877
Q ss_pred ccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCCHHH
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAF 286 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 286 (362)
..........+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......+ .+..+|+.+
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 247 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 247 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHH
Confidence 666666677899999999999999999999999999999999999999999988888777765443322 336789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+||.+||+.||++|||+.|+++
T Consensus 248 ~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 248 KDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHhc
Confidence 99999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=394.02 Aligned_cols=251 Identities=27% Similarity=0.550 Sum_probs=213.3
Q ss_pred eeee-eeecccCCeeEEEEEEC----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 57 LFIG-CKFASGRHSRIYRGIYK----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 57 ~~~~-~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
+.+. ++||+|+||+||+|.+. ++.||||++.....+.. ..+.+.+|+.++++++||||+++++++.. +..
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~ 82 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAEANVMQQLDNPYIVRMIGICEA-ESW 82 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH----HHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHH----HHHHHHHHHHHHHhCCCCCCceEEEEecc-CCE
Confidence 4444 46999999999999874 35799999976433322 24678999999999999999999999865 457
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~lvmE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 83 MLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp EEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 89999999999999998765 5999999999999999999999999999999999999999999999999999754432
Q ss_pred C----CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHH
Q 017994 212 G----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 286 (362)
Q Consensus 212 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (362)
. ......||+.|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+. ...+++.|..+|+++
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~ 239 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREM 239 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHH
Confidence 2 2234568999999999999999999999999999999998 999999988877666554 456778889999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
.+||.+||+.||++|||+.+|++.|+.+-
T Consensus 240 ~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 240 YDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 99999999999999999999999988653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.6e-56 Score=406.91 Aligned_cols=250 Identities=21% Similarity=0.325 Sum_probs=222.4
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|++++.||+|+||.||+|.+. ++.||||++....... .+.+.+|+.++++++||||+++++++.+++.+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD------KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHH------HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhh------HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 358999999999999999999986 7899999997654322 36788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc--CCCceEEeeeccccccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG--EDMCVKVADFGISCLES 209 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~--~~~~~kl~Dfg~~~~~~ 209 (362)
|+||||++||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ .+|.+||+|||++....
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 99999999999999996543 2599999999999999999999999999999999999996 46789999999998776
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCCHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFS 287 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 287 (362)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......+ ....+++++.
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 257 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 65666677899999999999999999999999999999999999999999988888877766554333 2356889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~~ 310 (362)
+||.+||+.||.+|||+.|+++.
T Consensus 258 ~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 258 DFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999873
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-55 Score=405.49 Aligned_cols=248 Identities=21% Similarity=0.325 Sum_probs=222.7
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||+|+||.||+|.+. ++.||||++....... ...+.+|+.++++++||||+++++++.+++.+|
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD------KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH------HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH------HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57999999999999999999986 7899999998754322 356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc--CCCceEEeeecccccccc
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG--EDMCVKVADFGISCLESQ 210 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~--~~~~~kl~Dfg~~~~~~~ 210 (362)
+|||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .+|.+||+|||++.....
T Consensus 103 ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 9999999999999887654 3699999999999999999999999999999999999997 578999999999987766
Q ss_pred CCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCCCHHHHH
Q 017994 211 CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAFSY 288 (362)
Q Consensus 211 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 288 (362)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... .....+|+++.+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 555666789999999999999999999999999999999999999999999888887776655433 344678999999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 017994 289 LISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 289 li~~~l~~~p~~Rps~~ell~ 309 (362)
||.+||+.||.+|||+.|+++
T Consensus 262 li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999987
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=403.17 Aligned_cols=250 Identities=23% Similarity=0.407 Sum_probs=210.1
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
+..++|++.+.||+|+||+||+|.+. ++.||||+++...... ....+.+|+.+|++++|||||++++++.+++
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-----IRNQIIRELQVLHECNSPYIVGFYGAFYSDG 77 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTT-----HHHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHH-----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 44578999999999999999999986 7899999998654332 1467889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
.+|+||||++||+|.+++.+.. .+++..+..++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|...
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 9999999999999999998765 59999999999999999999997 59999999999999999999999999999865
Q ss_pred ccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHH---------------------
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF--------------------- 267 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~--------------------- 267 (362)
... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+...
T Consensus 156 ~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 156 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp HHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred CCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 432 3446789999999999999999999999999999999999999997654322100
Q ss_pred --------------------HHHhcCCCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 268 --------------------AVCQKNARPPVP-PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 268 --------------------~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
........+..+ ..++.++.+||.+||..||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000011111122 346789999999999999999999999997
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=390.17 Aligned_cols=245 Identities=25% Similarity=0.481 Sum_probs=208.0
Q ss_pred eeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe----CCe
Q 017994 57 LFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK----PPV 130 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----~~~ 130 (362)
|++.++||+|+||+||+|.+. ++.||+|++........ ..+.+.+|++++++++||||+++++++.+ ...
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS----ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH----HHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 477889999999999999997 67899999876543322 14678899999999999999999999865 456
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEc-CCCceEEeeeccccc
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLG-EDMCVKVADFGISCL 207 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dlk~~Nil~~-~~~~~kl~Dfg~~~~ 207 (362)
+++||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 899999999999999998765 5899999999999999999999998 99999999999996 578999999999975
Q ss_pred cccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCCCCCCCCCCCHHH
Q 017994 208 ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-VCQKNARPPVPPTCPKAF 286 (362)
Q Consensus 208 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 286 (362)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......... +.........+..+++++
T Consensus 165 ~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (270)
T d1t4ha_ 165 KRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242 (270)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred ccC-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHH
Confidence 443 23446789999999999865 589999999999999999999999987655544443 333333334566788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 017994 287 SYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 287 ~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.+||.+||+.||++|||+.|+++
T Consensus 243 ~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 243 KEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHccCCHhHCcCHHHHhC
Confidence 99999999999999999999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-55 Score=399.80 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=222.2
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP 129 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 129 (362)
+..++|++++.||+|+||.||+|.++ ++.||||++....... ....+.+.+|+.+|++++||||+++++++.+++
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 78 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC---HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence 34678999999999999999999986 7899999997532111 111366789999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccc
Q 017994 130 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 209 (362)
Q Consensus 130 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 209 (362)
.+|+||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred ccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 9999999999999999999876 58999999999999999999999999999999999999999999999999998654
Q ss_pred c-CCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHH
Q 017994 210 Q-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 288 (362)
Q Consensus 210 ~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 288 (362)
. .......+||+.|+|||++.+..++.++|+|||||++|+|++|.+||.+.+..+....+... ...+|..+|+++.+
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~d 234 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKS 234 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHH
T ss_pred cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHH
Confidence 3 33455678999999999999999999999999999999999999999999988877766554 45678889999999
Q ss_pred HHHHhcccCCCCCCC-----HHHHHH
Q 017994 289 LISRCWSSSPDRRPH-----FDQIVS 309 (362)
Q Consensus 289 li~~~l~~~p~~Rps-----~~ell~ 309 (362)
||.+||+.||.+|++ +.|+++
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHhhccCCchhhcccccccHHHHHc
Confidence 999999999999995 777776
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-54 Score=386.02 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=223.9
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcch---HHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDA---SLASMLEKQFTSEVALLFRLN-HPHIITFVAACKK 127 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~ 127 (362)
.++|++.+.||+|+||+||+|.+. ++.||||++....... .......+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999985 7899999998754322 222344577889999999997 9999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
++.+|+||||++||+|.++++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 999999999999999999998766 699999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccccccccChhhhhcC------CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CC
Q 017994 208 ESQCGSAKGFTGTYRWMAPEMIKEK------RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VP 279 (362)
Q Consensus 208 ~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~ 279 (362)
...........||+.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+.......+.......+ ..
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 7665566677899999999998642 468899999999999999999999999998887777776654433 33
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 280 PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 280 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+|+++.+|+.+||+.||.+|||+.|+++
T Consensus 240 ~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 578999999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-54 Score=391.81 Aligned_cols=262 Identities=29% Similarity=0.544 Sum_probs=227.5
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEECC-------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceee
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYKQ-------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIIT 120 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~ 120 (362)
..|++..++|++.+.||+|+||+||+|.+.+ +.||||+++...... ..+.|.+|+.++++++||||++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~E~~il~~l~h~niv~ 80 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-----MQADFQREAALMAEFDNPNIVK 80 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHH-----HHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChH-----HHHHHHHHHHHHHhcCCCCccc
Confidence 3477788899999999999999999998753 689999987654332 2467899999999999999999
Q ss_pred eeEEEEeCCeEEEEEecCCCCCHHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 017994 121 FVAACKKPPVFCIITEYLAGGSLRKYLHQQE----------------------PYSVPLNLVLKLALDIARGMQYLHSQG 178 (362)
Q Consensus 121 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~ 178 (362)
+++++......+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+++
T Consensus 81 ~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ 160 (301)
T d1lufa_ 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160 (301)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence 9999999999999999999999999997532 124888999999999999999999999
Q ss_pred ccccCCCCCcEEEcCCCceEEeeeccccccccC---CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhC-C
Q 017994 179 ILHRDLKSENLLLGEDMCVKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-L 254 (362)
Q Consensus 179 i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g-~ 254 (362)
|+||||||+|||++.++.+||+|||++...... .......+++.|+|||.+.+..++.++||||||+++|||++| .
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 999999999999999999999999998754332 223345688999999999999999999999999999999997 5
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 017994 255 TPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 315 (362)
Q Consensus 255 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 315 (362)
+||.+.+..+....+.. ...++.+..+|+++.+||.+||+.||++|||+.||+++|+.+.
T Consensus 241 ~p~~~~~~~e~~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 241 QPYYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 78999888887777654 4567778899999999999999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-54 Score=393.62 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=220.0
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|++++.||+|+||+||+|.++ ++.||||+++...... ....+.+.+|+.++++++||||+++++++.+++.+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR---LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC---HHHHHHHHHHHHHHHhccCcChhheeeeEeeCCee
Confidence 468999999999999999999986 7899999987532111 11136788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
|+||||++||+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 80 ~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~- 156 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 156 (316)
T ss_dssp EEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-
Confidence 99999999999999998876 588999999999999999999999999999999999999999999999999976544
Q ss_pred CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+... ....++.+++++.+++.
T Consensus 157 -~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 157 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLS 233 (316)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHH
T ss_pred -ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCCCCHHHHHHHH
Confidence 334678999999999999999999999999999999999999999999988887777654 34667889999999999
Q ss_pred HhcccCCCCCC-----CHHHHHH
Q 017994 292 RCWSSSPDRRP-----HFDQIVS 309 (362)
Q Consensus 292 ~~l~~~p~~Rp-----s~~ell~ 309 (362)
+||..||.+|+ +++++++
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHhhhCHHhccccchhhHHHHHc
Confidence 99999999996 8999886
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=391.39 Aligned_cols=266 Identities=25% Similarity=0.506 Sum_probs=219.1
Q ss_pred CcccccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCc
Q 017994 46 GEEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPH 117 (362)
Q Consensus 46 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~ 117 (362)
....|+++.++|++++.||+|+||.||+|.+. ++.||||++........ .+.+.+|+..+.++ +|||
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~-----~~~~~~e~~~l~~~~~h~~ 78 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLN 78 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHH-----HHHHHHHHHHHHHHCCCTT
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHH-----HHHHHHHHHHHHhhcCCCe
Confidence 34678899999999999999999999999874 25799999876443322 35667788877776 6899
Q ss_pred eeeeeEEEEeC-CeEEEEEecCCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 017994 118 IITFVAACKKP-PVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHR 182 (362)
Q Consensus 118 iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 182 (362)
|+.+++++..+ ..+++||||+++|+|.++++... ...+++..+..++.||+.||.|||++||+||
T Consensus 79 iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHr 158 (299)
T d1ywna1 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 158 (299)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence 99999988654 56899999999999999997542 1248899999999999999999999999999
Q ss_pred CCCCCcEEEcCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhC-CCCCC
Q 017994 183 DLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFD 258 (362)
Q Consensus 183 dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g-~~p~~ 258 (362)
||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++| .+||.
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 999999999999999999999997543322 23456799999999999999999999999999999999985 67898
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 259 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
+....+...........+..+..+++++.+||.+||+.||++|||+.|++++|+.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 239 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 8766666666666777888889999999999999999999999999999999998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-54 Score=388.89 Aligned_cols=264 Identities=28% Similarity=0.553 Sum_probs=226.8
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEECC---------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCC
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYKQ---------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHP 116 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp 116 (362)
...|+++.++|++++.||+|+||.||+|.+.+ ..||||+++....... ...+.+|...+.++ +||
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~e~~~l~~~~~Hp 79 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-----LSDLISEMEMMKMIGKHK 79 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHH-----HHHHHHHHHHHHHHCCCT
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHH-----HHHHHHHHHHHHHhcCCC
Confidence 34599999999999999999999999998742 3699999987554332 35678888888888 899
Q ss_pred ceeeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 017994 117 HIITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHR 182 (362)
Q Consensus 117 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 182 (362)
||+++++++.+++..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+||
T Consensus 80 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHr 159 (299)
T d1fgka_ 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 159 (299)
T ss_dssp TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEee
Confidence 999999999999999999999999999999976532 358999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCceEEeeeccccccccCC---CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCC
Q 017994 183 DLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFD 258 (362)
Q Consensus 183 dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~ 258 (362)
||||+|||++.++.+||+|||++....... ......+++.|+|||.+.++.++.++||||||+++|||++ |.+||.
T Consensus 160 DiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp CCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 999999999999999999999998655433 2344678999999999999999999999999999999998 799999
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 259 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
+.+..+....+ .....++.+..+++++.+||.+||+.||.+|||+.||++.|+.+.+
T Consensus 240 ~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 240 GVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp TCCHHHHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHH-HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 88887665544 4567788889999999999999999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.7e-54 Score=383.96 Aligned_cols=256 Identities=23% Similarity=0.396 Sum_probs=216.2
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC---
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP--- 129 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~--- 129 (362)
++|++.+.||+|+||.||+|.+. ++.||||++........ .....+.+|+.+++.++||||+++++++...+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCH---HHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 56999999999999999999986 88999999987543321 12467889999999999999999999987654
Q ss_pred -eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccccc
Q 017994 130 -VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 208 (362)
Q Consensus 130 -~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 208 (362)
..|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++..+++|||.+...
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred ceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 4899999999999999998776 5999999999999999999999999999999999999999999999999987643
Q ss_pred ccC----CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCCCC
Q 017994 209 SQC----GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTC 282 (362)
Q Consensus 209 ~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~ 282 (362)
... .......||+.|+|||++.+..++.++||||||+++|+|+||.+||.+.+..+....+......+ .....+
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 322 22345679999999999999999999999999999999999999999999888877776655443 234678
Q ss_pred CHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhh
Q 017994 283 PKAFSYLISRCWSSSPDRRP-HFDQIVSILEGYS 315 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rp-s~~ell~~L~~~~ 315 (362)
|+++.+||.+||+.||.+|| |++++++.|..+.
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 99999999999999999999 8999999887753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=386.85 Aligned_cols=257 Identities=27% Similarity=0.483 Sum_probs=214.7
Q ss_pred cccCeeeeeeecccCCeeEEEEEECC-----eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
+.++|++.+.||+|+||.||+|.+.+ ..||||++........ ...+.|.+|+.++++++||||++++|++.+
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP---EAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C---HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 45789999999999999999998742 3689999876433221 124678999999999999999999999976
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
+..++||||+++|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred -cchheeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhh
Confidence 467899999999999998876542 599999999999999999999999999999999999999999999999999986
Q ss_pred cccCCC----CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCC
Q 017994 208 ESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 282 (362)
Q Consensus 208 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (362)
...... .....++..|+|||++.+..++.++||||||+++|||+| |..||.+.+..+....+......++.+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccc
Confidence 544322 234457889999999999999999999999999999998 899999999999888888888888888999
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 017994 283 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 314 (362)
Q Consensus 283 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 314 (362)
|+.+.+||.+||+.||++|||+.+|.+.|...
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99999999999999999999999999988753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=393.46 Aligned_cols=248 Identities=16% Similarity=0.261 Sum_probs=220.8
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
+++|++++.||+|+||+||+|.++ ++.||||+++....+ ...+.+|+.+|++++||||+++++++.+++.+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-------~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVLVKKEISILNIARHRNILHLHESFESMEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-------HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-------HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 468999999999999999999986 789999999875433 24577899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCC--CceEEeeeccccccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED--MCVKVADFGISCLES 209 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~--~~~kl~Dfg~~~~~~ 209 (362)
|+|||||+||+|.+++...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999999999998654 358999999999999999999999999999999999999854 489999999998766
Q ss_pred cCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCCCCCHHHH
Q 017994 210 QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFS 287 (362)
Q Consensus 210 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 287 (362)
.........+++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+.......+ ....+|+++.
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 55555567789999999999999999999999999999999999999999998888887766544332 2246899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~ 309 (362)
+||.+||..||.+|||+.|+++
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=385.78 Aligned_cols=265 Identities=27% Similarity=0.507 Sum_probs=233.4
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCce
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHI 118 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~i 118 (362)
...|+++.++|++++.||+|+||.||+|++. ++.||||+++....... ...+.+|+.+++++ +||||
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~E~~~~~~l~~HpnI 89 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-----REALMSELKVLSYLGNHMNI 89 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTTB
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHH-----HHHHHHHHHHHHhccCCCCE
Confidence 4579999999999999999999999999863 36899999987544322 45788999999999 69999
Q ss_pred eeeeEEEEeCCeEEEEEecCCCCCHHHHHhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 017994 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP----------------YSVPLNLVLKLALDIARGMQYLHSQGILHR 182 (362)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 182 (362)
+++++++.+.+..++||||+++|+|.++++.... ..+++..+..++.||+.||.|||++|++||
T Consensus 90 v~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHr 169 (311)
T d1t46a_ 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169 (311)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 9999999999999999999999999999976431 258899999999999999999999999999
Q ss_pred CCCCCcEEEcCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCC
Q 017994 183 DLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFD 258 (362)
Q Consensus 183 dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~ 258 (362)
||||+||+++.++.++++|||.+........ .....||+.|+|||++.+..++.++||||||+++|||+| |.+||.
T Consensus 170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986543322 234678999999999999999999999999999999998 777787
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 259 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
.....+....+.....++..+..+|+.+.+||.+||+.||.+|||+.+|+++|+.+..
T Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 7777677777777888888889999999999999999999999999999999987654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.6e-54 Score=394.06 Aligned_cols=247 Identities=22% Similarity=0.308 Sum_probs=219.9
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|++++.||+|+||.||+|.++ ++.||||++....... ....+.+.+|+.+|+.++||||+++++++.+....
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK---LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC---HHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 468999999999999999999986 7899999986532111 11135678999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+.||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred ccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 99999999999999998876 599999999999999999999999999999999999999999999999999986544
Q ss_pred CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 291 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 291 (362)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... ....+..+++++.+||.
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHHH
T ss_pred -ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHHHHH
Confidence 334678999999999999999999999999999999999999999999888877777654 34567789999999999
Q ss_pred HhcccCCCCCC-----CHHHHHH
Q 017994 292 RCWSSSPDRRP-----HFDQIVS 309 (362)
Q Consensus 292 ~~l~~~p~~Rp-----s~~ell~ 309 (362)
+||+.||.+|+ +++++++
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHhhhCHHhccccccccHHHHHc
Confidence 99999999994 8999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-54 Score=388.54 Aligned_cols=260 Identities=29% Similarity=0.515 Sum_probs=224.0
Q ss_pred ccccCeeeeeeecccCCeeEEEEEEC--Ce--eEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC-CCCceeeeeEEEE
Q 017994 52 ADMSQLFIGCKFASGRHSRIYRGIYK--QR--DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL-NHPHIITFVAACK 126 (362)
Q Consensus 52 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~ 126 (362)
++.++|++.+.||+|+||.||+|.++ +. .||||.+........ .+.+.+|+.+|+++ +||||+++++++.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----HRDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHH-----HHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence 45688999999999999999999986 33 578888765333221 35788999999998 7999999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 192 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~ 192 (362)
+.+.+++||||+++|+|.++++... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 9999999999999999999997541 24699999999999999999999999999999999999999
Q ss_pred CCCceEEeeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhC-CCCCCCCCHHHHHHHHHh
Q 017994 193 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQ 271 (362)
Q Consensus 193 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g-~~p~~~~~~~~~~~~~~~ 271 (362)
.++.+||+|||++.............+|..|+|||.+.+..++.++||||||+++|||++| .+||.+.+..+....+.
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~- 240 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-
T ss_pred CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-
Confidence 9999999999999876665556667799999999999999999999999999999999995 56898888877766654
Q ss_pred cCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 272 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 272 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
...+++.+..+++++.+||.+||+.||++|||+.+|++.|+.+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 4567778889999999999999999999999999999999998764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-53 Score=394.23 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=210.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 131 (362)
.++|++.+.||+|+||.||+|.+. ++.||||++...................++.+++.++||||+++++++.+++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 568999999999999999999986 789999998653221111111112233457788888999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999999999998775 5899999999999999999999999999999999999999999999999999865543
Q ss_pred CCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCCCCCCCCCCCHHHHHH
Q 017994 212 GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-VCQKNARPPVPPTCPKAFSYL 289 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l 289 (362)
......||+.|+|||++.. ..++.++|||||||++|+|++|..||........... ..........+..+|+++.+|
T Consensus 161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (364)
T d1omwa3 161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 239 (364)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHH
T ss_pred -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHH
Confidence 3456689999999999964 5689999999999999999999999987544322211 122344556678899999999
Q ss_pred HHHhcccCCCCCCC-----HHHHHH
Q 017994 290 ISRCWSSSPDRRPH-----FDQIVS 309 (362)
Q Consensus 290 i~~~l~~~p~~Rps-----~~ell~ 309 (362)
|.+||+.||.+||| ++|+++
T Consensus 240 i~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 240 LEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHHcccCHHHhCCCcccCHHHHHc
Confidence 99999999999999 678875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=385.23 Aligned_cols=264 Identities=28% Similarity=0.524 Sum_probs=230.3
Q ss_pred cccccccccCeeeeeeecccCCeeEEEEEEC-------CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCcee
Q 017994 47 EEEWSADMSQLFIGCKFASGRHSRIYRGIYK-------QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHII 119 (362)
Q Consensus 47 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv 119 (362)
+++|+++.++|.+++.||+|+||.||+|.+. ++.||||+++....... ...|.+|+.++++++||||+
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~-----~~~~~~E~~il~~l~h~nIv 86 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-----RIEFLNEASVMKEFNCHHVV 86 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHH-----HHHHHHHHHHGGGCCCTTBC
T ss_pred ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHH-----HHHHHHHHHHHHHcCCCCEe
Confidence 3579999999999999999999999999875 36899999976443321 35688999999999999999
Q ss_pred eeeEEEEeCCeEEEEEecCCCCCHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 017994 120 TFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 191 (362)
Q Consensus 120 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~ 191 (362)
++++++..++..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 87 ~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 166 (308)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred eeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee
Confidence 99999999999999999999999999986421 1247889999999999999999999999999999999999
Q ss_pred cCCCceEEeeeccccccccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhC-CCCCCCCCHHHHHH
Q 017994 192 GEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAF 267 (362)
Q Consensus 192 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g-~~p~~~~~~~~~~~ 267 (362)
+.++++||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||+|| .+||.+.+..+...
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~ 246 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999975543322 3344689999999999999999999999999999999997 68899988888777
Q ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 268 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
.+.. ...++.+..+|+.+.++|.+||+.||++|||+.+|+++|+...+
T Consensus 247 ~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 247 FVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 6654 45677788999999999999999999999999999999987644
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=388.33 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=215.9
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHH-cCCCCceeeeeEEEEeCCeE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLF-RLNHPHIITFVAACKKPPVF 131 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~-~l~hp~iv~~~~~~~~~~~~ 131 (362)
++|++++.||+|+||+||+|.+. ++.||||+++...... ....+.+..|+.++. .++||||+++++++.+++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~---~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~ 78 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM---DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 78 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC---hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence 57999999999999999999996 7899999997532110 001244556666655 68999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 79 yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999999998776 5899999999999999999999999999999999999999999999999999755432
Q ss_pred -CCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Q 017994 212 -GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 290 (362)
Q Consensus 212 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 290 (362)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+... .+.+|..+|+++.+||
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli 234 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLL 234 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHH
Confidence 3344568999999999999999999999999999999999999999999988887777543 4567788999999999
Q ss_pred HHhcccCCCCCCCHH-HHHH
Q 017994 291 SRCWSSSPDRRPHFD-QIVS 309 (362)
Q Consensus 291 ~~~l~~~p~~Rps~~-ell~ 309 (362)
.+||+.||.+||++. ++++
T Consensus 235 ~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 235 VKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHSCSSGGGSBTTBSCGGG
T ss_pred HHhcccCCCCCcCHHHHHHh
Confidence 999999999999995 7764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=385.88 Aligned_cols=255 Identities=26% Similarity=0.541 Sum_probs=215.7
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--Ce----eEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QR----DVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK 127 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 127 (362)
.++|++.+.||+|+||+||+|.+. ++ .||||.+........ .+.+.+|+.++++++||||+++++++.+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-----NKEILDEAYVMASVDNPHVCRLLGICLT 82 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CT-----HHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 367999999999999999999986 32 589998875432221 4678999999999999999999999986
Q ss_pred CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 128 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 128 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
+ ..++++||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 83 ~-~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 83 S-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred C-CeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccccee
Confidence 5 5667889999999999887754 3699999999999999999999999999999999999999999999999999986
Q ss_pred cccCCC---CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCCC
Q 017994 208 ESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 283 (362)
Q Consensus 208 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (362)
...... .....||+.|+|||++.++.++.++||||||+++|||+| |.+||.+.+..+....+ ....+++.+..++
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~~p~~~~ 239 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICT 239 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-HHTCCCCCCTTBC
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCcccC
Confidence 543322 234468999999999999999999999999999999998 89999988776655444 4566778888999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 017994 284 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 316 (362)
Q Consensus 284 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 316 (362)
+.+.+|+.+||+.||.+|||+.||++.|..+..
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999999987754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=388.42 Aligned_cols=245 Identities=23% Similarity=0.370 Sum_probs=205.1
Q ss_pred ccCeeeee-eecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHc-CCCCceeeeeEEEEe--
Q 017994 54 MSQLFIGC-KFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFR-LNHPHIITFVAACKK-- 127 (362)
Q Consensus 54 ~~~~~~~~-~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~-l~hp~iv~~~~~~~~-- 127 (362)
.++|.+.. .||+|+||.||+|.+. ++.||||++... ..+.+|+.++.+ .+||||+++++++.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLY 78 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence 36798765 6999999999999986 789999998652 445679988765 489999999999875
Q ss_pred --CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCceEEeee
Q 017994 128 --PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADF 202 (362)
Q Consensus 128 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~---~~~~kl~Df 202 (362)
...+|+|||||+||+|.+++...+...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence 467899999999999999998766567999999999999999999999999999999999999975 567999999
Q ss_pred ccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCCC-
Q 017994 203 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN--ARPPVP- 279 (362)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~--~~~~~~- 279 (362)
|++.............||+.|+|||++.+..++.++|||||||++|+|+||.+||.+.+.......+.... ....++
T Consensus 159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred ceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 99987766666677889999999999999999999999999999999999999998765443333222211 111222
Q ss_pred ---CCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 280 ---PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 280 ---~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
..+|+++.+||.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 357889999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-52 Score=374.87 Aligned_cols=255 Identities=25% Similarity=0.490 Sum_probs=212.6
Q ss_pred eeeeeecccCCeeEEEEEECC-----eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe-CCeE
Q 017994 58 FIGCKFASGRHSRIYRGIYKQ-----RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK-PPVF 131 (362)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~~~ 131 (362)
.+.++||+|+||+||+|.+.. ..||||+++....... .+.|.+|+.++++++||||++++|++.. ++..
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 104 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 104 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHH-----HHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHH-----HHHHHHHHHHHHhCCCCCEeEEeEEEEecCCce
Confidence 346789999999999999852 3589999975433222 4678999999999999999999999865 5689
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 211 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (362)
++||||+++++|.+++..... .+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEEEEEeecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 999999999999999886553 6788899999999999999999999999999999999999999999999999865432
Q ss_pred CC-----CCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCCCCCCCHH
Q 017994 212 GS-----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM-TPEQAAFAVCQKNARPPVPPTCPKA 285 (362)
Q Consensus 212 ~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|..||... +..+....+ ....++..|..+++.
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i-~~g~~~~~p~~~~~~ 262 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPDP 262 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH-HTTCCCCCCTTCCHH
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCcccCcHH
Confidence 22 22356899999999999999999999999999999999966666543 333333443 345667788899999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 017994 286 FSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 319 (362)
Q Consensus 286 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~ 319 (362)
+.+||.+||+.||++||++.||++.|+.+.....
T Consensus 263 l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 263 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 9999999999999999999999999999876533
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=372.09 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=208.7
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||+|+||+||+|.+. ++.||||+++....... ..+.+.+|+.++++++||||+++++++.++..+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~ 77 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChH----HHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence 58999999999999999999996 78999999976432211 1367889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC- 211 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 211 (362)
+||||+. +++.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 78 LVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred EEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9999995 46666665555557999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccccChhhhhcCC-CCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-------------
Q 017994 212 GSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------- 277 (362)
Q Consensus 212 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 277 (362)
.......||+.|+|||++.... ++.++|+||||+++|+|++|+.||.+.+..+....+......+.
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 3445668999999999987665 58899999999999999999999999887776665543211110
Q ss_pred --------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 --------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 --------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
....+++++.+||.+||..||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 01356788999999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=376.05 Aligned_cols=248 Identities=22% Similarity=0.271 Sum_probs=203.0
Q ss_pred eeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEEEEe
Q 017994 59 IGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCIITE 136 (362)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 136 (362)
..+.||+|+||+||+|.+. ++.||||++........ .....+.+.+|+.++++++||||+++++++..++.+|+|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA-KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhh-hHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 3578999999999999986 78899999976433221 11123568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-CCCC
Q 017994 137 YLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-GSAK 215 (362)
Q Consensus 137 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 215 (362)
|+.++++..+..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~~~~~~~~~~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CCSEEHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hhcchHHhhhhhccc--CCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 998877776665443 5888999999999999999999999999999999999999999999999999765443 3345
Q ss_pred cccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-----------------
Q 017994 216 GFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP----------------- 277 (362)
Q Consensus 216 ~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~----------------- 277 (362)
..+||+.|+|||++... .++.++|||||||++|+|++|.+||.+.+..+....+......+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 56799999999998654 579999999999999999999999999888877666544211110
Q ss_pred ---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 ---------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
....+++++.+||.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 01356789999999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=374.39 Aligned_cols=244 Identities=25% Similarity=0.394 Sum_probs=204.3
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC--CCceeeeeEEEEeCCe
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN--HPHIITFVAACKKPPV 130 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--hp~iv~~~~~~~~~~~ 130 (362)
++|++++.||+|+||.||+|.+. ++.||||++................+.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999986 7899999987532111000000123567999999986 8999999999999999
Q ss_pred EEEEEecCCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-CCceEEeeecccccc
Q 017994 131 FCIITEYLAG-GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFGISCLE 208 (362)
Q Consensus 131 ~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~~ 208 (362)
.++||||+.+ +++.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999976 68888888765 6999999999999999999999999999999999999985 479999999999765
Q ss_pred ccCCCCCcccccccccChhhhhcCCC-CCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCCCCCHHHH
Q 017994 209 SQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 287 (362)
Q Consensus 209 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 287 (362)
.. .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .+. .....++..+|+++.
T Consensus 162 ~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~--~~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 162 KD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII--RGQVFFRQRVSSECQ 232 (273)
T ss_dssp CS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH--HCCCCCSSCCCHHHH
T ss_pred cc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHh--hcccCCCCCCCHHHH
Confidence 44 23456789999999999987664 678999999999999999999997632 122 234556788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 017994 288 YLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 288 ~li~~~l~~~p~~Rps~~ell~ 309 (362)
+||.+||+.||++|||+.|+++
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCCHhHCcCHHHHhc
Confidence 9999999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=371.53 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=207.5
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC---CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcC---CCCceeeeeEEEEe
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK---QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRL---NHPHIITFVAACKK 127 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~~ 127 (362)
-++|++.+.||+|+||+||+|.+. ++.||||++......... ...+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~ 81 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM----PLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC----BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH----HHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence 368999999999999999999984 567999998754322111 12345677766655 89999999999853
Q ss_pred -----CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 128 -----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 128 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
...++++|||+.++.+...... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 82 SRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccccCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecch
Confidence 3578999999987666544443 3347999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------
Q 017994 203 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------ 276 (362)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~------ 276 (362)
|++.............||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+....+......+
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 99887666566677889999999999999999999999999999999999999999988877766654321111
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 -------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.....+++.+.+||.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 134567889999999999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.9e-51 Score=365.66 Aligned_cols=249 Identities=18% Similarity=0.277 Sum_probs=207.6
Q ss_pred cCeeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~l 133 (362)
++|++.++||+|+||+||+|.++ ++.||||++......... .+.+.+|+.++++++||||+++++++..++..++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCC----CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHH----HHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence 58999999999999999999987 789999999775433221 3678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccC-C
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC-G 212 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 212 (362)
++||+.++.+..+..... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||.+...... .
T Consensus 78 ~~e~~~~~~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEECCSEEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEeehhhhHHHHHhhcC--CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 999997766666655443 6999999999999999999999999999999999999999999999999998765432 2
Q ss_pred CCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC---------------
Q 017994 213 SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--------------- 276 (362)
Q Consensus 213 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 276 (362)
......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||.+.+..+....+......+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 33455689999999998754 56999999999999999999999999988777666544321111
Q ss_pred ------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 ------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.....+++.+.+||.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 123557889999999999999999999999984
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-51 Score=367.43 Aligned_cols=253 Identities=28% Similarity=0.495 Sum_probs=202.8
Q ss_pred cCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC----e
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP----V 130 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~----~ 130 (362)
.+|.+.+.||+|+||.||+|+++++.||||+++..... ......|+..+.+++||||+++++++.+++ .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~-------~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-------SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHH-------HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-------HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 46899999999999999999999999999998653221 122334666667889999999999997654 6
Q ss_pred EEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCccccCCCCCcEEEcCCCceEEeee
Q 017994 131 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS--------QGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 131 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--------~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
+++||||+++|+|.+++++. .+++..++.++.|++.||.|||+ +||+||||||+||||+.++.+||+||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 89999999999999999875 48999999999999999999996 59999999999999999999999999
Q ss_pred ccccccccCC-----CCCcccccccccChhhhhcCC------CCCcccchhhhHHHHHHHhCCCCCCCC-----------
Q 017994 203 GISCLESQCG-----SAKGFTGTYRWMAPEMIKEKR------HTKKVDVYSFGIVLWELLTALTPFDNM----------- 260 (362)
Q Consensus 203 g~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~------~~~~~Dv~slG~~l~ell~g~~p~~~~----------- 260 (362)
|++....... ......||+.|+|||++.+.. ++.++||||||+++|||+||..||...
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 9987654332 234567999999999987643 567899999999999999998776321
Q ss_pred ----CHHHHHHHHHhcCCCCCCCCCC-----CHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 261 ----TPEQAAFAVCQKNARPPVPPTC-----PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 261 ----~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
..............++..+... +..+.+|+.+||+.||.+|||+.||++.|+.+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 2223333333344444444332 24589999999999999999999999999987653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=365.52 Aligned_cols=252 Identities=22% Similarity=0.368 Sum_probs=206.0
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
..|++ .++|++.+.||+|+||+||+|.+. ++.||||+++....... ..+.+.+|+.+|++++|||||++++++
T Consensus 12 ~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~Ei~il~~l~hpniv~l~~~~ 86 (346)
T d1cm8a_ 12 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMRHENVIGLLDVF 86 (346)
T ss_dssp SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred ceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChH----HHHHHHHHHHHHHhcCCCCeeEEEEEe
Confidence 34555 478999999999999999999986 78999999986543322 246788999999999999999999999
Q ss_pred EeCC------eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEE
Q 017994 126 KKPP------VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 199 (362)
Q Consensus 126 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl 199 (362)
...+ .+|+||||+ +.+|..+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+|+
T Consensus 87 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl 162 (346)
T d1cm8a_ 87 TPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKI 162 (346)
T ss_dssp CSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred ccCccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccc
Confidence 7654 579999999 77888887764 4999999999999999999999999999999999999999999999
Q ss_pred eeeccccccccCCCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--
Q 017994 200 ADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-- 276 (362)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-- 276 (362)
+|||++..... ......+|+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..............+
T Consensus 163 ~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 163 LDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp CCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence 99999976544 34567799999999998764 57999999999999999999999999887665544333211111
Q ss_pred ---------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 277 ---------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 277 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
.....+++.+.+||.+||..||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1235678899999999999999999999999973
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.1e-49 Score=352.93 Aligned_cols=257 Identities=19% Similarity=0.286 Sum_probs=213.7
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC-CceeeeeEEEEeCCeE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-PHIITFVAACKKPPVF 131 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-p~iv~~~~~~~~~~~~ 131 (362)
++|++++.||+|+||+||+|++. ++.||||++...... ..+.+|++.++.+.| +|++.+++++......
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 57999999999999999999986 789999998765433 345678899999865 8999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC-----CCceEEeeecccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-----DMCVKVADFGISC 206 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~-----~~~~kl~Dfg~~~ 206 (362)
++||||+ +++|.+++.... ..++...+..++.|++.||+|||++||+||||||+|||++. ++.++|+|||+++
T Consensus 77 ~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 9999999 789999997655 36899999999999999999999999999999999999964 5789999999997
Q ss_pred ccccCC--------CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHhc---
Q 017994 207 LESQCG--------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP---EQAAFAVCQK--- 272 (362)
Q Consensus 207 ~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~---~~~~~~~~~~--- 272 (362)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 643321 23356799999999999999999999999999999999999999976433 2222222211
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCC
Q 017994 273 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 321 (362)
Q Consensus 273 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~l~~~ 321 (362)
.........+|+++.+++..|++.+|++||+++.+.+.|+.+.+.....
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 1112234678899999999999999999999999999998877665433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=362.05 Aligned_cols=247 Identities=24% Similarity=0.353 Sum_probs=200.8
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCC---
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPP--- 129 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~--- 129 (362)
++|++++.||+|+||+||+|.++ ++.||||++....... ..+.+.+|+.+|++++||||+++++++..+.
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT-----YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHH-----HHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChH-----HHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 56999999999999999999986 8899999997654322 1357889999999999999999999986653
Q ss_pred --eEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccc
Q 017994 130 --VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 207 (362)
Q Consensus 130 --~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 207 (362)
..+++ +|+.+++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~~~~l~-~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 83 MKDVYLV-THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp CCCEEEE-EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEE-EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 34555 556699999999865 489999999999999999999999999999999999999999999999999875
Q ss_pred cccCC----CCCcccccccccChhhhh-cCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------
Q 017994 208 ESQCG----SAKGFTGTYRWMAPEMIK-EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------ 276 (362)
Q Consensus 208 ~~~~~----~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~------ 276 (362)
..... ......||+.|+|||++. +..++.++||||+|+++|+|++|..||...+..+...........+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 43322 234567899999999984 4567899999999999999999999999877655444332211111
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 277 -----------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 277 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
...+.+++++.+|+.+||+.||.+|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0124567889999999999999999999999863
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.2e-49 Score=354.64 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=204.8
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCce-eeeeEEEEeCCeE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI-ITFVAACKKPPVF 131 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~ 131 (362)
++|++++.||+|+||.||+|.+. ++.||||++...... ..+..|+++++.++|+++ +.+.+++...+..
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--------HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 46999999999999999999986 789999998875443 346789999999987665 5556666888899
Q ss_pred EEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcC---CCceEEeeecccccc
Q 017994 132 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCVKVADFGISCLE 208 (362)
Q Consensus 132 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~---~~~~kl~Dfg~~~~~ 208 (362)
++||||+ +++|.+.+.... ..+++..+..++.|++.||+|||++||+||||||+|||++. +..++|+|||++...
T Consensus 79 ~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 9999999 667877776544 36999999999999999999999999999999999999863 457999999999865
Q ss_pred ccCC--------CCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHH---h---cCC
Q 017994 209 SQCG--------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC---Q---KNA 274 (362)
Q Consensus 209 ~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~---~---~~~ 274 (362)
.... ......||+.|+|||++.+..++.++||||||+++|||++|..||............. . ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 4322 2235579999999999999999999999999999999999999998766544322211 1 111
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 017994 275 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 317 (362)
Q Consensus 275 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 317 (362)
.......+|+++.+|+.+||+.+|++||++.+|.+.|+.+...
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 1223467899999999999999999999999999999876543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=362.18 Aligned_cols=244 Identities=24% Similarity=0.299 Sum_probs=202.6
Q ss_pred CeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeC-----
Q 017994 56 QLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKP----- 128 (362)
Q Consensus 56 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~----- 128 (362)
+|...++||+|+||+||+|++. ++.||||++...... ..+|+.+|++++||||+++++++...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----------HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 6999999999999999999996 789999999875432 23699999999999999999998543
Q ss_pred -CeEEEEEecCCCCCHHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-ceEEeeeccc
Q 017994 129 -PVFCIITEYLAGGSLRKYLH-QQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGIS 205 (362)
Q Consensus 129 -~~~~lv~e~~~~~~L~~~l~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg~~ 205 (362)
..+++||||++++.+..+.. ......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccch
Confidence 35899999997654443332 12334699999999999999999999999999999999999999775 8999999999
Q ss_pred cccccCCCCCcccccccccChhhhhc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------
Q 017994 206 CLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-------- 276 (362)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-------- 276 (362)
.............|++.|+|||.+.+ ..++.++||||+||++|||++|..||...+..+....+......+
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred hhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 87766666667789999999998865 468999999999999999999999999888776655543311100
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 -------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
.....+++++.+||.+||..||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112457889999999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=356.08 Aligned_cols=251 Identities=19% Similarity=0.281 Sum_probs=201.3
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe---
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK--- 127 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--- 127 (362)
+.++|++.++||+|+||+||+|++. ++.||||++......... ...+.+|+.+|++++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~E~~il~~l~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF----PITALREIKILQLLKHENVVNLIEICRTKAS 83 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSS----CHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHH----HHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence 4689999999999999999999986 789999998765433211 3567789999999999999999998855
Q ss_pred -----CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeee
Q 017994 128 -----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 202 (362)
Q Consensus 128 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Df 202 (362)
+..+++||||+.++.+..+..... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHTCTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred cccccCceEEEEEeccCCCccchhhhccc--ccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeec
Confidence 346899999997766655444333 6899999999999999999999999999999999999999999999999
Q ss_pred ccccccccC-----CCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Q 017994 203 GISCLESQC-----GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 276 (362)
Q Consensus 203 g~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 276 (362)
|++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999654322 223446799999999998765 68999999999999999999999999888777665544322211
Q ss_pred CCC--C----------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 277 PVP--P----------------------------TCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 277 ~~~--~----------------------------~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
... . ..++.+.+||.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 100 0 12557789999999999999999999984
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-48 Score=356.21 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=206.1
Q ss_pred ccccccccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEE
Q 017994 48 EEWSADMSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAAC 125 (362)
Q Consensus 48 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~ 125 (362)
..|++ .++|++.+.||+|+||+||+|.+. ++.||||++.....+... .+.+.+|+.+|++++||||+++++++
T Consensus 12 ~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~Ei~il~~l~h~~iv~~~~~~ 86 (348)
T d2gfsa1 12 TIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH----AKRTYRELRLLKHMKHENVIGLLDVF 86 (348)
T ss_dssp SEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHH----HHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 34554 478999999999999999999986 889999999876544322 35678999999999999999999998
Q ss_pred EeC-----CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEe
Q 017994 126 KKP-----PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 200 (362)
Q Consensus 126 ~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~ 200 (362)
... ...+++++|+.||+|.+++..+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|++
T Consensus 87 ~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~ 163 (348)
T d2gfsa1 87 TPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 163 (348)
T ss_dssp CSCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eeccccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccccc
Confidence 533 3345666777899999999764 59999999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--
Q 017994 201 DFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-- 277 (362)
Q Consensus 201 Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-- 277 (362)
|||++..... ......|++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+.......+......+.
T Consensus 164 dfg~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 164 DFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp CC----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccchhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 9999875443 34456789999999987665 468999999999999999999999998877666555443222211
Q ss_pred ---------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 278 ---------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 278 ---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
....+++++.+||.+||..||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 12357889999999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=347.67 Aligned_cols=249 Identities=18% Similarity=0.266 Sum_probs=208.7
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEeCCeEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKKPPVFC 132 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 132 (362)
++|++.+.||+|+||+||+|.+. ++.||||+++....... ....+.+|+.+++.++||||+++++++.+....+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT----HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChH----HHHHHHHHHHHHHhcCcCCEEeecccccccccee
Confidence 57999999999999999999996 67899999977544322 2467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeeccccccccCC
Q 017994 133 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 212 (362)
Q Consensus 133 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (362)
+|++++.+++|..++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.+.......
T Consensus 78 iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred EEeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999999999988887654 68999999999999999999999999999999999999999999999999998655433
Q ss_pred -CCCcccccccccChhhhhcCC-CCCcccchhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHhcCCC--------------
Q 017994 213 -SAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPF-DNMTPEQAAFAVCQKNAR-------------- 275 (362)
Q Consensus 213 -~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~l~ell~g~~p~-~~~~~~~~~~~~~~~~~~-------------- 275 (362)
......+++.|+|||++.... ++.++|||||||++|+|++|..|| .+.+..+....+......
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 334556788899999987665 699999999999999999998885 444555444443321111
Q ss_pred -------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 276 -------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 276 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
......+++.+.+||.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1133456789999999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=359.21 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=209.1
Q ss_pred cccCeeeeeeecccCCeeEEEEEEC-----CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC-CceeeeeEEEE
Q 017994 53 DMSQLFIGCKFASGRHSRIYRGIYK-----QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH-PHIITFVAACK 126 (362)
Q Consensus 53 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-p~iv~~~~~~~ 126 (362)
..++|++++.||+|+||+||+|.+. ++.||||++......... ...+.+.+|+.++++++| |||+++++++.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~--~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE--SSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch--HHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 4578999999999999999999872 578999998753211000 002456789999999976 89999999999
Q ss_pred eCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 127 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 127 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
+....+++|||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred cCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999999998876 57889999999999999999999999999999999999999999999999997
Q ss_pred ccccC--CCCCcccccccccChhhhhcC--CCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCCCCCCC
Q 017994 207 LESQC--GSAKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ--KNARPPVPP 280 (362)
Q Consensus 207 ~~~~~--~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~ 280 (362)
..... .......|++.|+|||.+.+. .++.++|||||||++|+|++|..||......+....+.. ....++.+.
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 54332 234556799999999999764 468899999999999999999999977654333222222 233456678
Q ss_pred CCCHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 017994 281 TCPKAFSYLISRCWSSSPDRRPH-----FDQIVS 309 (362)
Q Consensus 281 ~~~~~l~~li~~~l~~~p~~Rps-----~~ell~ 309 (362)
.+++.+.+||.+||+.||++||| ++|+++
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 89999999999999999999995 778875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.4e-48 Score=352.12 Aligned_cols=242 Identities=16% Similarity=0.278 Sum_probs=200.9
Q ss_pred ccCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEe--C
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKK--P 128 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~--~ 128 (362)
.++|+++++||+|+||+||+|.+. ++.||||++.... .+.+.+|+.+|+.+. ||||+++++++.. .
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---------KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 468999999999999999999986 7899999997543 256788999999995 9999999999974 4
Q ss_pred CeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCC-ceEEeeeccccc
Q 017994 129 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGISCL 207 (362)
Q Consensus 129 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg~~~~ 207 (362)
..+++||||+.+++|..+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||++..
T Consensus 105 ~~~~~v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp CSEEEEEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred CceeEEEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence 57999999999999976532 589999999999999999999999999999999999998655 699999999987
Q ss_pred cccCCCCCcccccccccChhhhhcC-CCCCcccchhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHh-------------c
Q 017994 208 ESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQ-------------K 272 (362)
Q Consensus 208 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~-~~~~~~~-------------~ 272 (362)
...........+|+.|+|||.+.+. .++.++|+||+|+++|+|++|..||....... ....+.. .
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred ccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 7665666677899999999998765 47999999999999999999999997654322 1111110 0
Q ss_pred C----------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Q 017994 273 N----------------------ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 309 (362)
Q Consensus 273 ~----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 309 (362)
. ........+++++.+||.+||..||.+|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 011122346789999999999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=355.78 Aligned_cols=247 Identities=22% Similarity=0.289 Sum_probs=193.7
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCceeeeeEEEEe-----
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHIITFVAACKK----- 127 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----- 127 (362)
.+|++.++||+|+||+||+|.+. ++.||||++......... ...+.+|+.++++++||||+++++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHH----HHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence 57999999999999999999997 899999999876543221 3568899999999999999999999953
Q ss_pred -CCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 128 -PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 128 -~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
...+|+||||+.++ +.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||++.
T Consensus 93 ~~~~~~iv~Ey~~~~-l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 93 EFQDVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp TCCEEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cCceeEEEEeccchH-HHHhhhc----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence 46899999999664 5444432 58999999999999999999999999999999999999999999999999988
Q ss_pred ccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------
Q 017994 207 LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP---------- 276 (362)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~---------- 276 (362)
............+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+......+
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 7766666677789999999999999999999999999999999999999998877665544433211110
Q ss_pred ----------CC--------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 017994 277 ----------PV--------------------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 310 (362)
Q Consensus 277 ----------~~--------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 310 (362)
.. ....++++.+||.+||..||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 01124578899999999999999999999853
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-41 Score=313.95 Aligned_cols=246 Identities=21% Similarity=0.323 Sum_probs=187.6
Q ss_pred cCeeeeeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-----------CCceeee
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-----------HPHIITF 121 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------hp~iv~~ 121 (362)
++|+++++||+|+||+||+|++. ++.||||+++..... .+.+.+|+.+++.++ |+||+++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~-------~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-------TEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH-------HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc-------hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 46999999999999999999985 799999999764322 355677888887774 5789999
Q ss_pred eEEEEe--CCeEEEEEecCCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEcCCC--
Q 017994 122 VAACKK--PPVFCIITEYLAGG-SLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDM-- 195 (362)
Q Consensus 122 ~~~~~~--~~~~~lv~e~~~~~-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dlk~~Nil~~~~~-- 195 (362)
++++.. ....+++++++..+ .............+++..+..++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 988754 35566666655443 44444555555578999999999999999999998 8999999999999998665
Q ss_pred ----ceEEeeeccccccccCCCCCcccccccccChhhhhcCCCCCcccchhhhHHHHHHHhCCCCCCCCCHH------HH
Q 017994 196 ----CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE------QA 265 (362)
Q Consensus 196 ----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~ell~g~~p~~~~~~~------~~ 265 (362)
.++++|||.+..... ......||+.|+|||++.+..++.++|+||+|+++++|++|+.||...... ..
T Consensus 166 ~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 399999999875443 345667999999999999999999999999999999999999999754321 11
Q ss_pred HHHHHhcCC----------------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 017994 266 AFAVCQKNA----------------------------------------RPPVPPTCPKAFSYLISRCWSSSPDRRPHFD 305 (362)
Q Consensus 266 ~~~~~~~~~----------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 305 (362)
......... ....+...++.+.+||.+||..||.+|||+.
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 111100000 0011223456789999999999999999999
Q ss_pred HHHH
Q 017994 306 QIVS 309 (362)
Q Consensus 306 ell~ 309 (362)
|+++
T Consensus 324 e~L~ 327 (362)
T d1q8ya_ 324 GLVN 327 (362)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.3e-26 Score=194.19 Aligned_cols=170 Identities=16% Similarity=0.138 Sum_probs=122.4
Q ss_pred eeeeeeecccCCeeEEEEEEC-CeeEEEEEecCCCcc------------hHHHHHHHHHHHHHHHHHHcCCCCceeeeeE
Q 017994 57 LFIGCKFASGRHSRIYRGIYK-QRDVAIKLVSQPEED------------ASLASMLEKQFTSEVALLFRLNHPHIITFVA 123 (362)
Q Consensus 57 ~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~------------~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~ 123 (362)
+.++++||+|+||+||+|.+. ++.||||+++..... .............|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 457899999999999999975 789999987643211 0111223345567899999999999998876
Q ss_pred EEEeCCeEEEEEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcCCCceEEeeec
Q 017994 124 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 203 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 203 (362)
+. ..+++|||+++..+.+ ++...+..++.|++.+|.|||++||+||||||+|||+++++ ++|+|||
T Consensus 82 ~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG 147 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFP 147 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCT
T ss_pred ec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECC
Confidence 53 2369999998765432 34455678999999999999999999999999999998765 8999999
Q ss_pred cccccccCCCCCcccccccccCh--h---hhhcCCCCCcccchhhhHHH
Q 017994 204 ISCLESQCGSAKGFTGTYRWMAP--E---MIKEKRHTKKVDVYSFGIVL 247 (362)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~aP--E---~~~~~~~~~~~Dv~slG~~l 247 (362)
.+........ ..|... + .+..+.|+.++|+||+.--+
T Consensus 148 ~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGW-------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 8865433211 111111 1 01235678899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.76 E-value=2.6e-08 Score=85.33 Aligned_cols=139 Identities=12% Similarity=0.115 Sum_probs=93.5
Q ss_pred cCeeeeeeecccCCeeEEEEEECCeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeEEEEeCCeEEE
Q 017994 55 SQLFIGCKFASGRHSRIYRGIYKQRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVAACKKPPVFCI 133 (362)
Q Consensus 55 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~l 133 (362)
+.|++.+..+.++.+.||+....+..++||+........ ...+.+|...+..+. +=-+.+++.+...++..++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc------hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 456666655555557899998788888999876543221 123556787777663 3335678888888999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 017994 134 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS------------------------------------- 176 (362)
Q Consensus 134 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~------------------------------------- 176 (362)
||++++|.++.+...... ....++.++...+..||+
T Consensus 88 v~~~l~G~~~~~~~~~~~-------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDEQ-------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHTTTCS-------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEecccccccccccccc-------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 999999988865432211 112233344444444441
Q ss_pred ----------------C------CccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 177 ----------------Q------GILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 177 ----------------~------~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
. .++|+|+.|.||++++++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 27899999999999987767799999764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.35 E-value=1.1e-06 Score=74.36 Aligned_cols=73 Identities=12% Similarity=0.083 Sum_probs=50.1
Q ss_pred eecccCC-eeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCC--CceeeeeEEEEeCCeEEEEEec
Q 017994 62 KFASGRH-SRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNH--PHIITFVAACKKPPVFCIITEY 137 (362)
Q Consensus 62 ~lg~G~~-g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--p~iv~~~~~~~~~~~~~lv~e~ 137 (362)
.+..|.. +.||+.... +..+++|........ .+..|...++.+.. -.+.+++.+..+++..++||++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence 3445554 679999886 456788986654322 34557777666532 2356778888888899999999
Q ss_pred CCCCCH
Q 017994 138 LAGGSL 143 (362)
Q Consensus 138 ~~~~~L 143 (362)
++|.++
T Consensus 88 i~G~~~ 93 (255)
T d1nd4a_ 88 VPGQDL 93 (255)
T ss_dssp CSSEET
T ss_pred eecccc
Confidence 988665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.93 E-value=2.8e-05 Score=70.14 Aligned_cols=82 Identities=11% Similarity=0.054 Sum_probs=46.2
Q ss_pred eeeecccCCeeEEEEEEC--CeeEEEEEecCCCcchH-HHHHHHHHHHHHHHHHHcCC--C-CceeeeeEEEEeCCeEEE
Q 017994 60 GCKFASGRHSRIYRGIYK--QRDVAIKLVSQPEEDAS-LASMLEKQFTSEVALLFRLN--H-PHIITFVAACKKPPVFCI 133 (362)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~--h-p~iv~~~~~~~~~~~~~l 133 (362)
.+.||.|....||+.... ++.++||.-........ .......+...|...|..+. - ..+++++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 346899999999999765 56789996543100000 00000123345777676552 2 345555544 4455678
Q ss_pred EEecCCCCCH
Q 017994 134 ITEYLAGGSL 143 (362)
Q Consensus 134 v~e~~~~~~L 143 (362)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.40 E-value=0.00024 Score=63.77 Aligned_cols=77 Identities=14% Similarity=0.257 Sum_probs=49.7
Q ss_pred ccCeeeeeeecccCCeeEEEEEECC---------eeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCC-CCceeeeeE
Q 017994 54 MSQLFIGCKFASGRHSRIYRGIYKQ---------RDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLN-HPHIITFVA 123 (362)
Q Consensus 54 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~ 123 (362)
.+++++ +.|+.|-.-.+|+....+ +.|.+++.-..... ....+|..+++.+. +.-..++++
T Consensus 42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~--------idr~~E~~i~~~ls~~gl~Pkll~ 112 (395)
T d1nw1a_ 42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE--------SHLVAESVIFTLLSERHLGPKLYG 112 (395)
T ss_dssp GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH--------HHHHHHHHHHHHHHHTTSSSCEEE
T ss_pred ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh--------hHHHHHHHHHHHHHhCCCCCeEEE
Confidence 345554 468888888999998652 45777776532221 22346888888774 433457777
Q ss_pred EEEeCCeEEEEEecCCCCCH
Q 017994 124 ACKKPPVFCIITEYLAGGSL 143 (362)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~~L 143 (362)
++.+ ++|+||++|.+|
T Consensus 113 ~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 113 IFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp EETT----EEEECCCCEEEC
T ss_pred EcCC----ceEEEEeccccC
Confidence 7643 588999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.26 E-value=0.00029 Score=61.50 Aligned_cols=67 Identities=13% Similarity=0.248 Sum_probs=42.7
Q ss_pred CeeEEEEEEC-CeeEEEEEecCCCcchHHHHHHHHHHHHHHHHHHcCCCCce-----eee--eEEEEeCCeEEEEEecCC
Q 017994 68 HSRIYRGIYK-QRDVAIKLVSQPEEDASLASMLEKQFTSEVALLFRLNHPHI-----ITF--VAACKKPPVFCIITEYLA 139 (362)
Q Consensus 68 ~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-----v~~--~~~~~~~~~~~lv~e~~~ 139 (362)
.-.||++... |+.+++|+.+...-. .+++..|...+..|...++ +.. -..+...+..+.+++++.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s-------~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWT-------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSC-------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCC-------HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 4679999875 778999998764332 2456667777776632111 111 113345677889999987
Q ss_pred CC
Q 017994 140 GG 141 (362)
Q Consensus 140 ~~ 141 (362)
|.
T Consensus 108 G~ 109 (325)
T d1zyla1 108 GR 109 (325)
T ss_dssp CE
T ss_pred Cc
Confidence 63
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.17 E-value=0.0009 Score=57.80 Aligned_cols=30 Identities=30% Similarity=0.576 Sum_probs=27.0
Q ss_pred CCccccCCCCCcEEEcCCCceEEeeecccc
Q 017994 177 QGILHRDLKSENLLLGEDMCVKVADFGISC 206 (362)
Q Consensus 177 ~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 206 (362)
.|+||+|+.++||+++.+...-|+||+.++
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 379999999999999988878999999874
|